1	GASTROENTEROLOGY	NN	O	gastroenterology	_	0	SENT_1	[p1l1507t81r1819b104],
2	2009	CD	DATE	2009	num	1	SENT_1	[p1l1831t81r2154b109],
3	;	:	O	;	_	0	SENT_1	[p1l1831t81r2154b109],
4	136:2127	CD	DURATION	136:2127	number	5	SENT_1	[p1l1831t81r2154b109],
5	-2136	CD	DURATION	-2136	dep	1	SENT_1	[p1l1831t81r2154b109],

1	Cytochrome	NN	O	cytochrome	nn	4	SENT_2	[p1l6t184r343b238],
2	P450	NN	O	p450	nn	4	SENT_2	[p1l364t185r501b228],
3	2C9	NN	O	2c9	nn	4	SENT_2	[p1l518t184r628b228],
4	Variants	NNS	O	variant	_	0	SENT_2	[p1l647t185r874b228],
5	Influence	NN	O	influence	nn	6	SENT_2	[p1l899t185r1151b228],
6	Response	NN	O	response	dep	4	SENT_2	[p1l1175t185r1448b238],
7	to	TO	O	to	_	0	SENT_2	[p1l1469t187r1523b228],
8	Celecoxib	NNP	O	Celecoxib	prep_to	6	SENT_2	[p1l1546t184r1819b228],
9	for	IN	O	for	_	0	SENT_2	[p1l1840t185r1918b228],
10	Prevention	NNP	O	Prevention	prep_for	8	SENT_2	[p1l6t251r299b294],
11	of	IN	O	of	_	0	SENT_2	[p1l323t251r376b294],
12	Colorectal	JJ	O	colorectal	amod	13	SENT_2	[p1l398t250r681b294],
13	Adenoma	NN	O	adenoma	prep_of	10	SENT_2	[p1l703t251r967b294],

1	ANDREW	NNP	PERSON	ANDREW	nn	3	SENT_3	[p1l6t428r154b454],
2	T.	NNP	PERSON	T.	nn	3	SENT_3	[p1l169t428r196b454],
3	CHAN	NNP	PERSON	CHAN	_	0	SENT_3	[p1l215t423r355b459],
4	,	,	O	,	_	0	SENT_3	[p1l215t423r355b459],
5	”	CD	NUMBER	”	num	8	SENT_3	[p1l215t423r355b459],
6	ANN	NNP	PERSON	ANN	nn	8	SENT_3	[p1l371t428r441b454],
7	G.	NNP	PERSON	G.	nn	8	SENT_3	[p1l459t428r491b455],
8	ZAUBER	NNP	PERSON	ZAUBER	appos	3	SENT_3	[p1l509t423r668b459],
9	,	,	O	,	_	0	SENT_3	[p1l509t423r668b459],
10	§	CD	NUMBER	§	num	12	SENT_3	[p1l509t423r668b459],
11	MEIER	NNP	PERSON	MEIER	nn	12	SENT_3	[p1l686t428r786b454],
12	HSU	NNP	O	HSU	appos	3	SENT_3	[p1l804t423r898b459],
13	,	,	O	,	_	0	SENT_3	[p1l804t423r898b459],
14	§	CD	NUMBER	§	num	16	SENT_3	[p1l804t423r898b459],
15	AURORA	NNP	ORGANIZATION	AURORA	nn	16	SENT_3	[p1l913t428r1056b455],
16	BREAzNA	NNP	O	BREAzNA	appos	3	SENT_3	[p1l1073t421r1247b459],
17	,	,	O	,	_	0	SENT_3	[p1l1073t421r1247b459],
18	“	CD	NUMBER	“	appos	3	SENT_3	[p1l1073t421r1247b459],
19	DAVID	NNP	O	DAVID	nn	21	SENT_3	[p1l1265t428r1361b454],
20	J.	NNP	O	J.	nn	21	SENT_3	[p1l1378t428r1402b455],
21	I	NNP	O	I	dep	18	SENT_3	[p1l1422t423r1606b459],
22	.	.	O	.	_	0	SENT_3	[p1l1422t423r1606b459],

1	—	NN	O	—	_	0	SENT_4	[p1l1422t423r1606b459],
2	.	.	O	.	_	0	SENT_4	[p1l1422t423r1606b459],

1	IIJNTER	NNP	LOCATION	IIJNTER	nsubj	24	SENT_5	[p1l1422t423r1606b459],
2	,	,	O	,	_	0	SENT_5	[p1l1422t423r1606b459],
3	W	NNP	O	W	nn	6	SENT_5	[p1l1422t423r1606b459],
4	REBECCA	NNP	PERSON	REBECCA	nn	6	SENT_5	[p1l9t471r168b498],
5	B.	NNP	PERSON	B.	nn	6	SENT_5	[p1l185t472r213b497],
6	RosENsTEIN	NNP	PERSON	RosENsTEIN	appos	1	SENT_5	[p1l233t464r463b502],
7	,	,	O	,	_	0	SENT_5	[p1l233t464r463b502],
8	“	CD	NUMBER	“	num	11	SENT_5	[p1l233t464r463b502],
9	CRAIG	NNP	O	CRAIG	nn	11	SENT_5	[p1l480t471r582b498],
10	J.	NNP	O	J.	nn	11	SENT_5	[p1l599t472r623b498],
11	EAGLE	NNP	O	EAGLE	appos	1	SENT_5	[p1l643t464r768b502],
12	,	,	O	,	_	0	SENT_5	[p1l643t464r768b502],
13	”	CD	NUMBER	”	num	16	SENT_5	[p1l643t464r768b502],
14	ERNEST	NNP	PERSON	ERNEST	nn	16	SENT_5	[p1l787t471r917b498],
15	T.	NNP	PERSON	T.	nn	16	SENT_5	[p1l931t472r958b497],
16	HAwI	NNP	PERSON	HAwI	conj_and	6	SENT_5	[p1l978t467r1103b502],
17	<	JJR	PERSON	<	dep	16	SENT_5	[p1l978t467r1103b502],
18	,	,	O	,	_	0	SENT_5	[p1l978t467r1103b502],
19	#	#	O	#	advmod	16	SENT_5	[p1l978t467r1103b502],
20	and	CC	O	and	_	0	SENT_5	[p1l1119t472r1174b498],
21	MONICA	NNP	PERSON	MONICA	nn	23	SENT_5	[p1l1193t471r1327b498],
22	M.	NNP	PERSON	M.	nn	23	SENT_5	[p1l1344t472r1378b497],
23	BERTAGNOLL	NNP	PERSON	BERTAGNOLL	appos	1	SENT_5	[p1l1398t471r1654b498],
24	|	VBD	O	|	_	0	SENT_5	[p1l1398t471r1654b498],
25	**	CD	NUMBER	**	dobj	24	SENT_5	[p1l1398t471r1654b498],

1	CLINICALALIMENTARY	NN	O	clinicalalimentary	nn	2	SENT_6	[p1l2057t440r2078b581, p1l2093t467r2113b652],
2	TRACT	NN	O	tract	_	0	SENT_6	[p1l2092t370r2114b457],

1	*	NN	O	*	nn	3	SENT_7	[p1l8t540r200b561],
2	Gastrointestinal	JJ	O	gastrointestinal	amod	3	SENT_7	[p1l8t540r200b561],
3	Unit	NN	O	unit	_	0	SENT_7	[p1l208t540r258b564],
4	,	,	O	,	_	0	SENT_7	[p1l208t540r258b564],
5	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	7	SENT_7	[p1l270t540r448b561],
6	General	NNP	ORGANIZATION	General	nn	7	SENT_7	[p1l458t540r550b561],
7	Hospital	NNP	ORGANIZATION	Hospital	appos	3	SENT_7	[p1l557t540r654b566],
8	and	CC	O	and	_	0	SENT_7	[p1l660t540r706b561],
9	Harvard	NNP	ORGANIZATION	Harvard	nn	11	SENT_7	[p1l713t540r808b561],
10	Medical	NNP	ORGANIZATION	Medical	nn	11	SENT_7	[p1l815t540r908b561],
11	School	NNP	ORGANIZATION	School	conj_and	7	SENT_7	[p1l915t540r1001b564],
12	,	,	O	,	_	0	SENT_7	[p1l915t540r1001b564],
13	Boston	NNP	LOCATION	Boston	appos	3	SENT_7	[p1l1013t540r1102b564],
14	,	,	O	,	_	0	SENT_7	[p1l1013t540r1102b564],
15	Massachusetts	NNP	LOCATION	Massachusetts	appos	3	SENT_7	[p1l1113t540r1299b564],
16	;	:	O	;	_	0	SENT_7	[p1l1113t540r1299b564],
17	‘	NNP	O	‘	nn	19	SENT_7	[p1l1308t536r1433b566],
18	Channing	NNP	ORGANIZATION	Channing	nn	19	SENT_7	[p1l1308t536r1433b566],
19	Laboratory	NNP	ORGANIZATION	Laboratory	dep	3	SENT_7	[p1l1442t540r1573b566],
20	,	,	O	,	_	0	SENT_7	[p1l1442t540r1573b566],
21	Department	NNP	ORGANIZATION	Department	poss	29	SENT_7	[p1l1585t540r1726b566],
22	of	IN	ORGANIZATION	of	_	0	SENT_7	[p1l1733t540r1758b561],
23	Medicine	NNP	ORGANIZATION	Medicine	prep_of	21	SENT_7	[p1l1763t540r1874b564],
24	,	,	O	,	_	0	SENT_7	[p1l1763t540r1874b564],
25	Brigham	NNP	ORGANIZATION	Brigham	prep_of	21	SENT_7	[p1l6t576r104b601],
26	and	CC	ORGANIZATION	and	_	0	SENT_7	[p1l113t576r159b596],
27	Women	NNP	ORGANIZATION	Women	prep_of	21	SENT_7	[p1l168t576r278b596],
28	's	POS	ORGANIZATION	's	_	0	SENT_7	[p1l168t576r278b596],
29	Hospital	NNP	ORGANIZATION	Hospital	appos	19	SENT_7	[p1l287t576r384b601],
30	and	CC	O	and	_	0	SENT_7	[p1l391t576r437b596],
31	Harvard	NNP	ORGANIZATION	Harvard	nn	33	SENT_7	[p1l444t576r538b596],
32	Medical	NNP	ORGANIZATION	Medical	nn	33	SENT_7	[p1l546t576r639b596],
33	School	NNP	ORGANIZATION	School	appos	19	SENT_7	[p1l646t575r731b599],
34	,	,	O	,	_	0	SENT_7	[p1l646t575r731b599],
35	Boston	NNP	LOCATION	Boston	appos	3	SENT_7	[p1l743t576r832b599],
36	,	,	O	,	_	0	SENT_7	[p1l743t576r832b599],
37	Massachusetts	NNP	LOCATION	Massachusetts	appos	3	SENT_7	[p1l844t576r1030b599],
38	;	:	O	;	_	0	SENT_7	[p1l844t576r1030b599],
39	§	CD	NUMBER	§	dep	3	SENT_7	[p1l1039t572r1161b596],
40	Memorial	NNP	O	Memorial	nn	41	SENT_7	[p1l1039t572r1161b596],
41	Sloan	NNP	PERSON	Sloan	dep	39	SENT_7	[p1l1168t575r1351b601],
42	.	.	O	.	_	0	SENT_7	[p1l1168t575r1351b601],

1	—	NN	O	—	_	0	SENT_8	[p1l1168t575r1351b601],
2	.	.	O	.	_	0	SENT_8	[p1l1168t575r1351b601],

1	Kettering	NNP	ORGANIZATION	Kettering	nn	3	SENT_9	[p1l1168t575r1351b601],
2	Cancer	NNP	ORGANIZATION	Cancer	nn	3	SENT_9	[p1l1360t575r1446b596],
3	Center	NNP	ORGANIZATION	Center	_	0	SENT_9	[p1l1454t575r1536b599],
4	,	,	O	,	_	0	SENT_9	[p1l1454t575r1536b599],
5	New	NNP	LOCATION	New	nn	9	SENT_9	[p1l1548t576r1602b596],
6	York	NNP	LOCATION	York	nn	9	SENT_9	[p1l1611t576r1666b599],
7	,	,	O	,	_	0	SENT_9	[p1l1611t576r1666b599],
8	New	NNP	LOCATION	New	appos	9	SENT_9	[p1l1678t576r1732b596],
9	York	NNP	LOCATION	York	appos	3	SENT_9	[p1l1741t576r1798b599],
10	;	:	O	;	_	0	SENT_9	[p1l1741t576r1798b599],
11	"	``	O	"	punct	13	SENT_9	[p1l1808t570r1880b596],
12	Pﬁzer	NNP	ORGANIZATION	Pﬁzer	nn	13	SENT_9	[p1l1808t570r1880b596],
13	Inc	NNP	ORGANIZATION	Inc	dep	3	SENT_9	[p1l1887t576r1925b599],
14	,	,	O	,	_	0	SENT_9	[p1l1887t576r1925b599],
15	New	NNP	LOCATION	New	nn	16	SENT_9	[p1l6t611r60b632],
16	York	NNP	LOCATION	York	appos	13	SENT_9	[p1l70t611r124b635],
17	,	,	O	,	_	0	SENT_9	[p1l70t611r124b635],
18	New	NNP	LOCATION	New	nn	19	SENT_9	[p1l136t611r190b632],
19	York	NNP	LOCATION	York	appos	13	SENT_9	[p1l200t611r256b635],
20	;	:	O	;	_	0	SENT_9	[p1l200t611r256b635],
21	7	CD	NUMBER	7	num	23	SENT_9	[p1l267t607r419b637],
22	’D	NN	O	’d	nn	23	SENT_9	[p1l267t607r419b637],
23	epartment	NN	O	epartment	dep	19	SENT_9	[p1l267t607r419b637],
24	of	IN	O	of	_	0	SENT_9	[p1l427t611r452b632],
25	Epidemiology	NNP	O	Epidemiology	prep_of	23	SENT_9	[p1l457t611r619b637],
26	,	,	O	,	_	0	SENT_9	[p1l457t611r619b637],
27	Han/ard	NNP	ORGANIZATION	Han/ard	nn	28	SENT_9	[p1l631t611r726b632],
28	School	NNP	ORGANIZATION	School	poss	57	SENT_9	[p1l733t611r816b632],
29	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l823t611r848b632],
30	Public	NNP	ORGANIZATION	Public	nn	31	SENT_9	[p1l853t611r925b632],
31	Health	NNP	ORGANIZATION	Health	prep_of	28	SENT_9	[p1l933t611r1013b635],
32	,	,	O	,	_	0	SENT_9	[p1l933t611r1013b635],
33	Boston	NNP	LOCATION	Boston	nn	35	SENT_9	[p1l1024t611r1113b635],
34	,	,	O	,	_	0	SENT_9	[p1l1024t611r1113b635],
35	Massachusetts	NNP	LOCATION	Massachusetts	appos	31	SENT_9	[p1l1125t611r1311b635],
36	;	:	O	;	_	0	SENT_9	[p1l1125t611r1311b635],
37	**	CD	NUMBER	**	prep_of	28	SENT_9	[p1l1321t608r1374b631],
38	MD	NNP	O	MD	nn	41	SENT_9	[p1l1321t608r1374b631],
39	Anderson	NNP	O	Anderson	nn	41	SENT_9	[p1l1380t611r1495b632],
40	Cancer	NNP	O	Cancer	nn	41	SENT_9	[p1l1505t611r1591b632],
41	Center	NNP	O	Center	dep	37	SENT_9	[p1l1598t611r1681b635],
42	,	,	O	,	_	0	SENT_9	[p1l1598t611r1681b635],
43	Houston	NNP	LOCATION	Houston	conj_and	31	SENT_9	[p1l1693t611r1797b635],
44	,	,	O	,	_	0	SENT_9	[p1l1693t611r1797b635],
45	Texas	NNP	LOCATION	Texas	appos	43	SENT_9	[p1l1811t611r1885b635],
46	;	:	O	;	_	0	SENT_9	[p1l1811t611r1885b635],
47	and	CC	O	and	_	0	SENT_9	[p1l1894t611r1940b632],
48	“	NNP	O	“	nn	49	SENT_9	[p1l8t646r166b672],
49	Department	NNP	ORGANIZATION	Department	conj_and	31	SENT_9	[p1l8t646r166b672],
50	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l174t647r199b667],
51	Surgery	NNP	ORGANIZATION	Surgery	prep_of	49	SENT_9	[p1l204t646r299b672],
52	,	,	O	,	_	0	SENT_9	[p1l204t646r299b672],
53	Brigham	NNP	ORGANIZATION	Brigham	prep_of	49	SENT_9	[p1l311t647r409b672],
54	and	CC	O	and	_	0	SENT_9	[p1l418t647r464b667],
55	Women	NNP	O	Women	conj_and	51	SENT_9	[p1l473t647r562b667],
56	’s	POS	O	’s	_	0	SENT_9	[p1l566t647r583b667],
57	Hospital	NN	O	hospital	appos	13	SENT_9	[p1l592t647r689b672],
58	and	CC	O	and	_	0	SENT_9	[p1l696t647r742b667],
59	Harvard	NNP	ORGANIZATION	Harvard	nn	61	SENT_9	[p1l749t647r843b667],
60	Medical	NNP	ORGANIZATION	Medical	nn	61	SENT_9	[p1l850t647r943b667],
61	School	NNP	ORGANIZATION	School	conj_and	13	SENT_9	[p1l951t646r1036b670],
62	,	,	O	,	_	0	SENT_9	[p1l951t646r1036b670],
63	Boston	NNP	LOCATION	Boston	nn	65	SENT_9	[p1l1048t647r1137b670],
64	,	,	O	,	_	0	SENT_9	[p1l1048t647r1137b670],
65	Massachusetts	NNP	LOCATION	Massachusetts	appos	61	SENT_9	[p1l1149t647r1327b667],

1	See	VB	O	see	_	0	SENT_10	[p1l82t937r235b1005],
2	related	JJ	O	related	amod	3	SENT_10	[p1l272t939r553b1004],
3	articles	NNS	O	article	dobj	1	SENT_10	[p1l590t938r918b1018],
4	,	,	O	,	_	0	SENT_10	[p1l590t938r918b1018],
5	Nguyen	NNP	PERSON	Nguyen	nn	6	SENT_10	[p1l959t939r1273b1023],
6	SP	NN	O	sp	appos	3	SENT_10	[p1l1311t937r1424b1005],
7	et	FW	O	et	nn	8	SENT_10	[p1l1459t943r1534b1004],
8	al	FW	O	al	dep	6	SENT_10	[p1l1568t939r1659b1018],
9	,	,	O	,	_	0	SENT_10	[p1l1568t939r1659b1018],
10	on	IN	O	on	_	0	SENT_10	[p1l1696t954r1797b1004],
11	page	NN	O	page	prep_on	1	SENT_10	[p1l1837t954r2037b1023],
12	676	CD	NUMBER	676	num	11	SENT_10	[p1l81t1037r249b1116],
13	;	:	O	;	_	0	SENT_10	[p1l81t1037r249b1116],
14	and	CC	O	and	_	0	SENT_10	[p1l288t1037r439b1103],
15	Tsoi	NNP	PERSON	Tsoi	nn	16	SENT_10	[p1l475t1036r651b1103],
16	KKF	NNP	O	KKF	conj_and	11	SENT_10	[p1l694t1037r867b1101],
17	et	FW	O	et	nn	18	SENT_10	[p1l900t1040r976b1103],
18	al	FW	O	al	dep	16	SENT_10	[p1l1009t1037r1100b1116],
19	,	,	O	,	_	0	SENT_10	[p1l1009t1037r1100b1116],
20	on	IN	O	on	_	0	SENT_10	[p1l1138t1052r1239b1103],
21	page	NN	O	page	prep_on	1	SENT_10	[p1l1279t1052r1479b1121],
22	682	CD	NUMBER	682	num	21	SENT_10	[p1l1513t1037r1655b1103],
23	in	IN	O	in	_	0	SENT_10	[p1l1694t1036r1762b1101],
24	CGH	NN	O	cgh	prep_in	21	SENT_10	[p1l1806t1035r2014b1103],
25	.	.	O	.	_	0	SENT_10	[p1l1806t1035r2014b1103],

1	BACKGROUND	NN	O	background	_	0	SENT_11	[p1l10t1356r664b1415],
2	&	CC	O	&	_	0	SENT_11	[p1l693t1356r1035b1415],
3	AIMS	NNS	O	aim	conj_and	1	SENT_11	[p1l693t1356r1035b1415],
4	:	:	O	:	_	0	SENT_11	[p1l693t1356r1035b1415],
5	Variants	NNS	O	variant	dep	1	SENT_11	[p1l1078t1353r1386b1414],
6	in	IN	O	in	_	0	SENT_11	[p1l1431t1353r1503b1414],
7	the	DT	O	the	det	10	SENT_11	[p1l1546t1350r1661b1415],
8	cytochrome	NN	O	cytochrome	nn	10	SENT_11	[p1l1705t1350r2139b1437],
9	P450	NN	O	p450	nn	10	SENT_11	[p1l10t1463r192b1523],
10	2C9	NN	O	2c9	prep_in	5	SENT_11	[p1l236t1464r381b1523],
11	(	CD	NUMBER	(	num	14	SENT_11	[p1l429t1461r776b1544],
12	CYPZC9	NN	O	cypzc9	nn	14	SENT_11	[p1l429t1461r776b1544],
13	)	NN	O	)	nn	14	SENT_11	[p1l429t1461r776b1544],
14	gene	NN	O	gene	nsubjpass	16	SENT_11	[p1l824t1482r990b1545],
15	are	VBP	O	be	auxpass	16	SENT_11	[p1l1033t1482r1140b1523],
16	associated	VBN	O	associate	rcmod	10	SENT_11	[p1l1183t1458r1560b1524],
17	with	IN	O	with	_	0	SENT_11	[p1l1600t1459r1765b1522],
18	impaired	JJ	O	impaired	amod	19	SENT_11	[p1l1807t1458r2141b1545],
19	metabolism	NN	O	metabolism	prep_with	16	SENT_11	[p1l11t1568r448b1632],
20	of	IN	O	of	_	0	SENT_11	[p1l487t1568r571b1632],
21	celecoxib	NN	O	celecoxib	prep_of	19	SENT_11	[p1l599t1568r947b1632],
22	.	.	O	.	_	0	SENT_11	[p1l599t1568r947b1632],

1	We	PRP	O	we	nsubj	2	SENT_12	[p1l987t1573r1103b1632],
2	examined	VBD	O	examine	_	0	SENT_12	[p1l1143t1567r1498b1633],
3	the	DT	O	the	det	4	SENT_12	[p1l1536t1568r1651b1632],
4	inﬂuence	NN	O	inﬂuence	dobj	2	SENT_12	[p1l1690t1568r2027b1632],
5	of	IN	O	of	_	0	SENT_12	[p1l2068t1568r2152b1632],
6	CYP2C9	NN	O	cyp2c9	nn	7	SENT_12	[p1l13t1680r383b1740],
7	*	NN	O	*	prep_of	4	SENT_12	[p1l13t1680r383b1740],
8	2	CD	NUMBER	2	number	9	SENT_12	[p1l13t1680r383b1740],
9	(	CD	NUMBER	(	num	11	SENT_12	[p1l437t1678r727b1761],
10	R144C	NN	O	r144c	nn	11	SENT_12	[p1l437t1678r727b1761],
11	)	NN	O	)	dep	7	SENT_12	[p1l437t1678r727b1761],
12	and	CC	O	and	_	0	SENT_12	[p1l781t1675r919b1741],
13	CYP2C9	NN	O	cyp2c9	conj_and	7	SENT_12	[p1l970t1681r1338b1740],
14	*	CD	NUMBER	*	number	15	SENT_12	[p1l970t1681r1338b1740],
15	3	CD	NUMBER	3	num	17	SENT_12	[p1l970t1681r1338b1740],
16	(	NN	O	(	nn	17	SENT_12	[p1l1393t1678r1651b1761],
17	I359L	NN	O	i359l	dep	13	SENT_12	[p1l1393t1678r1651b1761],
18	)	CD	NUMBER	)	num	19	SENT_12	[p1l1393t1678r1651b1761],
19	variants	NNS	O	variant	dep	13	SENT_12	[p1l1702t1678r1995b1740],
20	on	IN	O	on	_	0	SENT_12	[p1l2046t1699r2140b1740],
21	dose-related	JJ	O	dose-related	amod	22	SENT_12	[p1l11t1783r458b1849],
22	response	NN	O	response	prep_on	2	SENT_12	[p1l488t1807r808b1870],
23	or	CC	O	or	_	0	SENT_12	[p1l838t1807r915b1847],
24	toxicity	NN	O	toxicity	conj_or	22	SENT_12	[p1l944t1786r1220b1870],
25	in	IN	O	in	_	0	SENT_12	[p1l1246t1786r1318b1847],
26	a	DT	O	a	det	28	SENT_12	[p1l1348t1808r1386b1847],
27	randomized	JJ	O	randomized	amod	28	SENT_12	[p1l1414t1783r1860b1849],
28	trial	NN	O	trial	prep_in	2	SENT_12	[p1l1888t1784r2038b1847],
29	of	IN	O	of	_	0	SENT_12	[p1l2068t1784r2152b1847],
30	celecoxib	NN	O	celecoxib	prep_of	28	SENT_12	[p1l11t1893r360b1957],
31	.	.	O	.	_	0	SENT_12	[p1l11t1893r360b1957],

1	METHODS	NNS	O	method	_	0	SENT_13	[p1l412t1897r900b1957],
2	:	:	O	:	_	0	SENT_13	[p1l412t1897r900b1957],
3	We	PRP	O	we	nsubj	4	SENT_13	[p1l949t1898r1065b1957],
4	identiﬁed	VBD	O	identiﬁed	dep	1	SENT_13	[p1l1114t1892r1469b1958],
5	individuals	NNS	O	individual	dobj	4	SENT_13	[p1l1516t1892r1926b1958],
6	with	IN	O	with	_	0	SENT_13	[p1l1975t1893r2140b1956],
7	CYP2C9	NN	O	cyp2c9	nn	8	SENT_13	[p1l13t2006r383b2065],
8	*	NN	O	*	prep_with	4	SENT_13	[p1l13t2006r383b2065],
9	2	CD	NUMBER	2	number	13	SENT_13	[p1l13t2006r383b2065],
10	and	CC	O	and	_	0	SENT_13	[p1l412t2000r550b2066],
11	CYP2C9	CD	NUMBER	cyp2c9	num	14	SENT_13	[p1l578t2005r946b2065],
12	*	CD	NUMBER	*	number	13	SENT_13	[p1l578t2005r946b2065],
13	3	CD	NUMBER	3	num	14	SENT_13	[p1l578t2005r946b2065],
14	genotypes	NNS	O	genotype	dep	8	SENT_13	[p1l976t2019r1344b2087],
15	(	CD	NUMBER	(	num	16	SENT_13	[p1l1375t2001r1464b2084],
16	Z	NN	O	z	dep	8	SENT_13	[p1l1375t2001r1464b2084],
17	1	CD	NUMBER	1	num	20	SENT_13	[p1l1482t2006r1511b2064],
18	variant	JJ	O	variant	amod	20	SENT_13	[p1l1540t2003r1801b2065],
19	allele	NN	O	allele	nn	20	SENT_13	[p1l1828t2001r2038b2084],
20	)	NN	O	)	dep	16	SENT_13	[p1l1828t2001r2038b2084],
21	in	IN	O	in	_	0	SENT_13	[p1l2068t2003r2140b2064],
22	the	DT	O	the	det	24	SENT_13	[p1l11t2108r126b2172],
23	Adenoma	NNP	O	Adenoma	nn	24	SENT_13	[p1l156t2108r517b2174],
24	Prevention	NNP	O	Prevention	prep_in	4	SENT_13	[p1l548t2111r947b2173],
25	with	IN	O	with	_	0	SENT_13	[p1l979t2109r1143b2172],
26	Celecoxib	NNP	O	Celecoxib	nn	27	SENT_13	[p1l1179t2108r1530b2173],
27	trial	NN	O	trial	prep_with	24	SENT_13	[p1l1566t2109r1732b2173],
28	.	.	O	.	_	0	SENT_13	[p1l1566t2109r1732b2173],

1	Following	VBG	O	follow	_	0	SENT_14	[p1l1769t2108r2141b2195],
2	adenoma	NN	O	adenoma	nn	3	SENT_14	[p1l11t2217r353b2283],
3	removal	NN	O	removal	prep_following	7	SENT_14	[p1l395t2218r708b2297],
4	,	,	O	,	_	0	SENT_14	[p1l395t2218r708b2297],
5	patients	NNS	O	patient	nsubjpass	7	SENT_14	[p1l754t2220r1049b2304],
6	were	VBD	O	be	auxpass	7	SENT_14	[p1l1094t2241r1260b2282],
7	assigned	VBN	O	assign	_	0	SENT_14	[p1l1306t2217r1620b2304],
8	randomly	RB	O	randomly	advmod	7	SENT_14	[p1l1664t2217r2024b2304],
9	to	TO	O	to	_	0	SENT_14	[p1l2066t2236r2138b2281],
10	groups	NNS	O	group	prep_to	7	SENT_14	[p1l11t2348r265b2412],
11	given	VBN	O	give	partmod	10	SENT_14	[p1l295t2328r488b2412],
12	placebo	NN	O	placebo	nn	15	SENT_14	[p1l515t2326r795b2412],
13	or	CC	O	or	_	0	SENT_14	[p1l826t2349r903b2389],
14	low-dose	JJ	O	low-dose	nn	15	SENT_14	[p1l929t2325r1254b2391],
15	(	NN	O	(	iobj	11	SENT_14	[p1l1286t2326r1443b2409],
16	200	CD	NUMBER	200	num	17	SENT_14	[p1l1286t2326r1443b2409],
17	mg	NN	O	mg	dep	15	SENT_14	[p1l1473t2349r1590b2412],
18	twice	RB	O	twice	advmod	15	SENT_14	[p1l1617t2328r1804b2390],
19	daily	RB	SET	daily	advmod	15	SENT_14	[p1l1834t2325r2032b2412],
20	)	CD	NUMBER	)	dep	15	SENT_14	[p1l1834t2325r2032b2412],
21	or	CC	O	or	_	0	SENT_14	[p1l2065t2349r2142b2389],
22	high-dose	JJ	O	high-dose	amod	23	SENT_14	[p1l10t2433r373b2520],
23	(	NN	O	(	conj_or	20	SENT_14	[p1l409t2434r566b2517],
24	400	CD	NUMBER	400	num	25	SENT_14	[p1l409t2434r566b2517],
25	mg	NN	O	mg	dobj	11	SENT_14	[p1l601t2457r718b2520],
26	twice	RB	O	twice	advmod	25	SENT_14	[p1l750t2436r937b2497],
27	daily	JJ	SET	daily	amod	29	SENT_14	[p1l971t2433r1169b2520],
28	)	NN	O	)	nn	29	SENT_14	[p1l971t2433r1169b2520],
29	celecoxib	NN	O	celecoxib	dep	25	SENT_14	[p1l1206t2434r1537b2498],
30	and	CC	O	and	_	0	SENT_14	[p1l1572t2433r1710b2499],
31	underwent	VBD	O	undergo	conj_and	7	SENT_14	[p1l1741t2433r2141b2499],
32	follow-up	JJ	O	follow-up	amod	33	SENT_14	[p1l11t2542r366b2628],
33	colonoscopies	NNS	O	colonoscopy	dobj	31	SENT_14	[p1l402t2542r919b2628],
34	at	IN	O	at	_	0	SENT_14	[p1l954t2560r1023b2605],
35	1	CD	NUMBER	1	prep_at	33	SENT_14	[p1l1062t2547r1090b2605],
36	and	CC	O	and	_	0	SENT_14	[p1l1129t2541r1301b2625],
37	/	:	O	/	punct	39	SENT_14	[p1l1129t2541r1301b2625],
38	or	CC	O	or	dep	39	SENT_14	[p1l1306t2565r1383b2605],
39	3	CD	DURATION	3	dep	33	SENT_14	[p1l1415t2547r1453b2606],
40	years	NNS	NUMBER	year	dobj	31	SENT_14	[p1l1486t2565r1687b2628],
41	.	.	O	.	_	0	SENT_14	[p1l1486t2565r1687b2628],

1	RESULTS	NNS	O	result	_	0	SENT_15	[p1l1723t2546r2137b2606],
2	:	:	O	:	_	0	SENT_15	[p1l1723t2546r2137b2606],
3	Among	IN	O	among	_	0	SENT_15	[p1l7t2655r282b2736],
4	1660	CD	NUMBER	1660	num	5	SENT_15	[p1l315t2654r485b2714],
5	patients	NNS	O	patient	prep_among	11	SENT_15	[p1l513t2652r829b2736],
6	,	,	O	,	_	0	SENT_15	[p1l513t2652r829b2736],
7	21	CD	PERCENT	21	num	8	SENT_15	[p1l856t2655r1001b2713],
8	%	NN	PERCENT	%	nsubj	11	SENT_15	[p1l856t2655r1001b2713],
9	were	VBD	O	be	cop	11	SENT_15	[p1l1027t2673r1193b2714],
10	CYP2C9	CD	NUMBER	cyp2c9	num	11	SENT_15	[p1l1222t2655r1612b2729],
11	*	NN	O	*	dep	1	SENT_15	[p1l1222t2655r1612b2729],
12	2	CD	NUMBER	2	dep	11	SENT_15	[p1l1222t2655r1612b2729],
13	,	,	O	,	_	0	SENT_15	[p1l1222t2655r1612b2729],
14	and	CC	PERCENT	and	_	0	SENT_15	[p1l1640t2649r1778b2715],
15	12	CD	PERCENT	12	num	16	SENT_15	[p1l1810t2655r1948b2713],
16	%	NN	PERCENT	%	nsubj	19	SENT_15	[p1l1810t2655r1948b2713],
17	were	VBD	O	be	cop	19	SENT_15	[p1l1973t2673r2139b2714],
18	CYP2C9	CD	NUMBER	cyp2c9	number	19	SENT_15	[p1l13t2762r381b2822],
19	*	CD	NUMBER	*	conj_and	11	SENT_15	[p1l13t2762r381b2822],
20	3	CD	NUMBER	3	num	21	SENT_15	[p1l13t2762r381b2822],
21	genotypes	NNS	O	genotype	dep	19	SENT_15	[p1l433t2776r818b2844],
22	.	.	O	.	_	0	SENT_15	[p1l433t2776r818b2844],

1	Overall	RB	O	overall	advmod	5	SENT_16	[p1l871t2757r1154b2837],
2	,	,	O	,	_	0	SENT_16	[p1l871t2757r1154b2837],
3	celecoxib	NN	O	celecoxib	nsubjpass	5	SENT_16	[p1l1204t2758r1534b2822],
4	was	VBD	O	be	auxpass	5	SENT_16	[p1l1582t2782r1715b2822],
5	associated	VBN	O	associate	_	0	SENT_16	[p1l1765t2757r2142b2823],
6	with	IN	O	with	_	0	SENT_16	[p1l9t2866r174b2929],
7	a	DT	O	a	det	11	SENT_16	[p1l205t2890r244b2929],
8	dose	NN	O	dose	nn	11	SENT_16	[p1l273t2865r860b2952],
9	—	NN	O	—	nn	11	SENT_16	[p1l273t2865r860b2952],
10	dependent	JJ	O	dependent	amod	11	SENT_16	[p1l273t2865r860b2952],
11	reduction	NN	O	reduction	prep_with	5	SENT_16	[p1l891t2865r1250b2931],
12	in	IN	O	in	_	0	SENT_16	[p1l1280t2868r1352b2929],
13	adenoma	NN	O	adenoma	prep_in	11	SENT_16	[p1l1383t2865r1740b2945],
14	,	,	O	,	_	0	SENT_16	[p1l1383t2865r1740b2945],
15	compared	VBN	O	compare	_	0	SENT_16	[p1l1773t2865r2141b2952],
16	with	IN	O	with	prepc_compared_with	5	SENT_16	[p1l9t2974r174b3037],
17	placebo	NN	O	placebo	pobj	5	SENT_16	[p1l206t2974r506b3060],
18	,	,	O	,	_	0	SENT_16	[p1l206t2974r506b3060],
19	with	IN	O	with	_	0	SENT_16	[p1l538t2974r703b3037],
20	relative	JJ	O	relative	amod	22	SENT_16	[p1l736t2974r1001b3038],
21	risks	NNS	O	risk	nn	22	SENT_16	[p1l1034t2973r1202b3038],
22	p	NN	O	p	prep_with	17	SENT_16	[p1l1238t2974r1398b3057],
23	,9	CD	NUMBER	,9	dep	17	SENT_16	[p1l1238t2974r1398b3057],
24	+	CC	O	+	cc	23	SENT_16	[p1l1238t2974r1398b3057],
25	of	IN	O	of	_	0	SENT_16	[p1l1435t2974r1520b3037],
26	0.65	CD	PERCENT	0.65	number	27	SENT_16	[p1l1540t2978r1689b3038],
27	(	CD	PERCENT	(	num	30	SENT_16	[p1l1727t2974r1897b3057],
28	95	CD	PERCENT	95	number	29	SENT_16	[p1l1727t2974r1897b3057],
29	%	NN	PERCENT	%	amod	30	SENT_16	[p1l1727t2974r1897b3057],
30	conﬁdence	NN	O	conﬁdence	prep_of	23	SENT_16	[p1l1931t2974r2138b3037, p1l11t3082r220b3148],
31	interval	NN	O	interval	nn	34	SENT_16	[p1l250t3082r530b3147],
32	[	CD	NUMBER	[	num	34	SENT_16	[p1l565t3082r716b3166],
33	CI	NN	O	ci	nn	34	SENT_16	[p1l565t3082r716b3166],
34	]	NN	O	]	dep	30	SENT_16	[p1l565t3082r716b3166],
35	:	:	O	:	_	0	SENT_16	[p1l565t3082r716b3166],
36	0.56-0	CD	NUMBER	0.56-0	num	38	SENT_16	[p1l750t3083r1148b3166],
37	.76	CD	NUMBER	.76	num	38	SENT_16	[p1l750t3083r1148b3166],
38	)	NN	O	)	dep	30	SENT_16	[p1l750t3083r1148b3166],
39	for	IN	O	for	_	0	SENT_16	[p1l1182t3083r1289b3147],
40	the	DT	O	the	det	41	SENT_16	[p1l1319t3083r1433b3147],
41	low-dose	JJ	O	low-dose	prep_for	38	SENT_16	[p1l1463t3082r1788b3148],
42	and	CC	O	and	_	0	SENT_16	[p1l1819t3082r1957b3148],
43	0.54	CD	PERCENT	0.54	num	47	SENT_16	[p1l1987t3087r2140b3147],
44	(	CD	PERCENT	(	number	45	SENT_16	[p1l13t3191r183b3274],
45	95	CD	PERCENT	95	dep	46	SENT_16	[p1l13t3191r183b3274],
46	%	NN	PERCENT	%	dep	47	SENT_16	[p1l13t3191r183b3274],
47	CI	NN	O	ci	conj_and	41	SENT_16	[p1l221t3196r321b3255],
48	:	:	O	:	_	0	SENT_16	[p1l221t3196r321b3255],
49	0.46-0	CD	NUMBER	0.46-0	num	51	SENT_16	[p1l360t3191r758b3274],
50	.63	CD	NUMBER	.63	num	51	SENT_16	[p1l360t3191r758b3274],
51	)	NN	O	)	dep	30	SENT_16	[p1l360t3191r758b3274],
52	for	IN	O	for	_	0	SENT_16	[p1l797t3191r904b3254],
53	the	DT	O	the	det	55	SENT_16	[p1l939t3191r1054b3254],
54	high-dose	JJ	O	high-dose	amod	55	SENT_16	[p1l1089t3190r1452b3277],
55	groups	NNS	O	group	prep_for	51	SENT_16	[p1l1488t3213r1760b3277],
56	.	.	O	.	_	0	SENT_16	[p1l1488t3213r1760b3277],

1	However	RB	O	however	advmod	18	SENT_17	[p1l1799t3197r2138b3270],
2	,	,	O	,	_	0	SENT_17	[p1l1799t3197r2138b3270],
3	the	DT	O	the	det	6	SENT_17	[p1l11t3298r126b3362],
4	additional	JJ	O	additional	amod	6	SENT_17	[p1l170t3298r551b3364],
5	protective	JJ	O	protective	amod	6	SENT_17	[p1l593t3301r959b3385],
6	effect	NN	O	effect	nsubjpass	18	SENT_17	[p1l1003t3299r1203b3363],
7	of	IN	O	of	_	0	SENT_17	[p1l1245t3299r1330b3362],
8	the	DT	O	the	det	10	SENT_17	[p1l1361t3299r1476b3362],
9	high	JJ	O	high	amod	10	SENT_17	[p1l1519t3299r1685b3385],
10	dose	NN	O	dose	prep_of	6	SENT_17	[p1l1729t3298r1912b3378],
11	,	,	O	,	_	0	SENT_17	[p1l1729t3298r1912b3378],
12	compared	VBN	O	compare	_	0	SENT_17	[p1l1957t3322r2138b3363, p1l10t3406r218b3493],
13	with	IN	O	with	prepc_compared_with	6	SENT_17	[p1l243t3406r408b3470],
14	the	DT	O	the	det	15	SENT_17	[p1l437t3407r552b3471],
15	low-dose	JJ	O	low-dose	pobj	6	SENT_17	[p1l580t3406r923b3486],
16	,	,	O	,	_	0	SENT_17	[p1l580t3406r923b3486],
17	was	VBD	O	be	auxpass	18	SENT_17	[p1l951t3431r1084b3471],
18	observed	VBN	O	observe	_	0	SENT_17	[p1l1114t3406r1438b3472],
19	only	RB	O	only	advmod	18	SENT_17	[p1l1465t3407r1626b3493],
20	in	IN	O	in	_	0	SENT_17	[p1l1650t3409r1723b3470],
21	those	DT	O	those	prep_in	18	SENT_17	[p1l1751t3407r1948b3471],
22	with	IN	O	with	_	0	SENT_17	[p1l1975t3406r2139b3470],
23	CYP2C9	NN	O	cyp2c9	prep_with	21	SENT_17	[p1l13t3520r381b3579],
24	*	CD	NUMBER	*	number	25	SENT_17	[p1l13t3520r381b3579],
25	3	CD	NUMBER	3	num	26	SENT_17	[p1l13t3520r381b3579],
26	genotypes	NNS	O	genotype	dep	21	SENT_17	[p1l419t3533r787b3601],
27	(	CD	NUMBER	(	num	28	SENT_17	[p1l825t3515r980b3598],
28	RR	NN	O	rr	dep	26	SENT_17	[p1l825t3515r980b3598],
29	,	,	O	,	_	0	SENT_17	[p1l825t3515r980b3598],
30	0.51	CD	NUMBER	0.51	appos	21	SENT_17	[p1l1017t3519r1188b3594],
31	;	:	O	;	_	0	SENT_17	[p1l1017t3519r1188b3594],
32	95	CD	PERCENT	95	number	33	SENT_17	[p1l1225t3519r1368b3579],
33	%	NN	PERCENT	%	amod	34	SENT_17	[p1l1225t3519r1368b3579],
34	CI	NN	O	ci	dep	30	SENT_17	[p1l1405t3520r1505b3579],
35	:	:	O	:	_	0	SENT_17	[p1l1405t3520r1505b3579],
36	0.30-0	CD	NUMBER	0.30-0	number	37	SENT_17	[p1l1543t3515r1961b3598],
37	.87	CD	NUMBER	.87	num	38	SENT_17	[p1l1543t3515r1961b3598],
38	)	NN	O	)	dep	34	SENT_17	[p1l1543t3515r1961b3598],
39	.	.	O	.	_	0	SENT_17	[p1l1543t3515r1961b3598],

1	The	DT	O	the	det	3	SENT_18	[p1l1997t3515r2139b3578],
2	high	JJ	O	high	amod	3	SENT_18	[p1l10t3623r177b3709],
3	dose	NN	O	dose	nsubjpass	12	SENT_18	[p1l216t3622r398b3702],
4	,	,	O	,	_	0	SENT_18	[p1l216t3622r398b3702],
5	compared	VBN	O	compare	_	0	SENT_18	[p1l438t3622r806b3709],
6	with	IN	O	with	prepc_compared_with	3	SENT_18	[p1l840t3623r1005b3686],
7	low	JJ	O	low	amod	8	SENT_18	[p1l1042t3623r1175b3686],
8	dose	NN	O	dose	pobj	3	SENT_18	[p1l1210t3622r1393b3702],
9	,	,	O	,	_	0	SENT_18	[p1l1210t3622r1393b3702],
10	was	VBD	O	be	auxpass	12	SENT_18	[p1l1430t3647r1562b3686],
11	not	RB	O	not	neg	12	SENT_18	[p1l1601t3641r1728b3686],
12	associated	VBN	O	associate	_	0	SENT_18	[p1l1765t3622r2142b3688],
13	with	IN	O	with	_	0	SENT_18	[p2l9t18r174b81],
14	signiﬁcant	JJ	O	signiﬁcant	amod	16	SENT_18	[p2l252t18r640b104],
15	risk	NN	O	risk	nn	16	SENT_18	[p2l718t17r853b82],
16	reduction	NN	O	reduction	prep_with	12	SENT_18	[p2l931t17r1290b83],
17	among	IN	O	among	_	0	SENT_18	[p2l1368t41r1624b104],
18	those	DT	O	those	prep_among	16	SENT_18	[p2l1702t18r1898b82],
19	with	IN	O	with	_	0	SENT_18	[p2l1975t18r2139b81],
20	CYP2C9	NN	O	cyp2c9	nn	21	SENT_18	[p2l13t130r383b190],
21	*	NN	O	*	prep_with	18	SENT_18	[p2l13t130r383b190],
22	2	CD	NUMBER	2	number	23	SENT_18	[p2l13t130r383b190],
23	(	CD	NUMBER	(	num	24	SENT_18	[p2l414t126r569b209],
24	RR	NN	O	rr	dep	21	SENT_18	[p2l414t126r569b209],
25	,	,	O	,	_	0	SENT_18	[p2l414t126r569b209],
26	0.83	CD	NUMBER	0.83	appos	24	SENT_18	[p2l598t131r770b205],
27	;	:	O	;	_	0	SENT_18	[p2l598t131r770b205],
28	95	CD	PERCENT	95	num	29	SENT_18	[p2l800t130r943b190],
29	%	NN	PERCENT	%	dep	24	SENT_18	[p2l800t130r943b190],
30	CI	NN	O	ci	dep	29	SENT_18	[p2l972t131r1072b190],
31	:	:	O	:	_	0	SENT_18	[p2l972t131r1072b190],
32	0.57-1	CD	NUMBER	0.57-1	num	34	SENT_18	[p2l1103t126r1479b209],
33	.21	CD	NUMBER	.21	num	34	SENT_18	[p2l1103t126r1479b209],
34	)	NN	O	)	dep	24	SENT_18	[p2l1103t126r1479b209],
35	or	CC	O	or	_	0	SENT_18	[p2l1511t149r1588b190],
36	wild-type	JJ	O	wild-type	amod	38	SENT_18	[p2l1612t125r1954b212],
37	(	NN	O	(	nn	38	SENT_18	[p2l1983t126r2138b209],
38	RR	NN	O	rr	dep	24	SENT_18	[p2l1983t126r2138b209],
39	,	,	O	,	_	0	SENT_18	[p2l1983t126r2138b209],
40	0.89	CD	NUMBER	0.89	amod	34	SENT_18	[p2l11t239r182b313],
41	;	:	O	;	_	0	SENT_18	[p2l11t239r182b313],
42	95	CD	PERCENT	95	num	43	SENT_18	[p2l220t238r364b298],
43	%	NN	PERCENT	%	dep	24	SENT_18	[p2l220t238r364b298],
44	CI	NN	O	ci	dep	43	SENT_18	[p2l401t239r501b298],
45	:	:	O	:	_	0	SENT_18	[p2l401t239r501b298],
46	0.72-1	CD	NUMBER	0.72-1	number	47	SENT_18	[p2l540t234r916b317],
47	.11	CD	NUMBER	.11	dep	24	SENT_18	[p2l540t234r916b317],
48	)	NN	O	)	nn	49	SENT_18	[p2l540t234r916b317],
49	genotypes	NNS	O	genotype	dep	47	SENT_18	[p2l955t252r1341b320],
50	.	.	O	.	_	0	SENT_18	[p2l955t252r1341b320],

1	Compared	VBN	O	compare	_	0	SENT_19	[p2l1381t233r1770b320],
2	with	IN	O	with	prepc_compared_with	12	SENT_19	[p2l1802t234r1967b297],
3	placebo	NN	O	placebo	pobj	12	SENT_19	[p2l2002t234r2138b320, p2l11t342r196b421],
4	,	,	O	,	_	0	SENT_19	[p2l2002t234r2138b320, p2l11t342r196b421],
5	a	DT	O	a	det	7	SENT_19	[p2l248t366r288b405],
6	higher	JJR	O	higher	amod	7	SENT_19	[p2l335t342r575b428],
7	incidence	NN	O	incidence	nsubjpass	12	SENT_19	[p2l623t341r971b407],
8	of	IN	O	of	_	0	SENT_19	[p2l1023t342r1108b406],
9	cardiovascular	JJ	O	cardiovascular	amod	10	SENT_19	[p2l1147t341r1680b407],
10	events	NNS	O	event	prep_of	7	SENT_19	[p2l1730t360r1956b406],
11	was	VBD	O	be	auxpass	12	SENT_19	[p2l2006t366r2138b406],
12	associated	VBN	O	associate	_	0	SENT_19	[p2l11t449r388b515],
13	with	IN	O	with	_	0	SENT_19	[p2l430t450r595b513],
14	both	DT	O	both	det	15	SENT_19	[p2l639t450r814b513],
15	doses	NNS	O	dose	prep_with	12	SENT_19	[p2l861t449r1059b515],
16	among	IN	O	among	_	0	SENT_19	[p2l1106t473r1362b536],
17	patients	NNS	O	patient	prep_among	15	SENT_19	[p2l1406t452r1702b536],
18	with	IN	O	with	_	0	SENT_19	[p2l1747t449r1912b513],
19	wildtype	JJ	O	wildtype	amod	20	SENT_19	[p2l1956t449r2138b515, p2l11t577r164b645],
20	genotypes	NNS	O	genotype	prep_with	17	SENT_19	[p2l202t577r570b645],
21	but	CC	O	but	_	0	SENT_19	[p2l608t559r736b622],
22	only	RB	O	only	_	0	SENT_19	[p2l774t559r935b645],
23	with	IN	O	with	_	0	SENT_19	[p2l968t559r1133b622],
24	the	DT	O	the	det	26	SENT_19	[p2l1172t559r1287b622],
25	high	JJ	O	high	amod	26	SENT_19	[p2l1325t558r1492b645],
26	dose	NN	O	dose	conj_only	15	SENT_19	[p2l1531t558r1695b624],
27	among	IN	O	among	_	0	SENT_19	[p2l1734t582r1991b645],
28	patients	NNS	O	patient	prep_among	26	SENT_19	[p2l2027t581r2138b645, p2l11t669r215b731],
29	with	IN	O	with	_	0	SENT_19	[p2l270t667r435b730],
30	variant	JJ	O	variant	amod	31	SENT_19	[p2l487t669r749b730],
31	genotypes	NNS	O	genotype	prep_with	28	SENT_19	[p2l804t685r1189b753],
32	.	.	O	.	_	0	SENT_19	[p2l804t685r1189b753],

1	CONCLUSIONS	NNS	O	conclusion	_	0	SENT_20	[p2l1248t672r1932b731],
2	:	:	O	:	_	0	SENT_20	[p2l1248t672r1932b731],
3	The	DT	O	the	det	5	SENT_20	[p2l1987t666r2140b731],
4	greater	JJR	O	greater	amod	5	SENT_20	[p2l9t791r288b861],
5	efﬁcacy	NN	O	efﬁcacy	dep	1	SENT_20	[p2l349t774r644b861],
6	of	IN	O	of	_	0	SENT_20	[p2l704t774r797b838],
7	high-dose	JJ	O	high-dose	amod	8	SENT_20	[p2l845t774r1236b861],
8	celecoxib	NN	O	celecoxib	prep_of	5	SENT_20	[p2l1299t774r1683b854],
9	,	,	O	,	_	0	SENT_20	[p2l1299t774r1683b854],
10	compared	VBN	O	compare	_	0	SENT_20	[p2l1746t774r2142b861],
11	with	IN	O	with	prepc_compared_with	8	SENT_20	[p2l8t882r184b946],
12	the	DT	O	the	det	15	SENT_20	[p2l217t882r341b946],
13	low	JJ	O	low	amod	15	SENT_20	[p2l374t882r748b962],
14	—	NN	O	—	nn	15	SENT_20	[p2l374t882r748b962],
15	dose	NN	O	dose	pobj	8	SENT_20	[p2l374t882r748b962],
16	,	,	O	,	_	0	SENT_20	[p2l374t882r748b962],
17	in	IN	O	in	_	0	SENT_20	[p2l781t885r863b946],
18	preventing	VBG	O	prevent	prepc_in	8	SENT_20	[p2l894t885r1322b969],
19	colorectal	JJ	O	colorectal	amod	20	SENT_20	[p2l1355t882r1745b947],
20	adenoma	NN	O	adenoma	nsubj	21	SENT_20	[p2l1776t882r2142b948],
21	appears	VBZ	O	appear	ccomp	18	SENT_20	[p2l10t1013r316b1077],
22	conﬁned	VBN	O	conﬁned	dep	21	SENT_20	[p2l364t990r711b1056],
23	to	TO	O	to	_	0	SENT_20	[p2l754t1007r832b1054],
24	individuals	NNS	O	individual	prep_to	22	SENT_20	[p2l879t990r1324b1056],
25	with	IN	O	with	_	0	SENT_20	[p2l1370t990r1546b1054],
26	slow	JJ	O	slow	amod	29	SENT_20	[p2l1593t990r1773b1054],
27	metabolizer	NN	O	metabolizer	nn	29	SENT_20	[p2l1815t990r2138b1055, p2l9t1099r184b1163],
28	(	NN	O	(	nn	29	SENT_20	[p2l215t1099r679b1183],
29	CYP2C9	NN	O	cyp2c9	prep_with	24	SENT_20	[p2l215t1099r679b1183],
30	*	CD	NUMBER	*	number	31	SENT_20	[p2l215t1099r679b1183],
31	3	CD	NUMBER	3	num	33	SENT_20	[p2l215t1099r679b1183],
32	)	NN	O	)	nn	33	SENT_20	[p2l215t1099r679b1183],
33	genotypes	NNS	O	genotype	dobj	22	SENT_20	[p2l711t1116r1127b1186],
34	.	.	O	.	_	0	SENT_20	[p2l711t1116r1127b1186],

1	Genetic	JJ	O	genetic	amod	3	SENT_21	[p2l1161t1102r1459b1163],
2	variability	NN	O	variability	nn	3	SENT_21	[p2l1487t1099r1897b1186],
3	inﬂuences	NNS	O	inﬂuences	_	0	SENT_21	[p2l1924t1099r2138b1163, p2l11t1231r219b1271],
4	susceptibility	NN	O	susceptibility	dep	3	SENT_21	[p2l251t1207r782b1294],
5	to	TO	O	to	_	0	SENT_21	[p2l807t1224r885b1271],
6	the	DT	O	the	det	8	SENT_21	[p2l916t1207r1040b1271],
7	potential	JJ	O	potential	amod	8	SENT_21	[p2l1068t1207r1430b1294],
8	beneﬁts	NNS	O	beneﬁts	prep_to	4	SENT_21	[p2l1455t1207r1767b1271],
9	and	CC	O	and	_	0	SENT_21	[p2l1798t1207r1948b1272],
10	hazards	NNS	O	hazard	conj_and	8	SENT_21	[p2l1975t1207r2138b1271, p2l10t1316r178b1381],
11	of	IN	O	of	_	0	SENT_21	[p2l213t1316r306b1380],
12	celecoxib	NN	O	celecoxib	prep_of	8	SENT_21	[p2l327t1316r708b1380],
13	.	.	O	.	_	0	SENT_21	[p2l327t1316r708b1380],

1	lthough	JJ	O	lthough	amod	3	SENT_22	[p2l190t1698r489b1786],
2	colorectal	JJ	O	colorectal	amod	3	SENT_22	[p2l547t1698r909b1763],
3	cancer	NN	O	cancer	nsubjpass	7	SENT_22	[p2l966t1722r1203b1763],
4	can	MD	O	can	aux	7	SENT_22	[p2l1260t1722r1386b1763],
5	be	VB	O	be	auxpass	7	SENT_22	[p2l1441t1698r1524b1763],
6	effectively	RB	O	effectively	advmod	7	SENT_22	[p2l1583t1698r1953b1786],
7	prevented	VBN	O	prevent	_	0	SENT_22	[p2l2007t1722r2149b1786, p2l188t1805r436b1871],
8	through	IN	O	through	_	0	SENT_22	[p2l470t1805r775b1892],
9	early	JJ	O	early	amod	10	SENT_22	[p2l810t1805r985b1893],
10	detection	NN	O	detection	prep_through	7	SENT_22	[p2l1017t1805r1363b1871],
11	and	CC	O	and	_	0	SENT_22	[p2l1397t1805r1536b1871],
12	removal	NN	O	removal	conj_and	10	SENT_22	[p2l1570t1805r1866b1870],
13	of	IN	O	of	_	0	SENT_22	[p2l1900t1805r1985b1870],
14	precursor	NN	O	precursor	nn	16	SENT_22	[p2l2007t1828r2148b1893, p2l11t1938r246b1980],
15	adenomatous	JJ	O	adenomatous	amod	16	SENT_22	[p2l274t1915r779b1981],
16	polyps	NNS	O	polyp	prep_of	10	SENT_22	[p2l810t1915r1071b2003],
17	,	,	O	,	_	0	SENT_22	[p2l810t1915r1071b2003],
18	suboptimal	JJ	O	suboptimal	amod	19	SENT_22	[p2l1102t1915r1528b2003],
19	rates	NNS	O	rate	appos	16	SENT_22	[p2l1558t1933r1730b1980],
20	of	IN	O	of	_	0	SENT_22	[p2l1762t1915r1847b1980],
21	population	NN	O	population	prep_of	19	SENT_22	[p2l1863t1915r2149b2003, p2l11t2060r162b2122],

1	screening	VBG	O	screen	dep	106	SENT_23	[p2l195t2060r546b2145],
2	highlight	NN	O	highlight	dep	106	SENT_23	[p2l577t2057r923b2145],
3	the	DT	O	the	dep	106	SENT_23	[p2l956t2057r1071b2122],
4	importance	NN	O	importance	dep	106	SENT_23	[p2l1104t2060r1532b2145],
5	of	IN	O	of	dep	106	SENT_23	[p2l1566t2057r1651b2122],
6	investigating	VBG	O	investigate	dep	106	SENT_23	[p2l1671t2060r2152b2145],
7	chemopreventative	JJ	O	chemopreventative	dep	106	SENT_23	[p2l11t2163r714b2251],
8	strategies	NNS	O	strategy	dep	106	SENT_23	[p2l763t2166r1159b2251],
9	}	VBP	O	}	dep	106	SENT_23	[p2l763t2166r1159b2251],
10	Recently	RB	DATE	recently	dep	106	SENT_23	[p2l1211t2163r1544b2251],
11	,	,	O	,	_	0	SENT_23	[p2l1211t2163r1544b2251],
12	2	CD	NUMBER	2	dep	106	SENT_23	[p2l1593t2169r1632b2227],
13	randomized	VBN	O	randomize	dep	106	SENT_23	[p2l1684t2163r2149b2243],
14	,	,	O	,	_	0	SENT_23	[p2l1684t2163r2149b2243],
15	placebo	NN	O	placebo	dep	106	SENT_23	[p2l10t2270r726b2358],
16	—	NN	O	—	dep	106	SENT_23	[p2l10t2270r726b2358],
17	controlled	VBN	O	control	dep	106	SENT_23	[p2l10t2270r726b2358],
18	,	,	O	,	_	0	SENT_23	[p2l10t2270r726b2358],
19	clinical	JJ	O	clinical	dep	106	SENT_23	[p2l754t2270r1018b2335],
20	trials	NNS	O	trial	dep	106	SENT_23	[p2l1044t2270r1227b2335],
21	have	VBP	O	have	dep	106	SENT_23	[p2l1255t2270r1420b2335],
22	offered	VBN	O	offer	dep	106	SENT_23	[p2l1448t2270r1710b2336],
23	compelling	JJ	O	compelling	dep	106	SENT_23	[p2l1736t2270r2152b2358],
24	evidence	NN	O	evidence	dep	106	SENT_23	[p2l11t2377r323b2443],
25	that	IN	O	that	dep	106	SENT_23	[p2l382t2377r534b2442],
26	the	DT	O	the	dep	106	SENT_23	[p2l591t2377r706b2442],
27	cyclooxygenase	NN	O	cyclooxygenase	dep	106	SENT_23	[p2l765t2377r1396b2465],
28	—	NN	O	—	dep	106	SENT_23	[p2l765t2377r1396b2465],
29	2	CD	NUMBER	2	dep	106	SENT_23	[p2l765t2377r1396b2465],
30	selective	JJ	O	selective	dep	106	SENT_23	[p2l1457t2377r1759b2442],
31	inhibitor	NN	O	inhibitor	dep	106	SENT_23	[p2l1817t2377r2152b2442],
32	celecoxib	NN	O	celecoxib	dep	106	SENT_23	[p2l11t2485r343b2549],
33	reduces	VBZ	O	reduce	dep	106	SENT_23	[p2l372t2484r648b2551],
34	the	DT	O	the	dep	106	SENT_23	[p2l677t2485r792b2549],
35	risk	NN	O	risk	dep	106	SENT_23	[p2l819t2484r956b2549],
36	of	IN	O	of	dep	106	SENT_23	[p2l982t2485r1067b2549],
37	sporadic	JJ	O	sporadic	dep	106	SENT_23	[p2l1081t2484r1396b2572],
38	colorectal	JJ	O	colorectal	dep	106	SENT_23	[p2l1423t2485r1783b2549],
39	adenoma	NN	O	adenoma	dep	106	SENT_23	[p2l1810t2484r2153b2551],
40	among	IN	O	among	dep	106	SENT_23	[p2l11t2620r269b2683],
41	patients	NNS	O	patient	dep	106	SENT_23	[p2l293t2598r590b2683],
42	with	IN	O	with	dep	106	SENT_23	[p2l616t2596r782b2660],
43	a	DT	O	a	dep	106	SENT_23	[p2l809t2620r848b2660],
44	prior	JJ	O	prior	dep	106	SENT_23	[p2l871t2598r1057b2683],
45	history	NN	O	history	dep	106	SENT_23	[p2l1081t2596r1343b2683],
46	of	IN	O	of	dep	106	SENT_23	[p2l1367t2596r1452b2660],
47	adenoma	NN	O	adenoma	dep	106	SENT_23	[p2l1466t2595r1903b2662],
48	.2	NN	NUMBER	.2	dep	106	SENT_23	[p2l1466t2595r1903b2662],
49	=	JJ	O	=	dep	106	SENT_23	[p2l1466t2595r1903b2662],
50	3	CD	NUMBER	3	dep	106	SENT_23	[p2l1466t2595r1903b2662],
51	In	IN	O	in	dep	106	SENT_23	[p2l1930t2602r2008b2660],
52	the	DT	O	the	dep	106	SENT_23	[p2l2035t2596r2150b2660],
53	Adenoma	NNP	O	Adenoma	dep	106	SENT_23	[p2l7t2703r370b2769],
54	Prevention	NNP	O	Prevention	dep	106	SENT_23	[p2l396t2706r797b2767],
55	with	IN	O	with	dep	106	SENT_23	[p2l824t2703r990b2767],
56	Celecoxib	NNP	MISC	Celecoxib	dep	106	SENT_23	[p2l1021t2703r1374b2767],
57	(	CD	NUMBER	(	dep	106	SENT_23	[p2l1408t2703r1618b2787],
58	APC	NN	ORGANIZATION	apc	dep	106	SENT_23	[p2l1408t2703r1618b2787],
59	)	CD	NUMBER	)	dep	106	SENT_23	[p2l1408t2703r1618b2787],
60	trial	NN	O	trial	dep	106	SENT_23	[p2l1652t2703r1821b2783],
61	,	,	O	,	_	0	SENT_23	[p2l1652t2703r1821b2783],
62	patients	NNS	O	patient	dep	106	SENT_23	[p2l1852t2706r2149b2791],
63	who	WP	O	who	dep	106	SENT_23	[p2l9t2810r165b2875],
64	had	VBD	O	have	dep	106	SENT_23	[p2l196t2810r336b2876],
65	recently	RB	DATE	recently	dep	106	SENT_23	[p2l365t2810r658b2898],
66	undergone	VBN	O	undergo	dep	106	SENT_23	[p2l684t2810r1085b2898],
67	colonoscopic	JJ	O	colonoscopic	dep	106	SENT_23	[p2l1115t2810r1602b2898],
68	removal	NN	O	removal	dep	106	SENT_23	[p2l1633t2810r1929b2875],
69	of	IN	O	of	dep	106	SENT_23	[p2l1959t2810r2045b2875],
70	an	DT	O	a	dep	106	SENT_23	[p2l2063t2834r2150b2875],
71	adenoma	NN	O	adenoma	dep	106	SENT_23	[p2l11t2921r355b2987],
72	were	VBD	O	be	dep	106	SENT_23	[p2l376t2944r543b2986],
73	randomly	RB	O	randomly	dep	106	SENT_23	[p2l570t2921r931b3009],
74	assigned	VBN	O	assign	dep	106	SENT_23	[p2l954t2921r1270b3008],
75	to	TO	O	to	dep	106	SENT_23	[p2l1295t2940r1367b2986],
76	receive	VB	O	receive	dep	106	SENT_23	[p2l1395t2924r1640b2986],
77	placebo	NN	O	placebo	dep	106	SENT_23	[p2l1665t2921r1967b3009],
78	,	,	O	,	_	0	SENT_23	[p2l1665t2921r1967b3009],
79	lowdose	NN	O	lowdose	dep	106	SENT_23	[p2l1993t2921r2149b2986, p2l11t3028r176b3094],
80	(	NN	O	(	dep	106	SENT_23	[p2l209t3028r367b3112],
81	200	CD	NUMBER	200	dep	106	SENT_23	[p2l209t3028r367b3112],
82	mg	NN	O	mg	dep	106	SENT_23	[p2l399t3052r517b3116],
83	twice	RB	O	twice	dep	106	SENT_23	[p2l546t3031r734b3093],
84	daily	JJ	SET	daily	dep	106	SENT_23	[p2l766t3028r965b3116],
85	)	NN	O	)	dep	106	SENT_23	[p2l766t3028r965b3116],
86	of	IN	O	of	dep	106	SENT_23	[p2l999t3028r1084b3093],
87	celecoxib	NN	O	celecoxib	dep	106	SENT_23	[p2l1102t3028r1455b3108],
88	,	,	O	,	_	0	SENT_23	[p2l1102t3028r1455b3108],
89	or	CC	O	or	dep	106	SENT_23	[p2l1487t3052r1565b3093],
90	high-dose	JJ	O	high-dose	dep	106	SENT_23	[p2l1593t3028r1957b3116],
91	(	NN	O	(	dep	106	SENT_23	[p2l1990t3028r2148b3112],
92	400	CD	NUMBER	400	dep	106	SENT_23	[p2l1990t3028r2148b3112],
93	mg	NN	O	mg	dep	106	SENT_23	[p2l11t3159r126b3223],
94	twice	RB	O	twice	dep	106	SENT_23	[p2l148t3138r329b3200],
95	daily	JJ	SET	daily	dep	106	SENT_23	[p2l353t3135r544b3223],
96	)	NN	O	)	dep	106	SENT_23	[p2l353t3135r544b3223],
97	celecoxib	NN	O	celecoxib	dep	106	SENT_23	[p2l571t3135r889b3200],
98	and	CC	O	and	dep	106	SENT_23	[p2l914t3135r1049b3201],
99	underwent	VBD	O	undergo	dep	106	SENT_23	[p2l1070t3135r1458b3201],
100	follow-up	JJ	O	follow-up	dep	106	SENT_23	[p2l1480t3135r1824b3223],
101	colonoscopies	NNS	O	colonoscopy	dep	106	SENT_23	[p2l1849t3135r2149b3200, p2l11t3245r229b3330],
102	at	IN	O	at	dep	106	SENT_23	[p2l269t3261r336b3307],
103	1	CD	NUMBER	1	dep	106	SENT_23	[p2l381t3247r409b3306],
104	and	CC	O	and	dep	106	SENT_23	[p2l454t3242r593b3308],
105	3	CD	DURATION	3	dep	106	SENT_23	[p2l632t3247r670b3307],
106	years	NNS	NUMBER	year	_	0	SENT_23	[p2l710t3266r912b3330],
107	.	.	O	.	_	0	SENT_23	[p2l710t3266r912b3330],

1	The	DT	O	the	det	4	SENT_24	[p2l952t3242r1096b3307],
2	estimated	VBN	O	estimate	amod	4	SENT_24	[p2l1137t3242r1499b3308],
3	cumulative	JJ	O	cumulative	amod	4	SENT_24	[p2l1538t3242r1949b3307],
4	incidence	NN	O	incidence	nsubj	19	SENT_24	[p2l1989t3245r2149b3307, p2l11t3349r221b3415],
5	of	IN	O	of	_	0	SENT_24	[p2l253t3349r338b3414],
6	the	DT	O	the	det	7	SENT_24	[p2l358t3349r473b3414],
7	detection	NN	O	detection	prep_of	4	SENT_24	[p2l505t3349r852b3415],
8	of	IN	O	of	_	0	SENT_24	[p2l884t3349r969b3414],
9	one	CD	NUMBER	one	num	13	SENT_24	[p2l988t3373r1120b3414],
10	or	CC	O	or	_	0	SENT_24	[p2l1153t3372r1230b3414],
11	more	JJR	O	more	conj_or	9	SENT_24	[p2l1260t3373r1450b3414],
12	new	JJ	O	new	amod	13	SENT_24	[p2l1482t3373r1631b3414],
13	adenomas	NNS	O	adenoma	prep_of	7	SENT_24	[p2l1660t3349r2034b3415],
14	by	IN	O	by	_	0	SENT_24	[p2l2065t3349r2153b3437],
15	year	NN	DURATION	year	prep_by	13	SENT_24	[p2l8t3479r160b3544],
16	3	CD	NUMBER	3	num	15	SENT_24	[p2l194t3461r231b3521],
17	was	VBD	O	be	cop	19	SENT_24	[p2l268t3481r401b3521],
18	60.7	CD	PERCENT	60.7	num	19	SENT_24	[p2l439t3461r649b3522],
19	%	NN	PERCENT	%	_	0	SENT_24	[p2l439t3461r649b3522],
20	for	IN	O	for	_	0	SENT_24	[p2l685t3456r793b3521],
21	patients	NNS	O	patient	prep_for	19	SENT_24	[p2l826t3459r1123b3544],
22	receiving	VBG	O	receive	partmod	21	SENT_24	[p2l1160t3459r1488b3544],
23	placebo	NN	O	placebo	dobj	22	SENT_24	[p2l1521t3456r1823b3544],
24	,	,	O	,	_	0	SENT_24	[p2l1521t3456r1823b3544],
25	as	IN	O	as	advmod	19	SENT_24	[p2l1860t3481r1930b3521],
26	compared	VBN	O	compare	_	0	SENT_24	[p2l1967t3480r2149b3521, p2l10t3563r219b3651],
27	with	IN	O	with	prepc_compared_with	19	SENT_24	[p2l253t3563r419b3628],
28	43.2	CD	PERCENT	43.2	num	29	SENT_24	[p2l456t3568r669b3628],
29	%	NN	PERCENT	%	pobj	19	SENT_24	[p2l456t3568r669b3628],
30	for	IN	O	for	_	0	SENT_24	[p2l707t3563r814b3628],
31	those	DT	O	those	prep_for	29	SENT_24	[p2l851t3563r1049b3628],
32	receiving	VBG	O	receive	partmod	31	SENT_24	[p2l1087t3566r1416b3651],
33	low	JJ	O	low	amod	37	SENT_24	[p2l1451t3563r1778b3629],
34	—	NN	O	—	nn	37	SENT_24	[p2l1451t3563r1778b3629],
35	dose	NN	O	dose	nn	37	SENT_24	[p2l1451t3563r1778b3629],
36	celecoxib	NN	O	celecoxib	nn	37	SENT_24	[p2l1816t3563r2148b3628],
37	(	NN	O	(	dobj	32	SENT_24	[p2l13t3671r305b3755],
38	relative	JJ	O	relative	advmod	32	SENT_24	[p2l13t3671r305b3755],
39	risk	NN	O	risk	nn	42	SENT_24	[p2l358t3671r494b3736],
40	[	CD	NUMBER	[	num	42	SENT_24	[p2l550t3671r731b3755],
41	RR	NN	O	rr	nn	42	SENT_24	[p2l550t3671r731b3755],
42	]	NN	O	]	dep	38	SENT_24	[p2l550t3671r731b3755],
43	,	,	O	,	_	0	SENT_24	[p2l550t3671r731b3755],
44	0.67	CD	NUMBER	0.67	appos	42	SENT_24	[p2l784t3676r956b3751],
45	;	:	O	;	_	0	SENT_24	[p2l784t3676r956b3751],
46	95	CD	PERCENT	95	number	47	SENT_24	[p2l1011t3676r1155b3737],
47	%	NN	PERCENT	%	amod	48	SENT_24	[p2l1011t3676r1155b3737],
48	conﬁdence	NN	O	conﬁdence	dep	44	SENT_24	[p2l1208t3671r1606b3737],
49	interval	NN	O	interval	nn	52	SENT_24	[p2l1658t3671r1939b3736],
50	[	CD	NUMBER	[	num	52	SENT_24	[p2l1995t3671r2147b3755],
51	CI	NN	O	ci	nn	52	SENT_24	[p2l1995t3671r2147b3755],
52	]	NN	O	]	dep	48	SENT_24	[p2l1995t3671r2147b3755],
53	:	:	O	:	_	0	SENT_24	[p2l1995t3671r2147b3755],

1	0.59-0	CD	NUMBER	0.59-0	num	2	SENT_25	[p3l11t23r405b98],
2	.77	CD	NUMBER	.77	_	0	SENT_25	[p3l11t23r405b98],
3	;	:	O	;	_	0	SENT_25	[p3l11t23r405b98],
4	P	NN	O	p	dep	5	SENT_25	[p3l432t24r485b82],
5	<	JJR	O	<	dep	2	SENT_25	[p3l516t27r576b78],
6	.001	CD	NUMBER	.001	num	7	SENT_25	[p3l613t18r790b102],
7	)	NN	O	)	dep	5	SENT_25	[p3l613t18r790b102],
8	and	CC	O	and	_	0	SENT_25	[p3l824t18r963b84],
9	37.5	CD	PERCENT	37.5	num	10	SENT_25	[p3l992t23r1203b84],
10	%	NN	PERCENT	%	dep	2	SENT_25	[p3l992t23r1203b84],
11	for	IN	O	for	_	0	SENT_25	[p3l1233t18r1341b83],
12	those	DT	O	those	prep_for	10	SENT_25	[p3l1370t18r1568b83],
13	receiving	VBG	O	receive	partmod	12	SENT_25	[p3l1599t21r1928b106],
14	highdose	NN	O	highdose	nn	15	SENT_25	[p3l1956t18r2149b106, p3l11t125r176b191],
15	celecoxib	NN	O	celecoxib	dobj	13	SENT_25	[p3l212t125r543b190],
16	(	CD	NUMBER	(	num	17	SENT_25	[p3l582t125r738b209],
17	RR	NN	O	rr	tmod	13	SENT_25	[p3l582t125r738b209],
18	,	,	O	,	_	0	SENT_25	[p3l582t125r738b209],
19	0.55	CD	NUMBER	0.55	appos	17	SENT_25	[p3l774t130r946b205],
20	;	:	O	;	_	0	SENT_25	[p3l774t130r946b205],
21	95	CD	PERCENT	95	number	22	SENT_25	[p3l983t130r1127b191],
22	%	NN	PERCENT	%	amod	23	SENT_25	[p3l983t130r1127b191],
23	CI	NN	O	ci	dep	2	SENT_25	[p3l1164t130r1264b190],
24	:	:	O	:	_	0	SENT_25	[p3l1164t130r1264b190],
25	0.48-0	CD	NUMBER	0.48-0	number	26	SENT_25	[p3l1302t130r1696b205],
26	.64	CD	NUMBER	.64	dep	23	SENT_25	[p3l1302t130r1696b205],
27	;	:	O	;	_	0	SENT_25	[p3l1302t130r1696b205],
28	P	NN	O	p	dep	29	SENT_25	[p3l1728t131r1780b189],
29	<	JJR	O	<	dep	2	SENT_25	[p3l1815t134r1876b185],
30	.001	CD	NUMBER	.001	num	31	SENT_25	[p3l1917t125r2149b209],
31	)	NN	O	)	dep	29	SENT_25	[p3l1917t125r2149b209],
32	?	.	O	?	_	0	SENT_25	[p3l1917t125r2149b209],

1	Unfortunately	RB	O	unfortunately	advmod	15	SENT_26	[p3l10t233r560b320],
2	,	,	O	,	_	0	SENT_26	[p3l10t233r560b320],
3	in	IN	O	in	_	0	SENT_26	[p3l595t235r668b296],
4	a	DT	O	a	det	9	SENT_26	[p3l702t257r741b297],
5	separate	JJ	O	separate	amod	9	SENT_26	[p3l773t251r1094b320],
6	,	,	O	,	_	0	SENT_26	[p3l773t251r1094b320],
7	adjudicated	JJ	O	adjudicated	amod	9	SENT_26	[p3l1130t232r1565b320],
8	safety	NN	O	safety	nn	9	SENT_26	[p3l1599t233r1811b320],
9	analysis	NN	O	analysis	prep_in	15	SENT_26	[p3l1843t232r2149b320],
10	,	,	O	,	_	0	SENT_26	[p3l1843t232r2149b320],
11	the	DT	O	the	det	13	SENT_26	[p3l11t340r126b404],
12	APC	NN	ORGANIZATION	apc	nn	13	SENT_26	[p3l161t345r324b404],
13	trial	NN	O	trial	nsubj	15	SENT_26	[p3l364t340r515b404],
14	also	RB	O	also	advmod	15	SENT_26	[p3l552t340r694b404],
15	revealed	VBD	O	reveal	_	0	SENT_26	[p3l735t339r1033b406],
16	unexpected	JJ	O	unexpected	amod	18	SENT_26	[p3l1069t339r1494b427],
17	dose	NN	O	dose	nn	18	SENT_26	[p3l1530t339r1980b406],
18	—	NN	O	—	nsubj	19	SENT_26	[p3l1530t339r1980b406],
19	related	JJ	O	related	ccomp	15	SENT_26	[p3l1530t339r1980b406],
20	cardiovascular	JJ	O	cardiovascular	amod	22	SENT_26	[p3l2017t363r2149b404, p3l11t446r435b513],
21	toxicity	NN	O	toxicity	nn	22	SENT_26	[p3l468t449r795b534],
22	.4	NN	NUMBER	.4	dobj	19	SENT_26	[p3l468t449r795b534],

1	The	DT	O	the	dep	119	SENT_27	[p3l97t558r241b622],
2	highly	RB	O	highly	dep	119	SENT_27	[p3l269t558r505b645],
3	polymorphic	JJ	O	polymorphic	dep	119	SENT_27	[p3l529t558r1008b645],
4	cytochrome	NN	O	cytochrome	dep	119	SENT_27	[p3l1037t558r1473b645],
5	p450	NN	O	p450	dep	119	SENT_27	[p3l1501t562r1684b645],
6	enzyme	NN	O	enzyme	dep	119	SENT_27	[p3l1715t582r1992b645],
7	isoform	NN	O	isoform	dep	119	SENT_27	[p3l2020t560r2149b622, p3l11t665r193b729],
8	2C9	NN	O	2c9	dep	119	SENT_27	[p3l227t670r372b730],
9	(	CD	NUMBER	(	dep	119	SENT_27	[p3l412t665r770b749],
10	CYPZC9	NN	O	cypzc9	dep	119	SENT_27	[p3l412t665r770b749],
11	)	NN	O	)	dep	119	SENT_27	[p3l412t665r770b749],
12	is	VBZ	O	be	dep	119	SENT_27	[p3l808t668r863b729],
13	the	DT	O	the	dep	119	SENT_27	[p3l899t665r1014b729],
14	principal	JJ	O	principal	dep	119	SENT_27	[p3l1049t665r1383b752],
15	enzyme	NN	O	enzyme	dep	119	SENT_27	[p3l1417t689r1694b752],
16	responsible	JJ	O	responsible	dep	119	SENT_27	[p3l1730t665r2150b753],
17	for	IN	O	for	dep	119	SENT_27	[p3l11t772r119b836],
18	the	DT	O	the	dep	119	SENT_27	[p3l172t772r287b836],
19	metabolism	NN	O	metabolism	dep	119	SENT_27	[p3l343t772r781b837],
20	of	IN	O	of	dep	119	SENT_27	[p3l837t772r922b837],
21	several	JJ	O	several	dep	119	SENT_27	[p3l964t772r1210b837],
22	drugs	NNS	O	drug	dep	119	SENT_27	[p3l1264t771r1491b859],
23	,	,	O	,	_	0	SENT_27	[p3l1264t771r1491b859],
24	including	VBG	O	include	dep	119	SENT_27	[p3l1546t772r1904b859],
25	some	DT	O	some	dep	119	SENT_27	[p3l1958t796r2150b836],
26	nonselective	JJ	O	nonselective	dep	119	SENT_27	[p3l10t879r482b959],
27	,	,	O	,	_	0	SENT_27	[p3l10t879r482b959],
28	nonaspirin	JJ	O	nonaspirin	dep	119	SENT_27	[p3l512t881r936b966],
29	,	,	O	,	_	0	SENT_27	[p3l512t881r936b966],
30	nonsteroidal	JJ	O	nonsteroidal	dep	119	SENT_27	[p3l965t878r1438b945],
31	anti	JJ	O	anti	dep	119	SENT_27	[p3l1466t879r2153b966],
32	—	NN	O	—	dep	119	SENT_27	[p3l1466t879r2153b966],
33	inﬂammatory	JJ	O	inﬂammatory	dep	119	SENT_27	[p3l1466t879r2153b966],
34	drugs	NNS	O	drug	dep	119	SENT_27	[p3l11t985r218b1073],
35	(	VBP	O	(	dep	119	SENT_27	[p3l261t986r636b1070],
36	NSAIDS	NNS	MISC	nsaid	dep	119	SENT_27	[p3l261t986r636b1070],
37	)	CD	NUMBER	)	dep	119	SENT_27	[p3l261t986r636b1070],
38	,	,	O	,	_	0	SENT_27	[p3l261t986r636b1070],
39	celecoxib	NN	O	celecoxib	dep	119	SENT_27	[p3l677t986r1030b1066],
40	,	,	O	,	_	0	SENT_27	[p3l677t986r1030b1066],
41	and	CC	O	and	dep	119	SENT_27	[p3l1070t985r1209b1052],
42	Warfarin	NNP	O	Warfarin	dep	119	SENT_27	[p3l1245t986r1608b1051],
43	.5	CD	NUMBER	.5	dep	119	SENT_27	[p3l1245t986r1608b1051],
44	A	DT	O	a	dep	119	SENT_27	[p3l1646t992r1703b1050],
45	substantial	JJ	O	substantial	dep	119	SENT_27	[p3l1740t986r2151b1051],
46	body	NN	O	body	dep	119	SENT_27	[p3l9t1093r195b1180],
47	of	IN	O	of	dep	119	SENT_27	[p3l231t1093r316b1157],
48	in	FW	O	in	dep	119	SENT_27	[p3l342t1096r415b1157],
49	vitro	FW	O	vitro	dep	119	SENT_27	[p3l450t1096r624b1157],
50	and	CC	O	and	dep	119	SENT_27	[p3l665t1092r804b1159],
51	in	FW	O	in	dep	119	SENT_27	[p3l841t1095r914b1157],
52	vivo	FW	O	vivo	dep	119	SENT_27	[p3l949t1095r1098b1157],
53	evidence	NN	O	evidence	dep	119	SENT_27	[p3l1140t1093r1452b1159],
54	demonstrate	VBP	O	demonstrate	dep	119	SENT_27	[p3l1492t1093r1959b1159],
55	that	IN	O	that	dep	119	SENT_27	[p3l2000t1093r2151b1157],
56	the	DT	O	the	dep	119	SENT_27	[p3l11t1201r126b1266],
57	variant	JJ	O	variant	dep	119	SENT_27	[p3l162t1203r425b1266],
58	CYP2C9	NN	O	cyp2c9	dep	119	SENT_27	[p3l465t1206r861b1267],
59	*	NN	O	*	dep	119	SENT_27	[p3l465t1206r861b1267],
60	3	CD	NUMBER	3	dep	119	SENT_27	[p3l465t1206r861b1267],
61	allele	NN	O	allele	dep	119	SENT_27	[p3l904t1201r1090b1266],
62	(	CD	NUMBER	(	dep	119	SENT_27	[p3l1132t1201r1418b1285],
63	I359L	NN	O	i359l	dep	119	SENT_27	[p3l1132t1201r1418b1285],
64	)	NN	O	)	dep	119	SENT_27	[p3l1132t1201r1418b1285],
65	,	,	O	,	_	0	SENT_27	[p3l1132t1201r1418b1285],
66	with	IN	O	with	dep	119	SENT_27	[p3l1457t1201r1623b1266],
67	an	DT	O	a	dep	119	SENT_27	[p3l1662t1225r1750b1266],
68	estimated	VBN	O	estimate	dep	119	SENT_27	[p3l1790t1201r2152b1267],
69	prevalence	NN	O	prevalence	dep	119	SENT_27	[p3l10t1312r414b1399],
70	among	IN	O	among	dep	119	SENT_27	[p3l448t1336r713b1399],
71	the	DT	O	the	dep	119	SENT_27	[p3l746t1312r865b1376],
72	white	JJ	O	white	dep	119	SENT_27	[p3l897t1312r1107b1376],
73	population	NN	O	population	dep	119	SENT_27	[p3l1141t1312r1574b1400],
74	of	IN	O	of	dep	119	SENT_27	[p3l1607t1312r1694b1376],
75	6	CD	PERCENT	6	dep	119	SENT_27	[p3l1717t1316r1837b1392],
76	%	NN	PERCENT	%	dep	119	SENT_27	[p3l1717t1316r1837b1392],
77	,	,	O	,	_	0	SENT_27	[p3l1717t1316r1837b1392],
78	is	VBZ	O	be	dep	119	SENT_27	[p3l1871t1314r1927b1376],
79	associated	VBN	O	associate	dep	119	SENT_27	[p3l1963t1336r2149b1376, p3l11t1419r240b1485],
80	with	IN	O	with	dep	119	SENT_27	[p3l287t1419r458b1483],
81	impaired	JJ	O	impaired	dep	119	SENT_27	[p3l508t1419r855b1506],
82	metabolism	NN	O	metabolism	dep	119	SENT_27	[p3l905t1419r1360b1483],
83	of	IN	O	of	dep	119	SENT_27	[p3l1410t1419r1497b1483],
84	these	DT	O	these	dep	119	SENT_27	[p3l1535t1419r1731b1483],
85	drugs	NNS	O	drug	dep	119	SENT_27	[p3l1782t1419r2149b1506],
86	.5	CD	NUMBER	.5	dep	119	SENT_27	[p3l1782t1419r2149b1506],
87	—	CD	NUMBER	—	dep	119	SENT_27	[p3l1782t1419r2149b1506],
88	13	CD	NUMBER	13	dep	119	SENT_27	[p3l1782t1419r2149b1506],
89	The	DT	O	the	dep	119	SENT_27	[p3l8t1527r155b1592],
90	more	JJR	O	more	dep	119	SENT_27	[p3l191t1551r386b1592],
91	common	JJ	O	common	dep	119	SENT_27	[p3l422t1551r764b1592],
92	CYP2C9	NN	O	cyp2c9	dep	119	SENT_27	[p3l800t1532r1210b1593],
93	*	NN	O	*	dep	119	SENT_27	[p3l800t1532r1210b1593],
94	2	CD	NUMBER	2	dep	119	SENT_27	[p3l800t1532r1210b1593],
95	(	CD	NUMBER	(	dep	119	SENT_27	[p3l1250t1527r1563b1611],
96	R144C	NN	O	r144c	dep	119	SENT_27	[p3l1250t1527r1563b1611],
97	)	CD	NUMBER	)	dep	119	SENT_27	[p3l1250t1527r1563b1611],
98	allele	NN	O	allele	dep	119	SENT_27	[p3l1602t1527r1819b1607],
99	,	,	O	,	_	0	SENT_27	[p3l1602t1527r1819b1607],
100	with	IN	O	with	dep	119	SENT_27	[p3l1853t1527r2025b1592],
101	an	DT	O	a	dep	119	SENT_27	[p3l2061t1551r2151b1592],
102	estimated	VBN	O	estimate	dep	119	SENT_27	[p3l11t1634r388b1700],
103	prevalence	NN	O	prevalence	dep	119	SENT_27	[p3l421t1634r824b1722],
104	of	IN	O	of	dep	119	SENT_27	[p3l861t1634r947b1699],
105	10	CD	PERCENT	10	dep	119	SENT_27	[p3l977t1639r1119b1699],
106	%	NN	PERCENT	%	dep	119	SENT_27	[p3l977t1639r1119b1699],
107	among	IN	O	among	dep	119	SENT_27	[p3l1155t1658r1420b1722],
108	white	JJ	O	white	dep	119	SENT_27	[p3l1452t1634r1663b1699],
109	individuals	NNS	O	individual	dep	119	SENT_27	[p3l1698t1634r2149b1714],
110	,	,	O	,	_	0	SENT_27	[p3l1698t1634r2149b1714],
111	has	VBZ	O	have	dep	119	SENT_27	[p3l10t1741r136b1805],
112	also	RB	O	also	dep	119	SENT_27	[p3l173t1741r320b1805],
113	been	VBN	O	be	dep	119	SENT_27	[p3l356t1741r534b1805],
114	associated	VBN	O	associate	dep	119	SENT_27	[p3l570t1741r965b1806],
115	with	IN	O	with	dep	119	SENT_27	[p3l997t1741r1168b1805],
116	a	DT	O	a	dep	119	SENT_27	[p3l1204t1765r1244b1805],
117	less	RBR	O	less	dep	119	SENT_27	[p3l1276t1741r1408b1805],
118	substantial	JJ	O	substantial	dep	119	SENT_27	[p3l1446t1741r1874b1805],
119	reducAbbreviation	NN	O	reducabbreviation	_	0	SENT_27	[p3l1910t1741r2149b1806, p3l77t2002r461b2051],

1	used	VBN	O	use	_	0	SENT_28	[p3l502t2003r646b2051],
2	in	IN	O	in	_	0	SENT_28	[p3l682t2002r733b2051],
3	this	DT	O	this	det	4	SENT_28	[p3l774t2002r883b2051],
4	paper	NN	O	paper	prep_in	1	SENT_28	[p3l918t2014r1110b2063],
5	:	:	O	:	_	0	SENT_28	[p3l918t2014r1110b2063],
6	APC	NN	ORGANIZATION	apc	dep	4	SENT_28	[p3l1147t2002r1288b2061],
7	,	,	O	,	_	0	SENT_28	[p3l1147t2002r1288b2061],
8	Adenoma	NNP	O	Adenoma	nn	9	SENT_28	[p3l1327t2003r1620b2051],
9	Prevention	NNP	O	Prevention	appos	6	SENT_28	[p3l1664t2002r1983b2051],
10	with	IN	O	with	prep	1	SENT_28	[p3l2023t2003r2148b2051],

1	Celecoxib	NNP	O	Celecoxib	_	0	SENT_29	[p3l10t2089r298b2138],
2	trial	NN	O	trial	dep	1	SENT_29	[p3l325t2090r458b2139],
3	.	.	O	.	_	0	SENT_29	[p3l325t2090r458b2139],

1	©	RB	O	©	dep	2	SENT_30	[p3l676t2185r720b2228],
2	2009	CD	DATE	2009	_	0	SENT_30	[p3l743t2179r896b2228],
3	by	IN	O	by	dep	2	SENT_30	[p3l921t2179r984b2240],
4	the	DT	O	the	det	6	SENT_30	[p3l1003t2179r1093b2228],
5	AGA	NNP	ORGANIZATION	AGA	nn	6	SENT_30	[p3l1113t2179r1240b2228],
6	Institute	NNP	ORGANIZATION	Institute	pobj	3	SENT_30	[p3l1263t2179r1486b2228],
7	0016-5085/09	CD	DURATION	0016-5085/09	num	6	SENT_30	[p3l718t2264r1442b2329],
8	/	:	O	/	punct	9	SENT_30	[p3l718t2264r1442b2329],
9	$	$	MONEY	$	dep	6	SENT_30	[p3l718t2264r1442b2329],
10	36.00	CD	MONEY	36.00	num	9	SENT_30	[p3l718t2264r1442b2329],

1	doi	FW	O	doi	nn	2	SENT_31	[p3l547t2356r1613b2419],
2	:10.1053	FW	O	:10.1053	_	0	SENT_31	[p3l547t2356r1613b2419],
3	/	:	O	/	punct	5	SENT_31	[p3l547t2356r1613b2419],
4	j.	NN	O	j.	nn	5	SENT_31	[p3l547t2356r1613b2419],
5	gastro	NN	O	gastro	dep	2	SENT_31	[p3l547t2356r1613b2419],
6	.2009.02.045	CD	NUMBER	.2009.02.045	dep	2	SENT_31	[p3l547t2356r1613b2419],

1	2128	CD	DATE	2128	_	0	SENT_32	[p3l369t2449r504b2491],
2	CHAN	NNP	MISC	CHAN	nn	4	SENT_32	[p3l566t2450r707b2491],
3	ET	NNP	MISC	ET	nn	4	SENT_32	[p3l735t2450r791b2490],
4	AL	NNP	MISC	AL	dep	1	SENT_32	[p3l811t2450r876b2490],

1	tion	NN	O	tion	dep	21	SENT_33	[p3l370t2627r499b2678],
2	in	IN	O	in	_	0	SENT_33	[p3l541t2627r601b2677],
3	enzyme	NN	O	enzyme	nn	4	SENT_33	[p3l642t2644r872b2697],
4	activity	NN	O	activity	prep_in	1	SENT_33	[p3l914t2627r1137b2697],
5	in	IN	O	in	_	0	SENT_33	[p3l1175t2627r1235b2677],
6	some	DT	O	some	det	8	SENT_33	[p3l1276t2628r1737b2691],
7	,5	CD	NUMBER	,5	num	8	SENT_33	[p3l1276t2628r1737b2691],
8	»	NN	O	»	prep_in	1	SENT_33	[p3l1276t2628r1737b2691],
9	1	CD	NUMBER	1	number	10	SENT_33	[p3l1276t2628r1737b2691],
10	°	CD	NUMBER	°	num	11	SENT_33	[p3l1276t2628r1737b2691],
11	»	NN	O	»	dep	8	SENT_33	[p3l1276t2628r1737b2691],
12	11	CD	NUMBER	11	number	13	SENT_33	[p3l1276t2628r1737b2691],
13	»	CD	NUMBER	»	dep	15	SENT_33	[p3l1276t2628r1737b2691],
14	14	CD	NUMBER	14	npadvmod	15	SENT_33	[p3l1276t2628r1737b2691],
15	>	JJR	O	>	amod	11	SENT_33	[p3l1276t2628r1737b2691],
16	15	CD	NUMBER	15	dep	8	SENT_33	[p3l1276t2628r1737b2691],
17	but	CC	O	but	_	0	SENT_33	[p3l1779t2624r1886b2678],
18	not	RB	O	not	_	0	SENT_33	[p3l1926t2640r2031b2678],
19	all	DT	O	all	det	20	SENT_33	[p3l2071t2624r2143b2678],
20	studies	NNS	O	study	prep_in	1	SENT_33	[p3l370t2713r693b2768],
21	.9	VBP	NUMBER	.9	_	0	SENT_33	[p3l370t2713r693b2768],
22	>	JJR	O	>	acomp	21	SENT_33	[p3l370t2713r693b2768],
23	12	CD	NUMBER	12	nsubj	21	SENT_33	[p3l370t2713r693b2768],

1	Because	IN	O	because	mark	7	SENT_34	[p3l444t2805r685b2854],
2	interindividual	JJ	O	interindividual	amod	3	SENT_34	[p3l713t2800r1175b2855],
3	variability	NN	O	variability	nsubj	7	SENT_34	[p3l1200t2800r1511b2873],
4	in	IN	O	in	_	0	SENT_34	[p3l1536t2803r1596b2853],
5	metabolism	NN	O	metabolism	prep_in	3	SENT_34	[p3l1625t2800r1988b2854],
6	may	MD	O	may	aux	7	SENT_34	[p3l2016t2820r2145b2873],
7	inﬂuence	VB	O	inﬂuence	advcl	15	SENT_34	[p3l369t2889r651b2943],
8	both	DT	O	both	det	10	SENT_34	[p3l675t2889r820b2943],
9	drug	NN	O	drug	nn	10	SENT_34	[p3l846t2889r991b2962],
10	efficacy	NN	O	efficacy	dobj	7	SENT_34	[p3l1016t2889r1244b2962],
11	and	CC	O	and	_	0	SENT_34	[p3l1266t2889r1381b2944],
12	safety	NN	O	safety	conj_and	10	SENT_34	[p3l1406t2889r1595b2962],
13	,	,	O	,	_	0	SENT_34	[p3l1406t2889r1595b2962],
14	we	PRP	O	we	nsubj	15	SENT_34	[p3l1620t2910r1700b2943],
15	examined	VBD	O	examine	_	0	SENT_34	[p3l1726t2889r2022b2944],
16	the	DT	O	the	det	17	SENT_34	[p3l2047t2889r2142b2943],
17	inﬂuence	NN	O	inﬂuence	dobj	15	SENT_34	[p3l369t2978r651b3032],
18	of	IN	O	of	_	0	SENT_34	[p3l691t2978r761b3032],
19	CYPZC9	NN	O	cypzc9	nn	21	SENT_34	[p3l791t2983r1043b3032],
20	genetic	JJ	O	genetic	amod	21	SENT_34	[p3l1085t2980r1302b3051],
21	variants	NNS	O	variant	prep_of	17	SENT_34	[p3l1338t2980r1583b3032],
22	on	IN	O	on	_	0	SENT_34	[p3l1624t2998r1702b3032],
23	the	DT	O	the	det	24	SENT_34	[p3l1742t2978r1837b3032],
24	effect	NN	O	effect	prep_on	21	SENT_34	[p3l1877t2978r2044b3032],
25	of	IN	O	of	_	0	SENT_34	[p3l2083t2978r2153b3032],
26	celecoxib	NN	O	celecoxib	prep_of	24	SENT_34	[p3l370t3067r645b3120],
27	in	IN	O	in	_	0	SENT_34	[p3l680t3069r740b3120],
28	patients	NNS	O	patient	prep_in	15	SENT_34	[p3l772t3069r1019b3140],
29	enrolled	VBN	O	enrol	partmod	28	SENT_34	[p3l1054t3067r1306b3122],
30	in	IN	O	in	_	0	SENT_34	[p3l1337t3069r1397b3120],
31	the	DT	O	the	det	33	SENT_34	[p3l1431t3067r1526b3120],
32	APC	NN	ORGANIZATION	apc	nn	33	SENT_34	[p3l1557t3071r1691b3121],
33	trial	NN	O	trial	prep_in	29	SENT_34	[p3l1727t3067r1865b3120],
34	.	.	O	.	_	0	SENT_34	[p3l1727t3067r1865b3120],

1	Because	IN	O	because	mark	10	SENT_35	[p3l1901t3072r2142b3120],
2	the	DT	O	the	det	4	SENT_35	[p3l370t3156r466b3209],
3	APC	NN	ORGANIZATION	apc	nn	4	SENT_35	[p3l490t3160r625b3209],
4	trial	NN	O	trial	nsubj	10	SENT_35	[p3l654t3156r779b3209],
5	was	VBD	O	be	cop	10	SENT_35	[p3l804t3176r914b3209],
6	a	DT	O	a	det	10	SENT_35	[p3l942t3176r975b3209],
7	placebo-controlled	JJ	O	placebo-controlled	amod	10	SENT_35	[p3l999t3156r1592b3229],
8	,	,	O	,	_	0	SENT_35	[p3l999t3156r1592b3229],
9	randomized	JJ	O	randomized	amod	10	SENT_35	[p3l1621t3156r1992b3211],
10	trial	NN	O	trial	advcl	23	SENT_35	[p3l2019t3156r2144b3209],
11	examining	VBG	O	examine	partmod	10	SENT_35	[p3l370t3247r693b3317],
12	both	CC	O	both	preconj	15	SENT_35	[p3l732t3244r878b3298],
13	low	JJ	O	low	amod	15	SENT_35	[p3l918t3244r1189b3299],
14	—	NN	O	—	nn	15	SENT_35	[p3l918t3244r1189b3299],
15	dose	NN	O	dose	dobj	11	SENT_35	[p3l918t3244r1189b3299],
16	and	CC	O	and	_	0	SENT_35	[p3l1231t3244r1346b3299],
17	high	JJ	O	high	amod	20	SENT_35	[p3l1386t3244r1688b3317],
18	—	NN	O	—	nn	20	SENT_35	[p3l1386t3244r1688b3317],
19	dose	NN	O	dose	nn	20	SENT_35	[p3l1386t3244r1688b3317],
20	celecoxib	NN	O	celecoxib	dobj	11	SENT_35	[p3l1730t3245r2022b3311],
21	,	,	O	,	_	0	SENT_35	[p3l1730t3245r2022b3311],
22	we	PRP	O	we	nsubj	23	SENT_35	[p3l2063t3265r2143b3298],
23	had	VBD	O	have	_	0	SENT_35	[p3l369t3333r485b3388],
24	a	DT	O	a	det	26	SENT_35	[p3l519t3354r552b3387],
25	unique	JJ	O	unique	amod	26	SENT_35	[p3l585t3336r800b3406],
26	opportunity	NN	O	opportunity	dobj	23	SENT_35	[p3l836t3336r1214b3406],
27	to	TO	O	to	aux	28	SENT_35	[p3l1247t3349r1308b3387],
28	examine	VB	O	examine	infmod	26	SENT_35	[p3l1345t3336r1598b3387],
29	the	DT	O	the	det	30	SENT_35	[p3l1634t3333r1730b3387],
30	inﬂuence	NN	O	inﬂuence	dobj	28	SENT_35	[p3l1765t3333r2046b3387],
31	of	IN	O	of	_	0	SENT_35	[p3l2082t3333r2153b3387],
32	CYPZC9	NN	O	cypzc9	nn	34	SENT_35	[p3l371t3427r623b3477],
33	variant	JJ	O	variant	amod	34	SENT_35	[p3l649t3425r867b3476],
34	genotypes	NNS	O	genotype	prep_of	30	SENT_35	[p3l894t3438r1200b3495],
35	on	IN	O	on	_	0	SENT_35	[p3l1229t3442r1307b3476],
36	celecoxib	NN	O	celecoxib	nn	37	SENT_35	[p3l1335t3422r1610b3476],
37	dosing	NN	O	dosing	prep_on	34	SENT_35	[p3l1639t3422r1846b3495],
38	and	CC	O	and	_	0	SENT_35	[p3l1872t3422r1988b3477],
39	subsequent	JJ	O	subsequent	amod	40	SENT_35	[p3l2014t3422r2142b3476, p3l370t3527r609b3584],
40	risk	NN	O	risk	conj_and	34	SENT_35	[p3l637t3511r750b3565],
41	of	IN	O	of	_	0	SENT_35	[p3l779t3511r849b3565],
42	both	CC	O	both	preconj	43	SENT_35	[p3l866t3511r1011b3565],
43	adenoma	NN	O	adenoma	prep_of	40	SENT_35	[p3l1040t3511r1325b3566],
44	and	CC	O	and	_	0	SENT_35	[p3l1351t3511r1467b3566],
45	adverse	JJ	O	adverse	amod	46	SENT_35	[p3l1494t3511r1717b3566],
46	events	NNS	O	event	conj_and	43	SENT_35	[p3l1746t3527r1949b3565],
47	.	.	O	.	_	0	SENT_35	[p3l1746t3527r1949b3565],

1	-	:	O	-	_	0	SENT_36	[p3l159t3181r200b3445],
2	'	''	O	'	_	0	SENT_36	[p3l159t3181r200b3445],
3	lV3INl	NN	O	lv3inl	nn	5	SENT_36	[p3l159t3181r200b3445],
4	'	''	O	'	_	0	SENT_36	[p3l159t3181r200b3445],
5	I3	NN	O	i3	_	0	SENT_36	[p3l159t3181r200b3445],
6	>	JJR	O	>	dep	5	SENT_36	[p3l93t3047r132b3087],
7	:	:	O	:	_	0	SENT_36	[p3l93t3091r132b3126],
8	3	CD	NUMBER	3	num	10	SENT_36	[p3l93t3131r132b3179],
9	M	NN	O	m	nn	10	SENT_36	[p3l93t3184r132b3206],
10	Z	NN	O	z	dep	5	SENT_36	[p3l93t3212r132b3251],
11	.	.	O	.	_	0	SENT_36	[p3l93t3255r132b3282],

1	—	NN	O	—	_	0	SENT_37	[p3l93t3255r132b3282],
2	.	.	O	.	_	0	SENT_37	[p3l93t3255r132b3282],

1	I	PRP	O	I	nn	7	SENT_38	[p3l93t3255r132b3282],
2	5	CD	NUMBER	5	dep	4	SENT_38	[p3l93t3283r132b3358],
3	'	''	O	'	_	0	SENT_38	[p3l93t3358r132b3395],
4	<	JJR	O	<	rcmod	1	SENT_38	[p3l93t3358r132b3395],
5	53	CD	NUMBER	53	dep	4	SENT_38	[p3l93t3413r132b3515],
6	'	''	O	'	_	0	SENT_38	[p3l93t3413r132b3515],
7	C	NN	O	c	_	0	SENT_38	[p3l92t3517r133b3547],
8	-	:	O	-	_	0	SENT_38	[p3l93t3550r132b3577],
9	I	PRP	O	I	dep	7	SENT_38	[p3l93t3550r132b3577],

1	Patients	NNS	O	patient	_	0	SENT_39	[p3l595t3689r903b3750],
2	and	CC	O	and	_	0	SENT_39	[p3l935t3690r1073b3750],
3	Methods	NNS	O	method	conj_and	1	SENT_39	[p3l1110t3690r1437b3750],

1	Study	NNP	O	Study	nn	3	SENT_40	[p4l591t35r775b115],
2	Population	NNP	O	Population	nn	3	SENT_40	[p4l802t35r1166b115],
3	Patients	NNPS	O	Patients	nsubjpass	5	SENT_40	[p4l591t131r848b182],
4	were	VBD	O	be	auxpass	5	SENT_40	[p4l887t148r1030b182],
5	derived	VBN	O	derive	_	0	SENT_40	[p4l1071t129r1303b183],
6	from	IN	O	from	_	0	SENT_40	[p4l1342t129r1498b182],
7	the	DT	O	the	det	9	SENT_40	[p4l1538t129r1636b182],
8	Adenoma	NNP	O	Adenoma	nn	9	SENT_40	[p4l1673t129r1983b183],
9	Prevention	NNP	O	Prevention	prep_from	5	SENT_40	[p4l2020t134r2142b182, p4l367t218r611b270],
10	with	IN	O	with	_	0	SENT_40	[p4l641t216r782b269],
11	Celecoxib	NNP	MISC	Celecoxib	nn	13	SENT_40	[p4l815t216r1120b270],
12	(	CD	NUMBER	(	num	13	SENT_40	[p4l1155t216r1336b286],
13	APC	NN	ORGANIZATION	apc	prep_with	9	SENT_40	[p4l1155t216r1336b286],
14	)	CD	NUMBER	)	num	15	SENT_40	[p4l1155t216r1336b286],
15	trial	NN	O	trial	tmod	9	SENT_40	[p4l1371t216r1518b282],
16	,	,	O	,	_	0	SENT_40	[p4l1371t216r1518b282],
17	(	CD	NUMBER	(	num	18	SENT_40	[p4l1553t216r2144b289],
18	ClinicalTrials	NNS	O	clinicaltrial	appos	15	SENT_40	[p4l1553t216r2144b289],
19	.	.	O	.	_	0	SENT_40	[p4l1553t216r2144b289],

1	gov	NN	O	gov	nn	3	SENT_41	[p4l1553t216r2144b289],
2	NCT00005094	NN	O	nct00005094	nn	3	SENT_41	[p4l369t304r847b373],
3	)	NN	O	)	_	0	SENT_41	[p4l369t304r847b373],
4	for	IN	O	for	_	0	SENT_41	[p4l876t304r966b357],
5	which	WDT	O	which	dobj	14	SENT_41	[p4l988t304r1174b357],
6	the	DT	O	the	det	7	SENT_41	[p4l1201t304r1296b357],
7	methods	NNS	O	method	nsubjpass	14	SENT_41	[p4l1323t304r1591b358],
8	and	CC	O	and	_	0	SENT_41	[p4l1618t304r1733b358],
9	main	JJ	O	main	amod	10	SENT_41	[p4l1758t306r1915b357],
10	results	NNS	O	result	nsubjpass	14	SENT_41	[p4l1941t304r2141b357],
11	have	VBP	O	have	aux	14	SENT_41	[p4l369t391r507b445],
12	been	VBN	O	be	auxpass	14	SENT_41	[p4l544t391r688b445],
13	previously	RB	DATE	previously	advmod	14	SENT_41	[p4l726t391r1043b464],
14	described	VBN	O	describe	prepc_for	3	SENT_41	[p4l1080t391r1370b446],
15	in	IN	O	in	_	0	SENT_41	[p4l1407t393r1468b444],
16	detail	NN	O	detail	prep_in	14	SENT_41	[p4l1506t391r1719b446],
17	?	.	O	?	_	0	SENT_41	[p4l1506t391r1719b446],

1	The	DT	O	the	det	2	SENT_42	[p4l1756t391r1875b445],
2	ﬂow	NN	O	ﬂow	nsubjpass	9	SENT_42	[p4l1914t391r2046b445],
3	of	IN	O	of	_	0	SENT_42	[p4l2083t391r2153b445],
4	patients	NNS	O	patient	prep_of	2	SENT_42	[p4l369t482r616b553],
5	through	IN	O	through	_	0	SENT_42	[p4l641t480r894b553],
6	the	DT	O	the	det	7	SENT_42	[p4l918t480r1014b534],
7	study	NN	O	study	prep_through	4	SENT_42	[p4l1038t480r1207b553],
8	is	VBZ	O	be	auxpass	9	SENT_42	[p4l1228t482r1273b534],
9	summarized	VBN	O	summarize	_	0	SENT_42	[p4l1298t480r1680b535],
10	in	IN	O	in	_	0	SENT_42	[p4l1702t482r1762b533],
11	Figure	NNP	O	Figure	prep_in	9	SENT_42	[p4l1785t482r1981b553],
12	1	CD	NUMBER	1	num	11	SENT_42	[p4l2011t484r2053b534],
13	.	.	O	.	_	0	SENT_42	[p4l2011t484r2053b534],

1	In	IN	O	in	_	0	SENT_43	[p4l2079t485r2143b533],
2	brief	NN	O	brief	prep_in	9	SENT_43	[p4l368t568r525b634],
3	,	,	O	,	_	0	SENT_43	[p4l368t568r525b634],
4	the	DT	O	the	det	6	SENT_43	[p4l549t568r645b622],
5	APC	NN	ORGANIZATION	apc	nn	6	SENT_43	[p4l664t572r799b622],
6	trial	NN	O	trial	nsubjpass	9	SENT_43	[p4l824t568r949b622],
7	was	VBD	O	be	auxpass	9	SENT_43	[p4l969t588r1079b622],
8	a	DT	O	a	dep	9	SENT_43	[p4l1104t588r1136b622],
9	randomized	VBN	O	randomize	_	0	SENT_43	[p4l1156t568r1542b634],
10	,	,	O	,	_	0	SENT_43	[p4l1156t568r1542b634],
11	placebo	NN	O	placebo	nn	12	SENT_43	[p4l1565t568r2144b641],
12	—	NN	O	—	dobj	9	SENT_43	[p4l1565t568r2144b641],
13	controlled	VBN	O	control	partmod	12	SENT_43	[p4l1565t568r2144b641],
14	trial	NN	O	trial	dobj	13	SENT_43	[p4l370t656r495b710],
15	designed	VBN	O	design	partmod	14	SENT_43	[p4l528t656r799b729],
16	to	TO	O	to	aux	17	SENT_43	[p4l831t672r891b710],
17	examine	VB	O	examine	xcomp	15	SENT_43	[p4l925t658r1179b710],
18	the	DT	O	the	det	19	SENT_43	[p4l1212t656r1307b710],
19	effect	NN	O	effect	dobj	17	SENT_43	[p4l1341t656r1507b710],
20	of	IN	O	of	_	0	SENT_43	[p4l1540t656r1610b710],
21	celecoxib	NN	O	celecoxib	prep_of	19	SENT_43	[p4l1633t656r1908b710],
22	on	IN	O	on	_	0	SENT_43	[p4l1942t676r2021b710],
23	occurrence	NN	O	occurrence	prep_on	17	SENT_43	[p4l2053t676r2142b710, p4l370t764r632b799],
24	of	IN	O	of	_	0	SENT_43	[p4l676t745r746b799],
25	endoscopically	RB	O	endoscopically	advmod	26	SENT_43	[p4l780t745r1234b818],
26	detected	VBN	O	detect	amod	27	SENT_43	[p4l1275t745r1533b800],
27	adenomas	NNS	O	adenoma	prep_of	23	SENT_43	[p4l1575t745r1886b800],
28	among	IN	O	among	_	0	SENT_43	[p4l1930t765r2144b818],
29	patients	NNS	O	patient	prep_among	13	SENT_43	[p4l369t835r616b906],
30	who	WP	O	who	nsubj	46	SENT_43	[p4l639t833r769b887],
31	had	VBD	O	have	aux	32	SENT_43	[p4l794t833r910b888],
32	undergone	VBN	O	undergo	rcmod	29	SENT_43	[p4l932t833r1264b906],
33	colonoscopic	JJ	O	colonoscopic	amod	34	SENT_43	[p4l1289t833r1692b906],
34	removal	NN	O	removal	dobj	32	SENT_43	[p4l1717t833r1963b887],
35	of	IN	O	of	_	0	SENT_43	[p4l1987t833r2057b887],
36	all	DT	O	all	det	38	SENT_43	[p4l2072t833r2143b887],
37	colorectal	JJ	O	colorectal	amod	38	SENT_43	[p4l370t921r669b975],
38	adenomas	NNS	O	adenoma	prep_of	34	SENT_43	[p4l693t921r1003b976],
39	within	IN	O	within	_	0	SENT_43	[p4l1027t921r1228b974],
40	6	CD	DURATION	6	num	41	SENT_43	[p4l1253t925r1284b975],
41	months	NNS	NUMBER	month	prep_within	32	SENT_43	[p4l1310t921r1547b975],
42	of	IN	O	of	_	0	SENT_43	[p4l1573t921r1643b975],
43	study	NN	O	study	nn	44	SENT_43	[p4l1657t921r1827b994],
44	entry	NN	O	entry	prep_of	41	SENT_43	[p4l1849t937r2007b994],
45	and	CC	O	and	_	0	SENT_43	[p4l2029t921r2144b976],
46	had	VBD	O	have	conj_and	32	SENT_43	[p4l369t1009r485b1064],
47	a	DT	O	a	det	49	SENT_43	[p4l512t1029r545b1063],
48	high	JJ	O	high	amod	49	SENT_43	[p4l570t1009r708b1082],
49	risk	NN	O	risk	dobj	46	SENT_43	[p4l737t1009r850b1063],
50	of	IN	O	of	_	0	SENT_43	[p4l877t1009r948b1063],
51	recurrent	JJ	O	recurrent	amod	52	SENT_43	[p4l966t1025r1251b1063],
52	adenomas	NNS	O	adenoma	prep_of	49	SENT_43	[p4l1278t1009r1588b1064],
53	on	IN	O	on	_	0	SENT_43	[p4l1617t1029r1696b1063],
54	the	DT	O	the	det	55	SENT_43	[p4l1724t1009r1819b1063],
55	basis	NN	O	basis	prep_on	46	SENT_43	[p4l1846t1009r1994b1063],
56	of	IN	O	of	_	0	SENT_43	[p4l2024t1009r2095b1063],
57	a	DT	O	a	det	58	SENT_43	[p4l2112t1029r2145b1063],
58	history	NN	O	history	prep_of	55	SENT_43	[p4l369t1097r586b1170],
59	of	IN	O	of	_	0	SENT_43	[p4l628t1097r698b1151],
60	either	CC	O	either	preconj	62	SENT_43	[p4l732t1097r909b1151],
61	multiple	JJ	O	multiple	amod	62	SENT_43	[p4l951t1097r1213b1170],
62	adenomas	NNS	O	adenoma	prep_of	58	SENT_43	[p4l1257t1097r1567b1152],
63	or	CC	O	or	_	0	SENT_43	[p4l1612t1116r1676b1151],
64	removal	NN	O	removal	conj_or	62	SENT_43	[p4l1719t1097r1965b1151],
65	of	IN	O	of	_	0	SENT_43	[p4l2008t1097r2079b1151],
66	a	DT	O	a	det	68	SENT_43	[p4l2112t1117r2145b1151],
67	single	JJ	O	single	amod	68	SENT_43	[p4l370t1185r546b1258],
68	adenoma	NN	O	adenoma	prep_of	58	SENT_43	[p4l570t1185r855b1240],
69	more	RBR	O	more	advmod	70	SENT_43	[p4l876t1204r1033b1239],
70	than	IN	O	than	quantmod	71	SENT_43	[p4l1057t1185r1198b1239],
71	5	CD	NUMBER	5	num	72	SENT_43	[p4l1221t1189r1252b1239],
72	mm	NN	O	mm	dobj	32	SENT_43	[p4l1279t1205r1401b1238],
73	in	IN	O	in	_	0	SENT_43	[p4l1423t1187r1483b1238],
74	diameter	NN	O	diameter	prep_in	72	SENT_43	[p4l1506t1185r1792b1240],
75	.	.	O	.	_	0	SENT_43	[p4l1506t1185r1792b1240],

1	Two	CD	DATE	two	num	2	SENT_44	[p4l1815t1190r1949b1239],
2	thousand	CD	DATE	thousand	nsubjpass	9	SENT_44	[p4l1974t1185r2141b1239, p4l370t1274r514b1329],
3	thirty	CD	DATE	thirty	num	6	SENT_44	[p4l543t1274r843b1347],
4	—	NN	O	—	nn	6	SENT_44	[p4l543t1274r843b1347],
5	ﬁve	NN	O	ﬁve	nn	6	SENT_44	[p4l543t1274r843b1347],
6	patients	NNS	O	patient	dep	2	SENT_44	[p4l873t1276r1119b1347],
7	were	VBD	O	be	auxpass	9	SENT_44	[p4l1149t1293r1287b1328],
8	randomly	RB	O	randomly	advmod	9	SENT_44	[p4l1318t1274r1618b1347],
9	assigned	VBN	O	assign	_	0	SENT_44	[p4l1646t1274r1908b1347],
10	to	TO	O	to	_	0	SENT_44	[p4l1937t1289r1997b1328],
11	placebo	NN	O	placebo	prep_to	9	SENT_44	[p4l2028t1274r2142b1347, p4l370t1362r524b1428],
12	,	,	O	,	_	0	SENT_44	[p4l2028t1274r2142b1347, p4l370t1362r524b1428],
13	ZOO	NN	O	zoo	nn	14	SENT_44	[p4l553t1366r664b1416],
14	mg	NN	O	mg	appos	11	SENT_44	[p4l695t1382r792b1435],
15	of	IN	O	of	_	0	SENT_44	[p4l820t1362r891b1416],
16	celecoxib	NN	O	celecoxib	prep_of	14	SENT_44	[p4l910t1362r1185b1416],
17	twice	RB	O	twice	advmod	11	SENT_44	[p4l1216t1364r1372b1416],
18	daily	RB	SET	daily	advmod	11	SENT_44	[p4l1402t1362r1549b1435],
19	(	RB	O	(	advmod	20	SENT_44	[p4l1578t1362r1908b1432],
20	low	JJ	O	low	amod	21	SENT_44	[p4l1578t1362r1908b1432],
21	—	NN	O	—	dep	11	SENT_44	[p4l1578t1362r1908b1432],
22	dose	NN	O	dose	nn	23	SENT_44	[p4l1578t1362r1908b1432],
23	)	NN	O	)	dep	21	SENT_44	[p4l1578t1362r1908b1432],
24	,	,	O	,	_	0	SENT_44	[p4l1578t1362r1908b1432],
25	or	CC	O	or	_	0	SENT_44	[p4l1939t1381r2003b1416],
26	400	CD	NUMBER	400	num	27	SENT_44	[p4l2031t1366r2141b1416],
27	mg	NN	O	mg	prep_to	9	SENT_44	[p4l370t1470r467b1523],
28	of	IN	O	of	_	0	SENT_44	[p4l498t1450r569b1504],
29	celecoxib	NN	O	celecoxib	prep_of	27	SENT_44	[p4l590t1450r866b1504],
30	twice	RB	O	twice	advmod	29	SENT_44	[p4l899t1452r1055b1504],
31	daily	RB	SET	daily	advmod	29	SENT_44	[p4l1088t1450r1235b1523],
32	(	RB	O	(	advmod	33	SENT_44	[p4l1267t1450r1627b1523],
33	high	JJ	O	high	amod	34	SENT_44	[p4l1267t1450r1627b1523],
34	—	NN	O	—	dep	29	SENT_44	[p4l1267t1450r1627b1523],
35	dose	NN	O	dose	nn	36	SENT_44	[p4l1267t1450r1627b1523],
36	)	NN	O	)	dep	34	SENT_44	[p4l1267t1450r1627b1523],
37	.	.	O	.	_	0	SENT_44	[p4l1267t1450r1627b1523],

1	Randomization	NN	O	randomization	nsubjpass	3	SENT_45	[p4l1662t1450r2143b1505],
2	was	VBD	O	be	auxpass	3	SENT_45	[p4l368t1559r479b1592],
3	stratiﬁed	VBN	O	stratiﬁed	_	0	SENT_45	[p4l510t1539r786b1593],
4	on	IN	O	on	_	0	SENT_45	[p4l815t1559r894b1592],
5	the	DT	O	the	det	6	SENT_45	[p4l924t1539r1019b1592],
6	basis	NN	O	basis	prep_on	3	SENT_45	[p4l1048t1539r1197b1592],
7	of	IN	O	of	_	0	SENT_45	[p4l1229t1539r1299b1592],
8	the	DT	O	the	det	9	SENT_45	[p4l1320t1539r1415b1592],
9	use	NN	O	use	dep	19	SENT_45	[p4l1446t1559r1544b1592],
10	or	CC	O	or	_	0	SENT_45	[p4l1575t1558r1640b1592],
11	nonuse	NN	O	nonuse	conj_or	9	SENT_45	[p4l1668t1559r1892b1592],
12	of	IN	O	of	_	0	SENT_45	[p4l1923t1539r1993b1592],
13	lowdose	NN	O	lowdose	nn	15	SENT_45	[p4l2012t1539r2142b1592, p4l370t1626r507b1681],
14	aspirin	NN	O	aspirin	nn	15	SENT_45	[p4l533t1628r744b1699],
15	(	NN	O	(	prep_of	9	SENT_45	[p4l771t1626r901b1696],
16	325	CD	NUMBER	325	num	17	SENT_45	[p4l771t1626r901b1696],
17	mg	NN	O	mg	dep	19	SENT_45	[p4l929t1646r1026b1699],
18	or	CC	O	or	_	0	SENT_45	[p4l1051t1645r1115b1680],
19	less	JJR	O	less	dep	30	SENT_45	[p4l1138t1626r1244b1680],
20	every	DT	SET	every	det	22	SENT_45	[p4l1271t1645r1425b1699],
21	other	JJ	SET	other	amod	22	SENT_45	[p4l1448t1626r1612b1680],
22	day	NN	SET	day	dep	19	SENT_45	[p4l1637t1626r1743b1699],
23	or	CC	O	or	_	0	SENT_45	[p4l1766t1645r1831b1680],
24	162.5	CD	NUMBER	162.5	num	25	SENT_45	[p4l1860t1630r2018b1680],
25	mg	NN	O	mg	conj_or	19	SENT_45	[p4l2046t1646r2143b1699],
26	or	CC	O	or	_	0	SENT_45	[p4l370t1733r434b1768],
27	less	JJR	O	less	conj_or	19	SENT_45	[p4l461t1714r567b1768],
28	every	DT	SET	every	det	29	SENT_45	[p4l597t1733r751b1787],
29	day	NN	SET	day	dep	27	SENT_45	[p4l778t1714r902b1787],
30	)	CD	NUMBER	)	prep_of	6	SENT_45	[p4l778t1714r902b1787],
31	and	CC	O	and	_	0	SENT_45	[p4l935t1714r1050b1769],
32	clinical	JJ	O	clinical	amod	33	SENT_45	[p4l1078t1714r1296b1768],
33	site	NN	O	site	prep_of	6	SENT_45	[p4l1325t1716r1441b1768],
34	.	.	O	.	_	0	SENT_45	[p4l1325t1716r1441b1768],

1	Further	JJ	O	further	amod	2	SENT_46	[p4l1473t1714r1709b1768],
2	details	NNS	O	detail	nsubj	7	SENT_46	[p4l1737t1714r1935b1769],
3	about	IN	O	about	_	0	SENT_46	[p4l1965t1714r2144b1768],
4	the	DT	O	the	det	5	SENT_46	[p4l370t1802r466b1856],
5	trial	NN	O	trial	prep_about	2	SENT_46	[p4l495t1802r620b1856],
6	are	VBP	O	be	cop	7	SENT_46	[p4l648t1821r737b1856],
7	available	JJ	O	available	_	0	SENT_46	[p4l766t1802r1030b1856],
8	in	IN	O	in	_	0	SENT_46	[p4l1059t1804r1119b1855],
9	the	DT	O	the	det	11	SENT_46	[p4l1147t1802r1243b1856],
10	Supplementary	NNP	O	Supplementary	nn	11	SENT_46	[p4l1272t1802r1745b1875],
11	Materials	NNPS	O	Materials	prep_in	7	SENT_46	[p4l1769t1802r2071b1856],
12	.	.	O	.	_	0	SENT_46	[p4l1769t1802r2071b1856],

1	GASTROENTEROLOGY	NN	O	gastroenterology	_	0	SENT_47	[p4l992t2345r1662b2394],
2	Vol	NN	O	vol	dep	1	SENT_47	[p4l1685t2345r1792b2394],
3	.	.	O	.	_	0	SENT_47	[p4l1685t2345r1792b2394],

1	136	CD	NUMBER	136	_	0	SENT_48	[p4l1825t2344r1959b2404],
2	,	,	O	,	_	0	SENT_48	[p4l1825t2344r1959b2404],
3	No.	NN	O	no.	appos	1	SENT_48	[p4l1992t2345r2084b2394],
4	7	CD	NUMBER	7	num	3	SENT_48	[p4l2116t2345r2151b2393],

1	The	DT	O	the	det	3	SENT_49	[p4l99t2565r243b2630],
2	APC	NN	ORGANIZATION	apc	nn	3	SENT_49	[p4l277t2571r439b2630],
3	trial	NN	O	trial	nsubjpass	5	SENT_49	[p4l479t2565r630b2630],
4	was	VBD	O	be	auxpass	5	SENT_49	[p4l665t2590r798b2630],
5	sponsored	VBN	O	sponsor	_	0	SENT_49	[p4l838t2565r1221b2653],
6	by	IN	O	by	_	0	SENT_49	[p4l1255t2565r1343b2653],
7	the	DT	O	the	det	10	SENT_49	[p4l1377t2565r1493b2630],
8	National	NNP	ORGANIZATION	National	nn	10	SENT_49	[p4l1529t2565r1859b2630],
9	Cancer	NNP	ORGANIZATION	Cancer	nn	10	SENT_49	[p4l1897t2571r2154b2630],
10	Institute	NNP	ORGANIZATION	Institute	agent	5	SENT_49	[p4l11t2674r332b2736],
11	and	CC	O	and	_	0	SENT_49	[p4l374t2671r513b2737],
12	Pﬁzer	NNP	ORGANIZATION	Pﬁzer	nn	13	SENT_49	[p4l553t2671r762b2736],
13	Inc	NNP	ORGANIZATION	Inc	agent	5	SENT_49	[p4l800t2677r934b2751],
14	,	,	O	,	_	0	SENT_49	[p4l800t2677r934b2751],
15	through	IN	O	through	_	0	SENT_49	[p4l978t2671r1283b2759],
16	a	DT	O	a	det	19	SENT_49	[p4l1325t2696r1365b2736],
17	clinical	JJ	O	clinical	amod	19	SENT_49	[p4l1404t2671r1668b2736],
18	trials	NNS	O	trial	nn	19	SENT_49	[p4l1709t2671r1893b2736],
19	agreement	NN	O	agreement	prep_through	5	SENT_49	[p4l1936t2695r2151b2759, p4l13t2796r222b2842],
20	.	.	O	.	_	0	SENT_49	[p4l1936t2695r2151b2759, p4l13t2796r222b2842],

1	All	DT	O	all	det	2	SENT_50	[p4l271t2777r377b2841],
2	patients	NNS	O	patient	nsubj	3	SENT_50	[p4l425t2780r722b2865],
3	provided	VBD	O	provide	_	0	SENT_50	[p4l773t2777r1103b2865],
4	written	VBN	O	write	amod	6	SENT_50	[p4l1149t2780r1419b2842],
5	informed	VBN	O	inform	amod	6	SENT_50	[p4l1468t2777r1816b2843],
6	consent	NN	O	consent	dobj	3	SENT_50	[p4l1864t2796r2153b2842],
7	before	IN	O	before	_	0	SENT_50	[p4l11t2884r243b2949],
8	enrollment	NN	O	enrollment	prep_before	3	SENT_50	[p4l276t2884r706b2964],
9	,	,	O	,	_	0	SENT_50	[p4l276t2884r706b2964],
10	and	CC	O	and	_	0	SENT_50	[p4l740t2884r880b2950],
11	the	DT	O	the	det	13	SENT_50	[p4l911t2884r1026b2949],
12	study	NN	O	study	nn	13	SENT_50	[p4l1060t2884r1265b2972],
13	protocol	NN	O	protocol	nsubjpass	15	SENT_50	[p4l1294t2884r1611b2972],
14	was	VBD	O	be	auxpass	15	SENT_50	[p4l1641t2909r1774b2949],
15	approved	VBN	O	approve	conj_and	3	SENT_50	[p4l1808t2884r2154b2972],
16	by	IN	O	by	_	0	SENT_50	[p4l11t2990r99b3078],
17	the	DT	O	the	det	19	SENT_50	[p4l130t2990r246b3055],
18	Human	JJ	ORGANIZATION	human	amod	19	SENT_50	[p4l281t2996r566b3055],
19	Subjects	NNPS	ORGANIZATION	Subjects	agent	15	SENT_50	[p4l601t2990r907b3078],
20	Committee	NNP	ORGANIZATION	Committee	dobj	15	SENT_50	[p4l944t2993r1361b3055],
21	at	IN	O	at	_	0	SENT_50	[p4l1396t3009r1465b3055],
22	each	DT	O	each	det	24	SENT_50	[p4l1499t2990r1662b3055],
23	study	NN	O	study	nn	24	SENT_50	[p4l1697t2990r1902b3078],
24	site	NN	O	site	prep_at	20	SENT_50	[p4l1934t2993r2074b3055],
25	.	.	O	.	_	0	SENT_50	[p4l1934t2993r2074b3055],

1	Outcome	NN	O	outcome	nn	2	SENT_51	[p4l283t3157r635b3223],
2	Ascertczinment	NN	O	ascertczinment	_	0	SENT_51	[p4l663t3156r1248b3223],

1	A	DT	O	a	det	3	SENT_52	[p4l277t3299r334b3357],
2	study	NN	O	study	nn	3	SENT_52	[p4l369t3293r567b3380],
3	investigator	NN	O	investigator	nsubj	4	SENT_52	[p4l599t3296r1021b3380],
4	performed	VBD	O	perform	_	0	SENT_52	[p4l1055t3293r1434b3380],
5	follow-up	JJ	O	follow-up	amod	6	SENT_52	[p4l1468t3293r1812b3381],
6	colonoscopies	NNS	O	colonoscopy	dobj	4	SENT_52	[p4l1850t3293r2151b3357, p5l13t34r231b120],

1	with	IN	O	with	_	0	SENT_53	[p5l262t32r422b96],
2	endoscopic	JJ	O	endoscopic	amod	3	SENT_53	[p5l454t32r854b120],
3	removal	NN	O	removal	pobj	1	SENT_53	[p5l886t32r1171b96],
4	of	IN	O	of	_	0	SENT_53	[p5l1202t32r1286b96],
5	polyps	NNS	O	polyp	prep_of	3	SENT_53	[p5l1304t32r1536b119],
6	at	IN	O	at	_	0	SENT_53	[p5l1569t50r1636b96],
7	1	CD	NUMBER	1	nn	10	SENT_53	[p5l1673t37r1702b96],
8	and	CC	O	and	_	0	SENT_53	[p5l1739t32r1874b98],
9	3	CD	DURATION	3	nn	10	SENT_53	[p5l1905t37r1942b96],
10	years	NNS	NUMBER	year	prep_at	5	SENT_53	[p5l1974t55r2151b119],
11	after	IN	O	after	_	0	SENT_53	[p5l13t138r177b202],
12	randomization	NN	O	randomization	prep_after	10	SENT_53	[p5l203t138r752b204],
13	.	.	O	.	_	0	SENT_53	[p5l203t138r752b204],

1	A	DT	O	a	det	4	SENT_54	[p5l779t144r837b202],
2	central	JJ	O	central	amod	4	SENT_54	[p5l862t138r1106b202],
3	study	NN	O	study	nn	4	SENT_54	[p5l1133t138r1331b225],
4	pathologist	NN	O	pathologist	nsubj	14	SENT_54	[p5l1355t138r1764b225],
5	examined	VBN	O	examine	partmod	4	SENT_54	[p5l1791t138r2151b218],
6	,	,	O	,	_	0	SENT_54	[p5l1791t138r2151b218],
7	in	IN	O	in	_	0	SENT_54	[p5l12t246r83b308],
8	a	DT	O	a	det	10	SENT_54	[p5l137t268r176b308],
9	blinded	JJ	O	blinded	amod	10	SENT_54	[p5l225t244r500b310],
10	fashion	NN	O	fashion	prep_in	14	SENT_54	[p5l552t244r835b324],
11	,	,	O	,	_	0	SENT_54	[p5l552t244r835b324],
12	all	DT	O	all	nsubj	14	SENT_54	[p5l890t244r974b308],
13	polyps	NNS	O	polyp	dep	12	SENT_54	[p5l1026t244r1258b331],
14	removed	VBN	O	remove	_	0	SENT_54	[p5l1315t244r1623b310],
15	during	IN	O	during	_	0	SENT_54	[p5l1676t244r1918b331],
16	these	DT	O	these	det	17	SENT_54	[p5l1971t244r2152b308],
17	colonoscopies	NNS	O	colonoscopy	prep_during	14	SENT_54	[p5l13t351r528b438],
18	.	.	O	.	_	0	SENT_54	[p5l13t351r528b438],

1	Adverse	JJ	O	adverse	amod	2	SENT_55	[p5l549t350r827b417],
2	events	NNS	O	event	nsubjpass	4	SENT_55	[p5l849t369r1067b415],
3	were	VBD	O	be	auxpass	4	SENT_55	[p5l1088t374r1250b415],
4	reported	VBN	O	report	_	0	SENT_55	[p5l1273t351r1577b438],
5	by	IN	O	by	_	0	SENT_55	[p5l1595t351r1682b438],
6	investigators	NNS	O	investigator	agent	4	SENT_55	[p5l1699t354r2151b438],
7	and	CC	O	and	_	0	SENT_55	[p5l13t456r149b523],
8	classiﬁed	JJ	O	classiﬁed	agent	4	SENT_55	[p5l184t456r504b523],
9	according	VBG	O	accord	_	0	SENT_55	[p5l540t457r891b544],
10	to	TO	O	to	prepc_according_to	4	SENT_55	[p5l927t475r998b521],
11	criteria	NNS	O	criterion	pobj	4	SENT_55	[p5l1037t460r1287b522],
12	from	IN	O	from	_	0	SENT_55	[p5l1321t457r1498b521],
13	the	DT	O	the	det	15	SENT_55	[p5l1535t457r1647b522],
14	Medical	JJ	O	medical	amod	15	SENT_55	[p5l1682t457r1968b523],
15	Dictionary	NNP	O	Dictionary	prep_from	11	SENT_55	[p5l2004t460r2151b521, p5l13t565r270b650],
16	for	IN	O	for	mark	19	SENT_55	[p5l298t563r403b627],
17	Regulatory	NNP	O	Regulatory	nn	18	SENT_55	[p5l432t563r824b650],
18	Activities	NNS	O	activity	nsubj	19	SENT_55	[p5l848t565r1174b627],
19	(	VBP	O	(	advcl	4	SENT_55	[p5l1209t563r1615b647],
20	MedDRA	NN	O	meddra	nn	21	SENT_55	[p5l1209t563r1615b647],
21	)	NN	O	)	dobj	19	SENT_55	[p5l1209t563r1615b647],
22	,	,	O	,	_	0	SENT_55	[p5l1209t563r1615b647],
23	version	NN	O	version	appos	21	SENT_55	[p5l1644t565r1902b627],
24	8.1.2	CD	NUMBER	8.1.2	num	23	SENT_55	[p5l1933t567r2085b627],

1	Genotyping	VBG	O	genotype	partmod	19	SENT_56	[p5l283t728r737b820],
2	Among	IN	O	among	_	0	SENT_56	[p5l277t843r554b925],
3	the	DT	O	the	det	5	SENT_56	[p5l597t837r712b902],
4	2035	CD	DATE	2035	num	5	SENT_56	[p5l756t842r934b902],
5	patients	NNS	O	patient	prep_among	1	SENT_56	[p5l981t840r1278b925],
6	who	WP	O	who	nsubjpass	8	SENT_56	[p5l1322t837r1478b902],
7	were	VBD	O	be	auxpass	8	SENT_56	[p5l1522t860r1689b902],
8	enrolled	VBN	O	enrol	rcmod	5	SENT_56	[p5l1734t837r2038b903],
9	in	IN	O	in	_	0	SENT_56	[p5l2080t840r2153b901],
10	the	DT	O	the	det	11	SENT_56	[p5l13t943r128b1008],
11	study	NN	O	study	prep_in	8	SENT_56	[p5l183t943r403b1031],
12	,	,	O	,	_	0	SENT_56	[p5l183t943r403b1031],
13	1707	CD	DATE	1707	num	14	SENT_56	[p5l466t948r640b1009],
14	patients	NNS	O	patient	nsubj	19	SENT_56	[p5l693t946r990b1031],
15	at	IN	O	at	_	0	SENT_56	[p5l1045t961r1114b1008],
16	the	DT	O	the	det	18	SENT_56	[p5l1167t943r1283b1008],
17	baseline	NN	O	baseline	nn	18	SENT_56	[p5l1335t943r1633b1008],
18	examination	NN	O	examination	prep_at	14	SENT_56	[p5l1688t946r2153b1008],
19	provided	VBD	O	provide	_	0	SENT_56	[p5l12t1050r342b1138],
20	a	DT	O	a	det	22	SENT_56	[p5l381t1075r421b1115],
21	blood	NN	O	blood	nn	22	SENT_56	[p5l455t1050r673b1116],
22	specimen	NN	O	specimen	dobj	19	SENT_56	[p5l712t1053r1058b1138],
23	suitable	JJ	O	suitable	amod	22	SENT_56	[p5l1097t1050r1387b1115],
24	for	IN	O	for	_	0	SENT_56	[p5l1427t1050r1535b1115],
25	separation	NN	O	separation	prep_for	23	SENT_56	[p5l1573t1053r1962b1138],
26	into	IN	O	into	_	0	SENT_56	[p5l2001t1053r2151b1115],
27	components	NNS	O	component	prep_into	19	SENT_56	[p5l13t1174r493b1244],
28	,	,	O	,	_	0	SENT_56	[p5l13t1174r493b1244],
29	which	WDT	O	which	nsubjpass	32	SENT_56	[p5l518t1156r742b1221],
30	was	VBD	O	be	auxpass	32	SENT_56	[p5l765t1180r899b1221],
31	subsequently	RB	O	subsequently	advmod	32	SENT_56	[p5l926t1156r1415b1244],
32	stored	VBN	O	store	rcmod	27	SENT_56	[p5l1438t1156r1670b1222],
33	at	IN	O	at	_	0	SENT_56	[p5l1694t1175r1763b1221],
34	—	CD	NUMBER	—	number	35	SENT_56	[p5l1795t1161r1986b1222],
35	70	CD	NUMBER	70	num	37	SENT_56	[p5l1795t1161r1986b1222],
36	°	NN	O	°	nn	37	SENT_56	[p5l1795t1161r1986b1222],
37	C	NN	O	c	prep_at	32	SENT_56	[p5l2002t1161r2054b1221],
38	in	IN	O	in	_	0	SENT_56	[p5l2080t1159r2153b1220],
39	a	DT	O	a	det	42	SENT_56	[p5l13t1287r52b1327],
40	central	JJ	O	central	amod	42	SENT_56	[p5l93t1262r347b1327],
41	tissue	NN	O	tissue	nn	42	SENT_56	[p5l390t1265r599b1327],
42	bank	NN	O	bank	prep_in	37	SENT_56	[p5l641t1262r843b1327],
43	.	.	O	.	_	0	SENT_56	[p5l641t1262r843b1327],

1	All	DT	O	all	det	2	SENT_57	[p5l886t1262r992b1326],
2	patients	NNS	O	patient	_	0	SENT_57	[p5l1034t1265r1331b1350],
3	who	WP	O	who	nsubj	4	SENT_57	[p5l1373t1262r1529b1327],
4	provided	VBD	O	provide	rcmod	2	SENT_57	[p5l1574t1262r1904b1350],
5	specimens	NNS	O	specimen	dobj	4	SENT_57	[p5l1946t1265r2151b1350, p5l13t1393r207b1434],
6	provided	VBN	O	provide	partmod	5	SENT_57	[p5l245t1369r575b1457],
7	separate	JJ	O	separate	dobj	6	SENT_57	[p5l611t1387r932b1457],
8	,	,	O	,	_	0	SENT_57	[p5l611t1387r932b1457],
9	informed	JJ	O	informed	amod	10	SENT_57	[p5l970t1369r1319b1435],
10	consent	NN	O	consent	dobj	6	SENT_57	[p5l1355t1388r1661b1449],
11	,	,	O	,	_	0	SENT_57	[p5l1355t1388r1661b1449],
12	and	CC	O	and	_	0	SENT_57	[p5l1700t1369r1839b1435],
13	a	DT	O	a	det	14	SENT_57	[p5l1875t1393r1915b1434],
14	genotyping	NN	O	genotyping	conj_and	7	SENT_57	[p5l1949t1393r2151b1457, p5l13t1515r251b1600],

1	study	NN	O	study	nn	2	SENT_58	[p5l282t1512r487b1600],
2	protocol	NN	O	protocol	nsubjpass	4	SENT_58	[p5l515t1512r833b1600],
3	was	VBD	O	be	auxpass	4	SENT_58	[p5l861t1537r995b1577],
4	approved	VBN	O	approve	_	0	SENT_58	[p5l1028t1512r1374b1600],
5	by	IN	O	by	_	0	SENT_58	[p5l1402t1512r1490b1600],
6	the	DT	O	the	det	8	SENT_58	[p5l1519t1512r1635b1577],
7	Human	JJ	O	human	amod	8	SENT_58	[p5l1667t1518r1952b1577],
8	Subjects	NNS	O	subject	agent	4	SENT_58	[p5l1984t1512r2151b1577, p5l6t1651r172b1736],

1	Committee	NNP	O	Committee	_	0	SENT_59	[p5l215t1651r632b1713],
2	at	IN	O	at	_	0	SENT_59	[p5l674t1667r742b1713],
3	Partners	NNP	ORGANIZATION	Partners	nn	4	SENT_59	[p5l781t1654r1088b1713],
4	Healthcare	NNP	ORGANIZATION	Healthcare	prep_at	1	SENT_59	[p5l1130t1648r1549b1713],
5	.	.	O	.	_	0	SENT_59	[p5l1130t1648r1549b1713],

1	All	DT	O	all	nsubjpass	4	SENT_60	[p5l1589t1648r1694b1712],
2	genotyping	VBG	O	genotype	amod	1	SENT_60	[p5l1734t1651r2154b1736],
3	was	VBD	O	be	auxpass	4	SENT_60	[p5l11t1778r144b1819],
4	performed	VBN	O	perform	_	0	SENT_60	[p5l175t1754r585b1842],
5	,	,	O	,	_	0	SENT_60	[p5l175t1754r585b1842],
6	in	IN	O	in	_	0	SENT_60	[p5l616t1757r689b1818],
7	a	DT	O	a	det	9	SENT_60	[p5l719t1778r758b1819],
8	blinded	JJ	O	blinded	amod	9	SENT_60	[p5l784t1754r1069b1820],
9	fashion	NN	O	fashion	prep_in	4	SENT_60	[p5l1097t1754r1392b1834],
10	,	,	O	,	_	0	SENT_60	[p5l1097t1754r1392b1834],
11	at	IN	O	at	_	0	SENT_60	[p5l1425t1773r1494b1819],
12	the	DT	O	the	det	13	SENT_60	[p5l1524t1754r1639b1819],
13	Dana	NNP	PERSON	Dana	prep_at	4	SENT_60	[p5l1670t1754r2154b1819],
14	.	.	O	.	_	0	SENT_60	[p5l1670t1754r2154b1819],

1	—	NN	O	—	_	0	SENT_61	[p5l1670t1754r2154b1819],
2	.	.	O	.	_	0	SENT_61	[p5l1670t1754r2154b1819],

1	Farber	NNP	ORGANIZATION	Farber	nn	9	SENT_62	[p5l1670t1754r2154b1819],
2	Harvard	NNP	ORGANIZATION	Harvard	nn	9	SENT_62	[p5l13t1860r317b1926],
3	Cancer	NNP	ORGANIZATION	Cancer	nn	9	SENT_62	[p5l344t1865r601b1925],
4	Center	NNP	ORGANIZATION	Center	nn	9	SENT_62	[p5l627t1865r874b1925],
5	High	NNP	O	High	nn	9	SENT_62	[p5l899t1860r1084b1948],
6	Throughput	NNP	O	Throughput	nn	9	SENT_62	[p5l1108t1860r1575b1948],
7	Polymorphism	NN	O	polymorphism	nn	9	SENT_62	[p5l1601t1860r2153b1948],
8	Detection	NN	O	detection	nn	9	SENT_62	[p5l13t1969r379b2031],
9	Core	NN	O	core	nsubj	24	SENT_62	[p5l430t1971r603b2031],
10	on	IN	O	on	_	0	SENT_62	[p5l654t1990r749b2031],
11	deidentiﬁed	JJ	O	deidentiﬁed	amod	13	SENT_62	[p5l799t1966r1242b2032],
12	patient	NN	O	patient	nn	13	SENT_62	[p5l1291t1969r1555b2054],
13	samples	NNS	O	sample	prep_on	9	SENT_62	[p5l1605t1966r1898b2054],
14	using	VBG	O	use	partmod	13	SENT_62	[p5l1950t1969r2154b2054],
15	previously	RB	DATE	previously	advmod	14	SENT_62	[p5l12t2072r395b2160],
16	described	VBN	O	describe	partmod	13	SENT_62	[p5l427t2072r777b2138],
17	methods	NNS	O	method	nsubj	18	SENT_62	[p5l810t2072r1133b2138],
18	(	VBP	O	(	ccomp	16	SENT_62	[p5l1171t2072r1302b2156],
19	see	VB	O	see	xcomp	18	SENT_62	[p5l1171t2072r1302b2156],
20	Supplementary	NNP	O	Supplementary	nn	21	SENT_62	[p5l1338t2072r1908b2160],
21	Materials	NNPS	O	Materials	dobj	19	SENT_62	[p5l1937t2078r2151b2137, p5l13t2178r166b2243],
22	for	IN	O	for	_	0	SENT_62	[p5l199t2178r306b2243],
23	details	NNS	O	detail	prep_for	21	SENT_62	[p5l337t2178r688b2262],
24	)	VBP	O	)	ccomp	33	SENT_62	[p5l337t2178r688b2262],
25	.16	CD	NUMBER	.16	dobj	24	SENT_62	[p5l337t2178r688b2262],
26	Among	IN	O	among	_	0	SENT_62	[p5l717t2184r994b2265],
27	the	DT	O	the	det	29	SENT_62	[p5l1024t2178r1140b2243],
28	1707	CD	DATE	1707	num	29	SENT_62	[p5l1179t2183r1353b2244],
29	patients	NNS	O	patient	prep_among	24	SENT_62	[p5l1383t2181r1701b2266],
30	,	,	O	,	_	0	SENT_62	[p5l1383t2181r1701b2266],
31	genotyping	VBG	O	genotype	nsubj	33	SENT_62	[p5l1734t2181r2154b2266],
32	was	VBD	O	be	cop	33	SENT_62	[p5l11t2308r144b2349],
33	unsuccessful	JJ	O	unsuccessful	_	0	SENT_62	[p5l179t2284r653b2349],
34	for	IN	O	for	_	0	SENT_62	[p5l686t2284r794b2349],
35	the	DT	O	the	det	38	SENT_62	[p5l826t2284r942b2349],
36	*	NN	O	*	nn	38	SENT_62	[p5l979t2289r1061b2348],
37	2	CD	NUMBER	2	num	38	SENT_62	[p5l979t2289r1061b2348],
38	allele	NN	O	allele	prep_for	33	SENT_62	[p5l1097t2284r1284b2349],
39	in	IN	O	in	_	0	SENT_62	[p5l1317t2287r1390b2348],
40	15	CD	NUMBER	15	num	41	SENT_62	[p5l1430t2289r1507b2349],
41	patients	NNS	O	patient	prep_in	38	SENT_62	[p5l1544t2287r1861b2372],
42	,	,	O	,	_	0	SENT_62	[p5l1544t2287r1861b2372],
43	for	IN	O	for	_	0	SENT_62	[p5l1896t2284r2004b2349],
44	the	DT	O	the	det	47	SENT_62	[p5l2036t2284r2152b2349],
45	*	NN	O	*	nn	47	SENT_62	[p5l16t2395r97b2455],
46	3	CD	NUMBER	3	num	47	SENT_62	[p5l16t2395r97b2455],
47	allele	NN	O	allele	prep_for	33	SENT_62	[p5l126t2390r313b2455],
48	in	IN	O	in	_	0	SENT_62	[p5l336t2393r409b2454],
49	14	CD	NUMBER	14	num	50	SENT_62	[p5l440t2395r522b2454],
50	patients	NNS	O	patient	prep_in	47	SENT_62	[p5l545t2393r862b2478],
51	,	,	O	,	_	0	SENT_62	[p5l545t2393r862b2478],
52	and	CC	O	and	_	0	SENT_62	[p5l888t2390r1027b2456],
53	for	IN	O	for	_	0	SENT_62	[p5l1050t2390r1158b2455],
54	both	DT	O	both	det	55	SENT_62	[p5l1179t2390r1354b2455],
55	alleles	NNS	O	allele	conj_and	47	SENT_62	[p5l1380t2390r1600b2455],
56	in	IN	O	in	_	0	SENT_62	[p5l1625t2393r1698b2454],
57	18	CD	NUMBER	18	num	58	SENT_62	[p5l1729t2395r1808b2455],
58	patients	NNS	O	patient	prep_in	55	SENT_62	[p5l1834t2393r2149b2478],
59	.	.	O	.	_	0	SENT_62	[p5l1834t2393r2149b2478],

1	These	DT	O	these	det	2	SENT_63	[p5l10t2496r226b2561],
2	patients	NNS	O	patient	nsubjpass	5	SENT_63	[p5l250t2499r548b2584],
3	were	VBD	O	be	auxpass	5	SENT_63	[p5l571t2519r739b2561],
4	subsequently	RB	O	subsequently	advmod	5	SENT_63	[p5l764t2496r1253b2584],
5	excluded	VBN	O	exclude	_	0	SENT_63	[p5l1275t2496r1602b2562],
6	from	IN	O	from	_	0	SENT_63	[p5l1624t2496r1807b2561],
7	the	DT	O	the	det	8	SENT_63	[p5l1832t2496r1947b2561],
8	analysis	NN	O	analysis	prep_from	5	SENT_63	[p5l1972t2496r2151b2561, p5l10t2605r159b2690],
9	.	.	O	.	_	0	SENT_63	[p5l1972t2496r2151b2561, p5l10t2605r159b2690],

1	We	PRP	O	we	nsubj	2	SENT_64	[p5l185t2608r301b2667],
2	inserted	VBD	O	insert	_	0	SENT_64	[p5l326t2602r625b2668],
3	blinded	JJ	O	blinded	amod	6	SENT_64	[p5l647t2602r932b2668],
4	quality	NN	O	quality	nn	6	SENT_64	[p5l956t2602r1216b2690],
5	control	NN	O	control	nn	6	SENT_64	[p5l1238t2602r1509b2667],
6	samples	NNS	O	sample	nsubj	18	SENT_64	[p5l1534t2602r1827b2690],
7	equal	JJ	O	equal	dep	18	SENT_64	[p5l1854t2602r2053b2690],
8	to	TO	O	to	_	0	SENT_64	[p5l2078t2620r2151b2667],
9	10	CD	PERCENT	10	num	10	SENT_64	[p5l20t2713r158b2773],
10	%	NN	PERCENT	%	prep_to	7	SENT_64	[p5l20t2713r158b2773],
11	of	IN	O	of	_	0	SENT_64	[p5l189t2708r275b2773],
12	the	DT	O	the	det	14	SENT_64	[p5l293t2708r408b2773],
13	total	JJ	O	total	amod	14	SENT_64	[p5l440t2708r612b2773],
14	number	NN	O	number	prep_of	10	SENT_64	[p5l641t2708r937b2773],
15	of	IN	O	of	_	0	SENT_64	[p5l966t2708r1051b2773],
16	samples	NNS	O	sample	prep_of	14	SENT_64	[p5l1069t2708r1362b2796],
17	to	TO	O	to	aux	18	SENT_64	[p5l1394t2726r1467b2773],
18	validate	VB	O	validate	xcomp	2	SENT_64	[p5l1496t2708r1785b2774],
19	genotype	NN	O	genotype	nn	21	SENT_64	[p5l1816t2726r2152b2796],
20	identiﬁcation	NN	O	identiﬁcation	nn	21	SENT_64	[p5l12t2814r515b2880],
21	procedures	NNS	O	procedure	dobj	18	SENT_64	[p5l544t2814r972b2902],
22	;	:	O	;	_	0	SENT_64	[p5l544t2814r972b2902],
23	concordance	NN	O	concordance	dep	21	SENT_64	[p5l1003t2814r1472b2880],
24	for	IN	O	for	_	0	SENT_64	[p5l1503t2814r1611b2879],
25	these	DT	O	these	det	26	SENT_64	[p5l1639t2814r1827b2879],
26	samples	NNS	O	sample	prep_for	23	SENT_64	[p5l1858t2814r2151b2902],

1	2457	CD	NUMBER	2457	num	2	SENT_65	[p5l727t2994r773b3011],
2	patients	NNS	O	patient	nsubj	3	SENT_65	[p5l780t2994r853b3015],
3	entered	VBD	O	enter	_	0	SENT_65	[p5l860t2994r929b3011],
4	P	NN	O	p	dobj	3	SENT_65	[p5l762t3018r895b3038],
5	'	''	O	'	_	0	SENT_65	[p5l762t3018r895b3038],
6	a	DT	O	a	det	8	SENT_65	[p5l762t3018r895b3038],
7	°	NN	O	°	nn	8	SENT_65	[p5l762t3018r895b3038],
8	eb	NN	O	eb	nsubj	9	SENT_65	[p5l762t3018r895b3038],
9	°	NN	O	°	rcmod	4	SENT_65	[p5l762t3018r895b3038],
10	r	NN	O	r	dobj	9	SENT_65	[p5l762t3018r895b3038],
11	°	CD	NUMBER	°	num	10	SENT_65	[p5l762t3018r895b3038],
12	"	``	O	"	punct	9	SENT_65	[p5l762t3018r895b3038],
13	-	:	O	-	_	0	SENT_65	[p5l762t3018r895b3038],
14	‘	NN	O	‘	nn	16	SENT_65	[p5l762t3018r895b3038],
15	n	NN	O	n	nn	16	SENT_65	[p5l762t3018r895b3038],
16	Figure	NN	O	figure	dobj	9	SENT_65	[p5l1661t3016r1760b3048],
17	1	CD	NUMBER	1	dep	16	SENT_65	[p5l1797t3017r1820b3041],
18	.	.	O	.	_	0	SENT_65	[p5l1797t3017r1820b3041],

1	Flow	NN	O	flow	_	0	SENT_66	[p5l1843t3017r1908b3041],
2	of	IN	O	of	_	0	SENT_66	[p5l1943t3017r1970b3041],
3	patients	NNS	O	patient	prep_of	1	SENT_66	[p5l2006t3017r2116b3047],
4	through	IN	O	through	_	0	SENT_66	[p5l1659t3058r1768b3089],
5	the	DT	O	the	det	6	SENT_66	[p5l1779t3058r1824b3083],
6	study	NN	O	study	prep_through	1	SENT_66	[p5l1835t3058r1919b3089],
7	.	.	O	.	_	0	SENT_66	[p5l1835t3058r1919b3089],

1	Patients	NNS	O	patient	_	0	SENT_67	[p5l1933t3058r2046b3083],
2	who	WP	O	who	dep	1	SENT_67	[p5l2056t3058r2116b3083],

1	2035	CD	DATE	2035	num	3	SENT_68	[p5l765t3102r812b3117],
2	Patiems	NN	O	patiem	nn	3	SENT_68	[p5l819t3102r892b3128],
3	L	NN	O	l	nsubjpass	10	SENT_68	[p5l953t3115r1217b3134],
4	,	,	O	,	_	0	SENT_68	[p5l953t3115r1217b3134],
5	violated	VBD	O	violate	dep	3	SENT_68	[p5l1659t3100r1767b3125],
6	study	NN	O	study	nn	8	SENT_68	[p5l1778t3100r1855b3131],
7	entry	NN	O	entry	nn	8	SENT_68	[p5l1865t3101r1935b3131],
8	criteria	NNS	O	criterion	dobj	5	SENT_68	[p5l1945t3100r2039b3125],
9	were	VBD	O	be	auxpass	10	SENT_68	[p5l2048t3106r2117b3125],
10	randomized	VBN	O	randomize	_	0	SENT_68	[p5l774t3124r883b3141],
11	those	DT	O	those	dobj	10	SENT_68	[p5l1658t3142r1738b3166],
12	for	IN	O	for	_	0	SENT_68	[p5l1748t3142r1786b3166],
13	whom	WP	O	whom	prep_for	11	SENT_68	[p5l1795t3142r1882b3166],
14	the	DT	O	the	det	15	SENT_68	[p5l1893t3142r1938b3166],
15	presence	NN	O	presence	npadvmod	21	SENT_68	[p5l1950t3148r2080b3172],
16	of	IN	O	of	_	0	SENT_68	[p5l2091t3142r2118b3166],
17	an	DT	O	a	det	18	SENT_68	[p5l1659t3189r1692b3208],
18	adenoma	NN	O	adenoma	prep_of	15	SENT_68	[p5l1705t3183r1839b3208],
19	on	IN	O	on	_	0	SENT_68	[p5l1851t3189r1884b3208],
20	colonoscopy	NN	O	colonoscopy	prep_on	18	SENT_68	[p5l1897t3183r2080b3214],
21	at	IN	O	at	advmod	10	SENT_68	[p5l2091t3185r2117b3208],

1	1707	CD	NUMBER	1707	num	2	SENT_69	[p5l723t3213r768b3228],
2	patients	NNS	O	patient	nsubj	3	SENT_69	[p5l775t3212r848b3233],
3	provided	VBD	O	provide	_	0	SENT_69	[p5l855t3212r934b3233],
4	’	CD	NUMBER	’	num	6	SENT_69	[p5l1195t3223r1205b3242],
5	47	CD	NUMBER	47	num	6	SENT_69	[p5l1281t3212r1304b3228],
6	(	NN	O	(	iobj	3	SENT_69	[p5l1311t3211r1370b3232],
7	2.8	CD	PERCENT	2.8	num	8	SENT_69	[p5l1311t3211r1370b3232],
8	%	NN	PERCENT	%	dobj	3	SENT_69	[p5l1311t3211r1370b3232],
9	)	CD	NUMBER	)	nsubj	10	SENT_69	[p5l1311t3211r1370b3232],
10	failed	VBD	O	fail	rcmod	8	SENT_69	[p5l1377t3211r1427b3228],
11	.	.	O	.	_	0	SENT_69	[p5l1736t3225r1739b3229],

1	.	.	O	.	_	0	SENT_70	[p5l2029t3225r2031b3229],

1	blood	NN	O	blood	nn	2	SENT_71	[p5l756t3235r806b3252],
2	specimen	NN	O	specimen	_	0	SENT_71	[p5l813t3235r902b3255],
3	genotyping	VBG	O	genotype	partmod	2	SENT_71	[p5l1303t3234r1405b3255],
4	baseline	NN	O	baseline	nn	6	SENT_71	[p5l1660t3225r1775b3250],
5	COUlCl	NN	O	coulcl	nn	6	SENT_71	[p5l1784t3225r1860b3250],
6	|	NN	O	|	dobj	3	SENT_71	[p5l1870t3226r1914b3250],
7	'	''	O	'	_	0	SENT_71	[p5l1870t3226r1914b3250],
8	10l	RB	O	10l	advmod	10	SENT_71	[p5l1870t3226r1914b3250],
9	be	VB	O	be	auxpass	10	SENT_71	[p5l1923t3225r1957b3250],
10	confirmed	VBN	O	confirm	rcmod	6	SENT_71	[p5l1966t3225r2114b3250],
11	.	.	O	.	_	0	SENT_71	[p5l1966t3225r2114b3250],

1	Patients	NNS	O	patient	_	0	SENT_72	[p5l1661t3267r1778b3291],
2	who	WP	O	who	nsubj	3	SENT_72	[p5l1786t3267r1848b3291],
3	withdrew	VBD	O	withdraw	rcmod	1	SENT_72	[p5l1856t3267r1991b3291],
4	consent	NN	O	consent	nn	5	SENT_72	[p5l2000t3268r2117b3291],
5	_	NN	O	_	dobj	3	SENT_72	[p5l327t3334r330b3336],
6	.	.	O	.	_	0	SENT_72	[p5l1382t3331r1385b3335],

1	for	IN	O	for	mark	4	SENT_73	[p5l1658t3308r1698b3333],
2	study	NN	O	study	nn	3	SENT_73	[p5l1708t3308r1789b3339],
3	participation	NN	O	participation	nsubj	4	SENT_73	[p5l1800t3308r1980b3339],
4	included	VBD	O	include	_	0	SENT_73	[p5l1994t3308r2116b3333],

1	560	CD	NUMBER	560	nsubj	2	SENT_74	[p5l214t3334r249b3351],
2	randomized	VBN	O	randomize	_	0	SENT_74	[p5l256t3334r363b3351],
3	to	TO	O	to	_	0	SENT_74	[p5l370t3335r388b3351],
4	Z	NN	O	z	prep_to	2	SENT_74	[p5l858t3336r869b3348],
5	randomize	VB	O	randomize	ccomp	2	SENT_74	[p5l1311t3331r1408b3348],
6	_	NN	O	_	nn	7	SENT_74	[p5l1422t3335r1443b3357],
7	o	NN	O	o	dobj	5	SENT_74	[p5l1422t3335r1443b3357],
8	,	,	O	,	_	0	SENT_74	[p5l1863t3350r1866b3354],

1	placebo	NN	O	placebo	nn	2	SENT_75	[p5l265t3357r338b3378],
2	cs	NNS	O	c	nsubj	3	SENT_75	[p5l823t3360r845b3372],
3	xi	VBP	O	xi	dep	5	SENT_75	[p5l884t3355r898b3372],
4	ms	NNS	O	m	dobj	3	SENT_75	[p5l1316t3358r1343b3375],
5	_	VBP	O	_	_	0	SENT_75	[p5l1385t3358r1399b3393],
6	|	NN	O	|	nn	7	SENT_75	[p5l1385t3358r1399b3393],
7	c	NN	O	c	nsubj	8	SENT_75	[p5l1385t3358r1399b3393],
8	I	PRP	O	I	xcomp	5	SENT_75	[p5l1422t3358r1426b3370],
9	those	DT	O	those	nsubj	5	SENT_75	[p5l1658t3350r1740b3375],
10	who	WP	O	who	nsubj	11	SENT_75	[p5l1757t3350r1819b3375],
11	withdrew	VBD	O	withdraw	rcmod	9	SENT_75	[p5l1836t3350r1971b3375],
12	from	IN	O	from	_	0	SENT_75	[p5l1987t3350r2053b3375],
13	the	DT	O	the	det	14	SENT_75	[p5l2071t3350r2117b3375],
14	I	NN	O	i	prep_from	11	SENT_75	[p5l1386t3381r1388b3393],
15	.	.	O	.	_	0	SENT_75	[p5l1873t3392r1875b3396],

1	.	.	O	.	_	0	SENT_76	[p5l2100t3392r2103b3395],

1	V	NN	O	v	nn	2	SENT_77	[p5l1394t3381r1405b3398],
2	study	NN	O	study	_	0	SENT_77	[p5l1659t3392r1739b3422],
3	for	IN	O	for	_	0	SENT_77	[p5l1753t3392r1792b3416],
4	medical	JJ	O	medical	amod	7	SENT_77	[p5l1806t3392r1918b3416],
5	or	CC	O	or	_	0	SENT_77	[p5l1934t3398r1963b3416],
6	nonmedical	JJ	O	nonmedical	amod	7	SENT_77	[p5l1977t3392r2116b3416, p5l1659t3433r1699b3458],
7	reasons	NNS	O	reason	prep_for	2	SENT_77	[p5l1710t3439r1833b3462],
8	,	,	O	,	_	0	SENT_77	[p5l1710t3439r1833b3462],
9	those	DT	O	those	appos	2	SENT_77	[p5l1843t3433r1925b3458],
10	who	WP	O	who	nsubj	11	SENT_77	[p5l1933t3433r1994b3458],
11	failed	VBD	O	fail	rcmod	9	SENT_77	[p5l2003t3433r2079b3458],
12	to	TO	O	to	prep	11	SENT_77	[p5l2088t3435r2116b3458],

1	-	:	O	-	_	0	SENT_78	[p5l57t3481r63b3486],
2	499	CD	PERCENT	499	_	0	SENT_78	[p5l69t3477r104b3492],
3	(	CD	PERCENT	(	rcmod	2	SENT_78	[p5l109t3475r183b3497],
4	89.1	CD	PERCENT	89.1	num	5	SENT_78	[p5l109t3475r183b3497],
5	%	NN	PERCENT	%	dep	3	SENT_78	[p5l109t3475r183b3497],
6	)	SYM	O	)	dep	3	SENT_78	[p5l109t3475r183b3497],
7	-	:	O	-	_	0	SENT_78	[p5l277t3481r283b3486],
8	61	CD	PERCENT	61	num	12	SENT_78	[p5l290t3477r309b3492],
9	(	CD	PERCENT	(	number	10	SENT_78	[p5l318t3475r392b3497],
10	10.9	CD	PERCENT	10.9	dep	11	SENT_78	[p5l318t3475r392b3497],
11	%	NN	PERCENT	%	dep	12	SENT_78	[p5l318t3475r392b3497],
12	)	NN	O	)	dep	2	SENT_78	[p5l318t3475r392b3497],
13	did	VBD	O	do	aux	15	SENT_78	[p5l399t3476r429b3492],
14	not	RB	O	not	neg	15	SENT_78	[p5l436t3477r468b3492],
15	have	VB	O	have	rcmod	12	SENT_78	[p5l475t3476r522b3492],
16	-	:	O	-	_	0	SENT_78	[p5l585t3481r590b3486],
17	(	NN	PERCENT	(	dobj	15	SENT_78	[p5l637t3475r710b3497],
18	90.7	CD	PERCENT	90.7	num	19	SENT_78	[p5l637t3475r710b3497],
19	%	NN	PERCENT	%	dep	17	SENT_78	[p5l637t3475r710b3497],
20	)	SYM	O	)	dep	17	SENT_78	[p5l637t3475r710b3497],
21	-	:	O	-	_	0	SENT_78	[p5l806t3481r811b3486],
22	51	CD	PERCENT	51	dep	2	SENT_78	[p5l818t3477r838b3492],
23	(	CD	PERCENT	(	number	24	SENT_78	[p5l846t3475r908b3497],
24	9.3	CD	PERCENT	9.3	num	25	SENT_78	[p5l846t3475r908b3497],
25	%	NN	PERCENT	%	nsubj	28	SENT_78	[p5l846t3475r908b3497],
26	)	CD	NUMBER	)	npadvmod	27	SENT_78	[p5l846t3475r908b3497],
27	not	RB	O	not	neg	28	SENT_78	[p5l953t3477r985b3492],
28	have	VB	O	have	rcmod	22	SENT_78	[p5l991t3476r1039b3492],
29	-	:	O	-	_	0	SENT_78	[p5l1112t3481r1118b3486],
30	500	CD	PERCENT	500	number	31	SENT_78	[p5l1124t3477r1159b3492],
31	(	CD	PERCENT	(	dobj	28	SENT_78	[p5l1165t3475r1238b3497],
32	90.7	CD	PERCENT	90.7	num	33	SENT_78	[p5l1165t3475r1238b3497],
33	%	NN	PERCENT	%	dep	31	SENT_78	[p5l1165t3475r1238b3497],
34	)	SYM	O	)	dep	31	SENT_78	[p5l1165t3475r1238b3497],
35	-	:	O	-	_	0	SENT_78	[p5l1332t3481r1338b3486],
36	51	CD	PERCENT	51	num	40	SENT_78	[p5l1345t3477r1364b3492],
37	(	CD	PERCENT	(	number	38	SENT_78	[p5l1373t3475r1435b3497],
38	9.3	CD	PERCENT	9.3	dep	39	SENT_78	[p5l1373t3475r1435b3497],
39	%	NN	PERCENT	%	dep	40	SENT_78	[p5l1373t3475r1435b3497],
40	)	NN	O	)	dobj	28	SENT_78	[p5l1373t3475r1435b3497],
41	did	VBD	O	do	rcmod	40	SENT_78	[p5l1442t3476r1472b3492],
42	nnl	NN	O	nnl	nsubj	43	SENT_78	[p5l1480t3477r1511b3492],
43	have	VBP	O	have	dep	41	SENT_78	[p5l1518t3476r1565b3492],
44	m	NN	O	m	nn	45	SENT_78	[p5l1697t3481r1722b3499],
45	|	NN	O	|	dobj	43	SENT_78	[p5l1746t3475r1748b3499],
46	1	CD	NUMBER	1	num	45	SENT_78	[p5l1769t3476r1778b3499],
47	;	:	O	;	_	0	SENT_78	[p5l1769t3476r1778b3499],
48	tr	NN	O	tr	nn	49	SENT_78	[p5l1897t3476r1918b3499],
49	n	NN	O	n	nsubj	53	SENT_78	[p5l1938t3481r1952b3499],
50	mjz	NN	O	mjz	nn	52	SENT_78	[p5l1995t3475r2044b3499],
51	ti	NN	O	ti	nn	52	SENT_78	[p5l2063t3475r2078b3499],
52	n	NN	O	n	dep	49	SENT_78	[p5l2101t3481r2116b3499],
53	underwent	VBD	O	undergo	parataxis	43	SENT_78	[p5l69t3499r174b3516],
54	yr	NN	DURATION	yr	nsubj	65	SENT_78	[p5l181t3503r201b3519],
55	1	CD	NUMBER	1	num	54	SENT_78	[p5l207t3499r215b3515],
56	or	CC	O	or	_	0	SENT_78	[p5l224t3503r245b3516],
57	endpoint	JJ	O	endpoint	amod	61	SENT_78	[p5l289t3499r378b3519],
58	determination	NN	O	determination	nn	61	SENT_78	[p5l384t3499r522b3516],
59	n	NN	O	n	nn	61	SENT_78	[p5l610t3503r621b3515],
60	erwe	NN	O	erwe	nn	61	SENT_78	[p5l634t3502r683b3516],
61	r1	NN	O	r1	conj_or	54	SENT_78	[p5l720t3499r742b3516],
62	or	CC	O	or	_	0	SENT_78	[p5l751t3503r773b3516],
63	endpoint	NN	O	endpoint	nn	64	SENT_78	[p5l817t3499r905b3519],
64	nnination	NN	O	nnination	conj_or	54	SENT_78	[p5l956t3499r1049b3516],
65	underwent	VBD	O	undergo	ccomp	53	SENT_78	[p5l1124t3499r1230b3516],
66	yr	NN	DURATION	yr	dobj	65	SENT_78	[p5l1236t3503r1256b3519],
67	1	CD	NUMBER	1	num	66	SENT_78	[p5l1262t3499r1270b3515],
68	or	CC	O	or	_	0	SENT_78	[p5l1279t3503r1300b3516],
69	endpoint	JJ	O	endpoint	amod	72	SENT_78	[p5l1344t3499r1433b3519],
70	determination	NN	O	determination	nn	72	SENT_78	[p5l1439t3499r1577b3516],
71	oo	NN	O	oo	nn	72	SENT_78	[p5l1659t3481r1694b3500],
72	p	NN	O	p	dobj	65	SENT_78	[p5l1726t3481r1742b3506],
73	e	SYM	O	e	dep	78	SENT_78	[p5l1752t3481r1767b3500],
74	e	SYM	O	e	dep	76	SENT_78	[p5l1780t3481r1796b3500],
75	a	DT	O	a	det	76	SENT_78	[p5l1811t3481r1827b3500],
76	pos	NN	O	po	dep	78	SENT_78	[p5l1843t3481r1895b3506],
77	a	DT	O	a	nsubj	78	SENT_78	[p5l1919t3481r1935b3500],
78	do	VBP	O	do	dep	43	SENT_78	[p5l1956t3475r1992b3500],
79	a	DT	O	a	det	83	SENT_78	[p5l2046t3481r2062b3500],
80	_	NN	O	_	nn	83	SENT_78	[p5l2070t3517r2073b3520],
81	O	NN	O	o	nn	83	SENT_78	[p5l2081t3481r2098b3500],
82	3	CD	NUMBER	3	num	83	SENT_78	[p5l69t3522r80b3539],
83	oolonoscopy	NN	O	oolonoscopy	dobj	78	SENT_78	[p5l87t3522r216b3543],
84	.	.	O	.	_	0	SENT_78	[p5l277t3536r283b3542],

1	M	NN	O	m	nsubj	11	SENT_79	[p5l339t3531r380b3551],
2	,	,	O	,	_	0	SENT_79	[p5l339t3531r380b3551],
3	\	NN	O	\	dep	1	SENT_79	[p5l387t3531r458b3548],
4	,	,	O	,	_	0	SENT_79	[p5l387t3531r458b3548],
5	,	,	O	,	_	0	SENT_79	[p5l387t3531r458b3548],
6	,	,	O	,	_	0	SENT_79	[p5l387t3531r458b3548],
7	,	,	O	,	_	0	SENT_79	[p5l387t3531r458b3548],
8	,	,	O	,	_	0	SENT_79	[p5l387t3531r458b3548],
9	a	DT	O	a	nsubj	11	SENT_79	[p5l387t3531r458b3548],
10	,	,	O	,	_	0	SENT_79	[p5l387t3531r458b3548],
11	ed	VBD	O	ed	ccomp	22	SENT_79	[p5l387t3531r458b3548],
12	My	PRP$	O	my	poss	15	SENT_79	[p5l465t3532r512b3551],
13	3	CD	NUMBER	3	num	15	SENT_79	[p5l597t3522r608b3539],
14	colonos	NN	O	colono	nn	15	SENT_79	[p5l613t3522r693b3539],
15	y	NN	O	y	dobj	11	SENT_79	[p5l732t3526r743b3543],
16	,	,	O	,	_	0	SENT_79	[p5l806t3536r811b3542],
17	7	CD	PERCENT	7	number	18	SENT_79	[p5l818t3531r829b3546],
18	(	CD	PERCENT	(	nsubj	22	SENT_79	[p5l836t3531r896b3551],
19	13	CD	PERCENT	13	num	20	SENT_79	[p5l836t3531r896b3551],
20	%	NN	PERCENT	%	dep	18	SENT_79	[p5l836t3531r896b3551],
21	)	CD	NUMBER	)	dep	18	SENT_79	[p5l836t3531r896b3551],
22	viewed	VBD	O	view	_	0	SENT_79	[p5l903t3531r974b3548],
23	my	PRP$	O	my	poss	25	SENT_79	[p5l981t3532r1028b3551],
24	3	CD	NUMBER	3	num	25	SENT_79	[p5l1124t3522r1135b3539],
25	colonoscopy	NN	O	colonoscopy	dobj	22	SENT_79	[p5l1142t3522r1271b3543],
26	.	.	O	.	_	0	SENT_79	[p5l1332t3536r1338b3542],

1	3	CD	NUMBER	3	num	3	SENT_80	[p5l1345t3531r1356b3548],
2	(	NN	O	(	nn	3	SENT_80	[p5l1364t3531r1423b3551],
3	D_5.	NN	O	d_5.	_	0	SENT_80	[p5l1364t3531r1423b3551],
4	,	,	O	,	_	0	SENT_80	[p5l1364t3531r1423b3551],
5	_	NN	O	_	appos	3	SENT_80	[p5l1364t3531r1423b3551],
6	,	,	O	,	_	0	SENT_80	[p5l1364t3531r1423b3551],
7	,	,	O	,	_	0	SENT_80	[p5l1364t3531r1423b3551],
8	Vmed	NNP	O	Vmed	appos	3	SENT_80	[p5l1430t3531r1502b3548],
9	my	PRP$	O	my	poss	10	SENT_80	[p5l1508t3531r1555b3551],
10	colonoscopy	NN	O	colonoscopy	dep	3	SENT_80	[p5l1659t3517r1848b3547],
11	for	IN	O	for	_	0	SENT_80	[p5l1878t3517r1917b3541],
12	nonmedicai	JJ	O	nonmedicai	prep_for	10	SENT_80	[p5l1948t3517r2116b3541],
13	-	:	O	-	_	0	SENT_80	[p5l57t3559r63b3564],
14	criteria	NNS	O	criterion	dep	10	SENT_80	[p5l818t3553r880b3570],
15	criteria	NNS	O	criterion	dep	14	SENT_80	[p5l1344t3553r1407b3570],

1	“	RB	O	“	dep	107	SENT_81	[p5l289t3558r353b3570],
2	"	``	O	"	dep	107	SENT_81	[p5l289t3558r353b3570],
3	9	CD	NUMBER	9	dep	107	SENT_81	[p5l289t3558r353b3570],
4	”	NN	O	”	dep	107	SENT_81	[p5l289t3558r353b3570],
5	°	CD	NUMBER	°	dep	107	SENT_81	[p5l696t3561r704b3570],
6	Memylr	NNP	O	Memylr	dep	107	SENT_81	[p5l1172t3554r1259b3597],
7	,	,	O	,	_	0	SENT_81	[p5l1172t3554r1259b3597],
8	reasons	NNS	O	reason	dep	107	SENT_81	[p5l1660t3564r1783b3587],
9	,	,	O	,	_	0	SENT_81	[p5l1660t3564r1783b3587],
10	or	CC	O	or	dep	107	SENT_81	[p5l1802t3564r1830b3583],
11	those	DT	O	those	dep	107	SENT_81	[p5l1844t3558r1923b3583],
12	who	WP	O	who	dep	107	SENT_81	[p5l1938t3558r1998b3583],
13	did	VBD	O	do	dep	107	SENT_81	[p5l2014t3558r2055b3583],
14	not	RB	O	not	dep	107	SENT_81	[p5l2073t3560r2117b3583],
15	rwe	VB	O	rwe	dep	107	SENT_81	[p5l117t3580r149b3594],
16	VI	NNP	O	VI	dep	107	SENT_81	[p5l172t3580r190b3597],
17	’	CD	NUMBER	’	dep	107	SENT_81	[p5l172t3580r190b3597],
18	1	LS	NUMBER	1	dep	107	SENT_81	[p5l198t3577r204b3593],
19	-	:	O	-	_	0	SENT_81	[p5l277t3591r283b3596],
20	7	CD	PERCENT	7	dep	107	SENT_81	[p5l290t3586r302b3602],
21	(	CD	PERCENT	(	dep	107	SENT_81	[p5l309t3585r368b3606],
22	1.3	CD	PERCENT	1.3	dep	107	SENT_81	[p5l309t3585r368b3606],
23	%	NN	PERCENT	%	dep	107	SENT_81	[p5l309t3585r368b3606],
24	)	CD	NUMBER	)	dep	107	SENT_81	[p5l309t3585r368b3606],
25	withdrew	VBD	O	withdraw	dep	107	SENT_81	[p5l375t3585r458b3602],
26	owing	VBG	O	owe	dep	107	SENT_81	[p5l463t3585r518b3606],
27	to	TO	O	to	dep	107	SENT_81	[p5l523t3586r542b3602],
28	"	``	O	"	dep	107	SENT_81	[p5l643t3580r687b3594],
29	"	``	O	"	dep	107	SENT_81	[p5l643t3580r687b3594],
30	9	CD	NUMBER	9	dep	107	SENT_81	[p5l643t3580r687b3594],
31	"	``	O	"	dep	107	SENT_81	[p5l643t3580r687b3594],
32	-	:	O	-	_	0	SENT_81	[p5l806t3591r811b3596],
33	13	CD	PERCENT	13	dep	107	SENT_81	[p5l819t3585r841b3602],
34	(	CD	PERCENT	(	dep	107	SENT_81	[p5l848t3585r908b3606],
35	2.4	CD	PERCENT	2.4	dep	107	SENT_81	[p5l848t3585r908b3606],
36	%	NN	PERCENT	%	dep	107	SENT_81	[p5l848t3585r908b3606],
37	)	CD	NUMBER	)	dep	107	SENT_81	[p5l848t3585r908b3606],
38	withdrew	VBD	O	withdraw	dep	107	SENT_81	[p5l914t3585r997b3602],
39	owing	VBG	O	owe	dep	107	SENT_81	[p5l1004t3585r1057b3606],
40	-	:	O	-	_	0	SENT_81	[p5l1332t3591r1338b3596],
41	15	CD	PERCENT	15	dep	107	SENT_81	[p5l1346t3586r1367b3602],
42	(	CD	PERCENT	(	dep	107	SENT_81	[p5l1374t3585r1435b3606],
43	2.7	CD	PERCENT	2.7	dep	107	SENT_81	[p5l1374t3585r1435b3606],
44	%	NN	PERCENT	%	dep	107	SENT_81	[p5l1374t3585r1435b3606],
45	)	CD	NUMBER	)	dep	107	SENT_81	[p5l1374t3585r1435b3606],
46	withdrew	VBD	O	withdraw	dep	107	SENT_81	[p5l1442t3585r1525b3602],
47	owing	VBG	O	owe	dep	107	SENT_81	[p5l1530t3585r1585b3606],
48	'	''	O	'	_	0	SENT_81	[p5l69t3600r186b3621],
49	3	CD	NUMBER	3	dep	107	SENT_81	[p5l69t3600r186b3621],
50	°	NN	O	°	dep	107	SENT_81	[p5l69t3600r186b3621],
51	'	''	O	'	_	0	SENT_81	[p5l69t3600r186b3621],
52	°	CD	NUMBER	°	dep	107	SENT_81	[p5l69t3600r186b3621],
53	"	``	O	"	dep	107	SENT_81	[p5l69t3600r186b3621],
54	°	NN	O	°	dep	107	SENT_81	[p5l69t3600r186b3621],
55	5	CD	NUMBER	5	dep	107	SENT_81	[p5l69t3600r186b3621],
56	°	NN	O	°	dep	107	SENT_81	[p5l69t3600r186b3621],
57	°	CD	NUMBER	°	dep	107	SENT_81	[p5l69t3600r186b3621],
58	pV	NN	O	pv	dep	107	SENT_81	[p5l69t3600r186b3621],
59	adverse	JJ	O	adverse	dep	107	SENT_81	[p5l289t3609r363b3624],
60	event	NN	O	event	dep	107	SENT_81	[p5l370t3609r421b3624],
61	°	CD	NUMBER	°	dep	107	SENT_81	[p5l596t3600r713b3621],
62	°	NN	O	°	dep	107	SENT_81	[p5l596t3600r713b3621],
63	'	''	O	'	_	0	SENT_81	[p5l596t3600r713b3621],
64	°	CD	NUMBER	°	dep	107	SENT_81	[p5l596t3600r713b3621],
65	"	``	O	"	dep	107	SENT_81	[p5l596t3600r713b3621],
66	°	NN	O	°	dep	107	SENT_81	[p5l596t3600r713b3621],
67	3	CD	NUMBER	3	dep	107	SENT_81	[p5l596t3600r713b3621],
68	°	NN	O	°	dep	107	SENT_81	[p5l596t3600r713b3621],
69	°	CD	NUMBER	°	dep	107	SENT_81	[p5l596t3600r713b3621],
70	F	NN	O	f	dep	107	SENT_81	[p5l596t3600r713b3621],
71	'	''	O	'	_	0	SENT_81	[p5l596t3600r713b3621],
72	V	NN	O	v	dep	107	SENT_81	[p5l596t3600r713b3621],
73	to	TO	O	to	dep	107	SENT_81	[p5l817t3609r834b3624],
74	adverse	JJ	O	adverse	dep	107	SENT_81	[p5l841t3609r914b3624],
75	event	NN	O	event	dep	107	SENT_81	[p5l921t3609r972b3624],
76	°	CD	NUMBER	°	dep	107	SENT_81	[p5l1124t3600r1241b3621],
77	°	NN	O	°	dep	107	SENT_81	[p5l1124t3600r1241b3621],
78	l	NN	O	l	dep	107	SENT_81	[p5l1124t3600r1241b3621],
79	°	CD	NUMBER	°	dep	107	SENT_81	[p5l1124t3600r1241b3621],
80	"	``	O	"	dep	107	SENT_81	[p5l1124t3600r1241b3621],
81	°	CD	NUMBER	°	dep	107	SENT_81	[p5l1124t3600r1241b3621],
82	9	CD	NUMBER	9	dep	107	SENT_81	[p5l1124t3600r1241b3621],
83	°	NN	O	°	dep	107	SENT_81	[p5l1124t3600r1241b3621],
84	°	CD	NUMBER	°	dep	107	SENT_81	[p5l1124t3600r1241b3621],
85	9V	NN	O	9v	dep	107	SENT_81	[p5l1124t3600r1241b3621],
86	to	TO	O	to	dep	107	SENT_81	[p5l1344t3609r1361b3624],
87	adverse	JJ	O	adverse	dep	107	SENT_81	[p5l1368t3609r1442b3624],
88	evem	NN	O	evem	dep	107	SENT_81	[p5l1448t3609r1499b3624],
89	adhere	VBP	O	adhere	dep	107	SENT_81	[p5l1659t3600r1757b3625],
90	to	TO	O	to	dep	107	SENT_81	[p5l1769t3601r1797b3625],
91	the	DT	O	the	dep	107	SENT_81	[p5l1809t3600r1853b3625],
92	pi'OlOCOl	NN	O	pi'olocol	dep	107	SENT_81	[p5l1867t3600r1982b3631],
93	fOl	NN	O	fol	dep	107	SENT_81	[p5l1994t3600r2032b3625],
94	'	''	O	'	_	0	SENT_81	[p5l1994t3600r2032b3625],
95	other	JJ	O	other	dep	107	SENT_81	[p5l2044t3600r2118b3625],
96	-422	CD	PERCENT	-422	dep	107	SENT_81	[p5l57t3631r183b3651],
97	(	CD	PERCENT	(	dep	107	SENT_81	[p5l57t3631r183b3651],
98	75.4	CD	PERCENT	75.4	dep	107	SENT_81	[p5l57t3631r183b3651],
99	%	NN	PERCENT	%	dep	107	SENT_81	[p5l57t3631r183b3651],
100	)	CD	NUMBER	)	dep	107	SENT_81	[p5l57t3631r183b3651],
101	,	,	O	,	_	0	SENT_81	[p5l277t3645r283b3651],
102	-	:	O	-	_	0	SENT_81	[p5l402t3640r405b3642],
103	-415	CD	PERCENT	-415	dep	107	SENT_81	[p5l585t3632r631b3648],
104	(	CD	PERCENT	(	dep	107	SENT_81	[p5l639t3631r710b3651],
105	75.6	CD	PERCENT	75.6	dep	107	SENT_81	[p5l639t3631r710b3651],
106	%	NN	PERCENT	%	dep	107	SENT_81	[p5l639t3631r710b3651],
107	)	CD	NUMBER	)	_	0	SENT_81	[p5l639t3631r710b3651],
108	.	.	O	.	_	0	SENT_81	[p5l806t3645r811b3651],

1	D	NN	O	d	_	0	SENT_82	[p5l893t3648r902b3656],
2	.	.	O	.	_	0	SENT_82	[p5l930t3640r934b3642],

1	-435	CD	NUMBER	-435	_	0	SENT_83	[p5l1112t3631r1159b3648],
2	(	CD	NUMBER	(	number	3	SENT_83	[p5l1166t3631r1222b3651],
3	79.1	CD	NUMBER	79.1	dep	1	SENT_83	[p5l1166t3631r1222b3651],
4	-	:	O	-	_	0	SENT_83	[p5l1166t3631r1222b3651],
5	»	CD	NUMBER	»	dep	1	SENT_83	[p5l1166t3631r1222b3651],
6	.	.	O	.	_	0	SENT_83	[p5l1332t3645r1338b3651],

1	D	NN	O	d	_	0	SENT_84	[p5l1421t3648r1429b3656],
2	underwenlyra	NN	O	underwenlyra	dep	1	SENT_84	[p5l1457t3640r1460b3642, p5l69t3654r207b3675],
3	.	.	O	.	_	0	SENT_84	[p5l277t3640r549b3692],

1	:	:	O	:	_	0	SENT_85	[p5l277t3640r549b3692],
2	’	CD	NUMBER	’	num	3	SENT_85	[p5l277t3640r549b3692],
3	5	CD	NUMBER	5	nsubj	38	SENT_85	[p5l277t3640r549b3692],
4	"	``	O	"	punct	5	SENT_85	[p5l277t3640r549b3692],
5	(	NN	O	(	dep	3	SENT_85	[p5l277t3640r549b3692],
6	1	CD	NUMBER	1	number	7	SENT_85	[p5l277t3640r549b3692],
7	‘	CD	NUMBER	‘	dep	3	SENT_85	[p5l277t3640r549b3692],
8	61	CD	NUMBER	61	dep	7	SENT_85	[p5l277t3640r549b3692],
9	'	''	O	'	_	0	SENT_85	[p5l277t3640r549b3692],
10	:	:	O	:	_	0	SENT_85	[p5l277t3640r549b3692],
11	B	NN	O	b	nn	12	SENT_85	[p5l277t3640r549b3692],
12	°	NN	O	°	dep	7	SENT_85	[p5l277t3640r549b3692],
13	;	:	O	;	_	0	SENT_85	[p5l277t3640r549b3692],
14	°	CD	NUMBER	°	num	16	SENT_85	[p5l277t3640r549b3692],
15	:	:	O	:	_	0	SENT_85	[p5l277t3640r549b3692],
16	”‘	CD	NUMBER	”‘	dep	12	SENT_85	[p5l277t3640r549b3692],
17	;	:	O	;	_	0	SENT_85	[p5l277t3640r549b3692],
18	"	``	O	"	punct	21	SENT_85	[p5l277t3640r549b3692],
19	r	NN	O	r	nn	21	SENT_85	[p5l277t3640r549b3692],
20	‘	CD	NUMBER	‘	num	21	SENT_85	[p5l277t3640r549b3692],
21	E	NN	O	e	dep	7	SENT_85	[p5l277t3640r549b3692],
22	:	:	O	:	_	0	SENT_85	[p5l277t3640r549b3692],
23	“	CD	NUMBER	“	number	24	SENT_85	[p5l277t3640r549b3692],
24	|	CD	NUMBER	|	dep	21	SENT_85	[p5l277t3640r549b3692],
25	‘	CD	NUMBER	‘	num	26	SENT_85	[p5l277t3640r549b3692],
26	°	NN	O	°	dep	24	SENT_85	[p5l277t3640r549b3692],
27	'	''	O	'	_	0	SENT_85	[p5l277t3640r549b3692],
28	:	:	O	:	_	0	SENT_85	[p5l277t3640r549b3692],
29	‘	CD	NUMBER	‘	dep	7	SENT_85	[p5l277t3640r549b3692],
30	"	``	O	"	punct	29	SENT_85	[p5l277t3640r549b3692],
31	’	NN	O	’	dep	29	SENT_85	[p5l277t3640r549b3692],
32	:	:	O	:	_	0	SENT_85	[p5l277t3640r549b3692],
33	°	CD	NUMBER	°	dep	7	SENT_85	[p5l277t3640r549b3692],
34	"	``	O	"	punct	37	SENT_85	[p5l277t3640r549b3692],
35	5e	JJ	O	5e	amod	37	SENT_85	[p5l277t3640r549b3692],
36	"	''	O	"	punct	37	SENT_85	[p5l277t3640r549b3692],
37	‘	NN	O	‘	dep	33	SENT_85	[p5l277t3640r549b3692],
38	underwent	VBD	O	undergo	_	0	SENT_85	[p5l597t3654r693b3671],
39	yrs	NNS	DURATION	yr	dobj	38	SENT_85	[p5l700t3655r734b3675],
40	_	CD	NUMBER	_	num	39	SENT_85	[p5l806t3640r1076b3692],
41	2	CD	NUMBER	2	number	42	SENT_85	[p5l806t3640r1076b3692],
42	“‘	CD	NUMBER	“‘	amod	39	SENT_85	[p5l806t3640r1076b3692],
43	:	:	O	:	_	0	SENT_85	[p5l806t3640r1076b3692],
44	‘	CD	NUMBER	‘	num	45	SENT_85	[p5l806t3640r1076b3692],
45	°	CD	NUMBER	°	dep	42	SENT_85	[p5l806t3640r1076b3692],
46	‘	NN	O	‘	dep	45	SENT_85	[p5l806t3640r1076b3692],
47	/	:	O	/	punct	45	SENT_85	[p5l806t3640r1076b3692],
48	?	.	O	?	_	0	SENT_85	[p5l806t3640r1076b3692],

1	~	NN	O	~	nn	3	SENT_86	[p5l806t3640r1076b3692],
2	"	''	O	"	punct	3	SENT_86	[p5l806t3640r1076b3692],
3	€	NN	O	€	_	0	SENT_86	[p5l806t3640r1076b3692],
4	:	:	O	:	_	0	SENT_86	[p5l806t3640r1076b3692],
5	l'	NN	O	l'	nn	6	SENT_86	[p5l806t3640r1076b3692],
6	r	NN	O	r	dep	13	SENT_86	[p5l806t3640r1076b3692],
7	‘	CD	NUMBER	‘	dep	6	SENT_86	[p5l806t3640r1076b3692],
8	e	SYM	O	e	dep	13	SENT_86	[p5l806t3640r1076b3692],
9	*	CD	NUMBER	*	nsubj	13	SENT_86	[p5l806t3640r1076b3692],
10	“	CD	NUMBER	“	num	11	SENT_86	[p5l806t3640r1076b3692],
11	l	NN	O	l	tmod	9	SENT_86	[p5l806t3640r1076b3692],
12	‘	CD	NUMBER	‘	dep	13	SENT_86	[p5l806t3640r1076b3692],
13	D'	NNP	O	D'	dep	3	SENT_86	[p5l806t3640r1076b3692],
14	:	:	O	:	_	0	SENT_86	[p5l806t3640r1076b3692],
15	‘	CD	NUMBER	‘	dep	13	SENT_86	[p5l806t3640r1076b3692],
16	"	``	O	"	punct	17	SENT_86	[p5l806t3640r1076b3692],
17	“	NN	O	“	dep	15	SENT_86	[p5l806t3640r1076b3692],
18	'	''	O	'	_	0	SENT_86	[p5l806t3640r1076b3692],
19	;	:	O	;	_	0	SENT_86	[p5l806t3640r1076b3692],
20	‘	CD	NUMBER	‘	number	21	SENT_86	[p5l806t3640r1076b3692],
21	°	CD	NUMBER	°	dep	17	SENT_86	[p5l806t3640r1076b3692],
22	"	``	O	"	punct	23	SENT_86	[p5l806t3640r1076b3692],
23	5e	JJ	O	5e	dep	21	SENT_86	[p5l806t3640r1076b3692],
24	"	''	O	"	punct	17	SENT_86	[p5l806t3640r1076b3692],
25	'	''	O	'	_	0	SENT_86	[p5l806t3640r1076b3692],
26	rwem	FW	O	rwem	nn	27	SENT_86	[p5l1172t3655r1222b3671],
27	_	FW	O	_	dep	13	SENT_86	[p5l1332t3640r1424b3692],
28	2	CD	NUMBER	2	dep	27	SENT_86	[p5l1332t3640r1424b3692],
29	"	``	O	"	punct	28	SENT_86	[p5l1332t3640r1424b3692],
30	““	NN	O	““	nn	31	SENT_86	[p5l1332t3640r1424b3692],
31	3-Z/3	NN	O	3-z/3	dep	28	SENT_86	[p5l1332t3640r1424b3692],
32	:	:	O	:	_	0	SENT_86	[p5l1430t3640r1604b3687],
33	”	CD	NUMBER	”	dep	28	SENT_86	[p5l1430t3640r1604b3687],
34	:	:	O	:	_	0	SENT_86	[p5l1430t3640r1604b3687],
35	"	``	O	"	punct	13	SENT_86	[p5l1430t3640r1604b3687],
36	:	:	O	:	_	0	SENT_86	[p5l1430t3640r1604b3687],
37	E	NN	O	e	prep	13	SENT_86	[p5l1430t3640r1604b3687],
38	‘	CD	NUMBER	‘	dep	37	SENT_86	[p5l1430t3640r1604b3687],
39	:	:	O	:	_	0	SENT_86	[p5l1430t3640r1604b3687],
40	:	:	O	:	_	0	SENT_86	[p5l1430t3640r1604b3687],
41	:	:	O	:	_	0	SENT_86	[p5l1430t3640r1604b3687],
42	t	NN	O	t	dep	3	SENT_86	[p5l1430t3640r1604b3687],
43	"	''	O	"	punct	42	SENT_86	[p5l1430t3640r1604b3687],
44	:	:	O	:	_	0	SENT_86	[p5l1430t3640r1604b3687],
45	:	:	O	:	_	0	SENT_86	[p5l1430t3640r1604b3687],
46	°	CD	NUMBER	°	dep	49	SENT_86	[p5l1430t3640r1604b3687],
47	"	``	O	"	punct	49	SENT_86	[p5l1430t3640r1604b3687],
48	5	CD	NUMBER	5	num	49	SENT_86	[p5l1430t3640r1604b3687],
49	°	CD	NUMBER	°	dep	52	SENT_86	[p5l1430t3640r1604b3687],
50	"	``	O	"	punct	49	SENT_86	[p5l1430t3640r1604b3687],
51	‘	NN	O	‘	dep	49	SENT_86	[p5l1430t3640r1604b3687],
52	reasons	NNS	O	reason	dep	42	SENT_86	[p5l1660t3648r1778b3666],
53	.	.	O	.	_	0	SENT_86	[p5l1660t3648r1778b3666],

1	Adherence	NN	O	adherence	nsubj	32	SENT_87	[p5l1795t3642r1950b3666],
2	to	TO	O	to	_	0	SENT_87	[p5l1965t3643r1992b3666],
3	the	DT	O	the	det	5	SENT_87	[p5l2007t3642r2052b3666],
4	use	NN	O	use	nn	5	SENT_87	[p5l2068t3648r2117b3666],
5	colonosoopy	NN	O	colonosoopy	prep_to	1	SENT_87	[p5l69t3678r186b3698],
6	W-w_up	JJ	MISC	w-w_up	amod	9	SENT_87	[p5l289t3684r373b3714],
7	colonoscopy	NN	O	colonoscopy	nn	9	SENT_87	[p5l596t3678r713b3698],
8	D	NN	O	d	nn	9	SENT_87	[p5l823t3699r835b3711],
9	mun	NN	O	mun	dep	5	SENT_87	[p5l843t3684r901b3714],
10	"	''	O	"	punct	1	SENT_87	[p5l1163t3681r1241b3698],
11	°	CD	NUMBER	°	number	12	SENT_87	[p5l1163t3681r1241b3698],
12	9	CD	NUMBER	9	num	14	SENT_87	[p5l1163t3681r1241b3698],
13	°	NN	O	°	nn	14	SENT_87	[p5l1163t3681r1241b3698],
14	°	NN	O	°	dep	1	SENT_87	[p5l1163t3681r1241b3698],
15	i	FW	O	i	nn	18	SENT_87	[p5l1163t3681r1241b3698],
16	°	FW	O	°	nn	18	SENT_87	[p5l1163t3681r1241b3698],
17	Y	NN	O	y	nn	18	SENT_87	[p5l1163t3681r1241b3698],
18	O	NN	O	o	dep	14	SENT_87	[p5l1350t3699r1361b3711],
19	°	CD	NUMBER	°	num	20	SENT_87	[p5l1371t3684r1428b3714],
20	‘	NN	O	‘	dep	18	SENT_87	[p5l1371t3684r1428b3714],
21	,	,	O	,	_	0	SENT_87	[p5l1371t3684r1428b3714],
22	,	,	O	,	_	0	SENT_87	[p5l1371t3684r1428b3714],
23	,	,	O	,	_	0	SENT_87	[p5l1371t3684r1428b3714],
24	_	NN	O	_	nn	25	SENT_87	[p5l1371t3684r1428b3714],
25	u	NN	O	u	dep	18	SENT_87	[p5l1371t3684r1428b3714],
26	,	,	O	,	_	0	SENT_87	[p5l1371t3684r1428b3714],
27	,	,	O	,	_	0	SENT_87	[p5l1371t3684r1428b3714],
28	of	IN	O	of	_	0	SENT_87	[p5l1659t3683r1686b3708],
29	study	NN	O	study	nn	30	SENT_87	[p5l1699t3683r1776b3714],
30	medication	NN	O	medication	prep_of	1	SENT_87	[p5l1791t3683r1945b3708],
31	was	VBD	O	be	cop	32	SENT_87	[p5l1959t3689r2016b3708],
32	calcu	FW	O	calcu	_	0	SENT_87	[p5l2030t3683r2116b3708, p5l42t3460r1617b3724],

1	,	,	O	,	_	0	SENT_88	[p6l1119t31r1124b38],
2	1	CD	NUMBER	1	number	3	SENT_88	[p6l1179t27r1542b47],
3	°	CD	NUMBER	°	nsubj	16	SENT_88	[p6l1179t27r1542b47],
4	-8	CD	NUMBER	-8	num	5	SENT_88	[p6l1179t27r1542b47],
5	V	NN	O	v	dep	3	SENT_88	[p6l1179t27r1542b47],
6	°	CD	NUMBER	°	number	7	SENT_88	[p6l1179t27r1542b47],
7	)	CD	NUMBER	)	dep	3	SENT_88	[p6l1179t27r1542b47],
8	hN2w	NN	O	hn2w	dep	7	SENT_88	[p6l1179t27r1542b47],
9	§	CD	NUMBER	§	num	8	SENT_88	[p6l1179t27r1542b47],
10	/	:	O	/	punct	15	SENT_88	[p6l1179t27r1542b47],
11	’	CD	NUMBER	’	num	12	SENT_88	[p6l1179t27r1542b47],
12	adhe'enwt	NN	O	adhe'enwt	dep	15	SENT_88	[p6l1179t27r1542b47],
13	°	CD	NUMBER	°	num	14	SENT_88	[p6l1179t27r1542b47],
14	drug	NN	O	drug	dep	12	SENT_88	[p6l1179t27r1542b47],
15	We	PRP	O	we	dep	3	SENT_88	[p6l1550t30r1585b43],
16	Iated	VBD	O	iat	_	0	SENT_88	[p6l1660t8r1727b33],
17	as	IN	O	as	_	0	SENT_88	[p6l1744t14r1776b53],
18	the	DT	O	the	det	19	SENT_88	[p6l1788t8r1836b53],
19	duration	NN	O	duration	prep_as	16	SENT_88	[p6l1853t8r1968b33],
20	of	IN	O	of	_	0	SENT_88	[p6l1985t8r2012b33],
21	use	NN	O	use	prep_of	19	SENT_88	[p6l2029t14r2077b33],
22	in	IN	O	in	prep	16	SENT_88	[p6l2095t8r2116b32],
23	-	:	O	-	_	0	SENT_88	[p6l1119t63r1124b69],
24	1	CD	PERCENT	1	num	25	SENT_88	[p6l1179t58r1222b78],
25	%	NN	PERCENT	%	nsubj	36	SENT_88	[p6l1179t58r1222b78],
26	}	CD	NUMBER	}	dep	25	SENT_88	[p6l1179t58r1222b78],
27	had	VBD	O	have	aux	36	SENT_88	[p6l1229t58r1264b75],
28	so	RB	O	so	advmod	36	SENT_88	[p6l1271t58r1294b75],
29	to	TO	O	to	_	0	SENT_88	[p6l1300t58r1385b75],
30	<	JJR	PERCENT	<	amod	34	SENT_88	[p6l1300t58r1385b75],
31	8o	CD	PERCENT	8o	num	32	SENT_88	[p6l1300t58r1385b75],
32	%	NN	PERCENT	%	dep	30	SENT_88	[p6l1300t58r1385b75],
33	adherence	NN	O	adherence	nn	34	SENT_88	[p6l1392t58r1496b75],
34	days	NNS	DURATION	day	prep_to	36	SENT_88	[p6l1660t50r1733b80],
35	,	,	O	,	_	0	SENT_88	[p6l1660t50r1733b80],
36	divided	VBN	O	divide	dep	22	SENT_88	[p6l1746t50r1846b74],
37	by	IN	O	by	_	0	SENT_88	[p6l1859t50r1891b80],
38	1095	CD	DATE	1095	prep_by	36	SENT_88	[p6l1904t50r1981b74],
39	.	.	O	.	_	0	SENT_88	[p6l1904t50r1981b74],

1	Percent	NN	O	percent	_	0	SENT_89	[p6l1996t50r2116b74, p6l1119t90r1207b110],
2	“	CD	NUMBER	“	number	3	SENT_89	[p6l1996t50r2116b74, p6l1119t90r1207b110],
3	33	CD	NUMBER	33	num	1	SENT_89	[p6l1996t50r2116b74, p6l1119t90r1207b110],
4	(	NN	O	(	npadvmod	1	SENT_89	[p6l1996t50r2116b74, p6l1119t90r1207b110],
5	'	''	O	'	_	0	SENT_89	[p6l1996t50r2116b74, p6l1119t90r1207b110],
6	-	:	O	-	_	0	SENT_89	[p6l1996t50r2116b74, p6l1119t90r1207b110],
7	"	``	O	"	punct	4	SENT_89	[p6l1996t50r2116b74, p6l1119t90r1207b110],
8	-	:	O	-	_	0	SENT_89	[p6l1996t50r2116b74, p6l1119t90r1207b110],
9	°	NN	O	°	nsubj	21	SENT_89	[p6l1230t97r1238b106],
10	'	''	O	'	_	0	SENT_89	[p6l1252t90r1355b106],
11	“	CD	NUMBER	“	dep	9	SENT_89	[p6l1252t90r1355b106],
12	"	``	O	"	punct	11	SENT_89	[p6l1252t90r1355b106],
13	<	JJR	O	<	dep	11	SENT_89	[p6l1252t90r1355b106],
14	5	CD	NUMBER	5	dep	11	SENT_89	[p6l1252t90r1355b106],
15	"	``	O	"	punct	21	SENT_89	[p6l1252t90r1355b106],
16	'	''	O	'	_	0	SENT_89	[p6l1252t90r1355b106],
17	/	:	O	/	punct	18	SENT_89	[p6l1252t90r1355b106],
18	°	CD	NUMBER	°	dep	21	SENT_89	[p6l1252t90r1355b106],
19	‘	CD	NUMBER	‘	dep	18	SENT_89	[p6l1361t90r1466b106],
20	"	``	O	"	punct	21	SENT_89	[p6l1361t90r1466b106],
21	1	CD	NUMBER	1	rcmod	4	SENT_89	[p6l1361t90r1466b106],
22	"	``	O	"	punct	21	SENT_89	[p6l1361t90r1466b106],
23	’	SYM	O	’	dep	31	SENT_89	[p6l1361t90r1466b106],
24	-	:	O	-	_	0	SENT_89	[p6l1361t90r1466b106],
25	"	``	O	"	punct	26	SENT_89	[p6l1361t90r1466b106],
26	°	CD	NUMBER	°	dep	30	SENT_89	[p6l1361t90r1466b106],
27	"	``	O	"	punct	26	SENT_89	[p6l1361t90r1466b106],
28	°	CD	NUMBER	°	dep	26	SENT_89	[p6l1361t90r1466b106],
29	°	CD	NUMBER	°	num	30	SENT_89	[p6l1361t90r1466b106],
30	ages	NNS	O	age	nsubj	31	SENT_89	[p6l1659t97r1727b122],
31	do	VBP	O	do	parataxis	36	SENT_89	[p6l1736t91r1771b116],
32	not	RB	O	not	neg	34	SENT_89	[p6l1781t93r1825b116],
33	always	RB	O	always	advmod	34	SENT_89	[p6l1834t91r1929b122],
34	total	JJ	O	total	iobj	31	SENT_89	[p6l1937t91r1997b116],
35	100	CD	NUMBER	100	dobj	31	SENT_89	[p6l2009t92r2060b116],
36	be	VB	O	be	rcmod	21	SENT_89	[p6l2070t91r2116b116, p6l1119t126r1124b132],
37	-	:	O	-	_	0	SENT_89	[p6l2070t91r2116b116, p6l1119t126r1124b132],
38	2	CD	PERCENT	2	advmod	36	SENT_89	[p6l1131t120r1204b141],
39	(	CD	PERCENT	(	nsubj	43	SENT_89	[p6l1131t120r1204b141],
40	0.-1	CD	PERCENT	0.-1	num	41	SENT_89	[p6l1131t120r1204b141],
41	%	NN	PERCENT	%	npadvmod	42	SENT_89	[p6l1131t120r1204b141],
42	never	RB	O	never	advmod	39	SENT_89	[p6l1217t124r1273b138],
43	started	VBD	O	start	dep	21	SENT_89	[p6l1278t121r1347b137],
44	on	IN	O	on	_	0	SENT_89	[p6l1354t124r1379b138],
45	treatment	NN	O	treatment	nn	46	SENT_89	[p6l1385t121r1481b138],
46	Cause	NN	O	cause	prep_on	1	SENT_89	[p6l1659t139r1744b158],
47	of	IN	O	of	_	0	SENT_89	[p6l1755t133r1782b158],
48	rounding	VBG	O	round	prepc_of	1	SENT_89	[p6l1792t133r1915b164],

1	-	:	O	-	_	0	SENT_90	[p6l63t31r68b38],
2	373	CD	PERCENT	373	number	3	SENT_90	[p6l75t27r110b43],
3	(	CD	PERCENT	(	nsubj	7	SENT_90	[p6l115t27r189b47],
4	67.5	CD	PERCENT	67.5	num	5	SENT_90	[p6l115t27r189b47],
5	%	NN	PERCENT	%	dep	3	SENT_90	[p6l115t27r189b47],
6	)	CD	NUMBER	)	dep	3	SENT_90	[p6l115t27r189b47],
7	had	VBD	O	have	parataxis	20	SENT_90	[p6l196t27r231b43],
8	280	CD	PERCENT	280	num	10	SENT_90	[p6l238t27r297b43],
9	%	NN	PERCENT	%	nn	10	SENT_90	[p6l238t27r297b43],
10	adherence	NN	O	adherence	dobj	7	SENT_90	[p6l304t27r408b43],
11	to	TO	O	to	_	0	SENT_90	[p6l414t27r434b43],
12	drug	NN	O	drug	nn	13	SENT_90	[p6l441t27r486b47],
13	use	NN	O	use	prep_to	10	SENT_90	[p6l493t30r528b43],
14	-	:	O	-	_	0	SENT_90	[p6l63t63r68b69],
15	45	CD	PERCENT	45	number	16	SENT_90	[p6l75t58r98b75],
16	(	CD	PERCENT	(	dep	10	SENT_90	[p6l103t57r165b78],
17	8.0	CD	PERCENT	8.0	num	18	SENT_90	[p6l103t57r165b78],
18	%	NN	PERCENT	%	dep	16	SENT_90	[p6l103t57r165b78],
19	)	CD	NUMBER	)	tmod	7	SENT_90	[p6l103t57r165b78],
20	had	VBD	O	have	_	0	SENT_90	[p6l172t58r208b75],
21	50	CD	NUMBER	50	dobj	20	SENT_90	[p6l216t58r238b75],
22	to	TO	O	to	_	0	SENT_90	[p6l244t58r264b75],
23	<	JJR	O	<	nn	27	SENT_90	[p6l270t62r282b75],
24	80	CD	PERCENT	80	number	25	SENT_90	[p6l288t58r330b75],
25	%	NN	PERCENT	%	amod	27	SENT_90	[p6l288t58r330b75],
26	adherence	NN	O	adherence	nn	27	SENT_90	[p6l336t58r441b75],
27	O	NN	O	o	prep_to	21	SENT_90	[p6l63t94r68b101],
28	134	CD	PERCENT	134	number	29	SENT_90	[p6l76t90r110b105],
29	(	CD	PERCENT	(	nsubj	20	SENT_90	[p6l115t89r189b110],
30	23.9	CD	PERCENT	23.9	num	31	SENT_90	[p6l115t89r189b110],
31	%	NN	PERCENT	%	nsubj	33	SENT_90	[p6l115t89r189b110],
32	)	CD	NUMBER	)	dep	31	SENT_90	[p6l115t89r189b110],
33	had	VBD	O	have	rcmod	29	SENT_90	[p6l196t90r231b106],
34	<	JJR	O	<	dobj	33	SENT_90	[p6l238t93r251b105],
35	50	CD	PERCENT	50	number	36	SENT_90	[p6l257t90r299b105],
36	%	NN	PERCENT	%	amod	37	SENT_90	[p6l257t90r299b105],
37	adherence	NN	O	adherence	dep	34	SENT_90	[p6l304t90r410b105],
38	-	:	O	-	_	0	SENT_90	[p6l63t126r68b132],
39	3	CD	PERCENT	3	num	40	SENT_90	[p6l75t121r86b138],
40	(	NN	PERCENT	(	dep	34	SENT_90	[p6l93t120r153b141],
41	0.5	CD	PERCENT	0.5	number	42	SENT_90	[p6l93t120r153b141],
42	%	NN	PERCENT	%	amod	40	SENT_90	[p6l93t120r153b141],
43	)	CD	NUMBER	)	npadvmod	44	SENT_90	[p6l93t120r153b141],
44	never	RB	O	never	advmod	40	SENT_90	[p6l161t124r216b138],
45	started	VBN	O	start	partmod	40	SENT_90	[p6l222t121r291b138],
46	on	IN	O	on	_	0	SENT_90	[p6l298t124r323b137],
47	treatment	NN	O	treatment	prep_on	45	SENT_90	[p6l330t121r425b138],

1	-	:	O	-	_	0	SENT_91	[p6l591t32r597b37],
2	373	CD	PERCENT	373	number	3	SENT_91	[p6l603t27r638b43],
3	(	CD	PERCENT	(	nsubj	7	SENT_91	[p6l643t27r717b47],
4	53.9	CD	PERCENT	53.9	num	5	SENT_91	[p6l643t27r717b47],
5	%	NN	PERCENT	%	dep	3	SENT_91	[p6l643t27r717b47],
6	)	CD	NUMBER	)	dep	3	SENT_91	[p6l643t27r717b47],
7	had	VBD	O	have	_	0	SENT_91	[p6l724t27r760b43],
8	a	DT	O	a	det	11	SENT_91	[p6l766t30r779b42],
9	30	CD	PERCENT	30	number	10	SENT_91	[p6l784t27r827b43],
10	%	NN	PERCENT	%	amod	11	SENT_91	[p6l784t27r827b43],
11	adherence	NN	O	adherence	dobj	7	SENT_91	[p6l833t27r938b43],
12	to	TO	O	to	_	0	SENT_91	[p6l944t27r962b43],
13	drug	NN	O	drug	nn	14	SENT_91	[p6l969t27r1015b47],
14	use	NN	O	use	prep_to	11	SENT_91	[p6l1022t30r1058b43],
15	-	:	O	-	_	0	SENT_91	[p6l591t63r597b69],
16	42	CD	PERCENT	42	nsubj	21	SENT_91	[p6l603t58r627b74],
17	(	CD	PERCENT	(	number	18	SENT_91	[p6l633t58r693b78],
18	7.7	CD	PERCENT	7.7	dep	19	SENT_91	[p6l633t58r693b78],
19	%	NN	PERCENT	%	dep	16	SENT_91	[p6l633t58r693b78],
20	)	CD	NUMBER	)	dep	16	SENT_91	[p6l633t58r693b78],
21	had	VBD	O	have	dep	11	SENT_91	[p6l702t58r737b75],
22	so	RB	O	so	advmod	21	SENT_91	[p6l744t58r767b75],
23	to	TO	O	to	aux	24	SENT_91	[p6l772t58r793b75],
24	<	VBG	O	<	xcomp	21	SENT_91	[p6l798t62r812b74],
25	an	DT	O	a	dobj	24	SENT_91	[p6l817t58r859b75],
26	-	:	O	-	_	0	SENT_91	[p6l817t58r859b75],
27	/	:	O	/	punct	21	SENT_91	[p6l817t58r859b75],
28	.	.	O	.	_	0	SENT_91	[p6l817t58r859b75],

1	adherence	NN	O	adherence	_	0	SENT_92	[p6l865t58r970b75],
2	-	:	O	-	_	0	SENT_92	[p6l591t94r597b100],
3	23.1	CD	NUMBER	23.1	num	4	SENT_92	[p6l651t90r689b105],
4	Va	NNP	O	Va	dep	1	SENT_92	[p6l693t90r717b110],
5	)	CD	NUMBER	)	num	4	SENT_92	[p6l693t90r717b110],
6	had	VBD	O	have	rcmod	4	SENT_92	[p6l724t90r760b105],
7	<	JJR	O	<	dobj	6	SENT_92	[p6l766t93r780b105],
8	50	CD	PERCENT	50	number	9	SENT_92	[p6l786t90r827b106],
9	%	NN	PERCENT	%	amod	10	SENT_92	[p6l786t90r827b106],
10	adherence	NN	O	adherence	dep	7	SENT_92	[p6l833t90r938b105],
11	-	:	O	-	_	0	SENT_92	[p6l591t126r597b132],
12	3	CD	PERCENT	3	num	13	SENT_92	[p6l640t120r682b141],
13	%	NN	PERCENT	%	dep	7	SENT_92	[p6l640t120r682b141],
14	)	CD	NUMBER	)	npadvmod	15	SENT_92	[p6l640t120r682b141],
15	never	RB	O	never	neg	16	SENT_92	[p6l690t124r744b138],
16	started	VBN	O	start	partmod	13	SENT_92	[p6l750t121r820b138],
17	on	IN	O	on	_	0	SENT_92	[p6l827t124r851b137],
18	treatment	NN	O	treatment	prep_on	16	SENT_92	[p6l858t121r954b138],

1	June	NNP	DATE	June	_	0	SENT_93	[p6l7t324r146b373],
2	2009	CD	DATE	2009	dep	1	SENT_93	[p6l174t324r335b373],

1	was	VBD	O	be	cop	3	SENT_94	[p6l9t558r141b597],
2	100	CD	PERCENT	100	num	3	SENT_94	[p6l194t538r394b597],
3	%	NN	PERCENT	%	_	0	SENT_94	[p6l194t538r394b597],
4	.	.	O	.	_	0	SENT_94	[p6l194t538r394b597],

1	As	IN	O	as	prep	10	SENT_95	[p6l438t539r526b597],
2	in	IN	O	in	pcomp	1	SENT_95	[p6l571t536r643b597],
3	our	PRP$	O	we	poss	5	SENT_95	[p6l687t557r815b597],
4	previous	JJ	O	previous	amod	5	SENT_95	[p6l857t536r1170b620],
5	study	NN	O	study	pobj	2	SENT_95	[p6l1215t533r1499b620],
6	,	,	O	,	_	0	SENT_95	[p6l1215t533r1499b620],
7	”	CD	NUMBER	”	appos	5	SENT_95	[p6l1215t533r1499b620],
8	we	PRP	O	we	nsubj	10	SENT_95	[p6l1542t557r1638b597],
9	further	RB	O	further	advmod	10	SENT_95	[p6l1682t533r1946b597],
10	validated	VBD	O	validate	_	0	SENT_95	[p6l1984t533r2138b597, p6l11t639r217b705],
11	our	PRP$	O	we	poss	13	SENT_95	[p6l244t663r372b704],
12	genotyping	VBG	O	genotype	amod	13	SENT_95	[p6l398t642r816b726],
13	quality	NN	O	quality	dobj	10	SENT_95	[p6l843t640r1101b726],
14	by	IN	O	by	_	0	SENT_95	[p6l1124t640r1211b726],
15	examining	VBG	O	examine	prepc_by	10	SENT_95	[p6l1236t642r1624b726],
16	Hardy	NNP	PERSON	Hardy	dobj	15	SENT_95	[p6l1651t639r2138b726, p6l9t778r170b864],
17	.	.	O	.	_	0	SENT_95	[p6l1651t639r2138b726, p6l9t778r170b864],

1	—	NN	O	—	_	0	SENT_96	[p6l1651t639r2138b726, p6l9t778r170b864],
2	.	.	O	.	_	0	SENT_96	[p6l1651t639r2138b726, p6l9t778r170b864],

1	Weinberg	NNP	PERSON	Weinberg	_	0	SENT_97	[p6l1651t639r2138b726, p6l9t778r170b864],

1	equilibrium	NN	O	equilibrium	_	0	SENT_98	[p6l196t778r634b864],
2	among	IN	O	among	_	0	SENT_98	[p6l661t801r917b864],
3	the	DT	O	the	det	6	SENT_98	[p6l943t778r1058b842],
4	non-Hispanic	JJ	MISC	non-hispanic	amod	5	SENT_98	[p6l1084t780r1589b864],
5	white	JJ	O	white	amod	6	SENT_98	[p6l1613t778r1816b842],
6	patients	NNS	O	patient	prep_among	1	SENT_98	[p6l1842t780r2138b864],
7	who	WP	O	who	nsubj	10	SENT_98	[p6l9t883r164b947],
8	did	VBD	O	do	aux	10	SENT_98	[p6l201t883r321b948],
9	not	RB	O	not	neg	10	SENT_98	[p6l353t901r480b947],
10	develop	VB	O	develop	rcmod	6	SENT_98	[p6l514t883r793b970],
11	an	DT	O	a	det	12	SENT_98	[p6l830t907r918b947],
12	adenoma	NN	O	adenoma	dobj	10	SENT_98	[p6l952t883r1294b948],
13	over	IN	O	over	prep	12	SENT_98	[p6l1326t906r1481b947],
14	follow	VB	O	follow	dep	13	SENT_98	[p6l1514t883r1888b970],
15	—	RB	O	—	advmod	14	SENT_98	[p6l1514t883r1888b970],
16	up	RB	O	up	advmod	14	SENT_98	[p6l1514t883r1888b970],
17	.	.	O	.	_	0	SENT_98	[p6l1514t883r1888b970],

1	Using	VBG	O	use	partmod	16	SENT_99	[p6l1924t886r2141b970],
2	the	DT	O	the	det	5	SENT_99	[p6l11t989r126b1054],
3	X2	NN	O	x2	nn	5	SENT_99	[p6l154t988r229b1072],
4	goodness-of-ﬁt	NN	O	goodness-of-ﬁt	nn	5	SENT_99	[p6l260t989r816b1077],
5	test	NN	O	test	dobj	1	SENT_99	[p6l844t1008r993b1069],
6	,	,	O	,	_	0	SENT_99	[p6l844t1008r993b1069],
7	the	DT	O	the	det	9	SENT_99	[p6l1024t989r1139b1054],
8	genotype	NN	O	genotype	nn	9	SENT_99	[p6l1168t1008r1502b1077],
9	distribution	NN	O	distribution	nsubj	16	SENT_99	[p6l1533t989r1979b1055],
10	was	VBD	O	be	cop	16	SENT_99	[p6l2006t1014r2138b1054],
11	in	IN	O	in	_	0	SENT_99	[p6l10t1096r82b1157],
12	Hardy	NNP	O	Hardy	prep_in	16	SENT_99	[p6l106t1093r734b1180],
13	—	CD	NUMBER	—	number	14	SENT_99	[p6l106t1093r734b1180],
14	\	CD	NUMBER	\	num	16	SENT_99	[p6l106t1093r734b1180],
15	X/einberg	NN	O	x/einberg	nn	16	SENT_99	[p6l106t1093r734b1180],
16	equilibrium	NN	O	equilibrium	_	0	SENT_99	[p6l757t1093r1195b1180],
17	for	IN	O	for	mark	24	SENT_99	[p6l1220t1093r1327b1157],
18	the	DT	O	the	det	23	SENT_99	[p6l1350t1093r1465b1157],
19	*	NN	O	*	nn	23	SENT_99	[p6l1493t1099r1575b1157],
20	2	CD	NUMBER	2	num	23	SENT_99	[p6l1493t1099r1575b1157],
21	allele	NN	O	allele	nn	23	SENT_99	[p6l1603t1093r1788b1157],
22	(	CD	NUMBER	(	num	23	SENT_99	[p6l1816t1094r1890b1177],
23	P	NN	O	p	nsubj	24	SENT_99	[p6l1816t1094r1890b1177],
24	=	JJ	O	=	ccomp	16	SENT_99	[p6l1918t1117r1971b1138],
25	.86	CD	NUMBER	.86	iobj	24	SENT_99	[p6l2006t1093r2136b1177],
26	)	NN	O	)	nn	35	SENT_99	[p6l2006t1093r2136b1177],
27	and	CC	O	and	_	0	SENT_99	[p6l11t1198r149b1264],
28	*	NN	O	*	conj_and	26	SENT_99	[p6l185t1204r266b1263],
29	3	CD	NUMBER	3	num	35	SENT_99	[p6l185t1204r266b1263],
30	allele	NN	O	allele	nn	35	SENT_99	[p6l304t1198r490b1263],
31	(	CD	NUMBER	(	num	35	SENT_99	[p6l527t1199r600b1282],
32	P	NN	O	p	nn	35	SENT_99	[p6l527t1199r600b1282],
33	=	JJ	O	=	amod	35	SENT_99	[p6l638t1222r692b1243],
34	.99	CD	NUMBER	.99	num	35	SENT_99	[p6l737t1199r887b1282],
35	)	NN	O	)	dobj	24	SENT_99	[p6l737t1199r887b1282],
36	.	.	O	.	_	0	SENT_99	[p6l737t1199r887b1282],

1	Statistical	JJ	O	statistical	amod	2	SENT_100	[p6l276t1401r666b1471],
2	Analysis	NN	O	analysis	nsubj	11	SENT_100	[p6l692t1401r1023b1497],
3	Consistent	JJ	O	consistent	amod	2	SENT_100	[p6l279t1517r677b1579],
4	with	IN	O	with	_	0	SENT_100	[p6l703t1515r868b1579],
5	the	DT	O	the	det	8	SENT_100	[p6l899t1515r1013b1579],
6	primary	JJ	O	primary	amod	8	SENT_100	[p6l1043t1518r1338b1602],
7	efﬁcacy	NN	O	efﬁcacy	nn	8	SENT_100	[p6l1365t1515r1638b1601],
8	analyses	NNS	O	analysis	prep_with	3	SENT_100	[p6l1664t1515r2015b1601],
9	,2	CD	NUMBER	,2	tmod	3	SENT_100	[p6l1664t1515r2015b1601],
10	we	PRP	O	we	nsubj	11	SENT_100	[p6l2043t1539r2139b1579],
11	used	VBD	O	use	_	0	SENT_100	[p6l10t1620r180b1685],
12	the	DT	O	the	det	13	SENT_100	[p6l209t1620r323b1684],
13	detection	NN	O	detection	dobj	11	SENT_100	[p6l353t1620r697b1685],
14	of	IN	O	of	_	0	SENT_100	[p6l727t1620r811b1684],
15	an	DT	O	a	det	16	SENT_100	[p6l828t1644r916b1684],
16	adenoma	NN	O	adenoma	prep_of	13	SENT_100	[p6l945t1620r1287b1685],
17	during	IN	O	during	_	0	SENT_100	[p6l1314t1620r1564b1707],
18	a	DT	O	a	det	22	SENT_100	[p6l1592t1644r1631b1684],
19	postrandom	NN	O	postrandom	nn	22	SENT_100	[p6l1657t1620r2138b1707],
20	—	NN	O	—	nn	22	SENT_100	[p6l1657t1620r2138b1707],
21	ization	NN	O	ization	nn	22	SENT_100	[p6l10t1729r266b1790],
22	colonoscopy	NN	O	colonoscopy	prep_during	11	SENT_100	[p6l313t1726r792b1813],
23	,	,	O	,	_	0	SENT_100	[p6l313t1726r792b1813],
24	regardless	RB	O	regardless	_	0	SENT_100	[p6l841t1726r1204b1813],
25	of	IN	O	of	_	0	SENT_100	[p6l1253t1726r1337b1790],
26	whether	IN	O	whether	complm	29	SENT_100	[p6l1369t1726r1671b1790],
27	the	DT	O	the	det	28	SENT_100	[p6l1716t1726r1831b1790],
28	patient	NN	O	patient	nsubj	29	SENT_100	[p6l1877t1729r2141b1813],
29	adhered	VBD	O	adhere	prepc_regardless_of	11	SENT_100	[p6l11t1864r307b1930],
30	to	TO	O	to	_	0	SENT_100	[p6l349t1883r421b1928],
31	the	DT	O	the	det	33	SENT_100	[p6l467t1864r582b1928],
32	treatment	NN	O	treatment	nn	33	SENT_100	[p6l626t1883r992b1928],
33	regimen	NN	O	regimen	prep_to	29	SENT_100	[p6l1035t1867r1352b1951],
34	,	,	O	,	_	0	SENT_100	[p6l1035t1867r1352b1951],
35	as	IN	O	as	_	0	SENT_100	[p6l1398t1888r1467b1928],
36	the	DT	O	the	det	39	SENT_100	[p6l1512t1864r1627b1928],
37	primary	JJ	O	primary	amod	39	SENT_100	[p6l1670t1867r1965b1951],
38	end	NN	O	end	nn	39	SENT_100	[p6l2006t1864r2141b1930],
39	point	NN	O	point	prep_as	11	SENT_100	[p6l10t1972r227b2056],
40	.	.	O	.	_	0	SENT_100	[p6l10t1972r227b2056],

1	We	PRP	O	we	nsubj	2	SENT_101	[p6l259t1975r374b2033],
2	used	VBD	O	use	_	0	SENT_101	[p6l405t1969r575b2035],
3	the	DT	O	the	det	4	SENT_101	[p6l605t1969r720b2033],
4	Mantel	NNP	O	Mantel	dobj	2	SENT_101	[p6l749t1969r1204b2033],
5	.	.	O	.	_	0	SENT_101	[p6l749t1969r1204b2033],

1	—	NN	O	—	_	0	SENT_102	[p6l749t1969r1204b2033],
2	.	.	O	.	_	0	SENT_102	[p6l749t1969r1204b2033],

1	Cox	NNP	O	Cox	nn	2	SENT_103	[p6l749t1969r1204b2033],
2	test	NN	O	test	_	0	SENT_103	[p6l1233t1988r1382b2048],
3	,	,	O	,	_	0	SENT_103	[p6l1233t1988r1382b2048],
4	which	WDT	O	which	nsubj	7	SENT_103	[p6l1412t1969r1635b2033],
5	is	VBZ	O	be	cop	7	SENT_103	[p6l1665t1972r1719b2033],
6	a	DT	O	a	det	7	SENT_103	[p6l1752t1993r1791b2033],
7	life	NN	O	life	rcmod	2	SENT_103	[p6l1818t1969r2139b2033],
8	—	RB	O	—	advmod	7	SENT_103	[p6l1818t1969r2139b2033],
9	table	NN	O	table	nn	10	SENT_103	[p6l1818t1969r2139b2033],
10	extension	NN	O	extension	attr	7	SENT_103	[p6l11t2078r364b2140],
11	of	IN	O	of	_	0	SENT_103	[p6l399t2076r484b2140],
12	the	DT	O	the	det	13	SENT_103	[p6l506t2076r621b2140],
13	Mantel	NNP	O	Mantel	prep_of	10	SENT_103	[p6l655t2075r1297b2140],
14	.	.	O	.	_	0	SENT_103	[p6l655t2075r1297b2140],

1	—	NN	O	—	_	0	SENT_104	[p6l655t2075r1297b2140],
2	.	.	O	.	_	0	SENT_104	[p6l655t2075r1297b2140],

1	Haenszel	NNP	PERSON	Haenszel	_	0	SENT_105	[p6l655t2075r1297b2140],
2	statistic	NN	O	statistic	dep	1	SENT_105	[p6l1332t2078r1636b2155],
3	,	,	O	,	_	0	SENT_105	[p6l1332t2078r1636b2155],
4	with	IN	O	with	_	0	SENT_105	[p6l1671t2075r1835b2139],
5	stratiﬁcation	NN	O	stratiﬁcation	prep_with	1	SENT_105	[p6l1871t2076r2138b2140, p6l11t2184r240b2246],
6	for	IN	O	for	_	0	SENT_105	[p6l281t2182r388b2246],
7	aspirin	NN	O	aspirin	nn	8	SENT_105	[p6l428t2184r682b2270],
8	use	NN	O	use	prep_for	5	SENT_105	[p6l723t2206r841b2246],
9	or	CC	O	or	_	0	SENT_105	[p6l884t2205r961b2246],
10	nonuse	NN	O	nonuse	prep_for	5	SENT_105	[p6l1001t2206r1287b2262],
11	,	,	O	,	_	0	SENT_105	[p6l1001t2206r1287b2262],
12	sex	NN	O	sex	prep_for	5	SENT_105	[p6l1331t2206r1458b2262],
13	,	,	O	,	_	0	SENT_105	[p6l1331t2206r1458b2262],
14	and	CC	O	and	_	0	SENT_105	[p6l1500t2182r1639b2248],
15	age	NN	O	age	nn	16	SENT_105	[p6l1679t2206r1797b2269],
16	(	NN	O	(	dep	17	SENT_105	[p6l1841t2182r2025b2266],
17	<	JJR	O	<	prep_for	5	SENT_105	[p6l1841t2182r2025b2266],
18	65	CD	NUMBER	65	dep	17	SENT_105	[p6l1841t2182r2025b2266],
19	vs	CC	O	vs	_	0	SENT_105	[p6l2066t2206r2138b2246],
20	265	CD	DURATION	265	num	21	SENT_105	[p6l15t2291r168b2351],
21	years	NNS	NUMBER	year	conj_and	8	SENT_105	[p6l210t2287r438b2374],
22	)	RB	O	)	advmod	21	SENT_105	[p6l210t2287r438b2374],
23	.	.	O	.	_	0	SENT_105	[p6l210t2287r438b2374],

1	The	DT	O	the	det	2	SENT_106	[p6l479t2287r622b2351],
2	Mantel	NNP	O	Mantel	_	0	SENT_106	[p6l661t2287r1115b2351],
3	.	.	O	.	_	0	SENT_106	[p6l661t2287r1115b2351],

1	—	NN	O	—	_	0	SENT_107	[p6l661t2287r1115b2351],
2	.	.	O	.	_	0	SENT_107	[p6l661t2287r1115b2351],

1	Cox	NN	O	cox	nn	2	SENT_108	[p6l661t2287r1115b2351],
2	procedure	NN	O	procedure	nsubj	4	SENT_108	[p6l1154t2287r1527b2374],
3	also	RB	O	also	advmod	4	SENT_108	[p6l1568t2287r1709b2351],
4	provides	VBZ	O	provide	_	0	SENT_108	[p6l1751t2287r2062b2374],
5	a	DT	O	a	det	8	SENT_108	[p6l2104t2311r2143b2351],
6	summary	NN	O	summary	nn	8	SENT_108	[p6l11t2416r359b2480],
7	risk	NN	O	risk	nn	8	SENT_108	[p6l388t2393r523b2457],
8	ratio	NN	O	ratio	dobj	4	SENT_108	[p6l553t2396r744b2472],
9	,	,	O	,	_	0	SENT_108	[p6l553t2396r744b2472],
10	which	WDT	O	which	nsubj	14	SENT_108	[p6l774t2393r996b2457],
11	is	VBZ	O	be	cop	14	SENT_108	[p6l1026t2396r1080b2457],
12	the	DT	O	the	det	14	SENT_108	[p6l1112t2393r1227b2457],
13	weighted	JJ	O	weighted	amod	14	SENT_108	[p6l1256t2393r1592b2480],
14	average	NN	O	average	rcmod	8	SENT_108	[p6l1621t2416r1891b2480],
15	of	IN	O	of	_	0	SENT_108	[p6l1922t2393r2006b2457],
16	the	DT	O	the	det	18	SENT_108	[p6l2025t2393r2139b2457],
17	relative	JJ	O	relative	amod	18	SENT_108	[p6l11t2497r275b2561],
18	risk	NN	O	risk	conj_and	18	SENT_108	[p6l328t2497r464b2561],
19	over	IN	O	over	_	0	SENT_108	[p6l515t2521r669b2561],
20	the	DT	O	the	det	22	SENT_108	[p6l719t2497r834b2561],
21	2	CD	NUMBER	2	num	22	SENT_108	[p6l885t2503r925b2561],
22	intervals	NNS	O	interval	prep_over	18	SENT_108	[p6l978t2497r1290b2561],
23	and	CC	O	and	_	0	SENT_108	[p6l1343t2497r1482b2563],
24	across	IN	O	across	_	0	SENT_108	[p6l1532t2520r1754b2561],
25	strata	NN	O	stratum	prep_across	18	SENT_108	[p6l1808t2516r2018b2561],
26	of	IN	O	of	_	0	SENT_108	[p6l2067t2497r2152b2561],
27	aspirin	NN	O	aspirin	nn	28	SENT_108	[p6l11t2606r265b2690],
28	use	NN	O	use	prep_of	25	SENT_108	[p6l317t2627r454b2683],
29	,	,	O	,	_	0	SENT_108	[p6l317t2627r454b2683],
30	sex	NN	O	sex	prep_of	25	SENT_108	[p6l508t2627r635b2682],
31	,	,	O	,	_	0	SENT_108	[p6l508t2627r635b2682],
32	and	CC	O	and	_	0	SENT_108	[p6l690t2603r828b2669],
33	age	NN	O	age	conj_and	28	SENT_108	[p6l879t2627r1014b2690],
34	.	.	O	.	_	0	SENT_108	[p6l879t2627r1014b2690],

1	Patients	NNS	O	patient	nsubj	4	SENT_109	[p6l1070t2606r1366b2667],
2	with	IN	O	with	advmod	4	SENT_109	[p6l1418t2603r1583b2667],
3	no	DT	O	no	dep	2	SENT_109	[p6l1636t2627r1728b2667],
4	follow	VBP	O	follow	_	0	SENT_109	[p6l1782t2603r2138b2690],
5	—	CD	NUMBER	—	dobj	4	SENT_109	[p6l1782t2603r2138b2690],
6	up	IN	O	up	_	0	SENT_109	[p6l1782t2603r2138b2690],
7	colonoscopy	NN	O	colonoscopy	nn	9	SENT_109	[p6l11t2709r475b2795],
8	(	CD	NUMBER	(	num	9	SENT_109	[p6l523t2709r596b2792],
9	n	NN	O	n	prep_up	4	SENT_109	[p6l523t2709r596b2792],
10	=	JJ	O	=	amod	12	SENT_109	[p6l652t2732r705b2753],
11	163	CD	NUMBER	163	num	12	SENT_109	[p6l771t2709r921b2792],
12	)	NN	O	)	nsubjpass	14	SENT_109	[p6l771t2709r921b2792],
13	were	VBD	O	be	auxpass	14	SENT_109	[p6l973t2732r1139b2773],
14	excluded	VBN	O	exclude	rcmod	9	SENT_109	[p6l1189t2708r1515b2774],
15	from	IN	O	from	_	0	SENT_109	[p6l1563t2709r1745b2772],
16	both	DT	O	both	det	18	SENT_109	[p6l1791t2709r1966b2772],
17	follow-up	JJ	O	follow-up	amod	18	SENT_109	[p6l2016t2709r2138b2772, p6l10t2815r264b2901],
18	intervals	NNS	O	interval	prep_from	14	SENT_109	[p6l300t2815r630b2879],
19	.	.	O	.	_	0	SENT_109	[p6l300t2815r630b2879],

1	A	DT	O	a	det	2	SENT_110	[p6l664t2821r721b2878],
2	patient	NN	O	patient	nsubjpass	17	SENT_110	[p6l753t2817r1017b2901],
3	with	IN	O	with	_	0	SENT_110	[p6l1048t2815r1213b2879],
4	a	DT	O	a	det	5	SENT_110	[p6l1248t2839r1287b2879],
5	colonoscopy	NN	O	colonoscopy	prep_with	2	SENT_110	[p6l1320t2815r1783b2901],
6	at	IN	O	at	_	0	SENT_110	[p6l1815t2833r1883b2879],
7	year	NN	DURATION	year	prep_at	5	SENT_110	[p6l1914t2838r2066b2901],
8	3	CD	NUMBER	3	num	7	SENT_110	[p6l2099t2820r2136b2879],
9	but	CC	O	but	_	0	SENT_110	[p6l9t2920r137b2984],
10	with	IN	O	with	_	0	SENT_110	[p6l173t2920r338b2984],
11	no	DT	O	no	det	12	SENT_110	[p6l377t2944r469b2984],
12	colonoscopy	NN	O	colonoscopy	prep_with	2	SENT_110	[p6l510t2920r974b3007],
13	at	IN	O	at	_	0	SENT_110	[p6l1010t2938r1079b2984],
14	year	NN	DURATION	year	prep_at	12	SENT_110	[p6l1114t2943r1265b3007],
15	1	CD	NUMBER	1	num	14	SENT_110	[p6l1309t2925r1338b2983],
16	was	VBD	O	be	auxpass	17	SENT_110	[p6l1381t2944r1513b2984],
17	included	VBN	O	include	_	0	SENT_110	[p6l1553t2920r1876b2985],
18	in	IN	O	in	_	0	SENT_110	[p6l1913t2923r1985b2983],
19	the	DT	O	the	det	20	SENT_110	[p6l2024t2920r2139b2984],
20	analysis	NN	O	analysis	prep_in	17	SENT_110	[p6l11t3026r296b3113],
21	through	IN	O	through	_	0	SENT_110	[p6l342t3026r645b3113],
22	year	NN	DURATION	year	prep_through	17	SENT_110	[p6l686t3049r838b3113],
23	1	CD	NUMBER	1	num	22	SENT_110	[p6l887t3031r939b3105],
24	,	,	O	,	_	0	SENT_110	[p6l887t3031r939b3105],
25	with	IN	O	with	_	0	SENT_110	[p6l982t3026r1147b3090],
26	the	DT	O	the	det	27	SENT_110	[p6l1192t3026r1306b3090],
27	assumption	NN	O	assumption	prep_with	17	SENT_110	[p6l1351t3029r1787b3113],
28	that	IN	O	that	complm	31	SENT_110	[p6l1831t3026r1982b3090],
29	the	DT	O	the	det	30	SENT_110	[p6l2025t3026r2139b3090],
30	patient	NN	O	patient	nsubj	31	SENT_110	[p6l10t3133r274b3217],
31	had	VBD	O	have	dep	27	SENT_110	[p6l299t3130r437b3196],
32	no	DT	O	no	det	33	SENT_110	[p6l462t3154r555b3194],
33	adenoma	NN	O	adenoma	dobj	31	SENT_110	[p6l583t3130r925b3196],
34	at	IN	O	at	_	0	SENT_110	[p6l949t3149r1018b3194],
35	year	NN	DURATION	year	prep_at	33	SENT_110	[p6l1040t3153r1191b3217],
36	1	CD	NUMBER	1	num	35	SENT_110	[p6l1223t3135r1276b3209],
37	,	,	O	,	_	0	SENT_110	[p6l1223t3135r1276b3209],
38	and	CC	O	and	_	0	SENT_110	[p6l1304t3130r1442b3196],
39	was	VBD	O	be	auxpass	41	SENT_110	[p6l1465t3154r1598b3194],
40	then	RB	O	then	advmod	41	SENT_110	[p6l1626t3130r1793b3194],
41	included	VBN	O	include	conj_and	31	SENT_110	[p6l1818t3130r2142b3196],
42	in	IN	O	in	_	0	SENT_110	[p6l10t3239r82b3300],
43	the	DT	O	the	det	44	SENT_110	[p6l117t3236r231b3300],
44	analysis	NN	O	analysis	prep_in	41	SENT_110	[p6l266t3236r551b3323],
45	through	IN	O	through	_	0	SENT_110	[p6l587t3236r891b3323],
46	year	NN	DURATION	year	prep_through	44	SENT_110	[p6l923t3259r1074b3323],
47	3	CD	NUMBER	3	num	46	SENT_110	[p6l1108t3242r1145b3300],
48	according	VBG	O	accord	_	0	SENT_110	[p6l1183t3236r1547b3323],
49	to	TO	O	to	prepc_according_to	41	SENT_110	[p6l1580t3255r1652b3300],
50	the	DT	O	the	det	51	SENT_110	[p6l1689t3236r1803b3300],
51	ﬁndings	NNS	O	ﬁndings	pobj	41	SENT_110	[p6l1838t3236r2138b3323],
52	of	IN	O	of	_	0	SENT_110	[p6l11t3342r96b3405],
53	the	DT	O	the	det	54	SENT_110	[p6l135t3342r249b3406],
54	colonoscopy	NN	O	colonoscopy	prep_of	51	SENT_110	[p6l301t3342r765b3428],
55	at	IN	O	at	_	0	SENT_110	[p6l812t3360r881b3405],
56	year	NN	DURATION	year	prep_at	54	SENT_110	[p6l928t3365r1079b3428],
57	3	CD	NUMBER	3	num	56	SENT_110	[p6l1129t3347r1187b3406],
58	.	.	O	.	_	0	SENT_110	[p6l1129t3347r1187b3406],

1	The	DT	O	the	det	2	SENT_111	[p6l1238t3342r1380b3405],
2	analyses	NNS	O	analysis	nsubj	6	SENT_111	[p6l1432t3342r1730b3428],
3	at	IN	O	at	_	0	SENT_111	[p6l1783t3360r1851b3405],
4	year	NN	DURATION	year	prep_at	2	SENT_111	[p6l1898t3365r2049b3428],
5	3	CD	NUMBER	3	num	4	SENT_111	[p6l2099t3347r2136b3406],
6	excluded	VBN	O	exclude	_	0	SENT_111	[p6l11t3448r337b3514],
7	patients	NNS	O	patient	dobj	6	SENT_111	[p6l360t3451r656b3535],
8	with	IN	O	with	_	0	SENT_111	[p6l680t3448r845b3512],
9	an	DT	O	a	det	10	SENT_111	[p6l871t3472r958b3512],
10	adenoma	NN	O	adenoma	prep_with	6	SENT_111	[p6l983t3448r1325b3514],
11	at	IN	O	at	_	0	SENT_111	[p6l1348t3466r1416b3512],
12	year	NN	DURATION	year	nn	14	SENT_111	[p6l1438t3471r1589b3535],
13	1	CD	NUMBER	1	num	14	SENT_111	[p6l1620t3453r1648b3512],
14	colonoscopy	NN	O	colonoscopy	prep_at	10	SENT_111	[p6l1679t3448r2143b3536],
15	and	CC	O	and	_	0	SENT_111	[p6l11t3553r149b3618],
16	patients	NNS	O	patient	prep_at	10	SENT_111	[p6l177t3556r473b3640],
17	with	IN	O	with	_	0	SENT_111	[p6l502t3553r667b3617],
18	no	DT	O	no	det	19	SENT_111	[p6l697t3577r789b3617],
19	adenoma	NN	O	adenoma	prep_with	6	SENT_111	[p6l821t3553r1163b3618],
20	at	IN	O	at	_	0	SENT_111	[p6l1190t3571r1259b3617],
21	year	NN	DURATION	year	prep_at	19	SENT_111	[p6l1285t3576r1436b3640],
22	1	CD	NUMBER	1	num	21	SENT_111	[p6l1471t3558r1500b3616],
23	and	CC	O	and	_	0	SENT_111	[p6l1535t3553r1674b3618],
24	no	DT	O	no	det	25	SENT_111	[p6l1702t3577r1794b3617],
25	colonoscopy	NN	O	colonoscopy	prep_with	6	SENT_111	[p6l1827t3553r2138b3617, p6l11t3681r183b3745],
26	at	IN	O	at	_	0	SENT_111	[p6l218t3677r287b3722],
27	year	NN	DURATION	year	prep_at	25	SENT_111	[p6l320t3681r471b3745],
28	3	CD	NUMBER	3	num	27	SENT_111	[p6l508t3663r565b3722],
29	.	.	O	.	_	0	SENT_111	[p6l508t3663r565b3722],

1	According	VBG	O	accord	_	0	SENT_112	[p6l602t3658r984b3745],
2	to	TO	O	to	pcomp	1	SENT_112	[p6l1021t3677r1093b3722],
3	methods	NNS	O	method	pobj	2	SENT_112	[p6l1132t3658r1454b3723],
4	of	IN	O	of	_	0	SENT_112	[p6l1493t3658r1577b3722],
5	Kaplan	NNP	PERSON	Kaplan	prep_of	3	SENT_112	[p6l1603t3658r2138b3745],
6	.	.	O	.	_	0	SENT_112	[p6l1603t3658r2138b3745],

1	—	NN	O	—	_	0	SENT_113	[p6l1603t3658r2138b3745],
2	.	.	O	.	_	0	SENT_113	[p6l1603t3658r2138b3745],

1	Meier	NNP	PERSON	Meier	_	0	SENT_114	[p6l1603t3658r2138b3745],
2	,	,	O	,	_	0	SENT_114	[p6l1603t3658r2138b3745],

1	3-year	JJ	DURATION	3-year	amod	3	SENT_115	[p7l11t21r231b102],
2	cumulative	JJ	O	cumulative	amod	3	SENT_115	[p7l282t15r691b79],
3	incidences	NNS	O	incidence	nsubjpass	5	SENT_115	[p7l743t15r1124b81],
4	were	VBD	O	be	auxpass	5	SENT_115	[p7l1176t38r1342b79],
5	calculated	VBN	O	calculate	_	0	SENT_115	[p7l1395t15r1785b94],
6	,	,	O	,	_	0	SENT_115	[p7l1395t15r1785b94],
7	and	CC	O	and	_	0	SENT_115	[p7l1839t15r1977b81],
8	patients	NNS	O	patient	nsubj	16	SENT_115	[p7l2027t38r2138b102, p7l11t123r215b184],
9	at	IN	O	at	_	0	SENT_115	[p7l269t139r338b184],
10	risk	NN	O	risk	prep_at	8	SENT_115	[p7l389t120r524b184],
11	at	IN	O	at	_	0	SENT_115	[p7l576t139r645b184],
12	each	DT	O	each	det	14	SENT_115	[p7l696t120r858b184],
13	time	NN	O	time	nn	14	SENT_115	[p7l911t123r1075b184],
14	point	NN	O	point	prep_at	10	SENT_115	[p7l1128t123r1328b207],
15	were	VBD	O	be	cop	16	SENT_115	[p7l1377t144r1544b184],
16	those	DT	O	those	conj_and	5	SENT_115	[p7l1597t120r1794b184],
17	without	IN	O	without	_	0	SENT_115	[p7l1844t120r2140b184],
18	previously	RB	DATE	previously	advmod	19	SENT_115	[p7l10t227r391b313],
19	detected	VBN	O	detect	amod	20	SENT_115	[p7l423t226r731b292],
20	adenomas	NNS	O	adenoma	prep_without	16	SENT_115	[p7l765t226r1155b292],
21	.	.	O	.	_	0	SENT_115	[p7l765t226r1155b292],

1	Investigator	NN	O	investigator	nn	2	SENT_116	[p7l98t368r888b456],
2	—	NN	O	—	nsubj	3	SENT_116	[p7l98t368r888b456],
3	reported	VBD	O	report	_	0	SENT_116	[p7l98t368r888b456],
4	adverse	JJ	O	adverse	amod	5	SENT_116	[p7l921t367r1189b434],
5	events	NNS	O	event	nsubj	6	SENT_116	[p7l1224t386r1450b432],
6	were	VBD	O	be	ccomp	3	SENT_116	[p7l1484t391r1650b432],
7	analyzed	VBN	O	analyze	prep	6	SENT_116	[p7l1685t368r2006b455],
8	according	VBG	O	accord	pcomp	7	SENT_116	[p7l2040t392r2138b432, p7l11t506r295b592],

1	to	TO	O	to	_	0	SENT_117	[p7l332t524r404b570],
2	prespeciﬁed	JJ	O	prespeciﬁed	amod	3	SENT_117	[p7l443t506r883b593],
3	categories	NNS	O	category	pobj	1	SENT_117	[p7l919t509r1283b593],
4	to	TO	O	to	aux	5	SENT_117	[p7l1322t524r1394b570],
5	describe	VB	O	describe	infmod	3	SENT_117	[p7l1434t506r1731b571],
6	cardiovascular	JJ	O	cardiovascular	amod	9	SENT_117	[p7l1770t506r2138b571, p7l11t611r195b675],
7	and	CC	O	and	_	0	SENT_117	[p7l234t611r373b676],
8	thrombotic	JJ	O	thrombotic	amod	9	SENT_117	[p7l412t611r835b675],
9	disorders	NNS	O	disorder	dobj	5	SENT_117	[p7l876t611r1234b690],
10	,	,	O	,	_	0	SENT_117	[p7l876t611r1234b690],
11	renal	JJ	O	renal	amod	14	SENT_117	[p7l1276t611r1459b675],
12	and	CC	O	and	_	0	SENT_117	[p7l1499t611r1638b676],
13	hypertensive	JJ	O	hypertensive	conj_and	11	SENT_117	[p7l1676t611r2139b698],
14	disorders	NNS	O	disorder	conj_and	9	SENT_117	[p7l11t716r368b795],
15	,	,	O	,	_	0	SENT_117	[p7l11t716r368b795],
16	and	CC	O	and	_	0	SENT_117	[p7l425t716r563b781],
17	gastrointestinal	JJ	O	gastrointestinal	amod	18	SENT_117	[p7l616t716r1196b803],
18	ulceration	NN	O	ulceration	conj_and	9	SENT_117	[p7l1251t716r1627b780],
19	and	CC	O	and	_	0	SENT_117	[p7l1681t716r1819b781],
20	hemorrhage	NN	O	hemorrhage	conj_and	18	SENT_117	[p7l1873t716r2138b780, p7l11t820r230b907],
21	.	.	O	.	_	0	SENT_117	[p7l1873t716r2138b780, p7l11t820r230b907],

1	The	DT	O	the	det	2	SENT_118	[p7l274t820r417b884],
2	analyses	NNS	O	analysis	nsubj	3	SENT_118	[p7l461t820r760b907],
3	included	VBD	O	include	_	0	SENT_118	[p7l805t820r1128b886],
4	all	DT	O	all	det	5	SENT_118	[p7l1171t820r1257b884],
5	events	NNS	O	event	dobj	3	SENT_118	[p7l1301t839r1527b884],
6	occurring	VBG	O	occur	partmod	5	SENT_118	[p7l1573t823r1929b907],
7	after	IN	O	after	_	0	SENT_118	[p7l1972t820r2142b884],
8	the	DT	O	the	det	10	SENT_118	[p7l11t925r126b989],
9	ﬁrst	NN	O	ﬁrst	nn	10	SENT_118	[p7l152t925r298b989],
10	dose	NN	O	dose	prep_after	6	SENT_118	[p7l324t925r488b991],
11	of	IN	O	of	_	0	SENT_118	[p7l516t925r600b989],
12	study	NN	O	study	nn	13	SENT_118	[p7l615t925r819b1012],
13	medication	NN	O	medication	prep_of	10	SENT_118	[p7l842t925r1259b991],
14	and	CC	O	and	_	0	SENT_118	[p7l1285t925r1423b991],
15	up	IN	DURATION	up	quantmod	17	SENT_118	[p7l1448t948r1542b1012],
16	to	TO	DURATION	to	dep	17	SENT_118	[p7l1571t944r1643b989],
17	30	CD	DURATION	30	num	18	SENT_118	[p7l1672t931r1756b989],
18	days	NNS	NUMBER	day	conj_and	10	SENT_118	[p7l1785t925r1944b1012],
19	after	IN	O	after	_	0	SENT_118	[p7l1971t925r2141b989],
20	the	DT	O	the	det	22	SENT_118	[p7l11t1030r126b1094],
21	last	JJ	O	last	amod	22	SENT_118	[p7l186t1030r316b1094],
22	dose	NN	O	dose	prep_after	6	SENT_118	[p7l376t1030r541b1096],
23	of	IN	O	of	_	0	SENT_118	[p7l603t1030r688b1094],
24	study	NN	O	study	nn	25	SENT_118	[p7l736t1030r940b1117],
25	medication	NN	O	medication	prep_of	22	SENT_118	[p7l999t1030r1434b1109],
26	,	,	O	,	_	0	SENT_118	[p7l999t1030r1434b1109],
27	including	VBG	O	include	_	0	SENT_118	[p7l1496t1030r1852b1117],
28	events	NNS	O	event	prep_including	3	SENT_118	[p7l1913t1049r2138b1094],
29	among	IN	O	among	_	0	SENT_118	[p7l11t1160r267b1223],
30	patients	NNS	O	patient	prep_among	28	SENT_118	[p7l300t1139r596b1223],
31	who	WP	O	who	nsubj	32	SENT_118	[p7l629t1137r784b1200],
32	continued	VBD	O	continue	rcmod	30	SENT_118	[p7l821t1136r1199b1202],
33	study	NN	O	study	nn	34	SENT_118	[p7l1232t1136r1436b1223],
34	medication	NN	O	medication	dobj	32	SENT_118	[p7l1467t1136r1884b1202],
35	in	IN	O	in	_	0	SENT_118	[p7l1918t1139r1990b1200],
36	the	DT	O	the	det	39	SENT_118	[p7l2024t1137r2139b1201],
37	24-month	JJ	DURATION	24-month	amod	39	SENT_118	[p7l10t1242r381b1305],
38	extension	NN	O	extension	nn	39	SENT_118	[p7l423t1244r776b1306],
39	study	NN	O	study	prep_in	32	SENT_118	[p7l817t1241r1035b1328],
40	.	.	O	.	_	0	SENT_118	[p7l817t1241r1035b1328],

1	The	DT	O	the	det	2	SENT_119	[p7l1077t1242r1220b1305],
2	outcome	NN	O	outcome	nsubjpass	8	SENT_119	[p7l1262t1260r1586b1305],
3	of	IN	O	of	_	0	SENT_119	[p7l1628t1242r1713b1305],
4	an	DT	O	a	det	6	SENT_119	[p7l1742t1265r1830b1306],
5	adverse	JJ	O	adverse	amod	6	SENT_119	[p7l1871t1241r2139b1307],
6	event	NN	O	event	prep_of	2	SENT_119	[p7l11t1366r205b1412],
7	was	VBD	O	be	auxpass	8	SENT_119	[p7l240t1372r373b1412],
8	based	VBN	O	base	_	0	SENT_119	[p7l411t1348r621b1414],
9	on	IN	O	on	_	0	SENT_119	[p7l659t1372r753b1412],
10	a	DT	O	a	det	12	SENT_119	[p7l791t1372r831b1412],
11	time-to-event	JJ	O	time-to-event	amod	12	SENT_119	[p7l867t1351r1362b1412],
12	analysis	NN	O	analysis	prep_on	8	SENT_119	[p7l1400t1348r1704b1435],
13	,	,	O	,	_	0	SENT_119	[p7l1400t1348r1704b1435],
14	and	CC	O	and	_	0	SENT_119	[p7l1745t1348r1883b1414],
15	a	DT	O	a	det	19	SENT_119	[p7l1921t1372r1960b1412],
16	Cox	NN	ORGANIZATION	cox	nn	19	SENT_119	[p7l1997t1353r2141b1413],
17	proportional	JJ	O	proportional	amod	19	SENT_119	[p7l10t1455r487b1542],
18	hazards	NNS	O	hazard	nn	19	SENT_119	[p7l518t1454r802b1521],
19	model	NN	O	model	nsubjpass	28	SENT_119	[p7l835t1455r1066b1521],
20	adjusting	VBG	O	adjust	partmod	19	SENT_119	[p7l1097t1454r1445b1542],
21	for	IN	O	for	_	0	SENT_119	[p7l1475t1455r1582b1519],
22	low	JJ	O	low	amod	26	SENT_119	[p7l1611t1455r1936b1521],
23	—	NN	O	—	nn	26	SENT_119	[p7l1611t1455r1936b1521],
24	dose	NN	O	dose	nn	26	SENT_119	[p7l1611t1455r1936b1521],
25	aspirin	NN	O	aspirin	nn	26	SENT_119	[p7l1968t1457r2138b1542, p7l11t1562r115b1623],
26	use	NN	O	use	prep_for	20	SENT_119	[p7l149t1584r267b1624],
27	was	VBD	O	be	auxpass	28	SENT_119	[p7l300t1584r432b1624],
28	used	VBN	O	use	conj_and	8	SENT_119	[p7l468t1560r638b1625],
29	to	TO	O	to	aux	30	SENT_119	[p7l671t1578r743b1624],
30	estimate	VB	O	estimate	xcomp	28	SENT_119	[p7l779t1563r1089b1624],
31	the	DT	O	the	det	33	SENT_119	[p7l1124t1560r1238b1624],
32	relative	JJ	O	relative	amod	33	SENT_119	[p7l1274t1560r1538b1624],
33	risk	NN	O	risk	dobj	30	SENT_119	[p7l1573t1560r1724b1624],
34	.	.	O	.	_	0	SENT_119	[p7l1573t1560r1724b1624],

1	Among	IN	O	among	_	0	SENT_120	[p7l96t1671r371b1752],
2	the	DT	O	the	det	4	SENT_120	[p7l397t1665r512b1729],
3	1660	CD	DATE	1660	num	4	SENT_120	[p7l546t1669r717b1729],
4	patients	NNS	O	patient	prep_among	6	SENT_120	[p7l745t1668r1041b1752],
5	successfully	RB	O	successfully	advmod	6	SENT_120	[p7l1070t1665r1506b1752],
6	genotyped	VBD	O	genotype	_	0	SENT_120	[p7l1529t1665r1931b1752],
7	,	,	O	,	_	0	SENT_120	[p7l1529t1665r1931b1752],
8	1102	CD	DATE	1102	nsubj	9	SENT_120	[p7l1967t1670r2137b1729],
9	had	VBD	O	have	ccomp	6	SENT_120	[p7l10t1770r149b1835],
10	no	DT	O	no	det	12	SENT_120	[p7l178t1794r270b1834],
11	variant	JJ	O	variant	amod	12	SENT_120	[p7l299t1773r560b1834],
12	*	NN	O	*	dobj	9	SENT_120	[p7l593t1775r675b1833],
13	2	CD	NUMBER	2	dep	12	SENT_120	[p7l593t1775r675b1833],
14	or	CC	O	or	_	0	SENT_120	[p7l708t1793r785b1834],
15	*	CD	NUMBER	*	number	16	SENT_120	[p7l817t1775r898b1834],
16	3	CD	NUMBER	3	num	17	SENT_120	[p7l817t1775r898b1834],
17	alleles	NNS	O	allele	dobj	9	SENT_120	[p7l932t1770r1152b1834],
18	(	JJ	O	(	amod	21	SENT_120	[p7l1185t1770r1368b1853],
19	wild	JJ	O	wild	amod	21	SENT_120	[p7l1185t1770r1368b1853],
20	type/wild	NN	O	type/wild	nn	21	SENT_120	[p7l1397t1770r1746b1857],
21	type	NN	O	type	dep	17	SENT_120	[p7l1775t1770r1974b1857],
22	)	CD	NUMBER	)	nsubj	6	SENT_120	[p7l1775t1770r1974b1857],
23	,	,	O	,	_	0	SENT_120	[p7l1775t1770r1974b1857],
24	346	CD	NUMBER	346	appos	22	SENT_120	[p7l2007t1774r2137b1834],
25	had	VBD	O	have	rcmod	24	SENT_120	[p7l10t1875r149b1940],
26	one	CD	NUMBER	one	num	27	SENT_120	[p7l192t1899r324b1939],
27	*	NN	O	*	dobj	25	SENT_120	[p7l372t1880r453b1938],
28	2	CD	NUMBER	2	num	29	SENT_120	[p7l372t1880r453b1938],
29	allele	NN	O	allele	dep	27	SENT_120	[p7l501t1875r687b1939],
30	(	CD	NUMBER	(	num	32	SENT_120	[p7l734t1875r916b1958],
31	wild	JJ	O	wild	amod	32	SENT_120	[p7l734t1875r916b1958],
32	type	NN	O	type	dep	27	SENT_120	[p7l959t1875r1285b1962],
33	/	:	O	/	punct	39	SENT_120	[p7l959t1875r1285b1962],
34	*	CD	NUMBER	*	number	35	SENT_120	[p7l959t1875r1285b1962],
35	2	CD	NUMBER	2	num	36	SENT_120	[p7l959t1875r1285b1962],
36	)	NN	O	)	nsubj	39	SENT_120	[p7l959t1875r1285b1962],
37	,	,	O	,	_	0	SENT_120	[p7l959t1875r1285b1962],
38	78	CD	NUMBER	78	appos	36	SENT_120	[p7l1333t1880r1417b1940],
39	had	VBD	O	have	dep	27	SENT_120	[p7l1463t1875r1602b1940],
40	one	CD	NUMBER	one	num	41	SENT_120	[p7l1645t1899r1776b1939],
41	*	NN	O	*	dobj	39	SENT_120	[p7l1824t1880r1906b1939],
42	3	CD	NUMBER	3	num	43	SENT_120	[p7l1824t1880r1906b1939],
43	allele	NN	O	allele	dep	41	SENT_120	[p7l1954t1875r2139b1939],
44	(	CD	NUMBER	(	num	46	SENT_120	[p7l13t1980r195b2063],
45	wild	JJ	O	wild	amod	46	SENT_120	[p7l13t1980r195b2063],
46	type	NN	O	type	dep	41	SENT_120	[p7l238t1980r565b2067],
47	/	:	O	/	punct	53	SENT_120	[p7l238t1980r565b2067],
48	*	CD	NUMBER	*	number	49	SENT_120	[p7l238t1980r565b2067],
49	3	CD	NUMBER	3	num	50	SENT_120	[p7l238t1980r565b2067],
50	)	NN	O	)	nsubj	53	SENT_120	[p7l238t1980r565b2067],
51	,	,	O	,	_	0	SENT_120	[p7l238t1980r565b2067],
52	17	CD	NUMBER	17	appos	50	SENT_120	[p7l618t1985r698b2045],
53	had	VBD	O	have	dep	41	SENT_120	[p7l742t1980r881b2045],
54	one	CD	NUMBER	one	num	55	SENT_120	[p7l925t2004r1056b2044],
55	*	NN	O	*	nsubj	64	SENT_120	[p7l1104t1985r1186b2043],
56	2	CD	NUMBER	2	num	57	SENT_120	[p7l1104t1985r1186b2043],
57	allele	NN	O	allele	dep	55	SENT_120	[p7l1233t1980r1418b2044],
58	and	CC	O	and	_	0	SENT_120	[p7l1464t1980r1602b2045],
59	one	CD	NUMBER	one	num	60	SENT_120	[p7l1645t2004r1776b2044],
60	*	NN	O	*	conj_and	55	SENT_120	[p7l1824t1985r1906b2044],
61	3	CD	NUMBER	3	num	62	SENT_120	[p7l1824t1985r1906b2044],
62	allele	NN	O	allele	dep	60	SENT_120	[p7l1954t1980r2139b2044],
63	(	CD	NUMBER	(	num	64	SENT_120	[p7l13t2084r299b2168],
64	*	NN	O	*	xcomp	53	SENT_120	[p7l13t2084r299b2168],
65	2	CD	NUMBER	2	nsubj	72	SENT_120	[p7l13t2084r299b2168],
66	/	:	O	/	punct	69	SENT_120	[p7l13t2084r299b2168],
67	*	CD	NUMBER	*	number	68	SENT_120	[p7l13t2084r299b2168],
68	3	CD	NUMBER	3	num	69	SENT_120	[p7l13t2084r299b2168],
69	)	NN	O	)	dep	65	SENT_120	[p7l13t2084r299b2168],
70	,	,	O	,	_	0	SENT_120	[p7l13t2084r299b2168],
71	11	CD	NUMBER	11	appos	69	SENT_120	[p7l339t2089r414b2148],
72	had	VBD	O	have	rcmod	64	SENT_120	[p7l450t2084r589b2150],
73	two	CD	NUMBER	two	num	74	SENT_120	[p7l619t2103r752b2148],
74	*	NN	O	*	dobj	72	SENT_120	[p7l788t2090r870b2148],
75	2	CD	NUMBER	2	num	76	SENT_120	[p7l788t2090r870b2148],
76	alleles	NNS	O	allele	npadvmod	77	SENT_120	[p7l904t2084r1123b2148],
77	(	JJ	O	(	amod	74	SENT_120	[p7l1158t2084r1444b2168],
78	*	NN	O	*	tmod	53	SENT_120	[p7l1158t2084r1444b2168],
79	2	CD	NUMBER	2	dep	78	SENT_120	[p7l1158t2084r1444b2168],
80	/	:	O	/	punct	53	SENT_120	[p7l1158t2084r1444b2168],
81	*	CD	NUMBER	*	number	82	SENT_120	[p7l1158t2084r1444b2168],
82	2	CD	NUMBER	2	dep	41	SENT_120	[p7l1158t2084r1444b2168],
83	)	NN	O	)	dep	82	SENT_120	[p7l1158t2084r1444b2168],
84	,	,	O	,	_	0	SENT_120	[p7l1158t2084r1444b2168],
85	and	CC	O	and	_	0	SENT_120	[p7l1477t2084r1615b2150],
86	6	CD	NUMBER	6	nsubj	87	SENT_120	[p7l1646t2089r1684b2148],
87	had	VBD	O	have	dep	27	SENT_120	[p7l1717t2084r1856b2150],
88	two	CD	NUMBER	two	dobj	87	SENT_120	[p7l1886t2103r2019b2148],
89	*	CD	NUMBER	*	number	90	SENT_120	[p7l2055t2090r2136b2148],
90	3	CD	NUMBER	3	num	91	SENT_120	[p7l2055t2090r2136b2148],
91	alleles	NNS	O	allele	nsubj	92	SENT_120	[p7l11t2189r230b2253],
92	(	VBP	O	(	rcmod	88	SENT_120	[p7l266t2189r415b2273],
93	*	CD	NUMBER	*	number	94	SENT_120	[p7l266t2189r415b2273],
94	3	CD	NUMBER	3	dobj	92	SENT_120	[p7l266t2189r415b2273],
95	/	:	O	/	punct	39	SENT_120	[p7l266t2189r415b2273],
96	*	CD	NUMBER	*	number	97	SENT_120	[p7l422t2190r551b2272],
97	3	CD	NUMBER	3	dep	27	SENT_120	[p7l422t2190r551b2272],
98	)	NN	O	)	dep	97	SENT_120	[p7l422t2190r551b2272],
99	.	.	O	.	_	0	SENT_120	[p7l422t2190r551b2272],

1	Consistent	JJ	O	consistent	_	0	SENT_121	[p7l588t2192r987b2253],
2	with	IN	O	with	_	0	SENT_121	[p7l1016t2189r1181b2253],
3	prior	JJ	O	prior	amod	4	SENT_121	[p7l1214t2192r1399b2276],
4	studies	NNS	O	study	prep_with	1	SENT_121	[p7l1431t2189r1707b2268],
5	,	,	O	,	_	0	SENT_121	[p7l1431t2189r1707b2268],
6	we	PRP	O	we	nsubj	7	SENT_121	[p7l1739t2213r1835b2253],
7	deﬁned	VBD	O	deﬁned	dep	4	SENT_121	[p7l1868t2189r2141b2255],
8	patients	NNS	O	patient	dobj	7	SENT_121	[p7l10t2298r306b2382],
9	with	IN	O	with	_	0	SENT_121	[p7l338t2295r503b2359],
10	wild	JJ	O	wild	amod	13	SENT_121	[p7l535t2295r875b2382],
11	—	NN	O	—	nn	13	SENT_121	[p7l535t2295r875b2382],
12	type	NN	O	type	nn	13	SENT_121	[p7l535t2295r875b2382],
13	genotypes	NNS	O	genotype	prep_with	7	SENT_121	[p7l909t2314r1276b2382],
14	as	IN	O	as	mark	15	SENT_121	[p7l1311t2319r1381b2359],
15	having	VBG	O	have	advcl	7	SENT_121	[p7l1415t2295r1664b2382],
16	no	DT	O	no	det	17	SENT_121	[p7l1695t2319r1787b2359],
17	*	NN	O	*	nsubj	81	SENT_121	[p7l1826t2301r1908b2359],
18	2	CD	NUMBER	2	number	21	SENT_121	[p7l1826t2301r1908b2359],
19	or	CC	O	or	_	0	SENT_121	[p7l1944t2318r2021b2359],
20	*	CD	NUMBER	*	conj_or	21	SENT_121	[p7l2055t2301r2136b2359],
21	3	CD	NUMBER	3	num	22	SENT_121	[p7l2055t2301r2136b2359],
22	alleles	NNS	O	allele	dep	17	SENT_121	[p7l11t2400r230b2465],
23	(	JJ	O	(	amod	17	SENT_121	[p7l287t2400r469b2484],
24	wild	JJ	O	wild	amod	26	SENT_121	[p7l287t2400r469b2484],
25	type/wild	NN	O	type/wild	nn	26	SENT_121	[p7l521t2400r870b2487],
26	type	NN	O	type	dep	23	SENT_121	[p7l921t2401r1121b2487],
27	)	CD	NUMBER	)	dep	26	SENT_121	[p7l921t2401r1121b2487],
28	,	,	O	,	_	0	SENT_121	[p7l921t2401r1121b2487],
29	patients	NNS	O	patient	appos	26	SENT_121	[p7l1175t2403r1471b2487],
30	with	IN	O	with	_	0	SENT_121	[p7l1523t2401r1687b2464],
31	CYP2C9	NN	O	cyp2c9	nn	32	SENT_121	[p7l1742t2406r2137b2465],
32	*	NN	O	*	prep_with	29	SENT_121	[p7l1742t2406r2137b2465],
33	2	CD	NUMBER	2	num	34	SENT_121	[p7l1742t2406r2137b2465],
34	genotypes	NNS	O	genotype	npadvmod	35	SENT_121	[p7l11t2524r378b2592],
35	as	IN	O	as	advmod	36	SENT_121	[p7l433t2530r502b2570],
36	having	VBG	O	have	partmod	32	SENT_121	[p7l556t2505r805b2592],
37	Zone	NNP	O	Zone	dobj	36	SENT_121	[p7l860t2516r1062b2569],
38	*	CD	NUMBER	*	number	39	SENT_121	[p7l1118t2511r1200b2569],
39	2	CD	NUMBER	2	num	40	SENT_121	[p7l1118t2511r1200b2569],
40	allele	NN	O	allele	dep	32	SENT_121	[p7l1256t2505r1442b2569],
41	(	CD	NUMBER	(	num	43	SENT_121	[p7l1497t2505r1679b2589],
42	wild	JJ	O	wild	amod	43	SENT_121	[p7l1497t2505r1679b2589],
43	type	NN	O	type	dep	32	SENT_121	[p7l1731t2505r1919b2592],
44	/	:	O	/	punct	45	SENT_121	[p7l1731t2505r1919b2592],
45	*	NN	O	*	dep	43	SENT_121	[p7l1927t2511r2008b2569],
46	2	CD	NUMBER	2	num	45	SENT_121	[p7l1927t2511r2008b2569],
47	or	CC	O	or	_	0	SENT_121	[p7l2064t2529r2141b2569],
48	*	CD	NUMBER	*	num	49	SENT_121	[p7l14t2611r133b2696],
49	2	CD	NUMBER	2	conj_or	32	SENT_121	[p7l14t2611r133b2696],
50	/	:	O	/	punct	63	SENT_121	[p7l14t2611r133b2696],
51	*	CD	NUMBER	*	number	52	SENT_121	[p7l141t2612r271b2696],
52	2	CD	NUMBER	2	num	53	SENT_121	[p7l141t2612r271b2696],
53	)	NN	O	)	dep	63	SENT_121	[p7l141t2612r271b2696],
54	,	,	O	,	_	0	SENT_121	[p7l141t2612r271b2696],
55	and	CC	O	and	_	0	SENT_121	[p7l299t2612r437b2678],
56	patients	NNS	O	patient	dep	63	SENT_121	[p7l462t2615r757b2699],
57	with	IN	O	with	_	0	SENT_121	[p7l783t2612r948b2676],
58	CYP2C9	NN	O	cyp2c9	prep_with	56	SENT_121	[p7l976t2617r1370b2677],
59	*	CD	NUMBER	*	num	58	SENT_121	[p7l976t2617r1370b2677],
60	3	CD	NUMBER	3	num	61	SENT_121	[p7l976t2617r1370b2677],
61	genotypes	NNS	O	genotype	dep	53	SENT_121	[p7l1400t2630r1767b2700],
62	as	IN	O	as	mark	63	SENT_121	[p7l1796t2636r1864b2676],
63	having	VBG	O	have	dep	49	SENT_121	[p7l1892t2612r2141b2699],
64	Zone	NNP	O	Zone	dobj	63	SENT_121	[p7l15t2729r216b2782],
65	*	CD	NUMBER	*	num	64	SENT_121	[p7l257t2723r338b2783],
66	3	CD	NUMBER	3	num	67	SENT_121	[p7l257t2723r338b2783],
67	allele	NN	O	allele	dep	63	SENT_121	[p7l378t2718r564b2782],
68	(	CD	NUMBER	(	num	70	SENT_121	[p7l604t2718r786b2802],
69	wild	JJ	O	wild	amod	70	SENT_121	[p7l604t2718r786b2802],
70	type	NN	O	type	dep	67	SENT_121	[p7l822t2717r1098b2805],
71	/	:	O	/	punct	63	SENT_121	[p7l822t2717r1098b2805],
72	*	CD	NUMBER	*	number	76	SENT_121	[p7l822t2717r1098b2805],
73	3	CD	NUMBER	3	number	76	SENT_121	[p7l822t2717r1098b2805],
74	or	CC	O	or	_	0	SENT_121	[p7l1139t2741r1216b2782],
75	*	CD	NUMBER	*	dep	79	SENT_121	[p7l1255t2717r1689b2802],
76	3/3	CD	NUMBER	3/3	dep	79	SENT_121	[p7l1255t2717r1689b2802],
77	)	NN	O	)	npadvmod	79	SENT_121	[p7l1255t2717r1689b2802],
78	.11	CD	NUMBER	.11	num	77	SENT_121	[p7l1255t2717r1689b2802],
79	>	JJR	O	>	amod	49	SENT_121	[p7l1255t2717r1689b2802],
80	16	CD	NUMBER	16	npadvmod	81	SENT_121	[p7l1255t2717r1689b2802],
81	>	JJR	O	>	xcomp	15	SENT_121	[p7l1255t2717r1689b2802],
82	17	CD	NUMBER	17	dep	15	SENT_121	[p7l1255t2717r1689b2802],
83	The	DT	O	the	det	85	SENT_121	[p7l1723t2719r1866b2783],
84	17	CD	NUMBER	17	num	85	SENT_121	[p7l1910t2724r1991b2784],
85	paCELECOXIB	NN	O	pacelecoxib	dep	82	SENT_121	[p7l2027t2742r2138b2806, p7l194t2941r491b2990],
86	,	,	O	,	_	0	SENT_121	[p7l2027t2742r2138b2806, p7l194t2941r491b2990],

1	CYP2C9	CD	NUMBER	cyp2c9	num	3	SENT_122	[p7l517t2941r720b2982],
2	GENE	NN	O	gene	nn	3	SENT_122	[p7l744t2941r882b2982],
3	VARIANTS	NNS	O	variant	_	0	SENT_122	[p7l904t2941r1176b2990],
4	,	,	O	,	_	0	SENT_122	[p7l904t2941r1176b2990],
5	AND	CC	O	and	cc	6	SENT_122	[p7l1199t2941r1311b2981],
6	ADENOMA	NN	O	adenoma	appos	3	SENT_122	[p7l1333t2941r1601b2982],
7	2129	CD	DATE	2129	dep	3	SENT_122	[p7l1663t2940r1799b2982],

1	tients	NNS	O	tient	dep	6	SENT_123	[p7l9t3128r181b3180],
2	with	IN	O	with	_	0	SENT_123	[p7l204t3125r342b3179],
3	one	CD	NUMBER	one	prep_with	1	SENT_123	[p7l366t3146r476b3180],
4	*	NN	O	*	dep	6	SENT_123	[p7l503t3130r571b3179],
5	2	CD	NUMBER	2	num	4	SENT_123	[p7l503t3130r571b3179],
6	allele	NN	O	allele	dep	11	SENT_123	[p7l597t3125r753b3180],
7	and	CC	O	and	_	0	SENT_123	[p7l777t3125r893b3181],
8	one	CD	NUMBER	one	num	9	SENT_123	[p7l916t3146r1026b3180],
9	*	NN	O	*	dep	11	SENT_123	[p7l1052t3130r1120b3180],
10	3	CD	NUMBER	3	num	11	SENT_123	[p7l1052t3130r1120b3180],
11	allele	NN	O	allele	_	0	SENT_123	[p7l1146t3125r1302b3180],
12	were	VBD	O	be	auxpass	13	SENT_123	[p7l1324t3145r1464b3180],
13	deﬁned	VBN	O	deﬁned	rcmod	11	SENT_123	[p7l1488t3125r1718b3181],
14	as	IN	O	as	prep	13	SENT_123	[p7l1740t3146r1798b3180],

1	CYP2C9	NN	O	cyp2c9	_	0	SENT_124	[p8l10t29r342b79],
2	*	CD	NUMBER	*	num	1	SENT_124	[p8l10t29r342b79],
3	3	CD	NUMBER	3	num	4	SENT_124	[p8l10t29r342b79],
4	genotypes	NNS	O	genotype	dep	1	SENT_124	[p8l365t40r689b98],
5	.	.	O	.	_	0	SENT_124	[p8l365t40r689b98],

1	The	DT	O	the	det	3	SENT_125	[p8l710t24r830b79],
2	genotype	NN	O	genotype	nn	3	SENT_125	[p8l851t40r1132b98],
3	groups	NNS	O	group	nsubjpass	5	SENT_125	[p8l1152t44r1366b98],
4	were	VBD	O	be	auxpass	5	SENT_125	[p8l1386t44r1526b79],
5	assessed	VBN	O	assess	_	0	SENT_125	[p8l1547t24r1800b80],
6	for	IN	O	for	_	0	SENT_125	[p8l9t113r99b168],
7	differences	NNS	O	difference	prep_for	5	SENT_125	[p8l119t113r452b169],
8	in	IN	O	in	_	0	SENT_125	[p8l473t116r534b167],
9	baseline	NN	O	baseline	nn	10	SENT_125	[p8l553t113r802b168],
10	characteristics	NNS	O	characteristic	prep_in	7	SENT_125	[p8l823t113r1265b168],
11	using	VBG	O	use	xcomp	5	SENT_125	[p8l1287t116r1457b187],
12	analysis	NN	O	analysis	dobj	11	SENT_125	[p8l1477t113r1716b187],
13	of	IN	O	of	_	0	SENT_125	[p8l1739t113r1810b168],
14	Variance	NNP	O	Variance	prep_of	12	SENT_125	[p8l6t205r262b257],
15	for	IN	O	for	_	0	SENT_125	[p8l297t203r387b257],
16	continuous	JJ	O	continuous	amod	17	SENT_125	[p8l420t205r775b257],
17	variables	NNS	O	variable	prep_for	11	SENT_125	[p8l807t203r1078b257],
18	and	CC	O	and	_	0	SENT_125	[p8l1114t203r1230b258],
19	X2	NN	O	x2	nn	20	SENT_125	[p8l1262t202r1325b272],
20	tests	NNS	O	test	prep_for	11	SENT_125	[p8l1361t219r1498b257],
21	for	IN	O	for	_	0	SENT_125	[p8l1533t203r1623b257],
22	categorical	JJ	O	categorical	amod	23	SENT_125	[p8l1657t219r1798b257, p8l9t293r219b366],
23	variables	NNS	O	variable	prep_for	17	SENT_125	[p8l241t293r527b347],
24	.	.	O	.	_	0	SENT_125	[p8l241t293r527b347],

1	To	TO	O	to	aux	2	SENT_126	[p8l553t298r637b347],
2	test	VB	O	test	purpcl	13	SENT_126	[p8l665t308r775b347],
3	whether	IN	O	whether	complm	7	SENT_126	[p8l799t293r1053b347],
4	the	DT	O	the	det	6	SENT_126	[p8l1078t293r1174b347],
5	dose	NN	O	dose	nn	6	SENT_126	[p8l1200t292r1338b348],
6	effect	NN	O	effect	nsubj	7	SENT_126	[p8l1365t293r1533b347],
7	differed	VBD	O	differ	ccomp	2	SENT_126	[p8l1559t293r1801b348],
8	between	IN	O	between	_	0	SENT_126	[p8l7t383r262b437],
9	genotype	NN	O	genotype	nn	10	SENT_126	[p8l288t398r569b456],
10	groups	NNS	O	group	prep_between	7	SENT_126	[p8l596t402r826b456],
11	,	,	O	,	_	0	SENT_126	[p8l596t402r826b456],
12	we	PRP	O	we	nsubj	13	SENT_126	[p8l852t403r933b437],
13	used	VBD	O	use	_	0	SENT_126	[p8l959t382r1102b438],
14	the	DT	O	the	det	18	SENT_126	[p8l1128t382r1225b437],
15	Cox	NN	ORGANIZATION	cox	nn	18	SENT_126	[p8l1253t387r1373b437],
16	proportional	JJ	O	proportional	amod	18	SENT_126	[p8l1399t383r1800b456],
17	hazards	NNS	O	hazard	nn	18	SENT_126	[p8l8t472r247b528],
18	model	NN	O	model	dobj	13	SENT_126	[p8l284t472r479b528],
19	with	IN	O	with	_	0	SENT_126	[p8l511t472r650b526],
20	ties	NNS	O	tie	prep_with	18	SENT_126	[p8l686t475r789b526],
21	handled	VBN	O	handle	partmod	20	SENT_126	[p8l825t472r1079b528],
22	by	IN	O	by	_	0	SENT_126	[p8l1111t472r1185b546],
23	the	DT	O	the	det	25	SENT_126	[p8l1217t472r1314b526],
24	exact	JJ	O	exact	amod	25	SENT_126	[p8l1350t488r1506b526],
25	method	NN	O	method	agent	21	SENT_126	[p8l1540t472r1798b539],
26	,	,	O	,	_	0	SENT_126	[p8l1540t472r1798b539],
27	which	WDT	O	which	nsubj	28	SENT_126	[p8l7t562r194b616],
28	assumes	VBZ	O	assume	rcmod	25	SENT_126	[p8l219t582r474b616],
29	that	IN	O	that	complm	31	SENT_126	[p8l499t562r626b616],
30	ties	NNS	O	tie	nsubj	31	SENT_126	[p8l649t564r751b616],
31	arise	VBP	O	arise	ccomp	28	SENT_126	[p8l776t564r916b616],
32	from	IN	O	from	_	0	SENT_126	[p8l940t562r1093b616],
33	grouping	VBG	O	group	prepc_from	31	SENT_126	[p8l1116t564r1404b636],
34	continuous	JJ	O	continuous	amod	36	SENT_126	[p8l1427t564r1798b629],
35	,	,	O	,	_	0	SENT_126	[p8l1427t564r1798b629],
36	untied	JJ	O	untied	amod	37	SENT_126	[p8l9t651r213b707],
37	data	NNS	O	datum	dobj	33	SENT_126	[p8l242t651r389b707],
38	.	.	O	.	_	0	SENT_126	[p8l242t651r389b707],

1	A	DT	O	a	det	3	SENT_127	[p8l419t657r467b705],
2	linear	JJ	O	linear	amod	3	SENT_127	[p8l495t652r672b706],
3	contrast	NN	O	contrast	nsubjpass	5	SENT_127	[p8l701t667r957b706],
4	was	VBD	O	be	auxpass	5	SENT_127	[p8l984t672r1096b706],
5	constructed	VBN	O	construct	_	0	SENT_127	[p8l1128t651r1497b707],
6	from	IN	O	from	_	0	SENT_127	[p8l1526t652r1679b706],
7	coefﬁcients	NNS	O	coefﬁcients	prep_from	5	SENT_127	[p8l1710t672r1798b706, p8l9t741r286b795],

1	of	IN	O	of	_	0	SENT_128	[p8l315t741r386b795],
2	this	DT	O	this	det	3	SENT_128	[p8l403t741r517b795],
3	model	NN	O	model	pobj	1	SENT_128	[p8l545t741r740b797],
4	to	TO	O	to	aux	5	SENT_128	[p8l766t757r827b795],
5	assess	VB	O	assess	infmod	3	SENT_128	[p8l856t762r1033b795],
6	whether	IN	O	whether	_	0	SENT_128	[p8l1060t741r1314b795],
7	the	DT	O	the	det	9	SENT_128	[p8l1340t741r1436b795],
8	CYP2C9	NN	O	cyp2c9	nn	9	SENT_128	[p8l1465t746r1797b796],
9	*	NN	O	*	prep_whether	5	SENT_128	[p8l1465t746r1797b796],
10	2	CD	NUMBER	2	dep	9	SENT_128	[p8l1465t746r1797b796],

1	or	CC	O	or	dep	2	SENT_129	[p8l9t851r74b885],
2	CYP2C9	NN	O	cyp2c9	_	0	SENT_129	[p8l103t836r435b886],
3	*	CD	NUMBER	*	num	2	SENT_129	[p8l103t836r435b886],
4	3	CD	NUMBER	3	num	5	SENT_129	[p8l103t836r435b886],
5	genotype	NN	O	genotype	nsubj	7	SENT_129	[p8l467t847r748b905],
6	was	VBD	O	be	cop	7	SENT_129	[p8l775t852r887b885],
7	different	JJ	O	different	rcmod	2	SENT_129	[p8l918t831r1187b886],
8	from	IN	O	from	_	0	SENT_129	[p8l1215t831r1368b885],
9	wild	JJ	O	wild	amod	12	SENT_129	[p8l1395t831r1682b905],
10	—	NN	O	—	nn	12	SENT_129	[p8l1395t831r1682b905],
11	type	NN	O	type	nn	12	SENT_129	[p8l1395t831r1682b905],
12	genotype	NN	O	genotype	prep_from	7	SENT_129	[p8l1712t852r1798b905, p8l9t937r221b994],
13	with	IN	O	with	_	0	SENT_129	[p8l261t921r400b975],
14	respect	NN	O	respect	prep_with	7	SENT_129	[p8l443t937r659b994],
15	to	TO	O	to	aux	16	SENT_129	[p8l700t937r761b975],
16	risk	VB	O	risk	xcomp	7	SENT_129	[p8l805t921r919b975],
17	reduction	NN	O	reduction	dobj	16	SENT_129	[p8l961t921r1263b976],
18	associated	VBN	O	associate	partmod	17	SENT_129	[p8l1304t921r1621b976],
19	with	IN	O	with	_	0	SENT_129	[p8l1660t921r1799b975],
20	dose	NN	O	dose	prep_with	18	SENT_129	[p8l9t1010r161b1066],
21	.	.	O	.	_	0	SENT_129	[p8l9t1010r161b1066],

1	The	DT	O	the	det	3	SENT_130	[p8l207t1011r327b1065],
2	statistical	JJ	O	statistical	amod	3	SENT_130	[p8l373t1011r669b1065],
3	signiﬁcance	NN	O	signiﬁcance	nsubjpass	8	SENT_130	[p8l714t1011r1076b1084],
4	of	IN	O	of	_	0	SENT_130	[p8l1122t1011r1194b1065],
5	this	DT	O	this	det	6	SENT_130	[p8l1229t1011r1342b1065],
6	contrast	NN	O	contrast	prep_of	3	SENT_130	[p8l1389t1026r1644b1065],
7	was	VBD	O	be	auxpass	8	SENT_130	[p8l1687t1031r1798b1065],
8	obtained	VBN	O	obtain	_	0	SENT_130	[p8l9t1100r284b1156],
9	using	VBG	O	use	xcomp	8	SENT_130	[p8l314t1103r485b1174],
10	the	DT	O	the	det	13	SENT_130	[p8l516t1100r612b1155],
11	Wald	NNP	O	Wald	nn	13	SENT_130	[p8l642t1100r806b1156],
12	method	NN	O	method	nn	13	SENT_130	[p8l836t1100r1214b1156],
13	.18	NN	NUMBER	.18	dobj	9	SENT_130	[p8l836t1100r1214b1156],
14	=	JJ	O	=	amod	13	SENT_130	[p8l836t1100r1214b1156],
15	19	CD	NUMBER	19	tmod	14	SENT_130	[p8l836t1100r1214b1156],
16	We	PRP	O	we	nsubj	17	SENT_130	[p8l1245t1105r1343b1155],
17	used	VBD	O	use	rcmod	13	SENT_130	[p8l1374t1100r1517b1156],
18	the	DT	O	the	det	20	SENT_130	[p8l1548t1100r1644b1155],
19	SAS	NNP	ORGANIZATION	SAS	nn	20	SENT_130	[p8l1676t1105r1797b1155],
20	version	NN	O	version	dobj	17	SENT_130	[p8l6t1192r231b1244],
21	9.1	CD	NUMBER	9.1	number	22	SENT_130	[p8l260t1194r344b1244],
22	(	CD	NUMBER	(	dep	20	SENT_130	[p8l379t1190r522b1260],
23	SAS	NNP	ORGANIZATION	SAS	nn	24	SENT_130	[p8l379t1190r522b1260],
24	institute	NN	O	institute	dep	22	SENT_130	[p8l551t1192r830b1256],
25	,	,	O	,	_	0	SENT_130	[p8l551t1192r830b1256],
26	Cary	NNP	PERSON	Cary	appos	20	SENT_130	[p8l860t1194r1016b1263],
27	,	,	O	,	_	0	SENT_130	[p8l860t1194r1016b1263],
28	NC	NNP	O	NC	nn	29	SENT_130	[p8l1044t1190r1170b1260],
29	)	NNP	O	)	appos	26	SENT_130	[p8l1044t1190r1170b1260],
30	for	IN	O	for	_	0	SENT_130	[p8l1201t1189r1291b1244],
31	all	DT	O	all	det	32	SENT_130	[p8l1318t1189r1390b1244],
32	analyses	NNS	O	analysis	prep_for	17	SENT_130	[p8l1418t1189r1684b1263],
33	.	.	O	.	_	0	SENT_130	[p8l1418t1189r1684b1263],

1	All	DT	O	all	det	3	SENT_131	[p8l1711t1189r1799b1243],
2	P	NN	O	p	nn	3	SENT_131	[p8l6t1283r49b1332],
3	values	NNS	O	value	nsubj	6	SENT_131	[p8l72t1278r263b1333],
4	are	VBP	O	be	cop	6	SENT_131	[p8l293t1298r383b1333],
5	2	CD	NUMBER	2	number	6	SENT_131	[p8l411t1278r647b1334],
6	—	CD	NUMBER	—	_	0	SENT_131	[p8l411t1278r647b1334],
7	sided	VBD	O	side	rcmod	6	SENT_131	[p8l411t1278r647b1334],
8	.	.	O	.	_	0	SENT_131	[p8l411t1278r647b1334],

1	Results	NNS	O	result	_	0	SENT_132	[p8l237t1455r525b1515],

1	Among	IN	O	among	_	0	SENT_133	[p8l230t1557r462b1626],
2	the	DT	O	the	det	4	SENT_133	[p8l506t1552r603b1607],
3	2035	CD	DATE	2035	num	4	SENT_133	[p8l648t1556r796b1607],
4	patients	NNS	O	patient	prep_among	17	SENT_133	[p8l844t1555r1093b1626],
5	who	WP	O	who	nsubjpass	8	SENT_133	[p8l1138t1552r1268b1607],
6	were	VBD	O	be	auxpass	8	SENT_133	[p8l1313t1572r1453b1607],
7	randomly	RB	O	randomly	advmod	8	SENT_133	[p8l1499t1552r1802b1626],
8	assigned	VBN	O	assign	dep	17	SENT_133	[p8l9t1641r274b1715],
9	to	TO	O	to	_	0	SENT_133	[p8l312t1657r372b1696],
10	treatment	NN	O	treatment	prep_to	8	SENT_133	[p8l413t1657r735b1709],
11	,	,	O	,	_	0	SENT_133	[p8l413t1657r735b1709],
12	1707	CD	PERCENT	1707	number	13	SENT_133	[p8l782t1646r927b1696],
13	(	CD	PERCENT	(	appos	10	SENT_133	[p8l968t1642r1132b1712],
14	84	CD	PERCENT	84	num	15	SENT_133	[p8l968t1642r1132b1712],
15	%	NN	PERCENT	%	dep	13	SENT_133	[p8l968t1642r1132b1712],
16	)	CD	NUMBER	)	nsubj	17	SENT_133	[p8l968t1642r1132b1712],
17	provided	VBD	O	provide	dep	36	SENT_133	[p8l1173t1641r1449b1715],
18	a	DT	O	a	det	21	SENT_133	[p8l1487t1662r1520b1696],
19	suitable	JJ	O	suitable	amod	21	SENT_133	[p8l1557t1641r1799b1696],
20	blood	NN	O	blood	nn	21	SENT_133	[p8l8t1730r189b1786],
21	specimen	NN	O	specimen	iobj	17	SENT_133	[p8l215t1733r504b1804],
22	for	IN	O	for	_	0	SENT_133	[p8l530t1731r620b1785],
23	genotyping	NN	O	genotyping	prep_for	21	SENT_133	[p8l645t1733r1011b1804],
24	,	,	O	,	_	0	SENT_133	[p8l645t1733r1011b1804],
25	and	CC	O	and	_	0	SENT_133	[p8l1039t1730r1155b1786],
26	1660	CD	DATE	1660	number	27	SENT_133	[p8l1186t1734r1330b1785],
27	(	CD	PERCENT	(	iobj	17	SENT_133	[p8l1360t1731r1524b1801],
28	97	CD	PERCENT	97	num	29	SENT_133	[p8l1360t1731r1524b1801],
29	%	NN	PERCENT	%	dep	27	SENT_133	[p8l1360t1731r1524b1801],
30	)	CD	NUMBER	)	dobj	17	SENT_133	[p8l1360t1731r1524b1801],
31	of	IN	O	of	_	0	SENT_133	[p8l1554t1731r1625b1785],
32	these	DT	O	these	det	33	SENT_133	[p8l1642t1730r1799b1785],
33	patients	NNS	O	patient	prep_of	30	SENT_133	[p8l9t1822r257b1893],
34	were	VBD	O	be	auxpass	36	SENT_133	[p8l287t1839r427b1874],
35	successfully	RB	O	successfully	advmod	36	SENT_133	[p8l457t1819r824b1893],
36	genotyped	VBN	O	genotype	_	0	SENT_133	[p8l851t1819r1175b1893],
37	(	CD	NUMBER	(	num	40	SENT_133	[p8l1206t1820r1425b1893],
38	Figure	NN	O	figure	nn	40	SENT_133	[p8l1206t1820r1425b1893],
39	1	CD	NUMBER	1	num	40	SENT_133	[p8l1461t1820r1527b1890],
40	)	NN	O	)	nsubjpass	36	SENT_133	[p8l1461t1820r1527b1890],
41	.	.	O	.	_	0	SENT_133	[p8l1461t1820r1527b1890],

1	Overall	RB	O	overall	advmod	8	SENT_134	[p8l1561t1819r1798b1887],
2	,	,	O	,	_	0	SENT_134	[p8l1561t1819r1798b1887],
3	1102	CD	PERCENT	1102	number	4	SENT_134	[p8l15t1913r158b1963],
4	(	CD	PERCENT	(	nsubj	8	SENT_134	[p8l212t1909r376b1979],
5	66	CD	PERCENT	66	num	6	SENT_134	[p8l212t1909r376b1979],
6	%	NN	PERCENT	%	dep	4	SENT_134	[p8l212t1909r376b1979],
7	)	CD	NUMBER	)	dep	4	SENT_134	[p8l212t1909r376b1979],
8	had	VBD	O	have	dep	37	SENT_134	[p8l428t1908r545b1964],
9	wild	JJ	O	wild	amod	12	SENT_134	[p8l591t1908r878b1982],
10	—	NN	O	—	nn	12	SENT_134	[p8l591t1908r878b1982],
11	type	NN	O	type	nn	12	SENT_134	[p8l591t1908r878b1982],
12	genotypes	NNS	O	genotype	nsubj	18	SENT_134	[p8l928t1924r1253b1982],
13	,	,	O	,	_	0	SENT_134	[p8l928t1924r1253b1982],
14	357	CD	PERCENT	357	number	15	SENT_134	[p8l1304t1912r1416b1963],
15	(	CD	PERCENT	(	appos	12	SENT_134	[p8l1468t1909r1631b1979],
16	21	CD	PERCENT	21	num	17	SENT_134	[p8l1468t1909r1631b1979],
17	%	NN	PERCENT	%	dep	15	SENT_134	[p8l1468t1909r1631b1979],
18	)	CD	NUMBER	)	xcomp	8	SENT_134	[p8l1468t1909r1631b1979],
19	had	VBD	O	have	partmod	18	SENT_134	[p8l1684t1908r1801b1964],
20	CYP2C9	NN	O	cyp2c9	nn	21	SENT_134	[p8l10t2002r342b2052],
21	*	NN	O	*	dobj	19	SENT_134	[p8l10t2002r342b2052],
22	2	CD	NUMBER	2	num	23	SENT_134	[p8l10t2002r342b2052],
23	genotypes	NNS	O	genotype	dep	21	SENT_134	[p8l365t2013r674b2071],
24	(	CD	NUMBER	(	num	26	SENT_134	[p8l698t1998r892b2068],
25	Zone	NNP	O	Zone	nn	26	SENT_134	[p8l698t1998r892b2068],
26	*	NN	O	*	dep	21	SENT_134	[p8l916t2002r944b2028],
27	2	CD	NUMBER	2	num	29	SENT_134	[p8l952t2002r985b2051],
28	allele	NN	O	allele	nn	29	SENT_134	[p8l1008t1997r1203b2068],
29	)	NN	O	)	dep	26	SENT_134	[p8l1008t1997r1203b2068],
30	,	,	O	,	_	0	SENT_134	[p8l1008t1997r1203b2068],
31	and	CC	O	and	_	0	SENT_134	[p8l1225t1997r1342b2053],
32	201	CD	PERCENT	201	number	33	SENT_134	[p8l1360t2002r1469b2052],
33	(	CD	PERCENT	(	dobj	19	SENT_134	[p8l1496t1998r1660b2068],
34	12	CD	PERCENT	12	num	35	SENT_134	[p8l1496t1998r1660b2068],
35	%	NN	PERCENT	%	tmod	8	SENT_134	[p8l1496t1998r1660b2068],
36	)	CD	NUMBER	)	dep	35	SENT_134	[p8l1496t1998r1660b2068],
37	had	VBD	O	have	_	0	SENT_134	[p8l1684t1997r1801b2053],
38	CYP2C9	NN	O	cyp2c9	dobj	37	SENT_134	[p8l10t2091r342b2141],
39	*	CD	NUMBER	*	number	40	SENT_134	[p8l10t2091r342b2141],
40	3	CD	NUMBER	3	num	41	SENT_134	[p8l10t2091r342b2141],
41	genotypes	NNS	O	genotype	dep	38	SENT_134	[p8l368t2102r677b2160],
42	(	CD	NUMBER	(	num	43	SENT_134	[p8l704t2087r898b2157],
43	Zone	NNP	O	Zone	dep	41	SENT_134	[p8l704t2087r898b2157],
44	*	CD	NUMBER	*	num	43	SENT_134	[p8l925t2091r993b2141],
45	3	CD	NUMBER	3	num	47	SENT_134	[p8l925t2091r993b2141],
46	allele	NN	O	allele	nn	47	SENT_134	[p8l1019t2086r1213b2157],
47	)	NN	O	)	nsubj	37	SENT_134	[p8l1019t2086r1213b2157],
48	.	.	O	.	_	0	SENT_134	[p8l1019t2086r1213b2157],

1	Baseline	NN	O	baseline	nn	2	SENT_135	[p8l1240t2086r1483b2141],
2	characteristics	NNS	O	characteristic	nsubj	5	SENT_135	[p8l1505t2086r1798b2141, p8l9t2179r154b2231],
3	were	VBD	O	be	cop	5	SENT_135	[p8l183t2196r318b2231],
4	largely	RB	O	largely	advmod	5	SENT_135	[p8l346t2176r543b2250],
5	similar	JJ	O	similar	_	0	SENT_135	[p8l570t2176r775b2231],
6	according	VBG	O	accord	_	0	SENT_135	[p8l803t2176r1097b2250],
7	to	TO	O	to	prepc_according_to	5	SENT_135	[p8l1125t2192r1184b2231],
8	genotype	NN	O	genotype	nn	10	SENT_135	[p8l1214t2192r1484b2250],
9	(	CD	NUMBER	(	num	10	SENT_135	[p8l1515t2176r1700b2247],
10	Table	NNP	O	Table	pobj	5	SENT_135	[p8l1515t2176r1700b2247],
11	1	CD	NUMBER	1	number	12	SENT_135	[p8l1735t2177r1798b2247],
12	)	CD	NUMBER	)	dep	10	SENT_135	[p8l1735t2177r1798b2247],
13	.	.	O	.	_	0	SENT_135	[p8l1735t2177r1798b2247],

1	Variant	JJ	O	variant	amod	2	SENT_136	[p8l6t2297r238b2349],
2	genotypes	NNS	O	genotype	nsubjpass	6	SENT_136	[p8l260t2310r570b2368],
3	were	VBD	O	be	auxpass	6	SENT_136	[p8l592t2314r732b2349],
4	more	RBR	O	more	advmod	5	SENT_136	[p8l755t2314r914b2349],
5	frequently	RB	O	frequently	advmod	6	SENT_136	[p8l937t2294r1258b2368],
6	observed	VBN	O	observe	_	0	SENT_136	[p8l1279t2294r1551b2350],
7	in	IN	O	in	_	0	SENT_136	[p8l1572t2297r1633b2348],
8	nonHispanic	JJ	O	nonhispanic	amod	9	SENT_136	[p8l1655t2315r1798b2349, p8l9t2386r285b2457],
9	whites	NNS	O	whites	prep_in	6	SENT_136	[p8l313t2383r528b2451],
10	,	,	O	,	_	0	SENT_136	[p8l313t2383r528b2451],
11	consistent	JJ	O	consistent	amod	9	SENT_136	[p8l560t2386r878b2438],
12	with	IN	O	with	_	0	SENT_136	[p8l906t2383r1045b2438],
13	other	JJ	O	other	amod	14	SENT_136	[p8l1075t2383r1241b2438],
14	studies	NNS	O	study	prep_with	11	SENT_136	[p8l1270t2383r1558b2451],
15	,2	VBP	O	,2	rcmod	14	SENT_136	[p8l1270t2383r1558b2451],
16	°	RB	O	°	advmod	15	SENT_136	[p8l1270t2383r1558b2451],
17	as	RB	O	as	_	0	SENT_136	[p8l1589t2404r1647b2438],
18	well	RB	O	well	_	0	SENT_136	[p8l1677t2383r1800b2438],
19	as	IN	O	as	_	0	SENT_136	[p8l9t2494r68b2528],
20	in	IN	O	in	_	0	SENT_136	[p8l96t2476r157b2527],
21	users	NNS	O	user	prep_in	6	SENT_136	[p8l184t2493r340b2528],
22	of	IN	O	of	_	0	SENT_136	[p8l370t2474r441b2528],
23	low-dose	JJ	O	low-dose	amod	24	SENT_136	[p8l458t2473r731b2529],
24	aspirin	NN	O	aspirin	prep_of	21	SENT_136	[p8l760t2476r973b2547],
25	and	CC	O	and	_	0	SENT_136	[p8l1001t2473r1117b2529],
26	patients	NNS	O	patient	conj_and	21	SENT_136	[p8l1144t2476r1393b2547],
27	with	IN	O	with	_	0	SENT_136	[p8l1420t2473r1559b2528],
28	a	DT	O	a	det	30	SENT_136	[p8l1587t2494r1620b2528],
29	prior	JJ	O	prior	amod	30	SENT_136	[p8l1645t2476r1801b2547],
30	history	NN	O	history	prep_with	26	SENT_136	[p8l9t2592r228b2666],
31	of	IN	O	of	_	0	SENT_136	[p8l254t2593r326b2647],
32	hypertension	NN	O	hypertension	prep_of	30	SENT_136	[p8l343t2592r765b2666],
33	.	.	O	.	_	0	SENT_136	[p8l343t2592r765b2666],

1	We	PRP	O	we	nsubj	2	SENT_137	[p8l82t2686r179b2736],
2	ﬁrst	VBD	O	ﬁrst	_	0	SENT_137	[p8l201t2682r325b2736],
3	examined	VBN	O	examine	dep	2	SENT_137	[p8l346t2681r645b2737],
4	the	DT	O	the	det	6	SENT_137	[p8l666t2681r762b2736],
5	main	JJ	O	main	amod	6	SENT_137	[p8l785t2684r943b2736],
6	effect	NN	O	effect	dobj	3	SENT_137	[p8l965t2682r1134b2736],
7	of	IN	O	of	_	0	SENT_137	[p8l1155t2682r1226b2736],
8	CYP2C9	NN	O	cyp2c9	nn	9	SENT_137	[p8l1239t2686r1493b2736],
9	genotype	NN	O	genotype	prep_of	6	SENT_137	[p8l1518t2697r1799b2755],
10	on	IN	O	on	_	0	SENT_137	[p8l9t2791r89b2825],
11	adenoma	NN	O	adenoma	nn	12	SENT_137	[p8l128t2770r416b2826],
12	risk	NN	O	risk	prep_on	3	SENT_137	[p8l453t2770r581b2825],
13	.	.	O	.	_	0	SENT_137	[p8l453t2770r581b2825],

1	The	DT	O	the	det	4	SENT_138	[p8l621t2770r741b2825],
2	estimated	VBN	O	estimate	amod	4	SENT_138	[p8l781t2770r1084b2826],
3	cumulative	JJ	O	cumulative	amod	4	SENT_138	[p8l1123t2771r1467b2825],
4	incidence	NN	O	incidence	nsubjpass	19	SENT_138	[p8l1506t2770r1799b2826],
5	through	IN	O	through	_	0	SENT_138	[p8l10t2859r265b2933],
6	the	DT	DATE	the	det	9	SENT_138	[p8l294t2859r391b2914],
7	year	NN	DATE	year	nn	9	SENT_138	[p8l417t2879r544b2933],
8	3	CD	NUMBER	3	num	9	SENT_138	[p8l572t2864r604b2914],
9	colonoscopy	NN	O	colonoscopy	prep_through	4	SENT_138	[p8l635t2859r1025b2933],
10	of	IN	O	of	_	0	SENT_138	[p8l1052t2860r1123b2914],
11	1	CD	NUMBER	1	num	14	SENT_138	[p8l1147t2864r1171b2913],
12	or	CC	O	or	_	0	SENT_138	[p8l1205t2879r1270b2914],
13	more	JJR	O	more	num	14	SENT_138	[p8l1297t2879r1456b2914],
14	adenomas	NNS	O	adenoma	prep_of	9	SENT_138	[p8l1485t2859r1798b2915],
15	according	VBG	O	accord	_	0	SENT_138	[p8l9t2949r315b3023],
16	to	TO	O	to	prepc_according_to	14	SENT_138	[p8l345t2965r405b3004],
17	genotype	NN	O	genotype	pobj	14	SENT_138	[p8l437t2965r718b3023],
18	is	VBZ	O	be	auxpass	19	SENT_138	[p8l748t2952r794b3004],
19	provided	VBN	O	provide	_	0	SENT_138	[p8l825t2949r1100b3023],
20	in	IN	O	in	_	0	SENT_138	[p8l1129t2952r1190b3003],
21	Table	NNP	O	Table	prep_in	19	SENT_138	[p8l1218t2949r1390b3004],
22	2	CD	NUMBER	2	num	21	SENT_138	[p8l1420t2954r1470b3004],
23	.	.	O	.	_	0	SENT_138	[p8l1420t2954r1470b3004],

1	Although	IN	O	although	mark	3	SENT_139	[p8l1500t2949r1799b3023],
2	there	EX	O	there	expl	3	SENT_139	[p8l10t3038r165b3093],
3	was	VBD	O	be	_	0	SENT_139	[p8l192t3059r304b3093],
4	some	DT	O	some	det	5	SENT_139	[p8l334t3059r494b3093],
5	evidence	NN	O	evidence	nsubj	3	SENT_139	[p8l523t3038r784b3094],
6	of	IN	O	of	_	0	SENT_139	[p8l813t3038r885b3093],
7	an	DT	O	a	det	9	SENT_139	[p8l903t3059r976b3093],
8	overall	JJ	O	overall	amod	9	SENT_139	[p8l1005t3038r1210b3093],
9	association	NN	O	association	prep_of	5	SENT_139	[p8l1238t3041r1585b3093],
10	of	IN	O	of	_	0	SENT_139	[p8l1613t3038r1684b3093],
11	the	DT	O	the	prep_of	9	SENT_139	[p8l1703t3038r1799b3093],

1	E	NN	O	e	nn	3	SENT_140	[p8l2037t355r2078b490],
2	’	CD	NUMBER	’	num	3	SENT_140	[p8l2037t355r2078b490],
3	_	NN	O	_	_	0	SENT_140	[p8l1970t489r2077b537, p8l1969t539r2077b652],
4	III5	CD	PERCENT	iii5	num	5	SENT_140	[p8l1970t489r2077b537, p8l1969t539r2077b652],
5	%	NN	PERCENT	%	dep	3	SENT_140	[p8l1970t489r2077b537, p8l1969t539r2077b652],
6	Zn	NN	O	zn	nn	9	SENT_140	[p8l1970t636r2077b680, p8l1970t683r2077b723],
7	:2	CD	NUMBER	:2	num	9	SENT_140	[p8l1970t636r2077b680, p8l1970t683r2077b723],
8	Um	NN	O	um	nn	9	SENT_140	[p8l1969t725r2077b755],
9	E	NN	O	e	dep	5	SENT_140	[p8l2037t757r2077b820],
10	.	.	O	.	_	0	SENT_140	[p8l2037t824r2077b846],

1	—	NN	O	—	_	0	SENT_141	[p8l2037t824r2077b846],
2	.	.	O	.	_	0	SENT_141	[p8l2037t824r2077b846],

1	I	PRP	O	I	_	0	SENT_142	[p8l2037t824r2077b846],
2	<	JJR	O	<	dep	1	SENT_142	[p8l2038t850r2077b890],

1	CYP2C9	NN	O	cyp2c9	nn	2	SENT_143	[p9l10t28r342b78],
2	*	NN	O	*	_	0	SENT_143	[p9l10t28r342b78],
3	2	CD	NUMBER	2	num	4	SENT_143	[p9l10t28r342b78],
4	genotype	NN	O	genotype	nsubj	10	SENT_143	[p9l368t39r648b97],
5	with	IN	O	with	_	0	SENT_143	[p9l670t23r809b78],
6	adenoma	NN	O	adenoma	nn	7	SENT_143	[p9l832t23r1120b79],
7	risk	NN	O	risk	prep_with	4	SENT_143	[p9l1141t23r1270b91],
8	,	,	O	,	_	0	SENT_143	[p9l1141t23r1270b91],
9	this	DT	O	this	appos	7	SENT_143	[p9l1294t23r1408b78],
10	appeared	VBD	O	appear	rcmod	2	SENT_143	[p9l1432t23r1715b97],
11	to	TO	O	to	aux	13	SENT_143	[p9l1737t39r1797b78],
12	be	VB	O	be	auxpass	13	SENT_143	[p9l8t114r77b168],
13	conﬁned	VBN	O	conﬁned	xcomp	10	SENT_143	[p9l102t113r373b169],
14	to	TO	O	to	_	0	SENT_143	[p9l396t129r456b168],
15	the	DT	O	the	det	16	SENT_143	[p9l483t113r579b168],
16	subgroup	NN	O	subgroup	prep_to	13	SENT_143	[p9l604t114r899b187],
17	of	IN	O	of	_	0	SENT_143	[p9l926t114r997b168],
18	patients	NNS	O	patient	prep_of	16	SENT_143	[p9l1010t116r1259b187],
19	who	WP	O	who	nsubj	21	SENT_143	[p9l1282t113r1413b168],
20	were	VBD	O	be	aux	21	SENT_143	[p9l1436t133r1577b168],
21	taking	VBG	O	take	rcmod	18	SENT_143	[p9l1601t113r1801b187],
22	low-dose	JJ	O	low-dose	amod	23	SENT_143	[p9l8t202r282b258],
23	aspirin	NN	O	aspirin	dobj	21	SENT_143	[p9l315t205r528b276],
24	(	CD	NUMBER	(	num	25	SENT_143	[p9l563t203r692b273],
25	RR	NN	O	rr	dep	23	SENT_143	[p9l563t203r692b273],
26	,	,	O	,	_	0	SENT_143	[p9l563t203r692b273],
27	1.44	CD	NUMBER	1.44	appos	23	SENT_143	[p9l732t207r871b270],
28	;	:	O	;	_	0	SENT_143	[p9l732t207r871b270],
29	95	CD	PERCENT	95	number	30	SENT_143	[p9l905t206r1026b257],
30	%	NN	PERCENT	%	amod	31	SENT_143	[p9l905t206r1026b257],
31	CI	NN	O	ci	dep	23	SENT_143	[p9l1060t207r1144b257],
32	:	:	O	:	_	0	SENT_143	[p9l1060t207r1144b257],
33	1.14-1	CD	NUMBER	1.14-1	number	34	SENT_143	[p9l1185t203r1505b273],
34	.81	CD	NUMBER	.81	num	35	SENT_143	[p9l1185t203r1505b273],
35	)	NN	O	)	dep	31	SENT_143	[p9l1185t203r1505b273],
36	and	CC	O	and	_	0	SENT_143	[p9l1541t202r1657b258],
37	was	VBD	O	be	cop	39	SENT_143	[p9l1687t223r1798b257],
38	not	RB	O	not	neg	39	SENT_143	[p9l9t308r116b347],
39	evident	JJ	O	evident	rcmod	2	SENT_143	[p9l138t292r363b348],
40	among	IN	O	among	_	0	SENT_143	[p9l386t313r602b366],
41	patients	NNS	O	patient	prep_among	39	SENT_143	[p9l624t295r872b366],
42	who	WP	O	who	nsubjpass	45	SENT_143	[p9l895t292r1025b347],
43	were	VBD	O	be	auxpass	45	SENT_143	[p9l1048t312r1188b347],
44	randomly	RB	O	randomly	advmod	45	SENT_143	[p9l1213t292r1515b366],
45	assigned	VBN	O	assign	rcmod	41	SENT_143	[p9l1536t292r1801b366],
46	to	TO	O	to	_	0	SENT_143	[p9l10t398r70b437],
47	placebo	NN	O	placebo	prep_to	45	SENT_143	[p9l96t382r333b456],
48	(	CD	NUMBER	(	num	49	SENT_143	[p9l361t383r491b453],
49	RR	NN	O	rr	dep	2	SENT_143	[p9l361t383r491b453],
50	,	,	O	,	_	0	SENT_143	[p9l361t383r491b453],
51	1.17	CD	NUMBER	1.17	appos	49	SENT_143	[p9l524t387r662b450],
52	;	:	O	;	_	0	SENT_143	[p9l524t387r662b450],
53	95	CD	PERCENT	95	number	54	SENT_143	[p9l690t386r811b437],
54	%	NN	PERCENT	%	amod	55	SENT_143	[p9l690t386r811b437],
55	CI	NN	O	ci	dep	2	SENT_143	[p9l837t387r921b437],
56	:	:	O	:	_	0	SENT_143	[p9l837t387r921b437],
57	0.96-1	CD	NUMBER	0.96-1	number	58	SENT_143	[p9l950t383r1292b453],
58	.43	CD	NUMBER	.43	num	59	SENT_143	[p9l950t383r1292b453],
59	)	NN	O	)	dep	55	SENT_143	[p9l950t383r1292b453],
60	.	.	O	.	_	0	SENT_143	[p9l950t383r1292b453],

1	The	DT	O	the	det	5	SENT_144	[p9l1318t382r1438b437],
2	CYP2C9	NN	O	cyp2c9	nn	5	SENT_144	[p9l1465t387r1796b437],
3	*	NN	O	*	nn	5	SENT_144	[p9l1465t387r1796b437],
4	3	CD	NUMBER	3	num	5	SENT_144	[p9l1465t387r1796b437],
5	genotype	NN	O	genotype	nsubj	8	SENT_144	[p9l9t488r290b546],
6	did	VBD	O	do	aux	8	SENT_144	[p9l320t472r421b528],
7	not	RB	O	not	neg	8	SENT_144	[p9l448t488r554b527],
8	appear	VB	O	appear	_	0	SENT_144	[p9l583t492r792b546],
9	to	TO	O	to	aux	12	SENT_144	[p9l820t488r881b527],
10	be	VB	O	be	auxpass	12	SENT_144	[p9l910t473r979b527],
11	independently	RB	O	independently	advmod	12	SENT_144	[p9l1008t472r1457b546],
12	associated	VBN	O	associate	xcomp	8	SENT_144	[p9l1484t472r1801b528],
13	with	IN	O	with	_	0	SENT_144	[p9l7t561r146b616],
14	adenoma	NN	O	adenoma	nn	15	SENT_144	[p9l175t561r463b617],
15	risk	NN	O	risk	prep_with	12	SENT_144	[p9l490t561r604b616],
16	across	IN	O	across	_	0	SENT_144	[p9l632t581r819b616],
17	all	DT	O	all	det	18	SENT_144	[p9l849t561r922b616],
18	subgroups	NNS	O	subgroup	prep_across	15	SENT_144	[p9l950t562r1291b635],
19	.	.	O	.	_	0	SENT_144	[p9l950t562r1291b635],

1	Because	IN	O	because	mark	4	SENT_145	[p9l84t656r327b705],
2	genotype	NN	O	genotype	nsubjpass	4	SENT_145	[p9l354t666r635b724],
3	is	VBZ	O	be	auxpass	4	SENT_145	[p9l661t653r706b705],
4	associated	VBN	O	associate	advcl	11	SENT_145	[p9l733t650r1050b706],
5	with	IN	O	with	_	0	SENT_145	[p9l1073t650r1212b705],
6	celecoxib	NN	O	celecoxib	nn	7	SENT_145	[p9l1239t650r1517b705],
7	metabolism	NN	O	metabolism	prep_with	4	SENT_145	[p9l1545t651r1798b705, p9l8t739r155b807],
8	,	,	O	,	_	0	SENT_145	[p9l1545t651r1798b705, p9l8t739r155b807],
9	we	PRP	O	we	nsubj	11	SENT_145	[p9l186t760r266b794],
10	then	RB	O	then	advmod	11	SENT_145	[p9l298t739r438b794],
11	investigated	VBD	O	investigate	_	0	SENT_145	[p9l469t739r843b813],
12	the	DT	O	the	det	13	SENT_145	[p9l873t739r970b794],
13	inﬂuence	NN	O	inﬂuence	dobj	11	SENT_145	[p9l1001t740r1285b794],
14	of	IN	O	of	_	0	SENT_145	[p9l1317t740r1388b794],
15	celecoxib	NN	O	celecoxib	prep_of	13	SENT_145	[p9l1409t739r1687b794],
16	on	IN	O	on	_	0	SENT_145	[p9l1721t760r1799b794],
17	risk	NN	O	risk	prep_on	15	SENT_145	[p9l9t828r119b883],
18	of	IN	O	of	_	0	SENT_145	[p9l145t829r215b883],
19	adenoma	NN	O	adenoma	prep_of	17	SENT_145	[p9l231t828r510b884],
20	according	VBG	O	accord	_	0	SENT_145	[p9l534t828r828b902],
21	to	TO	O	to	prepc_according_to	11	SENT_145	[p9l854t844r913b883],
22	CYP2C9	NN	O	cyp2c9	pobj	11	SENT_145	[p9l942t833r1189b883],
23	genotype	NN	O	genotype	nn	25	SENT_145	[p9l1218t844r1489b902],
24	(	CD	NUMBER	(	num	25	SENT_145	[p9l1517t828r1702b899],
25	Table	NNP	O	Table	dep	22	SENT_145	[p9l1517t828r1702b899],
26	3	CD	NUMBER	3	num	27	SENT_145	[p9l1729t829r1798b899],
27	)	NN	O	)	dep	25	SENT_145	[p9l1729t829r1798b899],
28	.	.	O	.	_	0	SENT_145	[p9l1729t829r1798b899],

1	For	IN	O	for	_	0	SENT_146	[p9l9t924r116b973],
2	patients	NNS	O	patient	prep_for	21	SENT_146	[p9l147t921r396b992],
3	of	IN	O	of	_	0	SENT_146	[p9l430t919r501b973],
4	all	DT	O	all	det	5	SENT_146	[p9l524t918r597b973],
5	genotypes	NNS	O	genotype	prep_of	2	SENT_146	[p9l629t934r955b992],
6	,	,	O	,	_	0	SENT_146	[p9l629t934r955b992],
7	the	DT	O	the	det	10	SENT_146	[p9l990t918r1086b973],
8	estimated	VBN	O	estimate	amod	10	SENT_146	[p9l1120t918r1422b974],
9	cumulative	JJ	O	cumulative	amod	10	SENT_146	[p9l1455t919r1799b973],
10	incidence	NN	O	incidence	nsubj	21	SENT_146	[p9l9t1007r301b1063],
11	of	IN	O	of	_	0	SENT_146	[p9l325t1008r397b1062],
12	1	CD	NUMBER	1	num	15	SENT_146	[p9l416t1012r440b1061],
13	or	CC	O	or	_	0	SENT_146	[p9l469t1027r533b1062],
14	more	JJR	O	more	conj_or	12	SENT_146	[p9l556t1027r715b1062],
15	adenomas	NNS	O	adenoma	prep_of	10	SENT_146	[p9l739t1007r1052b1063],
16	by	IN	O	by	_	0	SENT_146	[p9l1075t1008r1149b1081],
17	year	NN	DURATION	year	prep_by	15	SENT_146	[p9l1167t1027r1294b1081],
18	3	CD	NUMBER	3	num	17	SENT_146	[p9l1317t1012r1349b1062],
19	was	VBD	O	be	cop	21	SENT_146	[p9l1373t1028r1485b1062],
20	60.5	CD	PERCENT	60.5	num	21	SENT_146	[p9l1511t1011r1687b1062],
21	%	NN	PERCENT	%	_	0	SENT_146	[p9l1511t1011r1687b1062],
22	for	IN	O	for	_	0	SENT_146	[p9l1710t1008r1801b1062],
23	those	DT	O	those	nsubj	24	SENT_146	[p9l10t1096r175b1151],
24	receiving	VBG	O	receive	prepc_for	21	SENT_146	[p9l222t1099r497b1170],
25	placebo	NN	O	placebo	dobj	24	SENT_146	[p9l542t1097r794b1170],
26	,	,	O	,	_	0	SENT_146	[p9l542t1097r794b1170],
27	as	IN	O	as	advmod	21	SENT_146	[p9l842t1117r900b1151],
28	compared	VBN	O	compare	_	0	SENT_146	[p9l948t1096r1258b1170],
29	with	IN	O	with	prepc_compared_with	21	SENT_146	[p9l1301t1096r1440b1151],
30	42.5	CD	PERCENT	42.5	num	31	SENT_146	[p9l1486t1100r1664b1151],
31	%	NN	PERCENT	%	pobj	21	SENT_146	[p9l1486t1100r1664b1151],
32	for	IN	O	for	_	0	SENT_146	[p9l1710t1097r1800b1151],
33	those	DT	O	those	prep_for	31	SENT_146	[p9l10t1185r175b1240],
34	receiving	VBG	O	receive	partmod	33	SENT_146	[p9l209t1188r484b1259],
35	low-dose	JJ	O	low-dose	amod	36	SENT_146	[p9l516t1185r789b1241],
36	(	NN	O	(	dobj	34	SENT_146	[p9l825t1186r958b1256],
37	200	CD	NUMBER	200	num	38	SENT_146	[p9l825t1186r958b1256],
38	mg	NN	O	mg	npadvmod	39	SENT_146	[p9l993t1206r1091b1259],
39	twice	RB	O	twice	advmod	42	SENT_146	[p9l1124t1188r1281b1240],
40	daily	JJ	SET	daily	amod	42	SENT_146	[p9l1316t1185r1482b1259],
41	)	NN	O	)	nn	42	SENT_146	[p9l1316t1185r1482b1259],
42	celecoxib	NN	O	celecoxib	rcmod	36	SENT_146	[p9l1520t1185r1798b1240],
43	(	CD	NUMBER	(	num	44	SENT_146	[p9l11t1275r141b1345],
44	RR	NN	O	rr	dep	42	SENT_146	[p9l11t1275r141b1345],
45	,	,	O	,	_	0	SENT_146	[p9l11t1275r141b1345],
46	0.65	CD	NUMBER	0.65	appos	44	SENT_146	[p9l177t1278r321b1341],
47	;	:	O	;	_	0	SENT_146	[p9l177t1278r321b1341],
48	95	CD	PERCENT	95	number	49	SENT_146	[p9l357t1278r478b1329],
49	%	NN	PERCENT	%	amod	50	SENT_146	[p9l357t1278r478b1329],
50	CI	NN	O	ci	dep	44	SENT_146	[p9l513t1279r597b1329],
51	:	:	O	:	_	0	SENT_146	[p9l513t1279r597b1329],
52	0.56-0	CD	NUMBER	0.56-0	number	53	SENT_146	[p9l634t1278r964b1341],
53	.76	CD	NUMBER	.76	dep	50	SENT_146	[p9l634t1278r964b1341],
54	;	:	O	;	_	0	SENT_146	[p9l634t1278r964b1341],
55	P	NN	O	p	dep	56	SENT_146	[p9l996t1280r1039b1328],
56	<	JJR	O	<	dep	44	SENT_146	[p9l1074t1282r1124b1325],
57	.001	CD	NUMBER	.001	num	58	SENT_146	[p9l1165t1275r1312b1345],
58	)	NN	O	)	dep	56	SENT_146	[p9l1165t1275r1312b1345],
59	and	CC	O	and	_	0	SENT_146	[p9l1350t1274r1466b1330],
60	36.9	CD	PERCENT	36.9	num	61	SENT_146	[p9l1499t1278r1676b1329],
61	%	NN	PERCENT	%	dobj	34	SENT_146	[p9l1499t1278r1676b1329],
62	for	IN	O	for	_	0	SENT_146	[p9l1711t1274r1801b1329],
63	those	DT	O	those	prep_for	61	SENT_146	[p9l10t1363r175b1418],
64	receiving	VBG	O	receive	partmod	63	SENT_146	[p9l205t1366r480b1437],
65	high-dose	JJ	O	high-dose	amod	66	SENT_146	[p9l507t1363r812b1437],
66	(	NN	O	(	nsubj	90	SENT_146	[p9l844t1364r976b1434],
67	400	CD	NUMBER	400	num	68	SENT_146	[p9l844t1364r976b1434],
68	mg	NN	O	mg	npadvmod	69	SENT_146	[p9l1007t1384r1105b1437],
69	twice	RB	O	twice	advmod	72	SENT_146	[p9l1133t1366r1291b1418],
70	daily	JJ	SET	daily	amod	72	SENT_146	[p9l1320t1363r1487b1437],
71	)	NN	O	)	nn	72	SENT_146	[p9l1320t1363r1487b1437],
72	celecoxib	NN	O	celecoxib	rcmod	66	SENT_146	[p9l1520t1363r1798b1418],
73	(	CD	NUMBER	(	num	74	SENT_146	[p9l11t1453r141b1523],
74	RR	NN	O	rr	dep	72	SENT_146	[p9l11t1453r141b1523],
75	,	,	O	,	_	0	SENT_146	[p9l11t1453r141b1523],
76	0.54	CD	NUMBER	0.54	appos	74	SENT_146	[p9l171t1456r315b1519],
77	;	:	O	;	_	0	SENT_146	[p9l171t1456r315b1519],
78	95	CD	PERCENT	95	number	79	SENT_146	[p9l345t1456r465b1507],
79	%	NN	PERCENT	%	amod	80	SENT_146	[p9l345t1456r465b1507],
80	CI	NN	O	ci	dep	74	SENT_146	[p9l495t1457r578b1507],
81	:	:	O	:	_	0	SENT_146	[p9l495t1457r578b1507],
82	0.46-0	CD	NUMBER	0.46-0	number	83	SENT_146	[p9l609t1456r939b1520],
83	.63	CD	NUMBER	.63	dep	80	SENT_146	[p9l609t1456r939b1520],
84	;	:	O	;	_	0	SENT_146	[p9l609t1456r939b1520],
85	P	NN	O	p	dep	86	SENT_146	[p9l965t1457r1009b1506],
86	<	JJR	O	<	dep	74	SENT_146	[p9l1037t1460r1087b1503],
87	.001	CD	NUMBER	.001	num	88	SENT_146	[p9l1121t1453r1288b1523],
88	)	NN	O	)	dep	86	SENT_146	[p9l1121t1453r1288b1523],
89	,	,	O	,	_	0	SENT_146	[p9l1121t1453r1288b1523],
90	consistent	JJ	O	consistent	xcomp	64	SENT_146	[p9l1317t1455r1635b1507],
91	with	IN	O	with	_	0	SENT_146	[p9l1660t1452r1799b1506],
92	the	DT	O	the	det	94	SENT_146	[p9l10t1541r106b1596],
93	primary	JJ	O	primary	amod	94	SENT_146	[p9l134t1544r382b1615],
94	analysis	NN	O	analysis	prep_with	90	SENT_146	[p9l408t1541r648b1615],
95	of	IN	O	of	_	0	SENT_146	[p9l678t1542r749b1596],
96	the	DT	O	the	det	97	SENT_146	[p9l767t1541r864b1596],
97	trial	NN	O	trial	prep_of	94	SENT_146	[p9l893t1542r1061b1596],
98	?	.	O	?	_	0	SENT_146	[p9l893t1542r1061b1596],

1	Within	IN	O	within	_	0	SENT_147	[p9l1088t1541r1308b1596],
2	each	DT	O	each	det	3	SENT_147	[p9l1336t1541r1473b1596],
3	subgroup	NN	O	subgroup	prep_within	14	SENT_147	[p9l1502t1542r1798b1615],
4	deﬁned	VBN	O	deﬁned	partmod	3	SENT_147	[p9l9t1630r239b1686],
5	by	IN	O	by	_	0	SENT_147	[p9l268t1631r341b1704],
6	genotype	NN	O	genotype	agent	4	SENT_147	[p9l370t1646r667b1704],
7	,	,	O	,	_	0	SENT_147	[p9l370t1646r667b1704],
8	both	CC	O	both	preconj	9	SENT_147	[p9l698t1630r845b1685],
9	low-dose	JJ	O	low-dose	amod	12	SENT_147	[p9l876t1630r1150b1686],
10	and	CC	O	and	_	0	SENT_147	[p9l1182t1630r1298b1686],
11	high-dose	JJ	O	high-dose	amod	12	SENT_147	[p9l1328t1630r1633b1704],
12	celecoxib	NN	O	celecoxib	nsubjpass	14	SENT_147	[p9l1665t1630r1798b1685, p9l9t1720r171b1774],
13	were	VBD	O	be	auxpass	14	SENT_147	[p9l195t1739r336b1774],
14	associated	VBN	O	associate	_	0	SENT_147	[p9l361t1719r678b1775],
15	with	IN	O	with	_	0	SENT_147	[p9l700t1719r838b1774],
16	a	DT	O	a	det	18	SENT_147	[p9l863t1740r897b1774],
17	lower	JJR	O	lower	amod	18	SENT_147	[p9l918t1719r1088b1774],
18	risk	NN	O	risk	prep_with	14	SENT_147	[p9l1112t1719r1225b1774],
19	of	IN	O	of	_	0	SENT_147	[p9l1250t1720r1321b1774],
20	adenoma	NN	O	adenoma	prep_of	18	SENT_147	[p9l1335t1719r1623b1775],
21	compared	VBN	O	compare	_	0	SENT_147	[p9l1646t1740r1798b1774, p9l9t1809r184b1883],
22	with	IN	O	with	prepc_compared_with	14	SENT_147	[p9l209t1809r348b1864],
23	placebo	NN	O	placebo	pobj	14	SENT_147	[p9l377t1809r628b1883],
24	.	.	O	.	_	0	SENT_147	[p9l377t1809r628b1883],

1	2130	CD	DATE	2130	_	0	SENT_148	[p9l43t1958r119b1982],
2	CHAN	NNP	MISC	CHAN	nn	6	SENT_148	[p9l154t1958r234b1981],
3	ET	NNP	MISC	ET	nn	6	SENT_148	[p9l249t1959r281b1981],
4	AL	NNP	MISC	AL	nn	6	SENT_148	[p9l292t1959r329b1981],
5	GASTROENTEROLOGY	NNP	MISC	GASTROENTEROLOGY	nn	6	SENT_148	[p9l1576t1958r1888b1981],
6	Vol	NNP	O	Vol	dep	1	SENT_148	[p9l1899t1959r1949b1981],
7	.	.	O	.	_	0	SENT_148	[p9l1899t1959r1949b1981],

1	136	CD	NUMBER	136	_	0	SENT_149	[p9l1964t1958r2027b1986],
2	,	,	O	,	_	0	SENT_149	[p9l1964t1958r2027b1986],
3	No.	NN	O	no.	appos	1	SENT_149	[p9l2042t1959r2086b1981],
4	7	CD	NUMBER	7	num	3	SENT_149	[p9l2100t1959r2117b1981],

1	Table	NNP	O	Table	_	0	SENT_150	[p9l43t2061r132b2088],
2	1	CD	NUMBER	1	dep	1	SENT_150	[p9l147t2061r177b2088],
3	.	.	O	.	_	0	SENT_150	[p9l147t2061r177b2088],

1	Baseline	NN	O	baseline	nn	2	SENT_151	[p9l201t2061r338b2088],
2	Characteristics	NNS	O	characteristic	_	0	SENT_151	[p9l354t2061r596b2088],
3	of	IN	O	of	_	0	SENT_151	[p9l611t2061r643b2088],
4	the	DT	O	the	det	5	SENT_151	[p9l654t2061r705b2088],
5	Patients	NNS	O	patient	prep_of	2	SENT_151	[p9l721t2061r852b2088],
6	According	VBG	O	accord	_	0	SENT_151	[p9l866t2061r1024b2095],
7	to	TO	O	to	prepc_according_to	2	SENT_151	[p9l1036t2063r1067b2088],
8	CYP2C9	NNP	O	CYP2C9	nn	9	SENT_151	[p9l1082t2061r1213b2088],
9	Genotype	NN	O	genotype	pobj	2	SENT_151	[p9l1228t2061r1379b2095],

1	All	DT	O	all	det	5	SENT_152	[p9l922t2130r953b2154],
2	Wild	NNP	O	Wild	nn	5	SENT_152	[p9l1163t2130r1222b2154],
3	type	NN	O	type	nn	5	SENT_152	[p9l1235t2132r1294b2160],
4	CYP2C9	CD	NUMBER	cyp2c9	num	5	SENT_152	[p9l1441t2130r1597b2154],
5	*	NN	O	*	_	0	SENT_152	[p9l1441t2130r1597b2154],
6	2	CD	NUMBER	2	num	7	SENT_152	[p9l1441t2130r1597b2154],
7	CYP2C9	NN	O	cyp2c9	dep	5	SENT_152	[p9l1731t2130r1888b2154],
8	*	CD	NUMBER	*	number	9	SENT_152	[p9l1731t2130r1888b2154],
9	3	CD	NUMBER	3	dep	7	SENT_152	[p9l1731t2130r1888b2154],

1	Characteristics	NNS	O	characteristic	dep	2	SENT_153	[p9l290t2179r505b2203],
2	(	VBP	O	(	_	0	SENT_153	[p9l856t2179r881b2208],
3	n	NN	O	n	nsubj	18	SENT_153	[p9l856t2179r881b2208],
4	=	JJ	O	=	amod	3	SENT_153	[p9l897t2188r918b2196],
5	1660	CD	DATE	1660	number	6	SENT_153	[p9l935t2179r1021b2208],
6	)	CD	NUMBER	)	num	18	SENT_153	[p9l935t2179r1021b2208],
7	(	NN	O	(	nn	18	SENT_153	[p9l1146t2179r1171b2208],
8	n	NN	O	n	nn	18	SENT_153	[p9l1146t2179r1171b2208],
9	=	JJ	O	=	amod	18	SENT_153	[p9l1188t2188r1208b2196],
10	1102	CD	DATE	1102	number	11	SENT_153	[p9l1225t2179r1311b2208],
11	)	CD	NUMBER	)	num	18	SENT_153	[p9l1225t2179r1311b2208],
12	(	NN	O	(	nn	18	SENT_153	[p9l1447t2179r1471b2208],
13	n	NN	O	n	nn	18	SENT_153	[p9l1447t2179r1471b2208],
14	=	JJ	O	=	amod	18	SENT_153	[p9l1488t2188r1508b2196],
15	357	CD	NUMBER	357	number	16	SENT_153	[p9l1524t2179r1592b2208],
16	)	CD	NUMBER	)	num	18	SENT_153	[p9l1524t2179r1592b2208],
17	(	NN	O	(	nn	18	SENT_153	[p9l1737t2179r1762b2208],
18	n	NN	O	n	xcomp	2	SENT_153	[p9l1737t2179r1762b2208],
19	=	JJ	O	=	amod	18	SENT_153	[p9l1778t2188r1799b2196],
20	201	CD	NUMBER	201	tmod	19	SENT_153	[p9l1815t2179r1882b2208],
21	)	CD	NUMBER	)	num	22	SENT_153	[p9l1815t2179r1882b2208],
22	Pvaluea	NN	O	pvaluea	nsubj	2	SENT_153	[p9l1999t2179r2116b2203],

1	Age	NNP	O	Age	dep	10	SENT_154	[p9l370t2255r478b2308],
2	,	,	O	,	_	0	SENT_154	[p9l370t2255r478b2308],
3	median	NN	O	median	appos	1	SENT_154	[p9l507t2255r708b2304],
4	,	,	O	,	_	0	SENT_154	[p9l507t2255r708b2304],
5	y	NN	O	y	appos	1	SENT_154	[p9l732t2255r957b2308],
6	(	CD	NUMBER	(	num	5	SENT_154	[p9l732t2255r957b2308],
7	range	NN	O	range	dep	10	SENT_154	[p9l732t2255r957b2308],
8	)	CD	NUMBER	)	num	7	SENT_154	[p9l732t2255r957b2308],
9	59	CD	NUMBER	59	num	10	SENT_154	[p9l1842t2254r1908b2297],
10	(	NN	O	(	_	0	SENT_154	[p9l1928t2254r2152b2306],
11	31-88	CD	NUMBER	31-88	num	12	SENT_154	[p9l1928t2254r2152b2306],
12	)	NN	O	)	dep	10	SENT_154	[p9l1928t2254r2152b2306],

1	>	JJR	O	>	amod	2	SENT_155	[p9l94t2372r133b2412],
2	Women	NNS	O	woman	_	0	SENT_155	[p9l371t2329r577b2378],
3	,	,	O	,	_	0	SENT_155	[p9l371t2329r577b2378],
4	%	NN	O	%	appos	2	SENT_155	[p9l604t2329r643b2371],
5	31.9	CD	NUMBER	31.9	num	4	SENT_155	[p9l1914t2329r2034b2371],
6	:	:	O	:	_	0	SENT_155	[p9l94t2416r133b2452],
7	Race	NN	O	race	nn	10	SENT_155	[p9l375t2404r498b2446],
8	or	CC	O	or	_	0	SENT_155	[p9l522t2413r572b2446],
9	ethnic	JJ	O	ethnic	conj_or	7	SENT_155	[p9l593t2404r748b2446],
10	group	NN	O	group	dep	2	SENT_155	[p9l770t2409r928b2456],
11	,	,	O	,	_	0	SENT_155	[p9l770t2409r928b2456],
12	%	NN	O	%	nn	14	SENT_155	[p9l954t2398r1018b2446],
13	"	''	O	"	punct	14	SENT_155	[p9l954t2398r1018b2446],
14	E	NN	O	e	appos	10	SENT_155	[p9l94t2456r133b2532],
15	,	,	O	,	_	0	SENT_155	[p9l160t2507r201b2537],
16	,	,	O	,	_	0	SENT_155	[p9l160t2507r201b2537],
17	Non	NNP	O	Non	appos	10	SENT_155	[p9l434t2478r769b2530],
18	.	.	O	.	_	0	SENT_155	[p9l434t2478r769b2530],

1	—	NN	O	—	_	0	SENT_156	[p9l434t2478r769b2530],
2	.	.	O	.	_	0	SENT_156	[p9l434t2478r769b2530],

1	Hispanic	JJ	MISC	hispanic	amod	4	SENT_157	[p9l434t2478r769b2530],
2	white	JJ	O	white	amod	4	SENT_157	[p9l791t2478r925b2520],
3	92.2	CD	NUMBER	92.2	num	4	SENT_157	[p9l1913t2478r2033b2520],
4	E	NN	O	e	_	0	SENT_157	[p9l94t2538r133b2608],
5	E	NN	O	e	nn	6	SENT_157	[p9l161t2543r200b2625],
6	Non	NN	O	non	dep	4	SENT_157	[p9l434t2553r769b2604],
7	.	.	O	.	_	0	SENT_157	[p9l434t2553r769b2604],

1	—	NN	O	—	_	0	SENT_158	[p9l434t2553r769b2604],
2	.	.	O	.	_	0	SENT_158	[p9l434t2553r769b2604],

1	Hispanic	JJ	MISC	hispanic	amod	2	SENT_159	[p9l434t2553r769b2604],
2	black	JJ	O	black	_	0	SENT_159	[p9l794t2553r927b2595],
3	5.2	CD	NUMBER	5.2	number	4	SENT_159	[p9l1950t2552r2033b2595],
4	,3	CD	NUMBER	,3	dep	2	SENT_159	[p9l94t2609r133b2685],
5	:	:	O	:	_	0	SENT_159	[p9l94t2609r133b2685],
6	5	CD	NUMBER	5	num	9	SENT_159	[p9l160t2632r201b2677],
7	Hispanic	JJ	O	hispanic	amod	9	SENT_159	[p9l434t2627r652b2679],
8	1.8	CD	NUMBER	1.8	tmod	7	SENT_159	[p9l1951t2627r2034b2669],
9	j	NN	O	j	dep	4	SENT_159	[p9l94t2685r133b2767],
10	$	$	MONEY	$	amod	9	SENT_159	[p9l161t2680r200b2772],
11	Asian/Pacific	JJ	MONEY	asian/pacific	dep	10	SENT_159	[p9l430t2701r769b2753],
12	islander/other	NN	O	islander/other	dep	2	SENT_159	[p9l795t2702r1164b2753],
13	0.8	CD	NUMBER	0.8	number	14	SENT_159	[p9l1949t2701r2034b2744],
14	§	CD	NUMBER	§	num	19	SENT_159	[p9l94t2771r133b2843],
15	Current	JJ	DATE	current	amod	17	SENT_159	[p9l372t2776r560b2819],
16	cigarette	NN	O	cigarette	nn	17	SENT_159	[p9l582t2776r805b2829],
17	smoker	NN	O	smoker	dep	19	SENT_159	[p9l830t2776r1034b2826],
18	,	,	O	,	_	0	SENT_159	[p9l830t2776r1034b2826],
19	%	NN	O	%	dep	12	SENT_159	[p9l1059t2776r1099b2818],
20	16.6	CD	NUMBER	16.6	number	21	SENT_159	[p9l1915t2776r2034b2819],
21	2	CD	NUMBER	2	num	23	SENT_159	[p9l93t2845r134b2905],
22	Body	NN	O	body	nn	23	SENT_159	[p9l374t2851r497b2903],
23	mass	NN	O	mass	dep	2	SENT_159	[p9l520t2861r657b2893],
24	index	NN	O	index	dep	23	SENT_159	[p9l683t2851r838b2893],
25	‘	CD	NUMBER	‘	num	24	SENT_159	[p9l683t2851r838b2893],
26	?	.	O	?	_	0	SENT_159	[p9l683t2851r838b2893],

1	Men	NN	O	man	_	0	SENT_160	[p9l434t2925r539b2968],
2	28.8	CD	NUMBER	28.8	number	1	SENT_160	[p9l1789t2925r1909b2968],
3	(	CD	NUMBER	(	number	1	SENT_160	[p9l1928t2925r2048b2977],
4	0.1	CD	NUMBER	0.1	number	1	SENT_160	[p9l1928t2925r2048b2977],
5	)	CD	NUMBER	)	num	6	SENT_160	[p9l1928t2925r2048b2977],
6	Women	NNS	O	woman	dep	1	SENT_160	[p9l430t3000r620b3042],
7	29.0	CD	NUMBER	29.0	number	8	SENT_160	[p9l1789t3000r1909b3042],
8	(	CD	NUMBER	(	dep	1	SENT_160	[p9l1928t3000r2048b3052],
9	0.3	CD	NUMBER	0.3	num	10	SENT_160	[p9l1928t3000r2048b3052],
10	)	NN	O	)	dep	8	SENT_160	[p9l1928t3000r2048b3052],

1	Colorectal	JJ	O	colorectal	amod	2	SENT_161	[p9l372t3074r627b3116],
2	cancer	NN	O	cancer	_	0	SENT_161	[p9l653t3084r824b3116],
3	in	IN	O	in	_	0	SENT_161	[p9l848t3074r887b3116],
4	a	DT	O	a	det	5	SENT_161	[p9l913t3084r940b3116],
5	parent	NN	O	parent	prep_in	2	SENT_161	[p9l967t3077r1143b3126],
6	,	,	O	,	_	0	SENT_161	[p9l967t3077r1143b3126],
7	%	NN	O	%	appos	5	SENT_161	[p9l1168t3074r1208b3116],
8	21	CD	NUMBER	21	num	9	SENT_161	[p9l1914t3074r1980b3116],
9	Findings	NNS	O	finding	dep	2	SENT_161	[p9l375t3149r582b3202],
10	at	IN	O	at	_	0	SENT_161	[p9l608t3151r656b3191],
11	baseline	NN	O	baseline	nn	12	SENT_161	[p9l679t3149r894b3191],
12	colonoscopy	NN	O	colonoscopy	prep_at	9	SENT_161	[p9l918t3149r1238b3201],

1	No.	NN	O	no.	_	0	SENT_162	[p9l434t3222r514b3264],
2	of	IN	O	of	_	0	SENT_162	[p9l541t3222r591b3264],
3	adenomas	NNS	O	adenoma	prep_of	1	SENT_162	[p9l612t3222r880b3264],
4	2.1	CD	NUMBER	2.1	number	5	SENT_162	[p9l1824t3222r1909b3264],
5	(	CD	NUMBER	(	num	7	SENT_162	[p9l1928t3222r2084b3274],
6	0.04	CD	NUMBER	0.04	number	7	SENT_162	[p9l1928t3222r2084b3274],
7	)	CD	NUMBER	)	dep	3	SENT_162	[p9l1928t3222r2084b3274],
8	At	IN	O	at	quantmod	10	SENT_162	[p9l430t3294r482b3336],
9	least	JJS	O	least	mwe	8	SENT_162	[p9l506t3294r631b3336],
10	1	CD	NUMBER	1	dep	3	SENT_162	[p9l655t3294r684b3336],
11	adenoma	NN	O	adenoma	prep	10	SENT_162	[p9l709t3294r946b3336],
12	21	CD	NUMBER	21	num	13	SENT_162	[p9l973t3294r1052b3336],
13	cm	NN	O	cm	dep	11	SENT_162	[p9l1075t3304r1164b3343],
14	,	,	O	,	_	0	SENT_162	[p9l1075t3304r1164b3343],
15	%	NN	O	%	appos	3	SENT_162	[p9l1190t3294r1230b3336],
16	42.6	CD	NUMBER	42.6	num	18	SENT_162	[p9l1913t3294r2034b3336],
17	Multiple	JJ	O	multiple	amod	18	SENT_162	[p9l434t3368r635b3419],
18	adenomas	NNS	O	adenoma	dep	1	SENT_162	[p9l660t3368r943b3417],
19	,	,	O	,	_	0	SENT_162	[p9l660t3368r943b3417],
20	%	NN	O	%	nn	23	SENT_162	[p9l969t3367r1009b3410],
21	55.9	CD	NUMBER	55.9	num	23	SENT_162	[p9l1914t3367r2034b3410],
22	Adenoma	NN	O	adenoma	nn	23	SENT_162	[p9l430t3441r670b3483],
23	burden	NN	O	burden	appos	18	SENT_162	[p9l696t3441r886b3490],
24	,	,	O	,	_	0	SENT_162	[p9l696t3441r886b3490],
25	cm	NN	O	cm	nn	26	SENT_162	[p9l912t3436r1013b3483],
26	“	NN	O	“	appos	18	SENT_162	[p9l912t3436r1013b3483],
27	1.50	CD	NUMBER	1.50	num	30	SENT_162	[p9l1790t3441r1909b3483],
28	(	JJ	O	(	amod	30	SENT_162	[p9l1928t3441r2084b3493],
29	0.03	CD	NUMBER	0.03	tmod	28	SENT_162	[p9l1928t3441r2084b3493],
30	)	NN	O	)	dep	26	SENT_162	[p9l1928t3441r2084b3493],

1	History	NN	O	history	_	0	SENT_163	[p9l375t3514r550b3567],
2	of	IN	O	of	_	0	SENT_163	[p9l572t3514r622b3556],
3	cardiovascular	JJ	O	cardiovascular	amod	4	SENT_163	[p9l641t3514r1015b3556],
4	events	NNS	O	event	prep_of	1	SENT_163	[p9l1037t3517r1221b3564],
5	,	,	O	,	_	0	SENT_163	[p9l1037t3517r1221b3564],
6	%	NN	O	%	appos	4	SENT_163	[p9l1246t3514r1310b3556],
7	e	SYM	O	e	dep	9	SENT_163	[p9l1246t3514r1310b3556],
8	14.2	CD	NUMBER	14.2	num	9	SENT_163	[p9l1915t3514r2033b3556],
9	History	NN	O	history	dep	1	SENT_163	[p9l375t3589r550b3641],
10	of	IN	O	of	_	0	SENT_163	[p9l572t3588r622b3631],
11	hypertension	NN	O	hypertension	nn	15	SENT_163	[p9l644t3589r987b3641],
12	,	,	O	,	_	0	SENT_163	[p9l644t3589r987b3641],
13	%	NN	O	%	dep	15	SENT_163	[p9l1013t3588r1052b3631],
14	40.4	CD	NUMBER	40.4	num	15	SENT_163	[p9l1913t3588r2035b3631],
15	History	NN	O	history	prep_of	9	SENT_163	[p9l375t3662r550b3714],
16	of	IN	O	of	_	0	SENT_163	[p9l572t3662r622b3704],
17	diabetes	NN	O	diabetes	nn	21	SENT_163	[p9l642t3662r878b3711],
18	,	,	O	,	_	0	SENT_163	[p9l642t3662r878b3711],
19	%	NN	O	%	dep	21	SENT_163	[p9l904t3662r943b3704],
20	9.3	CD	NUMBER	9.3	num	21	SENT_163	[p9l1949t3662r2034b3704],
21	Use	NN	O	use	prep_of	1	SENT_163	[p9l375t3734r469b3776],
22	of	IN	O	of	_	0	SENT_163	[p9l493t3734r543b3776],
23	low-dose	JJ	O	low-dose	amod	24	SENT_163	[p9l566t3735r786b3776],
24	aspirin	NN	O	aspirin	prep_of	1	SENT_163	[p9l811t3735r996b3786],
25	,	,	O	,	_	0	SENT_163	[p9l811t3735r996b3786],
26	%	NN	O	%	appos	24	SENT_163	[p9l1022t3728r1082b3776],
27	"	''	O	"	punct	26	SENT_163	[p9l1022t3728r1082b3776],
28	32.0	CD	NUMBER	32.0	dep	1	SENT_163	[p9l1913t3734r2034b3776],

1	Randomized	VBN	O	randomize	_	0	SENT_164	[p10l375t18r685b60],
2	to	TO	O	to	_	0	SENT_164	[p10l708t20r757b60],
3	placebo	NN	O	placebo	prep_to	1	SENT_164	[p10l784t18r997b69],
4	,	,	O	,	_	0	SENT_164	[p10l784t18r997b69],
5	%	NN	O	%	dep	1	SENT_164	[p10l1023t17r1062b60],
6	33.7	CD	NUMBER	33.7	num	7	SENT_164	[p10l1913t17r2032b60],
7	Randomized	NNP	O	Randomized	dobj	5	SENT_164	[p10l375t92r685b134],
8	to	TO	O	to	_	0	SENT_164	[p10l708t95r757b134],
9	celecoxib	NN	O	celecoxib	prep_to	5	SENT_164	[p10l781t92r1034b142],
10	,	,	O	,	_	0	SENT_164	[p10l781t92r1034b142],
11	200	CD	NUMBER	200	num	12	SENT_164	[p10l1061t92r1163b134],
12	mg	NN	O	mg	dep	1	SENT_164	[p10l1189t98r1264b145],
13	twice	RB	O	twice	advmod	14	SENT_164	[p10l1284t92r1415b134],
14	daily	RB	SET	daily	advmod	12	SENT_164	[p10l1440t92r1569b145],
15	,	,	O	,	_	0	SENT_164	[p10l1440t92r1569b145],
16	%	NN	O	%	dep	1	SENT_164	[p10l1595t92r1634b134],
17	33.1	CD	NUMBER	33.1	num	18	SENT_164	[p10l1914t92r2034b134],
18	Randomized	NNP	O	Randomized	dobj	16	SENT_164	[p10l375t165r685b207],
19	to	TO	O	to	_	0	SENT_164	[p10l708t168r757b207],
20	celecoxib	NN	O	celecoxib	prep_to	16	SENT_164	[p10l781t165r1034b215],
21	,	,	O	,	_	0	SENT_164	[p10l781t165r1034b215],
22	400	CD	NUMBER	400	num	23	SENT_164	[p10l1060t165r1163b207],
23	mg	NN	O	mg	dep	1	SENT_164	[p10l1189t171r1264b218],
24	twice	RB	O	twice	advmod	25	SENT_164	[p10l1284t165r1415b207],
25	daily	RB	SET	daily	advmod	23	SENT_164	[p10l1440t165r1569b218],
26	,	,	O	,	_	0	SENT_164	[p10l1440t165r1569b218],
27	%	NN	O	%	dep	1	SENT_164	[p10l1595t165r1634b207],
28	33.2	CD	NUMBER	33.2	dobj	27	SENT_164	[p10l1914t165r2033b207],

1	NOTE	VB	O	note	_	0	SENT_165	[p10l45t2579r129b2603],
2	.	.	O	.	_	0	SENT_165	[p10l45t2579r129b2603],

1	Data	NNS	O	datum	nsubjpass	3	SENT_166	[p10l145t2579r210b2603],
2	are	VBP	O	be	auxpass	3	SENT_166	[p10l223t2585r267b2603],
3	expressed	VBN	O	express	_	0	SENT_166	[p10l280t2579r427b2608],
4	as	IN	O	as	_	0	SENT_166	[p10l442t2585r474b2603],
5	mean	JJ	O	mean	amod	8	SENT_166	[p10l488t2585r565b2603],
6	(	JJ	O	(	amod	8	SENT_166	[p10l580t2579r639b2609],
7	SD	NN	O	sd	nn	8	SENT_166	[p10l580t2579r639b2609],
8	)	NN	O	)	prep_as	3	SENT_166	[p10l580t2579r639b2609],
9	unless	IN	O	unless	mark	11	SENT_166	[p10l654t2579r747b2603],
10	otherwise	RB	O	otherwise	advmod	11	SENT_166	[p10l760t2579r899b2603],
11	indicated	VBN	O	indicate	dep	8	SENT_166	[p10l913t2579r1051b2603],
12	.	.	O	.	_	0	SENT_166	[p10l913t2579r1051b2603],

1	Wi	NN	O	wus	nn	6	SENT_167	[p10l1064t2579r1192b2609],
2	|	NN	O	|	nn	6	SENT_167	[p10l1064t2579r1192b2609],
3	d	NN	O	d	nn	6	SENT_167	[p10l1064t2579r1192b2609],
4	—	CD	NUMBER	—	num	6	SENT_167	[p10l1064t2579r1192b2609],
5	type	NN	O	type	nn	6	SENT_167	[p10l1064t2579r1192b2609],
6	genotypes	NNS	O	genotype	nsubj	7	SENT_167	[p10l1205t2580r1352b2609],
7	include	VBP	O	include	_	0	SENT_167	[p10l1366t2579r1466b2603],
8	individuals	NNS	O	individual	dobj	7	SENT_167	[p10l1481t2579r1631b2603],
9	with	IN	O	with	_	0	SENT_167	[p10l1643t2579r1700b2603],
10	no	DT	O	no	det	11	SENT_167	[p10l1715t2585r1748b2603],
11	*	NN	O	*	prep_with	7	SENT_167	[p10l1763t2579r1798b2603],
12	2	CD	NUMBER	2	number	13	SENT_167	[p10l1763t2579r1798b2603],
13	(	CD	NUMBER	(	num	11	SENT_167	[p10l1812t2579r1930b2609],
14	R1440	NN	O	r1440	dep	11	SENT_167	[p10l1812t2579r1930b2609],
15	)	CD	NUMBER	)	num	14	SENT_167	[p10l1812t2579r1930b2609],
16	or	CC	O	or	_	0	SENT_167	[p10l1944t2585r1971b2603],
17	3	CD	NUMBER	3	number	18	SENT_167	[p10l1983t2579r2001b2603],
18	(	CD	NUMBER	(	num	20	SENT_167	[p10l2014t2579r2117b2609],
19	|	NN	O	|	nn	20	SENT_167	[p10l2014t2579r2117b2609],
20	359L	NN	O	359l	prep_with	7	SENT_167	[p10l2014t2579r2117b2609],
21	)	CD	NUMBER	)	num	22	SENT_167	[p10l2014t2579r2117b2609],
22	alleles	NNS	O	allele	dep	20	SENT_167	[p10l44t2620r145b2644],
23	.	.	O	.	_	0	SENT_167	[p10l44t2620r145b2644],

1	CYP2C9	NN	O	cyp2c9	nn	2	SENT_168	[p10l158t2620r313b2644],
2	*	NN	O	*	nsubj	5	SENT_168	[p10l158t2620r313b2644],
3	2	CD	NUMBER	2	num	4	SENT_168	[p10l158t2620r313b2644],
4	genotypes	NNS	O	genotype	dep	2	SENT_168	[p10l324t2621r471b2650],
5	include	VBP	O	include	_	0	SENT_168	[p10l483t2620r584b2644],
6	individuals	NNS	O	individual	dobj	5	SENT_168	[p10l596t2620r747b2644],
7	with	IN	O	with	_	0	SENT_168	[p10l757t2620r813b2644],
8	zone	NN	O	zone	nn	9	SENT_168	[p10l827t2624r905b2644],
9	*	NN	O	*	prep_with	5	SENT_168	[p10l918t2620r953b2644],
10	2	CD	NUMBER	2	num	11	SENT_168	[p10l918t2620r953b2644],
11	allele	NN	O	allele	dep	9	SENT_168	[p10l965t2620r1049b2644],
12	.	.	O	.	_	0	SENT_168	[p10l965t2620r1049b2644],

1	CYP2C9	NN	O	cyp2c9	nsubj	5	SENT_169	[p10l1061t2620r1218b2644],
2	*	CD	NUMBER	*	num	1	SENT_169	[p10l1061t2620r1218b2644],
3	3	CD	NUMBER	3	num	4	SENT_169	[p10l1061t2620r1218b2644],
4	genotypes	NNS	O	genotype	dep	1	SENT_169	[p10l1228t2622r1375b2650],
5	include	VBP	O	include	_	0	SENT_169	[p10l1387t2620r1488b2644],
6	individuals	NNS	O	individual	dobj	5	SENT_169	[p10l1500t2620r1650b2644],
7	with	IN	O	with	_	0	SENT_169	[p10l1661t2620r1717b2644],
8	zone	NN	O	zone	prep_with	5	SENT_169	[p10l1730t2624r1808b2644],
9	*	CD	NUMBER	*	number	10	SENT_169	[p10l1822t2620r1857b2644],
10	3	CD	NUMBER	3	num	11	SENT_169	[p10l1822t2620r1857b2644],
11	allele	NN	O	allele	dep	5	SENT_169	[p10l1869t2620r1952b2644],
12	.	.	O	.	_	0	SENT_169	[p10l1869t2620r1952b2644],

1	Individuals	NNS	O	individual	nsubjpass	13	SENT_170	[p10l1967t2620r2117b2644],
2	with	IN	O	with	_	0	SENT_170	[p10l42t2661r99b2685],
3	one	CD	NUMBER	one	num	4	SENT_170	[p10l113t2667r165b2685],
4	*	NN	O	*	prep_with	1	SENT_170	[p10l180t2661r216b2685],
5	2	CD	NUMBER	2	num	6	SENT_170	[p10l180t2661r216b2685],
6	allele	NN	O	allele	dep	4	SENT_170	[p10l230t2661r305b2685],
7	and	CC	O	and	_	0	SENT_170	[p10l319t2661r369b2685],
8	one	CD	NUMBER	one	num	9	SENT_170	[p10l384t2667r435b2685],
9	*	NN	O	*	conj_and	4	SENT_170	[p10l451t2661r486b2685],
10	3	CD	NUMBER	3	num	11	SENT_170	[p10l451t2661r486b2685],
11	allele	NN	O	allele	dep	9	SENT_170	[p10l500t2661r575b2685],
12	were	VBD	O	be	auxpass	13	SENT_170	[p10l588t2667r655b2685],
13	classified	VBN	O	classify	_	0	SENT_170	[p10l669t2661r803b2685],
14	as	IN	O	as	_	0	SENT_170	[p10l818t2667r850b2685],
15	having	VBG	O	have	prepc_as	13	SENT_170	[p10l865t2661r956b2691],
16	CYP2C9	NN	O	cyp2c9	nn	19	SENT_170	[p10l968t2661r1125b2685],
17	*	NN	O	*	nn	19	SENT_170	[p10l968t2661r1125b2685],
18	3	CD	NUMBER	3	num	19	SENT_170	[p10l968t2661r1125b2685],
19	genotypes	NNS	O	genotype	dobj	15	SENT_170	[p10l1137t2663r1293b2691],
20	.	.	O	.	_	0	SENT_170	[p10l1137t2663r1293b2691],
21	"	''	O	"	punct	13	SENT_170	[p10l44t2702r117b2726],

1	’	NN	O	’	nn	2	SENT_171	[p10l44t2702r117b2726],
2	Test	NN	O	test	nsubjpass	19	SENT_171	[p10l44t2702r117b2726],
3	of	IN	O	of	_	0	SENT_171	[p10l133t2702r161b2726],
4	difference	NN	O	difference	prep_of	2	SENT_171	[p10l176t2702r319b2726],
5	between	IN	O	between	_	0	SENT_171	[p10l337t2702r456b2726],
6	wild-type	JJ	O	wild-type	prep_between	4	SENT_171	[p10l473t2702r604b2732],
7	,	,	O	,	_	0	SENT_171	[p10l473t2702r604b2732],
8	CYP2C9	NN	O	cyp2c9	nn	9	SENT_171	[p10l623t2702r788b2730],
9	*	NN	O	*	conj_and	4	SENT_171	[p10l623t2702r788b2730],
10	2	CD	NUMBER	2	dep	9	SENT_171	[p10l623t2702r788b2730],
11	,	,	O	,	_	0	SENT_171	[p10l623t2702r788b2730],
12	and	CC	O	and	_	0	SENT_171	[p10l807t2702r857b2726],
13	CYP2C9	NN	O	cyp2c9	conj_and	4	SENT_171	[p10l876t2702r1032b2726],
14	*	CD	NUMBER	*	number	15	SENT_171	[p10l876t2702r1032b2726],
15	3	CD	NUMBER	3	num	17	SENT_171	[p10l876t2702r1032b2726],
16	genotype	NN	O	genotype	nn	17	SENT_171	[p10l1048t2703r1178b2732],
17	groups	NNS	O	group	dep	13	SENT_171	[p10l1195t2705r1292b2732],
18	was	VBD	O	be	auxpass	19	SENT_171	[p10l1308t2708r1364b2726],
19	calculated	VBN	O	calculate	_	0	SENT_171	[p10l1382t2702r1527b2726],
20	by	IN	O	by	_	0	SENT_171	[p10l1546t2702r1577b2732],
21	analysis	NN	O	analysis	agent	19	SENT_171	[p10l1593t2702r1709b2732],
22	of	IN	O	of	_	0	SENT_171	[p10l1726t2702r1754b2726],
23	variance	NN	O	variance	prep_of	21	SENT_171	[p10l1768t2702r1888b2726],
24	for	IN	O	for	_	0	SENT_171	[p10l1905t2702r1943b2726],
25	continuous	JJ	O	continuous	amod	26	SENT_171	[p10l1959t2702r2117b2726],
26	variables	NNS	O	variable	prep_for	19	SENT_171	[p10l42t2743r180b2770],
27	,	,	O	,	_	0	SENT_171	[p10l42t2743r180b2770],
28	X2	NN	O	x2	appos	26	SENT_171	[p10l195t2739r225b2773],
29	for	IN	O	for	_	0	SENT_171	[p10l238t2742r276b2766],
30	categorical	JJ	O	categorical	amod	31	SENT_171	[p10l288t2743r443b2772],
31	variables	NNS	O	variable	prep_for	28	SENT_171	[p10l456t2743r594b2766],
32	.	.	O	.	_	0	SENT_171	[p10l456t2743r594b2766],

1	“	NN	O	“	nn	2	SENT_172	[p10l44t2780r126b2807],
2	Race	NN	O	race	nsubjpass	7	SENT_172	[p10l44t2780r126b2807],
3	or	CC	O	or	_	0	SENT_172	[p10l140t2789r167b2807],
4	ethnic	JJ	O	ethnic	amod	5	SENT_172	[p10l179t2783r266b2807],
5	group	NN	O	group	conj_or	2	SENT_172	[p10l278t2787r359b2813],
6	was	VBD	O	be	auxpass	7	SENT_172	[p10l371t2789r426b2807],
7	determined	VBN	O	determine	_	0	SENT_172	[p10l440t2783r602b2807],
8	by	IN	O	by	_	0	SENT_172	[p10l617t2783r647b2813],
9	the	DT	O	the	det	10	SENT_172	[p10l658t2783r703b2807],
10	investigator	NN	O	investigator	agent	7	SENT_172	[p10l718t2783r885b2813],
11	using	VBG	O	use	partmod	10	SENT_172	[p10l897t2783r974b2813],
12	predefined	JJ	O	predefined	amod	13	SENT_172	[p10l987t2783r1136b2812],
13	categories	NNS	O	category	dobj	11	SENT_172	[p10l1150t2783r1308b2813],
14	.	.	O	.	_	0	SENT_172	[p10l1150t2783r1308b2813],

1	“	NN	O	“	nn	2	SENT_173	[p10l44t2824r124b2854],
2	Body	NN	O	body	nsubj	7	SENT_173	[p10l44t2824r124b2854],
3	mass	NN	O	mass	nn	4	SENT_173	[p10l137t2830r214b2848],
4	index	NN	O	index	dep	2	SENT_173	[p10l228t2824r303b2848],
5	is	VBZ	O	be	cop	7	SENT_173	[p10l316t2824r338b2848],
6	the	DT	O	the	det	7	SENT_173	[p10l350t2824r396b2848],
7	weight	NN	O	weight	_	0	SENT_173	[p10l408t2824r502b2854],
8	in	IN	O	in	_	0	SENT_173	[p10l515t2824r537b2848],
9	kilograms	NNS	O	kilogram	prep_in	7	SENT_173	[p10l552t2824r689b2854],
10	divided	VBN	O	divide	partmod	9	SENT_173	[p10l703t2824r802b2848],
11	by	IN	O	by	_	0	SENT_173	[p10l817t2824r848b2854],
12	the	DT	O	the	det	13	SENT_173	[p10l858t2824r904b2848],
13	square	NN	O	square	agent	10	SENT_173	[p10l917t2830r1015b2853],
14	of	IN	O	of	_	0	SENT_173	[p10l1028t2824r1056b2848],
15	the	DT	O	the	det	16	SENT_173	[p10l1066t2824r1112b2848],
16	height	NN	O	height	prep_of	13	SENT_173	[p10l1126t2824r1214b2854],
17	in	IN	O	in	_	0	SENT_173	[p10l1227t2824r1249b2848],
18	meters	NNS	O	meter	prep_in	16	SENT_173	[p10l1264t2825r1371b2848],
19	.	.	O	.	_	0	SENT_173	[p10l1264t2825r1371b2848],
20	"	''	O	"	punct	7	SENT_173	[p10l44t2862r106b2889],

1	The	DT	O	the	det	3	SENT_174	[p10l44t2862r106b2889],
2	adenoma	NN	O	adenoma	nn	3	SENT_174	[p10l120t2865r252b2889],
3	burden	NN	O	burden	nsubjpass	5	SENT_174	[p10l267t2865r363b2889],
4	was	VBD	O	be	auxpass	5	SENT_174	[p10l377t2871r433b2889],
5	defined	VBN	O	define	_	0	SENT_174	[p10l446t2865r550b2889],
6	as	IN	O	as	_	0	SENT_174	[p10l565t2871r597b2889],
7	the	DT	O	the	det	8	SENT_174	[p10l609t2865r655b2889],
8	sum	NN	O	sum	prep_as	5	SENT_174	[p10l668t2871r728b2889],
9	of	IN	O	of	_	0	SENT_174	[p10l742t2865r770b2889],
10	the	DT	O	the	det	11	SENT_174	[p10l780t2865r825b2889],
11	diameter	NN	O	diameter	prep_of	8	SENT_174	[p10l839t2865r967b2889],
12	of	IN	O	of	_	0	SENT_174	[p10l979t2865r1007b2889],
13	all	DT	O	all	det	14	SENT_174	[p10l1018t2865r1048b2889],
14	adenomas	NNS	O	adenoma	prep_of	11	SENT_174	[p10l1064t2865r1213b2889],
15	reported	VBN	O	report	partmod	14	SENT_174	[p10l1228t2865r1346b2894],
16	during	IN	O	during	_	0	SENT_174	[p10l1360t2865r1448b2895],
17	colonoscopy	NN	O	colonoscopy	prep_during	15	SENT_174	[p10l1460t2865r1639b2895],
18	at	IN	O	at	_	0	SENT_174	[p10l1651t2867r1678b2889],
19	baseline	NN	O	baseline	prep_at	15	SENT_174	[p10l1691t2865r1820b2889],
20	.	.	O	.	_	0	SENT_174	[p10l1691t2865r1820b2889],

1	ecardiovascular	JJ	O	ecardiovascular	amod	2	SENT_175	[p10l44t2906r269b2930],
2	events	NNS	O	event	nsubjpass	4	SENT_175	[p10l282t2908r377b2930],
3	were	VBD	O	be	auxpass	4	SENT_175	[p10l391t2912r458b2930],
4	defined	VBN	O	define	_	0	SENT_175	[p10l473t2906r577b2930],
5	as	IN	O	as	_	0	SENT_175	[p10l593t2912r626b2930],
6	myocardial	JJ	O	myocardial	amod	7	SENT_175	[p10l642t2906r793b2936],
7	infarction	NN	O	infarction	prep_as	4	SENT_175	[p10l811t2906r951b2934],
8	,	,	O	,	_	0	SENT_175	[p10l811t2906r951b2934],
9	cerebrovascular	JJ	O	cerebrovascular	amod	10	SENT_175	[p10l967t2906r1197b2930],
10	disease	NN	O	disease	conj_and	7	SENT_175	[p10l1210t2906r1331b2934],
11	,	,	O	,	_	0	SENT_175	[p10l1210t2906r1331b2934],
12	congestive	JJ	O	congestive	amod	14	SENT_175	[p10l1348t2906r1501b2936],
13	heart	NN	O	heart	nn	14	SENT_175	[p10l1517t2906r1590b2930],
14	failure	NN	O	failure	prep_as	4	SENT_175	[p10l1603t2906r1701b2934],
15	,	,	O	,	_	0	SENT_175	[p10l1603t2906r1701b2934],
16	angina	NN	O	angina	prep_as	4	SENT_175	[p10l1718t2906r1820b2936],
17	,	,	O	,	_	0	SENT_175	[p10l1718t2906r1820b2936],
18	and	CC	O	and	_	0	SENT_175	[p10l1837t2906r1888b2930],
19	atherosclerotic	JJ	O	atherosclerotic	amod	21	SENT_175	[p10l1904t2906r2117b2930],
20	heart	NN	O	heart	nn	21	SENT_175	[p10l44t2948r118b2972],
21	disease	NN	O	disease	conj_and	7	SENT_175	[p10l130t2948r251b2972],
22	.	.	O	.	_	0	SENT_175	[p10l130t2948r251b2972],
23	"	''	O	"	punct	4	SENT_175	[p10l44t2985r183b3012],

1	Low	JJ	O	low	amod	4	SENT_176	[p10l44t2985r183b3012],
2	—	NN	O	—	nn	4	SENT_176	[p10l44t2985r183b3012],
3	dose	NN	O	dose	nn	4	SENT_176	[p10l44t2985r183b3012],
4	aspirin	NN	O	aspirin	nsubjpass	6	SENT_176	[p10l197t2989r292b3017],
5	was	VBD	O	be	auxpass	6	SENT_176	[p10l305t2994r361b3012],
6	defined	VBN	O	define	_	0	SENT_176	[p10l374t2988r478b3012],
7	as	IN	O	as	quantmod	8	SENT_176	[p10l493t2994r525b3012],
8	325	CD	NUMBER	325	num	9	SENT_176	[p10l539t2988r596b3012],
9	mg	NN	O	mg	dobj	6	SENT_176	[p10l611t2992r653b3018],
10	or	CC	O	or	_	0	SENT_176	[p10l665t2994r693b3012],
11	less	JJR	O	less	dobj	6	SENT_176	[p10l706t2989r763b3012],
12	every	DT	SET	every	det	14	SENT_176	[p10l776t2994r851b3018],
13	other	JJ	SET	other	amod	14	SENT_176	[p10l863t2989r937b3012],
14	day	NN	SET	day	dep	11	SENT_176	[p10l949t2989r998b3018],
15	or	CC	O	or	_	0	SENT_176	[p10l1010t2994r1038b3012],
16	162.5	CD	NUMBER	162.5	num	17	SENT_176	[p10l1051t2988r1138b3012],
17	mg	NN	O	mg	dobj	6	SENT_176	[p10l1152t2992r1194b3018],
18	or	CC	O	or	_	0	SENT_176	[p10l1206t2994r1234b3012],
19	less	JJR	O	less	conj_or	9	SENT_176	[p10l1247t2989r1304b3012],
20	every	DT	SET	every	det	21	SENT_176	[p10l1318t2994r1392b3018],
21	day	NN	SET	day	dep	19	SENT_176	[p10l1404t2989r1461b3018],
22	.	.	O	.	_	0	SENT_176	[p10l1404t2989r1461b3018],

1	To	TO	O	to	aux	3	SENT_177	[p10l95t3184r196b3243],
2	speciﬁcally	RB	O	speciﬁcally	advmod	3	SENT_177	[p10l239t3179r643b3266],
3	examine	VB	O	examine	purpcl	16	SENT_177	[p10l681t3181r987b3243],
4	the	DT	O	the	det	5	SENT_177	[p10l1029t3179r1144b3243],
5	inﬂuence	NN	O	inﬂuence	dobj	3	SENT_177	[p10l1184t3179r1524b3243],
6	of	IN	O	of	_	0	SENT_177	[p10l1566t3179r1652b3243],
7	genotype	NN	O	genotype	prep_of	5	SENT_177	[p10l1680t3197r2016b3266],
8	on	IN	O	on	_	0	SENT_177	[p10l2057t3203r2152b3243],
9	celecoxib	NN	O	celecoxib	nn	10	SENT_177	[p10l9t3285r342b3349],
10	dose	NN	O	dose	prep_on	7	SENT_177	[p10l384t3284r548b3351],
11	and	CC	O	and	_	0	SENT_177	[p10l589t3284r727b3351],
12	adenoma	NN	O	adenoma	nn	13	SENT_177	[p10l766t3284r1110b3351],
13	risk	NN	O	risk	conj_and	10	SENT_177	[p10l1147t3284r1301b3364],
14	,	,	O	,	_	0	SENT_177	[p10l1147t3284r1301b3364],
15	we	PRP	O	we	nsubj	16	SENT_177	[p10l1339t3309r1436b3349],
16	compared	VBD	O	compare	_	0	SENT_177	[p10l1476t3284r1847b3372],
17	the	DT	O	the	det	19	SENT_177	[p10l1885t3285r2000b3349],
18	cumulative	JJ	O	cumulative	amod	19	SENT_177	[p10l2040t3309r2150b3349, p10l9t3392r331b3456],
19	incidence	NN	O	incidence	dobj	16	SENT_177	[p10l363t3391r714b3458],
20	of	IN	O	of	_	0	SENT_177	[p10l747t3392r832b3456],
21	adenoma	NN	O	adenoma	prep_of	19	SENT_177	[p10l852t3391r1196b3458],
22	among	IN	O	among	_	0	SENT_177	[p10l1225t3416r1483b3479],
23	the	DT	O	the	det	24	SENT_177	[p10l1515t3392r1630b3456],
24	group	NN	O	group	prep_among	16	SENT_177	[p10l1663t3415r1883b3479],
25	receiving	VBG	O	receive	partmod	24	SENT_177	[p10l1918t3394r2150b3456, p11l8t37r126b122],

1	high	JJ	O	high	amod	4	SENT_178	[p11l173t34r538b122],
2	—	NN	O	—	nn	4	SENT_178	[p11l173t34r538b122],
3	dose	NN	O	dose	nn	4	SENT_178	[p11l173t34r538b122],
4	celecoxib	NN	O	celecoxib	_	0	SENT_178	[p11l587t35r920b99],
5	with	IN	O	with	_	0	SENT_178	[p11l968t35r1134b99],
6	the	DT	O	the	det	7	SENT_178	[p11l1183t35r1299b99],
7	group	NN	O	group	prep_with	4	SENT_178	[p11l1348t58r1568b122],
8	receiving	VBG	O	receive	partmod	4	SENT_178	[p11l1619t37r1948b122],
9	lowdose	NN	O	lowdose	nn	10	SENT_178	[p11l1994t35r2150b99, p11l9t140r174b207],
10	celecoxib	NN	O	celecoxib	nsubj	14	SENT_178	[p11l204t141r537b205],
11	(	CD	NUMBER	(	num	14	SENT_178	[p11l571t141r800b225],
12	Table	NNP	O	Table	nn	14	SENT_178	[p11l571t141r800b225],
13	3	CD	NUMBER	3	num	14	SENT_178	[p11l830t141r916b225],
14	)	NN	O	)	xcomp	8	SENT_178	[p11l830t141r916b225],
15	.	.	O	.	_	0	SENT_178	[p11l830t141r916b225],

1	Among	IN	O	among	_	0	SENT_179	[p11l945t147r1223b228],
2	all	DT	O	all	det	3	SENT_179	[p11l1251t141r1338b205],
3	genotypes	NNS	O	genotype	prep_among	10	SENT_179	[p11l1366t159r1756b228],
4	,	,	O	,	_	0	SENT_179	[p11l1366t159r1756b228],
5	high	JJ	O	high	amod	8	SENT_179	[p11l1787t140r2151b228],
6	—	NN	O	—	nn	8	SENT_179	[p11l1787t140r2151b228],
7	dose	NN	O	dose	nn	8	SENT_179	[p11l1787t140r2151b228],
8	celecoxib	NN	O	celecoxib	nsubjpass	10	SENT_179	[p11l9t247r342b311],
9	was	VBD	O	be	auxpass	10	SENT_179	[p11l372t271r505b311],
10	associated	VBN	O	associate	_	0	SENT_179	[p11l537t246r916b313],
11	with	IN	O	with	_	0	SENT_179	[p11l943t247r1109b311],
12	a	DT	O	a	det	16	SENT_179	[p11l1140t271r1179b311],
13	5.6	CD	PERCENT	5.6	num	14	SENT_179	[p11l1206t251r1372b311],
14	%	NN	PERCENT	%	npadvmod	15	SENT_179	[p11l1206t251r1372b311],
15	greater	JJR	O	greater	amod	16	SENT_179	[p11l1403t265r1660b334],
16	reduction	NN	O	reduction	prep_with	10	SENT_179	[p11l1689t246r2050b313],
17	in	IN	O	in	_	0	SENT_179	[p11l2079t249r2152b310],
18	3-year	JJ	DURATION	3-year	amod	20	SENT_179	[p11l9t358r231b440],
19	cumulative	JJ	O	cumulative	amod	20	SENT_179	[p11l265t353r677b417],
20	incidence	NN	O	incidence	prep_in	16	SENT_179	[p11l711t352r1062b419],
21	of	IN	O	of	_	0	SENT_179	[p11l1098t353r1183b417],
22	adenoma	NN	O	adenoma	prep_of	20	SENT_179	[p11l1206t352r1550b419],
23	compared	VBN	O	compare	_	0	SENT_179	[p11l1583t352r1953b440],
24	with	IN	O	with	prepc_compared_with	10	SENT_179	[p11l1985t353r2151b417],
25	low-dose	JJ	O	low-dose	amod	26	SENT_179	[p11l8t459r335b526],
26	celecoxib	NN	O	celecoxib	pobj	10	SENT_179	[p11l361t460r694b524],
27	(	CD	NUMBER	(	num	28	SENT_179	[p11l724t460r879b544],
28	RR	NN	O	rr	dep	26	SENT_179	[p11l724t460r879b544],
29	,	,	O	,	_	0	SENT_179	[p11l724t460r879b544],
30	0.82	CD	NUMBER	0.82	appos	28	SENT_179	[p11l907t465r1079b540],
31	;	:	O	;	_	0	SENT_179	[p11l907t465r1079b540],
32	95	CD	PERCENT	95	number	33	SENT_179	[p11l1107t464r1251b525],
33	%	NN	PERCENT	%	amod	34	SENT_179	[p11l1107t464r1251b525],
34	CI	NN	O	ci	dep	28	SENT_179	[p11l1279t465r1379b525],
35	:	:	O	:	_	0	SENT_179	[p11l1279t465r1379b525],
36	0.69	CD	NUMBER	0.69	number	37	SENT_179	[p11l1408t464r1559b525],
37	-0.98	CD	NUMBER	-0.98	dep	34	SENT_179	[p11l1578t465r1802b540],
38	;	:	O	;	_	0	SENT_179	[p11l1578t465r1802b540],
39	P	NN	O	p	dep	28	SENT_179	[p11l1825t466r1878b524],
40	=	JJ	O	=	amod	42	SENT_179	[p11l1907t484r1961b504],
41	.03	CD	NUMBER	.03	tmod	40	SENT_179	[p11l1997t460r2148b544],
42	)	NN	O	)	dep	39	SENT_179	[p11l1997t460r2148b544],
43	.	.	O	.	_	0	SENT_179	[p11l1997t460r2148b544],

1	However	RB	O	however	advmod	7	SENT_180	[p11l9t572r350b646],
2	,	,	O	,	_	0	SENT_180	[p11l9t572r350b646],
3	the	DT	O	the	det	4	SENT_180	[p11l391t566r507b630],
4	effect	NN	O	effect	nsubj	7	SENT_180	[p11l547t566r748b630],
5	of	IN	O	of	_	0	SENT_180	[p11l786t566r872b630],
6	dose	NN	O	dose	prep_of	4	SENT_180	[p11l899t565r1064b632],
7	appeared	VBD	O	appear	_	0	SENT_180	[p11l1104t565r1442b653],
8	to	TO	O	to	aux	10	SENT_180	[p11l1480t584r1552b630],
9	be	VB	O	be	auxpass	10	SENT_180	[p11l1591t566r1674b630],
10	conﬁned	VBN	O	conﬁned	xcomp	7	SENT_180	[p11l1715t565r2039b632],
11	to	TO	O	to	_	0	SENT_180	[p11l2077t584r2150b630],
12	patients	NNS	O	patient	prep_to	10	SENT_180	[p11l8t674r306b759],
13	with	IN	O	with	_	0	SENT_180	[p11l345t672r512b736],
14	CYP2C9	NN	O	cyp2c9	prep_with	10	SENT_180	[p11l553t677r951b737],
15	*	CD	NUMBER	*	number	16	SENT_180	[p11l553t677r951b737],
16	3	CD	NUMBER	3	num	17	SENT_180	[p11l553t677r951b737],
17	genotypes	NNS	O	genotype	dep	10	SENT_180	[p11l994t690r1382b759],
18	.	.	O	.	_	0	SENT_180	[p11l994t690r1382b759],

1	Among	IN	O	among	_	0	SENT_181	[p11l1423t677r1700b759],
2	individuals	NNS	O	individual	prep_among	14	SENT_181	[p11l1738t671r2150b738],
3	with	IN	O	with	_	0	SENT_181	[p11l7t777r173b842],
4	CYP2C9	NN	O	cyp2c9	prep_with	2	SENT_181	[p11l203t783r600b843],
5	*	CD	NUMBER	*	number	6	SENT_181	[p11l203t783r600b843],
6	3	CD	NUMBER	3	num	7	SENT_181	[p11l203t783r600b843],
7	genotypes	NNS	O	genotype	dep	4	SENT_181	[p11l632t796r1022b865],
8	,	,	O	,	_	0	SENT_181	[p11l632t796r1022b865],
9	high	JJ	O	high	amod	12	SENT_181	[p11l1051t777r1416b865],
10	—	NN	O	—	nn	12	SENT_181	[p11l1051t777r1416b865],
11	dose	NN	O	dose	nn	12	SENT_181	[p11l1051t777r1416b865],
12	celecoxib	NN	O	celecoxib	nsubjpass	14	SENT_181	[p11l1446t778r1778b842],
13	was	VBD	O	be	auxpass	14	SENT_181	[p11l1807t802r1941b842],
14	associated	VBN	O	associate	_	0	SENT_181	[p11l1971t802r2150b842, p11l9t883r229b950],
15	with	IN	O	with	_	0	SENT_181	[p11l257t884r423b948],
16	a	DT	O	a	det	20	SENT_181	[p11l454t908r494b948],
17	19.7	CD	PERCENT	19.7	num	18	SENT_181	[p11l529t889r734b949],
18	%	NN	PERCENT	%	npadvmod	19	SENT_181	[p11l529t889r734b949],
19	greater	JJR	O	greater	amod	20	SENT_181	[p11l765t902r1022b971],
20	reduction	NN	O	reduction	prep_with	14	SENT_181	[p11l1052t883r1413b950],
21	in	IN	O	in	_	0	SENT_181	[p11l1443t886r1516b948],
22	cumulative	JJ	O	cumulative	amod	23	SENT_181	[p11l1547t884r1959b948],
23	incidence	NN	O	incidence	prep_in	20	SENT_181	[p11l1990t886r2150b948, p11l9t989r219b1056],
24	of	IN	O	of	_	0	SENT_181	[p11l264t990r349b1054],
25	adenoma	NN	O	adenoma	prep_of	23	SENT_181	[p11l381t989r725b1056],
26	compared	VBN	O	compare	_	0	SENT_181	[p11l767t989r1138b1077],
27	with	IN	O	with	prepc_compared_with	14	SENT_181	[p11l1179t990r1345b1054],
28	low	JJ	O	low	advmod	31	SENT_181	[p11l1388t990r1522b1054],
29	dose	NN	O	dose	nn	31	SENT_181	[p11l1564t989r1729b1056],
30	(	NN	O	(	nn	31	SENT_181	[p11l1776t990r1931b1074],
31	RR	NN	O	rr	pobj	14	SENT_181	[p11l1776t990r1931b1074],
32	,	,	O	,	_	0	SENT_181	[p11l1776t990r1931b1074],
33	0.51	CD	NUMBER	0.51	appos	31	SENT_181	[p11l1977t994r2150b1070],
34	;	:	O	;	_	0	SENT_181	[p11l1977t994r2150b1070],
35	95	CD	PERCENT	95	number	36	SENT_181	[p11l10t1100r154b1161],
36	%	NN	PERCENT	%	amod	37	SENT_181	[p11l10t1100r154b1161],
37	CI	NN	O	ci	dep	31	SENT_181	[p11l188t1101r288b1160],
38	:	:	O	:	_	0	SENT_181	[p11l188t1101r288b1160],
39	0.30-0	CD	NUMBER	0.30-0	number	40	SENT_181	[p11l325t1101r719b1176],
40	.87	CD	NUMBER	.87	dep	37	SENT_181	[p11l325t1101r719b1176],
41	;	:	O	;	_	0	SENT_181	[p11l325t1101r719b1176],
42	P	NN	O	p	dep	31	SENT_181	[p11l748t1102r801b1160],
43	=	JJ	O	=	amod	45	SENT_181	[p11l837t1120r890b1140],
44	.01	CD	NUMBER	.01	tmod	43	SENT_181	[p11l933t1096r1084b1180],
45	)	NN	O	)	dep	42	SENT_181	[p11l933t1096r1084b1180],
46	.	.	O	.	_	0	SENT_181	[p11l933t1096r1084b1180],

1	In	IN	O	in	_	0	SENT_182	[p11l1118t1102r1197b1159],
2	contrast	NN	O	contrast	prep_in	13	SENT_182	[p11l1229t1114r1552b1176],
3	,	,	O	,	_	0	SENT_182	[p11l1229t1114r1552b1176],
4	compared	VBN	O	compare	_	0	SENT_182	[p11l1586t1095r1957b1183],
5	with	IN	O	with	prepc_compared_with	13	SENT_182	[p11l1985t1096r2151b1160],
6	low-dose	JJ	O	low-dose	amod	7	SENT_182	[p11l8t1201r335b1268],
7	celecoxib	NN	O	celecoxib	pobj	13	SENT_182	[p11l376t1202r729b1282],
8	,	,	O	,	_	0	SENT_182	[p11l376t1202r729b1282],
9	high	JJ	O	high	amod	11	SENT_182	[p11l771t1201r1136b1289],
10	—	NN	O	—	nn	11	SENT_182	[p11l771t1201r1136b1289],
11	dose	NN	O	dose	nsubjpass	13	SENT_182	[p11l771t1201r1136b1289],
12	was	VBD	O	be	auxpass	13	SENT_182	[p11l1175t1226r1308b1266],
13	associated	VBN	O	associate	_	0	SENT_182	[p11l1351t1201r1730b1268],
14	with	IN	O	with	_	0	SENT_182	[p11l1767t1202r1933b1266],
15	a	DT	O	a	det	18	SENT_182	[p11l1975t1226r2015b1266],
16	5	CD	PERCENT	5	number	17	SENT_182	[p11l2052t1206r2151b1266],
17	%	NN	PERCENT	%	amod	18	SENT_182	[p11l2052t1206r2151b1266],
18	reduction	NN	O	reduction	prep_with	13	SENT_182	[p11l9t1308r370b1375],
19	in	IN	O	in	_	0	SENT_182	[p11l398t1311r471b1373],
20	cumulative	JJ	O	cumulative	amod	21	SENT_182	[p11l499t1309r911b1373],
21	incidence	NN	O	incidence	prep_in	18	SENT_182	[p11l939t1308r1289b1375],
22	of	IN	O	of	_	0	SENT_182	[p11l1318t1309r1404b1373],
23	adenoma	NN	O	adenoma	prep_of	21	SENT_182	[p11l1420t1308r1764b1375],
24	(	CD	NUMBER	(	num	25	SENT_182	[p11l1792t1309r1947b1393],
25	RR	NN	O	rr	dep	23	SENT_182	[p11l1792t1309r1947b1393],
26	,	,	O	,	_	0	SENT_182	[p11l1792t1309r1947b1393],
27	0.83	CD	NUMBER	0.83	appos	25	SENT_182	[p11l1978t1314r2150b1389],
28	;	:	O	;	_	0	SENT_182	[p11l1978t1314r2150b1389],
29	95	CD	PERCENT	95	number	30	SENT_182	[p11l10t1419r154b1480],
30	%	NN	PERCENT	%	amod	31	SENT_182	[p11l10t1419r154b1480],
31	CI	NN	O	ci	dep	25	SENT_182	[p11l183t1420r283b1479],
32	:	:	O	:	_	0	SENT_182	[p11l183t1420r283b1479],
33	0.57-1	CD	NUMBER	0.57-1	number	34	SENT_182	[p11l314t1419r687b1495],
34	.21	CD	NUMBER	.21	dep	31	SENT_182	[p11l314t1419r687b1495],
35	;	:	O	;	_	0	SENT_182	[p11l314t1419r687b1495],
36	P	NN	O	p	dep	25	SENT_182	[p11l712t1421r764b1479],
37	=	JJ	O	=	amod	39	SENT_182	[p11l795t1439r849b1459],
38	.33	CD	NUMBER	.33	tmod	37	SENT_182	[p11l886t1415r1017b1499],
39	)	NN	O	)	dep	36	SENT_182	[p11l886t1415r1017b1499],
40	among	IN	O	among	_	0	SENT_182	[p11l1048t1439r1306b1502],
41	those	DT	O	those	prep_among	39	SENT_182	[p11l1333t1415r1531b1479],
42	with	IN	O	with	_	0	SENT_182	[p11l1556t1415r1723b1479],
43	CYP2C9	NN	O	cyp2c9	nn	44	SENT_182	[p11l1751t1420r2149b1480],
44	*	NN	O	*	prep_with	41	SENT_182	[p11l1751t1420r2149b1480],
45	2	CD	NUMBER	2	num	46	SENT_182	[p11l1751t1420r2149b1480],
46	genotypes	NNS	O	genotype	dep	44	SENT_182	[p11l9t1539r379b1608],
47	and	CC	O	and	_	0	SENT_182	[p11l414t1520r553b1587],
48	a	DT	O	a	det	51	SENT_182	[p11l585t1545r625b1585],
49	2.9	CD	PERCENT	2.9	number	50	SENT_182	[p11l655t1526r821b1586],
50	%	NN	PERCENT	%	amod	51	SENT_182	[p11l655t1526r821b1586],
51	reduction	NN	O	reduction	conj_and	44	SENT_182	[p11l856t1520r1217b1587],
52	in	IN	O	in	_	0	SENT_182	[p11l1249t1523r1322b1584],
53	cumulative	JJ	O	cumulative	amod	57	SENT_182	[p11l1356t1521r1768b1585],
54	incidence	NN	O	incidence	nn	57	SENT_182	[p11l1801t1520r2151b1587],
55	ofadenoma	NN	O	ofadenoma	nn	57	SENT_182	[p11l9t1626r453b1693],
56	(	CD	NUMBER	(	num	57	SENT_182	[p11l478t1627r633b1711],
57	RR	NN	O	rr	prep_in	51	SENT_182	[p11l478t1627r633b1711],
58	,	,	O	,	_	0	SENT_182	[p11l478t1627r633b1711],
59	0.89	CD	NUMBER	0.89	amod	51	SENT_182	[p11l662t1632r834b1707],
60	;	:	O	;	_	0	SENT_182	[p11l662t1632r834b1707],
61	95	CD	PERCENT	95	number	62	SENT_182	[p11l863t1631r1007b1692],
62	%	NN	PERCENT	%	amod	63	SENT_182	[p11l863t1631r1007b1692],
63	CI	NN	O	ci	dep	25	SENT_182	[p11l1035t1632r1135b1691],
64	:	:	O	:	_	0	SENT_182	[p11l1035t1632r1135b1691],
65	0.72-1	CD	NUMBER	0.72-1	number	66	SENT_182	[p11l1165t1632r1538b1707],
66	.11	CD	NUMBER	.11	dep	63	SENT_182	[p11l1165t1632r1538b1707],
67	;	:	O	;	_	0	SENT_182	[p11l1165t1632r1538b1707],
68	P	NN	O	p	dep	25	SENT_182	[p11l1561t1633r1614b1691],
69	=	JJ	O	=	amod	71	SENT_182	[p11l1644t1651r1697b1671],
70	.31	CD	NUMBER	.31	tmod	69	SENT_182	[p11l1734t1627r1864b1711],
71	)	NN	O	)	dep	68	SENT_182	[p11l1734t1627r1864b1711],
72	among	IN	O	among	_	0	SENT_182	[p11l1894t1651r2153b1714],
73	those	DT	O	those	prep_among	13	SENT_182	[p11l9t1734r207b1798],
74	with	IN	O	with	_	0	SENT_182	[p11l236t1734r402b1798],
75	wild-type	JJ	O	wild-type	amod	76	SENT_182	[p11l430t1733r774b1821],
76	genotypes	NNS	O	genotype	prep_with	73	SENT_182	[p11l804t1752r1192b1821],
77	.	.	O	.	_	0	SENT_182	[p11l804t1752r1192b1821],

1	A	DT	O	a	det	3	SENT_183	[p11l1222t1740r1279b1798],
2	formal	JJ	O	formal	amod	3	SENT_183	[p11l1308t1734r1557b1798],
3	test	NN	O	test	nsubj	25	SENT_183	[p11l1587t1752r1718b1798],
4	of	IN	O	of	_	0	SENT_183	[p11l1748t1734r1834b1798],
5	whether	IN	O	whether	complm	14	SENT_183	[p11l1849t1734r2153b1798],
6	the	DT	O	the	det	9	SENT_183	[p11l9t1840r124b1904],
7	increased	VBN	O	increase	amod	9	SENT_183	[p11l172t1839r519b1906],
8	risk	NN	O	risk	nn	9	SENT_183	[p11l567t1839r703b1904],
9	reduction	NN	O	reduction	nsubj	14	SENT_183	[p11l752t1839r1113b1906],
10	of	IN	O	of	_	0	SENT_183	[p11l1161t1840r1246b1904],
11	higher	JJR	O	higher	amod	13	SENT_183	[p11l1281t1840r1522b1927],
12	dose	NN	O	dose	nn	13	SENT_183	[p11l1570t1839r1735b1906],
13	treatment	NN	O	treatment	prep_of	9	SENT_183	[p11l1783t1858r2152b1904],
14	differed	VBD	O	differ	prepc_of	3	SENT_183	[p11l10t1945r299b2012],
15	between	IN	O	between	_	0	SENT_183	[p11l323t1946r627b2010],
16	the	DT	O	the	det	18	SENT_183	[p11l654t1946r769b2010],
17	CYP2C9	NN	O	cyp2c9	nn	18	SENT_183	[p11l798t1951r1194b2011],
18	*	NN	O	*	prep_between	14	SENT_183	[p11l798t1951r1194b2011],
19	3	CD	NUMBER	3	num	20	SENT_183	[p11l798t1951r1194b2011],
20	genotype	NN	O	genotype	dobj	14	SENT_183	[p11l1225t1964r1560b2033],
21	compared	VBN	O	compare	_	0	SENT_183	[p11l1588t1945r1958b2033],
22	with	IN	O	with	prepc_compared_with	20	SENT_183	[p11l1982t1946r2148b2010],
23	wild-type	JJ	O	wild-type	amod	24	SENT_183	[p11l7t2051r364b2139],
24	genotype	NN	O	genotype	pobj	20	SENT_183	[p11l405t2070r753b2139],
25	approached	VBD	O	approach	_	0	SENT_183	[p11l794t2051r1247b2139],
26	statistical	JJ	O	statistical	amod	29	SENT_183	[p11l1285t2052r1658b2116],
27	signiﬁcance	NN	O	signiﬁcance	nn	29	SENT_183	[p11l1698t2052r2148b2139],
28	(	NN	O	(	nn	29	SENT_183	[p11l12t2159r88b2243],
29	P	NN	O	p	dobj	25	SENT_183	[p11l12t2159r88b2243],
30	=	JJ	O	=	amod	29	SENT_183	[p11l130t2183r183b2203],
31	.09	CD	NUMBER	.09	num	32	SENT_183	[p11l232t2159r390b2243],
32	)	NN	O	)	dep	30	SENT_183	[p11l232t2159r390b2243],
33	.	.	O	.	_	0	SENT_183	[p11l232t2159r390b2243],

1	Although	IN	O	although	mark	7	SENT_184	[p11l96t2265r453b2352],
2	the	DT	O	the	det	3	SENT_184	[p11l493t2265r608b2329],
3	number	NN	O	number	nsubjpass	7	SENT_184	[p11l648t2265r943b2329],
4	of	IN	O	of	_	0	SENT_184	[p11l981t2265r1066b2329],
5	events	NNS	O	event	prep_of	3	SENT_184	[p11l1093t2283r1319b2329],
6	was	VBD	O	be	auxpass	7	SENT_184	[p11l1358t2289r1491b2329],
7	limited	VBN	O	limit	advcl	10	SENT_184	[p11l1531t2264r1815b2345],
8	,	,	O	,	_	0	SENT_184	[p11l1531t2264r1815b2345],
9	we	PRP	O	we	nsubj	10	SENT_184	[p11l1854t2289r1950b2329],
10	conducted	VBD	O	conduct	_	0	SENT_184	[p11l1990t2289r2147b2329, p11l10t2370r264b2437],
11	an	DT	O	a	det	13	SENT_184	[p11l304t2395r392b2435],
12	exploratory	JJ	O	exploratory	amod	13	SENT_184	[p11l432t2371r858b2458],
13	analysis	NN	O	analysis	nsubj	23	SENT_184	[p11l896t2371r1182b2458],
14	examining	VBG	O	examine	partmod	13	SENT_184	[p11l1224t2373r1614b2458],
15	the	DT	O	the	det	16	SENT_184	[p11l1654t2371r1769b2435],
16	inﬂuence	NN	O	inﬂuence	dobj	14	SENT_184	[p11l1809t2371r2148b2435],
17	of	IN	O	of	_	0	SENT_184	[p11l10t2477r95b2541],
18	CYPZC9	NN	O	cypzc9	nn	19	SENT_184	[p11l138t2482r442b2542],
19	genotype	NN	O	genotype	prep_of	16	SENT_184	[p11l500t2495r835b2564],
20	on	IN	O	on	_	0	SENT_184	[p11l890t2501r985b2541],
21	investigator	NN	O	investigator	nn	22	SENT_184	[p11l1038t2476r1825b2564],
22	—	NN	O	—	prep_on	14	SENT_184	[p11l1038t2476r1825b2564],
23	reported	VBD	O	report	ccomp	10	SENT_184	[p11l1038t2476r1825b2564],
24	adverse	JJ	O	adverse	amod	25	SENT_184	[p11l1879t2476r2148b2543],
25	events	NNS	O	event	dobj	23	SENT_184	[p11l10t2600r237b2646],
26	associated	VBN	O	associate	partmod	25	SENT_184	[p11l280t2581r659b2647],
27	with	IN	O	with	_	0	SENT_184	[p11l696t2582r862b2645],
28	celecoxib	NN	O	celecoxib	nn	29	SENT_184	[p11l904t2582r1236b2646],
29	treatment	NN	O	treatment	prep_with	26	SENT_184	[p11l1280t2600r1664b2646],
30	.	.	O	.	_	0	SENT_184	[p11l1280t2600r1664b2646],

1	We	PRP	O	we	nsubj	2	SENT_185	[p11l1706t2587r1822b2646],
2	focused	VBD	O	focus	_	0	SENT_185	[p11l1864t2581r2150b2647],
3	on	IN	O	on	_	0	SENT_185	[p11l10t2711r105b2752],
4	cardiovascular	JJ	O	cardiovascular	amod	7	SENT_185	[p11l149t2687r684b2753],
5	and	CC	O	and	_	0	SENT_185	[p11l727t2687r866b2753],
6	thrombotic	JJ	O	thrombotic	amod	7	SENT_185	[p11l909t2687r1334b2752],
7	disorders	NNS	O	disorder	prep_on	2	SENT_185	[p11l1378t2687r1737b2767],
8	,	,	O	,	_	0	SENT_185	[p11l1378t2687r1737b2767],
9	renal	JJ	O	renal	amod	12	SENT_185	[p11l1783t2688r1968b2752],
10	and	CC	O	and	_	0	SENT_185	[p11l2011t2687r2150b2753],
11	hypertensive	JJ	O	hypertensive	conj_and	9	SENT_185	[p11l9t2794r474b2881],
12	disorders	NNS	O	disorder	conj_and	7	SENT_185	[p11l529t2793r888b2874],
13	,	,	O	,	_	0	SENT_185	[p11l529t2793r888b2874],
14	élnd	JJ	O	élnd	amod	16	SENT_185	[p11l944t2793r1083b2860],
15	gastrointestinal	JJ	O	gastrointestinal	amod	16	SENT_185	[p11l1135t2794r1718b2881],
16	ulceration	NN	O	ulceration	conj_and	7	SENT_185	[p11l1771t2794r2149b2858],
17	and	CC	O	and	_	0	SENT_185	[p11l10t2899r149b2966],
18	hemorrhage	NN	O	hemorrhage	conj_and	7	SENT_185	[p11l182t2900r632b2987],
19	separately	RB	O	separately	advmod	18	SENT_185	[p11l668t2900r1054b2987],
20	,	,	O	,	_	0	SENT_185	[p11l668t2900r1054b2987],
21	consistent	JJ	O	consistent	dep	2	SENT_185	[p11l1091t2902r1471b2964],
22	with	IN	O	with	_	0	SENT_185	[p11l1503t2900r1668b2964],
23	the	DT	O	the	det	25	SENT_185	[p11l1704t2899r1820b2964],
24	primary	JJ	O	primary	amod	25	SENT_185	[p11l1855t2902r2151b2987],
25	analysis	NN	O	analysis	prep_with	2	SENT_185	[p11l10t3005r296b3093],
26	of	IN	O	of	_	0	SENT_185	[p11l335t3006r420b3070],
27	trial	NN	O	trial	nn	29	SENT_185	[p11l445t3006r596b3070],
28	(	CD	NUMBER	(	num	29	SENT_185	[p11l635t3006r863b3090],
29	Table	NNP	O	Table	prep_of	25	SENT_185	[p11l635t3006r863b3090],
30	4	CD	NUMBER	4	number	31	SENT_185	[p11l900t3006r987b3090],
31	)	CD	NUMBER	)	num	29	SENT_185	[p11l900t3006r987b3090],
32	.	.	O	.	_	0	SENT_185	[p11l900t3006r987b3090],

1	Among	IN	O	among	_	0	SENT_186	[p11l1024t3011r1300b3093],
2	patients	NNS	O	patient	prep_among	8	SENT_186	[p11l1335t3008r1632b3093],
3	of	IN	O	of	_	0	SENT_186	[p11l1671t3006r1756b3070],
4	any	DT	O	any	det	5	SENT_186	[p11l1780t3030r1911b3093],
5	genotype	NN	O	genotype	prep_of	2	SENT_186	[p11l1944t3030r2147b3093, p11l10t3130r182b3199],
6	,	,	O	,	_	0	SENT_186	[p11l1944t3030r2147b3093, p11l10t3130r182b3199],
7	there	EX	O	there	expl	8	SENT_186	[p11l221t3112r408b3176],
8	was	VBD	O	be	_	0	SENT_186	[p11l443t3136r576b3176],
9	a	DT	O	a	det	13	SENT_186	[p11l615t3136r654b3176],
10	dose	NN	O	dose	nn	13	SENT_186	[p11l689t3111r1139b3178],
11	—	NN	O	—	nn	13	SENT_186	[p11l689t3111r1139b3178],
12	related	JJ	O	related	amod	13	SENT_186	[p11l689t3111r1139b3178],
13	increase	NN	O	increase	nn	27	SENT_186	[p11l1173t3114r1468b3176],
14	in	IN	O	in	_	0	SENT_186	[p11l1505t3114r1578b3175],
15	cardiovascular	JJ	O	cardiovascular	amod	18	SENT_186	[p11l1615t3111r2150b3178],
16	and	CC	O	and	_	0	SENT_186	[p11l10t3218r149b3285],
17	thrombotic	JJ	O	thrombotic	conj_and	15	SENT_186	[p11l194t3219r619b3283],
18	disorders	NNS	O	disorder	prep_in	13	SENT_186	[p11l666t3218r1005b3285],
19	with	IN	O	with	_	0	SENT_186	[p11l1050t3219r1216b3283],
20	a	DT	O	a	det	21	SENT_186	[p11l1263t3243r1303b3283],
21	RR	NN	O	rr	prep_with	13	SENT_186	[p11l1346t3224r1462b3283],
22	of	IN	O	of	_	0	SENT_186	[p11l1504t3219r1589b3283],
23	1.69	CD	PERCENT	1.69	number	24	SENT_186	[p11l1630t3223r1774b3284],
24	(	CD	PERCENT	(	prep_of	21	SENT_186	[p11l1826t3219r1997b3303],
25	95	CD	PERCENT	95	number	26	SENT_186	[p11l1826t3219r1997b3303],
26	%	NN	PERCENT	%	amod	27	SENT_186	[p11l1826t3219r1997b3303],
27	CI	NN	O	ci	nsubj	8	SENT_186	[p11l2045t3224r2145b3284],
28	:	:	O	:	_	0	SENT_186	[p11l2045t3224r2145b3284],

1	1.02-2	CD	NUMBER	1.02-2	num	3	SENT_187	[p12l17t18r388b102],
2	.80	CD	NUMBER	.80	num	3	SENT_187	[p12l17t18r388b102],
3	)	NN	O	)	_	0	SENT_187	[p12l17t18r388b102],
4	for	IN	O	for	_	0	SENT_187	[p12l440t18r548b82],
5	high	JJ	O	high	amod	7	SENT_187	[p12l594t17r958b105],
6	—	NN	O	—	nn	7	SENT_187	[p12l594t17r958b105],
7	dose	NN	O	dose	prep_for	3	SENT_187	[p12l594t17r958b105],
8	compared	VBN	O	compare	_	0	SENT_187	[p12l1007t17r1377b105],
9	with	IN	O	with	prepc_compared_with	7	SENT_187	[p12l1421t18r1587b82],
10	placebo	NN	O	placebo	pobj	7	SENT_187	[p12l1635t18r1935b105],
11	.	.	O	.	_	0	SENT_187	[p12l1635t18r1935b105],

1	This	DT	O	this	nsubj	3	SENT_188	[p12l1984t18r2147b82],
2	substantially	RB	O	substantially	advmod	3	SENT_188	[p12l10t123r488b211],
3	agreed	VBN	O	agree	partmod	41	SENT_188	[p12l538t123r780b211],
4	with	IN	O	with	_	0	SENT_188	[p12l830t124r995b188],
5	the	DT	O	the	det	7	SENT_188	[p12l1049t124r1164b188],
6	primary	JJ	O	primary	amod	7	SENT_188	[p12l1218t126r1515b211],
7	analysis	NN	O	analysis	prep_with	3	SENT_188	[p12l1565t124r1851b211],
8	of	IN	O	of	_	0	SENT_188	[p12l1907t124r1992b188],
9	the	DT	O	the	det	10	SENT_188	[p12l2033t123r2148b188],
10	trial	NN	O	trial	prep_of	7	SENT_188	[p12l10t230r212b310],
11	,2	CD	NUMBER	,2	num	10	SENT_188	[p12l10t230r212b310],
12	as	RB	O	as	_	0	SENT_188	[p12l247t254r315b294],
13	well	RB	O	well	_	0	SENT_188	[p12l346t230r488b294],
14	as	IN	O	as	_	0	SENT_188	[p12l520t254r588b294],
15	a	DT	O	a	det	19	SENT_188	[p12l622t254r661b294],
16	separate	JJ	O	separate	amod	19	SENT_188	[p12l691t248r997b317],
17	,	,	O	,	_	0	SENT_188	[p12l691t248r997b317],
18	prespeciﬁed	JJ	O	prespeciﬁed	amod	19	SENT_188	[p12l1031t229r1456b317],
19	analysis	NN	O	analysis	prep_with	3	SENT_188	[p12l1486t229r1760b317],
20	of	IN	O	of	_	0	SENT_188	[p12l1795t230r1878b294],
21	adjudicated	VBN	O	adjudicate	prepc_of	19	SENT_188	[p12l1898t229r2147b317, p12l10t335r198b402],
22	cardiovascular	JJ	O	cardiovascular	amod	23	SENT_188	[p12l235t335r748b402],
23	events	NNS	O	event	dobj	21	SENT_188	[p12l786t354r1004b400],
24	that	WDT	O	that	nsubjpass	27	SENT_188	[p12l1044t336r1190b400],
25	was	VBD	O	be	auxpass	27	SENT_188	[p12l1225t360r1355b400],
26	previously	RB	DATE	previously	advmod	27	SENT_188	[p12l1394t336r1761b423],
27	reported	VBN	O	report	rcmod	23	SENT_188	[p12l1797t335r2150b423],
28	.4	NN	NUMBER	.4	dobj	27	SENT_188	[p12l1797t335r2150b423],
29	However	RB	O	however	advmod	27	SENT_188	[p12l10t448r350b522],
30	,	,	O	,	_	0	SENT_188	[p12l10t448r350b522],
31	the	DT	O	the	det	33	SENT_188	[p12l401t442r516b506],
32	dose	NN	O	dose	nn	33	SENT_188	[p12l566t441r731b508],
33	relationship	NN	O	relationship	nsubj	41	SENT_188	[p12l781t442r1227b529],
34	between	IN	O	between	_	0	SENT_188	[p12l1276t442r1579b506],
35	celecoxib	NN	O	celecoxib	prep_between	33	SENT_188	[p12l1628t441r1960b506],
36	and	CC	O	and	_	0	SENT_188	[p12l2011t441r2150b508],
37	cardiovascular	JJ	O	cardiovascular	amod	40	SENT_188	[p12l10t547r546b614],
38	and	CC	O	and	_	0	SENT_188	[p12l586t547r725b614],
39	thrombotic	JJ	O	thrombotic	amod	40	SENT_188	[p12l766t548r1191b612],
40	events	NNS	O	event	prep_between	33	SENT_188	[p12l1234t566r1460b612],
41	appeared	VBD	O	appear	_	0	SENT_188	[p12l1505t547r1842b635],
42	to	TO	O	to	aux	43	SENT_188	[p12l1883t566r1955b612],
43	vary	VB	O	vary	xcomp	41	SENT_188	[p12l1996t571r2152b635],
44	somewhat	RB	O	somewhat	advmod	43	SENT_188	[p12l10t654r388b718],
45	according	VBG	O	accord	_	0	SENT_188	[p12l443t653r808b741],
46	to	TO	O	to	prepc_according_to	43	SENT_188	[p12l862t672r935b718],
47	genotype	NN	O	genotype	pobj	43	SENT_188	[p12l992t672r1344b741],
48	.	.	O	.	_	0	SENT_188	[p12l992t672r1344b741],

1	Among	IN	O	among	_	0	SENT_189	[p12l1399t659r1676b741],
2	those	DT	O	those	pobj	1	SENT_189	[p12l1731t654r1928b718],
3	with	IN	O	with	_	0	SENT_189	[p12l1982t654r2147b718],
4	wild	JJ	O	wild	amod	7	SENT_189	[p12l7t759r350b847],
5	—	NN	O	—	nn	7	SENT_189	[p12l7t759r350b847],
6	type	NN	O	type	nn	7	SENT_189	[p12l7t759r350b847],
7	genotypes	NNS	O	genotype	prep_with	2	SENT_189	[p12l384t778r773b847],
8	,	,	O	,	_	0	SENT_189	[p12l384t778r773b847],
9	the	DT	O	the	det	11	SENT_189	[p12l808t760r923b824],
10	cumulative	JJ	O	cumulative	amod	11	SENT_189	[p12l958t760r1369b824],
11	incidence	NN	O	incidence	appos	7	SENT_189	[p12l1402t759r1751b826],
12	of	IN	O	of	_	0	SENT_189	[p12l1786t760r1871b824],
13	cardioJune	NN	O	cardiojune	prep_of	11	SENT_189	[p12l1892t759r2147b826, p12l42t923r107b945],

1	2009	CD	DATE	2009	num	2	SENT_190	[p12l120t922r196b945],
2	CELECOXIB	NNP	O	CELECOXIB	_	0	SENT_190	[p12l1222t922r1388b950],
3	,	,	O	,	_	0	SENT_190	[p12l1222t922r1388b950],
4	CYP2C9	NNP	O	CYP2C9	nn	6	SENT_190	[p12l1402t922r1516b945],
5	GENE	NNP	O	GENE	nn	6	SENT_190	[p12l1529t922r1606b945],
6	VARIANTS	NNP	O	VARIANTS	appos	2	SENT_190	[p12l1618t922r1769b950],
7	,	,	O	,	_	0	SENT_190	[p12l1618t922r1769b950],
8	AND	NNP	O	AND	nn	9	SENT_190	[p12l1782t923r1845b945],
9	ADENOMA	NNP	O	ADENOMA	appos	2	SENT_190	[p12l1857t922r2007b945],
10	2131	CD	DATE	2131	num	11	SENT_190	[p12l2041t922r2118b945],
11	Table	NNP	O	Table	dep	9	SENT_190	[p12l43t970r132b997],
12	2	CD	NUMBER	2	num	11	SENT_190	[p12l147t970r177b997],
13	.	.	O	.	_	0	SENT_190	[p12l147t970r177b997],

1	Risk	NN	O	risk	_	0	SENT_191	[p12l201t970r268b997],
2	of	IN	O	of	_	0	SENT_191	[p12l282t970r314b997],
3	Adenoma	NNP	O	Adenoma	prep_of	1	SENT_191	[p12l326t970r477b997],
4	According	VBG	O	accord	_	0	SENT_191	[p12l491t970r648b1004],
5	to	TO	O	to	prepc_according_to	1	SENT_191	[p12l660t972r691b997],
6	CYP2C9	NNP	O	CYP2C9	nn	7	SENT_191	[p12l707t970r837b997],
7	Genotype	NN	O	genotype	pobj	1	SENT_191	[p12l853t970r1004b1004],

1	Wild	NNP	O	Wild	nn	2	SENT_192	[p12l1181t1039r1240b1063],
2	type	NN	O	type	_	0	SENT_192	[p12l1253t1041r1312b1069],
3	CYP2C9	CD	NUMBER	cyp2c9	num	2	SENT_192	[p12l1511t1039r1667b1063],
4	*	NN	O	*	nn	6	SENT_192	[p12l1511t1039r1667b1063],
5	2	CD	NUMBER	2	num	6	SENT_192	[p12l1511t1039r1667b1063],
6	CYP2C9	NN	O	cyp2c9	dep	2	SENT_192	[p12l1904t1039r2061b1063],
7	*	CD	NUMBER	*	number	8	SENT_192	[p12l1904t1039r2061b1063],
8	3	CD	NUMBER	3	dep	6	SENT_192	[p12l1904t1039r2061b1063],

1	All	DT	O	all	_	0	SENT_193	[p12l7t1120r76b1171],
2	patients	NNS	O	patient	dep	1	SENT_193	[p12l111t1120r377b1183],
3	,	,	O	,	_	0	SENT_193	[p12l111t1120r377b1183],
4	No.	NN	O	no.	appos	2	SENT_193	[p12l413t1120r509b1171],
5	at	IN	O	at	_	0	SENT_193	[p12l543t1123r601b1171],
6	riska	NN	O	riska	prep_at	4	SENT_193	[p12l630t1120r767b1171],

1	Cumulative	JJ	O	cumulative	amod	2	SENT_194	[p12l81t1209r424b1261],
2	incidence	NN	O	incidence	_	0	SENT_194	[p12l456t1210r764b1270],
3	,	,	O	,	_	0	SENT_194	[p12l456t1210r764b1270],
4	3	CD	NUMBER	3	num	5	SENT_194	[p12l797t1209r835b1261],
5	y	NN	O	y	appos	2	SENT_194	[p12l860t1223r908b1273],
6	,	,	O	,	_	0	SENT_194	[p12l860t1223r908b1273],
7	%	NN	O	%	appos	2	SENT_194	[p12l939t1209r987b1261],
8	:	:	O	:	_	0	SENT_194	[p12l1020t1215r1063b1258],
9	SE	NN	O	se	nn	10	SENT_194	[p12l1099t1209r1179b1261],
10	RR	NN	O	rr	dep	2	SENT_194	[p12l84t1298r165b1348],
11	(	CD	PERCENT	(	num	14	SENT_194	[p12l195t1298r348b1361],
12	95	CD	PERCENT	95	number	13	SENT_194	[p12l195t1298r348b1361],
13	%	NN	PERCENT	%	amod	14	SENT_194	[p12l195t1298r348b1361],
14	Cl	NN	O	cl	dep	10	SENT_194	[p12l377t1292r487b1361],
15	)	CD	NUMBER	)	number	16	SENT_194	[p12l377t1292r487b1361],
16	‘’	CD	NUMBER	‘’	dep	2	SENT_194	[p12l377t1292r487b1361],
17	P	NN	O	p	nn	18	SENT_194	[p12l83t1387r124b1438],
18	valuec	NN	O	valuec	dep	16	SENT_194	[p12l143t1387r334b1438],

1	By	IN	O	by	_	0	SENT_195	[p12l12t1476r82b1539],
2	celecoxib	NN	O	celecoxib	nn	3	SENT_195	[p12l107t1476r394b1527],
3	treatment	NN	O	treatment	pobj	1	SENT_195	[p12l420t1479r727b1527],

1	Patients	NNS	O	patient	nsubj	2	SENT_196	[p12l83t1565r333b1616],
2	randomized	VBD	O	randomize	_	0	SENT_196	[p12l365t1565r719b1616],
3	to	TO	O	to	_	0	SENT_196	[p12l747t1568r806b1616],
4	placebo	NN	O	placebo	prep_to	2	SENT_196	[p12l838t1565r1095b1627],
5	,	,	O	,	_	0	SENT_196	[p12l838t1565r1095b1627],
6	No.	NN	O	no.	appos	4	SENT_196	[p12l1130t1565r1227b1616],
7	at	IN	O	at	_	0	SENT_196	[p12l1261t1568r1318b1616],
8	risk	NN	O	risk	prep_at	2	SENT_196	[p12l1347t1565r1484b1616],
9	‘	CD	NUMBER	‘	num	8	SENT_196	[p12l1347t1565r1484b1616],
10	?	.	O	?	_	0	SENT_196	[p12l1347t1565r1484b1616],

1	Cumulative	JJ	O	cumulative	amod	2	SENT_197	[p12l153t1653r496b1704],
2	incidence	NN	O	incidence	_	0	SENT_197	[p12l528t1653r837b1713],
3	,	,	O	,	_	0	SENT_197	[p12l528t1653r837b1713],
4	3	CD	NUMBER	3	num	5	SENT_197	[p12l870t1653r907b1704],
5	y	NN	O	y	appos	2	SENT_197	[p12l932t1666r979b1717],
6	,	,	O	,	_	0	SENT_197	[p12l932t1666r979b1717],
7	%	NN	O	%	appos	2	SENT_197	[p12l1011t1653r1058b1704],
8	:	:	O	:	_	0	SENT_197	[p12l1092t1658r1135b1702],
9	SE	NN	O	se	nn	10	SENT_197	[p12l1171t1653r1251b1704],
10	RR	NN	O	rr	dep	2	SENT_197	[p12l156t1742r236b1792],
11	(	CD	PERCENT	(	num	14	SENT_197	[p12l267t1741r421b1804],
12	95	CD	PERCENT	95	number	13	SENT_197	[p12l267t1741r421b1804],
13	%	NN	PERCENT	%	amod	14	SENT_197	[p12l267t1741r421b1804],
14	CDo	NN	O	cdo	dep	10	SENT_197	[p12l449t1735r561b1804],
15	’	CD	NUMBER	’	num	18	SENT_197	[p12l449t1735r561b1804],
16	P	NN	O	p	nn	18	SENT_197	[p12l155t1831r196b1881],
17	value	NN	O	value	nn	18	SENT_197	[p12l215t1831r406b1882],
18	“	NN	O	“	dep	2	SENT_197	[p12l215t1831r406b1882],

1	Patients	NNS	O	patient	nsubj	2	SENT_198	[p12l83t1919r333b1970],
2	randomized	VBD	O	randomize	_	0	SENT_198	[p12l365t1919r719b1970],
3	to	TO	O	to	_	0	SENT_198	[p12l747t1922r806b1970],
4	celecoxib	NN	O	celecoxib	nn	6	SENT_198	[p12l835t1919r1121b1970],
5	200	CD	NUMBER	200	num	6	SENT_198	[p12l1152t1919r1275b1970],
6	mg	NN	O	mg	prep_to	2	SENT_198	[p12l1306t1926r1397b1983],
7	twice	RB	O	twice	advmod	8	SENT_198	[p12l1421t1919r1579b1970],
8	daily	RB	SET	daily	tmod	2	SENT_198	[p12l1608t1919r1764b1983],
9	,	,	O	,	_	0	SENT_198	[p12l1608t1919r1764b1983],
10	No.	NN	O	no.	acomp	2	SENT_198	[p12l1799t1919r1896b1970],
11	at	IN	O	at	_	0	SENT_198	[p12l1929t1922r1988b1970],
12	risk	NN	O	risk	prep_at	10	SENT_198	[p12l2017t1919r2153b1970],
13	‘	CD	NUMBER	‘	num	12	SENT_198	[p12l2017t1919r2153b1970],
14	?	.	O	?	_	0	SENT_198	[p12l2017t1919r2153b1970],

1	Cumulative	JJ	O	cumulative	amod	2	SENT_199	[p12l153t2008r496b2060],
2	incidence	NN	O	incidence	_	0	SENT_199	[p12l528t2009r837b2069],
3	,	,	O	,	_	0	SENT_199	[p12l528t2009r837b2069],
4	3	CD	NUMBER	3	num	5	SENT_199	[p12l870t2008r907b2060],
5	y	NN	O	y	appos	2	SENT_199	[p12l932t2022r979b2072],
6	,	,	O	,	_	0	SENT_199	[p12l932t2022r979b2072],
7	%	NN	O	%	appos	2	SENT_199	[p12l1011t2008r1058b2060],
8	:	:	O	:	_	0	SENT_199	[p12l1092t2014r1135b2057],
9	SE	NN	O	se	nn	10	SENT_199	[p12l1171t2008r1251b2060],
10	RR	NN	O	rr	dep	2	SENT_199	[p12l156t2097r236b2147],
11	(	CD	PERCENT	(	num	14	SENT_199	[p12l267t2097r421b2160],
12	95	CD	PERCENT	95	number	13	SENT_199	[p12l267t2097r421b2160],
13	%	NN	PERCENT	%	amod	14	SENT_199	[p12l267t2097r421b2160],
14	Cl	NN	O	cl	dep	10	SENT_199	[p12l449t2091r561b2160],
15	)	CD	NUMBER	)	number	16	SENT_199	[p12l449t2091r561b2160],
16	“	CD	NUMBER	“	dep	2	SENT_199	[p12l449t2091r561b2160],
17	P	NN	O	p	nn	19	SENT_199	[p12l155t2185r196b2236],
18	value	NN	O	value	nn	19	SENT_199	[p12l215t2185r406b2236],
19	“	NN	O	“	dep	16	SENT_199	[p12l215t2185r406b2236],

1	Patients	NNS	O	patient	nsubj	2	SENT_200	[p12l83t2275r333b2326],
2	randomized	VBD	O	randomize	_	0	SENT_200	[p12l365t2275r719b2326],
3	to	TO	O	to	_	0	SENT_200	[p12l747t2278r806b2326],
4	celecoxib	NN	O	celecoxib	nn	6	SENT_200	[p12l835t2275r1121b2326],
5	400	CD	NUMBER	400	num	6	SENT_200	[p12l1150t2274r1275b2326],
6	mg	NN	O	mg	prep_to	2	SENT_200	[p12l1306t2282r1397b2339],
7	twice	RB	O	twice	advmod	8	SENT_200	[p12l1421t2275r1579b2326],
8	daily	RB	SET	daily	tmod	2	SENT_200	[p12l1608t2275r1764b2338],
9	,	,	O	,	_	0	SENT_200	[p12l1608t2275r1764b2338],
10	No.	NN	O	no.	acomp	2	SENT_200	[p12l1800t2275r1896b2326],
11	at	IN	O	at	_	0	SENT_200	[p12l1929t2278r1988b2326],
12	risk	NN	O	risk	prep_at	10	SENT_200	[p12l2017t2275r2153b2326],
13	‘	CD	NUMBER	‘	num	12	SENT_200	[p12l2017t2275r2153b2326],
14	?	.	O	?	_	0	SENT_200	[p12l2017t2275r2153b2326],

1	Cumulative	JJ	O	cumulative	amod	2	SENT_201	[p12l153t2364r496b2415],
2	incidence	NN	O	incidence	_	0	SENT_201	[p12l528t2364r837b2424],
3	,	,	O	,	_	0	SENT_201	[p12l528t2364r837b2424],
4	3	CD	NUMBER	3	num	5	SENT_201	[p12l870t2364r907b2415],
5	y	NN	O	y	appos	2	SENT_201	[p12l932t2377r979b2427],
6	,	,	O	,	_	0	SENT_201	[p12l932t2377r979b2427],
7	%	NN	O	%	appos	2	SENT_201	[p12l1011t2364r1058b2415],
8	:	:	O	:	_	0	SENT_201	[p12l1092t2369r1135b2413],
9	SE	NN	O	se	nn	10	SENT_201	[p12l1171t2364r1251b2415],
10	RR	NN	O	rr	dep	2	SENT_201	[p12l156t2453r236b2503],
11	(	CD	PERCENT	(	num	14	SENT_201	[p12l267t2452r421b2515],
12	95	CD	PERCENT	95	number	13	SENT_201	[p12l267t2452r421b2515],
13	%	NN	PERCENT	%	amod	14	SENT_201	[p12l267t2452r421b2515],
14	CD6	NN	O	cd6	dep	10	SENT_201	[p12l449t2446r561b2515],
15	’	CD	NUMBER	’	num	18	SENT_201	[p12l449t2446r561b2515],
16	P	NN	O	p	nn	18	SENT_201	[p12l155t2541r196b2591],
17	value	NN	O	value	nn	18	SENT_201	[p12l215t2541r406b2592],
18	“	NN	O	“	dep	2	SENT_201	[p12l215t2541r406b2592],

1	By	IN	O	by	_	0	SENT_202	[p12l12t2630r82b2693],
2	aspirin	NN	O	aspirin	nn	3	SENT_202	[p12l109t2630r313b2692],
3	strata	NN	O	stratum	pobj	1	SENT_202	[p12l344t2633r522b2681],

1	Patients	NNS	O	patient	_	0	SENT_203	[p12l83t2718r333b2769],
2	taking	VBG	O	take	partmod	1	SENT_203	[p12l360t2718r550b2782],
3	aspirin	NN	O	aspirin	dobj	2	SENT_203	[p12l578t2718r835b2781],
4	,	,	O	,	_	0	SENT_203	[p12l578t2718r835b2781],
5	‘’	CD	NUMBER	‘’	num	10	SENT_203	[p12l578t2718r835b2781],
6	No.	NN	O	no.	amod	10	SENT_203	[p12l864t2718r960b2769],
7	at	IN	O	at	_	0	SENT_203	[p12l994t2721r1052b2769],
8	riska	NN	O	riska	prep_at	6	SENT_203	[p12l1081t2718r1218b2769],
9	Cumulative	JJ	O	cumulative	amod	10	SENT_203	[p12l153t2807r496b2859],
10	incidence	NN	O	incidence	appos	3	SENT_203	[p12l528t2808r837b2868],
11	,	,	O	,	_	0	SENT_203	[p12l528t2808r837b2868],
12	3	CD	NUMBER	3	num	13	SENT_203	[p12l870t2807r907b2859],
13	y	NN	O	y	appos	3	SENT_203	[p12l932t2821r979b2871],
14	,	,	O	,	_	0	SENT_203	[p12l932t2821r979b2871],
15	%	NN	O	%	appos	13	SENT_203	[p12l1011t2807r1058b2859],
16	:	:	O	:	_	0	SENT_203	[p12l1092t2813r1135b2856],
17	SE	NN	O	se	nn	18	SENT_203	[p12l1171t2807r1251b2859],
18	RR	NN	O	rr	dep	3	SENT_203	[p12l156t2897r236b2946],
19	(	CD	PERCENT	(	num	22	SENT_203	[p12l267t2896r421b2959],
20	95	CD	PERCENT	95	number	21	SENT_203	[p12l267t2896r421b2959],
21	%	NN	PERCENT	%	amod	22	SENT_203	[p12l267t2896r421b2959],
22	Cl	NN	O	cl	dep	18	SENT_203	[p12l449t2889r554b2959],
23	)	CD	NUMBER	)	number	24	SENT_203	[p12l449t2889r554b2959],
24	’	CD	NUMBER	’	dep	18	SENT_203	[p12l449t2889r554b2959],
25	P	NN	O	p	nn	27	SENT_203	[p12l155t2984r196b3035],
26	value	NN	O	value	nn	27	SENT_203	[p12l215t2984r406b3035],
27	“	NN	O	“	dep	24	SENT_203	[p12l215t2984r406b3035],

1	Patients	NNS	O	patient	nsubj	2	SENT_204	[p12l83t3074r333b3125],
2	not	RB	O	not	_	0	SENT_204	[p12l365t3077r461b3125],
3	taking	VBG	O	take	xcomp	2	SENT_204	[p12l485t3074r675b3138],
4	aspirin	NN	O	aspirin	dobj	3	SENT_204	[p12l703t3074r960b3136],
5	,	,	O	,	_	0	SENT_204	[p12l703t3074r960b3136],
6	*	CD	NUMBER	*	number	7	SENT_204	[p12l703t3074r960b3136],
7	9	CD	NUMBER	9	dep	8	SENT_204	[p12l703t3074r960b3136],
8	No.	NN	O	no.	dep	4	SENT_204	[p12l989t3074r1085b3125],
9	at	IN	O	at	_	0	SENT_204	[p12l1118t3077r1177b3125],
10	risk	NN	O	risk	prep_at	3	SENT_204	[p12l1206t3074r1342b3125],
11	‘	CD	NUMBER	‘	num	10	SENT_204	[p12l1206t3074r1342b3125],
12	?	.	O	?	_	0	SENT_204	[p12l1206t3074r1342b3125],

1	Cumulative	JJ	O	cumulative	amod	2	SENT_205	[p12l153t3163r496b3214],
2	incidence	NN	O	incidence	_	0	SENT_205	[p12l528t3163r837b3223],
3	,	,	O	,	_	0	SENT_205	[p12l528t3163r837b3223],
4	3	CD	NUMBER	3	num	5	SENT_205	[p12l870t3163r907b3214],
5	y	NN	O	y	appos	2	SENT_205	[p12l932t3176r979b3226],
6	,	,	O	,	_	0	SENT_205	[p12l932t3176r979b3226],
7	%	NN	O	%	appos	2	SENT_205	[p12l1011t3163r1058b3214],
8	:	:	O	:	_	0	SENT_205	[p12l1092t3168r1135b3212],
9	SE	NN	O	se	nn	10	SENT_205	[p12l1171t3163r1251b3214],
10	RR	NN	O	rr	dep	2	SENT_205	[p12l156t3252r236b3302],
11	(	CD	PERCENT	(	number	12	SENT_205	[p12l267t3251r421b3314],
12	95	CD	PERCENT	95	num	13	SENT_205	[p12l267t3251r421b3314],
13	%	NN	PERCENT	%	dep	10	SENT_205	[p12l267t3251r421b3314],
14	Cl	NN	O	cl	dep	2	SENT_205	[p12l449t3244r554b3314],
15	)	CD	NUMBER	)	num	14	SENT_205	[p12l449t3244r554b3314],
16	"	``	O	"	punct	14	SENT_205	[p12l449t3244r554b3314],
17	P	NN	O	p	nn	19	SENT_205	[p12l155t3340r196b3390],
18	value	NN	O	value	nn	19	SENT_205	[p12l215t3340r406b3391],
19	“	NN	O	“	dep	14	SENT_205	[p12l215t3340r406b3391],

1	1.0	CD	NUMBER	1.0	num	2	SENT_206	[p13l153t102r240b146],
2	1.16	CD	NUMBER	1.16	_	0	SENT_206	[p13l554t102r677b147],
3	(	CD	NUMBER	(	num	4	SENT_206	[p13l698t102r1043b157],
4	1.00	CD	NUMBER	1.00	dep	10	SENT_206	[p13l698t102r1043b157],
5	—	NN	O	—	dep	4	SENT_206	[p13l698t102r1043b157],
6	1.35	CD	NUMBER	1.35	num	5	SENT_206	[p13l698t102r1043b157],
7	)	NN	O	)	dep	10	SENT_206	[p13l698t102r1043b157],
8	1.05	CD	NUMBER	1.05	num	7	SENT_206	[p13l1288t102r1411b146],
9	(	CD	NUMBER	(	num	10	SENT_206	[p13l1432t102r1777b157],
10	O.	NNP	O	O.	dep	24	SENT_206	[p13l1432t102r1777b157],
11	86	CD	NUMBER	86	num	10	SENT_206	[p13l1432t102r1777b157],
12	—	CD	NUMBER	—	number	13	SENT_206	[p13l1432t102r1777b157],
13	1.28	CD	NUMBER	1.28	num	14	SENT_206	[p13l1432t102r1777b157],
14	)	NN	O	)	dep	10	SENT_206	[p13l1432t102r1777b157],
15	,	,	O	,	_	0	SENT_206	[p13l2031t139r2072b167],
16	_	CD	NUMBER	_	number	17	SENT_206	[p13l2031t139r2072b167],
17	—	CD	NUMBER	—	num	19	SENT_206	[p13l127t205r190b210],
18	.05	CD	NUMBER	.05	number	19	SENT_206	[p13l794t180r879b224],
19	.66	CD	NUMBER	.66	appos	14	SENT_206	[p13l1547t180r1632b224],
20	5	CD	NUMBER	5	number	21	SENT_206	[p13l2030t171r2073b280],
21	’	CD	NUMBER	’	num	19	SENT_206	[p13l2030t171r2073b280],
22	_	NN	O	_	nn	24	SENT_206	[p13l1961t278r2001b329],
23	ll	NN	O	ll	nn	24	SENT_206	[p13l1961t278r2001b329],
24	I338	NN	O	i338	dep	28	SENT_206	[p13l2031t284r2072b312, p13l77t336r185b380],
25	111	CD	NUMBER	111	number	26	SENT_206	[p13l681t336r786b379],
26	50	CD	NUMBER	50	dep	24	SENT_206	[p13l1469t336r1539b380],
27	5	CD	NUMBER	5	dep	26	SENT_206	[p13l1960t333r2002b409],
28	E	NN	O	e	dep	2	SENT_206	[p13l2031t330r2072b403],
29	57.2	CD	NUMBER	57.2	num	28	SENT_206	[p13l8t413r133b458],
30	:	:	O	:	_	0	SENT_206	[p13l158t418r196b455],
31	2.8	CD	NUMBER	2.8	number	32	SENT_206	[p13l222t413r310b458],
32	68.4	CD	NUMBER	68.4	dep	2	SENT_206	[p13l647t413r773b458],
33	:	:	O	:	_	0	SENT_206	[p13l798t418r835b455],
34	4.6	CD	NUMBER	4.6	dep	32	SENT_206	[p13l860t413r949b458],
35	64.6	CD	NUMBER	64.6	rcmod	34	SENT_206	[p13l1381t413r1506b458],
36	:	:	O	:	_	0	SENT_206	[p13l1532t418r1569b455],
37	7.0	CD	NUMBER	7.0	dep	44	SENT_206	[p13l1596t413r1683b458],
38	2	CD	NUMBER	2	dep	37	SENT_206	[p13l1961t415r2002b473],
39	,	,	O	,	_	0	SENT_206	[p13l2031t407r2072b478],
40	<	JJR	O	<	appos	38	SENT_206	[p13l2031t407r2072b478],
41	_	CD	NUMBER	_	num	42	SENT_206	[p13l2031t407r2072b478],
42	t	NN	O	t	dep	44	SENT_206	[p13l2031t407r2072b478],
43	1.0	CD	NUMBER	1.0	num	44	SENT_206	[p13l154t491r240b536],
44	1.17	CD	NUMBER	1.17	dep	53	SENT_206	[p13l554t492r676b535],
45	(	CD	NUMBER	(	num	46	SENT_206	[p13l699t491r1043b546],
46	O.	NNP	O	O.	dep	44	SENT_206	[p13l699t491r1043b546],
47	96	CD	NUMBER	96	num	46	SENT_206	[p13l699t491r1043b546],
48	—	CD	NUMBER	—	number	49	SENT_206	[p13l699t491r1043b546],
49	1.43	CD	NUMBER	1.43	num	50	SENT_206	[p13l699t491r1043b546],
50	)	NN	O	)	dep	46	SENT_206	[p13l699t491r1043b546],
51	1.06	CD	NUMBER	1.06	number	52	SENT_206	[p13l1288t491r1412b536],
52	(	CD	NUMBER	(	num	50	SENT_206	[p13l1432t491r1777b545],
53	O.	NNP	O	O.	dep	60	SENT_206	[p13l1432t491r1777b545],
54	78	CD	NUMBER	78	num	53	SENT_206	[p13l1432t491r1777b545],
55	—	CD	NUMBER	—	number	56	SENT_206	[p13l1432t491r1777b545],
56	1.42	CD	NUMBER	1.42	num	57	SENT_206	[p13l1432t491r1777b545],
57	)	NN	O	)	dep	53	SENT_206	[p13l1432t491r1777b545],
58	5	CD	NUMBER	5	number	59	SENT_206	[p13l1960t480r2002b556],
59	5	CD	NUMBER	5	amod	57	SENT_206	[p13l2031t482r2072b553],
60	—	NN	O	—	dep	63	SENT_206	[p13l127t594r190b599],
61	.13	CD	NUMBER	.13	num	60	SENT_206	[p13l794t569r879b613],
62	.72	CD	NUMBER	.72	num	63	SENT_206	[p13l1547t569r1631b613],
63	§	NN	O	§	dep	65	SENT_206	[p13l2031t557r2072b624],
64	330	CD	NUMBER	330	num	65	SENT_206	[p13l77t647r184b691],
65	99	CD	NUMBER	99	dep	35	SENT_206	[p13l716t647r786b691],
66	69	CD	NUMBER	69	num	67	SENT_206	[p13l1469t647r1538b691],
67	2	CD	NUMBER	2	dep	35	SENT_206	[p13l2031t627r2072b696],
68	'	''	O	'	_	0	SENT_206	[p13l2031t627r2072b696],

1	1.0	CD	NUMBER	1.0	num	2	SENT_207	[p13l154t1110r240b1154],
2	1.11	CD	NUMBER	1.11	dep	8	SENT_207	[p13l554t1110r1043b1164],
3	(	CD	NUMBER	(	num	4	SENT_207	[p13l554t1110r1043b1164],
4	O.	NNP	O	O.	dep	2	SENT_207	[p13l554t1110r1043b1164],
5	81	CD	NUMBER	81	num	4	SENT_207	[p13l554t1110r1043b1164],
6	—	CD	NUMBER	—	dep	8	SENT_207	[p13l554t1110r1043b1164],
7	1.53	CD	NUMBER	1.53	num	8	SENT_207	[p13l554t1110r1043b1164],
8	)	NN	O	)	dep	18	SENT_207	[p13l554t1110r1043b1164],
9	0.79	CD	NUMBER	0.79	number	10	SENT_207	[p13l1286t1110r1411b1154],
10	(	CD	NUMBER	(	num	15	SENT_207	[p13l1432t1110r1777b1164],
11	o.	NN	O	o.	nn	15	SENT_207	[p13l1432t1110r1777b1164],
12	5o	NN	O	5o	nn	15	SENT_207	[p13l1432t1110r1777b1164],
13	—	CD	NUMBER	—	number	14	SENT_207	[p13l1432t1110r1777b1164],
14	1.25	CD	NUMBER	1.25	num	15	SENT_207	[p13l1432t1110r1777b1164],
15	)	NN	O	)	dep	8	SENT_207	[p13l1432t1110r1777b1164],
16	—	CD	NUMBER	—	dep	15	SENT_207	[p13l127t1212r190b1217],
17	.50	CD	NUMBER	.50	num	18	SENT_207	[p13l794t1187r879b1232],
18	.72	CD	NUMBER	.72	_	0	SENT_207	[p13l1547t1187r1631b1231],

1	1.0	CD	NUMBER	1.0	num	2	SENT_208	[p13l154t1497r240b1541],
2	1.44	CD	NUMBER	1.44	dep	10	SENT_208	[p13l554t1497r678b1540],
3	(	NN	O	(	dep	2	SENT_208	[p13l698t1497r1043b1551],
4	1.14	CD	NUMBER	1.14	num	3	SENT_208	[p13l698t1497r1043b1551],
5	—	CD	NUMBER	—	number	6	SENT_208	[p13l698t1497r1043b1551],
6	1.81	CD	NUMBER	1.81	dep	3	SENT_208	[p13l698t1497r1043b1551],
7	)	NN	O	)	dep	10	SENT_208	[p13l698t1497r1043b1551],
8	1.15	CD	NUMBER	1.15	num	7	SENT_208	[p13l1288t1497r1411b1541],
9	(	CD	NUMBER	(	num	10	SENT_208	[p13l1432t1497r1777b1551],
10	O.	NNP	O	O.	dep	14	SENT_208	[p13l1432t1497r1777b1551],
11	82	CD	NUMBER	82	num	10	SENT_208	[p13l1432t1497r1777b1551],
12	—	CD	NUMBER	—	num	13	SENT_208	[p13l1432t1497r1777b1551],
13	1.60	CD	NUMBER	1.60	dep	10	SENT_208	[p13l1432t1497r1777b1551],
14	)	NN	O	)	dep	17	SENT_208	[p13l1432t1497r1777b1551],
15	—	CD	NUMBER	—	num	14	SENT_208	[p13l127t1599r190b1604],
16	.003	CD	NUMBER	.003	num	17	SENT_208	[p13l794t1574r917b1618],
17	.43	CD	NUMBER	.43	_	0	SENT_208	[p13l1547t1574r1632b1618],

1	1.0	CD	NUMBER	1.0	num	2	SENT_209	[p13l154t1803r240b1847],
2	1.02	CD	NUMBER	1.02	dep	11	SENT_209	[p13l554t1803r677b1847],
3	(	CD	NUMBER	(	num	4	SENT_209	[p13l698t1803r1043b1857],
4	O.	NNP	O	O.	dep	2	SENT_209	[p13l698t1803r1043b1857],
5	84	CD	NUMBER	84	num	4	SENT_209	[p13l698t1803r1043b1857],
6	—	CD	NUMBER	—	number	7	SENT_209	[p13l698t1803r1043b1857],
7	1.24	CD	NUMBER	1.24	dep	4	SENT_209	[p13l698t1803r1043b1857],
8	)	NN	O	)	dep	11	SENT_209	[p13l698t1803r1043b1857],
9	1.00	CD	NUMBER	1.00	num	8	SENT_209	[p13l1288t1803r1412b1847],
10	(	CD	NUMBER	(	num	11	SENT_209	[p13l1432t1803r1777b1857],
11	O.	NNP	O	O.	dep	18	SENT_209	[p13l1432t1803r1777b1857],
12	78	CD	NUMBER	78	num	11	SENT_209	[p13l1432t1803r1777b1857],
13	—	CD	NUMBER	—	number	14	SENT_209	[p13l1432t1803r1777b1857],
14	1.28	CD	NUMBER	1.28	dep	11	SENT_209	[p13l1432t1803r1777b1857],
15	)	NN	O	)	dep	14	SENT_209	[p13l1432t1803r1777b1857],
16	—	CD	NUMBER	—	num	15	SENT_209	[p13l127t1905r190b1910],
17	.82	CD	NUMBER	.82	num	18	SENT_209	[p13l794t1880r878b1925],
18	.99	CD	NUMBER	.99	_	0	SENT_209	[p13l1547t1880r1632b1925],

1	NOTE	VB	O	note	_	0	SENT_210	[p13l45t1975r129b1999],
2	.	.	O	.	_	0	SENT_210	[p13l45t1975r129b1999],

1	Wi	NN	O	wus	nn	6	SENT_211	[p13l141t1975r268b2005],
2	|	NN	O	|	nn	6	SENT_211	[p13l141t1975r268b2005],
3	d	NN	O	d	nn	6	SENT_211	[p13l141t1975r268b2005],
4	—	CD	NUMBER	—	num	6	SENT_211	[p13l141t1975r268b2005],
5	type	NN	O	type	nn	6	SENT_211	[p13l141t1975r268b2005],
6	genotypes	NNS	O	genotype	nsubj	7	SENT_211	[p13l279t1976r426b2005],
7	include	VBP	O	include	_	0	SENT_211	[p13l439t1975r539b1999],
8	individuals	NNS	O	individual	dobj	7	SENT_211	[p13l552t1975r702b1999],
9	with	IN	O	with	_	0	SENT_211	[p13l712t1975r769b1999],
10	no	DT	O	no	det	11	SENT_211	[p13l782t1981r814b1999],
11	*	NN	O	*	prep_with	7	SENT_211	[p13l828t1975r863b1999],
12	2	CD	NUMBER	2	number	13	SENT_211	[p13l828t1975r863b1999],
13	(	CD	NUMBER	(	num	11	SENT_211	[p13l875t1975r993b2005],
14	R1440	NN	O	r1440	dep	11	SENT_211	[p13l875t1975r993b2005],
15	)	CD	NUMBER	)	num	14	SENT_211	[p13l875t1975r993b2005],
16	or	CC	O	or	_	0	SENT_211	[p13l1005t1981r1033b1999],
17	*	CD	NUMBER	*	number	18	SENT_211	[p13l1045t1975r1080b1999],
18	3	CD	NUMBER	3	num	19	SENT_211	[p13l1045t1975r1080b1999],
19	(	NN	O	(	prep_with	7	SENT_211	[p13l1092t1975r1194b2005],
20	|	CD	NUMBER	|	num	23	SENT_211	[p13l1092t1975r1194b2005],
21	359L	NN	O	359l	nn	23	SENT_211	[p13l1092t1975r1194b2005],
22	)	NN	O	)	nn	23	SENT_211	[p13l1092t1975r1194b2005],
23	alleles	NNS	O	allele	dep	19	SENT_211	[p13l1206t1975r1307b1999],
24	.	.	O	.	_	0	SENT_211	[p13l1206t1975r1307b1999],

1	CYP2C9	NN	O	cyp2c9	nn	2	SENT_212	[p13l1320t1975r1476b1999],
2	*	NN	O	*	nsubj	5	SENT_212	[p13l1320t1975r1476b1999],
3	2	CD	NUMBER	2	num	4	SENT_212	[p13l1320t1975r1476b1999],
4	genotypes	NNS	O	genotype	dep	2	SENT_212	[p13l1486t1977r1633b2005],
5	include	VBP	O	include	_	0	SENT_212	[p13l1646t1975r1746b1999],
6	individuals	NNS	O	individual	dobj	5	SENT_212	[p13l1759t1975r1909b1999],
7	with	IN	O	with	_	0	SENT_212	[p13l1920t1975r1976b1999],
8	zone	NN	O	zone	nn	9	SENT_212	[p13l1990t1979r2068b1999],
9	*	NN	O	*	prep_with	5	SENT_212	[p13l2081t1975r2116b1999],
10	2	CD	NUMBER	2	num	11	SENT_212	[p13l2081t1975r2116b1999],
11	allele	NN	O	allele	dep	9	SENT_212	[p13l44t2016r128b2040],
12	.	.	O	.	_	0	SENT_212	[p13l44t2016r128b2040],

1	CYP2C9	NN	O	cyp2c9	nsubj	5	SENT_213	[p13l141t2016r298b2040],
2	*	CD	NUMBER	*	num	1	SENT_213	[p13l141t2016r298b2040],
3	3	CD	NUMBER	3	num	4	SENT_213	[p13l141t2016r298b2040],
4	genotypes	NNS	O	genotype	dep	1	SENT_213	[p13l309t2018r456b2046],
5	include	VBP	O	include	_	0	SENT_213	[p13l470t2016r570b2040],
6	individuals	NNS	O	individual	dobj	5	SENT_213	[p13l584t2016r734b2040],
7	with	IN	O	with	_	0	SENT_213	[p13l745t2016r802b2040],
8	zone	NN	O	zone	prep_with	5	SENT_213	[p13l816t2020r894b2040],
9	*	CD	NUMBER	*	number	10	SENT_213	[p13l909t2016r944b2040],
10	3	CD	NUMBER	3	num	11	SENT_213	[p13l909t2016r944b2040],
11	allele	NN	O	allele	dep	5	SENT_213	[p13l957t2016r1041b2040],
12	.	.	O	.	_	0	SENT_213	[p13l957t2016r1041b2040],

1	Individuals	NNS	O	individual	nsubjpass	13	SENT_214	[p13l1056t2016r1206b2040],
2	with	IN	O	with	_	0	SENT_214	[p13l1218t2016r1274b2040],
3	one	CD	NUMBER	one	num	4	SENT_214	[p13l1287t2022r1339b2040],
4	*	NN	O	*	prep_with	1	SENT_214	[p13l1354t2016r1389b2040],
5	2	CD	NUMBER	2	num	6	SENT_214	[p13l1354t2016r1389b2040],
6	allele	NN	O	allele	dep	4	SENT_214	[p13l1402t2016r1477b2040],
7	and	CC	O	and	_	0	SENT_214	[p13l1490t2016r1540b2040],
8	one	CD	NUMBER	one	num	9	SENT_214	[p13l1553t2022r1605b2040],
9	*	NN	O	*	conj_and	4	SENT_214	[p13l1619t2016r1655b2040],
10	3	CD	NUMBER	3	num	11	SENT_214	[p13l1619t2016r1655b2040],
11	allele	NN	O	allele	dep	9	SENT_214	[p13l1667t2016r1742b2040],
12	were	VBD	O	be	auxpass	13	SENT_214	[p13l1754t2022r1821b2040],
13	classified	VBN	O	classify	_	0	SENT_214	[p13l1833t2016r1968b2040],
14	as	IN	O	as	_	0	SENT_214	[p13l1981t2022r2013b2040],
15	having	VBG	O	have	prepc_as	13	SENT_214	[p13l2027t2016r2118b2046],
16	CYP2C9	NN	O	cyp2c9	nn	19	SENT_214	[p13l43t2057r200b2081],
17	*	NN	O	*	nn	19	SENT_214	[p13l43t2057r200b2081],
18	3	CD	NUMBER	3	num	19	SENT_214	[p13l43t2057r200b2081],
19	genotypes	NNS	O	genotype	dobj	15	SENT_214	[p13l212t2058r368b2087],
20	.	.	O	.	_	0	SENT_214	[p13l212t2058r368b2087],

1	5N0	NN	O	5n0	_	0	SENT_215	[p13l44t2098r102b2122],
2	.	.	O	.	_	0	SENT_215	[p13l44t2098r102b2122],

1	at	IN	O	at	_	0	SENT_216	[p13l117t2100r144b2122],
2	risk	NN	O	risk	prep_at	3	SENT_216	[p13l158t2098r208b2122],
3	include	VBP	O	include	_	0	SENT_216	[p13l222t2098r322b2122],
4	patients	NNS	O	patient	dobj	3	SENT_216	[p13l337t2098r452b2127],
5	who	WP	O	who	nsubj	6	SENT_216	[p13l464t2098r521b2122],
6	underwent	VBD	O	undergo	rcmod	4	SENT_216	[p13l535t2098r685b2122],
7	a	DT	O	a	nsubj	8	SENT_216	[p13l697t2104r712b2122],
8	follow	VB	O	follow	ccomp	6	SENT_216	[p13l725t2098r851b2127],
9	—	CD	NUMBER	—	dobj	8	SENT_216	[p13l725t2098r851b2127],
10	up	IN	O	up	_	0	SENT_216	[p13l725t2098r851b2127],
11	colonoscopy	NN	O	colonoscopy	prep_up	8	SENT_216	[p13l864t2098r1043b2128],
12	at	IN	O	at	_	0	SENT_216	[p13l1055t2100r1082b2122],
13	year	NN	DURATION	year	nn	16	SENT_216	[p13l1093t2104r1154b2128],
14	1	CD	NUMBER	1	num	16	SENT_216	[p13l1167t2098r1184b2122],
15	and/or	NN	O	and/or	nn	16	SENT_216	[p13l1198t2098r1297b2128],
16	year	NN	DURATION	year	prep_at	3	SENT_216	[p13l1307t2104r1368b2128],
17	3	CD	NUMBER	3	nsubj	3	SENT_216	[p13l1380t2098r1406b2122],
18	.	.	O	.	_	0	SENT_216	[p13l1380t2098r1406b2122],

1	“	NN	O	“	nn	3	SENT_217	[p13l44t2136r169b2163],
2	Relative	JJ	O	relative	amod	3	SENT_217	[p13l44t2136r169b2163],
3	risk	NN	O	risk	nsubj	4	SENT_217	[p13l185t2139r235b2163],
4	calculated	VBN	O	calculate	_	0	SENT_217	[p13l249t2139r394b2163],
5	by	IN	O	by	_	0	SENT_217	[p13l410t2139r441b2169],
6	the	DT	O	the	det	8	SENT_217	[p13l453t2139r498b2163],
7	Mante	NNP	O	Mante	nn	8	SENT_217	[p13l514t2139r672b2163],
8	|	NN	O	|	prep_by	4	SENT_217	[p13l514t2139r672b2163],
9	.	.	O	.	_	0	SENT_217	[p13l514t2139r672b2163],

1	—	NN	O	—	_	0	SENT_218	[p13l514t2139r672b2163],
2	.	.	O	.	_	0	SENT_218	[p13l514t2139r672b2163],

1	Cox	NNP	O	Cox	nsubj	2	SENT_219	[p13l514t2139r672b2163],
2	test	NN	O	test	_	0	SENT_219	[p13l684t2141r749b2167],
3	,	,	O	,	_	0	SENT_219	[p13l684t2141r749b2167],
4	with	IN	O	with	dep	2	SENT_219	[p13l764t2139r820b2163],
5	stratification	NN	O	stratification	pobj	4	SENT_219	[p13l835t2139r1013b2163],
6	for	IN	O	for	_	0	SENT_219	[p13l1027t2139r1066b2163],
7	celecoxib	NN	O	celecoxib	nn	8	SENT_219	[p13l1079t2139r1211b2163],
8	treatment	NN	O	treatment	prep_for	5	SENT_219	[p13l1225t2141r1374b2167],
9	,	,	O	,	_	0	SENT_219	[p13l1225t2141r1374b2167],
10	aspirin	NN	O	aspirin	nn	11	SENT_219	[p13l1391t2139r1485b2168],
11	use	NN	O	use	dobj	2	SENT_219	[p13l1501t2145r1560b2167],
12	,	,	O	,	_	0	SENT_219	[p13l1501t2145r1560b2167],
13	time	NN	O	time	appos	11	SENT_219	[p13l1575t2139r1646b2167],
14	,	,	O	,	_	0	SENT_219	[p13l1575t2139r1646b2167],
15	age	NN	O	age	appos	11	SENT_219	[p13l1663t2143r1712b2169],
16	and	CC	O	and	_	0	SENT_219	[p13l1727t2139r1778b2163],
17	sex	NN	O	sex	appos	11	SENT_219	[p13l1793t2145r1849b2167],
18	,	,	O	,	_	0	SENT_219	[p13l1793t2145r1849b2167],
19	with	IN	O	with	_	0	SENT_219	[p13l1864t2139r1921b2163],
20	the	DT	O	the	det	24	SENT_219	[p13l1935t2139r1980b2163],
21	wild	JJ	O	wild	amod	24	SENT_219	[p13l1994t2139r2117b2169],
22	—	NN	O	—	nn	24	SENT_219	[p13l1994t2139r2117b2169],
23	type	NN	O	type	nn	24	SENT_219	[p13l1994t2139r2117b2169],
24	genotype	NN	O	genotype	prep_with	11	SENT_219	[p13l42t2181r172b2210],
25	as	IN	O	as	_	0	SENT_219	[p13l186t2186r219b2204],
26	the	DT	O	the	det	28	SENT_219	[p13l231t2180r276b2204],
27	referent	JJ	O	referent	amod	28	SENT_219	[p13l291t2180r403b2204],
28	group	NN	O	group	prep_as	24	SENT_219	[p13l414t2183r503b2210],
29	.	.	O	.	_	0	SENT_219	[p13l414t2183r503b2210],

1	‘	NN	O	‘	nsubj	7	SENT_220	[p13l44t2221r105b2245],
2	The	DT	O	the	det	4	SENT_220	[p13l44t2221r105b2245],
3	P	NN	O	p	nn	4	SENT_220	[p13l119t2221r138b2245],
4	value	NN	O	value	dep	1	SENT_220	[p13l147t2221r222b2245],
5	is	VBZ	O	be	cop	7	SENT_220	[p13l237t2221r259b2245],
6	the	DT	O	the	det	7	SENT_220	[p13l271t2221r316b2245],
7	Cochran	NNP	O	Cochran	_	0	SENT_220	[p13l330t2221r694b2245],
8	.	.	O	.	_	0	SENT_220	[p13l330t2221r694b2245],

1	—	NN	O	—	_	0	SENT_221	[p13l330t2221r694b2245],
2	.	.	O	.	_	0	SENT_221	[p13l330t2221r694b2245],

1	Mante	NNP	PERSON	Mante	nn	2	SENT_222	[p13l330t2221r694b2245],
2	|	NNP	O	|	_	0	SENT_222	[p13l330t2221r694b2245],
3	.	.	O	.	_	0	SENT_222	[p13l330t2221r694b2245],

1	—	NN	O	—	_	0	SENT_223	[p13l330t2221r694b2245],
2	.	.	O	.	_	0	SENT_223	[p13l330t2221r694b2245],

1	Haensze	NNP	O	Haensze	nn	3	SENT_224	[p13l330t2221r694b2245],
2	|	CD	NUMBER	|	num	3	SENT_224	[p13l330t2221r694b2245],
3	test	NN	O	test	_	0	SENT_224	[p13l707t2222r764b2245],
4	of	IN	O	of	_	0	SENT_224	[p13l776t2221r804b2245],
5	general	JJ	O	general	amod	6	SENT_224	[p13l814t2221r919b2251],
6	association	NN	O	association	prep_of	3	SENT_224	[p13l934t2221r1098b2245],
7	compared	VBN	O	compare	_	0	SENT_224	[p13l1112t2221r1253b2250],
8	to	TO	O	to	prepc_compared_to	6	SENT_224	[p13l1266t2223r1293b2245],
9	the	DT	O	the	det	13	SENT_224	[p13l1306t2221r1351b2245],
10	wild	JJ	O	wild	amod	13	SENT_224	[p13l1364t2221r1486b2251],
11	—	NN	O	—	nn	13	SENT_224	[p13l1364t2221r1486b2251],
12	type	NN	O	type	nn	13	SENT_224	[p13l1364t2221r1486b2251],
13	genotype	NN	O	genotype	pobj	6	SENT_224	[p13l1499t2222r1637b2251],
14	.	.	O	.	_	0	SENT_224	[p13l1499t2222r1637b2251],

1	dRe	NNP	O	dRe	nn	4	SENT_225	[p13l44t2259r169b2286],
2	|	NNP	O	|	nn	4	SENT_225	[p13l44t2259r169b2286],
3	ative	JJ	O	ative	amod	4	SENT_225	[p13l44t2259r169b2286],
4	risk	NN	O	risk	nsubj	5	SENT_225	[p13l182t2262r232b2286],
5	calculated	VBN	O	calculate	_	0	SENT_225	[p13l242t2262r388b2286],
6	by	IN	O	by	_	0	SENT_225	[p13l400t2262r430b2292],
7	the	DT	O	the	det	9	SENT_225	[p13l439t2262r484b2286],
8	Mante	NNP	O	Mante	nn	9	SENT_225	[p13l497t2262r655b2286],
9	|	NN	O	|	prep_by	5	SENT_225	[p13l497t2262r655b2286],
10	.	.	O	.	_	0	SENT_225	[p13l497t2262r655b2286],

1	—	NN	O	—	_	0	SENT_226	[p13l497t2262r655b2286],
2	.	.	O	.	_	0	SENT_226	[p13l497t2262r655b2286],

1	Cox	NNP	O	Cox	nsubj	2	SENT_227	[p13l497t2262r655b2286],
2	test	NN	O	test	_	0	SENT_227	[p13l664t2264r728b2290],
3	,	,	O	,	_	0	SENT_227	[p13l664t2264r728b2290],
4	with	IN	O	with	dep	2	SENT_227	[p13l739t2262r796b2286],
5	stratification	NN	O	stratification	pobj	4	SENT_227	[p13l808t2262r985b2286],
6	for	IN	O	for	_	0	SENT_227	[p13l996t2262r1035b2286],
7	aspirin	NN	O	aspirin	nn	8	SENT_227	[p13l1045t2262r1140b2291],
8	use	NN	O	use	prep_for	5	SENT_227	[p13l1152t2268r1211b2290],
9	,	,	O	,	_	0	SENT_227	[p13l1152t2268r1211b2290],
10	time	NN	O	time	nn	12	SENT_227	[p13l1222t2262r1294b2290],
11	,	,	O	,	_	0	SENT_227	[p13l1222t2262r1294b2290],
12	age	NN	O	age	dobj	2	SENT_227	[p13l1307t2266r1365b2292],
13	,	,	O	,	_	0	SENT_227	[p13l1307t2266r1365b2292],
14	and	CC	O	and	_	0	SENT_227	[p13l1378t2262r1429b2286],
15	sex	NN	O	sex	dobj	2	SENT_227	[p13l1441t2268r1497b2290],
16	,	,	O	,	_	0	SENT_227	[p13l1441t2268r1497b2290],
17	with	IN	O	with	_	0	SENT_227	[p13l1508t2262r1565b2286],
18	the	DT	O	the	det	22	SENT_227	[p13l1576t2262r1621b2286],
19	wild	JJ	O	wild	amod	22	SENT_227	[p13l1631t2262r1754b2292],
20	—	NN	O	—	nn	22	SENT_227	[p13l1631t2262r1754b2292],
21	type	NN	O	type	nn	22	SENT_227	[p13l1631t2262r1754b2292],
22	genotype	NN	O	genotype	prep_with	12	SENT_227	[p13l1764t2264r1894b2292],
23	as	IN	O	as	_	0	SENT_227	[p13l1906t2268r1938b2286],
24	the	DT	O	the	det	26	SENT_227	[p13l1948t2262r1993b2286],
25	referent	JJ	O	referent	amod	26	SENT_227	[p13l2006t2262r2117b2286],
26	group	NN	O	group	prep_as	22	SENT_227	[p13l43t2307r131b2333],
27	.	.	O	.	_	0	SENT_227	[p13l43t2307r131b2333],

1	ePatients	NNS	O	epatient	nsubjpass	3	SENT_228	[p13l44t2344r173b2368],
2	were	VBD	O	be	auxpass	3	SENT_228	[p13l184t2350r251b2368],
3	stratified	VBN	O	stratify	_	0	SENT_228	[p13l264t2344r388b2368],
4	at	IN	O	at	_	0	SENT_228	[p13l402t2345r429b2368],
5	study	NN	O	study	nn	6	SENT_228	[p13l440t2344r517b2374],
6	entry	NN	O	entry	prep_at	3	SENT_228	[p13l528t2346r598b2374],
7	according	VBG	O	accord	_	0	SENT_228	[p13l609t2344r747b2374],
8	to	TO	O	to	prepc_according_to	3	SENT_228	[p13l757t2346r784b2368],
9	the	DT	O	the	det	10	SENT_228	[p13l795t2344r841b2368],
10	use	NN	O	use	pobj	3	SENT_228	[p13l854t2350r904b2368],
11	or	CC	O	or	_	0	SENT_228	[p13l916t2350r944b2368],
12	nonuse	NN	O	nonuse	conj_or	10	SENT_228	[p13l956t2350r1060b2368],
13	of	IN	O	of	_	0	SENT_228	[p13l1072t2344r1100b2368],
14	low	JJ	O	low	amod	20	SENT_228	[p13l1111t2344r1234b2368],
15	—	NN	O	—	nn	20	SENT_228	[p13l1111t2344r1234b2368],
16	dose	NN	O	dose	nn	20	SENT_228	[p13l1111t2344r1234b2368],
17	aspirin	NN	O	aspirin	nn	20	SENT_228	[p13l1247t2344r1341b2373],
18	(	NN	O	(	nn	20	SENT_228	[p13l1355t2344r1422b2374],
19	325	CD	NUMBER	325	num	20	SENT_228	[p13l1355t2344r1422b2374],
20	mg	NN	O	mg	prep_of	3	SENT_228	[p13l1435t2347r1477b2374],
21	or	CC	O	or	cc	22	SENT_228	[p13l1488t2350r1516b2368],
22	less	JJR	O	less	num	25	SENT_228	[p13l1528t2344r1585b2368],
23	every	DT	SET	every	det	25	SENT_228	[p13l1597t2350r1672b2374],
24	other	JJ	SET	other	amod	25	SENT_228	[p13l1682t2344r1757b2368],
25	day	NN	SET	day	dobj	3	SENT_228	[p13l1768t2344r1817b2374],
26	or	CC	O	or	_	0	SENT_228	[p13l1828t2350r1855b2368],
27	162.5	CD	NUMBER	162.5	num	28	SENT_228	[p13l1867t2344r1953b2368],
28	mg	NN	O	mg	dobj	3	SENT_228	[p13l1967t2347r2009b2374],
29	or	CC	O	or	_	0	SENT_228	[p13l2020t2350r2048b2368],
30	less	JJR	O	less	conj_or	28	SENT_228	[p13l2060t2344r2116b2368],
31	every	DT	SET	every	det	32	SENT_228	[p13l43t2391r118b2415],
32	day	NN	SET	day	dep	30	SENT_228	[p13l130t2385r196b2415],
33	)	CD	NUMBER	)	dep	30	SENT_228	[p13l130t2385r196b2415],
34	.	.	O	.	_	0	SENT_228	[p13l130t2385r196b2415],

1	Patients	NNS	O	patient	nsubjpass	8	SENT_229	[p13l212t2385r328b2409],
2	not	RB	O	not	prep	1	SENT_229	[p13l342t2387r387b2409],
3	taking	VBG	O	take	dep	2	SENT_229	[p13l398t2385r486b2415],
4	aspirin	NN	O	aspirin	dobj	3	SENT_229	[p13l499t2385r593b2414],
5	at	IN	O	at	_	0	SENT_229	[p13l608t2387r635b2409],
6	baseline	NN	O	baseline	prep_at	3	SENT_229	[p13l648t2385r768b2409],
7	were	VBD	O	be	auxpass	8	SENT_229	[p13l781t2391r848b2409],
8	required	VBN	O	require	_	0	SENT_229	[p13l862t2385r978b2414],
9	to	TO	O	to	aux	10	SENT_229	[p13l990t2387r1018b2409],
10	abstain	VB	O	abstain	xcomp	8	SENT_229	[p13l1032t2385r1136b2409],
11	from	IN	O	from	_	0	SENT_229	[p13l1150t2385r1213b2409],
12	taking	VBG	O	take	prepc_from	10	SENT_229	[p13l1226t2385r1315b2415],
13	it	PRP	O	it	dobj	12	SENT_229	[p13l1328t2385r1344b2409],
14	during	IN	O	during	_	0	SENT_229	[p13l1356t2385r1445b2415],
15	the	DT	O	the	det	16	SENT_229	[p13l1456t2385r1501b2409],
16	trial	NN	O	trial	prep_during	12	SENT_229	[p13l1513t2385r1576b2409],
17	.	.	O	.	_	0	SENT_229	[p13l1513t2385r1576b2409],

1	‘	NN	O	‘	nn	3	SENT_230	[p13l44t2423r164b2450],
2	Relative	JJ	O	relative	amod	3	SENT_230	[p13l44t2423r164b2450],
3	risk	NN	O	risk	nsubj	4	SENT_230	[p13l177t2426r227b2450],
4	calculated	VBN	O	calculate	_	0	SENT_230	[p13l238t2426r383b2450],
5	by	IN	O	by	_	0	SENT_230	[p13l397t2426r427b2456],
6	the	DT	O	the	det	8	SENT_230	[p13l436t2426r481b2450],
7	Mante	NNP	O	Mante	nn	8	SENT_230	[p13l495t2426r653b2450],
8	|	NN	O	|	prep_by	4	SENT_230	[p13l495t2426r653b2450],
9	.	.	O	.	_	0	SENT_230	[p13l495t2426r653b2450],

1	—	NN	O	—	_	0	SENT_231	[p13l495t2426r653b2450],
2	.	.	O	.	_	0	SENT_231	[p13l495t2426r653b2450],

1	Cox	NNP	O	Cox	nsubj	2	SENT_232	[p13l495t2426r653b2450],
2	test	NN	O	test	_	0	SENT_232	[p13l662t2428r719b2450],
3	with	IN	O	with	_	0	SENT_232	[p13l728t2426r785b2450],
4	stratification	NN	O	stratification	prep_with	2	SENT_232	[p13l798t2426r975b2450],
5	for	IN	O	for	_	0	SENT_232	[p13l986t2426r1025b2450],
6	celecoxib	NN	O	celecoxib	nn	7	SENT_232	[p13l1035t2426r1168b2450],
7	treatment	NN	O	treatment	prep_for	2	SENT_232	[p13l1178t2428r1328b2454],
8	,	,	O	,	_	0	SENT_232	[p13l1178t2428r1328b2454],
9	time	NN	O	time	appos	7	SENT_232	[p13l1340t2426r1411b2454],
10	,	,	O	,	_	0	SENT_232	[p13l1340t2426r1411b2454],
11	age	NN	O	age	appos	7	SENT_232	[p13l1425t2430r1483b2456],
12	,	,	O	,	_	0	SENT_232	[p13l1425t2430r1483b2456],
13	and	CC	O	and	_	0	SENT_232	[p13l1497t2426r1547b2450],
14	sex	NN	O	sex	appos	7	SENT_232	[p13l1560t2432r1616b2454],
15	,	,	O	,	_	0	SENT_232	[p13l1560t2432r1616b2454],
16	with	IN	O	with	_	0	SENT_232	[p13l1628t2426r1685b2450],
17	the	DT	O	the	det	21	SENT_232	[p13l1696t2427r1742b2450],
18	wild	JJ	O	wild	amod	21	SENT_232	[p13l1752t2426r1875b2456],
19	—	NN	O	—	nn	21	SENT_232	[p13l1752t2426r1875b2456],
20	type	NN	O	type	nn	21	SENT_232	[p13l1752t2426r1875b2456],
21	genotype	NN	O	genotype	prep_with	2	SENT_232	[p13l1886t2428r2016b2456],
22	as	IN	O	as	_	0	SENT_232	[p13l2028t2432r2060b2450],
23	the	DT	O	the	det	25	SENT_232	[p13l2071t2427r2117b2450],
24	referent	JJ	O	referent	amod	25	SENT_232	[p13l12t2481r250b2531],
25	group	NN	O	group	prep_as	21	SENT_232	[p13l275t2488r463b2544],
26	.	.	O	.	_	0	SENT_232	[p13l275t2488r463b2544],

1	vascular	JJ	O	vascular	amod	4	SENT_233	[p13l7t2705r310b2768],
2	and	CC	O	and	_	0	SENT_233	[p13l351t2704r489b2770],
3	thrombotic	JJ	O	thrombotic	amod	4	SENT_233	[p13l530t2705r953b2768],
4	events	NNS	O	event	nsubj	7	SENT_233	[p13l995t2723r1221b2768],
5	was	VBD	O	be	cop	7	SENT_233	[p13l1262t2729r1394b2768],
6	5.7	CD	PERCENT	5.7	num	7	SENT_233	[p13l1437t2709r1602b2769],
7	%	NN	PERCENT	%	_	0	SENT_233	[p13l1437t2709r1602b2769],
8	among	IN	O	among	_	0	SENT_233	[p13l1644t2728r1901b2791],
9	those	DT	O	those	prep_among	7	SENT_233	[p13l1942t2705r2139b2768],
10	who	WP	O	who	nsubj	11	SENT_233	[p13l9t2810r164b2873],
11	received	VBD	O	receive	rcmod	9	SENT_233	[p13l202t2809r497b2875],
12	placebo	NN	O	placebo	dobj	11	SENT_233	[p13l531t2810r831b2896],
13	,	,	O	,	_	0	SENT_233	[p13l531t2810r831b2896],
14	compared	VBN	O	compare	_	0	SENT_233	[p13l870t2809r1238b2896],
15	with	IN	O	with	prepc_compared_with	11	SENT_233	[p13l1271t2810r1435b2873],
16	9.6	CD	PERCENT	9.6	num	17	SENT_233	[p13l1473t2814r1637b2874],
17	%	NN	PERCENT	%	pobj	11	SENT_233	[p13l1473t2814r1637b2874],
18	for	IN	O	for	_	0	SENT_233	[p13l1673t2810r1780b2873],
19	low-dose	JJ	O	low-dose	amod	22	SENT_233	[p13l1814t2809r2139b2875],
20	celecoxib	NN	O	celecoxib	nn	22	SENT_233	[p13l11t2915r341b2979],
21	(	CD	NUMBER	(	num	22	SENT_233	[p13l398t2915r552b2998],
22	RR	NN	O	rr	prep_for	17	SENT_233	[p13l398t2915r552b2998],
23	,	,	O	,	_	0	SENT_233	[p13l398t2915r552b2998],
24	1.62	CD	NUMBER	1.62	conj_and	7	SENT_233	[p13l613t2919r777b2994],
25	;	:	O	;	_	0	SENT_233	[p13l613t2919r777b2994],
26	95	CD	PERCENT	95	number	27	SENT_233	[p13l832t2919r976b2979],
27	%	NN	PERCENT	%	amod	28	SENT_233	[p13l832t2919r976b2979],
28	CI	NN	O	ci	dep	24	SENT_233	[p13l1030t2920r1129b2979],
29	:	:	O	:	_	0	SENT_233	[p13l1030t2920r1129b2979],
30	0.90	CD	NUMBER	0.90	number	31	SENT_233	[p13l1185t2920r1336b2979],
31	-2.92	CD	NUMBER	-2.92	num	32	SENT_233	[p13l1354t2915r1572b2998],
32	)	NN	O	)	conj_and	7	SENT_233	[p13l1354t2915r1572b2998],
33	and	CC	O	and	_	0	SENT_233	[p13l1628t2914r1766b2980],
34	8.1	CD	PERCENT	8.1	num	35	SENT_233	[p13l1817t2920r1981b2979],
35	%	NN	PERCENT	%	conj_and	7	SENT_233	[p13l1817t2920r1981b2979],
36	for	IN	O	for	_	0	SENT_233	[p13l2033t2915r2141b2979],
37	high-dose	JJ	O	high-dose	amod	39	SENT_233	[p13l10t3019r373b3106],
38	(	NN	O	(	nn	39	SENT_233	[p13l408t3020r562b3103],
39	RR	NN	O	rr	prep_for	35	SENT_233	[p13l408t3020r562b3103],
40	,	,	O	,	_	0	SENT_233	[p13l408t3020r562b3103],
41	1.37	CD	NUMBER	1.37	appos	39	SENT_233	[p13l603t3025r768b3099],
42	;	:	O	;	_	0	SENT_233	[p13l603t3025r768b3099],
43	95	CD	PERCENT	95	num	44	SENT_233	[p13l803t3024r946b3084],
44	%	NN	PERCENT	%	dep	35	SENT_233	[p13l803t3024r946b3084],
45	CI	NN	O	ci	dep	44	SENT_233	[p13l980t3025r1079b3084],
46	:	:	O	:	_	0	SENT_233	[p13l980t3025r1079b3084],
47	0.75-2	CD	NUMBER	0.75-2	dep	35	SENT_233	[p13l1115t3020r1512b3103],
48	.51	CD	NUMBER	.51	num	49	SENT_233	[p13l1115t3020r1512b3103],
49	)	NN	O	)	dep	47	SENT_233	[p13l1115t3020r1512b3103],
50	.	.	O	.	_	0	SENT_233	[p13l1115t3020r1512b3103],

1	However	RB	O	however	advmod	18	SENT_234	[p13l1548t3026r1887b3099],
2	,	,	O	,	_	0	SENT_234	[p13l1548t3026r1887b3099],
3	in	IN	O	in	_	0	SENT_234	[p13l1920t3022r1992b3083],
4	the	DT	O	the	det	5	SENT_234	[p13l2024t3020r2139b3083],
5	subgroups	NNS	O	subgroup	prep_in	18	SENT_234	[p13l11t3126r412b3212],
6	with	IN	O	with	_	0	SENT_234	[p13l441t3126r611b3189],
7	variant	JJ	O	variant	amod	8	SENT_234	[p13l637t3128r909b3189],
8	genotypes	NNS	O	genotype	prep_with	5	SENT_234	[p13l938t3144r1341b3212],
9	,	,	O	,	_	0	SENT_234	[p13l938t3144r1341b3212],
10	the	DT	O	the	det	12	SENT_234	[p13l1372t3126r1491b3189],
11	excess	JJ	O	excess	amod	12	SENT_234	[p13l1521t3150r1747b3189],
12	incidence	NN	O	incidence	nsubj	18	SENT_234	[p13l1777t3125r2139b3191],
13	of	IN	O	of	_	0	SENT_234	[p13l11t3267r98b3330],
14	cardiovascular	JJ	O	cardiovascular	amod	17	SENT_234	[p13l119t3266r675b3332],
15	and	CC	O	and	_	0	SENT_234	[p13l708t3266r850b3332],
16	thrombotic	JJ	O	thrombotic	conj_and	14	SENT_234	[p13l883t3267r1321b3330],
17	events	NNS	O	event	prep_of	12	SENT_234	[p13l1355t3285r1590b3330],
18	appeared	VBD	O	appear	_	0	SENT_234	[p13l1625t3266r1973b3353],
19	primarily	RB	O	primarily	advmod	18	SENT_234	[p13l2005t3269r2138b3353, p14l11t34r257b120],

1	among	IN	O	among	_	0	SENT_235	[p14l299t57r563b120],
2	those	DT	O	those	pobj	1	SENT_235	[p14l607t34r811b97],
3	assigned	VBN	O	assign	rcmod	2	SENT_235	[p14l857t33r1184b120],
4	to	TO	O	to	_	0	SENT_235	[p14l1228t52r1302b97],
5	high-dose	JJ	O	high-dose	amod	6	SENT_235	[p14l1349t33r1726b120],
6	celecoxib	NN	O	celecoxib	prep_to	3	SENT_235	[p14l1772t34r2138b113],
7	,	,	O	,	_	0	SENT_235	[p14l1772t34r2138b113],
8	but	CC	O	but	_	0	SENT_235	[p14l9t139r140b202],
9	not	RB	O	not	neg	10	SENT_235	[p14l172t157r303b202],
10	low-dose	JJ	O	low-dose	conj_but	2	SENT_235	[p14l333t138r690b204],
11	.	.	O	.	_	0	SENT_235	[p14l333t138r690b204],

1	Among	IN	O	among	_	0	SENT_236	[p14l723t145r1004b225],
2	those	DT	O	those	prep_among	24	SENT_236	[p14l1037t139r1240b202],
3	with	IN	O	with	_	0	SENT_236	[p14l1272t139r1442b202],
4	either	CC	O	either	preconj	6	SENT_236	[p14l1477t139r1697b202],
5	CYP2C9	NN	O	cyp2c9	nn	6	SENT_236	[p14l1730t144r2137b203],
6	*	NN	O	*	prep_with	2	SENT_236	[p14l1730t144r2137b203],
7	2	CD	NUMBER	2	dep	6	SENT_236	[p14l1730t144r2137b203],
8	or	CC	O	or	_	0	SENT_236	[p14l11t267r90b307],
9	CYP2C9	CD	NUMBER	cyp2c9	num	12	SENT_236	[p14l144t249r538b308],
10	*	CD	NUMBER	*	num	12	SENT_236	[p14l144t249r538b308],
11	3	CD	NUMBER	3	num	12	SENT_236	[p14l144t249r538b308],
12	genotypes	NNS	O	genotype	conj_or	6	SENT_236	[p14l595t262r982b330],
13	,	,	O	,	_	0	SENT_236	[p14l595t262r982b330],
14	the	DT	O	the	det	16	SENT_236	[p14l1036t244r1151b307],
15	cumulative	JJ	O	cumulative	amod	16	SENT_236	[p14l1204t244r1614b307],
16	incidence	NN	O	incidence	nsubj	24	SENT_236	[p14l1666t243r2014b309],
17	of	IN	O	of	_	0	SENT_236	[p14l2068t244r2152b307],
18	cardiovascular	JJ	O	cardiovascular	amod	21	SENT_236	[p14l11t348r544b414],
19	and	CC	O	and	_	0	SENT_236	[p14l586t348r724b414],
20	thrombotic	JJ	O	thrombotic	conj_and	18	SENT_236	[p14l766t349r1189b412],
21	events	NNS	O	event	prep_of	16	SENT_236	[p14l1232t367r1457b412],
22	was	VBD	O	be	cop	24	SENT_236	[p14l1500t373r1632b412],
23	4.0	CD	PERCENT	4.0	num	24	SENT_236	[p14l1676t354r1841b413],
24	%	NN	PERCENT	%	_	0	SENT_236	[p14l1676t354r1841b413],
25	among	IN	O	among	_	0	SENT_236	[p14l1884t372r2141b435],
26	those	DT	O	those	prep_among	24	SENT_236	[p14l11t454r208b517],
27	who	WP	O	who	nsubj	28	SENT_236	[p14l261t454r416b517],
28	received	VBD	O	receive	rcmod	26	SENT_236	[p14l473t453r767b519],
29	placebo	NN	O	placebo	dobj	28	SENT_236	[p14l820t454r1120b540],
30	,	,	O	,	_	0	SENT_236	[p14l820t454r1120b540],
31	compared	VBN	O	compare	_	0	SENT_236	[p14l1176t453r1544b540],
32	with	IN	O	with	prepc_compared_with	24	SENT_236	[p14l1595t454r1760b517],
33	3.1	CD	PERCENT	3.1	num	34	SENT_236	[p14l1816t459r1979b518],
34	%	NN	PERCENT	%	pobj	24	SENT_236	[p14l1816t459r1979b518],
35	for	IN	O	for	_	0	SENT_236	[p14l2034t454r2141b517],
36	low-dose	JJ	O	low-dose	amod	39	SENT_236	[p14l10t558r335b624],
37	celecoxib	NN	O	celecoxib	nn	39	SENT_236	[p14l389t559r719b623],
38	(	CD	NUMBER	(	num	39	SENT_236	[p14l777t559r931b642],
39	RR	NN	O	rr	prep_for	34	SENT_236	[p14l777t559r931b642],
40	,	,	O	,	_	0	SENT_236	[p14l777t559r931b642],
41	0.83	CD	NUMBER	0.83	appos	34	SENT_236	[p14l987t564r1158b638],
42	;	:	O	;	_	0	SENT_236	[p14l987t564r1158b638],
43	95	CD	PERCENT	95	number	44	SENT_236	[p14l1214t563r1357b623],
44	%	NN	PERCENT	%	amod	45	SENT_236	[p14l1214t563r1357b623],
45	CI	NN	O	ci	dep	41	SENT_236	[p14l1413t564r1512b623],
46	:	:	O	:	_	0	SENT_236	[p14l1413t564r1512b623],
47	0.25-2	CD	NUMBER	0.25-2	num	49	SENT_236	[p14l1569t559r1945b642],
48	.72	CD	NUMBER	.72	num	49	SENT_236	[p14l1569t559r1945b642],
49	)	NN	O	)	dep	41	SENT_236	[p14l1569t559r1945b642],
50	and	CC	O	and	_	0	SENT_236	[p14l2003t558r2140b624],
51	10.9	CD	PERCENT	10.9	num	52	SENT_236	[p14l18t669r221b728],
52	%	NN	PERCENT	%	dep	41	SENT_236	[p14l18t669r221b728],
53	for	IN	O	for	_	0	SENT_236	[p14l263t664r370b727],
54	high-dose	JJ	O	high-dose	amod	57	SENT_236	[p14l410t663r772b750],
55	celecoxib	NN	O	celecoxib	nn	57	SENT_236	[p14l814t664r1144b727],
56	(	CD	NUMBER	(	num	57	SENT_236	[p14l1191t664r1345b747],
57	RR	NN	O	rr	prep_for	52	SENT_236	[p14l1191t664r1345b747],
58	,	,	O	,	_	0	SENT_236	[p14l1191t664r1345b747],
59	2.76	CD	NUMBER	2.76	dep	41	SENT_236	[p14l1387t668r1559b743],
60	;	:	O	;	_	0	SENT_236	[p14l1387t668r1559b743],
61	95	CD	PERCENT	95	num	62	SENT_236	[p14l1604t668r1747b728],
62	%	NN	PERCENT	%	dep	41	SENT_236	[p14l1604t668r1747b728],
63	CI	NN	O	ci	dep	62	SENT_236	[p14l1790t669r1890b728],
64	:	:	O	:	_	0	SENT_236	[p14l1790t669r1890b728],
65	1.087.06	CD	NUMBER	1.087.06	dep	41	SENT_236	[p14l1941t669r2138b728, p14l13t769r209b852],
66	)	NN	O	)	dep	65	SENT_236	[p14l1941t669r2138b728, p14l13t769r209b852],
67	.	.	O	.	_	0	SENT_236	[p14l1941t669r2138b728, p14l13t769r209b852],

1	These	DT	O	these	det	2	SENT_237	[p14l252t769r468b832],
2	associations	NNS	O	association	nsubj	4	SENT_237	[p14l512t771r956b832],
3	appeared	VBD	O	appear	cop	4	SENT_237	[p14l1001t768r1337b855],
4	consistent	JJ	O	consistent	_	0	SENT_237	[p14l1380t771r1757b832],
5	when	WRB	O	when	advmod	6	SENT_237	[p14l1798t769r1996b832],
6	examining	VBG	O	examine	advcl	4	SENT_237	[p14l2040t793r2138b832, p14l11t876r320b960],
7	the	DT	O	the	det	9	SENT_237	[p14l356t874r470b937],
8	CYP2C9	NN	O	cyp2c9	nn	9	SENT_237	[p14l508t879r903b938],
9	*	NN	O	*	dobj	6	SENT_237	[p14l508t879r903b938],
10	2	CD	NUMBER	2	number	14	SENT_237	[p14l508t879r903b938],
11	and	CC	O	and	_	0	SENT_237	[p14l942t873r1080b939],
12	CYP2C9	CD	NUMBER	cyp2c9	num	15	SENT_237	[p14l1116t879r1510b938],
13	*	CD	NUMBER	*	number	14	SENT_237	[p14l1116t879r1510b938],
14	3	CD	NUMBER	3	num	15	SENT_237	[p14l1116t879r1510b938],
15	genotypes	NNS	O	genotype	npadvmod	16	SENT_237	[p14l1550t892r1918b960],
16	separately	RB	O	separately	advmod	6	SENT_237	[p14l1956t896r2138b960, p14l11t979r216b1065],
17	(	RB	O	(	advmod	6	SENT_237	[p14l250t979r478b1062],
18	Table	NNP	O	Table	dep	6	SENT_237	[p14l250t979r478b1062],
19	4	CD	NUMBER	4	num	18	SENT_237	[p14l512t979r599b1062],
20	)	CD	NUMBER	)	dep	18	SENT_237	[p14l512t979r599b1062],
21	.	.	O	.	_	0	SENT_237	[p14l512t979r599b1062],

1	For	IN	O	for	_	0	SENT_238	[p14l100t1090r227b1148],
2	all	DT	O	all	det	3	SENT_238	[p14l258t1085r345b1148],
3	patients	NNS	O	patient	prep_for	11	SENT_238	[p14l377t1087r673b1171],
4	of	IN	O	of	_	0	SENT_238	[p14l708t1085r792b1149],
5	any	DT	O	any	det	6	SENT_238	[p14l814t1108r944b1171],
6	genotype	NN	O	genotype	prep_of	3	SENT_238	[p14l974t1103r1327b1171],
7	,	,	O	,	_	0	SENT_238	[p14l974t1103r1327b1171],
8	there	EX	O	there	expl	11	SENT_238	[p14l1362t1085r1547b1149],
9	did	VBD	O	do	aux	11	SENT_238	[p14l1582t1084r1701b1150],
10	not	RB	O	not	neg	11	SENT_238	[p14l1733t1103r1860b1148],
11	appear	VB	O	appear	_	0	SENT_238	[p14l1893t1107r2141b1171],
12	to	TO	O	to	aux	16	SENT_238	[p14l11t1208r83b1253],
13	be	VB	O	be	cop	16	SENT_238	[p14l123t1190r206b1253],
14	a	DT	O	a	det	16	SENT_238	[p14l247t1214r286b1253],
15	dose-related	JJ	O	dose-related	amod	16	SENT_238	[p14l324t1189r772b1255],
16	increase	NN	O	increase	xcomp	11	SENT_238	[p14l810t1192r1103b1254],
17	in	IN	O	in	_	0	SENT_238	[p14l1143t1192r1216b1253],
18	either	CC	O	either	preconj	22	SENT_238	[p14l1256t1190r1468b1254],
19	renal	JJ	O	renal	amod	22	SENT_238	[p14l1508t1190r1690b1254],
20	and	CC	O	and	_	0	SENT_238	[p14l1731t1189r1869b1255],
21	hypertensive	JJ	O	hypertensive	amod	22	SENT_238	[p14l1907t1190r2138b1276, p14l11t1297r262b1359],
22	disorders	NNS	O	disorder	prep_in	16	SENT_238	[p14l294t1294r631b1360],
23	or	CC	O	or	_	0	SENT_238	[p14l664t1318r741b1358],
24	gastrointestinal	JJ	O	gastrointestinal	amod	25	SENT_238	[p14l770t1295r1350b1381],
25	ulceration	NN	O	ulceration	conj_or	22	SENT_238	[p14l1380t1295r1756b1359],
26	and	CC	O	and	_	0	SENT_238	[p14l1786t1294r1925b1360],
27	hemorrhage	NN	O	hemorrhage	conj_and	25	SENT_238	[p14l1953t1295r2138b1358, p14l11t1402r314b1489],
28	,	,	O	,	_	0	SENT_238	[p14l1953t1295r2138b1358, p14l11t1402r314b1489],
29	consistent	JJ	O	consistent	dep	47	SENT_238	[p14l352t1404r732b1466],
30	with	IN	O	with	_	0	SENT_238	[p14l765t1402r931b1466],
31	the	DT	O	the	det	33	SENT_238	[p14l969t1402r1084b1466],
32	overall	JJ	O	overall	amod	33	SENT_238	[p14l1122t1401r1367b1466],
33	results	NNS	O	result	prep_with	29	SENT_238	[p14l1404t1402r1645b1466],
34	of	IN	O	of	_	0	SENT_238	[p14l1684t1402r1769b1466],
35	the	DT	O	the	det	36	SENT_238	[p14l1794t1402r1909b1466],
36	trial.-2	NN	O	trial.-2	prep_of	33	SENT_238	[p14l1946t1402r2148b1466],
37	When	WRB	O	when	advmod	47	SENT_238	[p14l8t1510r228b1574],
38	examined	VBN	O	examine	partmod	47	SENT_238	[p14l267t1509r624b1576],
39	according	VBG	O	accord	_	0	SENT_238	[p14l662t1509r1028b1597],
40	to	TO	O	to	prepc_according_to	38	SENT_238	[p14l1066t1528r1139b1574],
41	subgroups	NNS	O	subgroup	pobj	38	SENT_238	[p14l1180t1510r1569b1597],
42	deﬁned	VBN	O	deﬁned	partmod	41	SENT_238	[p14l1610t1509r1884b1576],
43	by	IN	O	by	_	0	SENT_238	[p14l1920t1510r2008b1597],
44	genotype	NN	O	genotype	agent	42	SENT_238	[p14l2045t1534r2148b1597, p14l10t1635r282b1704],
45	,	,	O	,	_	0	SENT_238	[p14l2045t1534r2148b1597, p14l10t1635r282b1704],
46	there	EX	O	there	expl	47	SENT_238	[p14l318t1617r504b1681],
47	were	VBD	O	be	dep	16	SENT_238	[p14l535t1640r703b1681],
48	also	RB	O	also	advmod	47	SENT_238	[p14l737t1617r879b1681],
49	no	DT	O	no	det	51	SENT_238	[p14l914t1641r1007b1681],
50	consistent	JJ	O	consistent	amod	51	SENT_238	[p14l1043t1619r1422b1681],
51	differences	NNS	O	difference	nsubj	47	SENT_238	[p14l1455t1616r1854b1683],
52	in	IN	O	in	_	0	SENT_238	[p14l1888t1619r1960b1681],
53	risk	NN	O	risk	prep_in	51	SENT_238	[p14l1994t1616r2146b1681],
54	.	.	O	.	_	0	SENT_238	[p14l1994t1616r2146b1681],

1	Although	IN	O	although	mark	3	SENT_239	[p14l7t1725r364b1812],
2	there	EX	O	there	expl	3	SENT_239	[p14l392t1725r578b1789],
3	appeared	VBD	O	appear	advcl	46	SENT_239	[p14l605t1724r943b1812],
4	to	TO	O	to	aux	13	SENT_239	[p14l968t1743r1041b1789],
5	be	VB	O	be	cop	13	SENT_239	[p14l1067t1725r1169b1805],
6	,	,	O	,	_	0	SENT_239	[p14l1067t1725r1169b1805],
7	compared	VBN	O	compare	_	0	SENT_239	[p14l1197t1724r1567b1812],
8	with	IN	O	with	prepc_compared_with	13	SENT_239	[p14l1590t1725r1756b1789],
9	placebo	NN	O	placebo	pobj	13	SENT_239	[p14l1783t1725r2085b1812],
10	,	,	O	,	_	0	SENT_239	[p14l1783t1725r2085b1812],
11	a	DT	O	a	det	13	SENT_239	[p14l2113t1749r2152b1789],
12	higher	JJR	O	higher	amod	13	SENT_239	[p14l10t1831r251b1919],
13	risk	NN	O	risk	xcomp	3	SENT_239	[p14l293t1831r428b1896],
14	of	IN	O	of	_	0	SENT_239	[p14l471t1832r556b1896],
15	renal	JJ	O	renal	amod	18	SENT_239	[p14l587t1832r771b1896],
16	and	CC	O	and	_	0	SENT_239	[p14l813t1831r952b1898],
17	hypertensive	JJ	O	hypertensive	amod	18	SENT_239	[p14l993t1832r1458b1919],
18	events	NNS	O	event	prep_of	13	SENT_239	[p14l1501t1850r1728b1896],
19	associated	VBN	O	associate	partmod	18	SENT_239	[p14l1772t1831r2151b1898],
20	with	IN	O	with	_	0	SENT_239	[p14l9t1939r174b2004],
21	low-dose	JJ	O	low-dose	amod	24	SENT_239	[p14l223t1939r550b2006],
22	celecoxib	NN	O	celecoxib	nn	24	SENT_239	[p14l601t1940r933b2004],
23	(	CD	NUMBER	(	num	24	SENT_239	[p14l987t1940r1142b2024],
24	RR	NN	O	rr	prep_with	19	SENT_239	[p14l987t1940r1142b2024],
25	,	,	O	,	_	0	SENT_239	[p14l987t1940r1142b2024],
26	2.64	CD	NUMBER	2.64	appos	18	SENT_239	[p14l1192t1944r1366b2020],
27	;	:	O	;	_	0	SENT_239	[p14l1192t1944r1366b2020],
28	95	CD	PERCENT	95	number	29	SENT_239	[p14l1418t1944r1562b2005],
29	%	NN	PERCENT	%	amod	30	SENT_239	[p14l1418t1944r1562b2005],
30	CI	NN	O	ci	dep	26	SENT_239	[p14l1614t1945r1714b2005],
31	:	:	O	:	_	0	SENT_239	[p14l1614t1945r1714b2005],
32	1.22-5	CD	NUMBER	1.22-5	num	34	SENT_239	[p14l1774t1940r2145b2024],
33	.68	CD	NUMBER	.68	num	34	SENT_239	[p14l1774t1940r2145b2024],
34	)	NN	O	)	dep	18	SENT_239	[p14l1774t1940r2145b2024],
35	among	IN	O	among	_	0	SENT_239	[p14l11t2071r269b2134],
36	those	DT	O	those	prep_among	34	SENT_239	[p14l315t2047r513b2111],
37	with	IN	O	with	_	0	SENT_239	[p14l559t2047r724b2111],
38	CYP2C9	NN	O	cyp2c9	prep_with	36	SENT_239	[p14l773t2052r1170b2112],
39	*	CD	NUMBER	*	number	40	SENT_239	[p14l773t2052r1170b2112],
40	3	CD	NUMBER	3	num	41	SENT_239	[p14l773t2052r1170b2112],
41	genotypes	NNS	O	genotype	dep	34	SENT_239	[p14l1221t2065r1609b2134],
42	,	,	O	,	_	0	SENT_239	[p14l1221t2065r1609b2134],
43	this	DT	O	this	nsubjpass	46	SENT_239	[p14l1659t2046r1794b2111],
44	was	VBD	O	be	auxpass	46	SENT_239	[p14l1841t2071r1974b2111],
45	not	RB	O	not	neg	46	SENT_239	[p14l2023t2065r2150b2111],
46	observed	VBN	O	observe	_	0	SENT_239	[p14l11t2153r336b2220],
47	with	IN	O	with	_	0	SENT_239	[p14l380t2154r545b2218],
48	the	DT	O	the	det	52	SENT_239	[p14l593t2153r708b2218],
49	high	JJ	O	high	amod	52	SENT_239	[p14l755t2154r922b2241],
50	dose	NN	O	dose	nn	52	SENT_239	[p14l970t2153r1135b2220],
51	(	NN	O	(	nn	52	SENT_239	[p14l1185t2154r1340b2238],
52	RR	NN	O	rr	prep_with	46	SENT_239	[p14l1185t2154r1340b2238],
53	,	,	O	,	_	0	SENT_239	[p14l1185t2154r1340b2238],
54	1.30	CD	NUMBER	1.30	appos	52	SENT_239	[p14l1395t2159r1561b2234],
55	;	:	O	;	_	0	SENT_239	[p14l1395t2159r1561b2234],
56	95	CD	PERCENT	95	number	57	SENT_239	[p14l1611t2158r1755b2219],
57	%	NN	PERCENT	%	amod	58	SENT_239	[p14l1611t2158r1755b2219],
58	CI	NN	O	ci	dep	54	SENT_239	[p14l1803t2159r1903b2218],
59	:	:	O	:	_	0	SENT_239	[p14l1803t2159r1903b2218],
60	0.572.97	CD	NUMBER	0.572.97	num	61	SENT_239	[p14l1954t2158r2147b2219, p14l10t2262r210b2346],
61	)	NN	O	)	dep	46	SENT_239	[p14l1954t2158r2147b2219, p14l10t2262r210b2346],
62	.	.	O	.	_	0	SENT_239	[p14l1954t2158r2147b2219, p14l10t2262r210b2346],

1	Discussion	NN	O	discussion	_	0	SENT_240	[p14l282t2507r794b2580],

1	In	IN	O	in	_	0	SENT_241	[p14l277t2631r355b2689],
2	this	DT	O	this	det	3	SENT_241	[p14l381t2625r516b2690],
3	large	JJ	O	large	prep_in	14	SENT_241	[p14l542t2625r739b2713],
4	,	,	O	,	_	0	SENT_241	[p14l542t2625r739b2713],
5	randomized	VBN	O	randomize	partmod	3	SENT_241	[p14l766t2625r1230b2705],
6	,	,	O	,	_	0	SENT_241	[p14l766t2625r1230b2705],
7	placebo	NN	O	placebo	nn	8	SENT_241	[p14l1257t2625r1955b2713],
8	—	NN	O	—	dobj	5	SENT_241	[p14l1257t2625r1955b2713],
9	controlled	VBN	O	control	partmod	8	SENT_241	[p14l1257t2625r1955b2713],
10	trial	NN	O	trial	dobj	9	SENT_241	[p14l1979t2625r2148b2705],
11	,	,	O	,	_	0	SENT_241	[p14l1979t2625r2148b2705],
12	celecoxib	NN	O	celecoxib	nsubjpass	14	SENT_241	[p14l11t2732r329b2797],
13	was	VBD	O	be	auxpass	14	SENT_241	[p14l367t2757r496b2797],
14	associated	VBN	O	associate	_	0	SENT_241	[p14l535t2732r898b2798],
15	with	IN	O	with	_	0	SENT_241	[p14l932t2732r1092b2797],
16	a	DT	O	a	det	17	SENT_241	[p14l1131t2757r1170b2797],
17	decrease	NN	O	decrease	prep_with	14	SENT_241	[p14l1205t2732r1498b2799],
18	in	IN	O	in	_	0	SENT_241	[p14l1535t2735r1606b2796],
19	the	DT	O	the	det	22	SENT_241	[p14l1644t2732r1755b2797],
20	3-year	JJ	DURATION	3-year	amod	22	SENT_241	[p14l1794t2738r2006b2820],
21	cumulative	JJ	O	cumulative	amod	22	SENT_241	[p14l2042t2757r2148b2797, p14l11t2839r321b2904],
22	incidence	NN	O	incidence	prep_in	17	SENT_241	[p14l348t2839r684b2905],
23	of	IN	O	of	_	0	SENT_241	[p14l712t2839r796b2904],
24	adenoma	NN	O	adenoma	prep_of	22	SENT_241	[p14l811t2839r1144b2905],
25	among	IN	O	among	_	0	SENT_241	[p14l1169t2863r1420b2927],
26	patients	NNS	O	patient	prep_among	14	SENT_241	[p14l1446t2842r1743b2927],
27	with	IN	O	with	_	0	SENT_241	[p14l1772t2839r1937b2904],
28	wildtype	JJ	O	wildtype	amod	32	SENT_241	[p14l1965t2839r2148b2905, p14l11t2965r183b3034],
29	,	,	O	,	_	0	SENT_241	[p14l1965t2839r2148b2905, p14l11t2965r183b3034],
30	variant	JJ	O	variant	amod	32	SENT_241	[p14l230t2949r493b3011],
31	CYP2C9	NN	O	cyp2c9	nn	32	SENT_241	[p14l542t2952r939b3012],
32	*	NN	O	*	prep_with	26	SENT_241	[p14l542t2952r939b3012],
33	2	CD	NUMBER	2	number	34	SENT_241	[p14l542t2952r939b3012],
34	(	CD	NUMBER	(	dep	26	SENT_241	[p14l993t2946r1225b3031],
35	Zone	NNP	O	Zone	nn	37	SENT_241	[p14l993t2946r1225b3031],
36	R144C	NN	O	r144c	nn	37	SENT_241	[p14l1275t2947r1573b3030],
37	)	NN	O	)	dep	34	SENT_241	[p14l1275t2947r1573b3030],
38	,	,	O	,	_	0	SENT_241	[p14l1275t2947r1573b3030],
39	or	CC	O	or	_	0	SENT_241	[p14l1624t2970r1701b3011],
40	CYP2C9	NN	O	cyp2c9	conj_or	26	SENT_241	[p14l1750t2952r2146b3012],
41	*	CD	NUMBER	*	number	42	SENT_241	[p14l1750t2952r2146b3012],
42	3	CD	NUMBER	3	num	48	SENT_241	[p14l1750t2952r2146b3012],
43	(	NN	O	(	nn	48	SENT_241	[p14l13t3054r245b3137],
44	Zone	NNP	O	Zone	nn	48	SENT_241	[p14l13t3054r245b3137],
45	I359L	NNP	O	I359L	nn	48	SENT_241	[p14l281t3058r497b3119],
46	allele	NN	O	allele	nn	48	SENT_241	[p14l533t3053r743b3137],
47	)	NN	O	)	nn	48	SENT_241	[p14l533t3053r743b3137],
48	genotypes	NNS	O	genotype	dep	40	SENT_241	[p14l784t3072r1153b3141],
49	of	IN	O	of	_	0	SENT_241	[p14l1192t3053r1276b3118],
50	CYP2C9	NN	O	cyp2c9	prep_of	40	SENT_241	[p14l1301t3059r1626b3133],
51	,	,	O	,	_	0	SENT_241	[p14l1301t3059r1626b3133],
52	the	DT	O	the	det	54	SENT_241	[p14l1665t3053r1780b3118],
53	principal	JJ	O	principal	amod	54	SENT_241	[p14l1816t3053r2150b3141],
54	enzyme	NN	O	enzyme	appos	50	SENT_241	[p14l11t3185r288b3248],
55	responsible	JJ	O	responsible	amod	54	SENT_241	[p14l333t3160r753b3248],
56	for	IN	O	for	_	0	SENT_241	[p14l797t3160r905b3225],
57	celecoxib	NN	O	celecoxib	nn	58	SENT_241	[p14l947t3160r1279b3225],
58	metabolism	NN	O	metabolism	prep_for	55	SENT_241	[p14l1325t3160r1764b3225],
59	from	IN	O	from	_	0	SENT_241	[p14l1807t3160r1990b3225],
60	the	DT	O	the	det	64	SENT_241	[p14l2034t3160r2149b3225],
61	active	JJ	O	active	amod	63	SENT_241	[p14l11t3270r219b3332],
62	to	TO	O	to	dep	63	SENT_241	[p14l275t3286r348b3332],
63	inactive	JJ	O	inactive	amod	64	SENT_241	[p14l404t3270r689b3332],
64	state	NN	O	state	prep_from	14	SENT_241	[p14l745t3286r934b3332],
65	.	.	O	.	_	0	SENT_241	[p14l745t3286r934b3332],

1	However	RB	O	however	advmod	3	SENT_242	[p14l992t3273r1333b3347],
2	,	,	O	,	_	0	SENT_242	[p14l992t3273r1333b3347],
3	compared	VBN	O	compare	_	0	SENT_242	[p14l1390t3267r1760b3355],
4	with	IN	O	with	_	0	SENT_242	[p14l1812t3267r1978b3332],
5	the	DT	O	the	prep_with	3	SENT_242	[p14l2034t3267r2149b3332],

1	2132	CD	DATE	2132	_	0	SENT_243	[p14l43t3430r119b3454],
2	CHAN	NNP	MISC	CHAN	nn	6	SENT_243	[p14l154t3430r234b3453],
3	ET	NNP	MISC	ET	nn	6	SENT_243	[p14l249t3431r281b3453],
4	AL	NNP	MISC	AL	nn	6	SENT_243	[p14l292t3431r329b3453],
5	GASTROENTEROLOGY	NNP	MISC	GASTROENTEROLOGY	nn	6	SENT_243	[p14l1576t3430r1888b3453],
6	Vol	NNP	O	Vol	dep	1	SENT_243	[p14l1899t3431r1949b3453],
7	.	.	O	.	_	0	SENT_243	[p14l1899t3431r1949b3453],

1	136	CD	NUMBER	136	_	0	SENT_244	[p14l1964t3430r2027b3458],
2	,	,	O	,	_	0	SENT_244	[p14l1964t3430r2027b3458],
3	No.	NN	O	no.	nn	5	SENT_244	[p14l2042t3431r2086b3453],
4	7	CD	NUMBER	7	num	5	SENT_244	[p14l2100t3431r2117b3453],
5	Table	NNP	O	Table	appos	1	SENT_244	[p14l43t3477r132b3504],
6	3	CD	NUMBER	3	dep	5	SENT_244	[p14l146t3477r177b3504],
7	.	.	O	.	_	0	SENT_244	[p14l146t3477r177b3504],

1	Risk	NN	O	risk	_	0	SENT_245	[p14l201t3477r268b3504],
2	of	IN	O	of	_	0	SENT_245	[p14l282t3477r314b3504],
3	Adenoma	NNP	O	Adenoma	prep_of	1	SENT_245	[p14l326t3477r476b3504],
4	According	VBG	O	accord	_	0	SENT_245	[p14l491t3477r648b3511],
5	to	TO	O	to	prepc_according_to	1	SENT_245	[p14l660t3479r691b3504],
6	Celecoxib	NNP	MISC	Celecoxib	nn	7	SENT_245	[p14l707t3477r861b3504],
7	Dose	NNP	MISC	Dose	pobj	1	SENT_245	[p14l878t3477r968b3509],
8	,	,	O	,	_	0	SENT_245	[p14l878t3477r968b3509],
9	Stratified	VBN	O	stratify	partmod	7	SENT_245	[p14l985t3477r1129b3504],
10	by	IN	O	by	_	0	SENT_245	[p14l1146t3477r1180b3511],
11	CYP2C9	NNP	O	CYP2C9	nn	12	SENT_245	[p14l1193t3477r1324b3504],
12	Genotype	NN	O	genotype	agent	9	SENT_245	[p14l1340t3477r1490b3511],

1	Placebo	NNP	O	Placebo	nn	2	SENT_246	[p14l907t3546r1019b3570],
2	Celecoxib	NNP	O	Celecoxib	_	0	SENT_246	[p14l1143t3546r1289b3574],
3	,	,	O	,	_	0	SENT_246	[p14l1143t3546r1289b3574],
4	200	CD	NUMBER	200	num	5	SENT_246	[p14l1304t3546r1361b3570],
5	mg	NN	O	mg	npadvmod	6	SENT_246	[p14l1376t3549r1418b3576],
6	twice	RB	O	twice	dep	8	SENT_246	[p14l1428t3546r1502b3570],
7	daily	RB	SET	daily	advmod	8	SENT_246	[p14l1516t3546r1581b3576],
8	Celecoxib	NNP	O	Celecoxib	dep	2	SENT_246	[p14l1679t3546r1824b3574],
9	,	,	O	,	_	0	SENT_246	[p14l1679t3546r1824b3574],
10	400	CD	NUMBER	400	num	11	SENT_246	[p14l1839t3546r1897b3570],
11	mg	NN	O	mg	appos	8	SENT_246	[p14l1911t3549r1953b3576],
12	twice	RB	O	twice	advmod	13	SENT_246	[p14l1964t3546r2037b3570],
13	daily	RB	SET	daily	dep	2	SENT_246	[p14l2051t3546r2116b3576],

1	All	DT	O	all	_	0	SENT_247	[p14l368t3621r425b3663],
2	patients	NNS	O	patient	dep	1	SENT_247	[p14l453t3621r674b3673],
3	,	,	O	,	_	0	SENT_247	[p14l453t3621r674b3673],
4	No.	NN	O	no.	appos	2	SENT_247	[p14l703t3621r783b3663],
5	at	IN	O	at	_	0	SENT_247	[p14l810t3624r858b3663],
6	riska	NN	O	riska	prep_at	4	SENT_247	[p14l882t3621r995b3663],
7	499	CD	NUMBER	499	num	6	SENT_247	[p14l1930t3621r2033b3663],

1	Cumulative	JJ	O	cumulative	amod	2	SENT_248	[p15l429t18r712b61],
2	incidence	NN	O	incidence	_	0	SENT_248	[p15l739t19r993b68],
3	,	,	O	,	_	0	SENT_248	[p15l739t19r993b68],
4	3	CD	NUMBER	3	num	5	SENT_248	[p15l1020t18r1052b61],
5	y	NN	O	y	appos	2	SENT_248	[p15l1072t29r1112b71],
6	,	,	O	,	_	0	SENT_248	[p15l1072t29r1112b71],
7	%	NN	O	%	dep	2	SENT_248	[p15l1137t18r1177b61],
8	:	:	O	:	_	0	SENT_248	[p15l1204t23r1240b58],
9	SE	NN	O	se	dep	2	SENT_248	[p15l1269t18r1336b61],
10	60.5	CD	NUMBER	60.5	dep	9	SENT_248	[p15l1864t18r1984b61],
11	:	:	O	:	_	0	SENT_248	[p15l2008t23r2044b58],
12	2.3	CD	NUMBER	2.3	dep	10	SENT_248	[p15l2069t18r2153b61],

1	1	CD	NUMBER	1	number	2	SENT_249	[p15l93t136r132b176],
2	’	CD	NUMBER	’	num	3	SENT_249	[p15l93t136r132b176],
3	RR	NN	O	rr	_	0	SENT_249	[p15l431t93r498b134],
4	(	CD	PERCENT	(	number	5	SENT_249	[p15l523t93r650b145],
5	95	CD	PERCENT	95	dep	6	SENT_249	[p15l523t93r650b145],
6	%	NN	PERCENT	%	dep	3	SENT_249	[p15l523t93r650b145],
7	Cl	NN	O	cl	dep	3	SENT_249	[p15l673t93r738b145],
8	)	CD	NUMBER	)	num	7	SENT_249	[p15l673t93r738b145],
9	compared	VBN	O	compare	_	0	SENT_249	[p15l763t93r1014b144],
10	with	IN	O	with	prepc_compared_with	7	SENT_249	[p15l1038t93r1138b135],
11	placebo	NN	O	placebo	pobj	7	SENT_249	[p15l1166t87r1388b144],
12	”	CD	NUMBER	”	number	13	SENT_249	[p15l1166t87r1388b144],
13	1.0	CD	NUMBER	1.0	num	11	SENT_249	[p15l2004t93r2086b135],
14	:	:	O	:	_	0	SENT_249	[p15l93t179r132b215],
15	P	NN	O	p	nn	16	SENT_249	[p15l431t167r464b209],
16	value	NN	O	value	dep	7	SENT_249	[p15l480t167r638b209],
17	‘	CD	NUMBER	‘	dep	16	SENT_249	[p15l480t167r638b209],
18	?	.	O	?	_	0	SENT_249	[p15l480t167r638b209],

1	—	NN	O	—	_	0	SENT_250	[p15l1978t191r2038b195],
2	E	NN	O	e	dep	1	SENT_250	[p15l93t220r132b295],
3	,	,	O	,	_	0	SENT_250	[p15l159t270r200b300],
4	,	,	O	,	_	0	SENT_250	[p15l159t270r200b300],
5	RR	NN	O	rr	appos	1	SENT_250	[p15l431t242r498b283],
6	(	CD	PERCENT	(	number	7	SENT_250	[p15l523t241r650b293],
7	95	CD	PERCENT	95	num	8	SENT_250	[p15l523t241r650b293],
8	%	NN	PERCENT	%	dep	5	SENT_250	[p15l523t241r650b293],
9	Cl	NN	O	cl	nsubj	20	SENT_250	[p15l673t241r738b293],
10	)	CD	NUMBER	)	num	9	SENT_250	[p15l673t241r738b293],
11	compared	VBN	O	compare	_	0	SENT_250	[p15l763t242r1014b293],
12	with	IN	O	with	prepc_compared_with	9	SENT_250	[p15l1038t242r1138b284],
13	200	CD	NUMBER	200	num	15	SENT_250	[p15l1165t241r1267b284],
14	mg	NN	O	mg	nn	15	SENT_250	[p15l1292t236r1392b295],
15	“	NN	O	“	pobj	9	SENT_250	[p15l1292t236r1392b295],
16	—	CD	NUMBER	—	num	19	SENT_250	[p15l1978t265r2038b270],
17	E	NN	O	e	nn	19	SENT_250	[p15l93t302r132b371],
18	E	NN	O	e	nn	19	SENT_250	[p15l160t306r199b388],
19	P	NN	O	p	dep	15	SENT_250	[p15l431t316r464b357],
20	value	NN	O	value	rcmod	1	SENT_250	[p15l480t316r639b358],
21	‘	CD	NUMBER	‘	dobj	20	SENT_250	[p15l480t316r639b358],
22	?	.	O	?	_	0	SENT_250	[p15l480t316r639b358],

1	—	NN	O	—	_	0	SENT_251	[p15l1978t340r2038b344],
2	,3	CD	NUMBER	,3	number	3	SENT_251	[p15l93t372r132b448],
3	3	CD	NUMBER	3	dep	1	SENT_251	[p15l159t395r200b440],
4	By	IN	O	by	_	0	SENT_251	[p15l372t390r430b442],
5	genotype	NN	O	genotype	prep_by	3	SENT_251	[p15l450t393r681b443],
6	:	:	O	:	_	0	SENT_251	[p15l93t448r132b530],
7	$	$	MONEY	$	dep	1	SENT_251	[p15l160t443r199b535],
8	Patients	NNS	MONEY	patient	num	7	SENT_251	[p15l430t465r637b507],
9	with	IN	O	with	_	0	SENT_251	[p15l660t465r760b507],
10	wild-type	JJ	O	wild-type	amod	11	SENT_251	[p15l784t465r1003b517],
11	genotypes	NNS	O	genotype	prep_with	7	SENT_251	[p15l1025t467r1303b518],
12	,	,	O	,	_	0	SENT_251	[p15l1025t467r1303b518],
13	No.	NN	O	no.	appos	11	SENT_251	[p15l1332t465r1412b507],
14	at	IN	O	at	_	0	SENT_251	[p15l1440t467r1487b507],
15	risk	NN	O	risk	prep_at	13	SENT_251	[p15l1512t465r1624b507],
16	‘	CD	NUMBER	‘	num	15	SENT_251	[p15l1512t465r1624b507],
17	?	.	O	?	_	0	SENT_251	[p15l1512t465r1624b507],

1	338	CD	NUMBER	338	number	2	SENT_252	[p15l1931t464r2033b507],
2	§	CD	NUMBER	§	dep	4	SENT_252	[p15l93t534r132b606],
3	Cumulative	JJ	O	cumulative	dep	4	SENT_252	[p15l489t539r771b581],
4	incidence	NN	O	incidence	amod	9	SENT_252	[p15l798t539r1053b588],
5	,	,	O	,	_	0	SENT_252	[p15l798t539r1053b588],
6	3	CD	NUMBER	3	number	7	SENT_252	[p15l1080t539r1111b581],
7	y	NN	O	y	dep	4	SENT_252	[p15l1132t550r1171b591],
8	,	,	O	,	_	0	SENT_252	[p15l1132t550r1171b591],
9	%	NN	O	%	_	0	SENT_252	[p15l1197t539r1236b581],
10	:	:	O	:	_	0	SENT_252	[p15l1264t543r1300b579],
11	SE	NN	O	se	dep	9	SENT_252	[p15l1329t539r1395b581],
12	57.2	CD	NUMBER	57.2	num	11	SENT_252	[p15l1865t539r1984b581],
13	:	:	O	:	_	0	SENT_252	[p15l2008t543r2044b579],
14	2.8	CD	NUMBER	2.8	num	20	SENT_252	[p15l2069t539r2153b581],
15	Q	NNP	O	Q	nn	20	SENT_252	[p15l92t608r133b668],
16	RR	NNP	O	RR	nn	20	SENT_252	[p15l491t613r557b655],
17	(	CD	PERCENT	(	num	20	SENT_252	[p15l583t613r709b665],
18	95	CD	PERCENT	95	num	20	SENT_252	[p15l583t613r709b665],
19	%	NN	PERCENT	%	nn	20	SENT_252	[p15l583t613r709b665],
20	Cl	NN	O	cl	dep	11	SENT_252	[p15l733t613r798b665],
21	)	CD	NUMBER	)	dep	31	SENT_252	[p15l733t613r798b665],
22	compared	VBN	O	compare	prep	21	SENT_252	[p15l822t613r1073b665],
23	with	IN	O	with	pcomp	22	SENT_252	[p15l1097t613r1198b655],
24	placebo	NN	O	placebo	pobj	23	SENT_252	[p15l1226t608r1448b665],
25	“	CD	NUMBER	“	number	26	SENT_252	[p15l1226t608r1448b665],
26	1.0	CD	NUMBER	1.0	num	31	SENT_252	[p15l2004t613r2086b655],
27	P	NN	O	p	nn	31	SENT_252	[p15l490t688r524b729],
28	value	NN	O	value	nn	31	SENT_252	[p15l540t688r697b730],
29	“	CD	NUMBER	“	number	30	SENT_252	[p15l540t688r697b730],
30	—	CD	NUMBER	—	num	31	SENT_252	[p15l1978t711r2038b716],
31	RR	NN	O	rr	rcmod	20	SENT_252	[p15l491t762r557b803],
32	(	CD	PERCENT	(	number	34	SENT_252	[p15l583t762r710b814],
33	95	CD	PERCENT	95	number	34	SENT_252	[p15l583t762r710b814],
34	%	NN	PERCENT	%	amod	31	SENT_252	[p15l583t762r710b814],
35	Cl	NN	O	cl	dep	20	SENT_252	[p15l733t762r798b814],
36	)	CD	NUMBER	)	num	35	SENT_252	[p15l733t762r798b814],
37	compared	VBN	O	compare	_	0	SENT_252	[p15l822t762r1073b813],
38	with	IN	O	with	prepc_compared_with	35	SENT_252	[p15l1097t762r1198b804],
39	200	CD	NUMBER	200	num	40	SENT_252	[p15l1225t762r1326b804],
40	mg	NN	O	mg	pobj	35	SENT_252	[p15l1352t756r1451b815],
41	’	NN	O	’	dep	40	SENT_252	[p15l1352t756r1451b815],
42	—	CD	NUMBER	—	num	45	SENT_252	[p15l1978t786r2038b790],
43	Pvaluee	NNP	O	Pvaluee	nn	45	SENT_252	[p15l490t836r699b878],
44	—	CD	NUMBER	—	num	45	SENT_252	[p15l1978t860r2038b864],
45	Patients	NNS	O	patient	dobj	41	SENT_252	[p15l430t911r637b952],
46	with	IN	O	with	_	0	SENT_252	[p15l660t911r760b952],
47	CYP2C9	NN	O	cyp2c9	nn	50	SENT_252	[p15l786t910r1064b952],
48	*	NN	O	*	nn	50	SENT_252	[p15l786t910r1064b952],
49	2	CD	NUMBER	2	num	50	SENT_252	[p15l786t910r1064b952],
50	genotypes	NNS	O	genotype	prep_with	41	SENT_252	[p15l1087t913r1365b963],
51	,	,	O	,	_	0	SENT_252	[p15l1087t913r1365b963],
52	No.	NN	O	no.	appos	50	SENT_252	[p15l1394t911r1474b952],
53	at	IN	O	at	_	0	SENT_252	[p15l1501t913r1550b952],
54	risk	NN	O	risk	prep_at	41	SENT_252	[p15l1573t911r1686b952],
55	‘	CD	NUMBER	‘	num	54	SENT_252	[p15l1573t911r1686b952],
56	?	.	O	?	_	0	SENT_252	[p15l1573t911r1686b952],

1	111	CD	NUMBER	111	_	0	SENT_253	[p15l1932t911r2033b952],

1	Cumulative	JJ	O	cumulative	amod	2	SENT_254	[p15l489t984r771b1026],
2	incidence	NN	O	incidence	_	0	SENT_254	[p15l798t984r1053b1033],
3	,	,	O	,	_	0	SENT_254	[p15l798t984r1053b1033],
4	3	CD	NUMBER	3	num	5	SENT_254	[p15l1080t984r1111b1026],
5	y	NN	O	y	appos	2	SENT_254	[p15l1132t995r1171b1036],
6	,	,	O	,	_	0	SENT_254	[p15l1132t995r1171b1036],
7	%	NN	O	%	appos	2	SENT_254	[p15l1197t984r1236b1026],
8	:	:	O	:	_	0	SENT_254	[p15l1264t988r1300b1024],
9	SE	NN	O	se	dep	2	SENT_254	[p15l1329t984r1395b1026],
10	68.4	CD	NUMBER	68.4	dep	9	SENT_254	[p15l1864t984r1985b1026],
11	:	:	O	:	_	0	SENT_254	[p15l2008t988r2044b1024],
12	4.6	CD	NUMBER	4.6	number	13	SENT_254	[p15l2067t984r2152b1026],
13	RR	NN	O	rr	amod	17	SENT_254	[p15l491t1057r557b1098],
14	(	CD	PERCENT	(	number	16	SENT_254	[p15l583t1056r709b1108],
15	95	CD	PERCENT	95	number	16	SENT_254	[p15l583t1056r709b1108],
16	%	NN	PERCENT	%	amod	17	SENT_254	[p15l583t1056r709b1108],
17	Cl	NN	O	cl	dep	2	SENT_254	[p15l733t1056r798b1108],
18	)	CD	NUMBER	)	dep	31	SENT_254	[p15l733t1056r798b1108],
19	compared	VBN	O	compare	prep	18	SENT_254	[p15l822t1057r1073b1108],
20	with	IN	O	with	pcomp	19	SENT_254	[p15l1097t1057r1198b1098],
21	placebo	NN	O	placebo	pobj	20	SENT_254	[p15l1226t1051r1447b1108],
22	”	CD	NUMBER	”	num	21	SENT_254	[p15l1226t1051r1447b1108],
23	1.0	CD	NUMBER	1.0	num	31	SENT_254	[p15l2004t1056r2086b1098],
24	Pvalue	NNP	O	Pvalue	nn	31	SENT_254	[p15l490t1132r697b1174],
25	°	CD	NUMBER	°	num	31	SENT_254	[p15l490t1132r697b1174],
26	—	CD	NUMBER	—	num	31	SENT_254	[p15l1978t1155r2038b1160],
27	RR	NN	O	rr	nn	31	SENT_254	[p15l491t1202r557b1244],
28	(	CD	PERCENT	(	num	31	SENT_254	[p15l583t1202r710b1254],
29	95	CD	PERCENT	95	num	31	SENT_254	[p15l583t1202r710b1254],
30	%	NN	PERCENT	%	nn	31	SENT_254	[p15l583t1202r710b1254],
31	Cl	NN	O	cl	rcmod	17	SENT_254	[p15l733t1202r798b1254],
32	)	CD	NUMBER	)	dep	17	SENT_254	[p15l733t1202r798b1254],
33	compared	VBN	O	compare	_	0	SENT_254	[p15l822t1202r1073b1254],
34	with	IN	O	with	prepc_compared_with	32	SENT_254	[p15l1097t1202r1198b1244],
35	200	CD	NUMBER	200	num	36	SENT_254	[p15l1225t1202r1326b1244],
36	mg	NN	O	mg	pobj	32	SENT_254	[p15l1352t1197r1452b1255],
37	’	NN	O	’	dep	36	SENT_254	[p15l1352t1197r1452b1255],
38	—	CD	NUMBER	—	num	41	SENT_254	[p15l1978t1226r2038b1230],
39	Pvaluee	NNP	O	Pvaluee	nn	41	SENT_254	[p15l490t1278r699b1320],
40	—	CD	NUMBER	—	num	41	SENT_254	[p15l1978t1302r2038b1306],
41	Patients	NNS	O	patient	dobj	37	SENT_254	[p15l430t1348r637b1389],
42	with	IN	O	with	_	0	SENT_254	[p15l660t1348r760b1389],
43	CYP2C9	NN	O	cyp2c9	prep_with	37	SENT_254	[p15l786t1347r1065b1389],
44	*	CD	NUMBER	*	number	45	SENT_254	[p15l786t1347r1065b1389],
45	3	CD	NUMBER	3	num	46	SENT_254	[p15l786t1347r1065b1389],
46	genotypes	NNS	O	genotype	dep	43	SENT_254	[p15l1087t1350r1365b1400],
47	,	,	O	,	_	0	SENT_254	[p15l1087t1350r1365b1400],
48	No.	NN	O	no.	appos	43	SENT_254	[p15l1394t1348r1474b1389],
49	at	IN	O	at	_	0	SENT_254	[p15l1501t1350r1549b1389],
50	risk	NN	O	risk	prep_at	37	SENT_254	[p15l1573t1348r1686b1389],
51	‘	CD	NUMBER	‘	num	50	SENT_254	[p15l1573t1348r1686b1389],
52	?	.	O	?	_	0	SENT_254	[p15l1573t1348r1686b1389],

1	50	CD	NUMBER	50	_	0	SENT_255	[p15l1967t1347r2033b1389],

1	Cumulative	JJ	O	cumulative	amod	2	SENT_256	[p15l489t1421r772b1463],
2	incidence	NN	O	incidence	_	0	SENT_256	[p15l798t1421r1053b1470],
3	,	,	O	,	_	0	SENT_256	[p15l798t1421r1053b1470],
4	3	CD	NUMBER	3	num	5	SENT_256	[p15l1080t1421r1111b1463],
5	y	NN	O	y	appos	2	SENT_256	[p15l1132t1432r1171b1473],
6	,	,	O	,	_	0	SENT_256	[p15l1132t1432r1171b1473],
7	%	NN	O	%	appos	5	SENT_256	[p15l1197t1421r1236b1463],
8	:	:	O	:	_	0	SENT_256	[p15l1264t1425r1300b1461],
9	SE	NN	O	se	dep	5	SENT_256	[p15l1329t1421r1395b1463],
10	64.6	CD	NUMBER	64.6	dep	9	SENT_256	[p15l1864t1421r1984b1463],
11	:	:	O	:	_	0	SENT_256	[p15l2008t1425r2044b1461],
12	7.0	CD	NUMBER	7.0	num	13	SENT_256	[p15l2070t1421r2153b1463],
13	RR	NN	O	rr	dep	5	SENT_256	[p15l491t1494r557b1535],
14	(	CD	PERCENT	(	num	17	SENT_256	[p15l583t1493r710b1545],
15	95	CD	PERCENT	95	number	16	SENT_256	[p15l583t1493r710b1545],
16	%	NN	PERCENT	%	amod	17	SENT_256	[p15l583t1493r710b1545],
17	Cl	NN	O	cl	dep	13	SENT_256	[p15l733t1493r798b1545],
18	)	CD	NUMBER	)	dep	26	SENT_256	[p15l733t1493r798b1545],
19	compared	VBN	O	compare	prep	18	SENT_256	[p15l822t1494r1073b1545],
20	with	IN	O	with	pcomp	19	SENT_256	[p15l1097t1494r1198b1535],
21	placebo	NN	O	placebo	pobj	20	SENT_256	[p15l1226t1488r1448b1545],
22	”	CD	NUMBER	”	number	23	SENT_256	[p15l1226t1488r1448b1545],
23	1.0	CD	NUMBER	1.0	num	26	SENT_256	[p15l2004t1493r2086b1535],
24	Pvaluec	NNP	O	Pvaluec	nn	26	SENT_256	[p15l490t1569r697b1611],
25	—	CD	NUMBER	—	num	26	SENT_256	[p15l1978t1592r2038b1597],
26	RR	NN	O	rr	rcmod	2	SENT_256	[p15l491t1639r557b1681],
27	(	CD	PERCENT	(	number	29	SENT_256	[p15l583t1639r710b1691],
28	95	CD	PERCENT	95	number	29	SENT_256	[p15l583t1639r710b1691],
29	%	NN	PERCENT	%	amod	26	SENT_256	[p15l583t1639r710b1691],
30	Cl	NN	O	cl	dep	2	SENT_256	[p15l733t1639r798b1691],
31	)	CD	NUMBER	)	num	30	SENT_256	[p15l733t1639r798b1691],
32	compared	VBN	O	compare	_	0	SENT_256	[p15l822t1639r1073b1691],
33	with	IN	O	with	prepc_compared_with	30	SENT_256	[p15l1097t1639r1198b1681],
34	200	CD	NUMBER	200	num	35	SENT_256	[p15l1225t1639r1326b1681],
35	mg	NN	O	mg	pobj	30	SENT_256	[p15l1352t1634r1452b1692],
36	“	NN	O	“	nn	39	SENT_256	[p15l1352t1634r1452b1692],
37	—	CD	NUMBER	—	num	39	SENT_256	[p15l1978t1663r2038b1667],
38	Pvaluee	NN	O	pvaluee	nn	39	SENT_256	[p15l490t1715r699b1757],
39	—	NN	O	—	dep	2	SENT_256	[p15l1978t1739r2038b1743],

1	<	JJR	O	<	dep	8	SENT_257	[p15l279t3067r532b3132],
2	.001	CD	NUMBER	.001	num	3	SENT_257	[p15l279t3067r532b3132],
3	<	JJR	O	<	dep	1	SENT_257	[p15l1719t3067r1972b3132],
4	.001	CD	NUMBER	.001	number	5	SENT_257	[p15l1719t3067r1972b3132],
5	1.0	CD	NUMBER	1.0	dep	3	SENT_257	[p15l299t3179r424b3242],
6	0.89	CD	NUMBER	0.89	dep	8	SENT_257	[p15l1446t3179r1627b3242],
7	(	CD	NUMBER	(	num	8	SENT_257	[p15l1658t3179r2154b3257],
8	o.	NN	O	o.	dep	14	SENT_257	[p15l1658t3179r2154b3257],
9	72	CD	NUMBER	72	number	10	SENT_257	[p15l1658t3179r2154b3257],
10	—	CD	NUMBER	—	dep	8	SENT_257	[p15l1658t3179r2154b3257],
11	1.11	CD	NUMBER	1.11	num	12	SENT_257	[p15l1658t3179r2154b3257],
12	)	NN	O	)	dep	10	SENT_257	[p15l1658t3179r2154b3257],
13	—	CD	NUMBER	—	num	14	SENT_257	[p15l315t3324r406b3331],
14	0.31	CD	NUMBER	0.31	_	0	SENT_257	[p15l1737t3288r1918b3351],

1	1.0	CD	NUMBER	1.0	num	2	SENT_258	[p16l299t699r424b762],
2	0.51	CD	NUMBER	0.51	_	0	SENT_258	[p16l1446t699r1627b762],
3	(	CD	NUMBER	(	num	4	SENT_258	[p16l1658t699r2154b777],
4	O.	NNP	O	O.	dep	2	SENT_258	[p16l1658t699r2154b777],
5	30	CD	NUMBER	30	num	4	SENT_258	[p16l1658t699r2154b777],
6	.	.	O	.	_	0	SENT_258	[p16l1658t699r2154b777],

1	—	NN	O	—	_	0	SENT_259	[p16l1658t699r2154b777],
2	.	.	O	.	_	0	SENT_259	[p16l1658t699r2154b777],

1	O.	NNP	O	O.	_	0	SENT_260	[p16l1658t699r2154b777],
2	87	CD	NUMBER	87	number	3	SENT_260	[p16l1658t699r2154b777],
3	)	CD	NUMBER	)	dep	1	SENT_260	[p16l1658t699r2154b777],
4	—	NN	O	—	dep	3	SENT_260	[p16l315t823r406b830],
5	.01	CD	NUMBER	.01	num	4	SENT_260	[p16l1796t787r1918b850],

1	NOTE	VB	O	note	_	0	SENT_261	[p16l45t900r129b924],
2	.	.	O	.	_	0	SENT_261	[p16l45t900r129b924],

1	Wild-type	JJ	O	wild-type	amod	2	SENT_262	[p16l141t900r268b930],
2	genotypes	NNS	O	genotype	nsubj	3	SENT_262	[p16l279t901r426b930],
3	include	VBP	O	include	_	0	SENT_262	[p16l439t900r539b924],
4	individuals	NNS	O	individual	dobj	3	SENT_262	[p16l551t900r702b924],
5	with	IN	O	with	_	0	SENT_262	[p16l712t900r769b924],
6	no	DT	O	no	det	7	SENT_262	[p16l782t906r814b924],
7	*	NN	O	*	prep_with	3	SENT_262	[p16l828t900r863b924],
8	2	CD	NUMBER	2	number	9	SENT_262	[p16l828t900r863b924],
9	(	CD	NUMBER	(	num	7	SENT_262	[p16l875t900r993b930],
10	R1440	NN	O	r1440	dep	7	SENT_262	[p16l875t900r993b930],
11	)	CD	NUMBER	)	num	10	SENT_262	[p16l875t900r993b930],
12	or	CC	O	or	_	0	SENT_262	[p16l1005t906r1033b924],
13	*	CD	NUMBER	*	number	14	SENT_262	[p16l1045t900r1080b924],
14	3	CD	NUMBER	3	num	15	SENT_262	[p16l1045t900r1080b924],
15	(	NN	O	(	conj_or	7	SENT_262	[p16l1092t900r1194b930],
16	|	CD	NUMBER	|	num	19	SENT_262	[p16l1092t900r1194b930],
17	359L	NN	O	359l	nn	19	SENT_262	[p16l1092t900r1194b930],
18	)	NN	O	)	nn	19	SENT_262	[p16l1092t900r1194b930],
19	alleles	NNS	O	allele	dep	15	SENT_262	[p16l1206t900r1307b924],
20	.	.	O	.	_	0	SENT_262	[p16l1206t900r1307b924],

1	CYP2C9	NN	O	cyp2c9	nn	2	SENT_263	[p16l1320t900r1476b924],
2	*	NN	O	*	nsubj	5	SENT_263	[p16l1320t900r1476b924],
3	2	CD	NUMBER	2	num	4	SENT_263	[p16l1320t900r1476b924],
4	genotypes	NNS	O	genotype	dep	2	SENT_263	[p16l1486t901r1633b930],
5	include	VBP	O	include	_	0	SENT_263	[p16l1646t900r1746b924],
6	individuals	NNS	O	individual	dobj	5	SENT_263	[p16l1759t900r1909b924],
7	with	IN	O	with	_	0	SENT_263	[p16l1920t900r1976b924],
8	zone	NN	O	zone	nn	9	SENT_263	[p16l1990t903r2068b924],
9	*	NN	O	*	prep_with	5	SENT_263	[p16l2081t900r2116b924],
10	2	CD	NUMBER	2	num	11	SENT_263	[p16l2081t900r2116b924],
11	allele	NN	O	allele	dep	9	SENT_263	[p16l44t941r127b965],
12	.	.	O	.	_	0	SENT_263	[p16l44t941r127b965],

1	CYP2C9	NN	O	cyp2c9	nsubj	5	SENT_264	[p16l141t941r298b965],
2	*	CD	NUMBER	*	num	1	SENT_264	[p16l141t941r298b965],
3	3	CD	NUMBER	3	num	4	SENT_264	[p16l141t941r298b965],
4	genotypes	NNS	O	genotype	dep	1	SENT_264	[p16l309t942r456b971],
5	include	VBP	O	include	_	0	SENT_264	[p16l470t941r570b965],
6	individuals	NNS	O	individual	dobj	5	SENT_264	[p16l584t941r734b965],
7	with	IN	O	with	_	0	SENT_264	[p16l745t941r802b965],
8	Zone	NNP	O	Zone	prep_with	5	SENT_264	[p16l816t945r894b965],
9	*	CD	NUMBER	*	number	10	SENT_264	[p16l909t941r944b965],
10	3	CD	NUMBER	3	num	11	SENT_264	[p16l909t941r944b965],
11	allele	NN	O	allele	dep	5	SENT_264	[p16l957t941r1040b965],
12	.	.	O	.	_	0	SENT_264	[p16l957t941r1040b965],

1	Individuals	NNS	O	individual	nsubjpass	13	SENT_265	[p16l1056t941r1206b965],
2	with	IN	O	with	_	0	SENT_265	[p16l1218t941r1274b965],
3	one	CD	NUMBER	one	num	4	SENT_265	[p16l1287t947r1339b965],
4	*	NN	O	*	prep_with	1	SENT_265	[p16l1354t941r1389b965],
5	2	CD	NUMBER	2	num	6	SENT_265	[p16l1354t941r1389b965],
6	allele	NN	O	allele	dep	4	SENT_265	[p16l1402t941r1477b965],
7	and	CC	O	and	_	0	SENT_265	[p16l1490t941r1540b965],
8	one	CD	NUMBER	one	num	9	SENT_265	[p16l1553t947r1605b965],
9	*	NN	O	*	conj_and	4	SENT_265	[p16l1619t941r1655b965],
10	3	CD	NUMBER	3	num	11	SENT_265	[p16l1619t941r1655b965],
11	allele	NN	O	allele	dep	9	SENT_265	[p16l1667t941r1742b965],
12	were	VBD	O	be	auxpass	13	SENT_265	[p16l1754t947r1821b965],
13	classified	VBN	O	classify	_	0	SENT_265	[p16l1833t941r1967b965],
14	as	IN	O	as	_	0	SENT_265	[p16l1981t947r2013b965],
15	having	VBG	O	have	prepc_as	13	SENT_265	[p16l2027t941r2118b971],
16	CYP2C9	NN	O	cyp2c9	nn	19	SENT_265	[p16l43t982r200b1006],
17	*	NN	O	*	nn	19	SENT_265	[p16l43t982r200b1006],
18	3	CD	NUMBER	3	num	19	SENT_265	[p16l43t982r200b1006],
19	genotypes	NNS	O	genotype	dobj	15	SENT_265	[p16l212t984r368b1012],
20	.	.	O	.	_	0	SENT_265	[p16l212t984r368b1012],

1	aNo	NNP	O	aNo	_	0	SENT_266	[p16l44t1023r102b1047],
2	.	.	O	.	_	0	SENT_266	[p16l44t1023r102b1047],

1	at	IN	O	at	_	0	SENT_267	[p16l117t1024r144b1047],
2	risk	NN	O	risk	prep_at	3	SENT_267	[p16l158t1023r208b1047],
3	include	VBP	O	include	_	0	SENT_267	[p16l222t1023r322b1047],
4	patients	NNS	O	patient	dobj	3	SENT_267	[p16l337t1023r452b1052],
5	who	WP	O	who	nsubj	6	SENT_267	[p16l464t1023r521b1047],
6	underwent	VBD	O	undergo	rcmod	4	SENT_267	[p16l535t1023r685b1047],
7	a	DT	O	a	det	9	SENT_267	[p16l697t1029r712b1047],
8	follow-up	JJ	O	follow-up	amod	9	SENT_267	[p16l725t1023r851b1052],
9	colonoscopy	NN	O	colonoscopy	dobj	6	SENT_267	[p16l864t1023r1043b1052],
10	at	IN	O	at	_	0	SENT_267	[p16l1055t1024r1082b1047],
11	year	NN	DURATION	year	nn	14	SENT_267	[p16l1093t1028r1154b1052],
12	1	CD	NUMBER	1	num	14	SENT_267	[p16l1167t1023r1184b1046],
13	and/or	NN	O	and/or	nn	14	SENT_267	[p16l1198t1023r1297b1052],
14	year	NN	DURATION	year	prep_at	6	SENT_267	[p16l1307t1028r1368b1052],
15	3	CD	NUMBER	3	nsubj	3	SENT_267	[p16l1380t1023r1406b1047],
16	.	.	O	.	_	0	SENT_267	[p16l1380t1023r1406b1047],
17	"	''	O	"	punct	3	SENT_267	[p16l44t1060r169b1087],

1	Relative	JJ	O	relative	amod	2	SENT_268	[p16l44t1060r169b1087],
2	risk	NN	O	risk	nsubj	3	SENT_268	[p16l184t1063r234b1087],
3	calculated	VBN	O	calculate	_	0	SENT_268	[p16l247t1063r393b1087],
4	by	IN	O	by	_	0	SENT_268	[p16l408t1063r439b1093],
5	the	DT	O	the	det	7	SENT_268	[p16l450t1063r495b1087],
6	Mante	NNP	O	Mante	nn	7	SENT_268	[p16l511t1063r669b1087],
7	|	NN	O	|	prep_by	3	SENT_268	[p16l511t1063r669b1087],
8	.	.	O	.	_	0	SENT_268	[p16l511t1063r669b1087],

1	—	NN	O	—	_	0	SENT_269	[p16l511t1063r669b1087],
2	.	.	O	.	_	0	SENT_269	[p16l511t1063r669b1087],

1	Cox	NNP	O	Cox	nsubj	2	SENT_270	[p16l511t1063r669b1087],
2	test	NN	O	test	_	0	SENT_270	[p16l680t1064r744b1091],
3	,	,	O	,	_	0	SENT_270	[p16l680t1064r744b1091],
4	with	IN	O	with	dep	2	SENT_270	[p16l759t1063r815b1087],
5	stratification	NN	O	stratification	pobj	4	SENT_270	[p16l830t1063r1007b1087],
6	for	IN	O	for	_	0	SENT_270	[p16l1021t1063r1060b1087],
7	aspirin	NN	O	aspirin	nn	8	SENT_270	[p16l1073t1063r1167b1092],
8	use	NN	O	use	prep_for	5	SENT_270	[p16l1183t1069r1241b1091],
9	,	,	O	,	_	0	SENT_270	[p16l1183t1069r1241b1091],
10	time	NN	O	time	nn	12	SENT_270	[p16l1255t1063r1327b1091],
11	,	,	O	,	_	0	SENT_270	[p16l1255t1063r1327b1091],
12	age	NN	O	age	dobj	2	SENT_270	[p16l1342t1067r1401b1093],
13	,	,	O	,	_	0	SENT_270	[p16l1342t1067r1401b1093],
14	and	CC	O	and	_	0	SENT_270	[p16l1417t1063r1467b1087],
15	sex	NN	O	sex	dobj	2	SENT_270	[p16l1482t1069r1538b1091],
16	,	,	O	,	_	0	SENT_270	[p16l1482t1069r1538b1091],
17	with	IN	O	with	_	0	SENT_270	[p16l1552t1063r1608b1087],
18	the	DT	O	the	det	20	SENT_270	[p16l1622t1063r1667b1087],
19	placebo	NN	O	placebo	nn	20	SENT_270	[p16l1683t1063r1793b1092],
20	group	NN	O	group	prep_with	12	SENT_270	[p16l1806t1067r1886b1093],
21	as	IN	O	as	_	0	SENT_270	[p16l1900t1069r1933b1087],
22	the	DT	O	the	det	24	SENT_270	[p16l1945t1063r1991b1087],
23	referent	JJ	O	referent	amod	24	SENT_270	[p16l2006t1063r2118b1087],
24	group	NN	O	group	prep_as	20	SENT_270	[p16l43t1108r131b1135],
25	.	.	O	.	_	0	SENT_270	[p16l43t1108r131b1135],

1	“	NN	O	“	nsubj	8	SENT_271	[p16l44t1146r105b1170],
2	The	DT	O	the	det	4	SENT_271	[p16l44t1146r105b1170],
3	P	NN	O	p	nn	4	SENT_271	[p16l119t1146r138b1170],
4	value	NN	O	value	dep	1	SENT_271	[p16l147t1146r222b1170],
5	is	VBZ	O	be	cop	8	SENT_271	[p16l237t1146r259b1170],
6	the	DT	O	the	det	8	SENT_271	[p16l271t1146r316b1170],
7	Cochran-Mantel-Haenszel	NNP	O	Cochran-Mantel-Haenszel	nn	8	SENT_271	[p16l330t1146r694b1170],
8	test	NN	O	test	_	0	SENT_271	[p16l707t1147r764b1170],
9	of	IN	O	of	_	0	SENT_271	[p16l776t1146r804b1170],
10	general	JJ	O	general	amod	11	SENT_271	[p16l814t1146r919b1176],
11	association	NN	O	association	prep_of	8	SENT_271	[p16l934t1146r1098b1170],
12	compared	VBN	O	compare	_	0	SENT_271	[p16l1112t1146r1253b1175],
13	with	IN	O	with	prepc_compared_with	11	SENT_271	[p16l1266t1146r1323b1170],
14	the	DT	O	the	det	16	SENT_271	[p16l1336t1146r1381b1170],
15	placebo	NN	O	placebo	nn	16	SENT_271	[p16l1396t1146r1506b1175],
16	group	NN	O	group	pobj	11	SENT_271	[p16l1519t1149r1607b1176],
17	.	.	O	.	_	0	SENT_271	[p16l1519t1149r1607b1176],

1	“	NN	O	“	nn	3	SENT_272	[p16l44t1184r169b1211],
2	Relative	JJ	O	relative	amod	3	SENT_272	[p16l44t1184r169b1211],
3	risk	NN	O	risk	nsubj	4	SENT_272	[p16l181t1187r231b1211],
4	calculated	VBN	O	calculate	_	0	SENT_272	[p16l240t1187r386b1211],
5	by	IN	O	by	_	0	SENT_272	[p16l398t1187r428b1217],
6	the	DT	O	the	det	8	SENT_272	[p16l436t1187r481b1211],
7	Mante	NNP	O	Mante	nn	8	SENT_272	[p16l493t1187r651b1211],
8	|	NN	O	|	prep_by	4	SENT_272	[p16l493t1187r651b1211],
9	.	.	O	.	_	0	SENT_272	[p16l493t1187r651b1211],

1	—	NN	O	—	_	0	SENT_273	[p16l493t1187r651b1211],
2	.	.	O	.	_	0	SENT_273	[p16l493t1187r651b1211],

1	Cox	NNP	O	Cox	nsubj	2	SENT_274	[p16l493t1187r651b1211],
2	test	NN	O	test	_	0	SENT_274	[p16l659t1188r723b1215],
3	,	,	O	,	_	0	SENT_274	[p16l659t1188r723b1215],
4	with	IN	O	with	dep	2	SENT_274	[p16l734t1187r790b1211],
5	stratification	NN	O	stratification	pobj	4	SENT_274	[p16l802t1187r979b1211],
6	for	IN	O	for	_	0	SENT_274	[p16l989t1187r1028b1211],
7	aspirin	NN	O	aspirin	nn	8	SENT_274	[p16l1038t1187r1132b1216],
8	use	NN	O	use	prep_for	5	SENT_274	[p16l1144t1193r1203b1215],
9	,	,	O	,	_	0	SENT_274	[p16l1144t1193r1203b1215],
10	time	NN	O	time	nn	12	SENT_274	[p16l1213t1187r1285b1215],
11	,	,	O	,	_	0	SENT_274	[p16l1213t1187r1285b1215],
12	age	NN	O	age	dobj	2	SENT_274	[p16l1297t1190r1355b1217],
13	,	,	O	,	_	0	SENT_274	[p16l1297t1190r1355b1217],
14	and	CC	O	and	_	0	SENT_274	[p16l1368t1187r1418b1211],
15	sex	NN	O	sex	dobj	2	SENT_274	[p16l1429t1193r1485b1215],
16	,	,	O	,	_	0	SENT_274	[p16l1429t1193r1485b1215],
17	with	IN	O	with	_	0	SENT_274	[p16l1496t1187r1552b1211],
18	the	DT	O	the	det	21	SENT_274	[p16l1562t1187r1608b1211],
19	celecoxib	NN	O	celecoxib	nn	21	SENT_274	[p16l1618t1187r1751b1211],
20	200	CD	NUMBER	200	num	21	SENT_274	[p16l1762t1187r1819b1211],
21	mg	NN	O	mg	prep_with	12	SENT_274	[p16l1830t1190r1872b1217],
22	twice	RB	O	twice	advmod	12	SENT_274	[p16l1880t1187r1953b1211],
23	daily	JJ	SET	daily	amod	24	SENT_274	[p16l1964t1187r2029b1217],
24	group	NN	O	group	pobj	22	SENT_274	[p16l2037t1190r2117b1217],
25	as	IN	O	as	_	0	SENT_274	[p16l44t1234r76b1252],
26	the	DT	O	the	det	28	SENT_274	[p16l89t1228r134b1252],
27	referent	JJ	O	referent	amod	28	SENT_274	[p16l149t1228r260b1252],
28	group	NN	O	group	prep_as	22	SENT_274	[p16l272t1232r360b1258],
29	.	.	O	.	_	0	SENT_274	[p16l272t1232r360b1258],

1	5	CD	NUMBER	5	num	2	SENT_275	[p16l44t1269r106b1293],
2	’	CD	NUMBER	’	nsubj	9	SENT_275	[p16l44t1269r106b1293],
3	The	DT	O	the	det	5	SENT_275	[p16l44t1269r106b1293],
4	P	NN	O	p	nn	5	SENT_275	[p16l120t1269r139b1293],
5	value	NN	O	value	dep	2	SENT_275	[p16l148t1269r223b1293],
6	is	VBZ	O	be	cop	9	SENT_275	[p16l238t1269r260b1293],
7	the	DT	O	the	det	9	SENT_275	[p16l272t1269r318b1293],
8	Cochran-Mantel-Haenszel	NNP	O	Cochran-Mantel-Haenszel	nn	9	SENT_275	[p16l331t1269r695b1293],
9	test	NN	O	test	_	0	SENT_275	[p16l708t1270r765b1293],
10	of	IN	O	of	_	0	SENT_275	[p16l777t1269r805b1293],
11	general	JJ	O	general	amod	12	SENT_275	[p16l816t1269r920b1299],
12	association	NN	O	association	prep_of	9	SENT_275	[p16l936t1269r1099b1293],
13	compared	VBN	O	compare	_	0	SENT_275	[p16l1113t1269r1254b1298],
14	with	IN	O	with	prepc_compared_with	12	SENT_275	[p16l1267t1269r1324b1293],
15	celecoxib	NN	O	celecoxib	pobj	12	SENT_275	[p16l1338t1269r1471b1293],
16	200	CD	NUMBER	200	num	17	SENT_275	[p16l1485t1269r1542b1293],
17	mg	NN	O	mg	npadvmod	18	SENT_275	[p16l1556t1272r1598b1299],
18	twice	RB	O	twice	advmod	12	SENT_275	[p16l1609t1269r1682b1293],
19	daily	JJ	SET	daily	amod	20	SENT_275	[p16l1696t1269r1761b1299],
20	group	NN	O	group	pobj	18	SENT_275	[p16l1772t1272r1861b1299],
21	.	.	O	.	_	0	SENT_275	[p16l1772t1272r1861b1299],

1	lower	JJR	O	lower	amod	2	SENT_276	[p16l9t1461r212b1525],
2	dose	NN	O	dose	nsubj	12	SENT_276	[p16l242t1460r426b1540],
3	,	,	O	,	_	0	SENT_276	[p16l242t1460r426b1540],
4	the	DT	O	the	det	6	SENT_276	[p16l458t1461r573b1525],
5	additional	JJ	O	additional	amod	6	SENT_276	[p16l605t1460r988b1527],
6	beneﬁt	NN	O	beneﬁt	appos	2	SENT_276	[p16l1016t1461r1273b1525],
7	of	IN	O	of	_	0	SENT_276	[p16l1303t1461r1389b1525],
8	the	DT	O	the	det	10	SENT_276	[p16l1407t1461r1523b1525],
9	higher	JJR	O	higher	amod	10	SENT_276	[p16l1554t1461r1794b1548],
10	dose	NN	O	dose	prep_of	6	SENT_276	[p16l1824t1460r1989b1527],
11	was	VBD	O	be	cop	12	SENT_276	[p16l2018t1485r2151b1525],
12	restricted	JJ	O	restricted	_	0	SENT_276	[p16l10t1566r359b1633],
13	to	TO	O	to	_	0	SENT_276	[p16l413t1585r485b1631],
14	those	DT	O	those	prep_to	12	SENT_276	[p16l541t1567r739b1631],
15	with	IN	O	with	_	0	SENT_276	[p16l792t1567r958b1631],
16	the	DT	O	the	det	20	SENT_276	[p16l1013t1567r1129b1631],
17	CYP2C9	NN	O	cyp2c9	nn	20	SENT_276	[p16l1184t1572r1581b1632],
18	*	NN	O	*	nn	20	SENT_276	[p16l1184t1572r1581b1632],
19	3	CD	NUMBER	3	num	20	SENT_276	[p16l1184t1572r1581b1632],
20	genotype	NN	O	genotype	prep_with	14	SENT_276	[p16l1639t1585r1992b1654],
21	.	.	O	.	_	0	SENT_276	[p16l1639t1585r1992b1654],

1	Although	IN	O	although	mark	5	SENT_277	[p16l2046t1567r2151b1631, p16l10t1673r283b1760],
2	statistical	JJ	O	statistical	amod	3	SENT_277	[p16l309t1673r664b1737],
3	power	NN	O	power	nsubjpass	5	SENT_277	[p16l688t1696r915b1760],
4	was	VBD	O	be	auxpass	5	SENT_277	[p16l937t1697r1070b1737],
5	limited	VBN	O	limit	advcl	15	SENT_277	[p16l1095t1672r1363b1739],
6	by	IN	O	by	_	0	SENT_277	[p16l1385t1673r1473b1760],
7	the	DT	O	the	det	9	SENT_277	[p16l1496t1673r1611b1737],
8	small	JJ	O	small	amod	9	SENT_277	[p16l1637t1673r1834b1737],
9	number	NN	O	number	agent	5	SENT_277	[p16l1859t1673r2154b1737],
10	of	IN	O	of	_	0	SENT_277	[p16l10t1780r95b1844],
11	events	NNS	O	event	prep_of	9	SENT_277	[p16l133t1798r380b1859],
12	,	,	O	,	_	0	SENT_277	[p16l133t1798r380b1859],
13	it	PRP	O	it	nsubj	15	SENT_277	[p16l430t1782r484b1844],
14	also	RB	O	also	advmod	15	SENT_277	[p16l533t1780r675b1844],
15	appeared	VBD	O	appear	_	0	SENT_277	[p16l726t1779r1064b1867],
16	that	IN	O	that	complm	34	SENT_277	[p16l1113t1780r1282b1859],
17	,	,	O	,	_	0	SENT_277	[p16l1113t1780r1282b1859],
18	among	IN	O	among	_	0	SENT_277	[p16l1334t1804r1592b1867],
19	patients	NNS	O	patient	prep_among	34	SENT_277	[p16l1640t1782r1937b1867],
20	with	IN	O	with	_	0	SENT_277	[p16l1986t1780r2152b1844],
21	variant	JJ	O	variant	amod	22	SENT_277	[p16l6t1916r269b1978],
22	genotypes	NNS	O	genotype	prep_with	19	SENT_277	[p16l308t1932r697b2001],
23	,	,	O	,	_	0	SENT_277	[p16l308t1932r697b2001],
24	the	DT	O	the	det	26	SENT_277	[p16l739t1914r854b1978],
25	increased	VBN	O	increase	amod	26	SENT_277	[p16l893t1913r1240b1980],
26	incidence	NN	O	incidence	nsubjpass	34	SENT_277	[p16l1277t1913r1627b1980],
27	of	IN	O	of	_	0	SENT_277	[p16l1668t1914r1753b1978],
28	cardiovascular	JJ	O	cardiovascular	amod	31	SENT_277	[p16l1780t1913r2151b1980, p16l10t2020r195b2084],
29	and	CC	O	and	_	0	SENT_277	[p16l223t2019r362b2086],
30	thrombotic	JJ	O	thrombotic	amod	31	SENT_277	[p16l389t2020r815b2084],
31	events	NNS	O	event	prep_of	26	SENT_277	[p16l844t2038r1071b2084],
32	was	VBD	O	be	auxpass	34	SENT_277	[p16l1099t2044r1232b2084],
33	primarily	RB	O	primarily	advmod	34	SENT_277	[p16l1262t2020r1609b2107],
34	observed	VBN	O	observe	ccomp	15	SENT_277	[p16l1635t2019r1961b2086],
35	with	IN	O	with	_	0	SENT_277	[p16l1986t2020r2152b2084],
36	high	JJ	O	high	amod	39	SENT_277	[p16l9t2125r374b2213],
37	—	NN	O	—	nn	39	SENT_277	[p16l9t2125r374b2213],
38	dose	NN	O	dose	nn	39	SENT_277	[p16l9t2125r374b2213],
39	celecoxib	NN	O	celecoxib	prep_with	34	SENT_277	[p16l402t2126r734b2190],
40	but	CC	O	but	_	0	SENT_277	[p16l762t2126r891b2190],
41	not	RB	O	not	_	0	SENT_277	[p16l917t2144r1044b2190],
42	low	JJ	O	low	amod	43	SENT_277	[p16l1069t2126r1203b2190],
43	dose	NN	O	dose	prep_with	34	SENT_277	[p16l1228t2125r1409b2192],
44	.	.	O	.	_	0	SENT_277	[p16l1228t2125r1409b2192],

1	In	IN	O	in	dep	13	SENT_278	[p16l1439t2132r1517b2189],
2	contrast	NN	O	contrast	pobj	1	SENT_278	[p16l1544t2144r1867b2205],
3	,	,	O	,	_	0	SENT_278	[p16l1544t2144r1867b2205],
4	among	IN	O	among	_	0	SENT_278	[p16l1896t2150r2154b2213],
5	patients	NNS	O	patient	prep_among	2	SENT_278	[p16l9t2235r307b2320],
6	with	IN	O	with	_	0	SENT_278	[p16l354t2233r520b2297],
7	wild	JJ	O	wild	amod	10	SENT_278	[p16l567t2232r910b2320],
8	—	NN	O	—	nn	10	SENT_278	[p16l567t2232r910b2320],
9	type	NN	O	type	nn	10	SENT_278	[p16l567t2232r910b2320],
10	genotypes	NNS	O	genotype	prep_with	5	SENT_278	[p16l959t2251r1349b2320],
11	,	,	O	,	_	0	SENT_278	[p16l959t2251r1349b2320],
12	both	DT	O	both	det	13	SENT_278	[p16l1396t2233r1572b2297],
13	doses	NNS	O	dose	_	0	SENT_278	[p16l1621t2232r1820b2299],
14	of	IN	O	of	_	0	SENT_278	[p16l1870t2233r1956b2297],
15	celecoxib	NN	O	celecoxib	prep_of	13	SENT_278	[p16l1992t2233r2151b2297, p16l10t2367r204b2431],

1	appeared	VBD	O	appear	csubj	2	SENT_279	[p16l231t2366r569b2454],
2	associated	VBN	O	associate	_	0	SENT_279	[p16l593t2366r973b2433],
3	with	IN	O	with	_	0	SENT_279	[p16l995t2367r1161b2431],
4	risk	NN	O	risk	prep_with	2	SENT_279	[p16l1188t2366r1339b2431],
5	.	.	O	.	_	0	SENT_279	[p16l1188t2366r1339b2431],

1	There	EX	O	there	expl	4	SENT_280	[p16l1366t2367r1581b2431],
2	did	VBD	O	do	aux	4	SENT_280	[p16l1607t2366r1728b2433],
3	not	RB	O	not	neg	4	SENT_280	[p16l1751t2385r1879b2431],
4	appear	VB	O	appear	_	0	SENT_280	[p16l1904t2390r2154b2454],
5	to	TO	O	to	aux	11	SENT_280	[p16l10t2521r82b2567],
6	be	VB	O	be	cop	11	SENT_280	[p16l119t2503r202b2567],
7	a	DT	O	a	det	11	SENT_280	[p16l239t2527r279b2567],
8	signiﬁcant	JJ	O	signiﬁcant	amod	11	SENT_280	[p16l313t2503r703b2590],
9	independent	JJ	O	independent	amod	11	SENT_280	[p16l737t2502r1208b2590],
10	main	JJ	O	main	amod	11	SENT_280	[p16l1244t2505r1434b2567],
11	effect	NN	O	effect	xcomp	4	SENT_280	[p16l1470t2503r1671b2567],
12	of	IN	O	of	_	0	SENT_280	[p16l1707t2503r1792b2567],
13	genotype	NN	O	genotype	prep_of	11	SENT_280	[p16l1816t2521r2152b2590],
14	on	IN	O	on	_	0	SENT_280	[p16l10t2633r105b2674],
15	risk	NN	O	risk	prep_on	13	SENT_280	[p16l139t2608r276b2674],
16	of	IN	O	of	_	0	SENT_280	[p16l310t2609r395b2674],
17	adenoma	NN	O	adenoma	nn	20	SENT_280	[p16l417t2608r762b2675],
18	or	CC	O	or	_	0	SENT_280	[p16l794t2632r871b2674],
19	cardiovascular	JJ	O	cardiovascular	nn	20	SENT_280	[p16l904t2608r1441b2675],
20	events	NNS	O	event	prep_of	15	SENT_280	[p16l1474t2627r1719b2674],
21	.	.	O	.	_	0	SENT_280	[p16l1474t2627r1719b2674],

1	Our	PRP$	O	we	poss	2	SENT_281	[p16l100t2721r250b2780],
2	results	NNS	O	result	nsubj	17	SENT_281	[p16l284t2716r526b2780],
3	regarding	VBG	O	regard	partmod	2	SENT_281	[p16l563t2715r920b2803],
4	a	DT	O	a	det	6	SENT_281	[p16l954t2740r994b2780],
5	differential	JJ	O	differential	amod	6	SENT_281	[p16l1026t2715r1439b2782],
6	effect	NN	O	effect	dobj	3	SENT_281	[p16l1474t2716r1675b2780],
7	of	IN	O	of	_	0	SENT_281	[p16l1709t2716r1795b2780],
8	celecoxib	NN	O	celecoxib	prep_of	6	SENT_281	[p16l1818t2716r2150b2780],
9	on	IN	O	on	_	0	SENT_281	[p16l10t2846r105b2886],
10	adenoma	NN	O	adenoma	nn	11	SENT_281	[p16l143t2821r488b2888],
11	recurrence	NN	O	recurrence	prep_on	8	SENT_281	[p16l524t2845r911b2886],
12	according	VBG	O	accord	_	0	SENT_281	[p16l951t2821r1317b2909],
13	to	TO	O	to	prepc_according_to	3	SENT_281	[p16l1355t2840r1427b2886],
14	CYPZC9	NNP	O	CYPZC9	nn	15	SENT_281	[p16l1469t2827r1774b2887],
15	genotype	NN	O	genotype	pobj	3	SENT_281	[p16l1816t2840r2152b2909],
16	are	VBP	O	be	cop	17	SENT_281	[p16l10t2952r117b2993],
17	consistent	JJ	O	consistent	_	0	SENT_281	[p16l145t2931r525b2993],
18	with	IN	O	with	_	0	SENT_281	[p16l549t2929r715b2993],
19	our	PRP$	O	we	poss	21	SENT_281	[p16l742t2952r871b2993],
20	present	JJ	DATE	present	amod	21	SENT_281	[p16l896t2947r1169b3016],
21	understanding	NN	O	understanding	prep_with	17	SENT_281	[p16l1194t2928r1745b3016],
22	of	IN	O	of	_	0	SENT_281	[p16l1771t2929r1856b2993],
23	the	DT	O	the	det	24	SENT_281	[p16l1870t2929r1986b2993],
24	role	NN	O	role	prep_of	21	SENT_281	[p16l2014t2929r2152b2993],
25	of	IN	O	of	_	0	SENT_281	[p16l10t3035r95b3099],
26	CYPZC9	NN	O	cypzc9	prep_of	24	SENT_281	[p16l126t3040r430b3100],
27	in	IN	O	in	_	0	SENT_281	[p16l475t3037r547b3098],
28	phase	NN	O	phase	nn	31	SENT_281	[p16l588t3035r799b3122],
29	1	CD	NUMBER	1	num	31	SENT_281	[p16l848t3040r877b3098],
30	drug	NN	O	drug	nn	31	SENT_281	[p16l926t3034r1101b3122],
31	metabolism	NN	O	metabolism	prep_in	26	SENT_281	[p16l1141t3035r1581b3099],
32	and	CC	O	and	_	0	SENT_281	[p16l1623t3034r1761b3101],
33	the	DT	O	the	det	35	SENT_281	[p16l1803t3035r1918b3099],
34	functional	JJ	O	functional	amod	35	SENT_281	[p16l1960t3035r2151b3099, p16l10t3142r227b3206],
35	alterations	NNS	O	alteration	prep_with	17	SENT_281	[p16l269t3142r664b3206],
36	associated	VBN	O	associate	partmod	35	SENT_281	[p16l708t3141r1087b3208],
37	with	IN	O	with	_	0	SENT_281	[p16l1125t3142r1291b3206],
38	variant	JJ	O	variant	amod	39	SENT_281	[p16l1330t3144r1594b3206],
39	genotypes	NNS	O	genotype	prep_with	36	SENT_281	[p16l1635t3146r2151b3229],
40	.5	CD	NUMBER	.5	number	41	SENT_281	[p16l1635t3146r2151b3229],
41	‘	CD	NUMBER	‘	num	42	SENT_281	[p16l1635t3146r2151b3229],
42	13	CD	NUMBER	13	dobj	36	SENT_281	[p16l1635t3146r2151b3229],
43	The	DT	O	the	det	45	SENT_281	[p16l7t3247r150b3312],
44	CYPZC9	NN	O	cypzc9	nn	45	SENT_281	[p16l190t3253r495b3313],
45	enzyme	NN	O	enzyme	nsubj	46	SENT_281	[p16l536t3272r814b3335],
46	metabolizes	VBZ	O	metabolize	rcmod	42	SENT_281	[p16l853t3248r1292b3312],
47	celecoxib	NN	O	celecoxib	dobj	46	SENT_281	[p16l1333t3248r1665b3312],
48	from	IN	O	from	_	0	SENT_281	[p16l1705t3248r1888b3312],
49	its	PRP$	O	its	poss	51	SENT_281	[p16l1925t3250r2011b3312],
50	active	JJ	O	active	amod	51	SENT_281	[p16l2051t3272r2151b3312, p16l10t3356r139b3418],
51	state	NN	O	state	prep_from	46	SENT_281	[p16l171t3372r342b3418],
52	to	TO	O	to	_	0	SENT_281	[p16l374t3372r447b3418],
53	an	DT	O	a	det	55	SENT_281	[p16l480t3378r569b3418],
54	inactive	JJ	O	inactive	amod	55	SENT_281	[p16l598t3356r884b3418],
55	form	NN	O	form	prep_to	51	SENT_281	[p16l916t3354r1116b3434],
56	;	:	O	;	_	0	SENT_281	[p16l916t3354r1116b3434],
57	the	DT	O	the	det	61	SENT_281	[p16l1150t3354r1265b3418],
58	CYP2C9	NN	O	cyp2c9	nn	61	SENT_281	[p16l1298t3359r1695b3419],
59	*	NN	O	*	nn	61	SENT_281	[p16l1298t3359r1695b3419],
60	3	CD	NUMBER	3	num	61	SENT_281	[p16l1298t3359r1695b3419],
61	genotype	NN	O	genotype	nsubjpass	63	SENT_281	[p16l1729t3372r2065b3441],
62	is	VBZ	O	be	auxpass	63	SENT_281	[p16l2096t3356r2151b3418],
63	associated	VBN	O	associate	parataxis	17	SENT_281	[p16l10t3460r389b3527],
64	with	IN	O	with	_	0	SENT_281	[p16l425t3461r591b3525],
65	signiﬁcantly	RB	O	signiﬁcantly	advmod	66	SENT_281	[p16l632t3461r1088b3548],
66	greater	JJR	O	greater	amod	67	SENT_281	[p16l1124t3479r1381b3548],
67	impairment	NN	O	impairment	prep_with	63	SENT_281	[p16l1419t3463r1863b3548],
68	of	IN	O	of	_	0	SENT_281	[p16l1902t3461r1988b3525],
69	this	DT	O	this	det	70	SENT_281	[p16l2015t3461r2151b3525],
70	metabolism	NN	O	metabolism	prep_of	67	SENT_281	[p16l10t3567r449b3631],
71	than	IN	O	than	_	0	SENT_281	[p16l489t3566r660b3631],
72	either	CC	O	either	preconj	75	SENT_281	[p16l700t3567r914b3631],
73	the	DT	O	the	det	75	SENT_281	[p16l953t3567r1068b3631],
74	CYP2C9	NN	O	cyp2c9	nn	75	SENT_281	[p16l1109t3572r1507b3632],
75	*	NN	O	*	prep_than	63	SENT_281	[p16l1109t3572r1507b3632],
76	2	CD	NUMBER	2	dep	75	SENT_281	[p16l1109t3572r1507b3632],
77	or	CC	O	or	_	0	SENT_281	[p16l1550t3590r1628b3631],
78	wild	JJ	O	wild	amod	81	SENT_281	[p16l1664t3566r2007b3654],
79	—	NN	O	—	nn	81	SENT_281	[p16l1664t3566r2007b3654],
80	type	NN	O	type	nn	81	SENT_281	[p16l1664t3566r2007b3654],
81	genotype	NN	O	genotype	conj_or	75	SENT_281	[p16l2048t3591r2151b3654, p16l9t3691r280b3760],
82	.	.	O	.	_	0	SENT_281	[p16l2048t3591r2151b3654, p16l9t3691r280b3760],

1	Thus	RB	O	thus	advmod	8	SENT_282	[p16l319t3673r529b3753],
2	,	,	O	,	_	0	SENT_282	[p16l319t3673r529b3753],
3	high	JJ	O	high	amod	6	SENT_282	[p16l568t3672r933b3760],
4	—	NN	O	—	nn	6	SENT_282	[p16l568t3672r933b3760],
5	dose	NN	O	dose	nn	6	SENT_282	[p16l568t3672r933b3760],
6	celecoxib	NN	O	celecoxib	nsubj	8	SENT_282	[p16l972t3673r1305b3737],
7	may	MD	O	may	aux	8	SENT_282	[p16l1346t3697r1501b3760],
8	overwhelm	VB	O	overwhelm	_	0	SENT_282	[p16l1537t3673r1943b3737],
9	a	DT	O	a	dobj	8	SENT_282	[p16l1981t3697r2020b3737],
10	diminished	VBN	O	diminish	partmod	9	SENT_282	[p16l2056t3672r2151b3739, p17l10t16r357b83],

1	capacity	NN	O	capacity	_	0	SENT_283	[p17l393t19r696b104],
2	to	TO	O	to	aux	3	SENT_283	[p17l730t35r802b81],
3	inactivate	VB	O	inactivate	dep	1	SENT_283	[p17l840t19r1198b81],
4	drug	NN	O	drug	dobj	3	SENT_283	[p17l1236t16r1411b104],
5	among	IN	O	among	_	0	SENT_283	[p17l1446t41r1704b104],
6	individuals	NNS	O	individual	prep_among	4	SENT_283	[p17l1738t16r2151b83],
7	with	IN	O	with	_	0	SENT_283	[p17l8t122r173b187],
8	CYP2C9	NN	O	cyp2c9	prep_with	3	SENT_283	[p17l199t128r596b188],
9	*	CD	NUMBER	*	number	10	SENT_283	[p17l199t128r596b188],
10	3	CD	NUMBER	3	num	11	SENT_283	[p17l199t128r596b188],
11	genotypes	NNS	O	genotype	dep	3	SENT_283	[p17l623t141r1011b210],
12	.	.	O	.	_	0	SENT_283	[p17l623t141r1011b210],

1	This	DT	DATE	this	nsubj	3	SENT_284	[p17l1035t123r1199b187],
2	may	MD	DATE	may	aux	3	SENT_284	[p17l1225t147r1380b210],
3	lead	VB	O	lead	_	0	SENT_284	[p17l1401t122r1553b189],
4	to	TO	O	to	prep	3	SENT_284	[p17l1576t141r1648b187],
5	substantially	RB	O	substantially	pcomp	4	SENT_284	[p17l1675t122r2153b210],
6	increased	VBN	O	increase	amod	7	SENT_284	[p17l9t228r342b295],
7	accumulation	NN	O	accumulation	dobj	3	SENT_284	[p17l368t229r862b293],
8	of	IN	O	of	_	0	SENT_284	[p17l890t229r973b293],
9	active	JJ	O	active	amod	10	SENT_284	[p17l989t231r1188b293],
10	celecoxib	NN	O	celecoxib	prep_of	7	SENT_284	[p17l1217t228r1553b309],
11	,	,	O	,	_	0	SENT_284	[p17l1217t228r1553b309],
12	in	IN	O	in	_	0	SENT_284	[p17l1582t231r1653b293],
13	turn	NN	O	turn	prep_in	3	SENT_284	[p17l1680t247r1838b293],
14	potentiating	VBG	O	potentiate	partmod	13	SENT_284	[p17l1864t231r2148b316, p17l10t338r193b423],
15	greater	JJR	O	greater	amod	17	SENT_284	[p17l222t354r468b423],
16	anticancer	JJ	O	anticancer	amod	17	SENT_284	[p17l498t338r868b400],
17	efﬁcacy	NN	O	efﬁcacy	dobj	14	SENT_284	[p17l898t336r1173b423],
18	.	.	O	.	_	0	SENT_284	[p17l898t336r1173b423],

1	In	IN	O	in	_	0	SENT_285	[p17l1206t342r1282b399],
2	contrast	NN	O	contrast	prep_in	18	SENT_285	[p17l1313t354r1621b416],
3	,	,	O	,	_	0	SENT_285	[p17l1313t354r1621b416],
4	the	DT	O	the	det	6	SENT_285	[p17l1654t336r1766b400],
5	metabolic	JJ	O	metabolic	amod	6	SENT_285	[p17l1797t336r2149b400],
6	capacity	NN	O	capacity	nsubj	18	SENT_285	[p17l10t444r300b529],
7	of	IN	O	of	_	0	SENT_285	[p17l325t442r408b506],
8	patients	NNS	O	patient	prep_of	6	SENT_285	[p17l422t444r707b529],
9	with	IN	O	with	_	0	SENT_285	[p17l733t442r894b506],
10	wild-type	JJ	O	wild-type	amod	13	SENT_285	[p17l919t441r1248b529],
11	or	CC	O	or	_	0	SENT_285	[p17l1276t465r1352b506],
12	CYP2C9	NN	O	cyp2c9	conj_or	10	SENT_285	[p17l1378t447r1763b507],
13	*	NN	O	*	prep_with	8	SENT_285	[p17l1378t447r1763b507],
14	2	CD	NUMBER	2	num	15	SENT_285	[p17l1378t447r1763b507],
15	genotypes	NNS	O	genotype	dep	13	SENT_285	[p17l1793t460r2148b529],
16	may	MD	O	may	aux	18	SENT_285	[p17l10t572r162b635],
17	be	VB	O	be	cop	18	SENT_285	[p17l183t548r264b612],
18	sufﬁcient	JJ	O	sufﬁcient	_	0	SENT_285	[p17l292t548r624b612],
19	to	TO	O	to	aux	20	SENT_285	[p17l650t566r721b612],
20	inactivate	VB	O	inactivate	xcomp	18	SENT_285	[p17l749t550r1091b612],
21	high	JJ	O	high	amod	23	SENT_285	[p17l1117t547r1467b635],
22	—	NN	O	—	nn	23	SENT_285	[p17l1117t547r1467b635],
23	dose	NN	O	dose	dobj	20	SENT_285	[p17l1117t547r1467b635],
24	and	CC	O	and	_	0	SENT_285	[p17l1495t547r1630b614],
25	low	JJ	O	low	amod	28	SENT_285	[p17l1654t547r1969b614],
26	—	NN	O	—	nn	28	SENT_285	[p17l1654t547r1969b614],
27	dose	NN	O	dose	nn	28	SENT_285	[p17l1654t547r1969b614],
28	celecoxib	NN	O	celecoxib	conj_and	23	SENT_285	[p17l1996t547r2148b612, p17l10t654r196b718],
29	with	IN	O	with	_	0	SENT_285	[p17l227t654r388b718],
30	equivalent	JJ	O	equivalent	amod	31	SENT_285	[p17l420t653r789b741],
31	efﬁciency	NN	O	efﬁciency	prep_with	20	SENT_285	[p17l819t654r1164b741],
32	.	.	O	.	_	0	SENT_285	[p17l819t654r1164b741],

1	Thus	RB	O	thus	advmod	16	SENT_286	[p17l1196t654r1398b733],
2	,	,	O	,	_	0	SENT_286	[p17l1196t654r1398b733],
3	for	IN	O	for	_	0	SENT_286	[p17l1431t654r1536b718],
4	individuals	NNS	O	individual	prep_for	16	SENT_286	[p17l1564t653r1958b720],
5	with	IN	O	with	_	0	SENT_286	[p17l1989t654r2149b718],
6	these	DT	O	these	det	7	SENT_286	[p17l10t760r191b825],
7	genotypes	NNS	O	genotype	prep_with	4	SENT_286	[p17l220t779r594b848],
8	,	,	O	,	_	0	SENT_286	[p17l220t779r594b848],
9	high	JJ	O	high	amod	12	SENT_286	[p17l624t761r786b848],
10	and	CC	O	and	_	0	SENT_286	[p17l816t760r951b827],
11	low	JJ	O	low	amod	12	SENT_286	[p17l978t760r1108b825],
12	doses	NNS	O	dose	nsubj	16	SENT_286	[p17l1134t760r1326b827],
13	of	IN	O	of	_	0	SENT_286	[p17l1356t761r1440b825],
14	celecoxib	NN	O	celecoxib	prep_of	12	SENT_286	[p17l1457t760r1775b825],
15	may	MD	O	may	aux	16	SENT_286	[p17l1806t785r1958b848],
16	yield	VB	O	yield	_	0	SENT_286	[p17l1981t760r2151b848],
17	comparable	JJ	O	comparable	amod	18	SENT_286	[p17l10t867r427b954],
18	levels	NNS	O	level	dobj	16	SENT_286	[p17l449t867r635b931],
19	of	IN	O	of	_	0	SENT_286	[p17l660t867r743b931],
20	bioavailability	NN	O	bioavailability	prep_of	18	SENT_286	[p17l751t866r1268b954],
21	,	,	O	,	_	0	SENT_286	[p17l751t866r1268b954],
22	resulting	VBG	O	result	partmod	16	SENT_286	[p17l1292t867r1609b954],
23	in	IN	O	in	_	0	SENT_286	[p17l1629t869r1700b930],
24	no	DT	O	no	det	27	SENT_286	[p17l1721t891r1813b931],
25	clinically	RB	O	clinically	advmod	26	SENT_286	[p17l1838t866r2152b954],
26	apparent	JJ	O	apparent	amod	27	SENT_286	[p17l10t992r330b1061],
27	difference	NN	O	difference	prep_in	22	SENT_286	[p17l360t973r709b1040],
28	in	IN	O	in	_	0	SENT_286	[p17l740t976r810b1037],
29	therapeutic	JJ	O	therapeutic	amod	30	SENT_286	[p17l842t974r1247b1061],
30	effectiveness	NN	O	effectiveness	prep_in	27	SENT_286	[p17l1279t974r1734b1038],
31	.	.	O	.	_	0	SENT_286	[p17l1279t974r1734b1038],

1	To	TO	O	to	_	0	SENT_287	[p17l96t1085r197b1144],
2	our	PRP$	O	we	poss	3	SENT_287	[p17l225t1103r354b1144],
3	knowledge	NN	O	knowledge	prep_to	9	SENT_287	[p17l378t1079r795b1167],
4	,	,	O	,	_	0	SENT_287	[p17l378t1079r795b1167],
5	our	PRP$	O	we	poss	6	SENT_287	[p17l824t1103r952b1144],
6	study	NN	O	study	nsubj	9	SENT_287	[p17l977t1079r1182b1167],
7	is	VBZ	O	be	cop	9	SENT_287	[p17l1204t1082r1258b1144],
8	the	DT	O	the	det	9	SENT_287	[p17l1286t1080r1401b1144],
9	ﬁrst	NN	O	ﬁrst	_	0	SENT_287	[p17l1428t1080r1575b1144],
10	to	TO	O	to	aux	11	SENT_287	[p17l1600t1098r1673b1144],
11	examine	VB	O	examine	infmod	9	SENT_287	[p17l1701t1082r2006b1144],
12	the	DT	O	the	det	13	SENT_287	[p17l2033t1080r2149b1144],
13	relationship	NN	O	relationship	nn	17	SENT_287	[p17l10t1185r456b1273],
14	between	IN	O	between	_	0	SENT_287	[p17l497t1186r800b1250],
15	CYP2C9	NN	O	cyp2c9	prep_between	13	SENT_287	[p17l841t1191r1145b1251],
16	genetic	JJ	O	genetic	amod	17	SENT_287	[p17l1189t1188r1451b1273],
17	variants	NNS	O	variant	dobj	11	SENT_287	[p17l1487t1188r1782b1250],
18	and	CC	O	and	_	0	SENT_287	[p17l1824t1185r1963b1252],
19	randomly	RB	O	randomly	advmod	17	SENT_287	[p17l2003t1209r2148b1250, p17l10t1291r246b1379],
20	assigned	VBN	O	assign	amod	22	SENT_287	[p17l279t1291r595b1379],
21	celecoxib	NN	O	celecoxib	nn	22	SENT_287	[p17l631t1292r962b1356],
22	use	NN	O	use	dobj	11	SENT_287	[p17l1000t1316r1120b1356],
23	with	IN	O	with	_	0	SENT_287	[p17l1154t1292r1320b1356],
24	clinical	JJ	O	clinical	amod	25	SENT_287	[p17l1357t1292r1620b1356],
25	outcomes	NNS	O	outcome	prep_with	22	SENT_287	[p17l1657t1310r2033b1356],
26	.	.	O	.	_	0	SENT_287	[p17l1657t1310r2033b1356],

1	In	IN	O	in	_	0	SENT_288	[p17l2071t1298r2150b1355],
2	support	NN	O	support	prep_in	9	SENT_288	[p17l10t1417r304b1486],
3	of	IN	O	of	_	0	SENT_288	[p17l330t1399r415b1463],
4	our	PRP$	O	we	poss	5	SENT_288	[p17l430t1422r559b1463],
5	ﬁndings	NNS	O	ﬁndings	prep_of	2	SENT_288	[p17l584t1398r905b1486],
6	,	,	O	,	_	0	SENT_288	[p17l584t1398r905b1486],
7	previous	JJ	O	previous	amod	8	SENT_288	[p17l933t1401r1247b1486],
8	work	NN	O	work	nsubj	21	SENT_288	[p17l1273t1398r1462b1463],
9	demonstrated	VBD	O	demonstrate	_	0	SENT_288	[p17l1488t1398r2007b1465],
10	the	DT	O	the	det	11	SENT_288	[p17l2034t1399r2149b1463],
11	relevance	NN	O	relevance	dobj	9	SENT_288	[p17l10t1504r347b1569],
12	of	IN	O	of	_	0	SENT_288	[p17l390t1505r475b1569],
13	CYP2C9	NN	O	cyp2c9	nn	15	SENT_288	[p17l505t1510r809b1570],
14	genetic	JJ	O	genetic	amod	15	SENT_288	[p17l854t1507r1116b1592],
15	variation	NN	O	variation	prep_of	11	SENT_288	[p17l1154t1507r1489b1569],
16	with	IN	O	with	_	0	SENT_288	[p17l1528t1504r1694b1569],
17	other	JJ	O	other	amod	19	SENT_288	[p17l1737t1505r1935b1569],
18	drug	NN	O	drug	nn	19	SENT_288	[p17l1976t1504r2151b1592],
19	substrates	NNS	O	substrate	prep_with	15	SENT_288	[p17l10t1611r382b1675],
20	and	CC	O	and	_	0	SENT_288	[p17l428t1610r568b1677],
21	end	VB	O	end	conj_and	9	SENT_288	[p17l611t1610r747b1677],
22	points	NNS	O	point	dobj	21	SENT_288	[p17l789t1613r1042b1698],
23	.	.	O	.	_	0	SENT_288	[p17l789t1613r1042b1698],

1	Several	JJ	O	several	amod	2	SENT_289	[p17l1090t1611r1348b1675],
2	studies	NNS	O	study	nsubj	4	SENT_289	[p17l1393t1610r1651b1677],
3	have	VBP	O	have	aux	4	SENT_289	[p17l1697t1611r1863b1675],
4	shown	VBN	O	show	_	0	SENT_289	[p17l1908t1611r2150b1675],
5	that	IN	O	that	complm	10	SENT_289	[p17l10t1717r162b1781],
6	CYP2C9	NN	O	cyp2c9	nn	8	SENT_289	[p17l214t1722r517b1782],
7	genetic	JJ	O	genetic	amod	8	SENT_289	[p17l573t1719r834b1804],
8	variants	NNS	O	variant	nsubjpass	10	SENT_289	[p17l883t1719r1178b1781],
9	are	VBP	O	be	auxpass	10	SENT_289	[p17l1231t1740r1338b1781],
10	associated	VBN	O	associate	ccomp	4	SENT_289	[p17l1391t1716r1770b1783],
11	with	IN	O	with	_	0	SENT_289	[p17l1818t1717r1984b1781],
12	decreased	VBN	O	decrease	amod	13	SENT_289	[p17l2037t1716r2148b1783, p17l10t1822r290b1889],
13	elimination	NN	O	elimination	prep_with	10	SENT_289	[p17l344t1822r794b1887],
14	of	IN	O	of	_	0	SENT_289	[p17l848t1823r935b1887],
15	warfarin	NN	O	warfarin	prep_of	13	SENT_289	[p17l975t1823r1321b1903],
16	,	,	O	,	_	0	SENT_289	[p17l975t1823r1321b1903],
17	resulting	VBG	O	result	partmod	13	SENT_289	[p17l1378t1823r1722b1910],
18	in	IN	O	in	_	0	SENT_289	[p17l1775t1825r1850b1886],
19	an	DT	O	a	det	21	SENT_289	[p17l1904t1847r1994b1887],
20	increased	VBN	O	increase	amod	21	SENT_289	[p17l2047t1825r2148b1887, p17l10t1928r290b1995],
21	risk	NN	O	risk	prep_in	17	SENT_289	[p17l324t1928r466b1993],
22	of	IN	O	of	_	0	SENT_289	[p17l501t1929r587b1993],
23	overanticoagulation	NN	O	overanticoagulation	prep_of	21	SENT_289	[p17l610t1929r1390b2016],
24	and	CC	O	and	_	0	SENT_289	[p17l1425t1928r1568b1995],
25	complications	NNS	O	complication	conj_and	23	SENT_289	[p17l1602t1929r2148b2016],
26	from	IN	O	from	_	0	SENT_289	[p17l10t2035r197b2099],
27	bleeding	VBG	O	bleed	prepc_from	10	SENT_289	[p17l235t2034r807b2122],
28	.11	CD	NUMBER	.11	number	29	SENT_289	[p17l235t2034r807b2122],
29	»	CD	NUMBER	»	dobj	27	SENT_289	[p17l235t2034r807b2122],
30	21	CD	NUMBER	21	num	31	SENT_289	[p17l235t2034r807b2122],
31	“	NN	O	“	dep	29	SENT_289	[p17l235t2034r807b2122],
32	23	CD	NUMBER	23	num	35	SENT_289	[p17l235t2034r807b2122],
33	Previous	JJ	O	previous	amod	35	SENT_289	[p17l846t2037r1160b2099],
34	case-control	JJ	O	case-control	amod	35	SENT_289	[p17l1200t2035r1648b2099],
35	studies	NNS	O	study	nsubj	38	SENT_289	[p17l1686t2034r1944b2101],
36	have	VBP	O	have	aux	38	SENT_289	[p17l1983t2035r2149b2099],
37	also	RB	O	also	advmod	38	SENT_289	[p17l10t2141r152b2205],
38	demonstrated	VBN	O	demonstrate	rcmod	29	SENT_289	[p17l194t2140r714b2207],
39	that	IN	O	that	complm	52	SENT_289	[p17l753t2140r921b2220],
40	,	,	O	,	_	0	SENT_289	[p17l753t2140r921b2220],
41	compared	VBN	O	compare	_	0	SENT_289	[p17l963t2140r1333b2228],
42	with	IN	O	with	prepc_compared_with	52	SENT_289	[p17l1370t2141r1536b2205],
43	wild	JJ	O	wild	amod	45	SENT_289	[p17l1574t2140r1936b2228],
44	—	NN	O	—	nn	45	SENT_289	[p17l1574t2140r1936b2228],
45	type	NN	O	type	pobj	52	SENT_289	[p17l1574t2140r1936b2228],
46	,	,	O	,	_	0	SENT_289	[p17l1574t2140r1936b2228],
47	individuals	NNS	O	individual	nsubj	52	SENT_289	[p17l1977t2140r2148b2207, p17l6t2246r270b2313],
48	with	IN	O	with	_	0	SENT_289	[p17l299t2247r465b2311],
49	CYP2C9	NN	O	cyp2c9	nn	51	SENT_289	[p17l496t2252r800b2312],
50	variant	JJ	O	variant	amod	51	SENT_289	[p17l829t2249r1092b2311],
51	genotypes	NNS	O	genotype	prep_with	47	SENT_289	[p17l1121t2265r1490b2334],
52	have	VBP	O	have	ccomp	38	SENT_289	[p17l1521t2247r1687b2311],
53	a	DT	O	a	det	55	SENT_289	[p17l1717t2271r1757b2311],
54	lower	JJR	O	lower	amod	55	SENT_289	[p17l1782t2247r1986b2311],
55	risk	NN	O	risk	dobj	52	SENT_289	[p17l2014t2246r2151b2311],
56	of	IN	O	of	_	0	SENT_289	[p17l10t2353r95b2417],
57	colorectal	JJ	O	colorectal	amod	58	SENT_289	[p17l120t2353r481b2417],
58	cancer	NN	O	cancer	prep_of	55	SENT_289	[p17l518t2376r754b2417],
59	associated	VBN	O	associate	partmod	58	SENT_289	[p17l790t2352r1169b2419],
60	with	IN	O	with	_	0	SENT_289	[p17l1202t2353r1368b2417],
61	ibuprofen	NN	O	ibuprofen	prep_with	59	SENT_289	[p17l1405t2353r1861b2440],
62	,	,	O	,	_	0	SENT_289	[p17l1405t2353r1861b2440],
63	“	RB	O	“	advmod	59	SENT_289	[p17l1405t2353r1861b2440],
64	as	RB	O	as	advmod	65	SENT_289	[p17l1897t2377r1967b2417],
65	well	RB	O	well	advmod	10	SENT_289	[p17l2003t2353r2150b2417],

1	June	NNP	DATE	June	_	0	SENT_290	[p17l42t2516r107b2539],
2	2009	CD	DATE	2009	num	1	SENT_290	[p17l120t2515r196b2538],
3	CELECOXIB	NNP	O	CELECOXIB	nn	7	SENT_290	[p17l1222t2515r1388b2543],
4	,	,	O	,	_	0	SENT_290	[p17l1222t2515r1388b2543],
5	CYP2C9	NNP	O	CYP2C9	appos	7	SENT_290	[p17l1402t2515r1516b2538],
6	GENE	NNP	O	GENE	nn	7	SENT_290	[p17l1529t2515r1606b2538],
7	VARIANTS	NNP	O	VARIANTS	dep	1	SENT_290	[p17l1618t2515r1770b2543],
8	,	,	O	,	_	0	SENT_290	[p17l1618t2515r1770b2543],
9	AND	NNP	O	AND	nn	10	SENT_290	[p17l1782t2516r1845b2538],
10	ADENOMA	NNP	O	ADENOMA	appos	7	SENT_290	[p17l1857t2515r2007b2538],
11	2133	CD	DATE	2133	num	12	SENT_290	[p17l2041t2515r2117b2538],
12	Table	NNP	O	Table	dep	10	SENT_290	[p17l43t2562r132b2589],
13	4	CD	NUMBER	4	num	12	SENT_290	[p17l146t2562r177b2589],
14	.	.	O	.	_	0	SENT_290	[p17l146t2562r177b2589],

1	Incidence	NN	O	incidence	_	0	SENT_291	[p17l201t2562r353b2589],
2	of	IN	O	of	_	0	SENT_291	[p17l368t2562r399b2589],
3	Adverse	JJ	O	adverse	amod	4	SENT_291	[p17l411t2562r539b2589],
4	Events	NNS	O	event	prep_of	1	SENT_291	[p17l556t2562r661b2589],
5	After	IN	O	after	dep	1	SENT_291	[p17l675t2562r752b2589],
6	Randomization	NN	O	randomization	pobj	5	SENT_291	[p17l767t2562r1003b2589],
7	According	VBG	O	accord	_	0	SENT_291	[p17l1018t2562r1176b2596],
8	to	TO	O	to	prepc_according_to	6	SENT_291	[p17l1188t2564r1219b2589],
9	Celecoxib	NNP	MISC	Celecoxib	nn	10	SENT_291	[p17l1234t2562r1388b2589],
10	Dose	NNP	MISC	Dose	pobj	6	SENT_291	[p17l1405t2562r1495b2594],
11	,	,	O	,	_	0	SENT_291	[p17l1405t2562r1495b2594],
12	Stratified	VBN	O	stratify	partmod	6	SENT_291	[p17l1512t2562r1656b2589],
13	by	IN	O	by	_	0	SENT_291	[p17l1673t2562r1707b2596],
14	CYP2C9	NNP	O	CYP2C9	nn	15	SENT_291	[p17l1721t2562r1851b2589],
15	Genotype	NN	O	genotype	agent	12	SENT_291	[p17l1867t2562r2017b2596],

1	Placebo	NNP	O	Placebo	nn	2	SENT_292	[p17l811t2634r908b2655],
2	Celecoxib	NNP	O	Celecoxib	_	0	SENT_292	[p17l1141t2634r1268b2658],
3	,	,	O	,	_	0	SENT_292	[p17l1141t2634r1268b2658],
4	200	CD	NUMBER	200	num	5	SENT_292	[p17l1282t2634r1332b2655],
5	mg	NN	O	mg	npadvmod	6	SENT_292	[p17l1344t2637r1381b2660],
6	twice	RB	O	twice	dep	8	SENT_292	[p17l1391t2634r1455b2655],
7	daily	RB	SET	daily	advmod	8	SENT_292	[p17l1467t2634r1524b2660],
8	Celecoxib	NNP	O	Celecoxib	dep	2	SENT_292	[p17l1733t2634r1860b2658],
9	,	,	O	,	_	0	SENT_292	[p17l1733t2634r1860b2658],
10	400	CD	NUMBER	400	num	11	SENT_292	[p17l1873t2634r1924b2655],
11	mg	NN	O	mg	appos	8	SENT_292	[p17l1937t2637r1973b2660],
12	twice	RB	O	twice	advmod	13	SENT_292	[p17l1983t2634r2047b2655],
13	daily	RB	SET	daily	dep	2	SENT_292	[p17l2059t2634r2116b2660],

1	Cardiovascular	NNP	O	Cardiovascular	_	0	SENT_293	[p17l7t2723r457b2773],
2	disordersa	NN	O	disordersa	dep	1	SENT_293	[p17l483t2723r794b2773],

1	All	DT	O	all	_	0	SENT_294	[p17l75t2804r143b2852],
2	patients	NNS	O	patient	dep	1	SENT_294	[p17l176t2804r420b2864],

1	No.	NN	O	no.	_	0	SENT_295	[p17l151t2883r245b2932],
2	with	IN	O	with	_	0	SENT_295	[p17l275t2883r394b2933],
3	event	NN	O	event	prep_with	1	SENT_295	[p17l424t2886r590b2933],
4	/	:	O	/	punct	1	SENT_295	[p17l615t2883r649b2944],
5	No.	NN	O	no.	amod	10	SENT_295	[p17l679t2883r774b2933],
6	at	IN	O	at	_	0	SENT_295	[p17l807t2886r864b2933],
7	risk	NN	O	risk	prep_at	5	SENT_295	[p17l892t2883r998b2933],
8	24/557	CD	NUMBER	24/557	num	7	SENT_295	[p17l1881t2882r2121b2944],
9	Cumulative	JJ	O	cumulative	amod	10	SENT_295	[p17l148t2962r484b3012],
10	incidence	NN	O	incidence	dep	1	SENT_295	[p17l515t2962r818b3020],
11	,	,	O	,	_	0	SENT_295	[p17l515t2962r818b3020],
12	3	CD	NUMBER	3	num	13	SENT_295	[p17l850t2962r887b3012],
13	y	NN	O	y	appos	10	SENT_295	[p17l912t2975r958b3024],
14	,	,	O	,	_	0	SENT_295	[p17l912t2975r958b3024],
15	%	NN	O	%	appos	10	SENT_295	[p17l989t2962r1035b3012],
16	:	:	O	:	_	0	SENT_295	[p17l1068t2967r1110b3010],
17	SE	NN	O	se	dep	10	SENT_295	[p17l1145t2962r1224b3012],
18	5.1	CD	NUMBER	5.1	num	17	SENT_295	[p17l1852t2962r1951b3012],
19	:	:	O	:	_	0	SENT_295	[p17l1980t2967r2022b3010],
20	1.1	CD	NUMBER	1.1	num	21	SENT_295	[p17l2053t2962r2151b3012],
21	RR	NN	O	rr	dep	10	SENT_295	[p17l151t3043r230b3092],
22	(	CD	PERCENT	(	num	25	SENT_295	[p17l260t3042r410b3104],
23	95	CD	PERCENT	95	number	24	SENT_295	[p17l260t3042r410b3104],
24	%	NN	PERCENT	%	amod	25	SENT_295	[p17l260t3042r410b3104],
25	CI	NN	O	ci	dep	21	SENT_295	[p17l438t3042r515b3104],
26	)	CD	NUMBER	)	number	27	SENT_295	[p17l438t3042r515b3104],
27	1.0	CD	NUMBER	1.0	num	25	SENT_295	[p17l1932t3042r2030b3093],

1	By	IN	O	by	_	0	SENT_296	[p17l80t3124r148b3186],
2	genotype	NN	O	genotype	pobj	1	SENT_296	[p17l172t3126r446b3186],

1	Patients	NNS	O	patient	_	0	SENT_297	[p17l150t3203r394b3253],
2	with	IN	O	with	_	0	SENT_297	[p17l422t3203r541b3253],
3	wild	JJ	O	wild	amod	6	SENT_297	[p17l569t3203r829b3265],
4	—	NN	O	—	nn	6	SENT_297	[p17l569t3203r829b3265],
5	type	NN	O	type	nn	6	SENT_297	[p17l569t3203r829b3265],
6	genotypes	NNS	O	genotype	prep_with	1	SENT_297	[p17l856t3206r1167b3266],

1	No.	NN	O	no.	_	0	SENT_298	[p17l221t3283r316b3333],
2	with	IN	O	with	_	0	SENT_298	[p17l346t3283r465b3333],
3	event/No	NN	O	event/no	prep_with	1	SENT_298	[p17l495t3283r797b3344],
4	.	.	O	.	_	0	SENT_298	[p17l495t3283r797b3344],

1	at	IN	O	at	dep	5	SENT_299	[p17l831t3286r887b3333],
2	risk	NN	O	risk	pobj	1	SENT_299	[p17l916t3283r1022b3333],
3	18/377	CD	NUMBER	18/377	num	5	SENT_299	[p17l1882t3282r2121b3344],
4	Cumulative	JJ	O	cumulative	amod	5	SENT_299	[p17l219t3363r554b3414],
5	incidence	NN	O	incidence	_	0	SENT_299	[p17l586t3364r888b3422],
6	,	,	O	,	_	0	SENT_299	[p17l586t3364r888b3422],
7	3	CD	NUMBER	3	num	8	SENT_299	[p17l920t3363r958b3413],
8	y	NN	O	y	appos	5	SENT_299	[p17l982t3376r1028b3426],
9	,	,	O	,	_	0	SENT_299	[p17l982t3376r1028b3426],
10	%	NN	O	%	appos	5	SENT_299	[p17l1059t3363r1106b3413],
11	:	:	O	:	_	0	SENT_299	[p17l1139t3369r1181b3411],
12	SE	NN	O	se	dep	5	SENT_299	[p17l1216t3363r1294b3414],
13	5.7	CD	NUMBER	5.7	dep	12	SENT_299	[p17l1852t3364r1950b3413],
14	:	:	O	:	_	0	SENT_299	[p17l1980t3369r2022b3411],
15	1.4	CD	NUMBER	1.4	num	16	SENT_299	[p17l2053t3364r2152b3413],
16	RR	NN	O	rr	dep	12	SENT_299	[p17l221t3442r300b3492],
17	(	CD	PERCENT	(	num	20	SENT_299	[p17l330t3442r480b3504],
18	95	CD	PERCENT	95	number	19	SENT_299	[p17l330t3442r480b3504],
19	%	NN	PERCENT	%	amod	20	SENT_299	[p17l330t3442r480b3504],
20	CI	NN	O	ci	dep	16	SENT_299	[p17l508t3442r585b3504],
21	)	CD	NUMBER	)	number	22	SENT_299	[p17l508t3442r585b3504],
22	1.0	CD	NUMBER	1.0	num	20	SENT_299	[p17l1932t3442r2030b3492],

1	Patients	NNS	O	patient	_	0	SENT_300	[p17l150t3524r394b3574],
2	with	IN	O	with	_	0	SENT_300	[p17l422t3524r541b3574],
3	CYP2C9	NN	O	cyp2c9	nn	4	SENT_300	[p17l572t3523r901b3574],
4	*	NN	O	*	prep_with	1	SENT_300	[p17l572t3523r901b3574],
5	2	CD	NUMBER	2	num	6	SENT_300	[p17l572t3523r901b3574],
6	genotypes	NNS	O	genotype	dep	1	SENT_300	[p17l929t3527r1240b3587],

1	No.	NN	O	no.	_	0	SENT_301	[p17l221t3603r316b3652],
2	with	IN	O	with	_	0	SENT_301	[p17l345t3603r464b3653],
3	event/No	NN	O	event/no	prep_with	1	SENT_301	[p17l495t3603r797b3664],
4	.	.	O	.	_	0	SENT_301	[p17l495t3603r797b3664],

1	at	IN	O	at	dep	5	SENT_302	[p17l831t3606r887b3653],
2	risk	NN	O	risk	pobj	1	SENT_302	[p17l916t3603r1022b3653],
3	4/121	CD	NUMBER	4/121	num	5	SENT_302	[p17l1921t3602r2123b3664],
4	Cumulative	JJ	O	cumulative	amod	5	SENT_302	[p17l218t3682r554b3732],
5	incidence	NN	O	incidence	_	0	SENT_302	[p17l586t3682r888b3741],
6	,	,	O	,	_	0	SENT_302	[p17l586t3682r888b3741],
7	3	CD	NUMBER	3	num	8	SENT_302	[p17l920t3682r957b3732],
8	y	NN	O	y	appos	5	SENT_302	[p17l982t3695r1028b3744],
9	,	,	O	,	_	0	SENT_302	[p17l982t3695r1028b3744],
10	%	NN	O	%	appos	5	SENT_302	[p17l1059t3682r1106b3732],
11	:	:	O	:	_	0	SENT_302	[p17l1139t3687r1181b3730],
12	SE	NN	O	se	dep	5	SENT_302	[p17l1216t3682r1294b3732],
13	3.9	CD	NUMBER	3.9	dep	12	SENT_302	[p17l1851t3682r1951b3732],
14	:	:	O	:	_	0	SENT_302	[p17l1980t3687r2022b3730],
15	1.9	CD	NUMBER	1.9	num	16	SENT_302	[p17l2053t3682r2151b3732],
16	RR	NN	O	rr	dep	12	SENT_302	[p17l221t3763r300b3812],
17	(	CD	PERCENT	(	num	20	SENT_302	[p17l330t3762r480b3824],
18	95	CD	PERCENT	95	number	19	SENT_302	[p17l330t3762r480b3824],
19	%	NN	PERCENT	%	amod	20	SENT_302	[p17l330t3762r480b3824],
20	CI	NN	O	ci	dep	16	SENT_302	[p17l508t3762r585b3824],
21	)	CD	NUMBER	)	number	22	SENT_302	[p17l508t3762r585b3824],
22	1.0	CD	NUMBER	1.0	num	20	SENT_302	[p17l1932t3762r2030b3813],

1	Patients	NNS	O	patient	_	0	SENT_303	[p18l150t22r394b72],
2	with	IN	O	with	_	0	SENT_303	[p18l422t22r541b72],
3	CYP2C9	NN	O	cyp2c9	prep_with	1	SENT_303	[p18l572t21r902b72],
4	*	CD	NUMBER	*	num	3	SENT_303	[p18l572t21r902b72],
5	3	CD	NUMBER	3	num	6	SENT_303	[p18l572t21r902b72],
6	genotypes	NNS	O	genotype	dep	1	SENT_303	[p18l929t25r1240b84],

1	No.	NN	O	no.	_	0	SENT_304	[p18l221t100r316b150],
2	with	IN	O	with	_	0	SENT_304	[p18l345t100r465b150],
3	event/No	NN	O	event/no	prep_with	1	SENT_304	[p18l495t100r797b162],
4	.	.	O	.	_	0	SENT_304	[p18l495t100r797b162],

1	at	IN	O	at	dep	4	SENT_305	[p18l831t103r887b150],
2	risk	NN	O	risk	pobj	1	SENT_305	[p18l916t100r1022b150],
3	Cumulative	JJ	O	cumulative	amod	4	SENT_305	[p18l218t181r554b232],
4	incidence	NN	O	incidence	_	0	SENT_305	[p18l586t182r888b240],
5	,	,	O	,	_	0	SENT_305	[p18l586t182r888b240],
6	3	CD	NUMBER	3	num	7	SENT_305	[p18l920t181r957b232],
7	y	NN	O	y	appos	4	SENT_305	[p18l982t194r1028b244],
8	,	,	O	,	_	0	SENT_305	[p18l982t194r1028b244],
9	%	NN	O	%	appos	4	SENT_305	[p18l1059t181r1106b232],
10	:	:	O	:	_	0	SENT_305	[p18l1139t187r1181b229],
11	SE	NN	O	se	nn	12	SENT_305	[p18l1216t181r1294b232],
12	RR	NN	O	rr	dep	9	SENT_305	[p18l221t261r300b310],
13	(	CD	PERCENT	(	number	14	SENT_305	[p18l330t260r480b322],
14	95	CD	PERCENT	95	num	15	SENT_305	[p18l330t260r480b322],
15	%	NN	PERCENT	%	dep	12	SENT_305	[p18l330t260r480b322],
16	Cl	NN	O	cl	dep	12	SENT_305	[p18l508t260r585b322],
17	)	CD	NUMBER	)	num	16	SENT_305	[p18l508t260r585b322],

1	Renal	JJ	O	renal	amod	4	SENT_306	[p18l9t341r173b390],
2	and	CC	O	and	_	0	SENT_306	[p18l206t341r312b390],
3	hypertensive	JJ	O	hypertensive	conj_and	1	SENT_306	[p18l345t341r726b402],
4	disorders	NNS	O	disorder	_	0	SENT_306	[p18l754t338r1066b390],
5	‘	CD	NUMBER	‘	dep	4	SENT_306	[p18l754t338r1066b390],
6	?	.	O	?	_	0	SENT_306	[p18l754t338r1066b390],

1	All	DT	O	all	_	0	SENT_307	[p18l75t421r143b469],
2	patients	NNS	O	patient	dep	1	SENT_307	[p18l177t421r420b481],

1	No.	NN	O	no.	_	0	SENT_308	[p18l151t500r245b549],
2	with	IN	O	with	_	0	SENT_308	[p18l275t500r394b550],
3	event/No	NN	O	event/no	prep_with	1	SENT_308	[p18l424t500r727b561],
4	.	.	O	.	_	0	SENT_308	[p18l424t500r727b561],

1	at	IN	O	at	dep	4	SENT_309	[p18l760t503r817b550],
2	risk	NN	O	risk	pobj	1	SENT_309	[p18l845t500r951b550],
3	Cumulative	JJ	O	cumulative	amod	4	SENT_309	[p18l148t579r484b629],
4	incidence	NN	O	incidence	_	0	SENT_309	[p18l515t579r818b638],
5	,	,	O	,	_	0	SENT_309	[p18l515t579r818b638],
6	3	CD	NUMBER	3	num	7	SENT_309	[p18l850t579r887b629],
7	y	NN	O	y	appos	4	SENT_309	[p18l912t592r958b641],
8	,	,	O	,	_	0	SENT_309	[p18l912t592r958b641],
9	%	NN	O	%	appos	4	SENT_309	[p18l989t579r1035b629],
10	:	:	O	:	_	0	SENT_309	[p18l1068t584r1111b627],
11	SE	NN	O	se	nn	12	SENT_309	[p18l1145t579r1224b629],
12	RR	NN	O	rr	dep	9	SENT_309	[p18l151t660r230b709],
13	(	CD	PERCENT	(	number	14	SENT_309	[p18l260t659r410b721],
14	95	CD	PERCENT	95	num	15	SENT_309	[p18l260t659r410b721],
15	%	NN	PERCENT	%	dep	12	SENT_309	[p18l260t659r410b721],
16	Cl	NN	O	cl	dep	12	SENT_309	[p18l438t659r515b721],
17	)	CD	NUMBER	)	num	16	SENT_309	[p18l438t659r515b721],

1	By	IN	O	by	_	0	SENT_310	[p18l80t741r149b803],
2	genotype	NN	O	genotype	pobj	1	SENT_310	[p18l172t743r446b803],

1	Patients	NNS	O	patient	_	0	SENT_311	[p18l150t820r395b870],
2	with	IN	O	with	_	0	SENT_311	[p18l422t820r541b870],
3	wild	JJ	O	wild	amod	6	SENT_311	[p18l569t820r829b882],
4	—	NN	O	—	nn	6	SENT_311	[p18l569t820r829b882],
5	type	NN	O	type	nn	6	SENT_311	[p18l569t820r829b882],
6	genotypes	NNS	O	genotype	prep_with	1	SENT_311	[p18l856t823r1167b883],

1	No.	NN	O	no.	_	0	SENT_312	[p18l221t900r316b950],
2	with	IN	O	with	_	0	SENT_312	[p18l346t900r464b950],
3	event/No	NN	O	event/no	prep_with	1	SENT_312	[p18l495t900r797b961],
4	.	.	O	.	_	0	SENT_312	[p18l495t900r797b961],

1	at	IN	O	at	dep	4	SENT_313	[p18l831t903r888b950],
2	risk	NN	O	risk	pobj	1	SENT_313	[p18l916t900r1022b950],
3	Cumulative	JJ	O	cumulative	amod	4	SENT_313	[p18l219t980r554b1030],
4	incidence	NN	O	incidence	_	0	SENT_313	[p18l586t981r888b1039],
5	,	,	O	,	_	0	SENT_313	[p18l586t981r888b1039],
6	3	CD	NUMBER	3	num	7	SENT_313	[p18l920t980r958b1030],
7	y	NN	O	y	appos	4	SENT_313	[p18l982t993r1028b1043],
8	,	,	O	,	_	0	SENT_313	[p18l982t993r1028b1043],
9	%	NN	O	%	appos	4	SENT_313	[p18l1059t980r1106b1030],
10	:	:	O	:	_	0	SENT_313	[p18l1139t986r1181b1028],
11	SE	NN	O	se	nn	12	SENT_313	[p18l1216t980r1294b1031],
12	RR	NN	O	rr	dep	9	SENT_313	[p18l221t1059r300b1109],
13	(	CD	PERCENT	(	number	14	SENT_313	[p18l330t1059r480b1121],
14	95	CD	PERCENT	95	num	15	SENT_313	[p18l330t1059r480b1121],
15	%	NN	PERCENT	%	dep	12	SENT_313	[p18l330t1059r480b1121],
16	Cl	NN	O	cl	dep	12	SENT_313	[p18l509t1059r585b1121],
17	)	CD	NUMBER	)	num	16	SENT_313	[p18l509t1059r585b1121],

1	Patients	NNS	O	patient	_	0	SENT_314	[p18l150t1141r395b1191],
2	with	IN	O	with	_	0	SENT_314	[p18l422t1141r541b1191],
3	CYP2C9	NN	O	cyp2c9	nn	4	SENT_314	[p18l572t1140r901b1191],
4	*	NN	O	*	prep_with	1	SENT_314	[p18l572t1140r901b1191],
5	2	CD	NUMBER	2	num	6	SENT_314	[p18l572t1140r901b1191],
6	genotypes	NNS	O	genotype	dep	1	SENT_314	[p18l929t1144r1240b1204],

1	No.	NN	O	no.	_	0	SENT_315	[p18l221t1220r316b1269],
2	with	IN	O	with	_	0	SENT_315	[p18l346t1220r464b1270],
3	event/No	NN	O	event/no	prep_with	1	SENT_315	[p18l495t1220r797b1281],
4	.	.	O	.	_	0	SENT_315	[p18l495t1220r797b1281],

1	at	IN	O	at	dep	4	SENT_316	[p18l831t1223r888b1270],
2	risk	NN	O	risk	pobj	1	SENT_316	[p18l916t1220r1022b1270],
3	Cumulative	JJ	O	cumulative	amod	4	SENT_316	[p18l219t1299r554b1349],
4	incidence	NN	O	incidence	_	0	SENT_316	[p18l586t1299r888b1358],
5	,	,	O	,	_	0	SENT_316	[p18l586t1299r888b1358],
6	3	CD	NUMBER	3	num	7	SENT_316	[p18l920t1299r958b1349],
7	y	NN	O	y	appos	4	SENT_316	[p18l982t1312r1028b1361],
8	,	,	O	,	_	0	SENT_316	[p18l982t1312r1028b1361],
9	%	NN	O	%	appos	4	SENT_316	[p18l1059t1299r1106b1349],
10	:	:	O	:	_	0	SENT_316	[p18l1139t1304r1181b1347],
11	SE	NN	O	se	nn	12	SENT_316	[p18l1216t1299r1294b1349],
12	RR	NN	O	rr	dep	9	SENT_316	[p18l221t1380r300b1429],
13	(	CD	PERCENT	(	number	14	SENT_316	[p18l330t1379r480b1441],
14	95	CD	PERCENT	95	num	15	SENT_316	[p18l330t1379r480b1441],
15	%	NN	PERCENT	%	dep	12	SENT_316	[p18l330t1379r480b1441],
16	Cl	NN	O	cl	dep	12	SENT_316	[p18l509t1379r585b1441],
17	)	CD	NUMBER	)	num	16	SENT_316	[p18l509t1379r585b1441],

1	Patients	NNS	O	patient	_	0	SENT_317	[p18l150t1461r395b1511],
2	with	IN	O	with	_	0	SENT_317	[p18l422t1461r541b1511],
3	CYP2C9	NN	O	cyp2c9	prep_with	1	SENT_317	[p18l572t1460r902b1511],
4	*	CD	NUMBER	*	num	3	SENT_317	[p18l572t1460r902b1511],
5	3	CD	NUMBER	3	num	6	SENT_317	[p18l572t1460r902b1511],
6	genotypes	NNS	O	genotype	dep	1	SENT_317	[p18l929t1464r1240b1523],

1	No.	NN	O	no.	_	0	SENT_318	[p18l221t1539r316b1589],
2	with	IN	O	with	_	0	SENT_318	[p18l346t1539r464b1589],
3	event/No	NN	O	event/no	prep_with	1	SENT_318	[p18l495t1539r797b1601],
4	.	.	O	.	_	0	SENT_318	[p18l495t1539r797b1601],

1	at	IN	O	at	dep	4	SENT_319	[p18l831t1542r887b1589],
2	risk	NN	O	risk	pobj	1	SENT_319	[p18l916t1539r1022b1589],
3	Cumulative	JJ	O	cumulative	amod	4	SENT_319	[p18l219t1620r554b1671],
4	incidence	NN	O	incidence	_	0	SENT_319	[p18l586t1621r888b1679],
5	,	,	O	,	_	0	SENT_319	[p18l586t1621r888b1679],
6	3	CD	NUMBER	3	num	7	SENT_319	[p18l920t1620r958b1671],
7	y	NN	O	y	appos	4	SENT_319	[p18l982t1633r1028b1683],
8	,	,	O	,	_	0	SENT_319	[p18l982t1633r1028b1683],
9	%	NN	O	%	appos	4	SENT_319	[p18l1059t1620r1106b1671],
10	:	:	O	:	_	0	SENT_319	[p18l1139t1626r1181b1668],
11	SE	NN	O	se	nn	12	SENT_319	[p18l1216t1620r1294b1671],
12	RR	NN	O	rr	dep	9	SENT_319	[p18l221t1700r300b1749],
13	(	CD	PERCENT	(	number	14	SENT_319	[p18l330t1699r480b1761],
14	95	CD	PERCENT	95	num	15	SENT_319	[p18l330t1699r480b1761],
15	%	NN	PERCENT	%	dep	12	SENT_319	[p18l330t1699r480b1761],
16	Cl	NN	O	cl	dep	12	SENT_319	[p18l508t1699r585b1761],
17	)	CD	NUMBER	)	num	16	SENT_319	[p18l508t1699r585b1761],

1	Gastrointestinal	JJ	O	gastrointestinal	amod	3	SENT_320	[p18l7t1780r489b1830],
2	ulceration/hemorrhage	NN	O	ulceration/hemorrhage	nn	3	SENT_320	[p18l522t1780r1248b1843],
3	“	NN	O	“	_	0	SENT_320	[p18l522t1780r1248b1843],

1	All	DT	O	all	_	0	SENT_321	[p18l75t1860r143b1908],
2	patients	NNS	O	patient	dep	1	SENT_321	[p18l176t1860r420b1920],

1	No.	NN	O	no.	_	0	SENT_322	[p18l151t1939r245b1987],
2	with	IN	O	with	_	0	SENT_322	[p18l274t1939r394b1987],
3	event/No	NN	O	event/no	prep_with	1	SENT_322	[p18l424t1939r727b1999],
4	.	.	O	.	_	0	SENT_322	[p18l424t1939r727b1999],

1	at	IN	O	at	dep	4	SENT_323	[p18l760t1941r817b1987],
2	risk	NN	O	risk	pobj	1	SENT_323	[p18l845t1939r951b1988],
3	Cumulative	JJ	O	cumulative	amod	4	SENT_323	[p18l148t2017r484b2067],
4	incidence	NN	O	incidence	_	0	SENT_323	[p18l515t2017r818b2075],
5	,	,	O	,	_	0	SENT_323	[p18l515t2017r818b2075],
6	3	CD	NUMBER	3	num	7	SENT_323	[p18l850t2017r887b2067],
7	y	NN	O	y	appos	4	SENT_323	[p18l912t2030r958b2079],
8	,	,	O	,	_	0	SENT_323	[p18l912t2030r958b2079],
9	%	NN	O	%	appos	4	SENT_323	[p18l989t2017r1035b2067],
10	:	:	O	:	_	0	SENT_323	[p18l1068t2022r1111b2065],
11	SE	NN	O	se	nn	12	SENT_323	[p18l1145t2017r1224b2067],
12	RR	NN	O	rr	dep	9	SENT_323	[p18l151t2098r230b2147],
13	(	CD	PERCENT	(	number	14	SENT_323	[p18l260t2097r410b2159],
14	95	CD	PERCENT	95	num	15	SENT_323	[p18l260t2097r410b2159],
15	%	NN	PERCENT	%	dep	12	SENT_323	[p18l260t2097r410b2159],
16	Cl	NN	O	cl	dep	12	SENT_323	[p18l438t2097r515b2159],
17	)	CD	NUMBER	)	num	16	SENT_323	[p18l438t2097r515b2159],

1	By	IN	O	by	_	0	SENT_324	[p18l80t2179r149b2241],
2	genotype	NN	O	genotype	pobj	1	SENT_324	[p18l172t2181r446b2241],

1	Patients	NNS	O	patient	_	0	SENT_325	[p18l150t2258r395b2308],
2	with	IN	O	with	_	0	SENT_325	[p18l422t2258r541b2308],
3	wild	JJ	O	wild	amod	6	SENT_325	[p18l569t2258r829b2320],
4	—	NN	O	—	nn	6	SENT_325	[p18l569t2258r829b2320],
5	type	NN	O	type	nn	6	SENT_325	[p18l569t2258r829b2320],
6	genotypes	NNS	O	genotype	prep_with	1	SENT_325	[p18l856t2261r1167b2321],

1	No.	NN	O	no.	_	0	SENT_326	[p18l221t2338r316b2388],
2	with	IN	O	with	_	0	SENT_326	[p18l346t2338r464b2388],
3	event/No	NN	O	event/no	prep_with	1	SENT_326	[p18l495t2338r797b2399],
4	.	.	O	.	_	0	SENT_326	[p18l495t2338r797b2399],

1	at	IN	O	at	dep	4	SENT_327	[p18l831t2341r888b2388],
2	risk	NN	O	risk	pobj	1	SENT_327	[p18l916t2338r1022b2388],
3	Cumulative	JJ	O	cumulative	amod	4	SENT_327	[p18l219t2418r554b2468],
4	incidence	NN	O	incidence	_	0	SENT_327	[p18l586t2419r888b2477],
5	,	,	O	,	_	0	SENT_327	[p18l586t2419r888b2477],
6	3	CD	NUMBER	3	num	7	SENT_327	[p18l920t2418r958b2469],
7	y	NN	O	y	appos	4	SENT_327	[p18l982t2431r1028b2481],
8	,	,	O	,	_	0	SENT_327	[p18l982t2431r1028b2481],
9	%	NN	O	%	appos	4	SENT_327	[p18l1059t2418r1106b2468],
10	:	:	O	:	_	0	SENT_327	[p18l1139t2424r1181b2466],
11	SE	NN	O	se	nn	12	SENT_327	[p18l1216t2418r1294b2469],
12	RR	NN	O	rr	dep	9	SENT_327	[p18l221t2497r300b2547],
13	(	CD	PERCENT	(	number	14	SENT_327	[p18l330t2497r480b2559],
14	95	CD	PERCENT	95	num	15	SENT_327	[p18l330t2497r480b2559],
15	%	NN	PERCENT	%	dep	12	SENT_327	[p18l330t2497r480b2559],
16	Cl	NN	O	cl	dep	12	SENT_327	[p18l509t2497r585b2559],
17	)	CD	NUMBER	)	num	16	SENT_327	[p18l509t2497r585b2559],

1	Patients	NNS	O	patient	_	0	SENT_328	[p18l150t2579r395b2629],
2	with	IN	O	with	_	0	SENT_328	[p18l422t2579r541b2629],
3	CYP2C9	NN	O	cyp2c9	nn	4	SENT_328	[p18l572t2578r901b2629],
4	*	NN	O	*	prep_with	1	SENT_328	[p18l572t2578r901b2629],
5	2	CD	NUMBER	2	num	6	SENT_328	[p18l572t2578r901b2629],
6	genotypes	NNS	O	genotype	dep	1	SENT_328	[p18l929t2582r1240b2642],

1	No.	NN	O	no.	_	0	SENT_329	[p18l221t2658r316b2708],
2	with	IN	O	with	_	0	SENT_329	[p18l346t2658r464b2708],
3	event/No	NN	O	event/no	prep_with	1	SENT_329	[p18l495t2658r797b2719],
4	.	.	O	.	_	0	SENT_329	[p18l495t2658r797b2719],

1	at	IN	O	at	dep	4	SENT_330	[p18l831t2661r888b2708],
2	risk	NN	O	risk	pobj	1	SENT_330	[p18l916t2658r1022b2708],
3	Cumulative	JJ	O	cumulative	amod	4	SENT_330	[p18l219t2737r554b2787],
4	incidence	NN	O	incidence	_	0	SENT_330	[p18l586t2737r888b2796],
5	,	,	O	,	_	0	SENT_330	[p18l586t2737r888b2796],
6	3	CD	NUMBER	3	num	7	SENT_330	[p18l920t2737r958b2787],
7	y	NN	O	y	appos	4	SENT_330	[p18l982t2750r1028b2799],
8	,	,	O	,	_	0	SENT_330	[p18l982t2750r1028b2799],
9	%	NN	O	%	appos	4	SENT_330	[p18l1059t2737r1106b2787],
10	:	:	O	:	_	0	SENT_330	[p18l1139t2742r1181b2785],
11	SE	NN	O	se	nn	12	SENT_330	[p18l1216t2737r1294b2787],
12	RR	NN	O	rr	dep	9	SENT_330	[p18l221t2818r300b2867],
13	(	CD	PERCENT	(	number	14	SENT_330	[p18l330t2817r480b2879],
14	95	CD	PERCENT	95	num	15	SENT_330	[p18l330t2817r480b2879],
15	%	NN	PERCENT	%	dep	12	SENT_330	[p18l330t2817r480b2879],
16	Cl	NN	O	cl	dep	12	SENT_330	[p18l508t2817r585b2879],
17	)	CD	NUMBER	)	num	16	SENT_330	[p18l508t2817r585b2879],

1	Patients	NNS	O	patient	_	0	SENT_331	[p18l150t2899r394b2949],
2	with	IN	O	with	_	0	SENT_331	[p18l422t2899r541b2949],
3	CYP2C9	NN	O	cyp2c9	prep_with	1	SENT_331	[p18l572t2898r902b2949],
4	*	CD	NUMBER	*	num	3	SENT_331	[p18l572t2898r902b2949],
5	3	CD	NUMBER	3	num	6	SENT_331	[p18l572t2898r902b2949],
6	genotypes	NNS	O	genotype	dep	1	SENT_331	[p18l929t2902r1240b2961],

1	No.	NN	O	no.	_	0	SENT_332	[p18l221t2977r316b3027],
2	with	IN	O	with	_	0	SENT_332	[p18l345t2977r464b3027],
3	event	NN	O	event	prep_with	1	SENT_332	[p18l495t2980r660b3027],
4	/	:	O	/	punct	1	SENT_332	[p18l686t2977r720b3039],
5	No.	NN	O	no.	dep	1	SENT_332	[p18l750t2977r844b3027],
6	at	IN	O	at	_	0	SENT_332	[p18l877t2980r934b3027],
7	risk	NN	O	risk	nn	9	SENT_332	[p18l963t2977r1069b3027],
8	Cumulative	JJ	O	cumulative	amod	9	SENT_332	[p18l218t3058r554b3109],
9	incidence	NN	O	incidence	prep_at	5	SENT_332	[p18l586t3059r888b3117],
10	,	,	O	,	_	0	SENT_332	[p18l586t3059r888b3117],
11	3	CD	NUMBER	3	num	12	SENT_332	[p18l920t3058r957b3109],
12	y	NN	O	y	appos	9	SENT_332	[p18l982t3071r1028b3121],
13	,	,	O	,	_	0	SENT_332	[p18l982t3071r1028b3121],
14	%	NN	O	%	appos	12	SENT_332	[p18l1059t3058r1106b3109],
15	:	:	O	:	_	0	SENT_332	[p18l1139t3064r1181b3106],
16	SE	NN	O	se	nn	17	SENT_332	[p18l1216t3058r1294b3109],
17	RR	NN	O	rr	dep	5	SENT_332	[p18l221t3138r300b3187],
18	(	CD	PERCENT	(	number	19	SENT_332	[p18l330t3137r480b3199],
19	95	CD	PERCENT	95	num	20	SENT_332	[p18l330t3137r480b3199],
20	%	NN	PERCENT	%	dep	17	SENT_332	[p18l330t3137r480b3199],
21	Cl	NN	O	cl	dep	17	SENT_332	[p18l508t3137r585b3199],
22	)	CD	NUMBER	)	num	21	SENT_332	[p18l508t3137r585b3199],

1	97/557	CD	NUMBER	97/557	number	2	SENT_333	[p18l1880t499r2121b561],
2	19.8	CD	NUMBER	19.8	_	0	SENT_333	[p18l1811t579r1952b629],
3	i	FW	O	i	dep	2	SENT_333	[p18l1980t584r2022b627],
4	1.9	CD	NUMBER	1.9	dep	2	SENT_333	[p18l2053t579r2151b629],

1	41/377	CD	NUMBER	41/377	num	2	SENT_334	[p18l1879t2337r2121b2399],
2	1z9	CD	NUMBER	1z9	_	0	SENT_334	[p18l1811t2418r2152b2469],
3	:2	NN	O	:2	nn	4	SENT_334	[p18l1811t2418r2152b2469],
4	o	NN	O	o	dep	2	SENT_334	[p18l1811t2418r2152b2469],

1	10/121	CD	NUMBER	10/121	num	2	SENT_335	[p18l1882t2657r2123b2719],
2	8	CD	NUMBER	8	_	0	SENT_335	[p18l1851t2737r2150b2787],
3	£	NN	MONEY	£	dep	2	SENT_335	[p18l1851t2737r2150b2787],
4	3	CD	MONEY	3	num	3	SENT_335	[p18l1851t2737r2150b2787],
5	:	:	O	:	_	0	SENT_335	[p18l1851t2737r2150b2787],
6	i17	CD	NUMBER	i17	dep	3	SENT_335	[p18l1851t2737r2150b2787],

1	34/547	CD	NUMBER	34/547	number	2	SENT_336	[p19l151t113r346b163],
2	7.4	CD	NUMBER	7.4	_	0	SENT_336	[p19l130t179r210b218],
3	i	FW	O	i	dep	2	SENT_336	[p19l232t182r266b217],
4	1.3	CD	NUMBER	1.3	dep	2	SENT_336	[p19l291t178r371b219],

1	1.41	CD	NUMBER	1.41	num	2	SENT_337	[p19l9t244r122b284],
2	(	CD	NUMBER	(	_	0	SENT_337	[p19l141t243r457b293],
3	O.	NNP	O	O.	dep	2	SENT_337	[p19l141t243r457b293],
4	83	CD	NUMBER	83	num	3	SENT_337	[p19l141t243r457b293],
5	—	CD	NUMBER	—	number	6	SENT_337	[p19l141t243r457b293],
6	2.37	CD	NUMBER	2.37	num	7	SENT_337	[p19l141t243r457b293],
7	)	NN	O	)	dep	3	SENT_337	[p19l141t243r457b293],

1	3.4	CD	NUMBER	3.4	_	0	SENT_338	[p19l128t1025r209b1066],
2	i	FW	O	i	dep	1	SENT_338	[p19l232t1030r266b1064],
3	2.4	CD	NUMBER	2.4	dep	1	SENT_338	[p19l290t1025r371b1065],

1	1.23	CD	NUMBER	1.23	num	2	SENT_339	[p19l9t1737r122b1777],
2	(	CD	NUMBER	(	_	0	SENT_339	[p19l142t1737r457b1787],
3	O.	NNP	O	O.	dep	2	SENT_339	[p19l142t1737r457b1787],
4	88	CD	NUMBER	88	num	3	SENT_339	[p19l142t1737r457b1787],
5	—	CD	NUMBER	—	number	6	SENT_339	[p19l142t1737r457b1787],
6	1.71	CD	NUMBER	1.71	num	7	SENT_339	[p19l142t1737r457b1787],
7	)	NN	O	)	dep	3	SENT_339	[p19l142t1737r457b1787],

1	1.85	CD	NUMBER	1.85	num	2	SENT_340	[p19l9t3131r122b3172],
2	(	CD	NUMBER	(	_	0	SENT_340	[p19l141t3131r457b3181],
3	O.	NNP	O	O.	dep	2	SENT_340	[p19l141t3131r457b3181],
4	84	CD	NUMBER	84	num	3	SENT_340	[p19l141t3131r457b3181],
5	—	CD	NUMBER	—	number	6	SENT_340	[p19l141t3131r457b3181],
6	4.07	CD	NUMBER	4.07	num	7	SENT_340	[p19l141t3131r457b3181],
7	)	NN	O	)	dep	3	SENT_340	[p19l141t3131r457b3181],

1	2.69	CD	NUMBER	2.69	number	2	SENT_341	[p19l1148t1090r1262b1131],
2	(	CD	NUMBER	(	_	0	SENT_341	[p19l1281t1090r1631b1140],
3	O.	NNP	O	O.	dep	2	SENT_341	[p19l1281t1090r1631b1140],
4	56	CD	NUMBER	56	number	5	SENT_341	[p19l1281t1090r1631b1140],
5	—	CD	NUMBER	—	dep	2	SENT_341	[p19l1281t1090r1631b1140],
6	12.79	CD	NUMBER	12.79	num	7	SENT_341	[p19l1281t1090r1631b1140],
7	)	NN	O	)	dep	5	SENT_341	[p19l1281t1090r1631b1140],

1	1.00	CD	NUMBER	1.00	number	2	SENT_342	[p19l1166t1995r1280b2036],
2	(	CD	NUMBER	(	_	0	SENT_342	[p19l1298t1995r1614b2045],
3	O.	NNP	O	O.	dep	2	SENT_342	[p19l1298t1995r1614b2045],
4	55	CD	NUMBER	55	number	5	SENT_342	[p19l1298t1995r1614b2045],
5	—	CD	NUMBER	—	dep	2	SENT_342	[p19l1298t1995r1614b2045],
6	1.85	CD	NUMBER	1.85	num	7	SENT_342	[p19l1298t1995r1614b2045],
7	)	NN	O	)	dep	5	SENT_342	[p19l1298t1995r1614b2045],

1	55/549	CD	NUMBER	55/549	number	2	SENT_343	[p19l1309t2449r1504b2499],
2	11.7	CD	NUMBER	11.7	_	0	SENT_343	[p19l1252t2499r1365b2539],
3	i	FW	O	i	dep	2	SENT_343	[p19l1389t2503r1423b2537],
4	1.5	CD	NUMBER	1.5	dep	2	SENT_343	[p19l1448t2499r1527b2539],

1	0.98	CD	NUMBER	0.98	num	2	SENT_344	[p19l1164t3390r1280b3431],
2	(	CD	NUMBER	(	_	0	SENT_344	[p19l1298t3390r1614b3440],
3	O.	NNP	O	O.	dep	2	SENT_344	[p19l1298t3390r1614b3440],
4	34	CD	NUMBER	34	num	3	SENT_344	[p19l1298t3390r1614b3440],
5	—	CD	NUMBER	—	number	6	SENT_344	[p19l1298t3390r1614b3440],
6	2.84	CD	NUMBER	2.84	num	7	SENT_344	[p19l1298t3390r1614b3440],
7	)	NN	O	)	dep	3	SENT_344	[p19l1298t3390r1614b3440],

1	E	NN	O	e	_	0	SENT_345	[p19l2025t179r2070b326],
2	_	CD	NUMBER	_	dep	1	SENT_345	[p19l1953t325r2069b378, p19l1952t379r2069b478],
3	III	CD	NUMBER	iii	rcmod	2	SENT_345	[p19l1953t325r2069b378, p19l1952t379r2069b478],
4	.155	CD	NUMBER	.155	number	5	SENT_345	[p19l1953t325r2069b378, p19l1952t379r2069b478],
5	25	CD	NUMBER	25	dep	3	SENT_345	[p19l1953t459r2069b533],
6	:	:	O	:	_	0	SENT_345	[p19l1953t536r2069b580],
7	.	.	O	.	_	0	SENT_345	[p19l1953t536r2069b580],

1	z	SYM	O	z	dep	2	SENT_346	[p19l1953t536r2069b580],
2	UH	NNP	O	UH	_	0	SENT_346	[p19l1952t582r2069b615],
3	]	CD	NUMBER	]	dep	2	SENT_346	[p19l1952t582r2069b615],
4	§	CD	NUMBER	§	num	5	SENT_346	[p19l2026t616r2069b686],
5	£	NN	MONEY	£	rcmod	3	SENT_346	[p19l2026t690r2069b714],
6	4	CD	MONEY	4	dep	5	SENT_346	[p19l2026t718r2069b762],
7	:	:	O	:	_	0	SENT_346	[p19l2026t718r2069b762],

1	NOTE	VB	O	note	_	0	SENT_347	[p20l44t19r118b40],
2	.	.	O	.	_	0	SENT_347	[p20l44t19r118b40],

1	Wild-type	JJ	O	wild-type	amod	2	SENT_348	[p20l130t19r242b45],
2	genotypes	NNS	O	genotype	nsubj	3	SENT_348	[p20l252t20r381b45],
3	include	VBP	O	include	_	0	SENT_348	[p20l393t19r481b40],
4	individuals	NNS	O	individual	dobj	3	SENT_348	[p20l494t19r625b40],
5	with	IN	O	with	_	0	SENT_348	[p20l636t19r685b40],
6	no	DT	O	no	det	7	SENT_348	[p20l698t24r726b40],
7	*	NN	O	*	prep_with	3	SENT_348	[p20l740t19r770b40],
8	2	CD	NUMBER	2	number	9	SENT_348	[p20l740t19r770b40],
9	(	CD	NUMBER	(	num	7	SENT_348	[p20l782t19r886b45],
10	R144C	NN	O	r144c	dep	7	SENT_348	[p20l782t19r886b45],
11	)	CD	NUMBER	)	num	10	SENT_348	[p20l782t19r886b45],
12	or	CC	O	or	_	0	SENT_348	[p20l897t24r922b40],
13	*	CD	NUMBER	*	number	14	SENT_348	[p20l934t19r965b40],
14	3	CD	NUMBER	3	num	15	SENT_348	[p20l934t19r965b40],
15	(	NN	O	(	conj_or	7	SENT_348	[p20l974t19r1064b45],
16	|	CD	NUMBER	|	num	19	SENT_348	[p20l974t19r1064b45],
17	359L	NN	O	359l	nn	19	SENT_348	[p20l974t19r1064b45],
18	)	NN	O	)	nn	19	SENT_348	[p20l974t19r1064b45],
19	alleles	NNS	O	allele	dep	15	SENT_348	[p20l1076t19r1164b40],
20	.	.	O	.	_	0	SENT_348	[p20l1076t19r1164b40],

1	CYP2C9	NN	O	cyp2c9	nn	2	SENT_349	[p20l1177t19r1313b40],
2	*	NN	O	*	nsubj	5	SENT_349	[p20l1177t19r1313b40],
3	2	CD	NUMBER	2	num	4	SENT_349	[p20l1177t19r1313b40],
4	genotypes	NNS	O	genotype	dep	2	SENT_349	[p20l1324t20r1453b45],
5	include	VBP	O	include	_	0	SENT_349	[p20l1465t19r1553b40],
6	individuals	NNS	O	individual	dobj	5	SENT_349	[p20l1565t19r1697b40],
7	with	IN	O	with	_	0	SENT_349	[p20l1707t19r1757b40],
8	zone	NN	O	zone	nn	9	SENT_349	[p20l1770t22r1838b40],
9	*	NN	O	*	prep_with	5	SENT_349	[p20l1852t19r1882b40],
10	2	CD	NUMBER	2	num	11	SENT_349	[p20l1852t19r1882b40],
11	allele	NN	O	allele	dep	9	SENT_349	[p20l1894t19r1968b40],
12	.	.	O	.	_	0	SENT_349	[p20l1894t19r1968b40],

1	CYP2C9	NN	O	cyp2c9	nsubj	5	SENT_350	[p20l1980t19r2117b40],
2	*	CD	NUMBER	*	num	1	SENT_350	[p20l1980t19r2117b40],
3	3	CD	NUMBER	3	num	4	SENT_350	[p20l1980t19r2117b40],
4	genotypes	NNS	O	genotype	dep	1	SENT_350	[p20l43t53r171b78],
5	include	VBP	O	include	_	0	SENT_350	[p20l183t52r271b73],
6	individuals	NNS	O	individual	dobj	5	SENT_350	[p20l282t52r414b73],
7	with	IN	O	with	_	0	SENT_350	[p20l424t52r473b73],
8	zone	NN	O	zone	prep_with	5	SENT_350	[p20l485t55r554b73],
9	*	CD	NUMBER	*	number	10	SENT_350	[p20l566t52r597b73],
10	3	CD	NUMBER	3	num	11	SENT_350	[p20l566t52r597b73],
11	allele	NN	O	allele	dep	5	SENT_350	[p20l608t52r681b73],
12	.	.	O	.	_	0	SENT_350	[p20l608t52r681b73],

1	Individuals	NNS	O	individual	nsubjpass	13	SENT_351	[p20l694t52r826b73],
2	with	IN	O	with	_	0	SENT_351	[p20l836t52r885b73],
3	one	CD	NUMBER	one	num	4	SENT_351	[p20l897t57r942b73],
4	*	NN	O	*	prep_with	1	SENT_351	[p20l954t52r985b72],
5	2	CD	NUMBER	2	num	6	SENT_351	[p20l954t52r985b72],
6	allele	NN	O	allele	dep	4	SENT_351	[p20l996t52r1062b73],
7	and	CC	O	and	_	0	SENT_351	[p20l1073t52r1117b73],
8	one	CD	NUMBER	one	num	9	SENT_351	[p20l1128t57r1173b73],
9	*	NN	O	*	conj_and	4	SENT_351	[p20l1186t52r1217b73],
10	3	CD	NUMBER	3	num	11	SENT_351	[p20l1186t52r1217b73],
11	allele	NN	O	allele	dep	9	SENT_351	[p20l1228t52r1293b73],
12	were	VBD	O	be	auxpass	13	SENT_351	[p20l1303t57r1362b73],
13	classified	VBN	O	classify	_	0	SENT_351	[p20l1372t52r1490b73],
14	as	IN	O	as	_	0	SENT_351	[p20l1501t57r1530b73],
15	having	VBG	O	have	prepc_as	13	SENT_351	[p20l1541t52r1621b78],
16	CYP2C9	NN	O	cyp2c9	nn	19	SENT_351	[p20l1630t52r1767b73],
17	*	NN	O	*	nn	19	SENT_351	[p20l1630t52r1767b73],
18	3	CD	NUMBER	3	num	19	SENT_351	[p20l1630t52r1767b73],
19	genotypes	NNS	O	genotype	dobj	15	SENT_351	[p20l1777t53r1913b78],
20	.	.	O	.	_	0	SENT_351	[p20l1777t53r1913b78],

1	Adverse	JJ	O	adverse	amod	2	SENT_352	[p20l1924t52r2024b73],
2	events	NNS	O	event	nsubj	3	SENT_352	[p20l2034t53r2117b73],
3	include	VBP	O	include	_	0	SENT_352	[p20l44t85r132b106],
4	those	DT	O	those	dobj	3	SENT_352	[p20l144t85r215b106],
5	that	WDT	O	that	nsubjpass	7	SENT_352	[p20l227t85r278b106],
6	were	VBD	O	be	auxpass	7	SENT_352	[p20l289t90r348b106],
7	reported	VBN	O	report	rcmod	4	SENT_352	[p20l362t85r465b111],
8	during	IN	O	during	_	0	SENT_352	[p20l479t85r557b111],
9	the	DT	O	the	det	10	SENT_352	[p20l568t85r607b106],
10	time	NN	O	time	prep_during	7	SENT_352	[p20l620t85r675b106],
11	after	IN	O	after	_	0	SENT_352	[p20l689t85r746b106],
12	the	DT	O	the	det	14	SENT_352	[p20l757t85r797b106],
13	first	JJ	ORDINAL	first	amod	14	SENT_352	[p20l809t85r858b106],
14	dose	NN	O	dose	prep_after	7	SENT_352	[p20l870t85r930b106],
15	of	IN	O	of	_	0	SENT_352	[p20l944t85r968b106],
16	the	DT	O	the	det	18	SENT_352	[p20l978t85r1018b106],
17	study	NN	O	study	nn	18	SENT_352	[p20l1032t85r1099b111],
18	drug	NN	O	drug	prep_of	14	SENT_352	[p20l1111t85r1166b111],
19	until	IN	O	until	_	0	SENT_352	[p20l1178t85r1229b106],
20	30	CD	DURATION	30	num	21	SENT_352	[p20l1244t85r1277b106],
21	days	NNS	NUMBER	day	prep_until	7	SENT_352	[p20l1290t85r1347b111],
22	after	IN	O	after	_	0	SENT_352	[p20l1361t85r1418b106],
23	the	DT	O	the	det	25	SENT_352	[p20l1429t85r1469b106],
24	last	JJ	O	last	amod	25	SENT_352	[p20l1484t85r1529b106],
25	dose	NN	O	dose	prep_after	21	SENT_352	[p20l1541t85r1601b106],
26	of	IN	O	of	_	0	SENT_352	[p20l1615t85r1639b106],
27	study	NN	O	study	nn	28	SENT_352	[p20l1651t85r1718b111],
28	drug	NN	O	drug	prep_of	25	SENT_352	[p20l1730t85r1791b111],
29	.	.	O	.	_	0	SENT_352	[p20l1730t85r1791b111],

1	The	DT	O	the	det	2	SENT_353	[p20l1805t85r1849b106],
2	analysis	NN	O	analysis	nsubj	3	SENT_353	[p20l1863t85r1964b111],
3	excludes	VBZ	O	exclude	_	0	SENT_353	[p20l1978t85r2088b106],
4	7	CD	NUMBER	7	num	5	SENT_353	[p20l2102t85r2116b106],
5	participants	NNS	O	participant	dobj	3	SENT_353	[p20l44t118r191b143],
6	with	IN	O	with	_	0	SENT_353	[p20l200t118r250b139],
7	genotype	NN	O	genotype	nn	8	SENT_353	[p20l260t119r373b144],
8	information	NN	O	information	prep_with	5	SENT_353	[p20l384t118r525b139],
9	who	WP	O	who	nsubjpass	14	SENT_353	[p20l535t118r584b139],
10	were	VBD	O	be	auxpass	11	SENT_353	[p20l593t123r652b139],
11	randomized	VBN	O	randomize	rcmod	5	SENT_353	[p20l663t118r806b139],
12	but	CC	O	but	_	0	SENT_353	[p20l818t118r857b139],
13	never	RB	O	never	neg	14	SENT_353	[p20l867t123r935b139],
14	initiated	VBN	O	initiate	rcmod	5	SENT_353	[p20l944t118r1043b139],
15	treatment	NN	O	treatment	dobj	14	SENT_353	[p20l1053t119r1183b139],
16	:	:	O	:	_	0	SENT_353	[p20l1053t119r1183b139],
17	3	CD	NUMBER	3	num	18	SENT_353	[p20l1195t118r1210b139],
18	patients	NNS	O	patient	dobj	3	SENT_353	[p20l1221t118r1322b143],
19	in	IN	O	in	_	0	SENT_353	[p20l1333t118r1352b139],
20	the	DT	O	the	det	22	SENT_353	[p20l1362t118r1402b139],
21	placebo	NN	O	placebo	nn	22	SENT_353	[p20l1413t118r1509b143],
22	group	NN	O	group	prep_in	18	SENT_353	[p20l1519t121r1596b144],
23	,	,	O	,	_	0	SENT_353	[p20l1519t121r1596b144],
24	2	CD	NUMBER	2	appos	22	SENT_353	[p20l1608t118r1622b139],
25	assigned	VBN	O	assign	partmod	24	SENT_353	[p20l1633t118r1745b144],
26	to	TO	O	to	_	0	SENT_353	[p20l1754t119r1779b139],
27	200	CD	NUMBER	200	num	28	SENT_353	[p20l1789t118r1839b139],
28	mg	NN	O	mg	prep_to	25	SENT_353	[p20l1850t121r1887b144],
29	of	IN	O	of	_	0	SENT_353	[p20l1896t118r1920b139],
30	celecoxib	NN	O	celecoxib	prep_of	28	SENT_353	[p20l1928t118r2044b139],
31	twice	RB	O	twice	advmod	32	SENT_353	[p20l2053t118r2117b139],
32	daily	RB	SET	daily	advmod	25	SENT_353	[p20l43t151r106b177],
33	,	,	O	,	_	0	SENT_353	[p20l43t151r106b177],
34	and	CC	O	and	_	0	SENT_353	[p20l120t151r165b172],
35	2	CD	NUMBER	2	dobj	3	SENT_353	[p20l178t151r193b171],
36	assigned	VBN	O	assign	partmod	35	SENT_353	[p20l206t151r317b177],
37	to	TO	O	to	_	0	SENT_353	[p20l329t152r353b172],
38	400	CD	NUMBER	400	num	39	SENT_353	[p20l365t151r416b172],
39	mg	NN	O	mg	prep_to	36	SENT_353	[p20l429t154r466b177],
40	of	IN	O	of	_	0	SENT_353	[p20l477t151r502b172],
41	celecoxib	NN	O	celecoxib	prep_of	39	SENT_353	[p20l512t151r628b172],
42	twice	RB	O	twice	advmod	43	SENT_353	[p20l639t151r703b172],
43	daily	RB	SET	daily	advmod	36	SENT_353	[p20l716t151r779b177],
44	.	.	O	.	_	0	SENT_353	[p20l716t151r779b177],

1	Data	NNS	O	datum	nsubj	5	SENT_354	[p20l794t151r850b172],
2	on	IN	O	on	_	0	SENT_354	[p20l863t156r891b172],
3	adverse	JJ	O	adverse	amod	4	SENT_354	[p20l905t151r1003b172],
4	events	NNS	O	event	prep_on	1	SENT_354	[p20l1015t152r1097b172],
5	include	VBP	O	include	_	0	SENT_354	[p20l1111t151r1199b172],
6	events	NNS	O	event	nsubj	7	SENT_354	[p20l1211t152r1293b172],
7	reported	VBD	O	report	ccomp	5	SENT_354	[p20l1307t151r1410b176],
8	among	IN	O	among	_	0	SENT_354	[p20l1423t154r1508b177],
9	639	CD	NUMBER	639	num	10	SENT_354	[p20l1519t151r1569b172],
10	patients	NNS	O	patient	prep_among	7	SENT_354	[p20l1583t151r1683b176],
11	who	WP	O	who	nsubj	12	SENT_354	[p20l1695t151r1744b172],
12	continued	VBD	O	continue	rcmod	10	SENT_354	[p20l1756t151r1879b172],
13	blinded	JJ	O	blinded	amod	14	SENT_354	[p20l1892t151r1982b172],
14	treatment	NN	O	treatment	dobj	12	SENT_354	[p20l1993t152r2118b172],
15	beyond	IN	O	beyond	_	0	SENT_354	[p20l44t184r131b210],
16	the	DT	O	the	det	19	SENT_354	[p20l143t184r183b205],
17	36-month	JJ	DURATION	36-month	amod	19	SENT_354	[p20l195t184r314b205],
18	core	NN	O	core	nn	19	SENT_354	[p20l326t189r379b205],
19	phase	NN	O	phase	prep_beyond	12	SENT_354	[p20l392t184r467b210],
20	of	IN	O	of	_	0	SENT_354	[p20l479t184r503b205],
21	the	DT	O	the	det	22	SENT_354	[p20l512t184r552b205],
22	study	NN	O	study	prep_of	19	SENT_354	[p20l564t184r631b210],
23	who	WP	O	who	nsubjpass	25	SENT_354	[p20l640t184r690b205],
24	were	VBD	O	be	auxpass	25	SENT_354	[p20l701t189r760b205],
25	enrolled	VBN	O	enrol	rcmod	22	SENT_354	[p20l772t184r871b205],
26	in	IN	O	in	_	0	SENT_354	[p20l884t184r903b205],
27	the	DT	O	the	det	30	SENT_354	[p20l915t184r954b205],
28	24-month	JJ	DURATION	24-month	amod	30	SENT_354	[p20l967t184r1085b205],
29	extension	NN	O	extension	nn	30	SENT_354	[p20l1098t184r1218b205],
30	study	NN	O	study	prep_in	25	SENT_354	[p20l1231t184r1304b210],
31	.	.	O	.	_	0	SENT_354	[p20l1231t184r1304b210],

1	acardiovascular	JJ	O	acardiovascular	amod	2	SENT_355	[p20l44t217r240b238],
2	events	NNS	O	event	nsubj	3	SENT_355	[p20l250t218r333b238],
3	include	VBP	O	include	_	0	SENT_355	[p20l346t217r433b238],
4	cardiovascular	JJ	O	cardiovascular	amod	5	SENT_355	[p20l445t217r628b238],
5	death	NN	O	death	dobj	3	SENT_355	[p20l638t217r708b238],
6	or	CC	O	or	_	0	SENT_355	[p20l720t222r745b238],
7	circulatory	JJ	O	circulatory	amod	8	SENT_355	[p20l755t217r884b243],
8	collapse	NN	O	collapse	conj_or	5	SENT_355	[p20l894t217r1006b242],
9	,	,	O	,	_	0	SENT_355	[p20l894t217r1006b242],
10	stroke	NN	O	stroke	conj_or	5	SENT_355	[p20l1019t217r1104b241],
11	,	,	O	,	_	0	SENT_355	[p20l1019t217r1104b241],
12	myocardial	JJ	O	myocardial	amod	13	SENT_355	[p20l1118t217r1250b243],
13	infarction	NN	O	infarction	conj_or	5	SENT_355	[p20l1264t217r1387b241],
14	,	,	O	,	_	0	SENT_355	[p20l1264t217r1387b241],
15	congestive	JJ	O	congestive	amod	17	SENT_355	[p20l1400t217r1534b243],
16	heart	NN	O	heart	nn	17	SENT_355	[p20l1547t217r1611b238],
17	failure	NN	O	failure	dobj	3	SENT_355	[p20l1620t217r1706b241],
18	,	,	O	,	_	0	SENT_355	[p20l1620t217r1706b241],
19	venous	JJ	O	venous	amod	20	SENT_355	[p20l1718t222r1808b238],
20	thrombosis	NN	O	thrombosis	dobj	3	SENT_355	[p20l1819t217r1960b238],
21	or	CC	O	or	_	0	SENT_355	[p20l1972t222r1997b238],
22	thromboembolism	NN	O	thromboembolism	conj_or	5	SENT_355	[p20l2006t217r2118b238, p20l43t250r173b275],
23	,	,	O	,	_	0	SENT_355	[p20l2006t217r2118b238, p20l43t250r173b275],
24	cardiovasculartherapeutic	JJ	O	cardiovasculartherapeutic	amod	25	SENT_355	[p20l183t250r514b276],
25	procedures	NNS	O	procedure	dobj	3	SENT_355	[p20l524t250r670b276],
26	,	,	O	,	_	0	SENT_355	[p20l524t250r670b276],
27	vascular	JJ	O	vascular	amod	29	SENT_355	[p20l679t250r785b271],
28	therapeutic	JJ	O	therapeutic	amod	29	SENT_355	[p20l791t250r934b276],
29	procedures	NNS	O	procedure	conj_or	5	SENT_355	[p20l943t250r1090b276],
30	,	,	O	,	_	0	SENT_355	[p20l943t250r1090b276],
31	cerebrovascular	JJ	O	cerebrovascular	amod	32	SENT_355	[p20l1100t250r1300b271],
32	disease	NN	O	disease	conj_or	5	SENT_355	[p20l1308t250r1413b275],
33	,	,	O	,	_	0	SENT_355	[p20l1308t250r1413b275],
34	and	CC	O	and	_	0	SENT_355	[p20l1424t250r1468b271],
35	vascular	JJ	O	vascular	amod	36	SENT_355	[p20l1476t250r1582b271],
36	disease	NN	O	disease	dobj	3	SENT_355	[p20l1589t250r1695b271],
37	.	.	O	.	_	0	SENT_355	[p20l1589t250r1695b271],

1	Four	CD	NUMBER	four	num	2	SENT_356	[p20l1706t250r1759b271],
2	ofthe	NN	O	ofthe	nsubj	5	SENT_356	[p20l1766t250r1836b271],
3	cardiovascular	JJ	O	cardiovascular	amod	4	SENT_356	[p20l1844t250r2027b271],
4	events	NNS	O	event	dep	2	SENT_356	[p20l2034t252r2117b271],
5	occurred	VBD	O	occur	_	0	SENT_356	[p20l43t283r150b304],
6	after	IN	O	after	_	0	SENT_356	[p20l165t283r223b304],
7	36	CD	DURATION	36	num	8	SENT_356	[p20l235t283r268b304],
8	months	NNS	NUMBER	month	prep_after	5	SENT_356	[p20l282t283r382b304],
9	.	.	O	.	_	0	SENT_356	[p20l282t283r382b304],

1	All	DT	O	all	quantmod	2	SENT_357	[p20l397t283r424b304],
2	4	CD	NUMBER	4	nsubj	6	SENT_357	[p20l439t283r455b304],
3	of	IN	O	of	_	0	SENT_357	[p20l468t283r493b304],
4	these	DT	O	these	det	5	SENT_357	[p20l503t283r574b304],
5	patients	NNS	O	patient	prep_of	2	SENT_357	[p20l588t283r689b308],
6	had	VBD	O	have	_	0	SENT_357	[p20l703t283r747b304],
7	wild	JJ	O	wild	amod	10	SENT_357	[p20l761t283r868b309],
8	—	NN	O	—	nn	10	SENT_357	[p20l761t283r868b309],
9	type	NN	O	type	nn	10	SENT_357	[p20l761t283r868b309],
10	genotypes	NNS	O	genotype	dobj	6	SENT_357	[p20l881t284r1017b309],
11	:	:	O	:	_	0	SENT_357	[p20l881t284r1017b309],
12	1	CD	NUMBER	1	num	13	SENT_357	[p20l1033t283r1047b304],
13	patient	NN	O	patient	nsubjpass	15	SENT_357	[p20l1062t283r1148b308],
14	was	VBD	O	be	auxpass	15	SENT_357	[p20l1160t288r1209b304],
15	randomized	VBN	O	randomize	conj_and	6	SENT_357	[p20l1223t283r1367b304],
16	to	TO	O	to	_	0	SENT_357	[p20l1380t284r1404b304],
17	placebo	NN	O	placebo	prep_to	15	SENT_357	[p20l1419t283r1515b308],
18	with	IN	O	with	_	0	SENT_357	[p20l1528t283r1577b304],
19	an	DT	O	a	det	20	SENT_357	[p20l1592t288r1620b304],
20	event	NN	O	event	prep_with	15	SENT_357	[p20l1635t284r1703b304],
21	at	IN	O	at	_	0	SENT_357	[p20l1716t284r1740b304],
22	38	CD	DURATION	38	num	23	SENT_357	[p20l1752t283r1785b304],
23	months	NNS	NUMBER	month	prep_at	20	SENT_357	[p20l1799t283r1900b307],
24	;	:	O	;	_	0	SENT_357	[p20l1799t283r1900b307],
25	2	CD	NUMBER	2	num	26	SENT_357	[p20l1915t283r1930b304],
26	patients	NNS	O	patient	nsubjpass	28	SENT_357	[p20l1945t283r2045b308],
27	were	VBD	O	be	auxpass	28	SENT_357	[p20l2058t288r2117b304],
28	randomized	VBN	O	randomize	conj_and	6	SENT_357	[p20l44t316r188b337],
29	to	TO	O	to	_	0	SENT_357	[p20l199t317r223b337],
30	200	CD	NUMBER	200	num	31	SENT_357	[p20l235t316r285b337],
31	mg	NN	O	mg	prep_to	28	SENT_357	[p20l298t319r335b342],
32	twice	RB	O	twice	advmod	33	SENT_357	[p20l344t316r408b337],
33	daily	RB	SET	daily	advmod	28	SENT_357	[p20l420t316r477b342],
34	with	IN	O	with	_	0	SENT_357	[p20l487t316r536b337],
35	events	NNS	O	event	prep_with	28	SENT_357	[p20l549t317r631b337],
36	at	IN	O	at	_	0	SENT_357	[p20l644t317r667b337],
37	40	CD	NUMBER	40	nn	40	SENT_357	[p20l678t316r711b337],
38	and	CC	O	and	_	0	SENT_357	[p20l723t316r767b337],
39	49	CD	DURATION	49	conj_and	37	SENT_357	[p20l779t316r812b337],
40	months	NNS	NUMBER	month	prep_at	35	SENT_357	[p20l825t316r925b340],
41	;	:	O	;	_	0	SENT_357	[p20l825t316r925b340],
42	and	CC	O	and	_	0	SENT_357	[p20l939t316r983b337],
43	1	CD	NUMBER	1	num	44	SENT_357	[p20l996t316r1011b336],
44	patient	NN	O	patient	nsubjpass	46	SENT_357	[p20l1024t316r1110b341],
45	was	VBD	O	be	auxpass	46	SENT_357	[p20l1120t321r1169b337],
46	randomized	VBN	O	randomize	conj_and	6	SENT_357	[p20l1182t316r1325b337],
47	to	TO	O	to	_	0	SENT_357	[p20l1336t317r1360b337],
48	400	CD	NUMBER	400	num	49	SENT_357	[p20l1372t316r1423b337],
49	mg	NN	O	mg	prep_to	46	SENT_357	[p20l1435t319r1472b342],
50	twice	RB	O	twice	advmod	51	SENT_357	[p20l1482t316r1546b337],
51	daily	RB	SET	daily	advmod	46	SENT_357	[p20l1558t316r1615b342],
52	with	IN	O	with	_	0	SENT_357	[p20l1624t316r1674b337],
53	an	DT	O	a	det	54	SENT_357	[p20l1687t321r1715b337],
54	event	NN	O	event	prep_with	46	SENT_357	[p20l1727t317r1796b337],
55	at	IN	O	at	_	0	SENT_357	[p20l1807t317r1831b337],
56	44	CD	DURATION	44	num	57	SENT_357	[p20l1841t316r1875b336],
57	months	NNS	NUMBER	month	prep_at	54	SENT_357	[p20l1887t316r1987b337],
58	.	.	O	.	_	0	SENT_357	[p20l1887t316r1987b337],
59	"	''	O	"	punct	6	SENT_357	[p20l43t348r123b370],

1	Renal	JJ	O	renal	amod	4	SENT_358	[p20l43t348r123b370],
2	and	CC	O	and	_	0	SENT_358	[p20l138t349r182b370],
3	hypertensive	JJ	O	hypertensive	conj_and	1	SENT_358	[p20l198t349r355b376],
4	events	NNS	O	event	nsubj	5	SENT_358	[p20l369t351r452b370],
5	include	VBP	O	include	_	0	SENT_358	[p20l467t349r555b370],
6	elevated	JJ	O	elevated	amod	7	SENT_358	[p20l569t349r674b370],
7	creatinine	NN	O	creatinine	dobj	5	SENT_358	[p20l689t349r820b374],
8	,	,	O	,	_	0	SENT_358	[p20l689t349r820b374],
9	fluid	NN	O	fluid	nn	10	SENT_358	[p20l834t349r886b370],
10	retention	NN	O	retention	dobj	5	SENT_358	[p20l901t349r1011b370],
11	or	CC	O	or	_	0	SENT_358	[p20l1026t354r1050b370],
12	edema	NN	O	edema	conj_or	10	SENT_358	[p20l1063t349r1155b374],
13	,	,	O	,	_	0	SENT_358	[p20l1063t349r1155b374],
14	hypertension	NN	O	hypertension	dobj	5	SENT_358	[p20l1172t349r1340b376],
15	,	,	O	,	_	0	SENT_358	[p20l1172t349r1340b376],
16	proteinuria	NN	O	proteinurium	conj_and	7	SENT_358	[p20l1356t349r1497b375],
17	,	,	O	,	_	0	SENT_358	[p20l1356t349r1497b375],
18	and	CC	O	and	_	0	SENT_358	[p20l1513t349r1557b370],
19	renal	JJ	O	renal	amod	20	SENT_358	[p20l1572t349r1632b370],
20	failure	NN	O	failure	dobj	5	SENT_358	[p20l1646t349r1732b370],
21	.	.	O	.	_	0	SENT_358	[p20l1646t349r1732b370],

1	Eighteen	CD	NUMBER	eighteen	nsubj	6	SENT_359	[p20l1748t349r1855b376],
2	of	IN	O	of	_	0	SENT_359	[p20l1869t349r1894b370],
3	the	DT	O	the	det	5	SENT_359	[p20l1905t349r1945b370],
4	renal	JJ	O	renal	amod	5	SENT_359	[p20l1960t349r2019b370],
5	events	NNS	O	event	prep_of	1	SENT_359	[p20l2034t351r2117b370],
6	occurred	VBD	O	occur	_	0	SENT_359	[p20l43t382r150b403],
7	after	IN	O	after	_	0	SENT_359	[p20l161t382r218b403],
8	36	CD	DURATION	36	num	9	SENT_359	[p20l227t382r259b403],
9	months	NNS	NUMBER	month	prep_after	6	SENT_359	[p20l269t382r369b403],
10	.	.	O	.	_	0	SENT_359	[p20l269t382r369b403],

1	Eleven	CD	NUMBER	eleven	num	2	SENT_360	[p20l381t382r461b403],
2	patients	NNS	O	patient	nsubj	3	SENT_360	[p20l472t382r572b407],
3	had	VBD	O	have	_	0	SENT_360	[p20l583t382r626b403],
4	wild	JJ	O	wild	amod	7	SENT_360	[p20l635t382r742b408],
5	—	NN	O	—	nn	7	SENT_360	[p20l635t382r742b408],
6	type	NN	O	type	nn	7	SENT_360	[p20l635t382r742b408],
7	genotypes	NNS	O	genotype	dobj	3	SENT_360	[p20l751t383r887b408],
8	:	:	O	:	_	0	SENT_360	[p20l751t383r887b408],
9	4	CD	NUMBER	4	num	10	SENT_360	[p20l898t382r914b403],
10	patients	NNS	O	patient	nsubjpass	12	SENT_360	[p20l924t382r1024b407],
11	were	VBD	O	be	auxpass	12	SENT_360	[p20l1033t387r1092b403],
12	randomized	VBN	O	randomize	parataxis	3	SENT_360	[p20l1102t382r1245b403],
13	to	TO	O	to	_	0	SENT_360	[p20l1254t383r1278b403],
14	placebo	NN	O	placebo	prep_to	12	SENT_360	[p20l1289t382r1385b407],
15	with	IN	O	with	_	0	SENT_360	[p20l1394t382r1443b403],
16	events	NNS	O	event	prep_with	12	SENT_360	[p20l1453t383r1535b403],
17	at	IN	O	at	_	0	SENT_360	[p20l1545t383r1569b403],
18	36.1	CD	NUMBER	36.1	prep_at	16	SENT_360	[p20l1577t382r1644b406],
19	,	,	O	,	_	0	SENT_360	[p20l1577t382r1644b406],
20	36.4	CD	NUMBER	36.4	conj_and	18	SENT_360	[p20l1654t382r1721b406],
21	,	,	O	,	_	0	SENT_360	[p20l1654t382r1721b406],
22	38	CD	NUMBER	38	conj_and	18	SENT_360	[p20l1732t382r1772b406],
23	,	,	O	,	_	0	SENT_360	[p20l1732t382r1772b406],
24	and	CC	DURATION	and	_	0	SENT_360	[p20l1783t382r1827b403],
25	41	CD	DURATION	41	num	26	SENT_360	[p20l1837t382r1870b403],
26	months	NNS	NUMBER	month	conj_and	18	SENT_360	[p20l1880t382r1980b406],
27	;	:	O	;	_	0	SENT_360	[p20l1880t382r1980b406],
28	4	CD	NUMBER	4	num	29	SENT_360	[p20l1990t382r2006b403],
29	patients	NNS	O	patient	nsubjpass	31	SENT_360	[p20l2016t382r2117b407],
30	were	VBD	O	be	auxpass	31	SENT_360	[p20l42t420r101b436],
31	randomized	VBN	O	randomize	parataxis	3	SENT_360	[p20l113t415r256b436],
32	to	TO	O	to	_	0	SENT_360	[p20l267t416r291b436],
33	200	CD	NUMBER	200	num	34	SENT_360	[p20l302t415r352b436],
34	mg	NN	O	mg	prep_to	31	SENT_360	[p20l364t418r401b441],
35	twice	RB	O	twice	advmod	36	SENT_360	[p20l409t415r474b436],
36	daily	RB	SET	daily	advmod	31	SENT_360	[p20l485t415r541b441],
37	with	IN	O	with	_	0	SENT_360	[p20l550t415r600b436],
38	events	NNS	O	event	prep_with	31	SENT_360	[p20l611t416r694b436],
39	at	IN	O	at	_	0	SENT_360	[p20l705t416r729b436],
40	36.3	CD	NUMBER	36.3	prep_at	38	SENT_360	[p20l739t415r805b439],
41	,	,	O	,	_	0	SENT_360	[p20l739t415r805b439],
42	36.6	CD	NUMBER	36.6	prep_at	38	SENT_360	[p20l818t415r884b439],
43	,	,	O	,	_	0	SENT_360	[p20l818t415r884b439],
44	36.8	CD	NUMBER	36.8	prep_at	38	SENT_360	[p20l896t415r963b439],
45	,	,	O	,	_	0	SENT_360	[p20l896t415r963b439],
46	and	CC	O	and	_	0	SENT_360	[p20l975t415r1020b436],
47	36.9	CD	DURATION	36.9	num	48	SENT_360	[p20l1031t415r1090b436],
48	months	NNS	NUMBER	month	prep_at	38	SENT_360	[p20l1102t415r1202b439],
49	;	:	O	;	_	0	SENT_360	[p20l1102t415r1202b439],
50	3	CD	NUMBER	3	num	51	SENT_360	[p20l1215t415r1230b436],
51	patients	NNS	O	patient	nsubjpass	53	SENT_360	[p20l1242t415r1342b440],
52	were	VBD	O	be	auxpass	53	SENT_360	[p20l1352t420r1411b436],
53	randomized	VBN	O	randomize	parataxis	3	SENT_360	[p20l1423t415r1567b436],
54	to	TO	O	to	_	0	SENT_360	[p20l1577t416r1601b436],
55	400	CD	NUMBER	400	num	56	SENT_360	[p20l1612t415r1662b436],
56	mg	NN	O	mg	prep_to	53	SENT_360	[p20l1674t418r1711b441],
57	twice	RB	O	twice	advmod	58	SENT_360	[p20l1719t415r1784b436],
58	daily	RB	SET	daily	advmod	53	SENT_360	[p20l1795t415r1852b441],
59	with	IN	O	with	_	0	SENT_360	[p20l1860t415r1910b436],
60	events	NNS	O	event	prep_with	53	SENT_360	[p20l1921t416r2004b436],
61	at	IN	O	at	_	0	SENT_360	[p20l2015t416r2039b436],
62	36.2	CD	NUMBER	36.2	prep_at	60	SENT_360	[p20l2049t415r2115b439],
63	,	,	O	,	_	0	SENT_360	[p20l2049t415r2115b439],
64	36.3	CD	NUMBER	36.3	prep_at	60	SENT_360	[p20l43t448r110b473],
65	,	,	O	,	_	0	SENT_360	[p20l43t448r110b473],
66	and	CC	DURATION	and	_	0	SENT_360	[p20l126t448r170b469],
67	41	CD	DURATION	41	num	68	SENT_360	[p20l184t448r218b469],
68	months	NNS	NUMBER	month	prep_at	60	SENT_360	[p20l233t448r333b469],
69	.	.	O	.	_	0	SENT_360	[p20l233t448r333b469],

1	Four	CD	NUMBER	four	num	2	SENT_361	[p20l350t448r402b469],
2	patients	NNS	O	patient	nsubj	3	SENT_361	[p20l416t448r517b474],
3	had	VBD	O	have	_	0	SENT_361	[p20l532t448r576b469],
4	CYP2C9	NN	O	cyp2c9	nn	7	SENT_361	[p20l591t448r727b469],
5	*	NN	O	*	nn	7	SENT_361	[p20l591t448r727b469],
6	2	CD	NUMBER	2	num	7	SENT_361	[p20l591t448r727b469],
7	genotypes	NNS	O	genotype	dobj	3	SENT_361	[p20l741t450r877b475],
8	:	:	O	:	_	0	SENT_361	[p20l741t450r877b475],
9	2	CD	NUMBER	2	num	10	SENT_361	[p20l893t448r908b469],
10	patients	NNS	O	patient	nsubjpass	12	SENT_361	[p20l923t448r1024b474],
11	were	VBD	O	be	auxpass	12	SENT_361	[p20l1037t453r1096b469],
12	randomized	VBN	O	randomize	parataxis	3	SENT_361	[p20l1111t448r1254b469],
13	to	TO	O	to	_	0	SENT_361	[p20l1268t450r1292b469],
14	placebo	NN	O	placebo	prep_to	12	SENT_361	[p20l1308t448r1404b474],
15	with	IN	O	with	_	0	SENT_361	[p20l1417t448r1467b469],
16	events	NNS	O	event	prep_with	12	SENT_361	[p20l1482t450r1564b469],
17	at	IN	O	at	_	0	SENT_361	[p20l1579t450r1603b469],
18	36.1	CD	NUMBER	36.1	num	21	SENT_361	[p20l1616t448r1675b469],
19	and	CC	O	and	_	0	SENT_361	[p20l1689t448r1734b469],
20	36.4	CD	DURATION	36.4	conj_and	18	SENT_361	[p20l1749t448r1808b469],
21	months	NNS	NUMBER	month	prep_at	16	SENT_361	[p20l1822t448r1923b473],
22	;	:	O	;	_	0	SENT_361	[p20l1822t448r1923b473],
23	1	CD	NUMBER	1	num	24	SENT_361	[p20l1939t448r1954b469],
24	patient	NN	O	patient	nsubjpass	26	SENT_361	[p20l1969t448r2056b474],
25	was	VBD	O	be	auxpass	26	SENT_361	[p20l2068t453r2117b469],
26	randomized	VBN	O	randomize	parataxis	3	SENT_361	[p20l44t481r188b502],
27	to	TO	O	to	_	0	SENT_361	[p20l198t482r222b502],
28	200	CD	NUMBER	200	num	29	SENT_361	[p20l234t481r284b502],
29	mg	NN	O	mg	prep_to	26	SENT_361	[p20l296t484r333b507],
30	twice	RB	O	twice	advmod	31	SENT_361	[p20l342t481r406b502],
31	daily	RB	SET	daily	advmod	26	SENT_361	[p20l417t481r474b507],
32	with	IN	O	with	_	0	SENT_361	[p20l483t481r533b502],
33	an	DT	O	a	det	34	SENT_361	[p20l545t486r573b502],
34	event	NN	O	event	prep_with	26	SENT_361	[p20l585t482r654b502],
35	at	IN	O	at	_	0	SENT_361	[p20l664t482r688b502],
36	36.5	CD	DURATION	36.5	num	37	SENT_361	[p20l698t481r757b502],
37	months	NNS	NUMBER	month	prep_at	34	SENT_361	[p20l769t481r870b505],
38	;	:	O	;	_	0	SENT_361	[p20l769t481r870b505],
39	1	CD	NUMBER	1	num	40	SENT_361	[p20l883t481r897b502],
40	patient	NN	O	patient	nsubjpass	42	SENT_361	[p20l910t481r996b506],
41	was	VBD	O	be	auxpass	42	SENT_361	[p20l1006t486r1054b502],
42	randomized	VBN	O	randomize	parataxis	3	SENT_361	[p20l1067t481r1210b502],
43	to	TO	O	to	_	0	SENT_361	[p20l1221t482r1245b502],
44	400	CD	NUMBER	400	num	45	SENT_361	[p20l1256t481r1306b502],
45	mg	NN	O	mg	prep_to	42	SENT_361	[p20l1318t484r1355b507],
46	twice	RB	O	twice	advmod	47	SENT_361	[p20l1364t481r1429b502],
47	daily	RB	SET	daily	advmod	42	SENT_361	[p20l1440t481r1497b507],
48	with	IN	O	with	_	0	SENT_361	[p20l1506t481r1555b502],
49	an	DT	O	a	det	50	SENT_361	[p20l1568t486r1596b502],
50	event	NN	O	event	prep_with	42	SENT_361	[p20l1608t482r1676b502],
51	at	IN	O	at	_	0	SENT_361	[p20l1687t482r1710b502],
52	41	CD	DURATION	41	num	53	SENT_361	[p20l1720t481r1753b502],
53	months	NNS	NUMBER	month	prep_at	50	SENT_361	[p20l1765t481r1866b502],
54	.	.	O	.	_	0	SENT_361	[p20l1765t481r1866b502],

1	Three	CD	NUMBER	three	num	2	SENT_362	[p20l1877t481r1947b502],
2	patients	NNS	O	patient	nsubj	3	SENT_362	[p20l1960t481r2060b506],
3	had	VBD	O	have	_	0	SENT_362	[p20l2072t481r2116b502],
4	CYP2C9	NN	O	cyp2c9	dobj	3	SENT_362	[p20l43t514r180b535],
5	*	CD	NUMBER	*	number	6	SENT_362	[p20l43t514r180b535],
6	3	CD	NUMBER	3	num	7	SENT_362	[p20l43t514r180b535],
7	genotypes	NNS	O	genotype	dep	4	SENT_362	[p20l190t515r327b540],
8	:	:	O	:	_	0	SENT_362	[p20l190t515r327b540],
9	1	CD	NUMBER	1	num	10	SENT_362	[p20l340t514r355b535],
10	patient	NN	O	patient	nsubjpass	12	SENT_362	[p20l367t514r453b539],
11	was	VBD	O	be	auxpass	12	SENT_362	[p20l463t519r511b535],
12	randomized	VBN	O	randomize	dep	4	SENT_362	[p20l524t514r667b535],
13	to	TO	O	to	_	0	SENT_362	[p20l678t515r702b535],
14	placebo	NN	O	placebo	prep_to	12	SENT_362	[p20l714t514r811b539],
15	with	IN	O	with	_	0	SENT_362	[p20l821t514r870b535],
16	an	DT	O	a	det	17	SENT_362	[p20l883t519r911b535],
17	event	NN	O	event	prep_with	12	SENT_362	[p20l923t515r991b535],
18	at	IN	O	at	_	0	SENT_362	[p20l1002t515r1026b535],
19	36.3	CD	DURATION	36.3	num	20	SENT_362	[p20l1036t514r1095b535],
20	months	NNS	NUMBER	month	prep_at	17	SENT_362	[p20l1107t514r1207b538],
21	;	:	O	;	_	0	SENT_362	[p20l1107t514r1207b538],
22	2	CD	NUMBER	2	num	23	SENT_362	[p20l1220t514r1235b535],
23	patients	NNS	O	patient	nsubjpass	25	SENT_362	[p20l1247t514r1348b539],
24	were	VBD	O	be	auxpass	25	SENT_362	[p20l1358t519r1417b535],
25	randomized	VBN	O	randomize	parataxis	3	SENT_362	[p20l1429t514r1573b535],
26	to	TO	O	to	_	0	SENT_362	[p20l1583t515r1607b535],
27	400	CD	NUMBER	400	num	28	SENT_362	[p20l1618t514r1669b535],
28	mg	NN	O	mg	prep_to	25	SENT_362	[p20l1681t517r1718b540],
29	twice	RB	O	twice	advmod	30	SENT_362	[p20l1727t514r1791b535],
30	daily	RB	SET	daily	advmod	28	SENT_362	[p20l1802t514r1859b540],
31	with	IN	O	with	_	0	SENT_362	[p20l1868t514r1918b535],
32	events	NNS	O	event	prep_with	30	SENT_362	[p20l1929t515r2012b535],
33	at	IN	O	at	quantmod	34	SENT_362	[p20l2024t515r2047b535],
34	36.6	CD	NUMBER	36.6	num	37	SENT_362	[p20l2058t514r2116b535],
35	and	CC	O	and	_	0	SENT_362	[p20l44t547r88b568],
36	36.8	CD	DURATION	36.8	num	37	SENT_362	[p20l100t547r160b568],
37	months	NNS	NUMBER	month	tmod	25	SENT_362	[p20l172t547r272b568],
38	.	.	O	.	_	0	SENT_362	[p20l172t547r272b568],

1	°	NN	O	°	nn	3	SENT_363	[p20l44t580r252b601],
2	Gastrointestinal	JJ	O	gastrointestinal	amod	3	SENT_363	[p20l44t580r252b601],
3	ulceration	NN	O	ulceration	nsubj	7	SENT_363	[p20l265t580r387b601],
4	and	CC	O	and	_	0	SENT_363	[p20l400t580r444b601],
5	hemorrhage	NN	O	hemorrhage	nn	6	SENT_363	[p20l457t580r606b606],
6	events	NNS	O	event	conj_and	3	SENT_363	[p20l618t581r700b601],
7	include	VBP	O	include	_	0	SENT_363	[p20l713t580r801b601],
8	anemia	NN	O	anemia	dobj	7	SENT_363	[p20l813t580r912b604],
9	,	,	O	,	_	0	SENT_363	[p20l813t580r912b604],
10	gastrointestinal	JJ	O	gastrointestinal	amod	11	SENT_363	[p20l924t580r1119b606],
11	bleeding	NN	O	bleeding	conj_and	8	SENT_363	[p20l1133t580r1245b606],
12	,	,	O	,	_	0	SENT_363	[p20l1133t580r1245b606],
13	gastritis/duodenitis	NN	O	gastritis/duodenitis	conj_or	11	SENT_363	[p20l1257t580r1514b606],
14	,	,	O	,	_	0	SENT_363	[p20l1257t580r1514b606],
15	upper	JJ	O	upper	conj_or	11	SENT_363	[p20l1528t585r1599b605],
16	or	CC	O	or	_	0	SENT_363	[p20l1609t585r1634b601],
17	lower	JJR	O	lower	amod	19	SENT_363	[p20l1645t580r1710b601],
18	gastrointestinal	JJ	O	gastrointestinal	amod	19	SENT_363	[p20l1720t580r1915b606],
19	ulceration	NN	O	ulceration	conj_or	11	SENT_363	[p20l1929t580r2059b604],
20	,	,	O	,	_	0	SENT_363	[p20l1929t580r2059b604],
21	and	CC	O	and	_	0	SENT_363	[p20l2072t580r2116b601],
22	other	JJ	O	other	amod	23	SENT_363	[p20l43t613r108b634],
23	hemorrhage	NN	O	hemorrhage	conj_and	8	SENT_363	[p20l117t613r274b639],
24	.	.	O	.	_	0	SENT_363	[p20l117t613r274b639],

1	Eleven	CD	NUMBER	eleven	nsubj	6	SENT_364	[p20l286t613r365b634],
2	of	IN	O	of	_	0	SENT_364	[p20l375t613r400b634],
3	the	DT	O	the	det	5	SENT_364	[p20l406t613r446b634],
4	gastrointestinal	JJ	O	gastrointestinal	amod	5	SENT_364	[p20l455t613r650b639],
5	events	NNS	O	event	prep_of	1	SENT_364	[p20l661t614r743b634],
6	occurred	VBD	O	occur	_	0	SENT_364	[p20l753t613r860b634],
7	after	IN	O	after	_	0	SENT_364	[p20l870t613r928b634],
8	36	CD	DURATION	36	num	9	SENT_364	[p20l937t613r969b634],
9	months	NNS	NUMBER	month	prep_after	6	SENT_364	[p20l979t613r1080b634],
10	.	.	O	.	_	0	SENT_364	[p20l979t613r1080b634],

1	Eight	CD	NUMBER	eight	num	2	SENT_365	[p20l1092t613r1153b639],
2	patients	NNS	O	patient	nsubj	3	SENT_365	[p20l1162t613r1263b638],
3	had	VBD	O	have	_	0	SENT_365	[p20l1273t613r1317b634],
4	wild	JJ	O	wild	amod	7	SENT_365	[p20l1326t613r1433b639],
5	—	NN	O	—	nn	7	SENT_365	[p20l1326t613r1433b639],
6	type	NN	O	type	nn	7	SENT_365	[p20l1326t613r1433b639],
7	genotypes	NNS	O	genotype	dobj	3	SENT_365	[p20l1442t614r1578b639],
8	:	:	O	:	_	0	SENT_365	[p20l1442t614r1578b639],
9	3	CD	NUMBER	3	nsubjpass	11	SENT_365	[p20l1589t613r1605b634],
10	were	VBD	O	be	auxpass	11	SENT_365	[p20l1613t618r1672b634],
11	randomized	VBN	O	randomize	parataxis	3	SENT_365	[p20l1682t613r1826b634],
12	to	TO	O	to	_	0	SENT_365	[p20l1835t614r1859b634],
13	placebo	NN	O	placebo	prep_to	11	SENT_365	[p20l1870t613r1966b638],
14	with	IN	O	with	_	0	SENT_365	[p20l1975t613r2024b634],
15	events	NNS	O	event	prep_with	11	SENT_365	[p20l2034t614r2117b634],
16	at	IN	O	at	_	0	SENT_365	[p20l44t648r67b667],
17	36.3	CD	NUMBER	36.3	prep_at	15	SENT_365	[p20l78t646r144b671],
18	,	,	O	,	_	0	SENT_365	[p20l78t646r144b671],
19	36.5	CD	NUMBER	36.5	conj_and	17	SENT_365	[p20l157t646r224b671],
20	,	,	O	,	_	0	SENT_365	[p20l157t646r224b671],
21	and	CC	O	and	_	0	SENT_365	[p20l237t646r281b667],
22	37.5	CD	DURATION	37.5	num	23	SENT_365	[p20l294t646r352b667],
23	months	NNS	NUMBER	month	prep_at	15	SENT_365	[p20l365t646r465b671],
24	;	:	O	;	_	0	SENT_365	[p20l365t646r465b671],
25	3	CD	NUMBER	3	nsubjpass	27	SENT_365	[p20l478t646r493b667],
26	were	VBD	O	be	auxpass	27	SENT_365	[p20l504t651r563b667],
27	randomized	VBN	O	randomize	parataxis	3	SENT_365	[p20l575t646r719b667],
28	to	TO	O	to	_	0	SENT_365	[p20l730t648r754b667],
29	200	CD	NUMBER	200	num	30	SENT_365	[p20l766t646r816b667],
30	mg	NN	O	mg	prep_to	27	SENT_365	[p20l828t649r865b673],
31	twice	RB	O	twice	advmod	32	SENT_365	[p20l874t646r938b667],
32	daily	RB	SET	daily	advmod	27	SENT_365	[p20l950t646r1007b673],
33	with	IN	O	with	_	0	SENT_365	[p20l1016t646r1066b667],
34	events	NNS	O	event	prep_with	27	SENT_365	[p20l1078t648r1160b667],
35	at	IN	O	at	_	0	SENT_365	[p20l1173t648r1196b667],
36	37	CD	NUMBER	37	prep_at	34	SENT_365	[p20l1207t646r1247b671],
37	,	,	O	,	_	0	SENT_365	[p20l1207t646r1247b671],
38	38	CD	NUMBER	38	prep_at	34	SENT_365	[p20l1260t646r1300b671],
39	,	,	O	,	_	0	SENT_365	[p20l1260t646r1300b671],
40	and	CC	DURATION	and	_	0	SENT_365	[p20l1314t646r1358b667],
41	48	CD	DURATION	48	num	42	SENT_365	[p20l1370t646r1403b667],
42	months	NNS	NUMBER	month	prep_at	34	SENT_365	[p20l1415t646r1515b671],
43	;	:	O	;	_	0	SENT_365	[p20l1415t646r1515b671],
44	2	CD	NUMBER	2	nsubjpass	46	SENT_365	[p20l1529t646r1543b667],
45	were	VBD	O	be	auxpass	46	SENT_365	[p20l1554t651r1613b667],
46	randomized	VBN	O	randomize	parataxis	3	SENT_365	[p20l1625t646r1769b667],
47	to	TO	O	to	_	0	SENT_365	[p20l1780t648r1804b667],
48	400	CD	NUMBER	400	num	49	SENT_365	[p20l1815t646r1866b667],
49	mg	NN	O	mg	prep_to	46	SENT_365	[p20l1878t649r1915b673],
50	twice	RB	O	twice	advmod	51	SENT_365	[p20l1924t646r1989b667],
51	daily	RB	SET	daily	advmod	46	SENT_365	[p20l2000t646r2057b673],
52	with	IN	O	with	_	0	SENT_365	[p20l2067t646r2116b667],
53	events	NNS	O	event	prep_with	46	SENT_365	[p20l43t680r126b700],
54	at	IN	O	at	_	0	SENT_365	[p20l136t680r159b700],
55	36.7	CD	NUMBER	36.7	nn	58	SENT_365	[p20l168t679r226b700],
56	and	CC	O	and	_	0	SENT_365	[p20l237t679r281b700],
57	42	CD	DURATION	42	conj_and	55	SENT_365	[p20l291t679r323b700],
58	months	NNS	NUMBER	month	prep_at	53	SENT_365	[p20l334t679r434b700],
59	.	.	O	.	_	0	SENT_365	[p20l334t679r434b700],

1	Two	CD	NUMBER	two	num	2	SENT_366	[p20l444t679r492b700],
2	patients	NNS	O	patient	nsubj	3	SENT_366	[p20l503t679r603b704],
3	had	VBD	O	have	_	0	SENT_366	[p20l614t679r658b700],
4	CYP2C9	NN	O	cyp2c9	nn	7	SENT_366	[p20l668t679r804b700],
5	*	NN	O	*	nn	7	SENT_366	[p20l668t679r804b700],
6	2	CD	NUMBER	2	num	7	SENT_366	[p20l668t679r804b700],
7	genotypes	NNS	O	genotype	dobj	3	SENT_366	[p20l813t680r949b705],
8	:	:	O	:	_	0	SENT_366	[p20l813t680r949b705],
9	1	CD	NUMBER	1	num	10	SENT_366	[p20l961t679r975b700],
10	patient	NN	O	patient	nsubjpass	12	SENT_366	[p20l986t679r1073b704],
11	was	VBD	O	be	auxpass	12	SENT_366	[p20l1080t684r1129b700],
12	randomized	VBN	O	randomize	parataxis	3	SENT_366	[p20l1139t679r1283b700],
13	to	TO	O	to	_	0	SENT_366	[p20l1292t680r1316b700],
14	placebo	NN	O	placebo	prep_to	12	SENT_366	[p20l1326t679r1423b704],
15	with	IN	O	with	_	0	SENT_366	[p20l1431t679r1481b700],
16	an	DT	O	a	det	17	SENT_366	[p20l1491t684r1520b700],
17	event	NN	O	event	prep_with	12	SENT_366	[p20l1530t680r1598b700],
18	at	IN	O	at	_	0	SENT_366	[p20l1607t680r1631b700],
19	37	CD	DURATION	37	num	20	SENT_366	[p20l1639t679r1671b700],
20	months	NNS	NUMBER	month	prep_at	17	SENT_366	[p20l1682t679r1782b703],
21	;	:	O	;	_	0	SENT_366	[p20l1682t679r1782b703],
22	1	CD	NUMBER	1	num	23	SENT_366	[p20l1794t679r1809b700],
23	patient	NN	O	patient	nsubjpass	25	SENT_366	[p20l1819t679r1906b704],
24	was	VBD	O	be	auxpass	25	SENT_366	[p20l1913t684r1962b700],
25	randomized	VBN	O	randomize	parataxis	3	SENT_366	[p20l1972t679r2116b700],
26	to	TO	O	to	_	0	SENT_366	[p20l42t713r66b733],
27	200	CD	NUMBER	200	num	28	SENT_366	[p20l76t712r126b733],
28	mg	NN	O	mg	prep_to	25	SENT_366	[p20l136t715r173b738],
29	twice	RB	O	twice	advmod	30	SENT_366	[p20l179t712r244b733],
30	daily	RB	SET	daily	advmod	25	SENT_366	[p20l253t712r310b738],
31	with	IN	O	with	_	0	SENT_366	[p20l317t712r366b733],
32	an	DT	O	a	det	33	SENT_366	[p20l376t717r405b733],
33	event	NN	O	event	prep_with	25	SENT_366	[p20l414t713r483b733],
34	at	IN	O	at	_	0	SENT_366	[p20l491t713r515b733],
35	36.3	CD	DURATION	36.3	num	36	SENT_366	[p20l523t712r582b733],
36	months	NNS	NUMBER	month	prep_at	33	SENT_366	[p20l592t712r692b733],
37	.	.	O	.	_	0	SENT_366	[p20l592t712r692b733],

1	One	CD	NUMBER	one	num	2	SENT_367	[p20l703t712r751b733],
2	patient	NN	O	patient	nsubjpass	11	SENT_367	[p20l762t712r848b737],
3	had	VBD	O	have	_	0	SENT_367	[p20l857t712r901b733],
4	a	DT	O	a	det	8	SENT_367	[p20l911t717r924b733],
5	CYP2C9	NN	O	cyp2c9	nn	8	SENT_367	[p20l933t712r1070b733],
6	*	NN	O	*	nn	8	SENT_367	[p20l933t712r1070b733],
7	3	CD	NUMBER	3	num	8	SENT_367	[p20l933t712r1070b733],
8	genotype	NN	O	genotype	dobj	3	SENT_367	[p20l1078t713r1192b738],
9	and	CC	O	and	_	0	SENT_367	[p20l1202t712r1246b733],
10	was	VBD	O	be	auxpass	11	SENT_367	[p20l1255t717r1303b733],
11	randomized	VBN	O	randomize	conj_and	3	SENT_367	[p20l1313t712r1457b733],
12	to	TO	O	to	_	0	SENT_367	[p20l1465t713r1490b733],
13	400	CD	NUMBER	400	num	14	SENT_367	[p20l1498t712r1549b733],
14	mg	NN	O	mg	prep_to	11	SENT_367	[p20l1559t715r1596b738],
15	twice	RB	O	twice	advmod	16	SENT_367	[p20l1603t712r1667b733],
16	daily	RB	SET	daily	advmod	11	SENT_367	[p20l1676t712r1733b738],
17	with	IN	O	with	_	0	SENT_367	[p20l1740t712r1789b733],
18	an	DT	O	a	det	19	SENT_367	[p20l1800t717r1828b733],
19	event	NN	O	event	prep_with	11	SENT_367	[p20l1838t713r1906b733],
20	at	IN	O	at	_	0	SENT_367	[p20l1915t713r1938b733],
21	36.6	CD	DURATION	36.6	num	22	SENT_367	[p20l1947t712r2005b733],
22	months	NNS	NUMBER	month	prep_at	19	SENT_367	[p20l2015t712r2116b733],
23	.	.	O	.	_	0	SENT_367	[p20l2015t712r2116b733],

1	2134	CD	DATE	2134	_	0	SENT_368	[p20l369t871r504b913],
2	CHAN	NNP	MISC	CHAN	nn	4	SENT_368	[p20l566t872r707b913],
3	ET	NNP	MISC	ET	nn	4	SENT_368	[p20l735t872r791b912],
4	AL	NNP	MISC	AL	dep	1	SENT_368	[p20l811t872r876b912],

1	as	IN	O	as	mark	8	SENT_369	[p20l370t1067r428b1100],
2	an	DT	O	a	det	4	SENT_369	[p20l450t1066r523b1100],
3	increased	VBN	O	increase	amod	4	SENT_369	[p20l543t1046r831b1101],
4	risk	NN	O	risk	nsubj	8	SENT_369	[p20l851t1046r964b1100],
5	of	IN	O	of	_	0	SENT_369	[p20l985t1046r1055b1100],
6	gastroduodenal	JJ	O	gastroduodenal	amod	7	SENT_369	[p20l1066t1046r1549b1119],
7	bleeding	NN	O	bleeding	prep_of	4	SENT_369	[p20l1568t1046r1831b1119],
8	related	VBN	O	relate	_	0	SENT_369	[p20l1852t1046r2061b1101],
9	to	TO	O	to	_	0	SENT_369	[p20l2081t1062r2141b1100],
10	NSAIDs	NNS	O	nsaid	prep_to	8	SENT_369	[p20l369t1139r692b1189],
11	.17	CD	NUMBER	.17	dep	10	SENT_369	[p20l369t1139r692b1189],

1	Interestingly	RB	O	interestingly	advmod	32	SENT_370	[p20l443t1225r847b1298],
2	,	,	O	,	_	0	SENT_370	[p20l443t1225r847b1298],
3	although	IN	O	although	mark	7	SENT_370	[p20l879t1225r1160b1298],
4	there	EX	O	there	expl	7	SENT_370	[p20l1192t1225r1346b1279],
5	did	VBD	O	do	aux	7	SENT_370	[p20l1377t1225r1477b1280],
6	not	RB	O	not	neg	7	SENT_370	[p20l1507t1241r1612b1279],
7	appear	VB	O	appear	advcl	32	SENT_370	[p20l1642t1245r1849b1298],
8	to	TO	O	to	aux	13	SENT_370	[p20l1879t1241r1939b1279],
9	be	VB	O	be	cop	13	SENT_370	[p20l1970t1226r2039b1279],
10	an	DT	O	a	det	13	SENT_370	[p20l2070t1245r2143b1279],
11	overall	JJ	O	overall	amod	13	SENT_370	[p20l370t1315r573b1368],
12	independent	JJ	O	independent	amod	13	SENT_370	[p20l593t1315r983b1388],
13	effect	NN	O	effect	xcomp	7	SENT_370	[p20l1004t1315r1171b1368],
14	of	IN	O	of	_	0	SENT_370	[p20l1191t1315r1262b1368],
15	CYPZC9	NN	O	cypzc9	nn	16	SENT_370	[p20l1273t1319r1525b1369],
16	genotype	NN	O	genotype	prep_of	13	SENT_370	[p20l1549t1331r1827b1388],
17	on	IN	O	on	_	0	SENT_370	[p20l1849t1335r1928b1368],
18	risk	NN	O	risk	prep_on	16	SENT_370	[p20l1949t1315r2062b1368],
19	of	IN	O	of	_	0	SENT_370	[p20l2083t1315r2153b1368],
20	adenoma	NN	O	adenoma	prep_of	18	SENT_370	[p20l370t1404r668b1471],
21	,	,	O	,	_	0	SENT_370	[p20l370t1404r668b1471],
22	patients	NNS	O	patient	nsubj	32	SENT_370	[p20l699t1407r945b1477],
23	in	IN	O	in	_	0	SENT_370	[p20l976t1407r1036b1457],
24	our	PRP$	O	we	poss	25	SENT_370	[p20l1067t1424r1173b1458],
25	study	NN	O	study	prep_in	22	SENT_370	[p20l1203t1404r1373b1477],
26	with	IN	O	with	_	0	SENT_370	[p20l1399t1404r1536b1458],
27	the	DT	O	the	det	31	SENT_370	[p20l1567t1404r1663b1458],
28	CYP2C9	NN	O	cyp2c9	nn	31	SENT_370	[p20l1695t1409r2024b1459],
29	*	NN	O	*	nn	31	SENT_370	[p20l1695t1409r2024b1459],
30	2	CD	NUMBER	2	num	31	SENT_370	[p20l1695t1409r2024b1459],
31	genotype	NN	O	genotype	prep_with	25	SENT_370	[p20l2056t1425r2142b1477, p20l369t1509r579b1566],
32	appeared	VBD	O	appear	_	0	SENT_370	[p20l607t1493r887b1566],
33	to	TO	O	to	aux	34	SENT_370	[p20l914t1509r973b1547],
34	have	VB	O	have	xcomp	32	SENT_370	[p20l1002t1494r1139b1547],
35	a	DT	O	a	det	38	SENT_370	[p20l1167t1514r1200b1547],
36	somewhat	RB	O	somewhat	advmod	37	SENT_370	[p20l1225t1494r1538b1547],
37	higher	JJR	O	higher	amod	38	SENT_370	[p20l1564t1494r1764b1566],
38	risk	NN	O	risk	dobj	34	SENT_370	[p20l1790t1493r1903b1547],
39	of	IN	O	of	_	0	SENT_370	[p20l1930t1494r2000b1547],
40	adenoma	NN	O	adenoma	prep_of	38	SENT_370	[p20l2018t1493r2141b1548, p20l369t1603r548b1637],
41	in	IN	O	in	_	0	SENT_370	[p20l576t1585r637b1636],
42	the	DT	O	the	det	43	SENT_370	[p20l668t1583r764b1637],
43	subgroup	NN	O	subgroup	prep_in	32	SENT_370	[p20l796t1583r1089b1656],
44	using	VBG	O	use	partmod	43	SENT_370	[p20l1122t1585r1291b1655],
45	low	JJ	O	low	amod	48	SENT_370	[p20l1320t1583r1591b1638],
46	—	NN	O	—	nn	48	SENT_370	[p20l1320t1583r1591b1638],
47	dose	NN	O	dose	nn	48	SENT_370	[p20l1320t1583r1591b1638],
48	aspirin	NN	O	aspirin	dobj	44	SENT_370	[p20l1623t1585r1848b1656],
49	.	.	O	.	_	0	SENT_370	[p20l1623t1585r1848b1656],

1	Previous	JJ	O	previous	amod	2	SENT_371	[p20l1882t1585r2142b1637],
2	studies	NNS	O	study	nsubj	4	SENT_371	[p20l370t1672r584b1727],
3	have	VBP	O	have	aux	4	SENT_371	[p20l626t1672r763b1726],
4	suggested	VBN	O	suggest	ccomp	73	SENT_371	[p20l805t1672r1107b1745],
5	that	IN	O	that	complm	12	SENT_371	[p20l1147t1672r1272b1725],
6	CYPZC9	NN	O	cypzc9	nn	8	SENT_371	[p20l1313t1677r1565b1726],
7	variant	JJ	O	variant	amod	8	SENT_371	[p20l1606t1674r1824b1726],
8	genotype	NN	O	genotype	nsubjpass	12	SENT_371	[p20l1864t1688r2142b1745],
9	may	MD	O	may	aux	12	SENT_371	[p20l370t1782r499b1834],
10	be	VB	O	be	auxpass	12	SENT_371	[p20l543t1761r612b1815],
11	independently	RB	O	independently	advmod	12	SENT_371	[p20l661t1761r1106b1834],
12	associated	VBN	O	associate	ccomp	4	SENT_371	[p20l1152t1761r1466b1816],
13	with	IN	O	with	_	0	SENT_371	[p20l1512t1761r1649b1815],
14	adenoma	NN	O	adenoma	nn	15	SENT_371	[p20l1699t1761r1984b1816],
15	risk	NN	O	risk	prep_with	12	SENT_371	[p20l2030t1761r2143b1815],
16	through	IN	O	through	_	0	SENT_371	[p20l370t1851r632b1923],
17	differential	JJ	O	differential	amod	18	SENT_371	[p20l677t1850r1034b1905],
18	metabolism	NN	O	metabolism	prep_through	12	SENT_371	[p20l1078t1851r1455b1904],
19	of	IN	O	of	_	0	SENT_371	[p20l1498t1851r1570b1904],
20	carcinogens	NNS	O	carcinogen	prep_of	18	SENT_371	[p20l1604t1853r1981b1923],
21	and	CC	O	and	_	0	SENT_371	[p20l2026t1850r2144b1905],
22	endogenous	JJ	O	endogenous	amod	23	SENT_371	[p20l370t1940r755b2013],
23	prostanoids	NNS	O	prostanoid	prep_of	18	SENT_371	[p20l787t1940r1167b2013],
24	or	CC	O	or	_	0	SENT_371	[p20l1200t1959r1266b1993],
25	induction	NN	O	induction	conj_or	18	SENT_371	[p20l1295t1940r1611b1995],
26	of	IN	O	of	_	0	SENT_371	[p20l1642t1940r1714b1993],
27	cyclooxygenase-2	NN	O	cyclooxygenase-2	prep_of	25	SENT_371	[p20l1735t1940r2142b2013, p20l370t2033r819b2083],
28	.13	CD	NUMBER	.13	num	27	SENT_371	[p20l1735t1940r2142b2013, p20l370t2033r819b2083],
29	’	CD	NUMBER	’	number	30	SENT_371	[p20l1735t1940r2142b2013, p20l370t2033r819b2083],
30	15	CD	NUMBER	15	npadvmod	31	SENT_371	[p20l1735t1940r2142b2013, p20l370t2033r819b2083],
31	>	JJR	O	>	amod	27	SENT_371	[p20l1735t1940r2142b2013, p20l370t2033r819b2083],
32	25	CD	NUMBER	25	number	33	SENT_371	[p20l1735t1940r2142b2013, p20l370t2033r819b2083],
33	'27	CD	NUMBER	'27	num	35	SENT_371	[p20l1735t1940r2142b2013, p20l370t2033r819b2083],
34	This	DT	O	this	det	35	SENT_371	[p20l844t2029r980b2083],
35	ﬁnding	NN	O	ﬁnding	nsubjpass	39	SENT_371	[p20l1009t2029r1232b2102],
36	may	MD	O	may	aux	39	SENT_371	[p20l1258t2049r1387b2102],
37	also	RB	O	also	advmod	39	SENT_371	[p20l1412t2029r1530b2083],
38	be	VB	O	be	auxpass	39	SENT_371	[p20l1557t2029r1626b2083],
39	explained	VBN	O	explain	rcmod	27	SENT_371	[p20l1654t2029r1948b2102],
40	by	IN	O	by	_	0	SENT_371	[p20l1973t2029r2046b2102],
41	an	DT	O	a	det	42	SENT_371	[p20l2070t2049r2143b2083],
42	effect	NN	O	effect	agent	39	SENT_371	[p20l370t2119r537b2172],
43	of	IN	O	of	_	0	SENT_371	[p20l575t2119r646b2172],
44	the	DT	O	the	det	48	SENT_371	[p20l674t2119r770b2172],
45	*	NN	O	*	nn	48	SENT_371	[p20l812t2123r879b2172],
46	3	CD	NUMBER	3	num	48	SENT_371	[p20l812t2123r879b2172],
47	variant	JJ	O	variant	amod	48	SENT_371	[p20l918t2121r1136b2172],
48	allele	NN	O	allele	prep_of	42	SENT_371	[p20l1174t2119r1329b2172],
49	in	IN	O	in	_	0	SENT_371	[p20l1367t2121r1427b2172],
50	CYP2C8	NN	O	cyp2c8	prep_in	48	SENT_371	[p20l1467t2123r1736b2185],
51	,	,	O	,	_	0	SENT_371	[p20l1467t2123r1736b2185],
52	which	WDT	O	which	nsubj	53	SENT_371	[p20l1774t2118r1960b2172],
53	is	VBZ	O	be	rcmod	50	SENT_371	[p20l1998t2121r2043b2172],
54	in	IN	O	in	_	0	SENT_371	[p20l2083t2121r2143b2172],
55	strong	JJ	O	strong	amod	56	SENT_371	[p20l370t2223r569b2280],
56	linkage	NN	O	linkage	prep_in	53	SENT_371	[p20l589t2208r812b2280],
57	with	IN	O	with	_	0	SENT_371	[p20l833t2208r970b2261],
58	the	DT	O	the	det	65	SENT_371	[p20l993t2208r1088b2261],
59	CYPZC9	NN	O	cypzc9	nn	65	SENT_371	[p20l1112t2212r1364b2262],
60	*	NN	O	*	nn	65	SENT_371	[p20l1392t2212r1460b2261],
61	2	CD	NUMBER	2	num	65	SENT_371	[p20l1392t2212r1460b2261],
62	allele	NN	O	allele	dep	65	SENT_371	[p20l1484t2208r1708b2261],
63	.28	CD	NUMBER	.28	num	62	SENT_371	[p20l1484t2208r1708b2261],
64	In	IN	O	in	prep	62	SENT_371	[p20l1730t2213r1795b2261],
65	support	NN	O	support	prep_with	56	SENT_371	[p20l1818t2223r2061b2281],
66	of	IN	O	of	_	0	SENT_371	[p20l2083t2208r2153b2261],
67	this	DT	O	this	det	68	SENT_371	[p20l370t2296r482b2350],
68	hypothesis	NN	O	hypothesis	prep_of	65	SENT_371	[p20l514t2296r861b2369],
69	,	,	O	,	_	0	SENT_371	[p20l514t2296r861b2369],
70	we	PRP	O	we	nsubj	73	SENT_371	[p20l891t2317r971b2350],
71	did	VBD	O	do	aux	73	SENT_371	[p20l1003t2296r1103b2351],
72	not	RB	O	not	neg	73	SENT_371	[p20l1132t2312r1238b2350],
73	observe	VB	O	observe	_	0	SENT_371	[p20l1268t2296r1495b2350],
74	any	DT	O	any	det	76	SENT_371	[p20l1527t2316r1635b2369],
75	increase	NN	O	increase	nn	76	SENT_371	[p20l1663t2299r1907b2350],
76	risk	NN	O	risk	nsubj	79	SENT_371	[p20l1939t2296r2052b2350],
77	of	IN	O	of	_	0	SENT_371	[p20l2083t2296r2153b2350],
78	adenoma	NN	O	adenoma	prep_of	76	SENT_371	[p20l370t2386r655b2441],
79	related	JJ	O	related	xcomp	73	SENT_371	[p20l681t2386r891b2441],
80	to	TO	O	to	_	0	SENT_371	[p20l918t2401r978b2440],
81	the	DT	O	the	det	85	SENT_371	[p20l1009t2386r1104b2440],
82	CYP2C9	NN	O	cyp2c9	nn	85	SENT_371	[p20l1134t2390r1462b2440],
83	*	NN	O	*	nn	85	SENT_371	[p20l1134t2390r1462b2440],
84	3	CD	NUMBER	3	num	85	SENT_371	[p20l1134t2390r1462b2440],
85	variant	NN	O	variant	prep_to	79	SENT_371	[p20l1490t2388r1722b2452],
86	,	,	O	,	_	0	SENT_371	[p20l1490t2388r1722b2452],
87	which	WDT	O	which	nsubjpass	91	SENT_371	[p20l1750t2386r1936b2440],
88	is	VBZ	O	be	auxpass	91	SENT_371	[p20l1964t2388r2009b2440],
89	not	RB	O	not	neg	91	SENT_371	[p20l2038t2401r2144b2440],
90	strongly	RB	O	strongly	advmod	91	SENT_371	[p20l370t2474r624b2547],
91	linked	VBN	O	link	rcmod	85	SENT_371	[p20l647t2474r841b2529],
92	to	TO	O	to	_	0	SENT_371	[p20l867t2490r927b2528],
93	the	DT	O	the	det	96	SENT_371	[p20l955t2474r1051b2528],
94	*	NN	O	*	nn	96	SENT_371	[p20l1080t2479r1148b2528],
95	3	CD	NUMBER	3	num	96	SENT_371	[p20l1080t2479r1148b2528],
96	allele	NN	O	allele	prep_to	91	SENT_371	[p20l1177t2474r1332b2528],
97	of	IN	O	of	_	0	SENT_371	[p20l1359t2474r1430b2528],
98	CYP2C8	NN	O	cyp2c8	prep_of	96	SENT_371	[p20l1447t2479r1715b2528],
99	.	.	O	.	_	0	SENT_371	[p20l1447t2479r1715b2528],

1	The	DT	O	the	det	4	SENT_372	[p20l1742t2474r1861b2528],
2	*	NN	O	*	nn	4	SENT_372	[p20l1891t2479r1958b2528],
3	3	CD	NUMBER	3	num	4	SENT_372	[p20l1891t2479r1958b2528],
4	allele	NN	O	allele	nsubjpass	9	SENT_372	[p20l1988t2474r2142b2528],
5	of	IN	O	of	_	0	SENT_372	[p20l370t2564r441b2618],
6	CYP2C8	NN	O	cyp2c8	prep_of	4	SENT_372	[p20l465t2568r718b2618],
7	has	VBZ	O	have	aux	9	SENT_372	[p20l753t2564r854b2618],
8	been	VBN	O	be	auxpass	9	SENT_372	[p20l887t2564r1031b2618],
9	associated	VBN	O	associate	_	0	SENT_372	[p20l1064t2564r1378b2619],
10	with	IN	O	with	_	0	SENT_372	[p20l1409t2564r1546b2618],
11	impaired	JJ	O	impaired	amod	12	SENT_372	[p20l1580t2564r1858b2637],
12	metabolism	NN	O	metabolism	prep_with	9	SENT_372	[p20l1891t2564r2142b2618, p20l369t2653r499b2707],
13	of	IN	O	of	_	0	SENT_372	[p20l527t2653r597b2706],
14	arachidonic	JJ	O	arachidonic	amod	15	SENT_372	[p20l614t2652r976b2708],
15	acid	NN	O	acid	prep_of	12	SENT_372	[p20l1004t2652r1143b2719],
16	,	,	O	,	_	0	SENT_372	[p20l1004t2652r1143b2719],
17	which	WDT	O	which	nsubj	18	SENT_372	[p20l1170t2653r1355b2707],
18	inﬂuences	VBZ	O	inﬂuences	rcmod	15	SENT_372	[p20l1382t2653r1691b2707],
19	adenoma	NN	O	adenoma	nn	20	SENT_372	[p20l1720t2652r2005b2708],
20	risk	NN	O	risk	nsubj	29	SENT_372	[p20l2031t2652r2143b2707],
21	as	RB	O	as	_	0	SENT_372	[p20l370t2763r428b2796],
22	well	RB	O	well	_	0	SENT_372	[p20l460t2742r582b2796],
23	as	IN	O	as	_	0	SENT_372	[p20l615t2763r673b2796],
24	Vascular	JJ	O	vascular	amod	25	SENT_372	[p20l704t2742r957b2796],
25	tone	NN	O	tone	conj_and	20	SENT_372	[p20l989t2758r1140b2809],
26	,	,	O	,	_	0	SENT_372	[p20l989t2758r1140b2809],
27	potentially	RB	O	potentially	advmod	25	SENT_372	[p20l1174t2742r1509b2815],
28	also	RB	O	also	advmod	29	SENT_372	[p20l1540t2742r1658b2796],
29	explaining	VBG	O	explain	dep	18	SENT_372	[p20l1693t2742r2015b2815],
30	the	DT	O	the	dobj	29	SENT_372	[p20l2047t2742r2142b2796],
31	'	''	O	'	_	0	SENT_372	[p20l159t1605r200b1868],

1	1VDIN	CD	NUMBER	1vdin	num	4	SENT_373	[p20l159t1605r200b1868],
2	|	NN	O	|	nn	4	SENT_373	[p20l159t1605r200b1868],
3	'	''	O	'	_	0	SENT_373	[p20l159t1605r200b1868],
4	ID	NNP	O	ID	_	0	SENT_373	[p20l159t1605r200b1868],
5	>	JJR	O	>	dep	4	SENT_373	[p20l93t1471r132b1511],
6	:	:	O	:	_	0	SENT_373	[p20l93t1515r132b1550],
7	3	CD	NUMBER	3	num	8	SENT_373	[p20l93t1555r132b1603],
8	M	NN	O	m	dep	4	SENT_373	[p20l93t1608r132b1630],
9	Z	NN	O	z	rcmod	8	SENT_373	[p20l93t1636r132b1675],
10	-	:	O	-	_	0	SENT_373	[p20l93t1679r132b1706],
11	|	NN	O	|	dep	9	SENT_373	[p20l93t1679r132b1706],
12	:33	CD	NUMBER	:33	num	11	SENT_373	[p20l93t1707r132b1782],
13	'	''	O	'	_	0	SENT_373	[p20l93t1782r132b1819],
14	<	JJR	O	<	dep	9	SENT_373	[p20l93t1782r132b1819],
15	52	CD	NUMBER	52	dep	14	SENT_373	[p20l93t1836r132b1939],
16	'	''	O	'	_	0	SENT_373	[p20l93t1836r132b1939],
17	(	CD	NUMBER	(	dep	4	SENT_373	[p20l92t1941r133b1971],
18	3	LS	NUMBER	3	dep	17	SENT_373	[p20l92t1941r133b1971],
19	-	:	O	-	_	0	SENT_373	[p20l93t1974r132b2001],
20	I	PRP	O	I	dep	17	SENT_373	[p20l93t1974r132b2001],

1	higher	JJR	O	higher	amod	2	SENT_374	[p20l369t2862r569b2935],
2	prevalence	NN	O	prevalence	_	0	SENT_374	[p20l607t2862r928b2935],
3	of	IN	O	of	_	0	SENT_374	[p20l968t2862r1039b2916],
4	baseline	NN	O	baseline	nn	5	SENT_374	[p20l1067t2862r1314b2916],
5	hypertension	NN	O	hypertension	prep_of	2	SENT_374	[p20l1353t2862r1757b2935],
6	among	IN	O	among	_	0	SENT_374	[p20l1797t2882r2011b2935],
7	patients	NNS	O	patient	prep_among	2	SENT_374	[p20l2049t2881r2142b2935, p20l370t2953r540b3004],
8	in	IN	O	in	_	0	SENT_374	[p20l569t2953r629b3003],
9	this	DT	O	this	det	10	SENT_374	[p20l658t2950r770b3004],
10	trial	NN	O	trial	prep_in	7	SENT_374	[p20l801t2950r926b3004],
11	with	IN	O	with	_	0	SENT_374	[p20l952t2950r1089b3004],
12	CYP2C9	NN	O	cyp2c9	nn	13	SENT_374	[p20l1119t2955r1448b3005],
13	*	NN	O	*	prep_with	10	SENT_374	[p20l1119t2955r1448b3005],
14	2	CD	NUMBER	2	num	15	SENT_374	[p20l1119t2955r1448b3005],
15	genotypes	NNS	O	genotype	dep	13	SENT_374	[p20l1479t2954r1855b3023],
16	.	.	O	.	_	0	SENT_374	[p20l1479t2954r1855b3023],

1	”	NN	O	”	_	0	SENT_375	[p20l1479t2954r1855b3023],

1	Given	VBN	O	give	prep	18	SENT_376	[p20l445t3042r629b3094],
2	the	DT	O	the	det	3	SENT_376	[p20l655t3040r753b3094],
3	importance	NN	O	importance	dep	1	SENT_376	[p20l779t3042r1146b3113],
4	of	IN	O	of	_	0	SENT_376	[p20l1173t3040r1245b3094],
5	the	DT	O	the	det	7	SENT_376	[p20l1261t3040r1360b3094],
6	APC	NN	ORGANIZATION	apc	nn	7	SENT_376	[p20l1383t3044r1521b3094],
7	trial	NN	O	trial	prep_of	3	SENT_376	[p20l1549t3040r1680b3094],
8	in	IN	O	in	_	0	SENT_376	[p20l1705t3042r1766b3093],
9	identifying	VBG	O	identify	prepc_in	7	SENT_376	[p20l1791t3040r2144b3113],
10	unexpected	JJ	O	unexpected	amod	11	SENT_376	[p20l369t3128r734b3201],
11	toxicity	NN	O	toxicity	dobj	9	SENT_376	[p20l761t3131r1001b3201],
12	associated	VBN	O	associate	partmod	11	SENT_376	[p20l1027t3128r1354b3183],
13	with	IN	O	with	_	0	SENT_376	[p20l1379t3128r1521b3182],
14	celecoxib	NN	O	celecoxib	prep_with	12	SENT_376	[p20l1549t3128r1885b3195],
15	,4	CD	NUMBER	,4	num	14	SENT_376	[p20l1549t3128r1885b3195],
16	we	PRP	O	we	nsubj	18	SENT_376	[p20l1909t3149r1991b3182],
17	also	RB	O	also	advmod	18	SENT_376	[p20l2019t3128r2141b3182],
18	examined	VBD	O	examine	_	0	SENT_376	[p20l370t3218r676b3273],
19	the	DT	O	the	det	20	SENT_376	[p20l699t3218r797b3272],
20	inﬂuence	NN	O	inﬂuence	dobj	18	SENT_376	[p20l820t3218r1111b3272],
21	of	IN	O	of	_	0	SENT_376	[p20l1135t3218r1207b3272],
22	CYPZC9	NN	O	cypzc9	nn	24	SENT_376	[p20l1221t3222r1480b3272],
23	genetic	JJ	O	genetic	amod	24	SENT_376	[p20l1505t3220r1731b3291],
24	variation	NN	O	variation	prep_of	20	SENT_376	[p20l1751t3220r2040b3272],
25	on	IN	O	on	_	0	SENT_376	[p20l2064t3238r2143b3272],
26	risk	NN	O	risk	prep_on	24	SENT_376	[p20l370t3306r488b3360],
27	of	IN	O	of	_	0	SENT_376	[p20l514t3306r586b3360],
28	adverse	JJ	O	adverse	amod	29	SENT_376	[p20l603t3306r834b3361],
29	events	NNS	O	event	prep_of	26	SENT_376	[p20l862t3322r1074b3360],
30	.	.	O	.	_	0	SENT_376	[p20l862t3322r1074b3360],

1	For	IN	O	for	_	0	SENT_377	[p20l1103t3311r1212b3360],
2	both	DT	O	both	det	6	SENT_377	[p20l1236t3306r1385b3360],
3	renal	JJ	O	renal	amod	6	SENT_377	[p20l1413t3306r1571b3360],
4	and	CC	O	and	_	0	SENT_377	[p20l1598t3306r1716b3361],
5	hypertensive	JJ	O	hypertensive	conj_and	3	SENT_377	[p20l1741t3306r2142b3379],
6	events	NNS	O	event	prep_for	11	SENT_377	[p20l370t3412r583b3462],
7	,	,	O	,	_	0	SENT_377	[p20l370t3412r583b3462],
8	there	EX	O	there	expl	11	SENT_377	[p20l617t3396r777b3450],
9	did	VBD	O	do	aux	11	SENT_377	[p20l810t3396r913b3451],
10	not	RB	O	not	neg	11	SENT_377	[p20l943t3412r1052b3450],
11	appear	VB	O	appear	_	0	SENT_377	[p20l1083t3415r1297b3469],
12	to	TO	O	to	aux	17	SENT_377	[p20l1328t3412r1390b3450],
13	be	VB	O	be	cop	17	SENT_377	[p20l1422t3396r1492b3450],
14	a	DT	O	a	det	17	SENT_377	[p20l1525t3416r1557b3450],
15	consistent	JJ	O	consistent	amod	16	SENT_377	[p20l1587t3398r1915b3450],
16	differential	JJ	O	differential	amod	17	SENT_377	[p20l1947t3396r2142b3451, p20l370t3485r549b3538],
17	effect	NN	O	effect	xcomp	11	SENT_377	[p20l590t3485r765b3538],
18	of	IN	O	of	_	0	SENT_377	[p20l805t3485r878b3538],
19	celecoxib	NN	O	celecoxib	prep_of	17	SENT_377	[p20l909t3485r1196b3538],
20	according	VBG	O	accord	_	0	SENT_377	[p20l1239t3484r1554b3557],
21	to	TO	O	to	prepc_according_to	11	SENT_377	[p20l1594t3500r1656b3538],
22	genotype	NN	O	genotype	pobj	11	SENT_377	[p20l1699t3500r2002b3558],
23	.	.	O	.	_	0	SENT_377	[p20l1699t3500r2002b3558],

1	We	PRP	O	we	nsubj	5	SENT_378	[p20l2045t3490r2143b3538],
2	also	RB	O	also	advmod	5	SENT_378	[p20l370t3573r492b3627],
3	did	VBD	O	do	aux	5	SENT_378	[p20l524t3573r627b3628],
4	not	RB	O	not	neg	5	SENT_378	[p20l655t3589r764b3627],
5	ﬁnd	VB	O	ﬁnd	_	0	SENT_378	[p20l793t3573r919b3628],
6	a	DT	O	a	det	7	SENT_378	[p20l948t3594r981b3627],
7	relationship	NN	O	relationship	dobj	5	SENT_378	[p20l1009t3573r1395b3646],
8	between	IN	O	between	_	0	SENT_378	[p20l1425t3573r1685b3627],
9	variant	JJ	O	variant	amod	10	SENT_378	[p20l1712t3576r1939b3627],
10	genotype	NN	O	genotype	prep_between	7	SENT_378	[p20l1968t3593r2142b3646, p20l370t3678r502b3736],
11	and	CC	O	and	_	0	SENT_378	[p20l526t3663r644b3718],
12	gastrointestinal	JJ	O	gastrointestinal	amod	13	SENT_378	[p20l667t3663r1172b3736],
13	bleeding	NN	O	bleeding	conj_and	7	SENT_378	[p20l1194t3663r1467b3736],
14	associated	VBN	O	associate	partmod	13	SENT_378	[p20l1490t3663r1817b3718],
15	with	IN	O	with	_	0	SENT_378	[p20l1838t3663r1980b3716],
16	celecoxib	NN	O	celecoxib	prep_with	14	SENT_378	[p20l2004t3663r2142b3717, p20l370t3752r553b3805],
17	.	.	O	.	_	0	SENT_378	[p20l2004t3663r2142b3717, p20l370t3752r553b3805],

1	This	DT	O	this	det	2	SENT_379	[p20l581t3751r722b3805],
2	ﬁnding	NN	O	ﬁnding	nsubj	3	SENT_379	[p20l751t3751r982b3824],
3	contrasts	VBZ	O	contrast	_	0	SENT_379	[p20l1009t3767r1301b3805],
4	with	IN	O	with	_	0	SENT_379	[p20l1328t3752r1470b3805],
5	a	DT	O	a	det	8	SENT_379	[p20l1499t3772r1532b3805],
6	small	JJ	O	small	amod	8	SENT_379	[p20l1558t3751r1727b3805],
7	case-control	JJ	O	case-control	amod	8	SENT_379	[p20l1755t3751r2143b3805],
8	study	NN	O	study	prep_with	3	SENT_379	[p21l370t19r546b92],
9	that	WDT	O	that	nsubj	10	SENT_379	[p21l569t19r699b73],
10	did	VBD	O	do	rcmod	8	SENT_379	[p21l724t19r827b74],
11	observe	VB	O	observe	dep	10	SENT_379	[p21l851t19r1087b73],
12	an	DT	O	a	det	13	SENT_379	[p21l1113t39r1188b73],
13	association	NN	O	association	dobj	11	SENT_379	[p21l1213t21r1571b73],
14	between	IN	O	between	_	0	SENT_379	[p21l1595t19r1855b73],
15	CYPZC9	NN	O	cypzc9	nn	17	SENT_379	[p21l1881t23r2140b73],
16	variant	JJ	O	variant	amod	17	SENT_379	[p21l367t110r593b161],
17	genotype	NN	O	genotype	prep_between	13	SENT_379	[p21l617t123r905b181],
18	and	CC	O	and	_	0	SENT_379	[p21l931t107r1049b162],
19	short-term	JJ	O	short-term	amod	20	SENT_379	[p21l1073t108r1416b161],
20	risk	NN	O	risk	prep_between	13	SENT_379	[p21l1441t108r1558b161],
21	of	IN	O	of	_	0	SENT_379	[p21l1582t108r1654b161],
22	NSAID	NN	O	nsaid	prep_of	20	SENT_379	[p21l1667t107r2144b162],
23	—	CD	NUMBER	—	num	26	SENT_379	[p21l1667t107r2144b162],
24	related	JJ	O	related	amod	26	SENT_379	[p21l1667t107r2144b162],
25	gastroduodenal	JJ	O	gastroduodenal	amod	26	SENT_379	[p21l370t196r872b269],
26	bleeding	NN	O	bleeding	nsubj	11	SENT_379	[p21l901t196r1249b269],
27	.	.	O	.	_	0	SENT_379	[p21l901t196r1249b269],

1	”	NN	O	”	ccomp	13	SENT_380	[p21l901t196r1249b269],
2	However	RB	O	however	advmod	1	SENT_380	[p21l1279t201r1572b262],
3	,	,	O	,	_	0	SENT_380	[p21l1279t201r1572b262],
4	most	RBS	O	most	advmod	5	SENT_380	[p21l1605t212r1763b250],
5	patients	NNS	O	patient	nsubjpass	13	SENT_380	[p21l1793t198r2050b269],
6	in	IN	O	in	_	0	SENT_380	[p21l2082t198r2143b249],
7	this	DT	O	this	det	8	SENT_380	[p21l370t285r487b339],
8	case	NN	O	case	prep_in	13	SENT_380	[p21l526t285r914b339],
9	—	CD	NUMBER	—	num	11	SENT_380	[p21l526t285r914b339],
10	control	NN	O	control	nn	11	SENT_380	[p21l526t285r914b339],
11	study	NN	O	study	dep	8	SENT_380	[p21l952t285r1128b358],
12	were	VBD	O	be	auxpass	13	SENT_380	[p21l1161t305r1304b339],
13	exposed	VBN	O	expose	_	0	SENT_380	[p21l1343t285r1597b358],
14	to	TO	O	to	_	0	SENT_380	[p21l1634t301r1695b339],
15	cyclooxygenase-2	NN	O	cyclooxygenase-2	prep_to	13	SENT_380	[p21l1735t285r2142b358, p21l370t379r524b429],
16	nonselective	JJ	O	nonselective	amod	15	SENT_380	[p21l554t375r946b429],
17	NSAIDS	NN	O	nsaid	dep	16	SENT_380	[p21l973t379r1232b429],
18	(	CD	NUMBER	(	num	17	SENT_380	[p21l1263t375r1369b448],
19	eg	FW	O	eg	dep	17	SENT_380	[p21l1263t375r1369b448],
20	,	,	O	,	_	0	SENT_380	[p21l1263t375r1369b448],
21	diclofenac	NN	O	diclofenac	nn	22	SENT_380	[p21l1398t375r1767b445],
22	)	NN	O	)	appos	17	SENT_380	[p21l1398t375r1767b445],
23	,	,	O	,	_	0	SENT_380	[p21l1398t375r1767b445],
24	which	WDT	O	which	nsubjpass	27	SENT_380	[p21l1794t375r1985b429],
25	may	MD	O	may	aux	27	SENT_380	[p21l2014t395r2145b448],
26	be	VB	O	be	auxpass	27	SENT_380	[p21l368t464r438b517],
27	associated	VBN	O	associate	rcmod	22	SENT_380	[p21l476t463r803b518],
28	with	IN	O	with	_	0	SENT_380	[p21l838t463r980b517],
29	a	DT	O	a	det	31	SENT_380	[p21l1018t484r1050b517],
30	greater	JJR	O	greater	amod	31	SENT_380	[p21l1085t479r1289b536],
31	risk	NN	O	risk	prep_with	27	SENT_380	[p21l1323t463r1431b517],
32	of	IN	O	of	_	0	SENT_380	[p21l1465t463r1535b517],
33	bleeding	NN	O	bleeding	prep_of	31	SENT_380	[p21l1557t463r1810b536],
34	than	IN	O	than	_	0	SENT_380	[p21l1844t463r1981b517],
35	celecoxib	NN	O	celecoxib	prep_than	27	SENT_380	[p21l2015t463r2142b517, p21l370t553r538b607],
36	.	.	O	.	_	0	SENT_380	[p21l2015t463r2142b517, p21l370t553r538b607],

1	In	IN	O	in	_	0	SENT_381	[p21l576t558r639b606],
2	fact	NN	O	fact	prep_in	23	SENT_381	[p21l675t553r797b619],
3	,	,	O	,	_	0	SENT_381	[p21l675t553r797b619],
4	in	IN	O	in	_	0	SENT_381	[p21l833t555r892b606],
5	the	DT	O	the	det	7	SENT_381	[p21l928t553r1021b607],
6	main	JJ	O	main	amod	7	SENT_381	[p21l1057t555r1210b607],
7	analysis	NN	O	analysis	prep_in	23	SENT_381	[p21l1246t553r1473b626],
8	of	IN	O	of	_	0	SENT_381	[p21l1510t553r1579b607],
9	the	DT	O	the	det	11	SENT_381	[p21l1606t553r1698b607],
10	APC	NN	ORGANIZATION	apc	nn	11	SENT_381	[p21l1732t557r1864b607],
11	trial	NN	O	trial	prep_of	7	SENT_381	[p21l1901t553r2034b619],
12	,	,	O	,	_	0	SENT_381	[p21l1901t553r2034b619],
13	an	DT	O	a	det	15	SENT_381	[p21l2071t573r2143b607],
14	overall	JJ	O	overall	amod	15	SENT_381	[p21l370t641r565b695],
15	association	NN	O	association	nsubjpass	23	SENT_381	[p21l599t644r927b695],
16	between	IN	O	between	_	0	SENT_381	[p21l960t642r1203b695],
17	celecoxib	NN	O	celecoxib	nn	20	SENT_381	[p21l1237t642r1500b695],
18	and	CC	O	and	_	0	SENT_381	[p21l1537t641r1649b696],
19	gastrointestinal	JJ	O	gastrointestinal	nn	20	SENT_381	[p21l1682t641r2143b714],
20	bleeding	NN	O	bleeding	prep_between	15	SENT_381	[p21l368t731r622b804],
21	was	VBD	O	be	auxpass	23	SENT_381	[p21l644t751r752b785],
22	not	RB	O	not	neg	23	SENT_381	[p21l778t747r881b785],
23	observed	VBN	O	observe	_	0	SENT_381	[p21l906t731r1204b786],
24	?	.	O	?	_	0	SENT_381	[p21l906t731r1204b786],

1	Interestingly	RB	O	interestingly	advmod	28	SENT_382	[p21l443t819r828b892],
2	,	,	O	,	_	0	SENT_382	[p21l443t819r828b892],
3	among	IN	O	among	_	0	SENT_382	[p21l861t839r1069b892],
4	individuals	NNS	O	individual	prep_among	28	SENT_382	[p21l1099t819r1426b874],
5	with	IN	O	with	_	0	SENT_382	[p21l1457t819r1590b873],
6	either	CC	O	either	preconj	8	SENT_382	[p21l1623t819r1792b873],
7	CYP2C9	NN	O	cyp2c9	nn	8	SENT_382	[p21l1823t824r2142b874],
8	*	NN	O	*	prep_with	4	SENT_382	[p21l1823t824r2142b874],
9	2	CD	NUMBER	2	dep	8	SENT_382	[p21l1823t824r2142b874],
10	or	CC	O	or	_	0	SENT_382	[p21l370t928r434b963],
11	CYP2C9	CD	NUMBER	cyp2c9	num	14	SENT_382	[p21l457t913r785b963],
12	*	CD	NUMBER	*	num	14	SENT_382	[p21l457t913r785b963],
13	3	CD	NUMBER	3	num	14	SENT_382	[p21l457t913r785b963],
14	genotypes	NNS	O	genotype	prep_with	4	SENT_382	[p21l812t925r1134b982],
15	,	,	O	,	_	0	SENT_382	[p21l812t925r1134b982],
16	the	DT	O	the	det	18	SENT_382	[p21l1159t909r1255b963],
17	excess	JJ	O	excess	amod	18	SENT_382	[p21l1279t929r1460b963],
18	number	NN	O	number	nsubj	28	SENT_382	[p21l1484t909r1728b963],
19	of	IN	O	of	_	0	SENT_382	[p21l1750t909r1821b963],
20	cardiovascular	JJ	O	cardiovascular	amod	23	SENT_382	[p21l1834t909r2142b964, p21l370t998r523b1052],
21	and	CC	O	and	_	0	SENT_382	[p21l562t998r677b1053],
22	thrombotic	JJ	O	thrombotic	conj_and	20	SENT_382	[p21l716t998r1069b1052],
23	events	NNS	O	event	prep_of	18	SENT_382	[p21l1108t1014r1296b1052],
24	associated	VBN	O	associate	partmod	18	SENT_382	[p21l1337t998r1651b1053],
25	with	IN	O	with	_	0	SENT_382	[p21l1688t998r1825b1052],
26	celecoxib	NN	O	celecoxib	prep_with	24	SENT_382	[p21l1866t998r2141b1052],
27	was	VBD	O	be	cop	28	SENT_382	[p21l368t1107r479b1141],
28	restricted	JJ	O	restricted	_	0	SENT_382	[p21l516t1087r805b1142],
29	to	TO	O	to	_	0	SENT_382	[p21l840t1102r900b1141],
30	those	DT	O	those	prep_to	28	SENT_382	[p21l938t1087r1102b1141],
31	randomized	VBN	O	randomize	partmod	30	SENT_382	[p21l1138t1087r1509b1142],
32	to	TO	O	to	_	0	SENT_382	[p21l1544t1102r1604b1141],
33	high	JJ	O	high	amod	36	SENT_382	[p21l1642t1087r1943b1160],
34	—	NN	O	—	nn	36	SENT_382	[p21l1642t1087r1943b1160],
35	dose	NN	O	dose	nn	36	SENT_382	[p21l1642t1087r1943b1160],
36	treatment	NN	O	treatment	prep_to	31	SENT_382	[p21l1980t1102r2142b1141, p21l370t1191r543b1229],
37	.	.	O	.	_	0	SENT_382	[p21l1980t1102r2142b1141, p21l370t1191r543b1229],

1	Overall	RB	O	overall	advmod	5	SENT_383	[p21l587t1175r822b1242],
2	,	,	O	,	_	0	SENT_383	[p21l587t1175r822b1242],
3	these	DT	O	these	det	4	SENT_383	[p21l865t1175r1021b1229],
4	data	NNS	O	datum	nsubj	5	SENT_383	[p21l1062t1175r1196b1230],
5	highlight	VBP	O	highlight	_	0	SENT_383	[p21l1234t1175r1521b1248],
6	the	DT	O	the	det	7	SENT_383	[p21l1561t1175r1657b1229],
7	potential	NN	O	potential	dobj	5	SENT_383	[p21l1698t1175r1977b1248],
8	that	WDT	O	that	dobj	14	SENT_383	[p21l2018t1175r2143b1229],
9	individuals	NNS	O	individual	nsubj	14	SENT_383	[p21l369t1265r710b1320],
10	with	IN	O	with	_	0	SENT_383	[p21l739t1265r877b1318],
11	impaired	JJ	O	impaired	amod	12	SENT_383	[p21l906t1265r1183b1338],
12	metabolism	NN	O	metabolism	prep_with	9	SENT_383	[p21l1212t1265r1576b1319],
13	may	MD	O	may	aux	14	SENT_383	[p21l1605t1285r1734b1338],
14	be	VB	O	be	rcmod	7	SENT_383	[p21l1759t1265r1828b1319],
15	at	IN	O	at	_	0	SENT_383	[p21l1858t1281r1915b1319],
16	particularly	RB	O	particularly	advmod	17	SENT_383	[p21l1943t1267r2142b1338, p21l369t1353r547b1426],
17	high	JJ	O	high	amod	18	SENT_383	[p21l582t1353r720b1426],
18	risk	NN	O	risk	prep_at	14	SENT_383	[p21l759t1353r872b1407],
19	of	IN	O	of	_	0	SENT_383	[p21l910t1353r980b1407],
20	dose-related	JJ	O	dose-related	amod	22	SENT_383	[p21l1008t1353r1381b1408],
21	cardiovascular	JJ	O	cardiovascular	amod	22	SENT_383	[p21l1418t1353r1862b1408],
22	toxicity	NN	O	toxicity	prep_of	18	SENT_383	[p21l1899t1356r2140b1426],
23	.	.	O	.	_	0	SENT_383	[p21l1899t1356r2140b1426],

1	Although	IN	O	although	mark	4	SENT_384	[p21l367t1443r663b1516],
2	it	PRP	O	it	nsubj	4	SENT_384	[p21l698t1445r742b1496],
3	is	VBZ	O	be	cop	4	SENT_384	[p21l776t1445r821b1497],
4	unclear	JJ	O	unclear	advcl	83	SENT_384	[p21l857t1443r1085b1497],
5	why	WRB	O	why	advmod	13	SENT_384	[p21l1117t1443r1243b1516],
6	low	JJ	O	low	amod	9	SENT_384	[p21l1275t1443r1546b1498],
7	—	NN	O	—	nn	9	SENT_384	[p21l1275t1443r1546b1498],
8	dose	NN	O	dose	nn	9	SENT_384	[p21l1275t1443r1546b1498],
9	celecoxib	NN	O	celecoxib	nsubj	13	SENT_384	[p21l1582t1443r1857b1497],
10	was	VBD	O	be	cop	13	SENT_384	[p21l1892t1463r2002b1497],
11	not	RB	O	not	neg	13	SENT_384	[p21l2038t1458r2144b1497],
12	strongly	RB	O	strongly	advmod	13	SENT_384	[p21l370t1531r624b1604],
13	related	JJ	O	related	advcl	27	SENT_384	[p21l647t1531r856b1586],
14	to	TO	O	to	_	0	SENT_384	[p21l881t1547r941b1585],
15	cardiovascular	JJ	O	cardiovascular	amod	18	SENT_384	[p21l968t1531r1412b1586],
16	and	CC	O	and	_	0	SENT_384	[p21l1436t1531r1551b1586],
17	thrombotic	JJ	O	thrombotic	conj_and	15	SENT_384	[p21l1576t1531r1928b1585],
18	events	NNS	O	event	prep_to	13	SENT_384	[p21l1954t1547r2142b1585],
19	among	IN	O	among	_	0	SENT_384	[p21l370t1641r584b1694],
20	individuals	NNS	O	individual	prep_among	13	SENT_384	[p21l615t1621r956b1676],
21	with	IN	O	with	_	0	SENT_384	[p21l989t1621r1126b1674],
22	variant	JJ	O	variant	amod	23	SENT_384	[p21l1157t1623r1375b1675],
23	genotypes	NNS	O	genotype	prep_with	20	SENT_384	[p21l1408t1637r1730b1694],
24	,	,	O	,	_	0	SENT_384	[p21l1408t1637r1730b1694],
25	it	PRP	O	it	nsubj	27	SENT_384	[p21l1764t1623r1810b1674],
26	is	VBZ	O	be	cop	27	SENT_384	[p21l1843t1623r1889b1675],
27	important	JJ	O	important	ccomp	4	SENT_384	[p21l1925t1623r2142b1694, p21l370t1726r500b1764],
28	to	TO	O	to	aux	29	SENT_384	[p21l530t1726r592b1764],
29	note	VB	O	note	xcomp	27	SENT_384	[p21l624t1726r764b1764],
30	that	IN	O	that	complm	39	SENT_384	[p21l795t1710r925b1764],
31	other	JJ	O	other	nsubj	39	SENT_384	[p21l955t1710r1126b1764],
32	randomized	VBN	O	randomize	partmod	31	SENT_384	[p21l1155t1710r1540b1765],
33	trials	NNS	O	trial	dobj	32	SENT_384	[p21l1569t1710r1729b1764],
34	of	IN	O	of	_	0	SENT_384	[p21l1761t1711r1833b1764],
35	celecoxib	NN	O	celecoxib	prep_of	33	SENT_384	[p21l1854t1710r2141b1764],
36	also	RB	O	also	advmod	39	SENT_384	[p21l370t1799r492b1852],
37	did	VBD	O	do	aux	39	SENT_384	[p21l527t1799r630b1853],
38	not	RB	O	not	neg	39	SENT_384	[p21l661t1814r770b1852],
39	demonstrate	VB	O	demonstrate	ccomp	29	SENT_384	[p21l803t1799r1205b1853],
40	an	DT	O	a	det	42	SENT_384	[p21l1239t1819r1313b1852],
41	increased	VBN	O	increase	amod	42	SENT_384	[p21l1345t1799r1644b1853],
42	risk	NN	O	risk	dobj	39	SENT_384	[p21l1677t1799r1794b1852],
43	of	IN	O	of	_	0	SENT_384	[p21l1827t1799r1899b1852],
44	cardiovascular	JJ	O	cardiovascular	amod	45	SENT_384	[p21l1922t1799r2142b1853, p21l367t1886r630b1940],
45	events	NNS	O	event	prep_of	42	SENT_384	[p21l653t1902r848b1940],
46	associated	VBN	O	associate	partmod	42	SENT_384	[p21l874t1886r1201b1941],
47	with	IN	O	with	_	0	SENT_384	[p21l1223t1886r1364b1940],
48	low	JJ	O	low	amod	51	SENT_384	[p21l1388t1886r1670b1941],
49	—	NN	O	—	nn	51	SENT_384	[p21l1388t1886r1670b1941],
50	dose	NN	O	dose	nn	51	SENT_384	[p21l1388t1886r1670b1941],
51	(	NN	O	(	prep_with	46	SENT_384	[p21l1696t1887r1832b1956],
52	200	CD	NUMBER	200	num	53	SENT_384	[p21l1696t1887r1832b1956],
53	mg	NN	O	mg	npadvmod	54	SENT_384	[p21l1858t1906r1957b1959],
54	twice	RB	O	twice	advmod	51	SENT_384	[p21l1981t1889r2142b1940],
55	daily	RB	SET	daily	advmod	46	SENT_384	[p21l370t1976r524b2049],
56	or	CC	O	or	_	0	SENT_384	[p21l546t1995r611b2030],
57	400	CD	NUMBER	400	num	58	SENT_384	[p21l633t1980r746b2030],
58	mg	NN	O	mg	npadvmod	59	SENT_384	[p21l772t1996r871b2049],
59	once	RB	DATE	once	advmod	42	SENT_384	[p21l894t1996r1039b2030],
60	daily	JJ	SET	daily	amod	62	SENT_384	[p21l1063t1976r1440b2049],
61	)	NN	O	)	nn	62	SENT_384	[p21l1063t1976r1440b2049],
62	.3	NN	NUMBER	.3	dobj	39	SENT_384	[p21l1063t1976r1440b2049],
63	>	JJR	O	>	dep	62	SENT_384	[p21l1063t1976r1440b2049],
64	3	CD	NUMBER	3	num	65	SENT_384	[p21l1063t1976r1440b2049],
65	°	NN	O	°	dep	62	SENT_384	[p21l1063t1976r1440b2049],
66	‘	CD	NUMBER	‘	number	67	SENT_384	[p21l1063t1976r1440b2049],
67	32	CD	NUMBER	32	dep	65	SENT_384	[p21l1063t1976r1440b2049],
68	Nonetheless	RB	O	nonetheless	advmod	29	SENT_384	[p21l1463t1975r1873b2042],
69	,	,	O	,	_	0	SENT_384	[p21l1463t1975r1873b2042],
70	because	IN	O	because	mark	72	SENT_384	[p21l1897t1976r2143b2029],
71	we	PRP	O	we	nsubj	72	SENT_384	[p21l368t2085r449b2119],
72	had	VBD	O	have	advcl	29	SENT_384	[p21l472t2065r591b2120],
73	a	DT	O	a	det	75	SENT_384	[p21l612t2085r645b2119],
74	limited	JJ	O	limited	amod	75	SENT_384	[p21l664t2065r895b2120],
75	number	NN	O	number	dobj	72	SENT_384	[p21l916t2065r1167b2119],
76	of	IN	O	of	_	0	SENT_384	[p21l1189t2065r1261b2119],
77	events	NNS	O	event	prep_of	75	SENT_384	[p21l1274t2081r1487b2131],
78	,	,	O	,	_	0	SENT_384	[p21l1274t2081r1487b2131],
79	our	PRP$	O	we	poss	80	SENT_384	[p21l1511t2084r1621b2119],
80	ﬁndings	NNS	O	ﬁndings	nsubj	87	SENT_384	[p21l1642t2065r1901b2138],
81	should	MD	O	should	aux	83	SENT_384	[p21l1925t2065r2144b2120],
82	be	VB	O	be	auxpass	83	SENT_384	[p21l368t2155r438b2208],
83	viewed	VBN	O	view	_	0	SENT_384	[p21l469t2154r685b2209],
84	as	IN	O	as	_	0	SENT_384	[p21l717t2175r776b2208],
85	exploratory	NN	O	exploratory	prep_as	83	SENT_384	[p21l810t2154r1179b2227],
86	and	CC	O	and	_	0	SENT_384	[p21l1209t2154r1327b2209],
87	support	VBP	O	support	conj_and	83	SENT_384	[p21l1359t2170r1611b2227],
88	the	DT	O	the	det	89	SENT_384	[p21l1644t2154r1742b2208],
89	importance	NN	O	importance	dobj	87	SENT_384	[p21l1775t2157r2143b2227],

1	GASTROENTEROLOGY	NN	O	gastroenterology	_	0	SENT_385	[p21l984t2388r1652b2437],
2	Vol	NN	O	vol	dep	1	SENT_385	[p21l1675t2388r1782b2437],
3	.	.	O	.	_	0	SENT_385	[p21l1675t2388r1782b2437],

1	136	CD	NUMBER	136	_	0	SENT_386	[p21l1814t2387r1948b2447],
2	,	,	O	,	_	0	SENT_386	[p21l1814t2387r1948b2447],
3	No.	NN	O	no.	appos	1	SENT_386	[p21l1981t2388r2073b2437],
4	7	CD	NUMBER	7	num	3	SENT_386	[p21l2104t2388r2139b2436],

1	of	IN	O	of	_	0	SENT_387	[p21l9t2607r96b2672],
2	examining	VBG	O	examine	pcomp	1	SENT_387	[p21l115t2610r518b2695],
3	CYPZC9	NN	O	cypzc9	nn	4	SENT_387	[p21l549t2613r860b2673],
4	genotype	NN	O	genotype	nsubj	9	SENT_387	[p21l895t2626r1241b2695],
5	within	IN	O	within	_	0	SENT_387	[p21l1271t2607r1513b2672],
6	ongoing	JJ	O	ongoing	amod	8	SENT_387	[p21l1542t2610r1850b2695],
7	clinical	JJ	O	clinical	amod	8	SENT_387	[p21l1878t2607r2141b2672],
8	trials	NNS	O	trial	prep_within	4	SENT_387	[p21l9t2715r192b2779],
9	focused	VBD	O	focus	ccomp	2	SENT_387	[p21l247t2715r532b2780],
10	on	IN	O	on	_	0	SENT_387	[p21l585t2739r678b2779],
11	adverse	JJ	O	adverse	amod	12	SENT_387	[p21l731t2715r1000b2780],
12	events	NNS	O	event	prep_on	9	SENT_387	[p21l1054t2733r1280b2779],
13	associated	VBN	O	associate	partmod	12	SENT_387	[p21l1335t2715r1712b2780],
14	with	IN	O	with	_	0	SENT_387	[p21l1762t2715r1927b2779],
15	celecoxib	NN	O	celecoxib	prep_with	13	SENT_387	[p21l1981t2715r2139b2779, p21l9t2822r286b2886],
16	.32	CD	NUMBER	.32	num	15	SENT_387	[p21l1981t2715r2139b2779, p21l9t2822r286b2886],

1	Our	PRP$	O	we	poss	2	SENT_388	[p21l99t2934r248b2994],
2	study	NN	O	study	nsubj	3	SENT_388	[p21l279t2929r484b3017],
3	had	VBD	O	have	_	0	SENT_388	[p21l513t2929r652b2995],
4	several	JJ	O	several	amod	5	SENT_388	[p21l683t2929r928b2994],
5	strengths	NNS	O	strength	dobj	3	SENT_388	[p21l961t2929r1322b3017],
6	.	.	O	.	_	0	SENT_388	[p21l961t2929r1322b3017],

1	First	RB	ORDINAL	first	advmod	7	SENT_389	[p21l1357t2932r1544b3009],
2	,	,	O	,	_	0	SENT_389	[p21l1357t2932r1544b3009],
3	celecoxib	NN	O	celecoxib	nn	4	SENT_389	[p21l1579t2929r1910b2994],
4	treatment	NN	O	treatment	nsubjpass	7	SENT_389	[p21l1945t2948r2139b2994, p21l9t3055r201b3101],
5	was	VBD	O	be	auxpass	7	SENT_389	[p21l225t3061r359b3101],
6	randomly	RB	O	randomly	advmod	7	SENT_389	[p21l388t3037r749b3124],
7	assigned	VBN	O	assign	_	0	SENT_389	[p21l773t3037r1105b3124],
8	,	,	O	,	_	0	SENT_389	[p21l773t3037r1105b3124],
9	dosing	NN	O	dosing	nsubjpass	12	SENT_389	[p21l1134t3037r1383b3124],
10	was	VBD	O	be	auxpass	12	SENT_389	[p21l1406t3061r1540b3101],
11	strictly	RB	O	strictly	advmod	12	SENT_389	[p21l1569t3037r1824b3124],
12	deﬁned	VBN	O	deﬁned	ccomp	7	SENT_389	[p21l1849t3036r2139b3117],
13	,	,	O	,	_	0	SENT_389	[p21l1849t3036r2139b3117],
14	treatment	NN	O	treatment	nn	15	SENT_389	[p21l9t3162r376b3208],
15	duration	NN	O	duration	nsubj	19	SENT_389	[p21l432t3143r757b3209],
16	was	VBD	O	be	cop	19	SENT_389	[p21l811t3168r944b3208],
17	long	JJ	O	long	advmod	19	SENT_389	[p21l1001t3143r1388b3231],
18	—	RB	O	—	advmod	19	SENT_389	[p21l1001t3143r1388b3231],
19	term	NN	O	term	ccomp	7	SENT_389	[p21l1001t3143r1388b3231],
20	,	,	O	,	_	0	SENT_389	[p21l1001t3143r1388b3231],
21	and	CC	O	and	_	0	SENT_389	[p21l1446t3143r1585b3209],
22	use	NN	O	use	nsubjpass	35	SENT_389	[p21l1639t3168r1758b3208],
23	of	IN	O	of	_	0	SENT_389	[p21l1815t3143r1900b3208],
24	other	JJ	O	other	amod	25	SENT_389	[p21l1945t3143r2143b3208],
25	NSAIDS	NNPS	O	NSAIDS	prep_of	22	SENT_389	[p21l7t3256r309b3316],
26	(	CD	NUMBER	(	dep	25	SENT_389	[p21l361t3251r619b3339],
27	except	IN	O	except	_	0	SENT_389	[p21l361t3251r619b3339],
28	low	JJ	O	low	amod	32	SENT_389	[p21l665t3251r990b3317],
29	—	NN	O	—	nn	32	SENT_389	[p21l665t3251r990b3317],
30	dose	NN	O	dose	nn	32	SENT_389	[p21l665t3251r990b3317],
31	aspirin	NN	O	aspirin	nn	32	SENT_389	[p21l1039t3251r1317b3339],
32	)	NN	O	)	prep_except	26	SENT_389	[p21l1039t3251r1317b3339],
33	was	VBD	O	be	auxpass	35	SENT_389	[p21l1367t3276r1499b3316],
34	not	RB	O	not	neg	35	SENT_389	[p21l1548t3270r1675b3316],
35	permitted	VBN	O	permit	conj_and	7	SENT_389	[p21l1722t3251r2139b3339],
36	?	.	O	?	_	0	SENT_389	[p21l1722t3251r2139b3339],

1	Thus	RB	O	thus	advmod	5	SENT_390	[p21l6t3357r215b3437],
2	,	,	O	,	_	0	SENT_390	[p21l6t3357r215b3437],
3	it	PRP	O	it	nsubj	5	SENT_390	[p21l254t3360r307b3422],
4	is	VBZ	O	be	cop	5	SENT_390	[p21l344t3360r398b3422],
5	unlikely	JJ	O	unlikely	_	0	SENT_390	[p21l437t3357r738b3445],
6	that	IN	O	that	complm	10	SENT_390	[p21l773t3357r924b3422],
7	our	PRP$	O	we	poss	8	SENT_390	[p21l962t3381r1090b3422],
8	ﬁndings	NNS	O	ﬁndings	nsubj	10	SENT_390	[p21l1127t3357r1428b3445],
9	are	VBP	O	be	cop	10	SENT_390	[p21l1467t3381r1574b3422],
10	related	JJ	O	related	ccomp	5	SENT_390	[p21l1613t3357r1866b3423],
11	to	TO	O	to	_	0	SENT_390	[p21l1903t3376r1975b3422],
12	differential	JJ	O	differential	amod	13	SENT_390	[p21l2015t3357r2139b3423, p21l8t3465r316b3530],
13	dosing	NN	O	dosing	prep_to	10	SENT_390	[p21l349t3465r614b3553],
14	,	,	O	,	_	0	SENT_390	[p21l349t3465r614b3553],
15	heterogeneity	NN	O	heterogeneity	conj_or	13	SENT_390	[p21l649t3465r1153b3553],
16	in	IN	O	in	_	0	SENT_390	[p21l1183t3468r1255b3529],
17	treatment	NN	O	treatment	nn	18	SENT_390	[p21l1288t3483r1655b3530],
18	duration	NN	O	duration	prep_in	15	SENT_390	[p21l1687t3465r2030b3545],
19	,	,	O	,	_	0	SENT_390	[p21l1687t3465r2030b3545],
20	or	CC	O	or	_	0	SENT_390	[p21l2065t3488r2142b3530],
21	exposure	NN	O	exposure	conj_or	13	SENT_390	[p21l9t3595r336b3659],
22	to	TO	O	to	_	0	SENT_390	[p21l364t3590r436b3636],
23	other	JJ	O	other	amod	25	SENT_390	[p21l465t3571r662b3636],
24	CYPZC9-metabolized	JJ	O	cypzc9-metabolized	amod	25	SENT_390	[p21l688t3571r1480b3638],
25	NSAIDS	NNS	MISC	nsaid	prep_to	10	SENT_390	[p21l1504t3577r1824b3637],
26	.	.	O	.	_	0	SENT_390	[p21l1504t3577r1824b3637],

1	Second	RB	ORDINAL	second	advmod	5	SENT_391	[p21l1854t3571r2139b3652],
2	,	,	O	,	_	0	SENT_391	[p21l1854t3571r2139b3652],
3	patients	NNS	O	patient	nsubjpass	5	SENT_391	[p21l8t3682r304b3767],
4	were	VBD	O	be	auxpass	5	SENT_391	[p21l348t3702r515b3744],
5	randomized	VBN	O	randomize	_	0	SENT_391	[p21l560t3679r1007b3745],
6	to	TO	O	to	_	0	SENT_391	[p21l1050t3698r1122b3744],
7	2	CD	NUMBER	2	num	9	SENT_391	[p21l1168t3684r1207b3743],
8	different	JJ	O	different	amod	9	SENT_391	[p21l1255t3679r1575b3745],
9	doses	NNS	O	dose	prep_to	5	SENT_391	[p21l1620t3679r1817b3745],
10	of	IN	O	of	_	0	SENT_391	[p21l1863t3679r1948b3744],
11	celecoxib	NN	O	celecoxib	prep_of	9	SENT_391	[p21l1981t3679r2139b3744, p22l9t16r222b96],
12	,	,	O	,	_	0	SENT_391	[p21l1981t3679r2139b3744, p22l9t16r222b96],

1	permitting	VBG	O	permit	_	0	SENT_392	[p22l262t19r664b103],
2	a	DT	O	a	det	4	SENT_392	[p22l702t40r742b80],
3	detailed	JJ	O	detailed	amod	4	SENT_392	[p22l779t16r1072b82],
4	assessment	NN	O	assessment	dobj	1	SENT_392	[p22l1111t34r1521b80],
5	of	IN	O	of	_	0	SENT_392	[p22l1560t16r1645b80],
6	the	DT	O	the	det	7	SENT_392	[p22l1673t16r1788b80],
7	effect	NN	O	effect	prep_of	4	SENT_392	[p22l1829t16r2029b80],
8	of	IN	O	of	_	0	SENT_392	[p22l2068t16r2153b80],
9	genotype	NN	O	genotype	prep_of	7	SENT_392	[p22l9t142r343b211],
10	on	IN	O	on	_	0	SENT_392	[p22l378t148r473b188],
11	dose	NN	O	dose	prep_on	1	SENT_392	[p22l507t123r688b189],
12	.	.	O	.	_	0	SENT_392	[p22l507t123r688b189],

1	Other	JJ	O	other	amod	2	SENT_393	[p22l727t123r945b188],
2	studies	NNS	O	study	nsubj	15	SENT_393	[p22l979t123r1236b189],
3	examining	VBG	O	examine	partmod	2	SENT_393	[p22l1272t126r1661b211],
4	single	JJ	O	single	amod	5	SENT_393	[p22l1694t123r1906b211],
5	doses	NNS	O	dose	dobj	3	SENT_393	[p22l1941t123r2139b189],
6	of	IN	O	of	_	0	SENT_393	[p22l9t231r94b296],
7	celecoxib	NN	O	celecoxib	prep_of	5	SENT_393	[p22l126t231r457b296],
8	or	CC	O	or	_	0	SENT_393	[p22l504t254r582b296],
9	exposure	NN	O	exposure	prep_of	5	SENT_393	[p22l624t254r952b319],
10	irrespective	RB	O	irrespective	_	0	SENT_393	[p22l996t234r1414b319],
11	of	IN	O	of	_	0	SENT_393	[p22l1459t231r1544b296],
12	dose	NN	O	dose	prep_irrespective_of	3	SENT_393	[p22l1576t231r1741b297],
13	would	MD	O	would	aux	15	SENT_393	[p22l1783t231r2016b297],
14	be	VB	O	be	cop	15	SENT_393	[p22l2058t231r2140b296],
15	unable	JJ	O	unable	_	0	SENT_393	[p22l8t338r257b403],
16	to	TO	O	to	aux	17	SENT_393	[p22l293t357r365b403],
17	uncover	VB	O	uncover	xcomp	15	SENT_393	[p22l402t362r697b403],
18	a	DT	O	a	det	20	SENT_393	[p22l731t363r771b403],
19	speciﬁc	NN	O	speciﬁc	nn	20	SENT_393	[p22l804t338r1072b426],
20	effect	NN	O	effect	dobj	17	SENT_393	[p22l1107t338r1307b403],
21	of	IN	O	of	_	0	SENT_393	[p22l1342t338r1427b403],
22	genotype	NN	O	genotype	prep_of	20	SENT_393	[p22l1450t357r1784b426],
23	on	IN	O	on	_	0	SENT_393	[p22l1820t363r1914b403],
24	doserelated	JJ	O	doserelated	amod	25	SENT_393	[p22l1950t338r2139b404, p22l9t446r261b512],
25	outcomes	NNS	O	outcome	prep_on	17	SENT_393	[p22l307t465r683b511],
26	.	.	O	.	_	0	SENT_393	[p22l307t465r683b511],

1	Third	NNP	ORDINAL	Third	nsubj	31	SENT_394	[p22l730t446r961b526],
2	,	,	O	,	_	0	SENT_394	[p22l730t446r961b526],
3	because	IN	O	because	mark	7	SENT_394	[p22l1008t446r1293b511],
4	all	DT	O	all	det	5	SENT_394	[p22l1341t446r1427b511],
5	patients	NNS	O	patient	nsubjpass	7	SENT_394	[p22l1473t449r1770b534],
6	were	VBD	O	be	auxpass	7	SENT_394	[p22l1816t469r1983b511],
7	enrolled	VBN	O	enrol	dep	1	SENT_394	[p22l2031t470r2139b511, p22l9t552r223b619],
8	in	IN	O	in	_	0	SENT_394	[p22l251t555r323b617],
9	a	DT	O	a	det	16	SENT_394	[p22l352t577r392b617],
10	randomized	JJ	O	randomized	amod	16	SENT_394	[p22l419t552r865b619],
11	trial	NN	O	trial	nn	13	SENT_394	[p22l894t553r1062b633],
12	,	,	O	,	_	0	SENT_394	[p22l894t553r1062b633],
13	treatment	NN	O	treatment	nn	16	SENT_394	[p22l1093t571r1460b617],
14	and	CC	O	and	_	0	SENT_394	[p22l1489t552r1628b619],
15	colonoscopic	JJ	O	colonoscopic	nn	16	SENT_394	[p22l1656t553r2141b640],
16	surveillance	NN	O	surveillance	prep_in	7	SENT_394	[p22l9t660r442b725],
17	for	IN	O	for	_	0	SENT_394	[p22l472t660r580b725],
18	outcomes	NNS	O	outcome	prep_for	16	SENT_394	[p22l608t679r985b740],
19	,	,	O	,	_	0	SENT_394	[p22l608t679r985b740],
20	as	RB	O	as	_	0	SENT_394	[p22l1017t685r1086b725],
21	well	RB	O	well	_	0	SENT_394	[p22l1115t660r1262b725],
22	as	IN	O	as	_	0	SENT_394	[p22l1291t685r1361b725],
23	reporting	NN	O	reporting	prep_in	7	SENT_394	[p22l1392t663r1741b748],
24	of	IN	O	of	_	0	SENT_394	[p22l1770t660r1855b725],
25	adverse	JJ	O	adverse	amod	26	SENT_394	[p22l1872t660r2140b726],
26	events	NNS	O	event	prep_of	23	SENT_394	[p22l9t785r255b846],
27	,	,	O	,	_	0	SENT_394	[p22l9t785r255b846],
28	were	VBD	O	be	cop	29	SENT_394	[p22l288t790r455b831],
29	uniform	JJ	O	uniform	_	0	SENT_394	[p22l490t767r799b831],
30	and	CC	O	and	_	0	SENT_394	[p22l833t766r971b832],
31	standardized	JJ	O	standardized	conj_and	29	SENT_394	[p22l1005t766r1499b832],
32	.	.	O	.	_	0	SENT_394	[p22l1005t766r1499b832],

1	Several	JJ	O	several	amod	2	SENT_395	[p22l98t873r356b938],
2	limitations	NNS	O	limitation	nsubj	6	SENT_395	[p22l409t873r816b938],
3	of	IN	O	of	_	0	SENT_395	[p22l872t873r957b938],
4	this	DT	O	this	det	5	SENT_395	[p22l1000t873r1135b938],
5	study	NN	O	study	prep_of	2	SENT_395	[p22l1191t873r1396b961],
6	deserve	VBP	O	deserve	_	0	SENT_395	[p22l1448t873r1712b939],
7	comment	NN	O	comment	dobj	6	SENT_395	[p22l1768t892r2137b938],
8	.	.	O	.	_	0	SENT_395	[p22l1768t892r2137b938],

1	First	RB	ORDINAL	first	advmod	4	SENT_396	[p22l9t984r195b1061],
2	,	,	O	,	_	0	SENT_396	[p22l9t984r195b1061],
3	we	PRP	O	we	nsubj	4	SENT_396	[p22l247t1006r343b1046],
4	had	VBD	O	have	_	0	SENT_396	[p22l395t981r534b1047],
5	a	DT	O	a	det	7	SENT_396	[p22l585t1006r625b1046],
6	limited	JJ	O	limited	amod	7	SENT_396	[p22l673t981r940b1047],
7	number	NN	O	number	dobj	4	SENT_396	[p22l990t981r1284b1046],
8	of	IN	O	of	_	0	SENT_396	[p22l1335t981r1420b1046],
9	patients	NNS	O	patient	prep_of	7	SENT_396	[p22l1459t984r1756b1069],
10	with	IN	O	with	_	0	SENT_396	[p22l1807t981r1972b1045],
11	the	DT	O	the	det	15	SENT_396	[p22l2025t981r2140b1046],
12	CYP2C9	NN	O	cyp2c9	nn	15	SENT_396	[p22l10t1093r405b1153],
13	*	NN	O	*	nn	15	SENT_396	[p22l10t1093r405b1153],
14	3	CD	NUMBER	3	num	15	SENT_396	[p22l10t1093r405b1153],
15	genotype	NN	O	genotype	prep_with	4	SENT_396	[p22l454t1106r807b1175],
16	,	,	O	,	_	0	SENT_396	[p22l454t1106r807b1175],
17	although	IN	O	although	mark	21	SENT_396	[p22l856t1088r1193b1175],
18	our	PRP$	O	we	poss	19	SENT_396	[p22l1241t1111r1369b1152],
19	study	NN	O	study	nsubj	21	SENT_396	[p22l1414t1087r1618b1175],
20	is	VBZ	O	be	cop	21	SENT_396	[p22l1661t1090r1715b1152],
21	consistent	JJ	O	consistent	advcl	4	SENT_396	[p22l1763t1090r2141b1152],
22	with	IN	O	with	_	0	SENT_396	[p22l7t1195r172b1260],
23	the	DT	O	the	det	24	SENT_396	[p22l209t1195r324b1260],
24	prevalence	NN	O	prevalence	prep_with	21	SENT_396	[p22l360t1195r746b1283],
25	of	IN	O	of	_	0	SENT_396	[p22l783t1195r868b1260],
26	this	DT	O	this	det	27	SENT_396	[p22l892t1195r1028b1260],
27	variant	NN	O	variant	prep_of	24	SENT_396	[p22l1062t1198r1324b1260],
28	in	IN	O	in	_	0	SENT_396	[p22l1358t1198r1431b1259],
29	other	JJ	O	other	amod	30	SENT_396	[p22l1467t1195r1665b1260],
30	cohorts	NNS	O	cohort	prep_in	27	SENT_396	[p22l1700t1195r1977b1260],
31	not	RB	O	not	dep	33	SENT_396	[p22l2015t1214r2141b1260],
32	speciﬁcally	RB	O	speciﬁcally	advmod	33	SENT_396	[p22l9t1302r411b1389],
33	selected	VBN	O	select	dep	24	SENT_396	[p22l437t1302r725b1368],
34	according	VBG	O	accord	_	0	SENT_396	[p22l753t1302r1117b1389],
35	to	TO	O	to	prepc_according_to	33	SENT_396	[p22l1145t1320r1218b1366],
36	genotype	NN	O	genotype	pobj	33	SENT_396	[p22l1248t1306r1823b1389],
37	.11:16	CD	TIME	.11:16	num	36	SENT_396	[p22l1248t1306r1823b1389],
38	»	CD	NUMBER	»	number	39	SENT_396	[p22l1248t1306r1823b1389],
39	33	CD	DURATION	33	dep	36	SENT_396	[p22l1248t1306r1823b1389],
40	Second	NNP	DURATION	Second	dep	39	SENT_396	[p22l1855t1301r2139b1381],
41	,	,	O	,	_	0	SENT_396	[p22l1855t1301r2139b1381],
42	as	IN	O	as	mark	46	SENT_396	[p22l9t1433r78b1474],
43	we	PRP	O	we	nsubj	46	SENT_396	[p22l107t1434r204b1474],
44	have	VBP	O	have	aux	46	SENT_396	[p22l233t1409r398b1474],
45	previously	RB	DATE	previously	advmod	46	SENT_396	[p22l429t1409r810b1497],
46	mentioned	VBN	O	mention	advcl	21	SENT_396	[p22l837t1409r1257b1489],
47	,	,	O	,	_	0	SENT_396	[p22l837t1409r1257b1489],
48	we	PRP	O	we	nsubj	49	SENT_396	[p22l1287t1434r1383b1474],
49	had	VBD	O	have	parataxis	46	SENT_396	[p22l1413t1409r1552b1475],
50	a	DT	O	a	det	52	SENT_396	[p22l1580t1434r1620b1474],
51	limited	JJ	O	limited	amod	52	SENT_396	[p22l1645t1409r1912b1475],
52	number	NN	O	number	dobj	49	SENT_396	[p22l1940t1433r2139b1473, p22l7t1517r124b1581],
53	of	IN	O	of	_	0	SENT_396	[p22l163t1517r248b1581],
54	adverse	JJ	O	adverse	amod	55	SENT_396	[p22l275t1516r544b1583],
55	events	NNS	O	event	prep_of	52	SENT_396	[p22l585t1535r810b1581],
56	for	IN	O	for	_	0	SENT_396	[p22l852t1517r959b1581],
57	analysis	NN	O	analysis	prep_for	49	SENT_396	[p22l998t1517r1303b1604],
58	,	,	O	,	_	0	SENT_396	[p22l998t1517r1303b1604],
59	especially	RB	O	especially	advmod	46	SENT_396	[p22l1345t1517r1696b1604],
60	among	IN	O	among	_	0	SENT_396	[p22l1733t1541r1990b1604],
61	patients	NNS	O	patient	prep_among	46	SENT_396	[p22l2028t1540r2139b1604, p22l9t1660r213b1722],

1	with	IN	O	with	_	0	SENT_397	[p22l265t1657r430b1722],
2	variant	JJ	O	variant	amod	3	SENT_397	[p22l479t1660r741b1722],
3	genotypes	NNS	O	genotype	pobj	1	SENT_397	[p22l793t1676r1179b1745],
4	.	.	O	.	_	0	SENT_397	[p22l793t1676r1179b1745],

1	Nonetheless	RB	O	nonetheless	advmod	5	SENT_398	[p22l1233t1657r1706b1737],
2	,	,	O	,	_	0	SENT_398	[p22l1233t1657r1706b1737],
3	our	PRP$	O	we	poss	4	SENT_398	[p22l1761t1680r1889b1722],
4	study	NN	O	study	nsubj	5	SENT_398	[p22l1940t1657r2144b1745],
5	represents	VBZ	O	represent	_	0	SENT_398	[p22l9t1819r383b1888],
6	the	DT	O	the	det	8	SENT_398	[p22l422t1801r536b1865],
7	largest	JJS	O	largest	amod	8	SENT_398	[p22l572t1801r817b1888],
8	cohort	NN	O	cohort	dobj	5	SENT_398	[p22l853t1801r1098b1865],
9	of	IN	O	of	_	0	SENT_398	[p22l1134t1801r1219b1865],
10	patients	NNS	O	patient	prep_of	8	SENT_398	[p22l1243t1804r1539b1889],
11	who	WP	O	who	nsubjpass	14	SENT_398	[p22l1575t1801r1730b1865],
12	have	VBP	O	have	aux	14	SENT_398	[p22l1768t1801r1933b1865],
13	been	VBN	O	be	auxpass	14	SENT_398	[p22l1968t1801r2141b1865],
14	randomized	VBN	O	randomize	rcmod	10	SENT_398	[p22l9t1907r455b1973],
15	to	TO	O	to	_	0	SENT_398	[p22l500t1926r572b1972],
16	long	JJ	O	long	amod	19	SENT_398	[p22l619t1907r989b1995],
17	—	NN	O	—	nn	19	SENT_398	[p22l619t1907r989b1995],
18	term	NN	O	term	nn	19	SENT_398	[p22l619t1907r989b1995],
19	treatment	NN	O	treatment	prep_to	14	SENT_398	[p22l1034t1926r1401b1972],
20	with	IN	O	with	_	0	SENT_398	[p22l1444t1907r1609b1972],
21	celecoxib	NN	O	celecoxib	prep_with	14	SENT_398	[p22l1656t1907r1987b1972],
22	for	IN	O	for	_	0	SENT_398	[p22l2035t1907r2142b1972],
23	whom	WP	O	whom	dobj	27	SENT_398	[p22l6t2015r240b2080],
24	toxicity	NN	O	toxicity	nn	25	SENT_398	[p22l272t2018r549b2103],
25	data	NNS	O	datum	nsubj	27	SENT_398	[p22l578t2015r739b2081],
26	are	VBP	O	be	cop	27	SENT_398	[p22l769t2038r875b2080],
27	available	JJ	O	available	prepc_for	21	SENT_398	[p22l908t2015r1243b2080],
28	.	.	O	.	_	0	SENT_398	[p22l908t2015r1243b2080],

1	Third	NNP	ORDINAL	Third	nsubj	42	SENT_399	[p22l1275t2015r1506b2095],
2	,	,	O	,	_	0	SENT_399	[p22l1275t2015r1506b2095],
3	although	IN	O	although	mark	18	SENT_399	[p22l1540t2015r1877b2103],
4	2	CD	NUMBER	2	num	5	SENT_399	[p22l1909t2020r1949b2079],
5	copies	NNS	O	copy	nsubjpass	18	SENT_399	[p22l1984t2038r2139b2103, p22l8t2124r100b2186],
6	of	IN	O	of	_	0	SENT_399	[p22l135t2122r220b2186],
7	the	DT	O	the	det	11	SENT_399	[p22l242t2122r357b2186],
8	I359L	NN	O	i359l	nn	11	SENT_399	[p22l389t2126r605b2187],
9	allele	NN	O	allele	nn	11	SENT_399	[p22l637t2122r823b2186],
10	(	CD	NUMBER	(	num	11	SENT_399	[p22l860t2122r1282b2206],
11	CYP2C9	NN	O	cyp2c9	prep_of	5	SENT_399	[p22l860t2122r1282b2206],
12	*	CD	NUMBER	*	number	13	SENT_399	[p22l860t2122r1282b2206],
13	3	CD	NUMBER	3	num	15	SENT_399	[p22l860t2122r1282b2206],
14	homozygotes	NNS	O	homozygote	nn	15	SENT_399	[p22l1319t2122r1836b2209],
15	)	NN	O	)	dep	11	SENT_399	[p22l1319t2122r1836b2209],
16	may	MD	O	may	aux	18	SENT_399	[p22l1874t2146r2029b2209],
17	be	VB	O	be	auxpass	18	SENT_399	[p22l2058t2122r2140b2186],
18	associated	VBN	O	associate	dep	42	SENT_399	[p22l9t2229r386b2295],
19	with	IN	O	with	_	0	SENT_399	[p22l418t2229r584b2294],
20	greater	JJR	O	greater	amod	21	SENT_399	[p22l620t2248r876b2317],
21	impairment	NN	O	impairment	prep_with	18	SENT_399	[p22l909t2232r1351b2317],
22	of	IN	O	of	_	0	SENT_399	[p22l1386t2229r1471b2294],
23	drug	NN	O	drug	nn	24	SENT_399	[p22l1495t2229r1669b2317],
24	metabolism	NN	O	metabolism	prep_of	21	SENT_399	[p22l1703t2229r2141b2294],
25	than	IN	O	than	_	0	SENT_399	[p22l9t2336r179b2400],
26	1	CD	NUMBER	1	num	29	SENT_399	[p22l219t2341r248b2400],
27	copy	NN	O	copy	nn	29	SENT_399	[p22l289t2359r461b2423],
28	(	NN	O	(	nn	29	SENT_399	[p22l494t2336r916b2420],
29	CYP2C9	NN	O	cyp2c9	prep_than	18	SENT_399	[p22l494t2336r916b2420],
30	*	CD	NUMBER	*	number	31	SENT_399	[p22l494t2336r916b2420],
31	3	CD	NUMBER	3	num	32	SENT_399	[p22l494t2336r916b2420],
32	heterozygotes	NNS	O	heterozygote	npadvmod	35	SENT_399	[p22l953t2336r1701b2423],
33	)	CD	NUMBER	)	number	34	SENT_399	[p22l953t2336r1701b2423],
34	,9	CD	NUMBER	,9	num	32	SENT_399	[p22l953t2336r1701b2423],
35	>	JJR	O	>	amod	29	SENT_399	[p22l953t2336r1701b2423],
36	12	CD	NUMBER	12	number	37	SENT_399	[p22l953t2336r1701b2423],
37	>	JJR	O	>	amod	29	SENT_399	[p22l953t2336r1701b2423],
38	34	CD	NUMBER	34	tmod	18	SENT_399	[p22l953t2336r1701b2423],
39	we	PRP	O	we	nsubj	42	SENT_399	[p22l1732t2360r1828b2400],
40	did	VBD	O	do	aux	42	SENT_399	[p22l1863t2335r1983b2402],
41	not	RB	O	not	neg	42	SENT_399	[p22l2015t2354r2142b2400],
42	have	VB	O	have	_	0	SENT_399	[p22l8t2443r168b2508],
43	enough	JJ	O	enough	amod	44	SENT_399	[p22l217t2443r487b2531],
44	patients	NNS	O	patient	dobj	42	SENT_399	[p22l536t2446r819b2531],
45	with	IN	O	with	_	0	SENT_399	[p22l868t2443r1027b2508],
46	2	CD	NUMBER	2	num	47	SENT_399	[p22l1075t2448r1115b2507],
47	copies	NNS	O	copy	prep_with	42	SENT_399	[p22l1167t2446r1384b2531],
48	of	IN	O	of	_	0	SENT_399	[p22l1435t2443r1518b2508],
49	I359L	NN	O	i359l	nn	50	SENT_399	[p22l1553t2448r1761b2509],
50	alleles	NNS	O	allele	prep_of	47	SENT_399	[p22l1809t2443r2018b2508],
51	to	TO	O	to	aux	52	SENT_399	[p22l2068t2462r2139b2508],
52	analyze	VB	O	analyze	xcomp	42	SENT_399	[p22l9t2551r268b2638],
53	outcomes	NNS	O	outcome	dobj	52	SENT_399	[p22l315t2569r661b2615],
54	according	VBG	O	accord	_	0	SENT_399	[p22l708t2551r1058b2638],
55	to	TO	O	to	prepc_according_to	52	SENT_399	[p22l1103t2569r1173b2615],
56	gene	NN	O	gene	nn	57	SENT_399	[p22l1221t2575r1382b2638],
57	dosage	NN	O	dosage	pobj	52	SENT_399	[p22l1429t2550r1685b2638],
58	.	.	O	.	_	0	SENT_399	[p22l1429t2550r1685b2638],

1	Fourth	JJ	ORDINAL	fourth	advmod	4	SENT_400	[p22l1734t2551r2001b2631],
2	,	,	O	,	_	0	SENT_400	[p22l1734t2551r2001b2631],
3	we	PRP	O	we	nsubj	4	SENT_400	[p22l2046t2575r2140b2615],
4	restricted	VBD	O	restrict	_	0	SENT_400	[p22l9t2658r341b2724],
5	our	PRP$	O	we	poss	6	SENT_400	[p22l382t2682r507b2723],
6	analysis	NN	O	analysis	dobj	4	SENT_400	[p22l547t2658r820b2746],
7	of	IN	O	of	_	0	SENT_400	[p22l864t2658r947b2723],
8	CYPZC9	NN	O	cypzc9	nn	9	SENT_400	[p22l978t2663r1272b2724],
9	variants	NNS	O	variant	prep_of	6	SENT_400	[p22l1313t2661r1595b2723],
10	to	TO	O	to	_	0	SENT_400	[p22l1639t2677r1710b2723],
11	CYP2C9	NN	O	cyp2c9	nn	12	SENT_400	[p22l1754t2663r2138b2724],
12	*	NN	O	*	prep_to	4	SENT_400	[p22l1754t2663r2138b2724],
13	2	CD	NUMBER	2	number	17	SENT_400	[p22l1754t2663r2138b2724],
14	and	CC	O	and	_	0	SENT_400	[p22l9t2765r144b2831],
15	CYP2C9	CD	NUMBER	cyp2c9	conj_and	17	SENT_400	[p22l173t2770r555b2830],
16	*	CD	NUMBER	*	number	17	SENT_400	[p22l173t2770r555b2830],
17	3	CD	NUMBER	3	num	18	SENT_400	[p22l173t2770r555b2830],
18	polymorphisms	NNS	O	polymorphism	dep	12	SENT_400	[p22l588t2765r1168b2853],
19	,	,	O	,	_	0	SENT_400	[p22l588t2765r1168b2853],
20	which	WDT	O	which	nsubj	25	SENT_400	[p22l1197t2765r1412b2829],
21	are	VBP	O	be	cop	25	SENT_400	[p22l1443t2788r1546b2829],
22	the	DT	O	the	det	25	SENT_400	[p22l1576t2765r1687b2829],
23	most	RBS	O	most	advmod	24	SENT_400	[p22l1718t2783r1898b2829],
24	prevalent	JJ	O	prevalent	amod	25	SENT_400	[p22l1926t2788r2139b2852, p22l8t2872r145b2937],
25	polymorphisms	NNS	O	polymorphism	rcmod	12	SENT_400	[p22l194t2872r755b2960],
26	among	IN	O	among	_	0	SENT_400	[p22l807t2896r1057b2960],
27	non	JJ	O	non	prep_among	25	SENT_400	[p22l1105t2875r1591b2960],
28	.	.	O	.	_	0	SENT_400	[p22l1105t2875r1591b2960],

1	—	NN	O	—	_	0	SENT_401	[p22l1105t2875r1591b2960],
2	.	.	O	.	_	0	SENT_401	[p22l1105t2875r1591b2960],

1	Hispanic	JJ	MISC	hispanic	amod	2	SENT_402	[p22l1105t2875r1591b2960],
2	whites	NNS	O	whites	_	0	SENT_402	[p22l1639t2872r2141b2937],
3	.5	CD	NUMBER	.5	num	4	SENT_402	[p22l1639t2872r2141b2937],
4	»	NN	O	»	dep	2	SENT_402	[p22l1639t2872r2141b2937],
5	2	CD	NUMBER	2	number	6	SENT_402	[p22l1639t2872r2141b2937],
6	°	CD	NUMBER	°	npadvmod	7	SENT_402	[p22l1639t2872r2141b2937],
7	>	JJR	O	>	amod	4	SENT_402	[p22l1639t2872r2141b2937],
8	35	CD	NUMBER	35	num	9	SENT_402	[p22l1639t2872r2141b2937],
9	>	JJR	O	>	dep	2	SENT_402	[p22l1639t2872r2141b2937],
10	35	CD	NUMBER	35	tmod	9	SENT_402	[p22l1639t2872r2141b2937],
11	However	RB	O	however	advmod	10	SENT_402	[p22l9t2985r348b3059],
12	,	,	O	,	_	0	SENT_402	[p22l9t2985r348b3059],
13	because	IN	O	because	_	0	SENT_402	[p22l388t2979r674b3043],
14	non	JJ	O	non	prep_because	2	SENT_402	[p22l714t2981r1219b3066],
15	.	.	O	.	_	0	SENT_402	[p22l714t2981r1219b3066],

1	—	NN	O	—	_	0	SENT_403	[p22l714t2981r1219b3066],
2	.	.	O	.	_	0	SENT_403	[p22l714t2981r1219b3066],

1	Hispanic	JJ	MISC	hispanic	amod	2	SENT_404	[p22l714t2981r1219b3066],
2	whites	NNS	O	whites	nsubj	3	SENT_404	[p22l1257t2979r1493b3043],
3	composed	VBN	O	compose	partmod	15	SENT_404	[p22l1535t2978r1912b3066],
4	more	JJR	O	more	mwe	5	SENT_404	[p22l1951t3002r2140b3043],
5	than	IN	O	than	quantmod	6	SENT_404	[p22l9t3086r179b3151],
6	90	CD	PERCENT	90	num	7	SENT_404	[p22l227t3091r371b3152],
7	%	NN	PERCENT	%	dobj	3	SENT_404	[p22l227t3091r371b3152],
8	of	IN	O	of	_	0	SENT_404	[p22l420t3086r504b3151],
9	our	PRP$	O	we	poss	11	SENT_404	[p22l540t3109r668b3151],
10	study	NN	O	study	nn	11	SENT_404	[p22l715t3086r919b3174],
11	population	NN	O	population	prep_of	7	SENT_404	[p22l963t3086r1396b3174],
12	,	,	O	,	_	0	SENT_404	[p22l963t3086r1396b3174],
13	it	PRP	O	it	nsubj	15	SENT_404	[p22l1444t3089r1497b3150],
14	is	VBZ	O	be	cop	15	SENT_404	[p22l1543t3089r1597b3151],
15	unlikely	JJ	O	unlikely	_	0	SENT_404	[p22l1645t3086r1946b3174],
16	that	IN	O	that	complm	29	SENT_404	[p22l1991t3086r2142b3151],
17	misclassiﬁcation	NN	O	misclassiﬁcation	nsubj	29	SENT_404	[p22l9t3193r623b3258],
18	of	IN	O	of	_	0	SENT_404	[p22l670t3194r755b3258],
19	genotypes	NNS	O	genotype	prep_of	17	SENT_404	[p22l791t3212r1159b3281],
20	that	WDT	O	that	nsubj	23	SENT_404	[p22l1208t3194r1359b3258],
21	are	VBP	O	be	cop	23	SENT_404	[p22l1406t3217r1513b3258],
22	more	RBR	O	more	advmod	23	SENT_404	[p22l1561t3217r1751b3258],
23	prevalent	JJ	O	prevalent	rcmod	19	SENT_404	[p22l1798t3193r2142b3281],
24	among	IN	O	among	_	0	SENT_404	[p22l9t3325r266b3389],
25	non	JJ	O	non	amod	27	SENT_404	[p22l306t3301r717b3366],
26	—	JJ	O	—	amod	27	SENT_404	[p22l306t3301r717b3366],
27	whites	NNS	O	whites	prep_among	23	SENT_404	[p22l306t3301r717b3366],
28	would	MD	O	would	aux	29	SENT_404	[p22l758t3301r991b3367],
29	inﬂuence	VB	O	inﬂuence	ccomp	15	SENT_404	[p22l1030t3301r1368b3366],
30	our	PRP$	O	we	poss	31	SENT_404	[p22l1411t3324r1539b3366],
31	results	NNS	O	result	dobj	29	SENT_404	[p22l1579t3301r1838b3366],
32	.	.	O	.	_	0	SENT_404	[p22l1579t3301r1838b3366],

1	Importantly	RB	O	importantly	advmod	9	SENT_405	[p22l1882t3307r2139b3389, p22l9t3408r241b3495],
2	,	,	O	,	_	0	SENT_405	[p22l1882t3307r2139b3389, p22l9t3408r241b3495],
3	our	PRP$	O	we	poss	4	SENT_405	[p22l278t3431r406b3472],
4	results	NNS	O	result	nsubjpass	9	SENT_405	[p22l440t3408r680b3472],
5	were	VBD	O	be	auxpass	9	SENT_405	[p22l714t3431r881b3472],
6	also	RB	O	also	advmod	9	SENT_405	[p22l916t3408r1058b3472],
7	not	RB	O	not	neg	9	SENT_405	[p22l1094t3426r1221b3472],
8	materially	RB	O	materially	advmod	9	SENT_405	[p22l1255t3408r1627b3495],
9	altered	VBN	O	alter	_	0	SENT_405	[p22l1659t3407r1911b3474],
10	when	WRB	O	when	advmod	12	SENT_405	[p22l1942t3408r2141b3472],
11	we	PRP	O	we	nsubj	12	SENT_405	[p22l6t3540r102b3580],
12	restricted	VBD	O	restrict	advcl	9	SENT_405	[p22l130t3515r477b3581],
13	our	PRP$	O	we	poss	14	SENT_405	[p22l503t3538r631b3580],
14	analyses	NNS	O	analysis	dobj	12	SENT_405	[p22l656t3515r956b3603],
15	to	TO	O	to	_	0	SENT_405	[p22l984t3534r1056b3580],
16	non	JJ	O	non	prep_to	12	SENT_405	[p22l1084t3518r1589b3603],
17	.	.	O	.	_	0	SENT_405	[p22l1084t3518r1589b3603],

1	—	NN	O	—	_	0	SENT_406	[p22l1084t3518r1589b3603],
2	.	.	O	.	_	0	SENT_406	[p22l1084t3518r1589b3603],

1	Hispanic	JJ	MISC	hispanic	amod	3	SENT_407	[p22l1084t3518r1589b3603],
2	white	JJ	O	white	amod	3	SENT_407	[p22l1613t3515r1817b3580],
3	patients	NNS	O	patient	nsubj	4	SENT_407	[p22l1843t3518r2139b3603],
4	(	VBP	O	(	_	0	SENT_407	[p22l11t3621r198b3706],
5	data	NNS	O	datum	dobj	4	SENT_407	[p22l11t3621r198b3706],
6	not	RB	O	not	neg	7	SENT_407	[p22l222t3640r348b3686],
7	shown	VBN	O	show	rcmod	5	SENT_407	[p22l375t3622r660b3706],
8	)	NN	O	)	dobj	7	SENT_407	[p22l375t3622r660b3706],
9	.	.	O	.	_	0	SENT_407	[p22l375t3622r660b3706],

1	Given	VBN	O	give	_	0	SENT_408	[p22l691t3624r905b3686],
2	potential	JJ	O	potential	amod	3	SENT_408	[p22l931t3621r1267b3709],
3	differences	NNS	O	difference	dep	1	SENT_408	[p22l1293t3621r1691b3688],
4	in	IN	O	in	_	0	SENT_408	[p22l1718t3624r1790b3685],
5	the	DT	O	the	det	6	SENT_408	[p22l1817t3622r1932b3686],
6	prevalence	NN	O	prevalence	prep_in	3	SENT_408	[p22l1958t3645r2139b3709, p22l9t3729r234b3794],
7	of	IN	O	of	_	0	SENT_408	[p22l270t3729r354b3794],
8	genetic	JJ	O	genetic	amod	9	SENT_408	[p22l376t3732r637b3816],
9	variants	NNS	O	variant	prep_of	6	SENT_408	[p22l668t3732r962b3794],
10	as	RB	O	as	_	0	SENT_408	[p22l998t3753r1068b3794],
11	well	RB	O	well	_	0	SENT_408	[p22l1101t3729r1248b3794],
12	as	IN	O	as	_	0	SENT_408	[p22l1281t3753r1351b3794],
13	their	PRP$	O	they	poss	15	SENT_408	[p22l1388t3729r1562b3794],
14	associated	VBN	O	associate	amod	15	SENT_408	[p22l1595t3729r1973b3795],
15	metabolizer	NN	O	metabolizer	conj_and	6	SENT_408	[p22l2005t3753r2139b3794, p23l9t18r334b82],

1	phenotypes	NNS	O	phenotype	nsubjpass	9	SENT_409	[p23l372t18r797b105],
2	in	IN	O	in	_	0	SENT_409	[p23l838t20r911b81],
3	non-white	JJ	O	non-white	amod	4	SENT_409	[p23l950t18r1328b82],
4	populations	NNS	O	population	prep_in	1	SENT_409	[p23l1369t18r1836b105],
5	,	,	O	,	_	0	SENT_409	[p23l1369t18r1836b105],
6	further	JJ	O	further	amod	7	SENT_409	[p23l1878t18r2142b82],
7	studies	NNS	O	study	appos	4	SENT_409	[p23l9t125r267b190],
8	are	VBP	O	be	auxpass	9	SENT_409	[p23l307t148r414b189],
9	warranted	VBN	O	warrant	_	0	SENT_409	[p23l451t125r830b190],
10	to	TO	O	to	aux	11	SENT_409	[p23l868t143r940b189],
11	examine	VB	O	examine	xcomp	9	SENT_409	[p23l982t128r1286b189],
12	CYPZC9	NN	O	cypzc9	nn	13	SENT_409	[p23l1327t130r1630b190],
13	variants	NNS	O	variant	dobj	11	SENT_409	[p23l1669t128r1963b189],
14	and	CC	O	and	_	0	SENT_409	[p23l2004t125r2142b190],
15	celecoxib	NN	O	celecoxib	nn	16	SENT_409	[p23l9t233r340b297],
16	use	NN	O	use	conj_and	13	SENT_409	[p23l376t257r495b297],
17	in	IN	O	in	_	0	SENT_409	[p23l529t235r601b296],
18	other	JJ	O	other	amod	19	SENT_409	[p23l635t232r833b297],
19	populations	NNS	O	population	prep_in	11	SENT_409	[p23l865t233r1331b320],
20	.	.	O	.	_	0	SENT_409	[p23l865t233r1331b320],

1	At	IN	O	at	_	0	SENT_410	[p23l94t346r180b404],
2	baseline	NN	O	baseline	prep_at	5	SENT_410	[p23l202t340r503b420],
3	,	,	O	,	_	0	SENT_410	[p23l202t340r503b420],
4	there	EX	O	there	expl	5	SENT_410	[p23l530t340r709b405],
5	were	VBD	O	be	_	0	SENT_410	[p23l731t363r893b405],
6	differences	NNS	O	difference	nsubj	5	SENT_410	[p23l919t340r1299b406],
7	in	IN	O	in	_	0	SENT_410	[p23l1324t343r1395b404],
8	low	JJ	O	low	amod	12	SENT_410	[p23l1418t340r1732b406],
9	—	NN	O	—	nn	12	SENT_410	[p23l1418t340r1732b406],
10	dose	NN	O	dose	nn	12	SENT_410	[p23l1418t340r1732b406],
11	aspirin	NN	O	aspirin	nn	12	SENT_410	[p23l1757t343r2001b428],
12	use	NN	O	use	prep_in	6	SENT_410	[p23l2025t364r2140b405],
13	according	VBG	O	accord	_	0	SENT_410	[p23l9t446r359b534],
14	to	TO	O	to	prepc_according_to	5	SENT_410	[p23l397t465r468b511],
15	genotype	NN	O	genotype	pobj	5	SENT_410	[p23l509t465r846b534],
16	.	.	O	.	_	0	SENT_410	[p23l509t465r846b534],

1	Unlike	IN	O	unlike	_	0	SENT_411	[p23l887t446r1125b512],
2	many	JJ	O	many	amod	4	SENT_411	[p23l1165t471r1366b534],
3	nonaspirin	JJ	O	nonaspirin	amod	4	SENT_411	[p23l1401t449r1791b534],
4	NSAIDs	NNS	MISC	nsaid	prep_unlike	20	SENT_411	[p23l1828t452r2139b527],
5	,	,	O	,	_	0	SENT_411	[p23l1828t452r2139b527],
6	aspirin	NN	O	aspirin	nsubjpass	10	SENT_411	[p23l9t557r253b642],
7	is	VBZ	O	be	auxpass	10	SENT_411	[p23l278t557r330b619],
8	not	RB	O	not	neg	10	SENT_411	[p23l358t573r481b619],
9	primarily	RB	O	primarily	advmod	10	SENT_411	[p23l506t554r837b642],
10	metabolized	VBN	O	metabolize	parataxis	20	SENT_411	[p23l861t554r1298b620],
11	by	IN	O	by	_	0	SENT_411	[p23l1321t554r1407b642],
12	CYP2C9	NN	O	cyp2c9	agent	10	SENT_411	[p23l1432t558r1836b620],
13	.37	CD	NUMBER	.37	num	12	SENT_411	[p23l1432t558r1836b620],
14	‘	CD	NUMBER	‘	num	15	SENT_411	[p23l1432t558r1836b620],
15	40	CD	NUMBER	40	npadvmod	16	SENT_411	[p23l1846t558r1905b594],
16	Thus	RB	O	thus	advmod	10	SENT_411	[p23l1930t554r2139b634],
17	,	,	O	,	_	0	SENT_411	[p23l1930t554r2139b634],
18	it	PRP	O	it	nsubj	20	SENT_411	[p23l8t664r61b726],
19	is	VBZ	O	be	cop	20	SENT_411	[p23l97t664r150b726],
20	unlikely	JJ	O	unlikely	_	0	SENT_411	[p23l189t661r489b749],
21	that	IN	O	that	complm	26	SENT_411	[p23l524t661r675b726],
22	this	DT	O	this	det	24	SENT_411	[p23l711t661r847b726],
23	association	NN	O	association	nn	24	SENT_411	[p23l886t664r1298b726],
24	reﬂects	NNS	O	reﬂects	nsubj	26	SENT_411	[p23l1336t661r1592b726],
25	genotype	NN	O	genotype	nn	26	SENT_411	[p23l1632t680r2139b749, p23l9t768r156b832],
26	—	NN	O	—	ccomp	20	SENT_411	[p23l1632t680r2139b749, p23l9t768r156b832],
27	speciﬁc	NN	O	speciﬁc	nn	28	SENT_411	[p23l1632t680r2139b749, p23l9t768r156b832],
28	differences	NNS	O	difference	dobj	26	SENT_411	[p23l185t768r582b834],
29	in	IN	O	in	_	0	SENT_411	[p23l612t771r684b832],
30	tolerance	NN	O	tolerance	prep_in	28	SENT_411	[p23l713t768r1050b832],
31	to	TO	O	to	_	0	SENT_411	[p23l1080t786r1152b832],
32	aspirin	NN	O	aspirin	nn	33	SENT_411	[p23l1183t771r1437b856],
33	therapy	NN	O	therapy	prep_to	26	SENT_411	[p23l1466t768r1761b855],
34	.	.	O	.	_	0	SENT_411	[p23l1466t768r1761b855],

1	Nonetheless	RB	O	nonetheless	advmod	18	SENT_412	[p23l1792t768r2139b833, p23l8t875r154b955],
2	,	,	O	,	_	0	SENT_412	[p23l1792t768r2139b833, p23l8t875r154b955],
3	because	RB	O	because	advmod	18	SENT_412	[p23l189t875r474b940],
4	low	JJ	O	low	amod	6	SENT_412	[p23l509t875r834b941],
5	—	NN	O	—	nn	6	SENT_412	[p23l509t875r834b941],
6	dose	NN	O	dose	npadvmod	18	SENT_412	[p23l509t875r834b941],
7	aspirin	NN	O	aspirin	nn	8	SENT_412	[p23l870t878r1125b963],
8	therapy	NN	O	therapy	nsubjpass	10	SENT_412	[p23l1160t875r1441b963],
9	was	VBD	O	be	auxpass	10	SENT_412	[p23l1471t900r1604b940],
10	included	VBN	O	include	rcmod	6	SENT_412	[p23l1640t875r1964b941],
11	as	IN	O	as	_	0	SENT_412	[p23l1998t900r2068b940],
12	a	DT	O	a	det	14	SENT_412	[p23l2105t900r2144b940],
13	stratiﬁcation	NN	O	stratiﬁcation	nn	14	SENT_412	[p23l9t982r486b1046],
14	variable	NN	O	variable	prep_as	18	SENT_412	[p23l509t982r817b1062],
15	,	,	O	,	_	0	SENT_412	[p23l509t982r817b1062],
16	we	PRP	O	we	nsubj	18	SENT_412	[p23l844t1006r940b1046],
17	were	VBD	O	be	cop	18	SENT_412	[p23l966t1005r1133b1046],
18	able	JJ	O	able	_	0	SENT_412	[p23l1161t982r1308b1046],
19	to	TO	O	to	aux	20	SENT_412	[p23l1337t1000r1409b1046],
20	adjust	VB	O	adjust	xcomp	18	SENT_412	[p23l1438t982r1665b1069],
21	carefully	RB	O	carefully	advmod	20	SENT_412	[p23l1692t982r2010b1069],
22	for	IN	O	for	_	0	SENT_412	[p23l2035t982r2142b1046],
23	June	NNP	DATE	June	prep_for	20	SENT_412	[p23l7t1095r146b1144],
24	2009	CD	DATE	2009	num	23	SENT_412	[p23l174t1095r335b1144],

1	use	NN	O	use	_	0	SENT_413	[p23l10t1328r129b1368],
2	of	IN	O	of	_	0	SENT_413	[p23l162t1304r246b1368],
3	low	JJ	O	low	amod	6	SENT_413	[p23l265t1304r590b1370],
4	—	NN	O	—	nn	6	SENT_413	[p23l265t1304r590b1370],
5	dose	NN	O	dose	nn	6	SENT_413	[p23l265t1304r590b1370],
6	aspirin	NN	O	aspirin	prep_of	1	SENT_413	[p23l622t1307r876b1391],
7	in	IN	O	in	_	0	SENT_413	[p23l907t1307r979b1368],
8	all	DT	O	all	prep_in	6	SENT_413	[p23l1011t1304r1097b1368],
9	of	IN	O	of	_	0	SENT_413	[p23l1129t1304r1213b1368],
10	our	PRP$	O	we	poss	12	SENT_413	[p23l1233t1328r1361b1368],
11	multivariate	JJ	O	multivariate	amod	12	SENT_413	[p23l1391t1304r1842b1368],
12	models	NNS	O	model	prep_of	8	SENT_413	[p23l1875t1304r2138b1370],
13	to	TO	O	to	aux	14	SENT_413	[p23l11t1429r83b1474],
14	minimize	VB	O	minimize	infmod	1	SENT_413	[p23l120t1413r468b1474],
15	any	DT	O	any	det	17	SENT_413	[p23l503t1434r633b1497],
16	potential	JJ	O	potential	amod	17	SENT_413	[p23l664t1410r999b1497],
17	confounding	NN	O	confounding	dobj	14	SENT_413	[p23l1033t1410r1530b1497],
18	.	.	O	.	_	0	SENT_413	[p23l1033t1410r1530b1497],

1	Our	PRP$	O	we	poss	2	SENT_414	[p23l101t1521r249b1579],
2	study	NN	O	study	nsubj	3	SENT_414	[p23l282t1515r486b1602],
3	has	VBZ	O	have	_	0	SENT_414	[p23l517t1515r637b1579],
4	speciﬁc	JJ	O	speciﬁc	amod	6	SENT_414	[p23l673t1515r941b1602],
5	clinical	JJ	O	clinical	amod	6	SENT_414	[p23l975t1515r1238b1579],
6	implications	NNS	O	implication	dobj	3	SENT_414	[p23l1270t1515r1750b1602],
7	.	.	O	.	_	0	SENT_414	[p23l1270t1515r1750b1602],

1	Although	IN	O	although	mark	4	SENT_415	[p23l1784t1515r2139b1602],
2	celecoxib	NN	O	celecoxib	nsubj	4	SENT_415	[p23l11t1620r341b1684],
3	effectively	RB	O	effectively	advmod	4	SENT_415	[p23l374t1620r742b1707],
4	prevents	VBZ	O	prevent	advcl	14	SENT_415	[p23l769t1639r1078b1707],
5	colorectal	JJ	O	colorectal	amod	6	SENT_415	[p23l1110t1620r1469b1684],
6	neoplasia	NN	O	neoplasium	dobj	4	SENT_415	[p23l1499t1620r1865b1707],
7	,	,	O	,	_	0	SENT_415	[p23l1499t1620r1865b1707],
8	the	DT	O	the	det	11	SENT_415	[p23l1897t1620r2012b1684],
9	associated	VBN	O	associate	amod	11	SENT_415	[p23l2043t1645r2138b1684, p23l11t1725r312b1791],
10	cardiovascular	JJ	O	cardiovascular	amod	11	SENT_415	[p23l344t1725r877b1791],
11	risk	NN	O	risk	nsubj	14	SENT_415	[p23l910t1725r1045b1789],
12	does	VBZ	O	do	aux	14	SENT_415	[p23l1079t1725r1241b1791],
13	not	RB	O	not	neg	14	SENT_415	[p23l1276t1744r1402b1789],
14	permit	VB	O	permit	_	0	SENT_415	[p23l1435t1728r1683b1812],
15	routine	JJ	O	routine	amod	16	SENT_415	[p23l1716t1728r1987b1789],
16	use	NN	O	use	dobj	14	SENT_415	[p23l2021t1750r2139b1789],
17	of	IN	O	of	_	0	SENT_415	[p23l11t1831r96b1895],
18	the	DT	O	the	det	19	SENT_415	[p23l120t1831r234b1895],
19	drug	NN	O	drug	prep_of	16	SENT_415	[p23l271t1831r445b1918],
20	for	IN	O	for	_	0	SENT_415	[p23l479t1831r586b1895],
21	population-based	JJ	O	population-based	amod	22	SENT_415	[p23l620t1831r1272b1918],
22	chemoprevention	NN	O	chemoprevention	prep_for	19	SENT_415	[p23l1307t1831r1972b1918],
23	.	.	O	.	_	0	SENT_415	[p23l1307t1831r1972b1918],

1	Despite	IN	O	despite	_	0	SENT_416	[p23l2012t1837r2138b1895, p23l11t1967r183b2051],

1	this	DT	O	this	nsubjpass	15	SENT_417	[p23l222t1964r377b2043],
2	,	,	O	,	_	0	SENT_417	[p23l222t1964r377b2043],
3	efforts	NNS	O	effort	appos	1	SENT_417	[p23l417t1964r654b2028],
4	to	TO	O	to	aux	5	SENT_417	[p23l694t1983r766b2028],
5	use	VB	O	use	infmod	3	SENT_417	[p23l806t1988r924b2028],
6	genetic	JJ	O	genetic	amod	7	SENT_417	[p23l963t1967r1223b2051],
7	information	NN	O	information	dobj	5	SENT_417	[p23l1261t1964r1715b2028],
8	to	TO	O	to	aux	9	SENT_417	[p23l1753t1983r1825b2028],
9	personalize	VB	O	personalize	xcomp	5	SENT_417	[p23l1865t1987r2138b2051, p23l11t2069r173b2133],
10	and	CC	O	and	_	0	SENT_417	[p23l202t2069r340b2135],
11	optimize	VB	O	optimize	conj_and	9	SENT_417	[p23l367t2072r692b2156],
12	chemoprevention	NN	O	chemoprevention	dobj	9	SENT_417	[p23l721t2069r1369b2156],
13	have	VBP	O	have	aux	15	SENT_417	[p23l1397t2069r1561b2133],
14	been	VBN	O	be	auxpass	15	SENT_417	[p23l1588t2069r1760b2133],
15	identiﬁed	VBN	O	identiﬁed	_	0	SENT_417	[p23l1787t2069r2141b2135],
16	as	IN	O	as	_	0	SENT_417	[p23l11t2200r80b2239],
17	a	DT	O	a	det	19	SENT_417	[p23l133t2200r172b2239],
18	high	JJ	O	high	amod	19	SENT_417	[p23l220t2175r386b2262],
19	priority	NN	O	priority	prep_as	15	SENT_417	[p23l437t2178r719b2262],
20	and	CC	O	and	_	0	SENT_417	[p23l767t2175r905b2241],
21	may	MD	O	may	aux	23	SENT_417	[p23l955t2199r1110b2262],
22	be	VB	O	be	auxpass	23	SENT_417	[p23l1156t2175r1238b2239],
23	warranted	VBN	O	warrant	conj_and	15	SENT_417	[p23l1288t2175r1665b2241],
24	for	IN	O	for	_	0	SENT_417	[p23l1714t2175r1822b2239],
25	speciﬁc	NN	O	speciﬁc	nn	26	SENT_417	[p23l1871t2175r2140b2262],
26	patients	NNS	O	patient	prep_for	23	SENT_417	[p23l10t2283r388b2367],
27	.	.	O	.	_	0	SENT_417	[p23l10t2283r388b2367],

1	“	NN	O	“	npadvmod	14	SENT_418	[p23l10t2283r388b2367],
2	For	IN	O	for	_	0	SENT_418	[p23l433t2286r560b2344],
3	example	NN	O	example	prep_for	14	SENT_418	[p23l600t2280r921b2367],
4	,	,	O	,	_	0	SENT_418	[p23l600t2280r921b2367],
5	high-dose	JJ	O	high-dose	amod	6	SENT_418	[p23l963t2280r1325b2367],
6	celecoxib	NN	O	celecoxib	nsubjpass	14	SENT_418	[p23l1367t2280r1698b2344],
7	at	IN	O	at	_	0	SENT_418	[p23l1741t2299r1810b2344],
8	400	CD	NUMBER	400	num	9	SENT_418	[p23l1849t2286r1981b2344],
9	mg	NN	O	mg	prep_at	6	SENT_418	[p23l2025t2304r2141b2367],
10	twice	RB	O	twice	advmod	11	SENT_418	[p23l11t2389r198b2450],
11	daily	RB	SET	daily	advmod	14	SENT_418	[p23l234t2386r412b2473],
12	is	VBZ	O	be	auxpass	14	SENT_418	[p23l443t2389r497b2450],
13	currently	RB	DATE	currently	advmod	14	SENT_418	[p23l534t2386r871b2473],
14	approved	VBN	O	approve	_	0	SENT_418	[p23l904t2386r1248b2473],
15	by	IN	O	by	_	0	SENT_418	[p23l1279t2386r1367b2473],
16	the	DT	O	the	det	20	SENT_418	[p23l1400t2386r1514b2450],
17	Food	NNP	ORGANIZATION	Food	nn	20	SENT_418	[p23l1550t2386r1741b2452],
18	and	CC	ORGANIZATION	and	_	0	SENT_418	[p23l1775t2386r1913b2452],
19	Drug	NNP	ORGANIZATION	Drug	nn	20	SENT_418	[p23l1947t2392r2141b2473],
20	Administration	NNP	ORGANIZATION	Administration	agent	14	SENT_418	[p23l7t2491r583b2557],
21	for	IN	O	for	_	0	SENT_418	[p23l611t2491r718b2555],
22	adjunctive	JJ	O	adjunctive	amod	23	SENT_418	[p23l745t2491r1127b2578],
23	treatment	NN	O	treatment	prep_for	14	SENT_418	[p23l1156t2510r1523b2555],
24	of	IN	O	of	_	0	SENT_418	[p23l1550t2491r1635b2555],
25	patients	NNS	O	patient	prep_of	23	SENT_418	[p23l1651t2494r1946b2578],
26	with	IN	O	with	_	0	SENT_418	[p23l1975t2491r2139b2555],
27	familial	JJ	O	familial	amod	29	SENT_418	[p23l11t2596r293b2660],
28	adenomatous	JJ	O	adenomatous	amod	29	SENT_418	[p23l357t2596r859b2662],
29	polyposis	NN	O	polyposis	prep_with	25	SENT_418	[p23l924t2596r1288b2683],
30	.	.	O	.	_	0	SENT_418	[p23l924t2596r1288b2683],

1	Celecoxib	NN	O	celecoxib	nn	2	SENT_419	[p23l1357t2596r1708b2660],
2	treatment	NN	O	treatment	nsubj	26	SENT_419	[p23l1774t2615r2141b2660],
3	also	RB	O	also	advmod	6	SENT_419	[p23l11t2701r152b2765],
4	has	VBZ	O	have	aux	6	SENT_419	[p23l180t2701r301b2765],
5	been	VBN	O	be	auxpass	6	SENT_419	[p23l327t2701r499b2765],
6	proposed	VBN	O	propose	_	0	SENT_419	[p23l524t2701r870b2788],
7	for	IN	O	for	_	0	SENT_419	[p23l894t2701r1002b2765],
8	speciﬁc	JJ	O	speciﬁc	amod	9	SENT_419	[p23l1027t2701r1295b2788],
9	individuals	NNS	O	individual	prep_for	6	SENT_419	[p23l1320t2701r1730b2767],
10	who	WP	O	who	nsubj	11	SENT_419	[p23l1755t2701r1911b2765],
11	are	VBP	O	be	rcmod	9	SENT_419	[p23l1939t2724r2045b2765],
12	at	IN	O	at	_	0	SENT_419	[p23l2072t2720r2141b2765],
13	high	JJ	O	high	amod	14	SENT_419	[p23l10t2806r177b2893],
14	risk	NN	O	risk	prep_at	11	SENT_419	[p23l204t2806r339b2870],
15	for	IN	O	for	_	0	SENT_419	[p23l364t2806r471b2870],
16	colorectal	JJ	O	colorectal	amod	17	SENT_419	[p23l496t2806r855b2870],
17	cancer	NN	O	cancer	prep_for	14	SENT_419	[p23l881t2829r1133b2885],
18	,	,	O	,	_	0	SENT_419	[p23l881t2829r1133b2885],
19	low	JJ	O	low	amod	20	SENT_419	[p23l1159t2806r1292b2870],
20	risk	NN	O	risk	appos	17	SENT_419	[p23l1316t2806r1451b2870],
21	for	IN	O	for	_	0	SENT_419	[p23l1476t2806r1583b2870],
22	cardiovascular	JJ	O	cardiovascular	amod	23	SENT_419	[p23l1608t2806r2141b2872],
23	events	NNS	O	event	prep_for	20	SENT_419	[p23l11t2930r257b2990],
24	,	,	O	,	_	0	SENT_419	[p23l11t2930r257b2990],
25	and	CC	O	and	_	0	SENT_419	[p23l285t2911r423b2977],
26	unable	JJ	O	unable	conj_and	6	SENT_419	[p23l449t2911r697b2975],
27	to	TO	O	to	aux	28	SENT_419	[p23l725t2930r797b2975],
28	tolerate	VB	O	tolerate	xcomp	26	SENT_419	[p23l827t2911r1106b2975],
29	routine	JJ	O	routine	amod	31	SENT_419	[p23l1134t2914r1405b2975],
30	endoscopic	JJ	O	endoscopic	amod	31	SENT_419	[p23l1433t2911r1846b2998],
31	surveillance	NN	O	surveillance	dobj	28	SENT_419	[p23l1873t2911r2138b2975, p23l10t3016r215b3080],
32	.	.	O	.	_	0	SENT_419	[p23l1873t2911r2138b2975, p23l10t3016r215b3080],

1	Finally	RB	O	finally	advmod	6	SENT_420	[p23l251t3016r520b3103],
2	,	,	O	,	_	0	SENT_420	[p23l251t3016r520b3103],
3	celecoxib	NN	O	celecoxib	nn	4	SENT_420	[p23l554t3016r885b3080],
4	treatment	NN	O	treatment	nsubj	6	SENT_420	[p23l920t3035r1286b3080],
5	is	VBZ	O	be	aux	6	SENT_420	[p23l1317t3019r1371b3080],
6	continuing	VBG	O	continue	_	0	SENT_420	[p23l1405t3019r1817b3103],
7	in	IN	O	in	_	0	SENT_420	[p23l1847t3019r1919b3080],
8	studies	NNS	O	study	prep_in	6	SENT_420	[p23l1952t3016r2138b3082, p23l10t3125r102b3186],
9	examining	VBG	O	examine	partmod	8	SENT_420	[p23l135t3125r523b3209],
10	its	PRP$	O	its	poss	12	SENT_420	[p23l552t3125r637b3186],
11	potential	JJ	O	potential	amod	12	SENT_420	[p23l669t3122r1005b3209],
12	role	NN	O	role	dobj	9	SENT_420	[p23l1036t3122r1174b3186],
13	in	IN	O	in	_	0	SENT_420	[p23l1205t3125r1277b3186],
14	multiagent	JJ	O	multiagent	amod	15	SENT_420	[p23l1308t3122r1717b3209],
15	chemoprevention	NN	O	chemoprevention	prep_in	9	SENT_420	[p23l1748t3122r2138b3209, p24l7t32r290b93],

1	or	CC	O	or	cc	16	SENT_421	[p24l332t52r409b93],
2	as	IN	O	as	_	0	SENT_421	[p24l450t53r519b93],
3	an	DT	O	a	det	5	SENT_421	[p24l563t53r650b93],
4	adjunctive	JJ	O	adjunctive	amod	5	SENT_421	[p24l693t29r1074b116],
5	treatment	NN	O	treatment	prep_as	16	SENT_421	[p24l1117t48r1483b93],
6	in	IN	O	in	_	0	SENT_421	[p24l1524t32r1596b93],
7	patients	NNS	O	patient	prep_in	5	SENT_421	[p24l1638t32r1933b116],
8	with	IN	O	with	_	0	SENT_421	[p24l1975t29r2139b93],
9	established	JJ	O	established	amod	10	SENT_421	[p24l11t134r422b200],
10	cancers	NNS	O	cancer	prep_with	7	SENT_421	[p24l467t139r896b198],
11	.42	CD	NUMBER	.42	num	12	SENT_421	[p24l467t139r896b198],
12	>	JJR	O	>	dep	10	SENT_421	[p24l467t139r896b198],
13	43	CD	NUMBER	43	dep	12	SENT_421	[p24l467t139r896b198],
14	Our	PRP$	O	we	poss	15	SENT_421	[p24l944t140r1093b198],
15	data	NNS	O	datum	nsubj	16	SENT_421	[p24l1137t134r1298b200],
16	suggest	VBP	O	suggest	_	0	SENT_421	[p24l1340t153r1615b221],
17	that	IN	O	that	complm	37	SENT_421	[p24l1659t134r1827b214],
18	,	,	O	,	_	0	SENT_421	[p24l1659t134r1827b214],
19	for	IN	O	for	_	0	SENT_421	[p24l1873t134r1981b198],
20	the	DT	O	the	det	22	SENT_421	[p24l2025t134r2139b198],
21	vast	JJ	O	vast	amod	22	SENT_421	[p24l7t258r153b303],
22	majority	NN	O	majority	prep_for	37	SENT_421	[p24l202t242r517b326],
23	of	IN	O	of	_	0	SENT_421	[p24l564t239r648b303],
24	individuals	NNS	O	individual	prep_of	22	SENT_421	[p24l685t239r1094b305],
25	without	IN	O	without	_	0	SENT_421	[p24l1143t239r1440b303],
26	CYP2C9	NN	O	cyp2c9	prep_without	24	SENT_421	[p24l1489t245r1883b304],
27	*	CD	NUMBER	*	number	28	SENT_421	[p24l1489t245r1883b304],
28	3	CD	NUMBER	3	num	29	SENT_421	[p24l1489t245r1883b304],
29	genotypes	NNS	O	genotype	dep	26	SENT_421	[p24l1937t263r2138b326, p24l11t363r217b431],
30	,	,	O	,	_	0	SENT_421	[p24l1937t263r2138b326, p24l11t363r217b431],
31	high	JJ	O	high	amod	34	SENT_421	[p24l246t344r609b431],
32	—	NN	O	—	nn	34	SENT_421	[p24l246t344r609b431],
33	dose	NN	O	dose	nn	34	SENT_421	[p24l246t344r609b431],
34	celecoxib	NN	O	celecoxib	nsubj	37	SENT_421	[p24l637t344r968b408],
35	does	VBZ	O	do	aux	37	SENT_421	[p24l998t344r1161b410],
36	not	RB	O	not	neg	37	SENT_421	[p24l1190t363r1317b408],
37	confer	VB	O	confer	ccomp	16	SENT_421	[p24l1344t344r1577b408],
38	any	DT	O	any	det	41	SENT_421	[p24l1604t368r1734b431],
39	additional	JJ	O	additional	amod	41	SENT_421	[p24l1759t344r2140b410],
40	chemopreventive	JJ	O	chemopreventive	amod	41	SENT_421	[p24l11t449r638b536],
41	beneﬁt	NN	O	beneﬁt	dobj	37	SENT_421	[p24l693t449r963b513],
42	.	.	O	.	_	0	SENT_421	[p24l693t449r963b513],

1	Thus	RB	O	thus	advmod	12	SENT_422	[p24l1020t449r1229b528],
2	,	,	O	,	_	0	SENT_422	[p24l1020t449r1229b528],
3	consideration	NN	O	consideration	nsubjpass	12	SENT_422	[p24l1288t449r1795b515],
4	of	IN	O	of	_	0	SENT_422	[p24l1851t449r1936b513],
5	celecoxib	NN	O	celecoxib	prep_of	3	SENT_422	[p24l1980t449r2138b513, p24l11t554r203b618],
6	for	IN	O	for	_	0	SENT_422	[p24l240t554r347b618],
7	any	DT	O	any	det	9	SENT_422	[p24l381t578r511b641],
8	chemopreventive	JJ	O	chemopreventive	amod	9	SENT_422	[p24l543t554r1170b641],
9	strategy	NN	O	strategy	prep_for	5	SENT_422	[p24l1206t573r1497b641],
10	should	MD	O	should	aux	12	SENT_422	[p24l1529t554r1784b620],
11	be	VB	O	be	auxpass	12	SENT_422	[p24l1816t554r1898b618],
12	based	VBN	O	base	_	0	SENT_422	[p24l1932t554r2141b620],
13	on	IN	O	on	_	0	SENT_422	[p24l11t683r105b723],
14	the	DT	O	the	det	16	SENT_422	[p24l146t659r260b723],
15	potential	JJ	O	potential	amod	16	SENT_422	[p24l301t659r636b746],
16	risks	NNS	O	risk	prep_on	12	SENT_422	[p24l677t659r845b723],
17	and	CC	O	and	_	0	SENT_422	[p24l887t659r1025b725],
18	beneﬁts	NNS	O	beneﬁts	prep_on	12	SENT_422	[p24l1062t659r1349b723],
19	associated	VBN	O	associate	partmod	16	SENT_422	[p24l1391t659r1768b725],
20	with	IN	O	with	_	0	SENT_422	[p24l1805t659r1970b723],
21	low	JJ	O	low	amod	22	SENT_422	[p24l2010t659r2143b723],
22	dose	NN	O	dose	prep_with	19	SENT_422	[p24l11t764r192b830],
23	.	.	O	.	_	0	SENT_422	[p24l11t764r192b830],

1	Finally	RB	O	finally	advmod	5	SENT_423	[p24l100t870r368b957],
2	,	,	O	,	_	0	SENT_423	[p24l100t870r368b957],
3	our	PRP$	O	we	poss	4	SENT_423	[p24l424t893r552b934],
4	study	NN	O	study	nsubj	5	SENT_423	[p24l605t870r808b957],
5	provides	VBZ	O	provide	_	0	SENT_423	[p24l859t870r1170b957],
6	proof	NN	O	proof	dobj	5	SENT_423	[p24l1224t870r1440b957],
7	of	IN	O	of	_	0	SENT_423	[p24l1482t870r1566b934],
8	principle	NN	O	principle	prep_of	6	SENT_423	[p24l1607t870r1935b957],
9	that	WDT	O	that	dobj	13	SENT_423	[p24l1990t870r2140b934],
10	genetic	JJ	O	genetic	amod	11	SENT_423	[p24l11t978r271b1062],
11	determinants	NNS	O	determinant	nsubj	13	SENT_423	[p24l304t975r797b1041],
12	can	MD	O	can	aux	13	SENT_423	[p24l832t999r957b1039],
13	inﬂuence	VB	O	inﬂuence	rcmod	6	SENT_423	[p24l989t975r1327b1039],
14	an	DT	O	a	det	15	SENT_423	[p24l1361t999r1448b1039],
15	indiVidual	JJ	O	individual	poss	18	SENT_423	[p24l1480t975r1909b1041],
16	’s	POS	O	’s	_	0	SENT_423	[p24l1480t975r1909b1041],
17	pharmacokinetic	JJ	O	pharmacokinetic	amod	18	SENT_423	[p24l1944t975r2138b1062, p24l11t1080r464b1144],
18	response	NN	O	response	dobj	13	SENT_423	[p24l490t1103r810b1167],
19	to	TO	O	to	_	0	SENT_423	[p24l837t1099r909b1144],
20	celecoxib	NN	O	celecoxib	prep_to	13	SENT_423	[p24l937t1080r1268b1144],
21	with	IN	O	with	_	0	SENT_423	[p24l1294t1080r1459b1144],
22	a	DT	O	a	det	23	SENT_423	[p24l1485t1104r1524b1144],
23	signiﬁcant	NN	O	signiﬁcant	prep_with	13	SENT_423	[p24l1548t1080r1953b1167],
24	,	,	O	,	_	0	SENT_423	[p24l1548t1080r1953b1167],
25	clinically	RB	O	clinically	advmod	26	SENT_423	[p24l1980t1080r2138b1144, p24l10t1186r202b1273],
26	apparent	JJ	O	apparent	amod	27	SENT_423	[p24l224t1205r554b1273],
27	impact	NN	O	impact	appos	23	SENT_423	[p24l578t1189r835b1273],
28	on	IN	O	on	_	0	SENT_423	[p24l859t1210r953b1250],
29	outcome	NN	O	outcome	prep_on	27	SENT_423	[p24l979t1191r1384b1250],
30	.	.	O	.	_	0	SENT_423	[p24l979t1191r1384b1250],

1	“	NN	O	“	nsubj	37	SENT_424	[p24l979t1191r1384b1250],
2	Because	IN	O	because	mark	6	SENT_424	[p24l1413t1192r1702b1250],
3	celecoxib	NN	O	celecoxib	nsubjpass	6	SENT_424	[p24l1728t1186r2058b1250],
4	is	VBZ	O	be	auxpass	6	SENT_424	[p24l2085t1189r2138b1250],
5	widely	RB	O	widely	advmod	6	SENT_424	[p24l8t1291r246b1378],
6	used	VBN	O	use	dep	1	SENT_424	[p24l282t1291r452b1357],
7	for	IN	O	for	_	0	SENT_424	[p24l490t1291r597b1355],
8	other	JJ	O	other	amod	9	SENT_424	[p24l635t1291r832b1355],
9	indications	NNS	O	indication	prep_for	6	SENT_424	[p24l869t1291r1302b1370],
10	,	,	O	,	_	0	SENT_424	[p24l869t1291r1302b1370],
11	such	JJ	O	such	_	0	SENT_424	[p24l1343t1291r1512b1355],
12	as	IN	O	as	_	0	SENT_424	[p24l1551t1315r1621b1355],
13	treatment	NN	O	treatment	prep_such_as	9	SENT_424	[p24l1662t1310r2028b1355],
14	of	IN	O	of	_	0	SENT_424	[p24l2067t1291r2152b1355],
15	arthritis	NN	O	arthritis	prep_of	13	SENT_424	[p24l11t1396r395b1475],
16	,44	CD	NUMBER	,44	num	15	SENT_424	[p24l11t1396r395b1475],
17	determining	VBG	O	determine	partmod	15	SENT_424	[p24l438t1396r895b1483],
18	the	DT	O	the	det	19	SENT_424	[p24l936t1396r1051b1460],
19	inﬂuence	NN	O	inﬂuence	dobj	17	SENT_424	[p24l1093t1396r1431b1460],
20	of	IN	O	of	_	0	SENT_424	[p24l1474t1396r1558b1460],
21	CYPZC9	NN	O	cypzc9	nn	22	SENT_424	[p24l1590t1402r1892b1461],
22	genotype	NN	O	genotype	prep_of	19	SENT_424	[p24l1937t1420r2138b1483, p24l11t1521r164b1589],
23	on	IN	O	on	_	0	SENT_424	[p24l191t1526r285b1566],
24	responsiveness	NN	O	responsiveness	prep_on	22	SENT_424	[p24l312t1505r853b1589],
25	to	TO	O	to	_	0	SENT_424	[p24l881t1521r953b1566],
26	therapy	NN	O	therapy	prep_to	24	SENT_424	[p24l982t1502r1263b1589],
27	as	RB	O	as	_	0	SENT_424	[p24l1287t1526r1356b1566],
28	well	RB	O	well	_	0	SENT_424	[p24l1381t1502r1528b1566],
29	as	IN	O	as	_	0	SENT_424	[p24l1554t1526r1623b1566],
30	susceptibility	NN	O	susceptibility	conj_and	19	SENT_424	[p24l1651t1502r2143b1589],
31	to	TO	O	to	_	0	SENT_424	[p24l11t1652r83b1697],
32	toxicity	NN	O	toxicity	prep_to	30	SENT_424	[p24l113t1636r389b1720],
33	within	IN	O	within	_	0	SENT_424	[p24l412t1633r653b1697],
34	other	JJ	O	other	amod	36	SENT_424	[p24l681t1633r879b1697],
35	patient	NN	O	patient	nn	36	SENT_424	[p24l904t1636r1168b1720],
36	populations	NNS	O	population	prep_within	17	SENT_424	[p24l1194t1633r1641b1720],
37	remains	VBZ	O	remain	_	0	SENT_424	[p24l1671t1636r1962b1697],
38	critically	RB	O	critically	advmod	37	SENT_424	[p24l1992t1636r2138b1697, p24l10t1766r201b1853],

1	important	JJ	O	important	_	0	SENT_425	[p24l232t1769r630b1853],
2	.	.	O	.	_	0	SENT_425	[p24l232t1769r630b1853],

1	In	IN	O	in	_	0	SENT_426	[p24l98t1902r176b1960],
2	summary	NN	O	summary	prep_in	6	SENT_426	[p24l220t1919r584b1983],
3	,	,	O	,	_	0	SENT_426	[p24l220t1919r584b1983],
4	this	DT	O	this	det	5	SENT_426	[p24l630t1896r764b1960],
5	study	NN	O	study	nsubj	6	SENT_426	[p24l810t1896r1014b1983],
6	observed	VBD	O	observe	_	0	SENT_426	[p24l1055t1896r1379b1962],
7	a	DT	O	a	det	9	SENT_426	[p24l1422t1920r1461b1960],
8	pharmacogenetic	JJ	O	pharmacogenetic	amod	9	SENT_426	[p24l1502t1896r2140b1983],
9	association	NN	O	association	dobj	6	SENT_426	[p24l11t2004r423b2065],
10	between	IN	O	between	_	0	SENT_426	[p24l446t2001r748b2065],
11	CYP2C9	NN	O	cyp2c9	prep_between	9	SENT_426	[p24l775t2007r1169b2066],
12	*	CD	NUMBER	*	number	13	SENT_426	[p24l775t2007r1169b2066],
13	3	CD	NUMBER	3	num	15	SENT_426	[p24l775t2007r1169b2066],
14	Variant	JJ	O	variant	amod	15	SENT_426	[p24l1195t2004r1457b2065],
15	genotype	NN	O	genotype	dep	11	SENT_426	[p24l1481t2020r1816b2088],
16	and	CC	O	and	_	0	SENT_426	[p24l1842t2001r1980b2067],
17	risk	NN	O	risk	prep_between	9	SENT_426	[p24l2005t2001r2140b2065],
18	of	IN	O	of	_	0	SENT_426	[p24l11t2107r96b2171],
19	adenoma	NN	O	adenoma	prep_of	17	SENT_426	[p24l112t2107r454b2173],
20	according	VBG	O	accord	_	0	SENT_426	[p24l480t2107r844b2194],
21	to	TO	O	to	prepc_according_to	6	SENT_426	[p24l871t2126r944b2171],
22	celecoxib	NN	O	celecoxib	nn	23	SENT_426	[p24l974t2107r1305b2171],
23	dosing	NN	O	dosing	pobj	6	SENT_426	[p24l1336t2107r1584b2194],
24	within	IN	O	within	_	0	SENT_426	[p24l1609t2107r1850b2171],
25	a	DT	O	a	det	26	SENT_426	[p24l1879t2131r1918b2171],
26	large	JJ	O	large	prep_within	23	SENT_426	[p24l1943t2107r2138b2194],
27	,	,	O	,	_	0	SENT_426	[p24l1943t2107r2138b2194],
28	randomized	VBN	O	randomize	partmod	23	SENT_426	[p24l11t2212r473b2291],
29	,	,	O	,	_	0	SENT_426	[p24l11t2212r473b2291],
30	placebo	NN	O	placebo	nn	31	SENT_426	[p24l502t2212r1197b2299],
31	—	NN	O	—	appos	23	SENT_426	[p24l502t2212r1197b2299],
32	controlled	VBN	O	control	partmod	31	SENT_426	[p24l502t2212r1197b2299],
33	trial	NN	O	trial	dobj	32	SENT_426	[p24l1223t2212r1389b2276],
34	.	.	O	.	_	0	SENT_426	[p24l1223t2212r1389b2276],

1	Although	IN	O	although	mark	11	SENT_427	[p24l1415t2212r1770b2299],
2	the	DT	O	the	det	3	SENT_427	[p24l1799t2212r1913b2276],
3	number	NN	O	number	nsubj	11	SENT_427	[p24l1940t2236r2138b2276, p24l9t2318r126b2382],
4	of	IN	O	of	_	0	SENT_427	[p24l182t2318r266b2382],
5	patients	NNS	O	patient	prep_of	3	SENT_427	[p24l310t2321r605b2405],
6	with	IN	O	with	_	0	SENT_427	[p24l661t2318r826b2382],
7	variant	JJ	O	variant	amod	8	SENT_427	[p24l879t2321r1141b2382],
8	genotypes	NNS	O	genotype	prep_with	5	SENT_427	[p24l1196t2337r1564b2405],
9	was	VBD	O	be	cop	11	SENT_427	[p24l1620t2342r1752b2382],
10	relatively	RB	O	relatively	advmod	11	SENT_427	[p24l1811t2318r2143b2405],
11	small	JJ	O	small	advcl	19	SENT_427	[p24l11t2423r225b2502],
12	,	,	O	,	_	0	SENT_427	[p24l11t2423r225b2502],
13	limiting	VBG	O	limit	xcomp	11	SENT_427	[p24l276t2423r576b2510],
14	the	DT	O	the	det	16	SENT_427	[p24l625t2423r740b2487],
15	statistical	JJ	O	statistical	amod	16	SENT_427	[p24l792t2423r1144b2487],
16	power	NN	O	power	dobj	13	SENT_427	[p24l1194t2446r1437b2510],
17	,	,	O	,	_	0	SENT_427	[p24l1194t2446r1437b2510],
18	there	EX	O	there	expl	19	SENT_427	[p24l1490t2423r1675b2487],
19	was	VBD	O	be	_	0	SENT_427	[p24l1724t2447r1857b2487],
20	also	RB	O	also	advmod	19	SENT_427	[p24l1909t2423r2051b2487],
21	a	DT	O	a	det	23	SENT_427	[p24l2104t2447r2143b2487],
22	potential	JJ	O	potential	amod	23	SENT_427	[p24l10t2528r346b2615],
23	relationship	NN	O	relationship	dep	19	SENT_427	[p24l402t2528r846b2615],
24	between	IN	O	between	_	0	SENT_427	[p24l903t2528r1204b2592],
25	CYPZC9	NN	O	cypzc9	nn	27	SENT_427	[p24l1262t2534r1564b2593],
26	variant	JJ	O	variant	amod	27	SENT_427	[p24l1620t2531r1882b2592],
27	genotypes	NNS	O	genotype	prep_between	23	SENT_427	[p24l1937t2552r2138b2615, p24l11t2652r197b2720],
28	and	CC	O	and	_	0	SENT_427	[p24l238t2633r376b2699],
29	risk	NN	O	risk	conj_and	23	SENT_427	[p24l415t2633r551b2697],
30	of	IN	O	of	_	0	SENT_427	[p24l590t2633r675b2697],
31	cardiovascular	JJ	O	cardiovascular	amod	34	SENT_427	[p24l702t2633r1235b2699],
32	and	CC	O	and	_	0	SENT_427	[p24l1273t2633r1411b2699],
33	thrombotic	JJ	O	thrombotic	amod	34	SENT_427	[p24l1450t2633r1873b2697],
34	events	NNS	O	event	prep_of	29	SENT_427	[p24l1913t2652r2138b2697],
35	according	VBG	O	accord	_	0	SENT_427	[p24l11t2739r374b2826],
36	to	TO	O	to	prepc_according_to	23	SENT_427	[p24l407t2758r479b2803],
37	celecoxib	NN	O	celecoxib	nn	38	SENT_427	[p24l515t2739r845b2803],
38	exposure	NN	O	exposure	pobj	23	SENT_427	[p24l881t2762r1224b2826],
39	.	.	O	.	_	0	SENT_427	[p24l881t2762r1224b2826],

1	These	DT	O	these	det	2	SENT_428	[p24l1258t2739r1474b2803],
2	data	NNS	O	datum	nsubj	3	SENT_428	[p24l1508t2739r1669b2805],
3	support	VBP	O	support	_	0	SENT_428	[p24l1699t2758r1992b2826],
4	the	DT	O	the	det	6	SENT_428	[p24l2025t2739r2139b2803],
5	potential	JJ	O	potential	amod	6	SENT_428	[p24l10t2872r346b2959],
6	importance	NN	O	importance	dobj	3	SENT_428	[p24l384t2875r809b2959],
7	of	IN	O	of	_	0	SENT_428	[p24l849t2872r934b2936],
8	genetic	JJ	O	genetic	amod	9	SENT_428	[p24l960t2875r1221b2959],
9	variability	NN	O	variability	prep_of	6	SENT_428	[p24l1257t2872r1631b2959],
10	in	IN	O	in	_	0	SENT_428	[p24l1666t2875r1738b2936],
11	determining	VBG	O	determine	prepc_in	3	SENT_428	[p24l1777t2872r2138b2938, p24l10t2980r128b3064],
12	susceptibility	NN	O	susceptibility	dobj	11	SENT_428	[p24l152t2977r644b3064],
13	to	TO	O	to	_	0	SENT_428	[p24l666t2996r738b3041],
14	the	DT	O	the	det	15	SENT_428	[p24l765t2977r880b3041],
15	beneﬁts	NNS	O	beneﬁts	prep_to	11	SENT_428	[p24l904t2977r1191b3041],
16	and	CC	O	and	_	0	SENT_428	[p24l1218t2977r1356b3043],
17	hazards	NNS	O	hazard	conj_and	15	SENT_428	[p24l1379t2977r1663b3043],
18	of	IN	O	of	_	0	SENT_428	[p24l1690t2977r1775b3041],
19	celecoxib	NN	O	celecoxib	prep_of	15	SENT_428	[p24l1788t2977r2137b3041],
20	.	.	O	.	_	0	SENT_428	[p24l1788t2977r2137b3041],

1	Further	JJ	O	further	amod	2	SENT_429	[p24l10t3082r294b3146],
2	research	NN	O	research	nsubjpass	4	SENT_429	[p24l323t3082r624b3146],
3	is	VBZ	O	be	auxpass	4	SENT_429	[p24l654t3085r708b3146],
4	needed	VBN	O	need	_	0	SENT_429	[p24l740t3082r1000b3148],
5	to	TO	O	to	aux	6	SENT_429	[p24l1030t3101r1102b3146],
6	examine	VB	O	examine	xcomp	4	SENT_429	[p24l1135t3085r1439b3146],
7	the	DT	O	the	det	9	SENT_429	[p24l1470t3082r1585b3146],
8	routine	JJ	O	routine	amod	9	SENT_429	[p24l1616t3085r1887b3146],
9	use	NN	O	use	dobj	6	SENT_429	[p24l1918t3107r2036b3146],
10	of	IN	O	of	_	0	SENT_429	[p24l2068t3082r2152b3146],
11	genetic	JJ	O	genetic	amod	12	SENT_429	[p24l10t3191r271b3275],
12	information	NN	O	information	prep_of	9	SENT_429	[p24l298t3188r752b3252],
13	in	IN	O	in	_	0	SENT_429	[p24l778t3191r850b3252],
14	tailoring	VBG	O	tailor	prepc_in	6	SENT_429	[p24l878t3188r1197b3275],
15	treatment	NN	O	treatment	dobj	14	SENT_429	[p24l1223t3207r1589b3252],
16	with	IN	O	with	_	0	SENT_429	[p24l1613t3188r1779b3252],
17	celecoxib	NN	O	celecoxib	prep_with	14	SENT_429	[p24l1807t3188r2137b3252],
18	across	IN	O	across	_	0	SENT_429	[p24l11t3344r233b3385],
19	a	DT	O	a	det	20	SENT_429	[p24l270t3345r309b3385],
20	range	NN	O	range	prep_across	14	SENT_429	[p24l343t3344r544b3408],
21	of	IN	O	of	_	0	SENT_429	[p24l580t3321r665b3385],
22	doses	NNS	O	dose	prep_of	20	SENT_429	[p24l688t3321r905b3400],
23	,	,	O	,	_	0	SENT_429	[p24l688t3321r905b3400],
24	indications	NNS	O	indication	prep_of	20	SENT_429	[p24l941t3321r1354b3387],
25	for	IN	O	for	_	0	SENT_429	[p24l1390t3321r1498b3385],
26	use	NN	O	use	prep_for	24	SENT_429	[p24l1531t3345r1669b3400],
27	,	,	O	,	_	0	SENT_429	[p24l1531t3345r1669b3400],
28	and	CC	O	and	_	0	SENT_429	[p24l1706t3321r1844b3387],
29	patient	NN	O	patient	nn	30	SENT_429	[p24l1877t3324r2141b3408],
30	populations	NNS	O	population	prep_of	20	SENT_429	[p24l10t3452r475b3539],
31	.	.	O	.	_	0	SENT_429	[p24l10t3452r475b3539],

1	Supplementary	NNP	O	Supplementary	nn	2	SENT_430	[p24l278t3642r979b3736],
2	Data	NNP	O	Data	_	0	SENT_430	[p24l1020t3644r1223b3716],

1	Note	VB	O	note	_	0	SENT_431	[p25l276t47r482b105],
2	:	:	O	:	_	0	SENT_431	[p25l276t47r482b105],
3	To	TO	O	to	aux	4	SENT_431	[p25l546t46r648b104],
4	access	VB	O	access	parataxis	1	SENT_431	[p25l713t65r939b105],
5	the	DT	O	the	det	7	SENT_431	[p25l1005t40r1123b104],
6	supplementary	JJ	O	supplementary	amod	7	SENT_431	[p25l1187t41r1762b127],
7	material	NN	O	material	dobj	4	SENT_431	[p25l1823t41r2140b105],
8	accompanying	VBG	O	accompany	partmod	7	SENT_431	[p25l11t171r568b255],
9	this	DT	O	this	det	10	SENT_431	[p25l611t169r752b233],
10	article	NN	O	article	dobj	8	SENT_431	[p25l797t169r1053b248],
11	,	,	O	,	_	0	SENT_431	[p25l797t169r1053b248],
12	Visit	NNP	O	Visit	dep	4	SENT_431	[p25l1095t171r1256b233],
13	the	DT	O	the	det	15	SENT_431	[p25l1300t169r1418b233],
14	online	JJ	O	online	amod	15	SENT_431	[p25l1463t169r1703b233],
15	Version	NNP	O	Version	dep	12	SENT_431	[p25l1743t171r2022b233],
16	of	IN	O	of	_	0	SENT_431	[p25l2066t169r2152b232],
17	Gastroenterology	NNP	O	Gastroenterology	prep_of	15	SENT_431	[p25l13t274r595b360],
18	at	IN	O	at	_	0	SENT_431	[p25l639t292r710b338],
19	www.gastrojourna1.org	NN	O	www.gastrojourna1.org	prep_at	15	SENT_431	[p25l750t274r1654b360],
20	,	,	O	,	_	0	SENT_431	[p25l750t274r1654b360],
21	and	CC	O	and	_	0	SENT_431	[p25l1700t273r1842b339],
22	at	IN	O	at	_	0	SENT_431	[p25l1884t292r1955b337],
23	cloi	NNS	O	clous	prep_at	15	SENT_431	[p25l1998t273r2136b339],
24	:	:	O	:	_	0	SENT_431	[p25l1998t273r2136b339],
25	10.1053	CD	NUMBER	10.1053	dep	12	SENT_431	[p25l18t378r1152b465],
26	/	:	O	/	punct	25	SENT_431	[p25l18t378r1152b465],
27	j.	NN	O	j.	nn	28	SENT_431	[p25l18t378r1152b465],
28	gastro	NN	O	gastro	dep	25	SENT_431	[p25l18t378r1152b465],
29	.2009.02.045	CD	NUMBER	.2009.02.045	dep	28	SENT_431	[p25l18t378r1152b465],
30	.	.	O	.	_	0	SENT_431	[p25l18t378r1152b465],

1	CELECOXIB	NNP	O	CELECOXIB	_	0	SENT_432	[p25l191t600r489b649],
2	,	,	O	,	_	0	SENT_432	[p25l191t600r489b649],
3	CYP2C9	NNP	O	CYP2C9	nn	8	SENT_432	[p25l514t600r718b641],
4	GENE	NNP	O	GENE	nn	8	SENT_432	[p25l742t600r880b641],
5	VARIANTS	NNP	O	VARIANTS	nn	8	SENT_432	[p25l902t600r1174b649],
6	,	,	O	,	_	0	SENT_432	[p25l902t600r1174b649],
7	AND	NNP	O	AND	appos	8	SENT_432	[p25l1197t600r1310b640],
8	ADENOMA	NNP	O	ADENOMA	appos	1	SENT_432	[p25l1332t600r1600b641],
9	2135	CD	DATE	2135	num	8	SENT_432	[p25l1662t599r1799b641],

1	References	NNS	O	reference	_	0	SENT_433	[p25l232t784r588b834],

1	.	.	O	.	_	0	SENT_434	[p25l74t928r82b935],

1	Use	NN	O	use	_	0	SENT_435	[p25l121t894r216b936],
2	of	IN	O	of	_	0	SENT_435	[p25l237t893r287b936],
3	colorectal	JJ	O	colorectal	amod	5	SENT_435	[p25l304t894r551b936],
4	cancer	NN	O	cancer	nn	5	SENT_435	[p25l574t904r746b936],
5	tests	NNS	O	test	prep_of	1	SENT_435	[p25l762t894r1121b936],
6	.	.	O	.	_	0	SENT_435	[p25l762t894r1121b936],

1	—	NN	O	—	_	0	SENT_436	[p25l762t894r1121b936],
2	.	.	O	.	_	0	SENT_436	[p25l762t894r1121b936],

1	United	NNP	LOCATION	United	nn	2	SENT_437	[p25l762t894r1121b936],
2	States	NNPS	LOCATION	States	_	0	SENT_437	[p25l1143t893r1325b943],
3	,	,	O	,	_	0	SENT_437	[p25l1143t893r1325b943],
4	2002	CD	DATE	2002	appos	2	SENT_437	[p25l1350t893r1504b943],
5	,	,	DATE	,	_	0	SENT_437	[p25l1350t893r1504b943],
6	2004	CD	DATE	2004	num	4	SENT_437	[p25l1528t893r1682b943],
7	,	,	DATE	,	_	0	SENT_437	[p25l1528t893r1682b943],
8	and	CC	DATE	and	_	0	SENT_437	[p25l1706t894r1797b936],
9	2006	CD	DATE	2006	appos	2	SENT_437	[p25l120t968r273b1011],
10	.	.	O	.	_	0	SENT_437	[p25l120t968r273b1011],

1	MMWR	NN	O	mmwr	nn	2	SENT_438	[p25l303t969r480b1010],
2	Morb	NN	O	morb	_	0	SENT_438	[p25l507t969r633b1011],
3	Mortal	JJ	O	mortal	amod	5	SENT_438	[p25l660t969r817b1011],
4	Wkly	NNP	O	Wkly	nn	5	SENT_438	[p25l842t969r961b1021],
5	Rep	NNP	O	Rep	dep	2	SENT_438	[p25l985t969r1081b1020],
6	2008	CD	DATE	2008	dep	2	SENT_438	[p25l1105t968r1612b1018],
7	;	:	O	;	_	0	SENT_438	[p25l1105t968r1612b1018],
8	57:253	CD	NUMBER	57:253	num	9	SENT_438	[p25l1105t968r1612b1018],
9	-258	CD	NUMBER	-258	dep	2	SENT_438	[p25l1105t968r1612b1018],
10	.	.	O	.	_	0	SENT_438	[p25l1105t968r1612b1018],

1	.	.	O	.	_	0	SENT_439	[p25l74t1079r82b1086],

1	Bertagnolli	NNP	PERSON	Bertagnolli	nn	2	SENT_440	[p25l121t1045r390b1098],
2	MM	NN	O	mm	_	0	SENT_440	[p25l427t1045r534b1094],
3	,	,	O	,	_	0	SENT_440	[p25l427t1045r534b1094],
4	Eagle	NNP	ORGANIZATION	Eagle	nn	5	SENT_440	[p25l571t1045r706b1098],
5	CJ	NNP	O	CJ	appos	2	SENT_440	[p25l738t1044r810b1094],
6	,	,	O	,	_	0	SENT_440	[p25l738t1044r810b1094],
7	Zauber	NNP	ORGANIZATION	Zauber	nn	8	SENT_440	[p25l843t1045r1024b1087],
8	AG	NNP	ORGANIZATION	AG	appos	2	SENT_440	[p25l1052t1044r1137b1094],
9	,	,	O	,	_	0	SENT_440	[p25l1052t1044r1137b1094],
10	et	FW	O	et	nn	11	SENT_440	[p25l1172t1047r1221b1087],
11	al.	FW	O	al.	appos	2	SENT_440	[p25l1252t1045r1309b1087],
12	.	.	O	.	_	0	SENT_440	[p25l1252t1045r1309b1087],

1	Celecoxib	NNP	O	Celecoxib	_	0	SENT_441	[p25l1344t1044r1589b1087],
2	for	IN	O	for	_	0	SENT_441	[p25l1619t1044r1689b1087],
3	the	DT	O	the	det	4	SENT_441	[p25l1716t1045r1798b1087],
4	prevention	NN	O	prevention	prep_for	1	SENT_441	[p25l121t1120r386b1172],
5	of	IN	O	of	_	0	SENT_441	[p25l408t1120r458b1163],
6	sporadic	JJ	O	sporadic	amod	8	SENT_441	[p25l474t1120r693b1172],
7	colorectal	JJ	O	colorectal	amod	8	SENT_441	[p25l712t1120r959b1163],
8	adenomas	NNS	O	adenoma	prep_of	1	SENT_441	[p25l983t1120r1267b1163],
9	.	.	O	.	_	0	SENT_441	[p25l983t1120r1267b1163],

1	N	NN	O	n	nn	3	SENT_442	[p25l1292t1120r1323b1162],
2	Engl	NNP	O	Engl	nn	3	SENT_442	[p25l1348t1120r1449b1174],
3	J	NNP	O	J	nsubj	4	SENT_442	[p25l1470t1120r1489b1163],
4	Med	VBD	O	med	_	0	SENT_442	[p25l1513t1120r1619b1163],
5	2006	CD	DATE	2006	dobj	4	SENT_442	[p25l1642t1120r1795b1170],
6	;	:	O	;	_	0	SENT_442	[p25l1642t1120r1795b1170],
7	355:873	CD	NUMBER	355:873	num	8	SENT_442	[p25l119t1196r508b1239],
8	—	NN	O	—	dep	5	SENT_442	[p25l119t1196r508b1239],
9	884	CD	NUMBER	884	dep	8	SENT_442	[p25l119t1196r508b1239],
10	.	.	O	.	_	0	SENT_442	[p25l119t1196r508b1239],

1	.	.	O	.	_	0	SENT_443	[p25l74t1307r82b1315],

1	Arber	NNP	ORGANIZATION	Arber	nn	2	SENT_444	[p25l117t1273r254b1315],
2	N	NNP	ORGANIZATION	N	_	0	SENT_444	[p25l275t1273r323b1322],
3	,	,	O	,	_	0	SENT_444	[p25l275t1273r323b1322],
4	Eagle	NNP	O	Eagle	nn	5	SENT_444	[p25l350t1273r485b1326],
5	CJ	NNP	O	CJ	appos	2	SENT_444	[p25l508t1272r579b1322],
6	,	,	O	,	_	0	SENT_444	[p25l508t1272r579b1322],
7	Spicak	NNP	PERSON	Spicak	nn	8	SENT_444	[p25l604t1272r776b1325],
8	J	NNP	PERSON	J	appos	2	SENT_444	[p25l795t1273r831b1322],
9	,	,	O	,	_	0	SENT_444	[p25l795t1273r831b1322],
10	et	FW	O	et	nn	11	SENT_444	[p25l855t1275r904b1315],
11	al.	FW	O	al.	appos	2	SENT_444	[p25l925t1273r981b1315],
12	.	.	O	.	_	0	SENT_444	[p25l925t1273r981b1315],

1	Celecoxib	NNP	O	Celecoxib	_	0	SENT_445	[p25l1006t1272r1252b1315],
2	for	IN	O	for	_	0	SENT_445	[p25l1272t1272r1341b1315],
3	the	DT	O	the	det	4	SENT_445	[p25l1358t1273r1440b1315],
4	prevention	NN	O	prevention	prep_for	1	SENT_445	[p25l1464t1273r1729b1325],
5	of	IN	O	of	_	0	SENT_445	[p25l1752t1272r1802b1315],
6	colorectal	JJ	O	colorectal	amod	8	SENT_445	[p25l118t1349r366b1391],
7	adenomatous	JJ	O	adenomatous	amod	8	SENT_445	[p25l398t1349r751b1391],
8	polyps	NNS	O	polyp	prep_of	1	SENT_445	[p25l783t1349r959b1401],
9	.	.	O	.	_	0	SENT_445	[p25l783t1349r959b1401],

1	N	NN	O	n	nn	3	SENT_446	[p25l993t1349r1024b1391],
2	Engl	NNP	O	Engl	nn	3	SENT_446	[p25l1058t1349r1159b1402],
3	J	NNP	O	J	nsubj	4	SENT_446	[p25l1189t1349r1207b1391],
4	Med	VBD	O	med	_	0	SENT_446	[p25l1241t1349r1347b1391],
5	2006	CD	DATE	2006	dobj	4	SENT_446	[p25l1378t1348r1801b1398, p25l118t1425r237b1467],
6	;	:	O	;	_	0	SENT_446	[p25l1378t1348r1801b1398, p25l118t1425r237b1467],
7	355:885895	CD	NUMBER	355:885895	dep	5	SENT_446	[p25l1378t1348r1801b1398, p25l118t1425r237b1467],
8	.	.	O	.	_	0	SENT_446	[p25l1378t1348r1801b1398, p25l118t1425r237b1467],

1	.	.	O	.	_	0	SENT_447	[p25l74t1535r82b1543],

1	Solomon	NNP	O	Solomon	nn	2	SENT_448	[p25l119t1501r343b1544],
2	SD	NN	O	sd	_	0	SENT_448	[p25l368t1501r455b1551],
3	,	,	O	,	_	0	SENT_448	[p25l368t1501r455b1551],
4	McMurray	NNP	PERSON	McMurray	nn	5	SENT_448	[p25l484t1501r735b1554],
5	JJ	NN	PERSON	jj	appos	2	SENT_448	[p25l754t1501r814b1551],
6	,	,	O	,	_	0	SENT_448	[p25l754t1501r814b1551],
7	Pfeffer	NNP	PERSON	Pfeffer	nn	8	SENT_448	[p25l841t1501r1010b1544],
8	MA	NNP	PERSON	MA	appos	2	SENT_448	[p25l1033t1501r1124b1551],
9	,	,	O	,	_	0	SENT_448	[p25l1033t1501r1124b1551],
10	et	FW	O	et	nn	11	SENT_448	[p25l1150t1504r1199b1544],
11	al.	FW	O	al.	appos	2	SENT_448	[p25l1221t1501r1278b1544],
12	.	.	O	.	_	0	SENT_448	[p25l1221t1501r1278b1544],

1	Cardiovascular	NNP	O	Cardiovascular	nn	2	SENT_449	[p25l1304t1501r1687b1544],
2	risk	NN	O	risk	nsubj	3	SENT_449	[p25l1709t1501r1799b1544],
3	associated	VBN	O	associate	_	0	SENT_449	[p25l120t1577r399b1619],
4	with	IN	O	with	_	0	SENT_449	[p25l417t1577r518b1619],
5	celecoxib	NN	O	celecoxib	prep_with	3	SENT_449	[p25l538t1577r776b1619],
6	in	IN	O	in	_	0	SENT_449	[p25l796t1577r835b1619],
7	a	DT	O	a	det	9	SENT_449	[p25l856t1587r883b1619],
8	clinical	JJ	O	clinical	amod	9	SENT_449	[p25l901t1577r1074b1619],
9	trial	NN	O	trial	prep_in	5	SENT_449	[p25l1093t1577r1188b1619],
10	for	IN	O	for	_	0	SENT_449	[p25l1207t1577r1276b1619],
11	colorectal	JJ	O	colorectal	amod	13	SENT_449	[p25l1291t1577r1539b1619],
12	adenoma	NN	O	adenoma	nn	13	SENT_449	[p25l1561t1577r1798b1619],
13	prevention	NN	O	prevention	prep_for	9	SENT_449	[p25l121t1653r403b1705],
14	.	.	O	.	_	0	SENT_449	[p25l121t1653r403b1705],

1	N	NN	O	n	nn	3	SENT_450	[p25l432t1653r463b1695],
2	Engl	NNP	O	Engl	nn	3	SENT_450	[p25l492t1653r593b1706],
3	J	NNP	O	J	nsubj	4	SENT_450	[p25l618t1653r637b1695],
4	Med	VBD	O	med	_	0	SENT_450	[p25l666t1653r771b1695],
5	2005	CD	DATE	2005	dobj	4	SENT_450	[p25l798t1653r1413b1703],
6	;	:	O	;	_	0	SENT_450	[p25l798t1653r1413b1703],
7	352:1071	CD	DURATION	352:1071	num	8	SENT_450	[p25l798t1653r1413b1703],
8	-1080	CD	DURATION	-1080	dep	5	SENT_450	[p25l798t1653r1413b1703],
9	.	.	O	.	_	0	SENT_450	[p25l798t1653r1413b1703],

1	.	.	O	.	_	0	SENT_451	[p25l74t1764r82b1771],

1	Lee	NNP	PERSON	Lee	nn	2	SENT_452	[p25l121t1729r209b1772],
2	CR	NN	O	cr	_	0	SENT_452	[p25l231t1729r316b1779],
3	,	,	O	,	_	0	SENT_452	[p25l231t1729r316b1779],
4	Goldstein	NNP	PERSON	Goldstein	nn	5	SENT_452	[p25l341t1729r583b1772],
5	JA	NNP	O	JA	appos	2	SENT_452	[p25l605t1729r675b1779],
6	,	,	O	,	_	0	SENT_452	[p25l605t1729r675b1779],
7	Pieper	NNP	PERSON	Pieper	nn	8	SENT_452	[p25l700t1729r861b1781],
8	JA	NNP	O	JA	appos	5	SENT_452	[p25l879t1729r949b1772],
9	.	.	O	.	_	0	SENT_452	[p25l879t1729r949b1772],

1	Cytochrome	NN	O	cytochrome	nn	4	SENT_453	[p25l974t1729r1277b1782],
2	P450	NN	O	p450	nn	4	SENT_453	[p25l1300t1729r1436b1772],
3	2C9	NN	O	2c9	nn	4	SENT_453	[p25l1459t1729r1562b1772],
4	polymorphisms	NNS	O	polymorphism	_	0	SENT_453	[p25l1586t1729r1800b1782, p25l121t1805r320b1857],
5	:	:	O	:	_	0	SENT_453	[p25l1586t1729r1800b1782, p25l121t1805r320b1857],
6	a	DT	O	a	det	8	SENT_453	[p25l347t1815r374b1848],
7	comprehensive	JJ	O	comprehensive	amod	8	SENT_453	[p25l397t1805r788b1857],
8	review	NN	O	review	dep	4	SENT_453	[p25l813t1805r972b1848],
9	of	IN	O	of	_	0	SENT_453	[p25l994t1805r1044b1848],
10	the	DT	O	the	det	11	SENT_453	[p25l1060t1805r1142b1848],
11	in-vitro	FW	O	in-vitro	prep_of	8	SENT_453	[p25l1167t1805r1332b1848],
12	and	CC	O	and	_	0	SENT_453	[p25l1356t1805r1446b1848],
13	human	JJ	O	human	amod	14	SENT_453	[p25l1473t1805r1644b1848],
14	data	NNS	O	datum	prep_of	8	SENT_453	[p25l1668t1805r1795b1848],
15	.	.	O	.	_	0	SENT_453	[p25l1668t1805r1795b1848],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_454	[p25l120t1882r595b1935],
2	2002	CD	DATE	2002	num	1	SENT_454	[p25l620t1881r1127b1931],
3	;	:	O	;	_	0	SENT_454	[p25l620t1881r1127b1931],
4	12:251	CD	NUMBER	12:251	number	5	SENT_454	[p25l620t1881r1127b1931],
5	-263	CD	NUMBER	-263	dep	1	SENT_454	[p25l620t1881r1127b1931],
6	.	.	O	.	_	0	SENT_454	[p25l620t1881r1127b1931],

1	.	.	O	.	_	0	SENT_455	[p25l74t1992r82b1999],

1	Miners	NNS	O	miner	_	0	SENT_456	[p25l121t1957r293b1999],
2	Jo	NNP	PERSON	Jo	dep	1	SENT_456	[p25l311t1957r387b2007],
3	,	,	O	,	_	0	SENT_456	[p25l311t1957r387b2007],
4	Birkett	NNP	PERSON	Birkett	nn	5	SENT_456	[p25l412t1957r578b1999],
5	DJ	NNP	O	DJ	appos	2	SENT_456	[p25l598t1957r670b1999],
6	.	.	O	.	_	0	SENT_456	[p25l598t1957r670b1999],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_457	[p25l692t1957r996b2010],
2	P4502C9	NN	O	p4502c9	_	0	SENT_457	[p25l1017t1957r1277b1999],
3	:	:	O	:	_	0	SENT_457	[p25l1017t1957r1277b1999],
4	an	DT	O	a	det	5	SENT_457	[p25l1300t1967r1358b1999],
5	enzyme	NN	O	enzyme	dep	2	SENT_457	[p25l1379t1967r1571b2010],
6	of	IN	O	of	_	0	SENT_457	[p25l1591t1957r1640b1999],
7	major	JJ	O	major	amod	8	SENT_457	[p25l1658t1957r1800b2010],
8	importance	NN	O	importance	prep_of	5	SENT_457	[p25l121t2034r406b2085],
9	in	IN	O	in	_	0	SENT_457	[p25l448t2034r486b2076],
10	human	JJ	O	human	amod	12	SENT_457	[p25l528t2034r699b2076],
11	drug	NN	O	drug	nn	12	SENT_457	[p25l739t2034r851b2087],
12	metabolism	NN	O	metabolism	prep_in	8	SENT_457	[p25l889t2034r1205b2076],
13	.	.	O	.	_	0	SENT_457	[p25l889t2034r1205b2076],

1	Br	NN	O	br	nn	3	SENT_458	[p25l1249t2034r1301b2076],
2	J	NN	O	j	nn	3	SENT_458	[p25l1335t2034r1354b2076],
3	Clin	NN	O	clin	_	0	SENT_458	[p25l1395t2033r1487b2076],
4	Pharmacol	NN	O	pharmacol	dep	3	SENT_458	[p25l1529t2034r1795b2076],
5	1998	CD	DATE	1998	num	4	SENT_458	[p25l121t2108r627b2158],
6	;	:	O	;	_	0	SENT_458	[p25l121t2108r627b2158],
7	45:525	CD	NUMBER	45:525	num	8	SENT_458	[p25l121t2108r627b2158],
8	-538	CD	NUMBER	-538	dep	3	SENT_458	[p25l121t2108r627b2158],
9	.	.	O	.	_	0	SENT_458	[p25l121t2108r627b2158],

1	.	.	O	.	_	0	SENT_459	[p25l74t2218r82b2225],

1	Takanashi	NNP	PERSON	Takanashi	nn	2	SENT_460	[p25l117t2184r380b2226],
2	K	NNP	PERSON	K	_	0	SENT_460	[p25l407t2184r452b2233],
3	,	,	O	,	_	0	SENT_460	[p25l407t2184r452b2233],
4	Tainaka	NNP	PERSON	Tainaka	nn	5	SENT_460	[p25l475t2184r676b2226],
5	H	NNP	PERSON	H	appos	2	SENT_460	[p25l701t2184r749b2233],
6	,	,	O	,	_	0	SENT_460	[p25l701t2184r749b2233],
7	Kobayashi	NNP	LOCATION	Kobayashi	nn	8	SENT_460	[p25l777t2184r1037b2236],
8	K	NNP	LOCATION	K	appos	2	SENT_460	[p25l1064t2184r1109b2233],
9	,	,	O	,	_	0	SENT_460	[p25l1064t2184r1109b2233],
10	et	FW	O	et	nn	11	SENT_460	[p25l1134t2186r1184b2226],
11	al.	FW	O	al.	appos	2	SENT_460	[p25l1205t2184r1261b2226],
12	.	.	O	.	_	0	SENT_460	[p25l1205t2184r1261b2226],

1	CYP2C9	CD	NUMBER	cyp2c9	number	2	SENT_461	[p25l1286t2183r1495b2226],
2	|	CD	NUMBER	|	_	0	SENT_461	[p25l1520t2183r1683b2226],
3	le359	NN	O	le359	nn	6	SENT_461	[p25l1520t2183r1683b2226],
4	and	CC	O	and	_	0	SENT_461	[p25l1706t2184r1797b2226],
5	Leu359	NN	O	leu359	nn	6	SENT_461	[p25l121t2259r316b2301],
6	variants	NNS	O	variant	dep	2	SENT_461	[p25l346t2259r566b2301],
7	:	:	O	:	_	0	SENT_461	[p25l346t2259r566b2301],
8	enzyme	NN	O	enzyme	nn	10	SENT_461	[p25l601t2269r792b2311],
9	kinetic	JJ	O	kinetic	amod	10	SENT_461	[p25l826t2259r991b2301],
10	study	NN	O	study	dep	2	SENT_461	[p25l1023t2259r1161b2311],
11	with	IN	O	with	_	0	SENT_461	[p25l1188t2259r1289b2301],
12	seven	CD	NUMBER	seven	num	13	SENT_461	[p25l1323t2269r1471b2301],
13	substrates	NNS	O	substrate	prep_with	10	SENT_461	[p25l1504t2259r1795b2301],
14	.	.	O	.	_	0	SENT_461	[p25l1504t2259r1795b2301],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_462	[p25l120t2335r595b2388],
2	2000	CD	DATE	2000	num	1	SENT_462	[p25l620t2334r1091b2384],
3	;	:	O	;	_	0	SENT_462	[p25l620t2334r1091b2384],
4	10:95	CD	NUMBER	10:95	number	5	SENT_462	[p25l620t2334r1091b2384],
5	-104	CD	NUMBER	-104	dep	1	SENT_462	[p25l620t2334r1091b2384],
6	.	.	O	.	_	0	SENT_462	[p25l620t2334r1091b2384],

1	.	.	O	.	_	0	SENT_463	[p25l74t2445r82b2452],

1	Tang	NNP	PERSON	Tang	nn	2	SENT_464	[p25l117t2411r242b2464],
2	C	NNP	PERSON	C	_	0	SENT_464	[p25l274t2410r322b2460],
3	,	,	O	,	_	0	SENT_464	[p25l274t2410r322b2460],
4	Shou	NNP	O	Shou	nn	5	SENT_464	[p25l360t2410r487b2453],
5	M	NNP	O	M	appos	2	SENT_464	[p25l526t2411r584b2460],
6	,	,	O	,	_	0	SENT_464	[p25l526t2411r584b2460],
7	Rushmore	NNP	ORGANIZATION	Rushmore	nn	8	SENT_464	[p25l624t2411r882b2453],
8	TH	NN	O	th	appos	2	SENT_464	[p25l916t2411r998b2460],
9	,	,	O	,	_	0	SENT_464	[p25l916t2411r998b2460],
10	et	FW	O	et	nn	11	SENT_464	[p25l1035t2413r1084b2453],
11	al.	FW	O	al.	appos	2	SENT_464	[p25l1118t2411r1175b2453],
12	.	.	O	.	_	0	SENT_464	[p25l1118t2411r1175b2453],

1	In-vitro	FW	O	in-vitro	conj_and	1	SENT_465	[p25l1215t2411r1380b2453],
2	metabolism	NN	O	metabolism	dep	1	SENT_465	[p25l1417t2411r1716b2453],
3	of	IN	O	of	_	0	SENT_465	[p25l1752t2410r1802b2453],
4	celecoxib	NN	O	celecoxib	prep_of	2	SENT_465	[p25l118t2485r372b2535],
5	,	,	O	,	_	0	SENT_465	[p25l118t2485r372b2535],
6	a	DT	O	a	det	7	SENT_465	[p25l395t2495r422b2527],
7	cyc	NN	O	cyc	appos	4	SENT_465	[p25l442t2485r890b2538],
8	|	NN	O	|	nn	10	SENT_465	[p25l442t2485r890b2538],
9	ooxygenase	NN	O	ooxygenase	nn	10	SENT_465	[p25l442t2485r890b2538],
10	—	NN	O	—	dep	1	SENT_465	[p25l442t2485r890b2538],
11	2	CD	NUMBER	2	num	12	SENT_465	[p25l442t2485r890b2538],
12	inhibitor	NN	O	inhibitor	dep	10	SENT_465	[p25l913t2485r1133b2535],
13	,	,	O	,	_	0	SENT_465	[p25l913t2485r1133b2535],
14	by	IN	O	by	_	0	SENT_465	[p25l1157t2485r1211b2538],
15	allelic	JJ	O	allelic	amod	17	SENT_465	[p25l1229t2485r1375b2527],
16	variant	JJ	O	variant	amod	17	SENT_465	[p25l1393t2485r1569b2527],
17	forms	NNS	O	form	prep_by	1	SENT_465	[p25l1585t2485r1732b2527],
18	of	IN	O	of	_	0	SENT_465	[p25l1752t2485r1802b2527],
19	human	JJ	O	human	amod	20	SENT_465	[p25l121t2561r291b2603],
20	liver	NN	O	liver	prep_of	17	SENT_465	[p25l320t2561r423b2603],
21	microsomal	JJ	O	microsomal	amod	24	SENT_465	[p25l447t2561r742b2603],
22	cytochrome	NN	O	cytochrome	nn	24	SENT_465	[p25l769t2561r1064b2613],
23	P450	NN	O	p450	nn	24	SENT_465	[p25l1091t2561r1226b2603],
24	2C9	NN	O	2c9	dep	20	SENT_465	[p25l1253t2561r1372b2603],
25	:	:	O	:	_	0	SENT_465	[p25l1253t2561r1372b2603],
26	correlation	NN	O	correlation	dep	20	SENT_465	[p25l1399t2561r1670b2603],
27	with	IN	O	with	_	0	SENT_465	[p25l1695t2561r1796b2603],
28	CYP2C9	NN	O	cyp2c9	nn	29	SENT_465	[p25l119t2636r327b2679],
29	genotype	NN	O	genotype	prep_with	26	SENT_465	[p25l346t2639r579b2690],
30	and	CC	O	and	_	0	SENT_465	[p25l601t2637r691b2679],
31	in	IN	O	in	_	0	SENT_465	[p25l715t2637r868b2679],
32	—	FW	O	—	nn	34	SENT_465	[p25l715t2637r868b2679],
33	vivo	FW	O	vivo	nn	34	SENT_465	[p25l715t2637r868b2679],
34	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	1	SENT_465	[p25l890t2637r1360b2688],
35	.	.	O	.	_	0	SENT_465	[p25l890t2637r1360b2688],

1	Pharmacogenet	NNP	O	Pharmacogenet	nn	3	SENT_466	[p25l1385t2637r1800b2690],
2	—	CD	NUMBER	—	num	3	SENT_466	[p25l1385t2637r1800b2690],
3	ics	NNS	O	ic	_	0	SENT_466	[p25l121t2712r188b2753],
4	2001	CD	DATE	2001	dep	3	SENT_466	[p25l214t2711r721b2760],
5	;	:	O	;	_	0	SENT_466	[p25l214t2711r721b2760],
6	11:223	CD	NUMBER	11:223	num	7	SENT_466	[p25l214t2711r721b2760],
7	-235	CD	NUMBER	-235	dep	3	SENT_466	[p25l214t2711r721b2760],
8	.	.	O	.	_	0	SENT_466	[p25l214t2711r721b2760],

1	.	.	O	.	_	0	SENT_467	[p25l74t2821r82b2828],

1	Sandberg	NNP	PERSON	Sandberg	nn	2	SENT_468	[p25l119t2786r365b2839],
2	M	NNP	PERSON	M	_	0	SENT_468	[p25l388t2786r446b2836],
3	,	,	O	,	_	0	SENT_468	[p25l388t2786r446b2836],
4	Yasar	NNP	PERSON	Yasar	nn	5	SENT_468	[p25l470t2786r619b2828],
5	U	NNP	PERSON	U	appos	2	SENT_468	[p25l642t2786r689b2836],
6	,	,	O	,	_	0	SENT_468	[p25l642t2786r689b2836],
7	Stromberg	NNP	PERSON	Stromberg	nn	8	SENT_468	[p25l715t2786r983b2839],
8	P	NN	O	p	appos	2	SENT_468	[p25l1006t2786r1049b2836],
9	,	,	O	,	_	0	SENT_468	[p25l1006t2786r1049b2836],
10	et	FW	O	et	nn	11	SENT_468	[p25l1075t2789r1124b2828],
11	al.	FW	O	al.	appos	2	SENT_468	[p25l1146t2786r1203b2828],
12	.	.	O	.	_	0	SENT_468	[p25l1146t2786r1203b2828],

1	Oxidation	NN	O	oxidation	_	0	SENT_469	[p25l1229t2786r1466b2828],
2	of	IN	O	of	_	0	SENT_469	[p25l1491t2786r1541b2828],
3	celecoxib	NN	O	celecoxib	prep_of	1	SENT_469	[p25l1560t2786r1798b2828],
4	by	IN	O	by	_	0	SENT_469	[p25l120t2862r174b2915],
5	polymorphic	JJ	O	polymorphic	amod	8	SENT_469	[p25l207t2862r513b2915],
6	cytochrome	NN	O	cytochrome	nn	8	SENT_469	[p25l545t2862r841b2914],
7	P450	NN	O	p450	nn	8	SENT_469	[p25l875t2862r1010b2904],
8	2C9	NN	O	2c9	prep_by	1	SENT_469	[p25l1044t2862r1147b2904],
9	and	CC	O	and	_	0	SENT_469	[p25l1181t2862r1272b2904],
10	alcohol	NN	O	alcohol	nn	11	SENT_469	[p25l1307t2862r1486b2904],
11	dehydrogenase	NN	O	dehydrogenase	conj_and	8	SENT_469	[p25l1521t2862r1800b2915, p25l121t2947r258b2979],
12	.	.	O	.	_	0	SENT_469	[p25l1521t2862r1800b2915, p25l121t2947r258b2979],

1	BrJ	NN	O	brj	nn	2	SENT_470	[p25l287t2937r379b2979],
2	Clin	NN	O	clin	_	0	SENT_470	[p25l405t2936r497b2979],
3	Pharmacol	NNP	O	Pharmacol	dep	2	SENT_470	[p25l525t2937r791b2979],
4	2002	CD	DATE	2002	num	3	SENT_470	[p25l818t2936r1332b2986],
5	;	:	O	;	_	0	SENT_470	[p25l818t2936r1332b2986],
6	54:423	CD	NUMBER	54:423	num	7	SENT_470	[p25l818t2936r1332b2986],
7	-429	CD	NUMBER	-429	dep	2	SENT_470	[p25l818t2936r1332b2986],
8	.	.	O	.	_	0	SENT_470	[p25l818t2936r1332b2986],

1	Scordo	NNP	O	Scordo	nn	2	SENT_471	[p25l125t3012r302b3055],
2	MG	NN	O	mg	_	0	SENT_471	[p25l333t3012r430b3062],
3	,	,	O	,	_	0	SENT_471	[p25l333t3012r430b3062],
4	Pengo	NNP	ORGANIZATION	Pengo	nn	5	SENT_471	[p25l463t3013r617b3066],
5	V	NNP	O	V	appos	2	SENT_471	[p25l644t3013r691b3062],
6	,	,	O	,	_	0	SENT_471	[p25l644t3013r691b3062],
7	Spina	NNP	O	Spina	nn	8	SENT_471	[p25l722t3012r865b3064],
8	E	NNP	O	E	appos	2	SENT_471	[p25l897t3013r939b3062],
9	,	,	O	,	_	0	SENT_471	[p25l897t3013r939b3062],
10	et	FW	O	et	nn	11	SENT_471	[p25l969t3015r1019b3055],
11	al.	FW	O	al.	appos	2	SENT_471	[p25l1046t3013r1103b3055],
12	.	.	O	.	_	0	SENT_471	[p25l1046t3013r1103b3055],

1	Influence	NN	O	influence	_	0	SENT_472	[p25l1137t3012r1365b3055],
2	of	IN	O	of	_	0	SENT_472	[p25l1394t3012r1444b3055],
3	CYP2C9	NN	O	cyp2c9	prep_of	1	SENT_472	[p25l1468t3012r1677b3055],
4	and	CC	O	and	_	0	SENT_472	[p25l1706t3013r1797b3055],
5	CYP2C19	NN	O	cyp2c19	prep_of	1	SENT_472	[p25l125t3087r369b3129],
6	genetic	JJ	O	genetic	amod	7	SENT_472	[p25l390t3087r577b3140],
7	polymorphisms	NNS	O	polymorphism	dep	1	SENT_472	[p25l601t3087r989b3140],
8	on	IN	O	on	_	0	SENT_472	[p25l1011t3097r1070b3129],
9	warfarin	NN	O	warfarin	nn	11	SENT_472	[p25l1092t3087r1295b3129],
10	maintenance	NN	O	maintenance	nn	11	SENT_472	[p25l1320t3087r1652b3129],
11	dose	NN	O	dose	prep_on	7	SENT_472	[p25l1674t3087r1798b3129],
12	and	CC	O	and	_	0	SENT_472	[p25l126t3163r216b3205],
13	metabolic	JJ	O	metabolic	amod	14	SENT_472	[p25l253t3163r503b3205],
14	clearance	NN	O	clearance	prep_on	7	SENT_472	[p25l536t3163r800b3205],
15	.	.	O	.	_	0	SENT_472	[p25l536t3163r800b3205],

1	Clin	NNP	O	Clin	nn	3	SENT_473	[p25l837t3162r929b3205],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_473	[p25l966t3163r1233b3205],
3	Ther	NNP	O	Ther	_	0	SENT_473	[p25l1267t3163r1382b3205],
4	2002	CD	DATE	2002	num	3	SENT_473	[p25l1414t3162r1800b3212, p25l126t3237r243b3280],
5	;	:	O	;	_	0	SENT_473	[p25l1414t3162r1800b3212, p25l126t3237r243b3280],
6	72:702710	CD	NUMBER	72:702710	dep	3	SENT_473	[p25l1414t3162r1800b3212, p25l126t3237r243b3280],
7	.	.	O	.	_	0	SENT_473	[p25l1414t3162r1800b3212, p25l126t3237r243b3280],

1	Higashi	NNP	PERSON	Higashi	nn	2	SENT_474	[p25l127t3313r312b3366],
2	MK	NNP	O	MK	_	0	SENT_474	[p25l338t3313r433b3362],
3	,	,	O	,	_	0	SENT_474	[p25l338t3313r433b3362],
4	Veenstra	NNP	PERSON	Veenstra	nn	5	SENT_474	[p25l456t3313r686b3355],
5	DL	NNP	O	DL	appos	2	SENT_474	[p25l710t3313r788b3362],
6	,	,	O	,	_	0	SENT_474	[p25l710t3313r788b3362],
7	Kondo	NNP	PERSON	Kondo	nn	8	SENT_474	[p25l815t3313r975b3355],
8	LM	NNP	O	LM	appos	2	SENT_474	[p25l999t3313r1087b3362],
9	,	,	O	,	_	0	SENT_474	[p25l999t3313r1087b3362],
10	et	FW	O	et	nn	11	SENT_474	[p25l1111t3315r1161b3355],
11	al.	FW	O	al.	appos	2	SENT_474	[p25l1181t3313r1238b3355],
12	.	.	O	.	_	0	SENT_474	[p25l1181t3313r1238b3355],

1	Association	NNP	O	Association	nsubj	11	SENT_475	[p25l1261t3313r1558b3355],
2	between	IN	O	between	_	0	SENT_475	[p25l1583t3313r1796b3355],
3	CYP2C9	NNP	O	CYP2C9	nn	5	SENT_475	[p25l125t3388r333b3430],
4	genetic	JJ	O	genetic	amod	5	SENT_475	[p25l360t3388r547b3441],
5	variants	NNS	O	variant	prep_between	1	SENT_475	[p25l573t3388r777b3430],
6	and	CC	O	and	_	0	SENT_475	[p25l807t3388r897b3430],
7	anticoagu	JJ	O	anticoagu	amod	10	SENT_475	[p25l928t3388r1515b3441],
8	|	NN	O	|	nn	10	SENT_475	[p25l928t3388r1515b3441],
9	ation	NN	O	ation	nn	10	SENT_475	[p25l928t3388r1515b3441],
10	—	NN	O	—	prep_between	1	SENT_475	[p25l928t3388r1515b3441],
11	related	JJ	O	related	_	0	SENT_475	[p25l928t3388r1515b3441],
12	outcomes	NNS	O	outcome	dobj	11	SENT_475	[p25l1545t3391r1798b3430],
13	during	IN	O	during	_	0	SENT_475	[p25l125t3464r283b3517],
14	warfarin	NN	O	warfarin	nn	15	SENT_475	[p25l303t3463r507b3506],
15	therapy	NN	O	therapy	prep_during	12	SENT_475	[p25l530t3464r736b3516],
16	.	.	O	.	_	0	SENT_475	[p25l530t3464r736b3516],

1	JAMA	NNP	O	JAMA	_	0	SENT_476	[p25l762t3464r901b3506],
2	2002	CD	DATE	2002	num	1	SENT_476	[p25l924t3463r1546b3513],
3	;	:	O	;	_	0	SENT_476	[p25l924t3463r1546b3513],
4	287:1690	CD	DURATION	287:1690	number	5	SENT_476	[p25l924t3463r1546b3513],
5	-1698	CD	DURATION	-1698	dep	1	SENT_476	[p25l924t3463r1546b3513],
6	.	.	O	.	_	0	SENT_476	[p25l924t3463r1546b3513],

1	Kirchheiner	NNP	PERSON	Kirchheiner	nn	2	SENT_477	[p25l127t3539r418b3581],
2	J	NNP	PERSON	J	_	0	SENT_477	[p25l442t3539r478b3588],
3	,	,	O	,	_	0	SENT_477	[p25l442t3539r478b3588],
4	Stormer	NNP	PERSON	Stormer	nn	5	SENT_477	[p25l509t3538r715b3581],
5	E	NNP	O	E	appos	2	SENT_477	[p25l743t3539r785b3588],
6	,	,	O	,	_	0	SENT_477	[p25l743t3539r785b3588],
7	Meisel	NNP	PERSON	Meisel	nn	8	SENT_477	[p25l818t3539r983b3581],
8	C	NNP	O	C	appos	2	SENT_477	[p25l1013t3538r1061b3588],
9	,	,	O	,	_	0	SENT_477	[p25l1013t3538r1061b3588],
10	et	FW	O	et	nn	11	SENT_477	[p25l1092t3541r1141b3581],
11	al.	FW	O	al.	appos	2	SENT_477	[p25l1168t3539r1225b3581],
12	.	.	O	.	_	0	SENT_477	[p25l1168t3539r1225b3581],

1	Influence	NN	O	influence	_	0	SENT_478	[p25l1258t3538r1487b3581],
2	of	IN	O	of	_	0	SENT_478	[p25l1515t3538r1565b3581],
3	CYP2C9	NN	O	cyp2c9	nn	5	SENT_478	[p25l1589t3538r1798b3581],
4	genetic	JJ	O	genetic	amod	5	SENT_478	[p25l123t3613r310b3666],
5	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_478	[p25l332t3613r721b3666],
6	on	IN	O	on	_	0	SENT_478	[p25l742t3623r800b3655],
7	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	1	SENT_478	[p25l825t3613r1279b3665],
8	of	IN	O	of	_	0	SENT_478	[p25l1300t3613r1350b3655],
9	celecoxib	NN	O	celecoxib	prep_of	7	SENT_478	[p25l1366t3613r1604b3655],
10	and	CC	O	and	_	0	SENT_478	[p25l1625t3613r1716b3655],
11	its	PRP$	O	its	poss	12	SENT_478	[p25l1740t3613r1798b3655],
12	metabolites	NNS	O	metabolite	prep_of	7	SENT_478	[p25l126t3689r445b3731],
13	.	.	O	.	_	0	SENT_478	[p25l126t3689r445b3731],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_479	[p25l473t3689r947b3742],
2	2003	CD	DATE	2003	num	1	SENT_479	[p25l973t3689r1487b3739],
3	;	:	O	;	_	0	SENT_479	[p25l973t3689r1487b3739],
4	13:473	CD	NUMBER	13:473	number	5	SENT_479	[p25l973t3689r1487b3739],
5	-480	CD	NUMBER	-480	dep	1	SENT_479	[p25l973t3689r1487b3739],
6	.	.	O	.	_	0	SENT_479	[p25l973t3689r1487b3739],

1	E	NN	O	e	_	0	SENT_480	[p25l2036t1207r2078b1342],
2	’	CD	NUMBER	’	num	1	SENT_480	[p25l2036t1207r2078b1342],
3	_	NN	O	_	dep	1	SENT_480	[p25l1970t1341r2077b1390, p25l1969t1391r2077b1482],
4	III	CD	NUMBER	iii	num	3	SENT_480	[p25l1970t1341r2077b1390, p25l1969t1391r2077b1482],
5	.	.	O	.	_	0	SENT_480	[p25l1970t1341r2077b1390, p25l1969t1391r2077b1482],

1	‘	NN	O	‘	_	0	SENT_481	[p25l1970t1341r2077b1390, p25l1969t1391r2077b1482],
2	_	SYM	O	_	dep	5	SENT_481	[p25l1970t1341r2077b1390, p25l1969t1391r2077b1482],
3	5	CD	NUMBER	5	num	5	SENT_481	[p25l1970t1341r2077b1390, p25l1969t1391r2077b1482],
4	§	CD	NUMBER	§	num	5	SENT_481	[p25l1970t1341r2077b1390, p25l1969t1391r2077b1482],
5	z.	NN	O	z.	rcmod	1	SENT_481	[p25l1970t1464r2077b1533],
6	‘	CD	NUMBER	‘	number	7	SENT_481	[p25l1970t1464r2077b1533],
7	5	CD	NUMBER	5	dep	1	SENT_481	[p25l1970t1464r2077b1533],
8	52	CD	NUMBER	52	num	9	SENT_481	[p25l1970t1535r2077b1576],
9	UI	NN	O	uus	dep	7	SENT_481	[p25l1969t1578r2077b1607],
10	.	.	O	.	_	0	SENT_481	[p25l1969t1578r2077b1607],

1	u	NN	O	u	_	0	SENT_482	[p25l1969t1578r2077b1607],
2	E	NN	O	e	dep	1	SENT_482	[p25l2037t1609r2077b1673],
3	.	.	O	.	_	0	SENT_482	[p25l2037t1676r2077b1699],

1	—	NN	O	—	_	0	SENT_483	[p25l2037t1676r2077b1699],
2	.	.	O	.	_	0	SENT_483	[p25l2037t1676r2077b1699],

1	I	PRP	O	I	_	0	SENT_484	[p25l2037t1676r2077b1699],
2	<	JJR	O	<	dep	1	SENT_484	[p25l2037t1703r2077b1743],

1	13	CD	NUMBER	13	_	0	SENT_485	[p26l7t17r88b60],
2	.	.	O	.	_	0	SENT_485	[p26l7t17r88b60],

1	Kirchheiner	NNP	PERSON	Kirchheiner	nn	2	SENT_486	[p26l127t18r418b60],
2	J	NNP	PERSON	J	_	0	SENT_486	[p26l454t18r491b67],
3	,	,	O	,	_	0	SENT_486	[p26l454t18r491b67],
4	Brockmoller	NNP	O	Brockmoller	nn	7	SENT_486	[p26l537t18r841b60],
5	J.	NNP	O	J.	nn	7	SENT_486	[p26l878t18r914b60],
6	Clinical	JJ	O	clinical	amod	7	SENT_486	[p26l958t17r1139b60],
7	consequences	NNS	O	consequence	appos	2	SENT_486	[p26l1182t28r1556b69],
8	of	IN	O	of	_	0	SENT_486	[p26l1597t17r1647b60],
9	cytochrome	NN	O	cytochrome	nn	12	SENT_486	[p26l1683t20r1800b70, p26l124t93r314b135],
10	P450	NN	O	p450	nn	12	SENT_486	[p26l345t92r480b135],
11	2C9	NN	O	2c9	nn	12	SENT_486	[p26l510t92r613b135],
12	polymorphisms	NNS	O	polymorphism	prep_of	7	SENT_486	[p26l645t93r1049b145],
13	.	.	O	.	_	0	SENT_486	[p26l645t93r1049b145],

1	Clin	NNP	O	Clin	nn	3	SENT_487	[p26l1081t92r1173b135],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_487	[p26l1205t93r1471b135],
3	Ther	NNP	O	Ther	_	0	SENT_487	[p26l1501t93r1614b135],
4	2005	CD	DATE	2005	num	3	SENT_487	[p26l1642t92r1795b142],
5	;	:	O	;	_	0	SENT_487	[p26l1642t92r1795b142],
6	77:1	CD	NUMBER	77:1	number	7	SENT_487	[p26l126t167r363b209],
7	—	CD	NUMBER	—	dep	3	SENT_487	[p26l126t167r363b209],
8	16	CD	NUMBER	16	dep	7	SENT_487	[p26l126t167r363b209],
9	.	.	O	.	_	0	SENT_487	[p26l126t167r363b209],

1	14	CD	NUMBER	14	_	0	SENT_488	[p26l7t243r88b285],
2	.	.	O	.	_	0	SENT_488	[p26l7t243r88b285],

1	Crespi	NNP	ORGANIZATION	Crespi	nn	2	SENT_489	[p26l125t243r285b295],
2	CL	NN	ORGANIZATION	cl	_	0	SENT_489	[p26l309t243r387b293],
3	,	,	O	,	_	0	SENT_489	[p26l309t243r387b293],
4	Miller	NNP	PERSON	Miller	nn	5	SENT_489	[p26l414t243r554b285],
5	VP	NNP	O	VP	appos	2	SENT_489	[p26l572t243r651b285],
6	.	.	O	.	_	0	SENT_489	[p26l572t243r651b285],

1	The	DT	O	the	det	3	SENT_490	[p26l674t243r766b285],
2	R144C	JJ	O	r144c	amod	3	SENT_490	[p26l790t243r965b285],
3	change	NN	O	change	nsubj	10	SENT_490	[p26l987t243r1171b296],
4	in	IN	O	in	_	0	SENT_490	[p26l1195t243r1234b285],
5	the	DT	O	the	det	9	SENT_490	[p26l1256t243r1337b285],
6	CYP2C9	NN	O	cyp2c9	nn	9	SENT_490	[p26l1360t243r1639b285],
7	*	NN	O	*	nn	9	SENT_490	[p26l1360t243r1639b285],
8	2	CD	NUMBER	2	num	9	SENT_490	[p26l1360t243r1639b285],
9	allele	NN	O	allele	prep_in	3	SENT_490	[p26l1663t243r1798b285],
10	alters	VBZ	O	alter	_	0	SENT_490	[p26l126t318r269b360],
11	interaction	NN	O	interaction	dobj	10	SENT_490	[p26l311t318r580b360],
12	of	IN	O	of	_	0	SENT_490	[p26l621t317r671b360],
13	the	DT	O	the	det	15	SENT_490	[p26l705t318r786b360],
14	cytochrome	NN	O	cytochrome	nn	15	SENT_490	[p26l826t318r1121b370],
15	P450	NN	O	p450	prep_of	11	SENT_490	[p26l1163t317r1299b360],
16	with	IN	O	with	_	0	SENT_490	[p26l1337t318r1438b360],
17	NADPH	NN	O	nadph	prep_with	15	SENT_490	[p26l1482t318r1800b370, p26l124t394r314b436],
18	:	:	O	:	_	0	SENT_490	[p26l1482t318r1800b370, p26l124t394r314b436],
19	cytochrome	NN	O	cytochrome	nn	21	SENT_490	[p26l1482t318r1800b370, p26l124t394r314b436],
20	P450	NN	O	p450	nn	21	SENT_490	[p26l343t393r479b436],
21	oxidoreductase	NN	O	oxidoreductase	dep	11	SENT_490	[p26l506t394r915b436],
22	.	.	O	.	_	0	SENT_490	[p26l506t394r915b436],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_491	[p26l947t394r1421b447],
2	1997	CD	DATE	1997	num	1	SENT_491	[p26l1451t393r1800b443],
3	;	:	O	;	_	0	SENT_491	[p26l1451t393r1800b443],
4	7:203	CD	NUMBER	7:203	num	5	SENT_491	[p26l1451t393r1800b443],
5	—	NN	O	—	dep	1	SENT_491	[p26l1451t393r1800b443],
6	210	CD	NUMBER	210	dep	5	SENT_491	[p26l126t468r243b510],
7	.	.	O	.	_	0	SENT_491	[p26l126t468r243b510],

1	15	CD	NUMBER	15	_	0	SENT_492	[p26l7t544r88b586],
2	.	.	O	.	_	0	SENT_492	[p26l7t544r88b586],

1	Fries	NNS	O	fries	nn	2	SENT_493	[p26l127t544r246b586],
2	S	NN	O	s	_	0	SENT_493	[p26l267t543r314b593],
3	,	,	O	,	_	0	SENT_493	[p26l267t543r314b593],
4	Grosser	NN	O	grosser	nn	5	SENT_493	[p26l337t543r540b586],
5	T	NN	O	t	appos	2	SENT_493	[p26l556t544r598b593],
6	,	,	O	,	_	0	SENT_493	[p26l556t544r598b593],
7	Price	NN	O	price	nn	8	SENT_493	[p26l623t544r745b586],
8	TS	NN	O	t	appos	2	SENT_493	[p26l763t543r843b593],
9	,	,	O	,	_	0	SENT_493	[p26l763t543r843b593],
10	et	FW	O	et	nn	11	SENT_493	[p26l866t546r915b586],
11	al.	FW	O	al.	appos	2	SENT_493	[p26l934t544r991b586],
12	.	.	O	.	_	0	SENT_493	[p26l934t544r991b586],

1	Marked	JJ	O	marked	amod	3	SENT_494	[p26l1016t544r1203b586],
2	interindividual	JJ	O	interindividual	amod	3	SENT_494	[p26l1227t544r1581b586],
3	variability	NN	O	variability	_	0	SENT_494	[p26l1601t544r1800b586, p26l127t620r181b672],
4	in	IN	O	in	_	0	SENT_494	[p26l211t620r249b661],
5	the	DT	O	the	det	6	SENT_494	[p26l278t620r359b662],
6	response	NN	O	response	prep_in	3	SENT_494	[p26l390t630r627b671],
7	to	TO	O	to	_	0	SENT_494	[p26l654t622r704b662],
8	selective	JJ	O	selective	amod	9	SENT_494	[p26l734t620r960b662],
9	inhibitors	NNS	O	inhibitor	prep_to	6	SENT_494	[p26l991t620r1227b662],
10	of	IN	O	of	_	0	SENT_494	[p26l1256t619r1306b662],
11	cyclooxygenase-2	NN	O	cyclooxygenase-2	prep_of	3	SENT_494	[p26l1331t619r1795b673],
12	.	.	O	.	_	0	SENT_494	[p26l1331t619r1795b673],

1	Gastroenterology	NNP	O	Gastroenterology	_	0	SENT_495	[p26l125t695r566b749],
2	2006	CD	DATE	2006	num	1	SENT_495	[p26l589t695r1067b745],
3	;	:	O	;	_	0	SENT_495	[p26l589t695r1067b745],
4	130:55	CD	NUMBER	130:55	number	5	SENT_495	[p26l589t695r1067b745],
5	—	CD	NUMBER	—	dep	1	SENT_495	[p26l589t695r1067b745],
6	64	CD	NUMBER	64	dep	5	SENT_495	[p26l589t695r1067b745],
7	.	.	O	.	_	0	SENT_495	[p26l589t695r1067b745],

1	16	CD	NUMBER	16	_	0	SENT_496	[p26l7t771r88b813],
2	.	.	O	.	_	0	SENT_496	[p26l7t771r88b813],

1	Chan	NNP	PERSON	Chan	nn	2	SENT_497	[p26l125t771r253b813],
2	AT	NNP	O	AT	_	0	SENT_497	[p26l273t771r348b820],
3	,	,	O	,	_	0	SENT_497	[p26l273t771r348b820],
4	Tranah	NNP	O	Tranah	nn	5	SENT_497	[p26l369t771r543b813],
5	GJ	NNP	O	GJ	appos	2	SENT_497	[p26l565t771r639b820],
6	,	,	O	,	_	0	SENT_497	[p26l565t771r639b820],
7	Giovannucci	NNP	PERSON	Giovannucci	nn	8	SENT_497	[p26l661t771r968b813],
8	EL	NNP	O	EL	appos	2	SENT_497	[p26l992t771r1064b820],
9	,	,	O	,	_	0	SENT_497	[p26l992t771r1064b820],
10	et	FW	O	et	nn	11	SENT_497	[p26l1086t774r1135b813],
11	al.	FW	O	al.	appos	2	SENT_497	[p26l1154t771r1210b813],
12	.	.	O	.	_	0	SENT_497	[p26l1154t771r1210b813],

1	A	DT	O	a	det	3	SENT_498	[p26l1231t771r1264b813],
2	prospective	JJ	O	prospective	amod	3	SENT_498	[p26l1283t771r1577b823],
3	study	NN	O	study	_	0	SENT_498	[p26l1597t771r1735b823],
4	of	IN	O	of	_	0	SENT_498	[p26l1752t771r1802b813],
5	genetic	JJ	O	genetic	amod	6	SENT_498	[p26l123t847r310b900],
6	polymorphisms	NNS	O	polymorphism	prep_of	3	SENT_498	[p26l331t847r719b899],
7	in	IN	O	in	_	0	SENT_498	[p26l741t847r780b889],
8	the	DT	O	the	det	12	SENT_498	[p26l798t847r880b889],
9	cytochrome	NN	O	cytochrome	nn	12	SENT_498	[p26l899t847r1194b899],
10	P450	NN	O	p450	nn	12	SENT_498	[p26l1215t846r1351b889],
11	2C9	NN	O	2c9	nn	12	SENT_498	[p26l1371t846r1474b889],
12	enzyme	NN	O	enzyme	prep_in	3	SENT_498	[p26l1494t857r1686b899],
13	and	CC	O	and	_	0	SENT_498	[p26l1706t847r1797b889],
14	the	DT	O	the	det	15	SENT_498	[p26l123t922r204b964],
15	risk	NN	O	risk	conj_and	12	SENT_498	[p26l227t922r317b964],
16	of	IN	O	of	_	0	SENT_498	[p26l336t921r387b964],
17	distal	JJ	O	distal	amod	19	SENT_498	[p26l404t922r541b964],
18	colorectal	JJ	O	colorectal	amod	19	SENT_498	[p26l564t922r811b964],
19	adenoma	NN	O	adenoma	prep_of	3	SENT_498	[p26l836t922r1089b964],
20	.	.	O	.	_	0	SENT_498	[p26l836t922r1089b964],

1	Clin	NNP	O	Clin	nn	3	SENT_499	[p26l1113t921r1205b964],
2	Gastroenterol	NNP	O	Gastroenterol	nn	3	SENT_499	[p26l1228t921r1577b964],
3	Hepatol	NNP	O	Hepatol	_	0	SENT_499	[p26l1602t922r1796b973],
4	2004	CD	DATE	2004	num	3	SENT_499	[p26l126t996r604b1045],
5	;	:	O	;	_	0	SENT_499	[p26l126t996r604b1045],
6	2:704	CD	NUMBER	2:704	num	7	SENT_499	[p26l126t996r604b1045],
7	—	NN	O	—	dep	3	SENT_499	[p26l126t996r604b1045],
8	712	CD	NUMBER	712	dep	7	SENT_499	[p26l126t996r604b1045],
9	.	.	O	.	_	0	SENT_499	[p26l126t996r604b1045],

1	17	CD	NUMBER	17	_	0	SENT_500	[p26l7t1072r88b1114],
2	.	.	O	.	_	0	SENT_500	[p26l7t1072r88b1114],

1	Pilotto	NN	O	pilotto	nn	2	SENT_501	[p26l126t1072r293b1114],
2	A	NN	O	a	_	0	SENT_501	[p26l316t1072r363b1121],
3	,	,	O	,	_	0	SENT_501	[p26l316t1072r363b1121],
4	Seripa	NN	PERSON	seripa	nn	5	SENT_501	[p26l390t1072r559b1124],
5	D	NN	PERSON	d	appos	2	SENT_501	[p26l586t1072r635b1121],
6	,	,	O	,	_	0	SENT_501	[p26l586t1072r635b1121],
7	Franceschi	NNP	PERSON	Franceschi	nn	8	SENT_501	[p26l664t1072r946b1114],
8	M	NNP	O	M	appos	2	SENT_501	[p26l974t1072r1034b1121],
9	,	,	O	,	_	0	SENT_501	[p26l974t1072r1034b1121],
10	et	FW	O	et	nn	11	SENT_501	[p26l1060t1074r1111b1114],
11	al.	FW	O	al.	appos	2	SENT_501	[p26l1134t1072r1193b1114],
12	.	.	O	.	_	0	SENT_501	[p26l1134t1072r1193b1114],

1	Genetic	JJ	O	genetic	amod	2	SENT_502	[p26l1220t1072r1422b1114],
2	susceptibility	NN	O	susceptibility	_	0	SENT_502	[p26l1446t1072r1801b1124],
3	to	TO	O	to	_	0	SENT_502	[p26l123t1150r173b1190],
4	nonsteroidal	JJ	O	nonsteroidal	amod	8	SENT_502	[p26l206t1148r536b1190],
5	anti-inflammatory	JJ	O	anti-inflammatory	amod	8	SENT_502	[p26l571t1147r1033b1200],
6	drug-related	JJ	O	drug-related	amod	8	SENT_502	[p26l1062t1148r1365b1201],
7	gastroduodenal	JJ	O	gastroduodenal	amod	8	SENT_502	[p26l1396t1148r1796b1201],
8	bleeding	NN	O	bleeding	prep_to	2	SENT_502	[p26l126t1224r356b1277],
9	:	:	O	:	_	0	SENT_502	[p26l126t1224r356b1277],
10	role	NN	O	role	dep	2	SENT_502	[p26l385t1224r477b1266],
11	of	IN	O	of	_	0	SENT_502	[p26l502t1223r552b1266],
12	cytochrome	NN	O	cytochrome	nn	15	SENT_502	[p26l572t1224r867b1276],
13	P450	NN	O	p450	nn	15	SENT_502	[p26l893t1223r1029b1266],
14	2C9	NN	O	2c9	nn	15	SENT_502	[p26l1054t1223r1157b1266],
15	polymorphisms	NNS	O	polymorphism	prep_of	10	SENT_502	[p26l1184t1224r1588b1276],
16	.	.	O	.	_	0	SENT_502	[p26l1184t1224r1588b1276],

1	Gastroenterology	NNP	O	Gastroenterology	_	0	SENT_503	[p26l1616t1223r1800b1266, p26l125t1298r392b1351],
2	2007	CD	DATE	2007	num	1	SENT_503	[p26l415t1298r965b1348],
3	;	:	O	;	_	0	SENT_503	[p26l415t1298r965b1348],
4	133:465	CD	NUMBER	133:465	num	5	SENT_503	[p26l415t1298r965b1348],
5	—	NN	O	—	dep	1	SENT_503	[p26l415t1298r965b1348],
6	471	CD	NUMBER	471	dep	5	SENT_503	[p26l415t1298r965b1348],
7	.	.	O	.	_	0	SENT_503	[p26l415t1298r965b1348],

1	18	CD	NUMBER	18	_	0	SENT_504	[p26l7t1374r88b1416],
2	.	.	O	.	_	0	SENT_504	[p26l7t1374r88b1416],

1	Kalbfleisch	NNP	O	Kalbfleisch	nn	2	SENT_505	[p26l127t1374r404b1416],
2	JD	NNP	O	JD	_	0	SENT_505	[p26l422t1374r498b1423],
3	,	,	O	,	_	0	SENT_505	[p26l422t1374r498b1423],
4	Prentice	NNP	ORGANIZATION	Prentice	nn	5	SENT_505	[p26l520t1374r726b1416],
5	RL	NNP	ORGANIZATION	RL	appos	2	SENT_505	[p26l746t1374r822b1416],
6	.	.	O	.	_	0	SENT_505	[p26l746t1374r822b1416],

1	The	DT	O	the	det	3	SENT_506	[p26l840t1374r932b1416],
2	statistical	JJ	O	statistical	amod	3	SENT_506	[p26l950t1374r1200b1416],
3	analysis	NN	O	analysis	_	0	SENT_506	[p26l1221t1374r1429b1426],
4	of	IN	O	of	_	0	SENT_506	[p26l1447t1374r1497b1416],
5	failure	NN	O	failure	nn	7	SENT_506	[p26l1509t1374r1669b1416],
6	time	NN	O	time	nn	7	SENT_506	[p26l1685t1374r1797b1416],
7	data	NNS	O	datum	prep_of	3	SENT_506	[p26l125t1449r251b1491],
8	.	.	O	.	_	0	SENT_506	[p26l125t1449r251b1491],

1	New	NNP	LOCATION	New	nn	2	SENT_507	[p26l281t1449r387b1491],
2	York	NNP	LOCATION	York	_	0	SENT_507	[p26l408t1449r536b1491],
3	:	:	O	:	_	0	SENT_507	[p26l408t1449r536b1491],
4	J.	NNP	PERSON	J.	nn	5	SENT_507	[p26l562t1449r598b1491],
5	Wiley	NNP	PERSON	Wiley	dep	2	SENT_507	[p26l623t1449r771b1501],
6	,	,	O	,	_	0	SENT_507	[p26l623t1449r771b1501],
7	2002	CD	DATE	2002	appos	5	SENT_507	[p26l799t1448r953b1491],
8	.	.	O	.	_	0	SENT_507	[p26l799t1448r953b1491],

1	19	CD	NUMBER	19	_	0	SENT_508	[p26l7t1524r88b1567],
2	.	.	O	.	_	0	SENT_508	[p26l7t1524r88b1567],

1	Delong	NNP	PERSON	Delong	nn	2	SENT_509	[p26l127t1525r304b1578],
2	DM	NN	O	dm	_	0	SENT_509	[p26l326t1525r423b1574],
3	,	,	O	,	_	0	SENT_509	[p26l326t1525r423b1574],
4	Guirguis	NNP	PERSON	Guirguis	nn	5	SENT_509	[p26l448t1524r656b1578],
5	GH	NN	O	gh	appos	2	SENT_509	[p26l679t1524r769b1574],
6	,	,	O	,	_	0	SENT_509	[p26l679t1524r769b1574],
7	So	RB	O	so	advmod	8	SENT_509	[p26l794t1524r858b1567],
8	YC	NN	O	yc	appos	5	SENT_509	[p26l879t1524r962b1567],
9	.	.	O	.	_	0	SENT_509	[p26l879t1524r962b1567],

1	Efficient	JJ	O	efficient	amod	2	SENT_510	[p26l990t1524r1193b1567],
2	computation	NN	O	computation	_	0	SENT_510	[p26l1213t1525r1532b1576],
3	of	IN	O	of	_	0	SENT_510	[p26l1555t1524r1605b1567],
4	subset	NN	O	subset	nn	6	SENT_510	[p26l1624t1525r1800b1567],
5	selection	NN	O	selection	nn	6	SENT_510	[p26l125t1600r356b1642],
6	probabilities	NNS	O	probability	prep_of	2	SENT_510	[p26l396t1600r710b1652],
7	with	IN	O	with	_	0	SENT_510	[p26l745t1600r847b1642],
8	application	NN	O	application	prep_with	2	SENT_510	[p26l885t1600r1164b1652],
9	to	TO	O	to	_	0	SENT_510	[p26l1200t1603r1249b1642],
10	Cox	NN	ORGANIZATION	cox	nn	11	SENT_510	[p26l1286t1600r1379b1642],
11	regression	NN	O	regression	prep_to	2	SENT_510	[p26l1415t1600r1699b1653],
12	.	.	O	.	_	0	SENT_510	[p26l1415t1600r1699b1653],

1	Biometrika	FW	O	biometrika	_	0	SENT_511	[p26l1740t1600r1800b1642, p26l125t1675r349b1717],
2	1994	CD	DATE	1994	dep	1	SENT_511	[p26l376t1674r888b1724],
3	;	:	O	;	_	0	SENT_511	[p26l376t1674r888b1724],
4	81:607	CD	NUMBER	81:607	num	5	SENT_511	[p26l376t1674r888b1724],
5	-611	CD	NUMBER	-611	dep	1	SENT_511	[p26l376t1674r888b1724],
6	.	.	O	.	_	0	SENT_511	[p26l376t1674r888b1724],

1	20	CD	NUMBER	20	_	0	SENT_512	[p26l6t1749r88b1791],
2	.	.	O	.	_	0	SENT_512	[p26l6t1749r88b1791],

1	Dickmann	NNP	PERSON	Dickmann	nn	2	SENT_513	[p26l127t1750r377b1791],
2	LJ	NNP	PERSON	LJ	_	0	SENT_513	[p26l416t1750r479b1798],
3	,	,	O	,	_	0	SENT_513	[p26l416t1750r479b1798],
4	Rettie	NNP	PERSON	Rettie	nn	5	SENT_513	[p26l518t1750r666b1791],
5	AE	NNP	O	AE	appos	2	SENT_513	[p26l699t1750r779b1798],
6	,	,	O	,	_	0	SENT_513	[p26l699t1750r779b1798],
7	Kneller	NNP	PERSON	Kneller	nn	8	SENT_513	[p26l819t1750r996b1791],
8	MB	NNP	O	MB	appos	2	SENT_513	[p26l1031t1750r1126b1798],
9	,	,	O	,	_	0	SENT_513	[p26l1031t1750r1126b1798],
10	et	FW	O	et	nn	11	SENT_513	[p26l1163t1752r1212b1791],
11	al.	FW	O	al.	appos	2	SENT_513	[p26l1245t1750r1302b1791],
12	.	.	O	.	_	0	SENT_513	[p26l1245t1750r1302b1791],

1	Identification	NN	O	identification	nn	4	SENT_514	[p26l1342t1749r1669b1791],
2	and	CC	O	and	_	0	SENT_514	[p26l1706t1750r1796b1791],
3	functional	JJ	O	functional	conj_and	1	SENT_514	[p26l123t1825r374b1867],
4	characterization	NN	O	characterization	nsubj	15	SENT_514	[p26l396t1825r805b1867],
5	of	IN	O	of	_	0	SENT_514	[p26l827t1825r877b1867],
6	a	DT	O	a	det	11	SENT_514	[p26l894t1835r921b1867],
7	new	JJ	O	new	amod	11	SENT_514	[p26l942t1835r1042b1867],
8	CYP2C9	NN	O	cyp2c9	nn	11	SENT_514	[p26l1061t1825r1269b1867],
9	variant	JJ	O	variant	amod	11	SENT_514	[p26l1287t1825r1463b1867],
10	(	NN	O	(	nn	11	SENT_514	[p26l1482t1825r1797b1877],
11	CYP2C9	NN	O	cyp2c9	prep_of	4	SENT_514	[p26l1482t1825r1797b1877],
12	*	CD	NUMBER	*	number	13	SENT_514	[p26l1482t1825r1797b1877],
13	5	CD	NUMBER	5	num	11	SENT_514	[p26l1482t1825r1797b1877],
14	)	RB	O	)	advmod	15	SENT_514	[p26l1482t1825r1797b1877],
15	expressed	VBN	O	express	_	0	SENT_514	[p26l124t1901r388b1952],
16	among	IN	O	among	_	0	SENT_514	[p26l418t1907r592b1954],
17	African	JJ	MISC	african	amod	18	SENT_514	[p26l616t1900r790b1943],
18	Americans	NNPS	MISC	Americans	prep_among	15	SENT_514	[p26l818t1901r1103b1943],
19	.	.	O	.	_	0	SENT_514	[p26l818t1901r1103b1943],

1	Mol	NNP	ORGANIZATION	Mol	nn	2	SENT_515	[p26l1136t1901r1223b1943],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_515	[p26l1255t1901r1521b1943],
3	2001	CD	DATE	2001	num	2	SENT_515	[p26l1552t1900r1795b1950],
4	;	:	O	;	_	0	SENT_515	[p26l1552t1900r1795b1950],
5	60	CD	NUMBER	60	num	7	SENT_515	[p26l1552t1900r1795b1950],
6	:	:	O	:	_	0	SENT_515	[p26l1552t1900r1795b1950],
7	382-387	CD	NUMBER	382-387	dep	2	SENT_515	[p26l125t1975r381b2017],
8	.	.	O	.	_	0	SENT_515	[p26l125t1975r381b2017],

1	2136	CD	DATE	2136	_	0	SENT_516	[p26l370t2061r505b2103],
2	CHAN	NNP	MISC	CHAN	nn	4	SENT_516	[p26l568t2062r709b2103],
3	ET	NNP	MISC	ET	nn	4	SENT_516	[p26l737t2062r793b2102],
4	AL	NNP	MISC	AL	dep	1	SENT_516	[p26l813t2062r878b2102],

1	21	CD	NUMBER	21	_	0	SENT_517	[p26l371t2237r452b2279],
2	.	.	O	.	_	0	SENT_517	[p26l371t2237r452b2279],

1	Aithal	NNP	O	Aithal	nn	2	SENT_518	[p26l487t2238r627b2280],
2	GP	NNP	O	GP	_	0	SENT_518	[p26l659t2237r742b2287],
3	,	,	O	,	_	0	SENT_518	[p26l659t2237r742b2287],
4	Day	NNP	DURATION	Day	nn	5	SENT_518	[p26l776t2238r868b2290],
5	CP	NNP	O	CP	appos	2	SENT_518	[p26l895t2237r976b2287],
6	,	,	O	,	_	0	SENT_518	[p26l895t2237r976b2287],
7	Kesteven	NNP	O	Kesteven	nn	8	SENT_518	[p26l1010t2238r1243b2280],
8	PJ	NNP	O	PJ	appos	2	SENT_518	[p26l1275t2238r1341b2287],
9	,	,	O	,	_	0	SENT_518	[p26l1275t2238r1341b2287],
10	et	FW	O	et	nn	11	SENT_518	[p26l1373t2240r1422b2280],
11	al.	FW	O	al.	appos	2	SENT_518	[p26l1450t2238r1506b2280],
12	.	.	O	.	_	0	SENT_518	[p26l1450t2238r1506b2280],

1	Association	NNP	O	Association	_	0	SENT_519	[p26l1537t2238r1832b2280],
2	of	IN	O	of	_	0	SENT_519	[p26l1862t2237r1912b2280],
3	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_519	[p26l1939t2238r2151b2290, p26l491t2314r673b2365],
4	in	IN	O	in	_	0	SENT_519	[p26l712t2314r750b2355],
5	the	DT	O	the	det	8	SENT_519	[p26l787t2314r867b2356],
6	cytochrome	NN	O	cytochrome	nn	8	SENT_519	[p26l904t2314r1197b2366],
7	P450	NN	O	p450	nn	8	SENT_519	[p26l1235t2313r1370b2356],
8	CYP2C9	NN	O	cyp2c9	prep_in	1	SENT_519	[p26l1407t2313r1614b2356],
9	with	IN	O	with	_	0	SENT_519	[p26l1649t2314r1749b2356],
10	warfarin	NN	O	warfarin	nn	12	SENT_519	[p26l1786t2313r1988b2356],
11	dose	NN	O	dose	nn	12	SENT_519	[p26l2026t2314r2149b2356],
12	requirement	NN	O	requirement	prep_with	1	SENT_519	[p26l490t2389r799b2439],
13	and	CC	O	and	_	0	SENT_519	[p26l828t2389r918b2430],
14	risk	NN	O	risk	conj_and	12	SENT_519	[p26l952t2389r1041b2430],
15	of	IN	O	of	_	0	SENT_519	[p26l1070t2388r1119b2430],
16	bleeding	VBG	O	bleed	amod	17	SENT_519	[p26l1147t2389r1362b2441],
17	complications	NNS	O	complication	prep_of	1	SENT_519	[p26l1390t2389r1760b2439],
18	.	.	O	.	_	0	SENT_519	[p26l1390t2389r1760b2439],

1	Lancet	NNP	O	Lancet	_	0	SENT_520	[p26l1796t2389r1965b2430],
2	1999	CD	DATE	1999	num	1	SENT_520	[p26l1995t2388r2147b2437],
3	;	:	O	;	_	0	SENT_520	[p26l1995t2388r2147b2437],
4	353:717	CD	NUMBER	353:717	num	5	SENT_520	[p26l489t2464r868b2506],
5	—	NN	O	—	dep	1	SENT_520	[p26l489t2464r868b2506],
6	719	CD	NUMBER	719	dep	5	SENT_520	[p26l489t2464r868b2506],
7	.	.	O	.	_	0	SENT_520	[p26l489t2464r868b2506],

1	22	CD	NUMBER	22	_	0	SENT_521	[p26l371t2541r452b2582],
2	.	.	O	.	_	0	SENT_521	[p26l371t2541r452b2582],

1	Malhi	NNP	PERSON	Malhi	nn	2	SENT_522	[p26l491t2541r624b2583],
2	H	NNP	PERSON	H	_	0	SENT_522	[p26l647t2541r695b2590],
3	,	,	O	,	_	0	SENT_522	[p26l647t2541r695b2590],
4	Atac	NNP	O	Atac	nn	5	SENT_522	[p26l715t2541r825b2583],
5	B	NNP	O	B	appos	2	SENT_522	[p26l846t2541r891b2590],
6	,	,	O	,	_	0	SENT_522	[p26l846t2541r891b2590],
7	Daly	NNP	PERSON	Daly	nn	8	SENT_522	[p26l915t2541r1021b2593],
8	AK	NNP	O	AK	appos	2	SENT_522	[p26l1036t2541r1118b2590],
9	,	,	O	,	_	0	SENT_522	[p26l1036t2541r1118b2590],
10	et	FW	O	et	nn	11	SENT_522	[p26l1140t2544r1189b2583],
11	al.	FW	O	al.	appos	2	SENT_522	[p26l1207t2541r1263b2583],
12	.	.	O	.	_	0	SENT_522	[p26l1207t2541r1263b2583],

1	Warfarin	NNP	O	Warfarin	dep	12	SENT_523	[p26l1283t2541r1493b2583],
2	and	CC	O	and	_	0	SENT_523	[p26l1515t2541r1604b2583],
3	celecoxib	NN	O	celecoxib	nn	4	SENT_523	[p26l1624t2541r1860b2583],
4	interaction	NN	O	interaction	conj_and	1	SENT_523	[p26l1881t2541r2148b2583],
5	in	IN	O	in	_	0	SENT_523	[p26l491t2617r529b2659],
6	the	DT	O	the	det	7	SENT_523	[p26l552t2617r633b2659],
7	setting	NN	O	setting	prep_in	1	SENT_523	[p26l658t2617r833b2670],
8	of	IN	O	of	_	0	SENT_523	[p26l854t2617r904b2659],
9	cytochrome	NN	O	cytochrome	prep_of	7	SENT_523	[p26l923t2617r1216b2669],
10	P450	NN	O	p450	dep	12	SENT_523	[p26l1242t2617r1377b2659],
11	(	CD	NUMBER	(	num	10	SENT_523	[p26l1401t2617r1643b2669],
12	CYP2C9	NN	O	cyp2c9	dep	15	SENT_523	[p26l1401t2617r1643b2669],
13	)	CD	NUMBER	)	num	14	SENT_523	[p26l1401t2617r1643b2669],
14	polymorphism	NN	O	polymorphism	dep	12	SENT_523	[p26l1670t2617r2023b2669],
15	with	IN	O	with	_	0	SENT_523	[p26l2047t2617r2147b2659],
16	bleeding	VBG	O	bleed	pcomp	15	SENT_523	[p26l490t2693r705b2746],
17	complication	NN	O	complication	dobj	16	SENT_523	[p26l727t2693r1066b2745],
18	.	.	O	.	_	0	SENT_523	[p26l727t2693r1066b2745],

1	Postgrad	NNP	O	Postgrad	nn	3	SENT_524	[p26l1094t2693r1315b2746],
2	Med	NNP	O	Med	nn	3	SENT_524	[p26l1343t2694r1448b2735],
3	J	NNP	O	J	_	0	SENT_524	[p26l1472t2694r1491b2735],
4	2004	CD	DATE	2004	num	3	SENT_524	[p26l1518t2693r2021b2743],
5	;	:	O	;	_	0	SENT_524	[p26l1518t2693r2021b2743],
6	80:107	CD	NUMBER	80:107	number	7	SENT_524	[p26l1518t2693r2021b2743],
7	-109	CD	NUMBER	-109	dep	3	SENT_524	[p26l1518t2693r2021b2743],
8	.	.	O	.	_	0	SENT_524	[p26l1518t2693r2021b2743],

1	23	CD	NUMBER	23	_	0	SENT_525	[p26l371t2769r452b2812],
2	.	.	O	.	_	0	SENT_525	[p26l371t2769r452b2812],

1	Visser	NNP	PERSON	Visser	nn	2	SENT_526	[p26l487t2770r647b2812],
2	LE	NNP	PERSON	LE	_	0	SENT_526	[p26l669t2770r740b2819],
3	,	,	O	,	_	0	SENT_526	[p26l669t2770r740b2819],
4	van	NNP	PERSON	van	nn	6	SENT_526	[p26l763t2780r849b2812],
5	Schaik	NNP	PERSON	Schaik	nn	6	SENT_526	[p26l872t2769r1043b2812],
6	RH	NNP	O	RH	appos	2	SENT_526	[p26l1065t2770r1150b2819],
7	,	,	O	,	_	0	SENT_526	[p26l1065t2770r1150b2819],
8	van	NNP	PERSON	van	nn	10	SENT_526	[p26l1172t2780r1258b2812],
9	Vliet	NNP	PERSON	Vliet	nn	10	SENT_526	[p26l1280t2770r1392b2812],
10	M	NN	O	m	appos	2	SENT_526	[p26l1414t2770r1471b2819],
11	,	,	O	,	_	0	SENT_526	[p26l1414t2770r1471b2819],
12	et	FW	O	et	nn	13	SENT_526	[p26l1495t2773r1544b2812],
13	al.	FW	O	al.	appos	2	SENT_526	[p26l1565t2770r1621b2812],
14	.	.	O	.	_	0	SENT_526	[p26l1565t2770r1621b2812],

1	The	DT	O	the	det	2	SENT_527	[p26l1644t2770r1735b2812],
2	risk	NN	O	risk	_	0	SENT_527	[p26l1758t2770r1848b2812],
3	of	IN	O	of	_	0	SENT_527	[p26l1868t2769r1917b2812],
4	bleeding	VBG	O	bleed	amod	5	SENT_527	[p26l1936t2770r2151b2823],
5	complications	NNS	O	complication	prep_of	2	SENT_527	[p26l488t2846r857b2897],
6	in	IN	O	in	_	0	SENT_527	[p26l881t2846r921b2887],
7	patients	NNS	O	patient	prep_in	2	SENT_527	[p26l946t2846r1159b2897],
8	with	IN	O	with	_	0	SENT_527	[p26l1179t2846r1283b2888],
9	cytochrome	NN	O	cytochrome	nn	18	SENT_527	[p26l1306t2846r1610b2898],
10	P450	NN	O	p450	nn	18	SENT_527	[p26l1633t2846r1771b2888],
11	CYP2C9	NN	O	cyp2c9	nn	18	SENT_527	[p26l1793t2846r2079b2888],
12	*	NN	O	*	nn	18	SENT_527	[p26l1793t2846r2079b2888],
13	2	CD	NUMBER	2	number	17	SENT_527	[p26l1793t2846r2079b2888],
14	or	CC	O	or	_	0	SENT_527	[p26l2101t2856r2152b2888],
15	CYP2C9	CD	NUMBER	cyp2c9	conj_or	17	SENT_527	[p26l489t2922r776b2964],
16	*	CD	NUMBER	*	number	17	SENT_527	[p26l489t2922r776b2964],
17	3	CD	NUMBER	3	num	18	SENT_527	[p26l489t2922r776b2964],
18	alleles	NNS	O	allele	prep_with	2	SENT_527	[p26l828t2922r999b2964],
19	on	IN	O	on	_	0	SENT_527	[p26l1051t2932r1111b2964],
20	acenocoumarol	NN	O	acenocoumarol	prep_on	2	SENT_527	[p26l1165t2922r1567b2964],
21	or	CC	O	or	_	0	SENT_527	[p26l1621t2932r1670b2964],
22	phenprocoumon	NN	O	phenprocoumon	conj_or	20	SENT_527	[p26l1720t2922r2146b2974],
23	.	.	O	.	_	0	SENT_527	[p26l1720t2922r2146b2974],

1	Thromb	NNP	O	Thromb	nn	2	SENT_528	[p26l487t2999r678b3040],
2	Haemost	NNP	O	Haemost	_	0	SENT_528	[p26l705t2999r934b3040],
3	2004	CD	DATE	2004	num	2	SENT_528	[p26l957t2998r1396b3048],
4	;	:	O	;	_	0	SENT_528	[p26l957t2998r1396b3048],
5	92:61	CD	NUMBER	92:61	number	6	SENT_528	[p26l957t2998r1396b3048],
6	—	CD	NUMBER	—	dep	2	SENT_528	[p26l957t2998r1396b3048],
7	66	CD	NUMBER	66	dep	6	SENT_528	[p26l957t2998r1396b3048],
8	.	.	O	.	_	0	SENT_528	[p26l957t2998r1396b3048],

1	24	CD	NUMBER	24	_	0	SENT_529	[p26l371t3074r452b3116],
2	.	.	O	.	_	0	SENT_529	[p26l371t3074r452b3116],

1	Samowitz	NNP	O	Samowitz	nn	2	SENT_530	[p26l489t3074r733b3117],
2	WS	NNP	O	WS	_	0	SENT_530	[p26l761t3074r859b3124],
3	,	,	O	,	_	0	SENT_530	[p26l761t3074r859b3124],
4	Wolff	NNP	PERSON	Wolff	nn	5	SENT_530	[p26l892t3074r1024b3117],
5	RK	NNP	O	RK	appos	2	SENT_530	[p26l1053t3075r1136b3124],
6	,	,	O	,	_	0	SENT_530	[p26l1053t3075r1136b3124],
7	Curtin	NNP	PERSON	Curtin	nn	8	SENT_530	[p26l1170t3074r1317b3117],
8	K	NNP	PERSON	K	appos	2	SENT_530	[p26l1352t3075r1398b3124],
9	,	,	O	,	_	0	SENT_530	[p26l1352t3075r1398b3124],
10	et	FW	O	et	nn	11	SENT_530	[p26l1431t3077r1480b3117],
11	al.	FW	O	al.	appos	2	SENT_530	[p26l1511t3075r1567b3117],
12	.	.	O	.	_	0	SENT_530	[p26l1511t3075r1567b3117],

1	Interactions	NNS	O	interaction	_	0	SENT_531	[p26l1604t3075r1903b3117],
2	between	IN	O	between	_	0	SENT_531	[p26l1936t3075r2147b3117],
3	CYP2C9	NN	O	cyp2c9	nn	6	SENT_531	[p26l489t3151r695b3193],
4	and	CC	O	and	_	0	SENT_531	[p26l729t3151r818b3193],
5	UGT1A6	NN	O	ugt1a6	conj_and	3	SENT_531	[p26l854t3151r1058b3193],
6	polymorphisms	NNS	O	polymorphism	prep_between	1	SENT_531	[p26l1093t3151r1478b3203],
7	and	CC	O	and	_	0	SENT_531	[p26l1511t3151r1600b3193],
8	nonsteroidal	JJ	O	nonsteroidal	amod	10	SENT_531	[p26l1636t3151r1949b3193],
9	anti	JJ	O	anti	amod	10	SENT_531	[p26l1984t3151r2151b3193, p26l487t3227r773b3279],
10	—	NN	O	—	prep_between	1	SENT_531	[p26l1984t3151r2151b3193, p26l487t3227r773b3279],
11	inflammatory	JJ	O	inflammatory	amod	12	SENT_531	[p26l1984t3151r2151b3193, p26l487t3227r773b3279],
12	drugs	NNS	O	drug	dep	1	SENT_531	[p26l793t3227r932b3280],
13	in	IN	O	in	_	0	SENT_531	[p26l957t3227r996b3269],
14	colorectal	JJ	O	colorectal	amod	16	SENT_531	[p26l1020t3227r1265b3269],
15	cancer	NN	O	cancer	nn	16	SENT_531	[p26l1290t3237r1461b3269],
16	prevention	NN	O	prevention	prep_in	12	SENT_531	[p26l1483t3227r1763b3279],
17	.	.	O	.	_	0	SENT_531	[p26l1483t3227r1763b3279],

1	Clin	NNP	O	Clin	nn	3	SENT_532	[p26l1788t3227r1879b3269],
2	Gastroenterol	NNP	O	Gastroenterol	nn	3	SENT_532	[p26l1904t3227r2151b3269, p26l486t3304r598b3345],
3	Hepatol	NNP	O	Hepatol	_	0	SENT_532	[p26l627t3304r819b3355],
4	2006	CD	DATE	2006	num	3	SENT_532	[p26l847t3303r1321b3353],
5	;	:	O	;	_	0	SENT_532	[p26l847t3303r1321b3353],
6	4:894	CD	NUMBER	4:894	num	7	SENT_532	[p26l847t3303r1321b3353],
7	—	NN	O	—	dep	3	SENT_532	[p26l847t3303r1321b3353],
8	901	CD	NUMBER	901	dep	7	SENT_532	[p26l847t3303r1321b3353],
9	.	.	O	.	_	0	SENT_532	[p26l847t3303r1321b3353],

1	25	CD	NUMBER	25	_	0	SENT_533	[p26l371t3379r452b3421],
2	.	.	O	.	_	0	SENT_533	[p26l371t3379r452b3421],

1	Yun	NNP	PERSON	Yun	nn	2	SENT_534	[p26l487t3380r580b3421],
2	CH	NN	O	ch	_	0	SENT_534	[p26l609t3379r696b3429],
3	,	,	O	,	_	0	SENT_534	[p26l609t3379r696b3429],
4	Shimada	NNP	PERSON	Shimada	nn	5	SENT_534	[p26l726t3379r950b3421],
5	T	NN	O	t	appos	2	SENT_534	[p26l976t3380r1018b3429],
6	,	,	O	,	_	0	SENT_534	[p26l976t3380r1018b3429],
7	Guengerich	NNP	PERSON	Guengerich	nn	8	SENT_534	[p26l1048t3379r1333b3432],
8	FP	NN	O	fp	appos	5	SENT_534	[p26l1365t3380r1434b3421],
9	.	.	O	.	_	0	SENT_534	[p26l1365t3380r1434b3421],

1	Roles	NNS	O	role	_	0	SENT_535	[p26l1467t3380r1606b3421],
2	of	IN	O	of	_	0	SENT_535	[p26l1634t3379r1683b3421],
3	human	JJ	O	human	amod	6	SENT_535	[p26l1709t3380r1878b3421],
4	liver	NN	O	liver	nn	6	SENT_535	[p26l1909t3380r2011b3421],
5	cytochrome	NN	O	cytochrome	nn	6	SENT_535	[p26l2035t3382r2151b3431, p26l488t3456r677b3498],
6	P4502C	NN	O	p4502c	prep_of	1	SENT_535	[p26l704t3455r911b3498],
7	and	CC	O	and	_	0	SENT_535	[p26l938t3456r1028b3498],
8	3A	NN	O	3a	nn	9	SENT_535	[p26l1055t3455r1122b3498],
9	enzymes	NNS	O	enzyme	prep_of	1	SENT_535	[p26l1146t3466r1367b3508],
10	in	IN	O	in	_	0	SENT_535	[p26l1396t3456r1434b3497],
11	the	DT	O	the	det	12	SENT_535	[p26l1459t3456r1540b3498],
12	3-hydroxylation	NN	O	3-hydroxylation	prep_in	1	SENT_535	[p26l1567t3455r1944b3508],
13	of	IN	O	of	_	0	SENT_535	[p26l1972t3455r2022b3498],
14	benzo	FW	O	benzo	nn	15	SENT_535	[p26l2045t3456r2151b3498, p26l488t3532r796b3584],
15	(	FW	O	(	prep_of	12	SENT_535	[p26l2045t3456r2151b3498, p26l488t3532r796b3584],
16	a	DT	O	a	det	18	SENT_535	[p26l2045t3456r2151b3498, p26l488t3532r796b3584],
17	)	NN	O	)	nn	18	SENT_535	[p26l2045t3456r2151b3498, p26l488t3532r796b3584],
18	pyrene	NN	O	pyrene	dep	15	SENT_535	[p26l2045t3456r2151b3498, p26l488t3532r796b3584],
19	.	.	O	.	_	0	SENT_535	[p26l2045t3456r2151b3498, p26l488t3532r796b3584],

1	Cancer	NNP	O	Cancer	nn	2	SENT_536	[p26l824t3531r1002b3574],
2	Res	NNP	O	Res	_	0	SENT_536	[p26l1026t3532r1119b3574],
3	1992	CD	DATE	1992	num	2	SENT_536	[p26l1145t3531r1726b3581],
4	;	:	O	;	_	0	SENT_536	[p26l1145t3531r1726b3581],
5	52:1868	CD	NUMBER	52:1868	number	6	SENT_536	[p26l1145t3531r1726b3581],
6	—	CD	NUMBER	—	dep	2	SENT_536	[p26l1145t3531r1726b3581],
7	1874	CD	DATE	1874	dep	6	SENT_536	[p26l1145t3531r1726b3581],
8	.	.	O	.	_	0	SENT_536	[p26l1145t3531r1726b3581],

1	26	CD	NUMBER	26	_	0	SENT_537	[p26l371t3606r452b3648],
2	.	.	O	.	_	0	SENT_537	[p26l371t3606r452b3648],

1	Bauer	NNP	PERSON	Bauer	nn	2	SENT_538	[p26l491t3607r639b3648],
2	E	NNP	O	E	_	0	SENT_538	[p26l665t3607r707b3655],
3	,	,	O	,	_	0	SENT_538	[p26l665t3607r707b3655],
4	Guo	NNP	O	Guo	nn	5	SENT_538	[p26l736t3606r834b3648],
5	Z	NNP	O	Z	appos	2	SENT_538	[p26l859t3607r903b3655],
6	,	,	O	,	_	0	SENT_538	[p26l859t3607r903b3655],
7	Ueng	NNP	O	Ueng	nn	8	SENT_538	[p26l935t3607r1062b3659],
8	YF	NNP	O	YF	appos	2	SENT_538	[p26l1085t3607r1159b3655],
9	,	,	O	,	_	0	SENT_538	[p26l1085t3607r1159b3655],
10	et	FW	O	et	nn	11	SENT_538	[p26l1187t3609r1236b3648],
11	al.	FW	O	al.	appos	2	SENT_538	[p26l1261t3607r1317b3648],
12	.	.	O	.	_	0	SENT_538	[p26l1261t3607r1317b3648],

1	Oxidation	NN	O	oxidation	_	0	SENT_539	[p26l1347t3606r1582b3648],
2	of	IN	O	of	_	0	SENT_539	[p26l1609t3606r1659b3648],
3	benzo	FW	O	benzo	nn	4	SENT_539	[p26l1682t3607r2070b3658],
4	[	FW	O	[	prep_of	1	SENT_539	[p26l1682t3607r2070b3658],
5	a	DT	O	a	det	7	SENT_539	[p26l1682t3607r2070b3658],
6	]	NN	O	]	nn	7	SENT_539	[p26l1682t3607r2070b3658],
7	pyrene	NN	O	pyrene	dep	1	SENT_539	[p26l1682t3607r2070b3658],
8	by	IN	O	by	_	0	SENT_539	[p26l2098t3607r2151b3658],
9	recombinant	JJ	O	recombinant	amod	13	SENT_539	[p26l490t3683r808b3725],
10	human	JJ	O	human	amod	13	SENT_539	[p26l830t3683r999b3725],
11	cytochrome	NN	O	cytochrome	nn	13	SENT_539	[p26l1021t3683r1314b3735],
12	P450	NN	O	p450	nn	13	SENT_539	[p26l1338t3683r1472b3725],
13	enzymes	NNS	O	enzyme	prep_by	7	SENT_539	[p26l1493t3693r1730b3735],
14	.	.	O	.	_	0	SENT_539	[p26l1493t3693r1730b3735],

1	Chem	NNP	ORGANIZATION	Chem	nn	3	SENT_540	[p26l1754t3683r1898b3725],
2	Res	NNP	ORGANIZATION	Res	nn	3	SENT_540	[p26l1924t3683r2017b3725],
3	Toxicol	NNP	O	Toxicol	_	0	SENT_540	[p26l2036t3683r2151b3725, p26l488t3759r557b3800],
4	1995	CD	DATE	1995	num	3	SENT_540	[p26l585t3758r1059b3807],
5	;	:	O	;	_	0	SENT_540	[p26l585t3758r1059b3807],
6	8:136	CD	NUMBER	8:136	dep	3	SENT_540	[p26l585t3758r1059b3807],
7	—	NN	O	—	prep	6	SENT_540	[p26l585t3758r1059b3807],
8	142	CD	NUMBER	142	dep	7	SENT_540	[p26l585t3758r1059b3807],
9	.	.	O	.	_	0	SENT_540	[p26l585t3758r1059b3807],
10	'	''	O	'	_	0	SENT_540	[p26l159t2796r200b3060],

1	1VDIN	CD	NUMBER	1vdin	num	2	SENT_541	[p26l159t2796r200b3060],
2	|	CD	NUMBER	|	_	0	SENT_541	[p26l159t2796r200b3060],
3	13	CD	NUMBER	13	num	5	SENT_541	[p26l159t2796r200b3060],
4	>	JJR	O	>	amod	5	SENT_541	[p26l93t2661r132b2701],
5	E	NN	O	e	dep	2	SENT_541	[p26l93t2705r132b2741],
6	3	CD	NUMBER	3	number	7	SENT_541	[p26l93t2745r132b2794],
7	III	CD	NUMBER	iii	num	8	SENT_541	[p26l93t2799r132b2821],
8	Z	NN	O	z	dep	5	SENT_541	[p26l93t2827r132b2866],
9	-	:	O	-	_	0	SENT_541	[p26l93t2870r132b2897],
10	I	PRP	O	I	dep	2	SENT_541	[p26l93t2870r132b2897],
11	E	NN	O	e	dep	10	SENT_541	[p26l93t2898r132b2973],
12	-	:	O	-	_	0	SENT_541	[p26l93t2973r132b3011],
13	<	JJR	O	<	amod	15	SENT_541	[p26l93t2973r132b3011],
14	E	NN	O	e	nn	15	SENT_541	[p26l93t3028r132b3131],
15	O	NN	O	o	dep	10	SENT_541	[p26l92t3133r133b3163],
16	-	:	O	-	_	0	SENT_541	[p26l93t3166r132b3193],
17	I	PRP	O	I	dep	15	SENT_541	[p26l93t3166r132b3193],

1	Michaelis	NNP	PERSON	Michaelis	nn	2	SENT_542	[p27l491t21r731b63],
2	UR	NNP	O	UR	_	0	SENT_542	[p27l757t21r840b70],
3	,	,	O	,	_	0	SENT_542	[p27l757t21r840b70],
4	Falck	NNP	ORGANIZATION	Falck	nn	5	SENT_542	[p27l868t21r996b63],
5	JR	NNP	ORGANIZATION	JR	appos	2	SENT_542	[p27l1015t21r1088b70],
6	,	,	O	,	_	0	SENT_542	[p27l1015t21r1088b70],
7	Schmidt	NNP	PERSON	Schmidt	nn	8	SENT_542	[p27l1114t21r1322b63],
8	R	NNP	O	R	appos	2	SENT_542	[p27l1345t21r1391b70],
9	,	,	O	,	_	0	SENT_542	[p27l1345t21r1391b70],
10	et	FW	O	et	nn	11	SENT_542	[p27l1416t24r1465b63],
11	al.	FW	O	al.	appos	2	SENT_542	[p27l1486t21r1542b63],
12	.	.	O	.	_	0	SENT_542	[p27l1486t21r1542b63],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_543	[p27l1568t21r1869b73],
2	P4502C9	NN	O	p4502c9	nsubj	7	SENT_543	[p27l1893t21r2151b63],
3	—	CD	NUMBER	—	dep	2	SENT_543	[p27l1893t21r2151b63],
4	derived	VBN	O	derive	partmod	2	SENT_543	[p27l488t97r670b139],
5	epoxyeicosatrienoic	JJ	O	epoxyeicosatrienoic	amod	6	SENT_543	[p27l691t97r1196b149],
6	acids	NNS	O	acid	dobj	4	SENT_543	[p27l1215t97r1348b139],
7	induce	VBP	O	induce	_	0	SENT_543	[p27l1369t97r1534b139],
8	the	DT	O	the	det	9	SENT_543	[p27l1551t97r1632b139],
9	expression	NN	O	expression	dobj	7	SENT_543	[p27l1651t97r1927b148],
10	of	IN	O	of	_	0	SENT_543	[p27l1947t96r1997b139],
11	cyclooxygenase	NN	O	cyclooxygenase	nn	12	SENT_543	[p27l2012t97r2151b149, p27l488t173r804b226],
12	—	NN	O	—	prep_of	9	SENT_543	[p27l2012t97r2151b149, p27l488t173r804b226],
13	2	CD	NUMBER	2	num	12	SENT_543	[p27l2012t97r2151b149, p27l488t173r804b226],
14	in	IN	O	in	_	0	SENT_543	[p27l835t173r873b215],
15	endothelial	JJ	O	endothelial	amod	16	SENT_543	[p27l902t173r1182b215],
16	cells	NNS	O	cell	prep_in	7	SENT_543	[p27l1212t173r1343b215],
17	.	.	O	.	_	0	SENT_543	[p27l1212t173r1343b215],

1	Arterioscler	NNP	O	Arterioscler	nn	4	SENT_544	[p27l1372t173r1666b215],
2	Thromb	NNP	O	Thromb	nn	4	SENT_544	[p27l1689t173r1880b215],
3	Vasc	NNP	O	Vasc	nn	4	SENT_544	[p27l1906t173r2028b215],
4	Biol	NNP	O	Biol	_	0	SENT_544	[p27l2058t173r2147b215],
5	2005	CD	DATE	2005	num	4	SENT_544	[p27l490t248r992b298],
6	;	:	O	;	_	0	SENT_544	[p27l490t248r992b298],
7	25:321	CD	NUMBER	25:321	number	8	SENT_544	[p27l490t248r992b298],
8	-326	CD	NUMBER	-326	dep	4	SENT_544	[p27l490t248r992b298],
9	.	.	O	.	_	0	SENT_544	[p27l490t248r992b298],

1	Yasar	NNP	PERSON	Yasar	nn	2	SENT_545	[p27l487t324r634b366],
2	U	NNP	PERSON	U	_	0	SENT_545	[p27l663t324r709b374],
3	,	,	O	,	_	0	SENT_545	[p27l663t324r709b374],
4	Bennet	NNP	ORGANIZATION	Bennet	nn	5	SENT_545	[p27l743t324r922b366],
5	AM	NNP	ORGANIZATION	AM	appos	2	SENT_545	[p27l947t324r1042b374],
6	,	,	O	,	_	0	SENT_545	[p27l947t324r1042b374],
7	Eliasson	NNP	PERSON	Eliasson	nn	8	SENT_545	[p27l1076t324r1287b366],
8	E	NNP	O	E	appos	2	SENT_545	[p27l1320t324r1361b374],
9	,	,	O	,	_	0	SENT_545	[p27l1320t324r1361b374],
10	et	FW	O	et	nn	11	SENT_545	[p27l1392t327r1441b366],
11	al.	FW	O	al.	appos	2	SENT_545	[p27l1469t324r1525b366],
12	.	.	O	.	_	0	SENT_545	[p27l1469t324r1525b366],

1	Allelic	JJ	O	allelic	amod	2	SENT_546	[p27l1555t324r1703b366],
2	variants	NNS	O	variant	nsubj	7	SENT_546	[p27l1730t324r1933b366],
3	of	IN	O	of	_	0	SENT_546	[p27l1961t324r2011b366],
4	cytochromes	NNS	O	cytochrome	nn	6	SENT_546	[p27l2035t327r2151b377, p27l488t401r707b443],
5	P450	NN	O	p450	nn	6	SENT_546	[p27l728t400r863b443],
6	2C	NN	O	2c	prep_of	2	SENT_546	[p27l882t400r949b443],
7	modify	VB	O	modify	_	0	SENT_546	[p27l970t400r1137b453],
8	the	DT	O	the	det	9	SENT_546	[p27l1151t401r1232b443],
9	risk	NN	O	risk	dobj	7	SENT_546	[p27l1253t401r1342b443],
10	for	IN	O	for	_	0	SENT_546	[p27l1357t400r1426b443],
11	acute	JJ	O	acute	amod	13	SENT_546	[p27l1444t403r1582b443],
12	myocardial	JJ	O	myocardial	amod	13	SENT_546	[p27l1603t401r1873b453],
13	infarction	NN	O	infarction	prep_for	9	SENT_546	[p27l1896t400r2146b443],
14	.	.	O	.	_	0	SENT_546	[p27l1896t400r2146b443],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_547	[p27l490t476r960b529],
2	2003	CD	DATE	2003	num	1	SENT_547	[p27l986t476r1489b526],
3	;	:	O	;	_	0	SENT_547	[p27l986t476r1489b526],
4	13:715	CD	NUMBER	13:715	number	5	SENT_547	[p27l986t476r1489b526],
5	-720	CD	NUMBER	-720	dep	1	SENT_547	[p27l986t476r1489b526],
6	.	.	O	.	_	0	SENT_547	[p27l986t476r1489b526],

1	Dai	NN	PERSON	daus	nn	2	SENT_548	[p27l491t553r568b595],
2	D	NN	PERSON	d	_	0	SENT_548	[p27l601t553r649b602],
3	,	,	O	,	_	0	SENT_548	[p27l601t553r649b602],
4	Zeldin	NNP	PERSON	Zeldin	nn	5	SENT_548	[p27l678t553r831b595],
5	DC	NNP	O	DC	appos	2	SENT_548	[p27l864t552r948b602],
6	,	,	O	,	_	0	SENT_548	[p27l864t552r948b602],
7	Blaisdell	NNP	PERSON	Blaisdell	nn	8	SENT_548	[p27l982t553r1194b595],
8	JA	NNP	O	JA	appos	2	SENT_548	[p27l1223t553r1293b602],
9	,	,	O	,	_	0	SENT_548	[p27l1223t553r1293b602],
10	et	FW	O	et	nn	11	SENT_548	[p27l1324t555r1373b595],
11	al.	FW	O	al.	appos	2	SENT_548	[p27l1400t553r1456b595],
12	.	.	O	.	_	0	SENT_548	[p27l1400t553r1456b595],

1	Polymorphisms	NNS	O	polymorphism	_	0	SENT_549	[p27l1489t553r1877b605],
2	in	IN	O	in	_	0	SENT_549	[p27l1908t553r1946b594],
3	human	JJ	O	human	amod	6	SENT_549	[p27l1978t553r2148b595],
4	CYP2C8	NN	O	cyp2c8	nn	6	SENT_549	[p27l489t628r696b670],
5	decrease	NN	O	decrease	nn	6	SENT_549	[p27l721t628r956b670],
6	metabolism	NN	O	metabolism	prep_in	1	SENT_549	[p27l983t628r1280b670],
7	of	IN	O	of	_	0	SENT_549	[p27l1307t628r1357b670],
8	the	DT	O	the	det	11	SENT_549	[p27l1376t628r1457b670],
9	anticancer	JJ	O	anticancer	amod	11	SENT_549	[p27l1484t628r1751b670],
10	drug	NN	O	drug	nn	11	SENT_549	[p27l1774t628r1885b681],
11	paclitaxel	NN	O	paclitaxel	prep_of	1	SENT_549	[p27l1910t628r2147b680],
12	and	CC	O	and	_	0	SENT_549	[p27l489t704r579b745],
13	arachidonic	JJ	O	arachidonic	amod	14	SENT_549	[p27l606t704r898b745],
14	acid	NN	O	acid	conj_and	11	SENT_549	[p27l923t704r1039b745],
15	.	.	O	.	_	0	SENT_549	[p27l923t704r1039b745],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_550	[p27l1068t704r1538b756],
2	2001	CD	DATE	2001	num	1	SENT_550	[p27l1564t703r2074b753],
3	;	:	O	;	_	0	SENT_550	[p27l1564t703r2074b753],
4	11:597	CD	NUMBER	11:597	number	5	SENT_550	[p27l1564t703r2074b753],
5	-607	CD	NUMBER	-607	dep	1	SENT_550	[p27l1564t703r2074b753],
6	.	.	O	.	_	0	SENT_550	[p27l1564t703r2074b753],

1	Cardiovascular	NNP	O	Cardiovascular	nsubj	9	SENT_551	[p27l489t779r868b821],
2	and	CC	O	and	_	0	SENT_551	[p27l897t780r987b821],
3	cerebrovascular	JJ	O	cerebrovascular	amod	4	SENT_551	[p27l1019t780r1427b821],
4	events	NNS	O	event	nsubj	9	SENT_551	[p27l1455t782r1623b821],
5	in	IN	O	in	_	0	SENT_551	[p27l1656t780r1694b821],
6	the	DT	O	the	prep_in	4	SENT_551	[p27l1725t780r1805b821],
7	randomized	VBN	O	randomize	partmod	6	SENT_551	[p27l1838t780r2147b828],
8	,	,	O	,	_	0	SENT_551	[p27l1838t780r2147b828],
9	controlled	VBN	O	control	_	0	SENT_551	[p27l488t856r738b898],
10	Alzheimer	NN	O	alzheimer	poss	13	SENT_551	[p27l757t856r1053b898],
11	’s	POS	O	’s	_	0	SENT_551	[p27l757t856r1053b898],
12	Disease	NN	O	disease	nn	13	SENT_551	[p27l1075t856r1279b898],
13	Anti	NN	O	anti	nsubj	23	SENT_551	[p27l1296t855r1742b908],
14	—	CD	NUMBER	—	number	15	SENT_551	[p27l1296t855r1742b908],
15	|	CD	NUMBER	|	num	17	SENT_551	[p27l1296t855r1742b908],
16	nf	NN	O	nf	nn	17	SENT_551	[p27l1296t855r1742b908],
17	|	NN	O	|	npadvmod	18	SENT_551	[p27l1296t855r1742b908],
18	ammatory	JJ	O	ammatory	amod	13	SENT_551	[p27l1296t855r1742b908],
19	Prevention	NNP	O	Prevention	nn	23	SENT_551	[p27l1759t856r2024b898],
20	Trial	NNP	O	Trial	nn	23	SENT_551	[p27l2042t856r2147b898],
21	(	NNP	O	(	nn	23	SENT_551	[p27l489t932r704b983],
22	ADAPT	NNP	O	ADAPT	nn	23	SENT_551	[p27l489t932r704b983],
23	)	NN	O	)	xcomp	9	SENT_551	[p27l489t932r704b983],
24	.	.	O	.	_	0	SENT_551	[p27l489t932r704b983],

1	PLoS	NN	O	plo	nn	3	SENT_552	[p27l732t931r858b974],
2	Clin	NN	O	clin	nn	3	SENT_552	[p27l883t931r974b974],
3	Trials	NNS	O	trial	_	0	SENT_552	[p27l998t932r1135b974],
4	2006	CD	DATE	2006	num	6	SENT_552	[p27l1161t931r1488b981],
5	;	:	O	;	_	0	SENT_552	[p27l1161t931r1488b981],
6	1	CD	NUMBER	1	dep	3	SENT_552	[p27l1161t931r1488b981],
7	:	:	O	:	_	0	SENT_552	[p27l1161t931r1488b981],
8	e33	NN	O	e33	dep	3	SENT_552	[p27l1161t931r1488b981],
9	.	.	O	.	_	0	SENT_552	[p27l1161t931r1488b981],

1	Feng	NNP	O	Feng	nn	2	SENT_553	[p27l491t1008r609b1061],
2	GS	NN	O	g	_	0	SENT_553	[p27l630t1008r717b1058],
3	,	,	O	,	_	0	SENT_553	[p27l630t1008r717b1058],
4	Ma	NNP	O	Ma	nn	5	SENT_553	[p27l745t1008r818b1050],
5	JL	NNP	O	JL	appos	2	SENT_553	[p27l840t1008r906b1058],
6	,	,	O	,	_	0	SENT_553	[p27l840t1008r906b1058],
7	Wong	NNP	PERSON	Wong	nn	8	SENT_553	[p27l930t1008r1072b1061],
8	BC	NNP	O	BC	appos	2	SENT_553	[p27l1095t1008r1178b1058],
9	,	,	O	,	_	0	SENT_553	[p27l1095t1008r1178b1058],
10	et	FW	O	et	nn	11	SENT_553	[p27l1203t1011r1252b1050],
11	al.	FW	O	al.	appos	2	SENT_553	[p27l1274t1008r1330b1050],
12	.	.	O	.	_	0	SENT_553	[p27l1274t1008r1330b1050],

1	Ce	NN	O	ce	dep	9	SENT_554	[p27l1356t1008r1792b1050],
2	|	SYM	O	|	dep	9	SENT_554	[p27l1356t1008r1792b1050],
3	ecoxib	FW	O	ecoxib	nn	6	SENT_554	[p27l1356t1008r1792b1050],
4	—	FW	O	—	nn	6	SENT_554	[p27l1356t1008r1792b1050],
5	re	FW	O	re	nn	6	SENT_554	[p27l1356t1008r1792b1050],
6	|	FW	O	|	nsubj	9	SENT_554	[p27l1356t1008r1792b1050],
7	ated	VBN	O	ate	partmod	6	SENT_554	[p27l1356t1008r1792b1050],
8	gastroduode	NN	O	gastroduode	nn	9	SENT_554	[p27l1815t1008r2151b1061],
9	—	NN	O	—	_	0	SENT_554	[p27l1815t1008r2151b1061],
10	nal	NN	O	nal	nn	11	SENT_554	[p27l490t1084r560b1125],
11	ulcer	NN	O	ulcer	dobj	9	SENT_554	[p27l599t1084r722b1125],
12	and	CC	O	and	_	0	SENT_554	[p27l755t1084r844b1125],
13	cardiovascular	JJ	O	cardiovascular	amod	14	SENT_554	[p27l880t1084r1252b1125],
14	events	NNS	O	event	dobj	9	SENT_554	[p27l1284t1086r1451b1125],
15	in	IN	O	in	_	0	SENT_554	[p27l1489t1084r1527b1125],
16	a	DT	O	a	det	18	SENT_554	[p27l1564t1093r1591b1125],
17	randomized	JJ	O	randomized	amod	18	SENT_554	[p27l1628t1084r1920b1125],
18	trial	NN	O	trial	prep_in	9	SENT_554	[p27l1953t1084r2048b1125],
19	for	IN	O	for	_	0	SENT_554	[p27l2083t1083r2152b1125],
20	gastric	JJ	O	gastric	amod	22	SENT_554	[p27l487t1160r658b1213],
21	cancer	NN	O	cancer	nn	22	SENT_554	[p27l676t1170r847b1202],
22	prevention	NN	O	prevention	prep_for	18	SENT_554	[p27l865t1160r1145b1212],
23	.	.	O	.	_	0	SENT_554	[p27l865t1160r1145b1212],

1	World	NNP	O	World	nn	3	SENT_555	[p27l1164t1160r1306b1202],
2	J	NNP	O	J	nn	3	SENT_555	[p27l1325t1160r1344b1202],
3	Gastroenterol	NNP	O	Gastroenterol	_	0	SENT_555	[p27l1365t1160r1710b1202],
4	2008	CD	DATE	2008	num	3	SENT_555	[p27l1732t1160r2151b1210, p27l488t1235r642b1278],
5	;	:	O	;	_	0	SENT_555	[p27l1732t1160r2151b1210, p27l488t1235r642b1278],
6	14:45354539	CD	NUMBER	14:45354539	dep	3	SENT_555	[p27l1732t1160r2151b1210, p27l488t1235r642b1278],
7	.	.	O	.	_	0	SENT_555	[p27l1732t1160r2151b1210, p27l488t1235r642b1278],

1	Solomon	NNP	O	Solomon	nn	2	SENT_556	[p27l489t1312r711b1354],
2	SD	NN	O	sd	_	0	SENT_556	[p27l748t1312r834b1361],
3	,	,	O	,	_	0	SENT_556	[p27l748t1312r834b1361],
4	Wittes	NNP	PERSON	Wittes	nn	5	SENT_556	[p27l870t1312r1031b1354],
5	J	NNP	PERSON	J	appos	2	SENT_556	[p27l1065t1312r1101b1361],
6	,	,	O	,	_	0	SENT_556	[p27l1065t1312r1101b1361],
7	Finn	NNP	O	Finn	nn	8	SENT_556	[p27l1141t1312r1239b1353],
8	PV	NNP	O	PV	appos	2	SENT_556	[p27l1277t1312r1353b1361],
9	,	,	O	,	_	0	SENT_556	[p27l1277t1312r1353b1361],
10	et	FW	O	et	nn	11	SENT_556	[p27l1391t1315r1440b1354],
11	al.	FW	O	al.	appos	2	SENT_556	[p27l1473t1312r1529b1354],
12	.	.	O	.	_	0	SENT_556	[p27l1473t1312r1529b1354],

1	Cardiovascular	NNP	O	Cardiovascular	nn	2	SENT_557	[p27l1567t1312r1947b1354],
2	risk	NN	O	risk	_	0	SENT_557	[p27l1981t1312r2070b1354],
3	of	IN	O	of	_	0	SENT_557	[p27l2104t1312r2153b1354],
4	celecoxib	NN	O	celecoxib	prep_of	2	SENT_557	[p27l488t1388r724b1430],
5	in	IN	O	in	_	0	SENT_557	[p27l759t1388r797b1429],
6	6	CD	NUMBER	6	prep_in	4	SENT_557	[p27l832t1387r863b1430],
7	randomized	VBN	O	randomize	partmod	2	SENT_557	[p27l898t1388r1190b1430],
8	placebo-controlled	JJ	O	placebo-controlled	amod	9	SENT_557	[p27l1226t1388r1690b1439],
9	trials	NNS	O	trial	dobj	7	SENT_557	[p27l1722t1388r1865b1430],
10	:	:	O	:	_	0	SENT_557	[p27l1722t1388r1865b1430],
11	the	DT	O	the	det	12	SENT_557	[p27l1898t1388r1979b1430],
12	cross	NN	O	cross	dep	2	SENT_557	[p27l2012t1398r2149b1430],
13	trial	NN	O	trial	nn	15	SENT_557	[p27l486t1463r580b1505],
14	safety	NN	O	safety	nn	15	SENT_557	[p27l607t1463r762b1516],
15	analysis	NN	O	analysis	dep	12	SENT_557	[p27l785t1463r1006b1516],
16	.	.	O	.	_	0	SENT_557	[p27l785t1463r1006b1516],

1	Circulation	NN	O	circulation	_	0	SENT_558	[p27l1033t1463r1302b1505],
2	2008	CD	DATE	2008	num	1	SENT_558	[p27l1328t1463r1945b1513],
3	;	:	O	;	_	0	SENT_558	[p27l1328t1463r1945b1513],
4	117:2104	CD	DURATION	117:2104	number	5	SENT_558	[p27l1328t1463r1945b1513],
5	-2113	CD	DURATION	-2113	dep	1	SENT_558	[p27l1328t1463r1945b1513],
6	.	.	O	.	_	0	SENT_558	[p27l1328t1463r1945b1513],

1	Bigler	NNP	PERSON	Bigler	nn	2	SENT_559	[p27l491t1539r633b1591],
2	J	NNP	PERSON	J	_	0	SENT_559	[p27l651t1539r687b1587],
3	,	,	O	,	_	0	SENT_559	[p27l651t1539r687b1587],
4	Whitton	NNP	PERSON	Whitton	nn	5	SENT_559	[p27l711t1539r904b1580],
5	J	NNP	PERSON	J	appos	2	SENT_559	[p27l927t1539r963b1587],
6	,	,	O	,	_	0	SENT_559	[p27l927t1539r963b1587],
7	Lampe	NNP	PERSON	Lampe	nn	8	SENT_559	[p27l990t1539r1158b1589],
8	JW	NNP	O	JW	appos	2	SENT_559	[p27l1179t1539r1264b1587],
9	,	,	O	,	_	0	SENT_559	[p27l1179t1539r1264b1587],
10	et	FW	O	et	nn	11	SENT_559	[p27l1289t1541r1338b1580],
11	al.	FW	O	al.	appos	2	SENT_559	[p27l1359t1539r1415b1580],
12	.	.	O	.	_	0	SENT_559	[p27l1359t1539r1415b1580],

1	CYP2C9	NN	O	cyp2c9	nn	4	SENT_560	[p27l1441t1538r1647b1580],
2	and	CC	O	and	_	0	SENT_560	[p27l1671t1539r1761b1580],
3	UGT1A6	NN	O	ugt1a6	nn	4	SENT_560	[p27l1787t1538r1992b1580],
4	genotypes	NNS	O	genotype	nsubj	5	SENT_560	[p27l2013t1545r2151b1591, p27l486t1618r623b1668],
5	modulate	VBP	O	modulate	_	0	SENT_560	[p27l643t1615r880b1657],
6	the	DT	O	the	det	8	SENT_560	[p27l897t1615r977b1657],
7	protective	JJ	O	protective	amod	8	SENT_560	[p27l999t1615r1246b1667],
8	effect	NN	O	effect	dobj	5	SENT_560	[p27l1265t1615r1410b1657],
9	of	IN	O	of	_	0	SENT_560	[p27l1427t1615r1476b1657],
10	aspirin	NN	O	aspirin	prep_of	8	SENT_560	[p27l1492t1615r1660b1667],
11	on	IN	O	on	_	0	SENT_560	[p27l1680t1625r1738b1657],
12	colon	NN	O	colon	nn	14	SENT_560	[p27l1758t1615r1892b1657],
13	adenoma	NN	O	adenoma	nn	14	SENT_560	[p27l1913t1615r2149b1657],
14	risk	NN	O	risk	prep_on	10	SENT_560	[p27l490t1691r593b1733],
15	.	.	O	.	_	0	SENT_560	[p27l490t1691r593b1733],

1	Cancer	NNP	O	Cancer	nn	2	SENT_561	[p27l620t1690r799b1733],
2	Res	NNP	O	Res	_	0	SENT_561	[p27l823t1691r916b1733],
3	2001	CD	DATE	2001	num	2	SENT_561	[p27l941t1690r1523b1740],
4	;	:	O	;	_	0	SENT_561	[p27l941t1690r1523b1740],
5	61:3566	CD	DURATION	61:3566	number	6	SENT_561	[p27l941t1690r1523b1740],
6	-3569	CD	DURATION	-3569	dep	2	SENT_561	[p27l941t1690r1523b1740],
7	.	.	O	.	_	0	SENT_561	[p27l941t1690r1523b1740],

1	Lundblad	NNP	PERSON	Lundblad	nn	2	SENT_562	[p27l491t1766r719b1808],
2	MS	NN	O	m	_	0	SENT_562	[p27l751t1766r846b1815],
3	,	,	O	,	_	0	SENT_562	[p27l751t1766r846b1815],
4	Ohlsson	NNP	PERSON	Ohlsson	nn	5	SENT_562	[p27l877t1766r1082b1808],
5	S	NNP	O	S	appos	2	SENT_562	[p27l1113t1766r1160b1815],
6	,	,	O	,	_	0	SENT_562	[p27l1113t1766r1160b1815],
7	Johansson	NNP	PERSON	Johansson	nn	8	SENT_562	[p27l1190t1766r1463b1808],
8	P	NN	O	p	appos	2	SENT_562	[p27l1495t1766r1538b1815],
9	,	,	O	,	_	0	SENT_562	[p27l1495t1766r1538b1815],
10	et	FW	O	et	nn	11	SENT_562	[p27l1569t1769r1617b1808],
11	al.	FW	O	al.	appos	2	SENT_562	[p27l1645t1766r1701b1808],
12	.	.	O	.	_	0	SENT_562	[p27l1645t1766r1701b1808],

1	Accumulation	NNP	O	Accumulation	_	0	SENT_563	[p27l1731t1766r2073b1808],
2	of	IN	O	of	_	0	SENT_563	[p27l2103t1766r2153b1808],
3	celecoxib	NN	O	celecoxib	prep_of	1	SENT_563	[p27l488t1842r724b1883],
4	with	IN	O	with	_	0	SENT_563	[p27l753t1842r853b1883],
5	a	DT	O	a	det	9	SENT_563	[p27l887t1852r913b1883],
6	7-fold	RB	O	7-fold	advmod	7	SENT_563	[p27l946t1841r1083b1883],
7	higher	JJR	O	higher	amod	9	SENT_563	[p27l1117t1842r1273b1894],
8	drug	NN	O	drug	nn	9	SENT_563	[p27l1301t1842r1412b1894],
9	exposure	NN	O	exposure	prep_with	3	SENT_563	[p27l1440t1852r1672b1892],
10	in	IN	O	in	_	0	SENT_563	[p27l1705t1842r1743b1883],
11	individuals	NNS	O	individual	prep_in	9	SENT_563	[p27l1777t1842r2045b1883],
12	homozygous	JJ	O	homozygous	amod	1	SENT_563	[p27l2078t1842r2151b1883, p27l490t1922r739b1969],
13	for	IN	O	for	_	0	SENT_563	[p27l771t1916r840b1958],
14	CYP2C9	NN	O	cyp2c9	prep_for	12	SENT_563	[p27l870t1916r1163b1958],
15	*	CD	NUMBER	*	number	16	SENT_563	[p27l870t1916r1163b1958],
16	3	CD	NUMBER	3	num	14	SENT_563	[p27l870t1916r1163b1958],
17	.	.	O	.	_	0	SENT_563	[p27l870t1916r1163b1958],

1	Clin	NNP	O	Clin	nn	3	SENT_564	[p27l1199t1916r1290b1958],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_564	[p27l1326t1917r1591b1958],
3	Ther	NNP	O	Ther	_	0	SENT_564	[p27l1624t1917r1737b1958],
4	2006	CD	DATE	2006	num	3	SENT_564	[p27l1768t1916r2151b1965, p27l490t1992r606b2035],
5	;	:	O	;	_	0	SENT_564	[p27l1768t1916r2151b1965, p27l490t1992r606b2035],
6	79:287288	CD	NUMBER	79:287288	dep	3	SENT_564	[p27l1768t1916r2151b1965, p27l490t1992r606b2035],
7	.	.	O	.	_	0	SENT_564	[p27l1768t1916r2151b1965, p27l490t1992r606b2035],

1	Kramer	NNP	PERSON	Kramer	nn	2	SENT_565	[p27l491t2069r675b2111],
2	MA	NNP	PERSON	MA	_	0	SENT_565	[p27l697t2069r787b2118],
3	,	,	O	,	_	0	SENT_565	[p27l697t2069r787b2118],
4	Rettie	NNP	PERSON	Rettie	nn	5	SENT_565	[p27l814t2069r960b2111],
5	AE	NNP	O	AE	appos	2	SENT_565	[p27l981t2069r1060b2118],
6	,	,	O	,	_	0	SENT_565	[p27l981t2069r1060b2118],
7	Rieder	NNP	PERSON	Rieder	nn	8	SENT_565	[p27l1087t2069r1250b2111],
8	MJ	NNP	PERSON	MJ	appos	2	SENT_565	[p27l1272t2069r1353b2118],
9	,	,	O	,	_	0	SENT_565	[p27l1272t2069r1353b2118],
10	et	FW	O	et	nn	11	SENT_565	[p27l1377t2071r1426b2111],
11	al.	FW	O	al.	appos	2	SENT_565	[p27l1447t2069r1503b2111],
12	.	.	O	.	_	0	SENT_565	[p27l1447t2069r1503b2111],

1	Novel	JJ	MISC	novel	amod	4	SENT_566	[p27l1531t2069r1665b2111],
2	CYP2C9	NN	MISC	cyp2c9	nn	4	SENT_566	[p27l1690t2068r1897b2111],
3	promoter	NN	O	promoter	nn	4	SENT_566	[p27l1922t2071r2152b2120],
4	variants	NNS	O	variant	_	0	SENT_566	[p27l487t2145r689b2187],
5	and	CC	O	and	_	0	SENT_566	[p27l722t2145r811b2187],
6	assessment	NN	O	assessment	conj_and	4	SENT_566	[p27l845t2148r1161b2187],
7	of	IN	O	of	_	0	SENT_566	[p27l1190t2145r1239b2187],
8	their	PRP$	O	they	poss	9	SENT_566	[p27l1264t2145r1381b2187],
9	impact	NN	O	impact	prep_of	4	SENT_566	[p27l1411t2145r1582b2197],
10	on	IN	O	on	_	0	SENT_566	[p27l1611t2155r1669b2187],
11	gene	NN	O	gene	nn	12	SENT_566	[p27l1700t2151r1822b2198],
12	expression	NN	O	expression	prep_on	4	SENT_566	[p27l1854t2145r2146b2197],
13	.	.	O	.	_	0	SENT_566	[p27l1854t2145r2146b2197],

1	Mol	NNP	ORGANIZATION	Mol	nn	2	SENT_567	[p27l491t2221r577b2262],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_567	[p27l605t2221r869b2262],
3	2008	CD	DATE	2008	num	2	SENT_567	[p27l897t2220r1471b2269],
4	;	:	O	;	_	0	SENT_567	[p27l897t2220r1471b2269],
5	73:1751	CD	DURATION	73:1751	number	6	SENT_567	[p27l897t2220r1471b2269],
6	-1760	CD	DURATION	-1760	dep	2	SENT_567	[p27l897t2220r1471b2269],
7	.	.	O	.	_	0	SENT_567	[p27l897t2220r1471b2269],

1	DeLozier	NNP	PERSON	DeLozier	nn	2	SENT_568	[p27l491t2297r710b2339],
2	TC	NNP	O	TC	_	0	SENT_568	[p27l733t2297r812b2346],
3	,	,	O	,	_	0	SENT_568	[p27l733t2297r812b2346],
4	Lee	NNP	PERSON	Lee	nn	5	SENT_568	[p27l843t2297r930b2339],
5	SC	NNP	O	SC	appos	2	SENT_568	[p27l957t2297r1042b2346],
6	,	,	O	,	_	0	SENT_568	[p27l957t2297r1042b2346],
7	Coulter	NNP	PERSON	Coulter	nn	8	SENT_568	[p27l1071t2297r1254b2339],
8	SJ	NNP	O	SJ	appos	2	SENT_568	[p27l1279t2297r1350b2346],
9	,	,	O	,	_	0	SENT_568	[p27l1279t2297r1350b2346],
10	et	FW	O	et	nn	11	SENT_568	[p27l1379t2300r1428b2339],
11	al.	FW	O	al.	appos	2	SENT_568	[p27l1454t2297r1509b2339],
12	.	.	O	.	_	0	SENT_568	[p27l1454t2297r1509b2339],

1	Functional	JJ	O	functional	amod	2	SENT_569	[p27l1541t2297r1797b2339],
2	characterization	NN	O	characterization	nsubj	10	SENT_569	[p27l1826t2297r2151b2339, p27l486t2373r580b2415],
3	of	IN	O	of	_	0	SENT_569	[p27l612t2372r662b2415],
4	novel	JJ	O	novel	amod	6	SENT_569	[p27l690t2373r818b2415],
5	allelic	JJ	O	allelic	amod	6	SENT_569	[p27l852t2373r997b2415],
6	variants	NNS	O	variant	prep_of	2	SENT_569	[p27l1025t2373r1228b2415],
7	of	IN	O	of	_	0	SENT_569	[p27l1259t2372r1309b2415],
8	CYP2C9	NN	O	cyp2c9	prep_of	6	SENT_569	[p27l1335t2372r1542b2415],
9	recently	RB	DATE	recently	advmod	10	SENT_569	[p27l1575t2373r1773b2425],
10	discovered	VBN	O	discover	_	0	SENT_569	[p27l1801t2373r2075b2415],
11	in	IN	O	in	_	0	SENT_569	[p27l2109t2373r2147b2414],
12	southeast	NN	O	southeast	nn	13	SENT_569	[p27l489t2449r746b2491],
13	Asians	NNPS	MISC	Asians	prep_in	10	SENT_569	[p27l763t2449r949b2491],
14	.	.	O	.	_	0	SENT_569	[p27l763t2449r949b2491],

1	J	NNP	O	J	nn	4	SENT_570	[p27l970t2449r989b2491],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_570	[p27l1013t2449r1277b2491],
3	Exp	NNP	O	Exp	nn	4	SENT_570	[p27l1302t2449r1387b2500],
4	Ther	NNP	O	Ther	_	0	SENT_570	[p27l1405t2449r1518b2491],
5	2005	CD	DATE	2005	num	4	SENT_570	[p27l1536t2449r2146b2498],
6	;	:	O	;	_	0	SENT_570	[p27l1536t2449r2146b2498],
7	315:1085	CD	DURATION	315:1085	number	8	SENT_570	[p27l1536t2449r2146b2498],
8	-1090	CD	DURATION	-1090	dep	4	SENT_570	[p27l1536t2449r2146b2498],
9	.	.	O	.	_	0	SENT_570	[p27l1536t2449r2146b2498],

1	Hutt	NNP	PERSON	Hutt	nn	2	SENT_571	[p27l491t2525r596b2567],
2	AJ	NNP	PERSON	AJ	_	0	SENT_571	[p27l614t2525r683b2574],
3	,	,	O	,	_	0	SENT_571	[p27l614t2525r683b2574],
4	Caldwell	NNP	PERSON	Caldwell	nn	5	SENT_571	[p27l707t2524r916b2567],
5	J	NNP	PERSON	J	appos	2	SENT_571	[p27l938t2525r974b2574],
6	,	,	O	,	_	0	SENT_571	[p27l938t2525r974b2574],
7	Smith	NNP	ORGANIZATION	Smith	nn	8	SENT_571	[p27l999t2524r1143b2567],
8	RL	NNP	ORGANIZATION	RL	appos	5	SENT_571	[p27l1169t2525r1244b2566],
9	.	.	O	.	_	0	SENT_571	[p27l1169t2525r1244b2566],

1	The	DT	O	the	det	2	SENT_572	[p27l1266t2525r1357b2567],
2	metabolism	NN	O	metabolism	_	0	SENT_572	[p27l1380t2525r1677b2567],
3	of	IN	O	of	_	0	SENT_572	[p27l1700t2524r1750b2567],
4	aspirin	NN	O	aspirin	prep_of	2	SENT_572	[p27l1768t2525r1936b2576],
5	in	IN	O	in	_	0	SENT_572	[p27l1961t2525r2000b2566],
6	man	NN	O	man	prep_in	4	SENT_572	[p27l2024t2535r2146b2567],
7	:	:	O	:	_	0	SENT_572	[p27l2024t2535r2146b2567],
8	a	DT	O	a	det	10	SENT_572	[p27l489t2611r516b2643],
9	population	NN	O	population	nn	10	SENT_572	[p27l543t2601r807b2653],
10	study	NN	O	study	dep	2	SENT_572	[p27l833t2601r982b2653],
11	.	.	O	.	_	0	SENT_572	[p27l833t2601r982b2653],

1	Xenobiotica	NNP	O	Xenobiotica	_	0	SENT_573	[p27l1008t2601r1305b2643],
2	1986	CD	DATE	1986	num	1	SENT_573	[p27l1332t2601r1841b2650],
3	;	:	O	;	_	0	SENT_573	[p27l1332t2601r1841b2650],
4	16:239	CD	NUMBER	16:239	number	5	SENT_573	[p27l1332t2601r1841b2650],
5	-249	CD	NUMBER	-249	dep	1	SENT_573	[p27l1332t2601r1841b2650],
6	.	.	O	.	_	0	SENT_573	[p27l1332t2601r1841b2650],

1	Leemann	NNP	O	Leemann	nn	2	SENT_574	[p27l491t2677r721b2719],
2	TD	NNP	O	TD	_	0	SENT_574	[p27l755t2677r837b2726],
3	,	,	O	,	_	0	SENT_574	[p27l755t2677r837b2726],
4	Transon	NNP	ORGANIZATION	Transon	nn	5	SENT_574	[p27l871t2677r1075b2719],
5	C	NNP	ORGANIZATION	C	appos	2	SENT_574	[p27l1111t2676r1158b2726],
6	,	,	O	,	_	0	SENT_574	[p27l1111t2676r1158b2726],
7	Bonnabry	NNP	PERSON	Bonnabry	nn	8	SENT_574	[p27l1197t2677r1434b2729],
8	P	NN	O	p	appos	2	SENT_574	[p27l1467t2677r1509b2726],
9	,	,	O	,	_	0	SENT_574	[p27l1467t2677r1509b2726],
10	et	FW	O	et	nn	11	SENT_574	[p27l1546t2679r1595b2719],
11	al.	FW	O	al.	appos	2	SENT_574	[p27l1628t2677r1683b2719],
12	.	.	O	.	_	0	SENT_574	[p27l1628t2677r1683b2719],

1	A	DT	O	a	det	3	SENT_575	[p27l1719t2677r1751b2718],
2	major	JJ	O	major	amod	3	SENT_575	[p27l1785t2677r1926b2729],
3	role	NN	O	role	_	0	SENT_575	[p27l1959t2677r2050b2719],
4	for	IN	O	for	_	0	SENT_575	[p27l2082t2676r2151b2719],
5	cytochrome	NN	O	cytochrome	nn	6	SENT_575	[p27l488t2753r781b2805],
6	P450TB	NN	O	p450tb	prep_for	3	SENT_575	[p27l815t2752r1016b2795],
7	(	CD	NUMBER	(	num	10	SENT_575	[p27l1049t2752r1238b2805],
8	CYP2C	NN	O	cyp2c	nn	10	SENT_575	[p27l1049t2752r1238b2805],
9	subfamily	NN	O	subfamily	nn	10	SENT_575	[p27l1270t2752r1531b2805],
10	)	NN	O	)	dep	3	SENT_575	[p27l1270t2752r1531b2805],
11	in	IN	O	in	_	0	SENT_575	[p27l1566t2753r1604b2794],
12	the	DT	O	the	det	13	SENT_575	[p27l1636t2753r1716b2795],
13	actions	NNS	O	action	prep_in	10	SENT_575	[p27l1750t2753r1933b2795],
14	of	IN	O	of	_	0	SENT_575	[p27l1966t2752r2016b2795],
15	nonsteroidal	JJ	O	nonsteroidal	amod	17	SENT_575	[p27l2046t2763r2151b2795, p27l489t2828r708b2870],
16	antiinflammatory	JJ	O	antiinflammatory	amod	17	SENT_575	[p27l738t2828r1165b2881],
17	drugs	NNS	O	drug	prep_of	13	SENT_575	[p27l1190t2828r1344b2881],
18	.	.	O	.	_	0	SENT_575	[p27l1190t2828r1344b2881],

1	Drugs	NNS	O	drug	nsubj	2	SENT_576	[p27l1376t2828r1520b2881],
2	Exp	VBP	O	exp	_	0	SENT_576	[p27l1550t2828r1635b2880],
3	Clin	NNP	O	Clin	nn	4	SENT_576	[p27l1662t2828r1753b2870],
4	Res	NNP	O	Res	dobj	2	SENT_576	[p27l1784t2828r1876b2870],
5	1993	CD	DATE	1993	dep	4	SENT_576	[p27l1906t2828r2146b2878],
6	;	:	O	;	_	0	SENT_576	[p27l1906t2828r2146b2878],
7	19	CD	NUMBER	19	num	9	SENT_576	[p27l1906t2828r2146b2878],
8	:	:	O	:	_	0	SENT_576	[p27l1906t2828r2146b2878],
9	189-195	CD	NUMBER	189-195	dep	4	SENT_576	[p27l491t2904r750b2947],
10	.	.	O	.	_	0	SENT_576	[p27l491t2904r750b2947],

1	GASTROENTEROLOGY	NN	O	gastroenterology	_	0	SENT_577	[p27l990t3000r1660b3049],
2	Vol	NN	O	vol	dep	1	SENT_577	[p27l1683t3000r1790b3049],
3	.	.	O	.	_	0	SENT_577	[p27l1683t3000r1790b3049],

1	136	CD	NUMBER	136	_	0	SENT_578	[p27l1823t2999r1957b3059],
2	,	,	O	,	_	0	SENT_578	[p27l1823t2999r1957b3059],
3	No.	NN	O	no.	appos	1	SENT_578	[p27l1990t3000r2082b3049],
4	7	CD	NUMBER	7	num	3	SENT_578	[p27l2114t3000r2149b3048],

1	39	CD	NUMBER	39	_	0	SENT_579	[p27l11t3220r109b3271],
2	.	.	O	.	_	0	SENT_579	[p27l11t3220r109b3271],

1	Chen	NNP	O	Chen	nn	2	SENT_580	[p27l153t3220r306b3271],
2	XP	NN	O	xp	_	0	SENT_580	[p27l335t3221r428b3280],
3	,	,	O	,	_	0	SENT_580	[p27l335t3221r428b3280],
4	Tan	NNP	O	Tan	nn	5	SENT_580	[p27l459t3221r567b3271],
5	ZR	NNP	O	ZR	appos	2	SENT_580	[p27l596t3221r693b3280],
6	,	,	O	,	_	0	SENT_580	[p27l596t3221r693b3280],
7	Huang	NNP	ORGANIZATION	Huang	nn	8	SENT_580	[p27l728t3221r922b3284],
8	SL	NNP	ORGANIZATION	SL	appos	2	SENT_580	[p27l949t3220r1041b3280],
9	,	,	O	,	_	0	SENT_580	[p27l949t3220r1041b3280],
10	et	FW	O	et	nn	13	SENT_580	[p27l1073t3224r1132b3271],
11	al.	FW	O	al.	nn	13	SENT_580	[p27l1160t3221r1227b3271],
12	lsozyme-specific	JJ	O	lsozyme-specific	amod	13	SENT_580	[p27l1263t3220r1758b3283],
13	induction	NN	O	induction	appos	2	SENT_580	[p27l1789t3221r2064b3271],
14	of	IN	O	of	_	0	SENT_580	[p27l2095t3220r2154b3271],
15	low-dose	JJ	O	low-dose	amod	16	SENT_580	[p27l156t3308r419b3358],
16	aspirin	NN	O	aspirin	prep_of	13	SENT_580	[p27l455t3308r657b3370],
17	on	IN	O	on	_	0	SENT_580	[p27l694t3320r764b3358],
18	cytochrome	NN	O	cytochrome	nn	19	SENT_580	[p27l800t3308r1152b3371],
19	P450	NN	O	p450	prep_on	16	SENT_580	[p27l1188t3308r1350b3358],
20	in	IN	O	in	_	0	SENT_580	[p27l1387t3308r1433b3358],
21	healthy	JJ	O	healthy	amod	22	SENT_580	[p27l1472t3308r1692b3371],
22	subjects	NNS	O	subject	prep_in	19	SENT_580	[p27l1724t3308r1999b3371],
23	.	.	O	.	_	0	SENT_580	[p27l1724t3308r1999b3371],

1	Clin	NNP	O	Clin	nn	3	SENT_581	[p27l2037t3308r2147b3358],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_581	[p27l155t3397r472b3447],
3	Ther	NNP	O	Ther	_	0	SENT_581	[p27l502t3397r638b3447],
4	2003	CD	DATE	2003	num	3	SENT_581	[p27l665t3396r1278b3456],
5	;	:	O	;	_	0	SENT_581	[p27l665t3396r1278b3456],
6	73:264	CD	NUMBER	73:264	number	7	SENT_581	[p27l665t3396r1278b3456],
7	-271	CD	NUMBER	-271	dep	3	SENT_581	[p27l665t3396r1278b3456],
8	.	.	O	.	_	0	SENT_581	[p27l665t3396r1278b3456],

1	40	CD	NUMBER	40	_	0	SENT_582	[p27l10t3484r109b3535],
2	.	.	O	.	_	0	SENT_582	[p27l10t3484r109b3535],

1	Takanohashi	NNP	ORGANIZATION	Takanohashi	nn	2	SENT_583	[p27l151t3485r541b3535],
2	T	NN	ORGANIZATION	t	_	0	SENT_583	[p27l583t3485r633b3544],
3	,	,	O	,	_	0	SENT_583	[p27l583t3485r633b3544],
4	Koizumi	NNP	PERSON	Koizumi	nn	5	SENT_583	[p27l681t3485r915b3535],
5	T	NN	PERSON	t	appos	2	SENT_583	[p27l956t3485r1007b3544],
6	,	,	O	,	_	0	SENT_583	[p27l956t3485r1007b3544],
7	Mihara	NNP	PERSON	Mihara	nn	8	SENT_583	[p27l1054t3485r1260b3535],
8	R	NNP	PERSON	R	appos	2	SENT_583	[p27l1305t3485r1359b3544],
9	,	,	O	,	_	0	SENT_583	[p27l1305t3485r1359b3544],
10	et	FW	O	et	nn	11	SENT_583	[p27l1403t3488r1462b3535],
11	al.	FW	O	al.	appos	2	SENT_583	[p27l1502t3485r1569b3535],
12	.	.	O	.	_	0	SENT_583	[p27l1502t3485r1569b3535],

1	Prediction	NN	O	prediction	nsubj	11	SENT_584	[p27l1616t3485r1915b3535],
2	of	IN	O	of	_	0	SENT_584	[p27l1959t3484r2018b3535],
3	the	DT	O	the	det	5	SENT_584	[p27l2052t3485r2149b3535],
4	metabolic	JJ	O	metabolic	amod	5	SENT_584	[p27l155t3572r452b3622],
5	interaction	NN	O	interaction	prep_of	1	SENT_584	[p27l480t3572r800b3622],
6	of	IN	O	of	_	0	SENT_584	[p27l828t3572r887b3622],
7	nateglinide	NN	O	nateglinide	prep_of	5	SENT_584	[p27l910t3572r1244b3635],
8	with	IN	O	with	_	0	SENT_584	[p27l1267t3572r1388b3622],
9	other	JJ	O	other	amod	10	SENT_584	[p27l1415t3572r1575b3622],
10	drugs	NNS	O	drug	prep_with	7	SENT_584	[p27l1597t3572r1764b3635],
11	based	VBN	O	base	_	0	SENT_584	[p27l1792t3572r1974b3622],
12	on	IN	O	on	prt	11	SENT_584	[p27l2002t3584r2072b3622],
13	in	FW	O	in	nn	15	SENT_584	[p27l2101t3572r2147b3622],
14	vitro	FW	O	vitro	dep	15	SENT_584	[p27l151t3661r281b3711],
15	studies	NNS	O	study	advmod	11	SENT_584	[p27l310t3661r553b3711],
16	.	.	O	.	_	0	SENT_584	[p27l310t3661r553b3711],

1	Drug	NN	O	drug	nn	3	SENT_585	[p27l588t3661r727b3724],
2	Metab	NNP	O	Metab	nn	3	SENT_585	[p27l756t3661r945b3711],
3	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_585	[p27l976t3661r1435b3711],
4	2007	CD	DATE	2007	num	3	SENT_585	[p27l1462t3660r2084b3719],
5	;	:	O	;	_	0	SENT_585	[p27l1462t3660r2084b3719],
6	22:409	CD	NUMBER	22:409	number	7	SENT_585	[p27l1462t3660r2084b3719],
7	-418	CD	NUMBER	-418	dep	3	SENT_585	[p27l1462t3660r2084b3719],
8	.	.	O	.	_	0	SENT_585	[p27l1462t3660r2084b3719],

1	41	CD	NUMBER	41	_	0	SENT_586	[p27l10t3749r109b3798],
2	.	.	O	.	_	0	SENT_586	[p27l10t3749r109b3798],

1	Lippman	NNP	PERSON	Lippman	nn	2	SENT_587	[p27l156t3749r412b3810],
2	SM	NNP	O	SM	_	0	SENT_587	[p27l450t3748r565b3808],
3	,	,	O	,	_	0	SENT_587	[p27l450t3748r565b3808],
4	Lee	NNP	PERSON	Lee	nn	5	SENT_587	[p27l606t3749r710b3799],
5	JJ	NN	PERSON	jj	appos	2	SENT_587	[p27l744t3749r816b3799],
6	.	.	O	.	_	0	SENT_587	[p27l744t3749r816b3799],

1	Reducing	VBG	O	reduce	_	0	SENT_588	[p27l857t3749r1138b3812],
2	the	DT	O	the	det	5	SENT_588	[p27l1168t3749r1265b3799],
3	“	NN	O	“	nn	5	SENT_588	[p27l1304t3749r1470b3799],
4	risk	NN	O	risk	nn	5	SENT_588	[p27l1304t3749r1470b3799],
5	”	NN	O	”	dobj	1	SENT_588	[p27l1304t3749r1470b3799],
6	of	IN	O	of	_	0	SENT_588	[p27l1509t3748r1569b3799],
7	chemoprevention	NN	O	chemoprevention	prep_of	5	SENT_588	[p27l1599t3749r2146b3810],
8	:	:	O	:	_	0	SENT_588	[p27l1599t3749r2146b3810],

1	defining	VBG	O	define	_	0	SENT_589	[p28l153t20r394b83],
2	and	CC	O	and	_	0	SENT_589	[p28l426t20r534b70],
3	targeting	VBG	O	target	conj_and	1	SENT_589	[p28l568t20r841b83],
4	high	JJ	O	high	acomp	3	SENT_589	[p28l875t20r995b83],
5	risk	NN	O	risk	nn	10	SENT_589	[p28l1034t20r1382b70],
6	—	CD	NUMBER	—	num	10	SENT_589	[p28l1034t20r1382b70],
7	2005	CD	DATE	2005	num	10	SENT_589	[p28l1034t20r1382b70],
8	AACR	NNP	O	AACR	nn	10	SENT_589	[p28l1415t20r1580b70],
9	Cancer	NNP	O	Cancer	nn	10	SENT_589	[p28l1615t20r1830b70],
10	Research	NNP	O	Research	dep	4	SENT_589	[p28l1864t20r2147b70],
11	and	CC	O	and	_	0	SENT_589	[p28l154t109r262b159],
12	Prevention	NNP	O	Prevention	nn	15	SENT_589	[p28l290t109r608b159],
13	Foundation	NNP	O	Foundation	nn	15	SENT_589	[p28l638t109r972b159],
14	Award	NN	O	award	nn	15	SENT_589	[p28l997t109r1179b159],
15	Lecture	NN	O	lecture	dep	4	SENT_589	[p28l1209t109r1450b159],
16	.	.	O	.	_	0	SENT_589	[p28l1209t109r1450b159],

1	Cancer	NN	O	cancer	_	0	SENT_590	[p28l1479t108r1693b159],
2	Res	NNP	O	Res	dep	1	SENT_590	[p28l1718t109r1829b159],
3	2006	CD	DATE	2006	num	2	SENT_590	[p28l1856t108r2146b168],
4	;	:	O	;	_	0	SENT_590	[p28l1856t108r2146b168],
5	66	CD	NUMBER	66	num	7	SENT_590	[p28l1856t108r2146b168],
6	:	:	O	:	_	0	SENT_590	[p28l1856t108r2146b168],
7	2893-2903	CD	DATE	2893-2903	dep	1	SENT_590	[p28l154t195r544b246],
8	.	.	O	.	_	0	SENT_590	[p28l154t195r544b246],

1	42	CD	NUMBER	42	_	0	SENT_591	[p28l10t283r109b333],
2	.	.	O	.	_	0	SENT_591	[p28l10t283r109b333],

1	Ulrich	NNP	PERSON	Ulrich	nn	2	SENT_592	[p28l156t283r321b333],
2	CM	NN	PERSON	cm	_	0	SENT_592	[p28l365t283r480b342],
3	,	,	O	,	_	0	SENT_592	[p28l365t283r480b342],
4	Bigler	NNP	PERSON	Bigler	nn	5	SENT_592	[p28l527t283r698b346],
5	J	NNP	PERSON	J	appos	2	SENT_592	[p28l734t283r777b342],
6	,	,	O	,	_	0	SENT_592	[p28l734t283r777b342],
7	Potter	NNP	PERSON	Potter	nn	8	SENT_592	[p28l823t283r1004b333],
8	JD	NNP	O	JD	appos	5	SENT_592	[p28l1040t283r1131b333],
9	.	.	O	.	_	0	SENT_592	[p28l1040t283r1131b333],

1	Non-steroidal	JJ	O	non-steroidal	amod	5	SENT_593	[p28l1178t283r1578b333],
2	anti	JJ	O	anti	amod	5	SENT_593	[p28l1623t283r2153b346],
3	—	NN	O	—	nn	5	SENT_593	[p28l1623t283r2153b346],
4	inflammatory	JJ	O	inflammatory	amod	5	SENT_593	[p28l1623t283r2153b346],
5	drugs	NNS	O	drug	_	0	SENT_593	[p28l153t372r320b435],
6	for	IN	O	for	_	0	SENT_593	[p28l343t371r426b422],
7	cancer	NN	O	cancer	nn	8	SENT_593	[p28l446t384r652b422],
8	prevention	NN	O	prevention	prep_for	5	SENT_593	[p28l676t372r1011b433],
9	:	:	O	:	_	0	SENT_593	[p28l676t372r1011b433],
10	promise	NN	O	promise	dep	5	SENT_593	[p28l1041t372r1303b433],
11	,	,	O	,	_	0	SENT_593	[p28l1041t372r1303b433],
12	perils	NNS	O	peril	conj_and	10	SENT_593	[p28l1333t372r1496b433],
13	and	CC	O	and	_	0	SENT_593	[p28l1522t372r1630b422],
14	pharmacogenet	NN	O	pharmacogenet	nn	16	SENT_593	[p28l1658t372r2152b435],
15	—	NN	O	—	nn	16	SENT_593	[p28l1658t372r2152b435],
16	ics	NNS	O	ic	dep	5	SENT_593	[p28l156t460r254b510],
17	.	.	O	.	_	0	SENT_593	[p28l156t460r254b510],

1	Nat	NNP	O	Nat	nn	3	SENT_594	[p28l290t460r393b510],
2	Rev	NN	O	rev	nn	3	SENT_594	[p28l422t460r531b510],
3	Cancer	NN	O	cancer	_	0	SENT_594	[p28l558t459r773b510],
4	2006	CD	DATE	2006	dep	3	SENT_594	[p28l800t459r1370b519],
5	;	:	O	;	_	0	SENT_594	[p28l800t459r1370b519],
6	6:130	CD	NUMBER	6:130	num	7	SENT_594	[p28l800t459r1370b519],
7	—	NN	O	—	dep	3	SENT_594	[p28l800t459r1370b519],
8	140	CD	NUMBER	140	dep	7	SENT_594	[p28l800t459r1370b519],
9	.	.	O	.	_	0	SENT_594	[p28l800t459r1370b519],

1	43	CD	NUMBER	43	_	0	SENT_595	[p28l10t547r109b597],
2	.	.	O	.	_	0	SENT_595	[p28l10t547r109b597],

1	Arber	NNP	O	Arber	nn	6	SENT_596	[p28l151t547r314b597],
2	N.	NNP	O	N.	nn	6	SENT_596	[p28l339t547r396b597],
3	Cyclooxygenase	NNP	O	Cyclooxygenase	nn	6	SENT_596	[p28l425t547r969b610],
4	—	NN	O	—	nn	6	SENT_596	[p28l425t547r969b610],
5	2	CD	NUMBER	2	num	6	SENT_596	[p28l425t547r969b610],
6	inhibitors	NNS	O	inhibitor	_	0	SENT_596	[p28l998t547r1278b597],
7	in	IN	O	in	_	0	SENT_596	[p28l1307t547r1353b597],
8	colorectal	JJ	O	colorectal	amod	10	SENT_596	[p28l1380t547r1675b597],
9	cancer	NN	O	cancer	nn	10	SENT_596	[p28l1703t559r1908b597],
10	prevention	NN	O	prevention	prep_in	6	SENT_596	[p28l1933t559r2152b609, p28l150t636r283b686],
11	:	:	O	:	_	0	SENT_596	[p28l1933t559r2152b609, p28l150t636r283b686],
12	point	NN	O	point	dep	6	SENT_596	[p28l322t636r488b697],
13	.	.	O	.	_	0	SENT_596	[p28l322t636r488b697],

1	Cancer	NNP	O	Cancer	nn	3	SENT_597	[p28l526t635r740b686],
2	Epidemiol	NNP	O	Epidemiol	nn	3	SENT_597	[p28l774t636r1067b697],
3	Biomarkers	NNS	O	biomarker	_	0	SENT_597	[p28l1106t636r1452b686],
4	Prev	NNP	O	Prev	dep	3	SENT_597	[p28l1488t636r1617b686],
5	2008	CD	DATE	2008	num	4	SENT_597	[p28l1648t635r2152b695],
6	;	:	O	;	_	0	SENT_597	[p28l1648t635r2152b695],
7	17:1852	CD	NUMBER	17:1852	number	8	SENT_597	[p28l1648t635r2152b695],
8	—	CD	NUMBER	—	dep	3	SENT_597	[p28l1648t635r2152b695],
9	1857	CD	DATE	1857	dep	8	SENT_597	[p28l156t722r337b773],
10	.	.	O	.	_	0	SENT_597	[p28l156t722r337b773],

1	44	CD	NUMBER	44	_	0	SENT_598	[p28l10t810r109b860],
2	.	.	O	.	_	0	SENT_598	[p28l10t810r109b860],

1	Dai	NN	PERSON	daus	nn	2	SENT_599	[p28l156t810r248b860],
2	C	NN	O	c	_	0	SENT_599	[p28l274t810r331b869],
3	,	,	O	,	_	0	SENT_599	[p28l274t810r331b869],
4	Stafford	NNP	O	Stafford	nn	5	SENT_599	[p28l358t810r599b860],
5	RS	NN	O	r	appos	2	SENT_599	[p28l627t810r725b869],
6	,	,	O	,	_	0	SENT_599	[p28l627t810r725b869],
7	Alexander	NNP	O	Alexander	nn	8	SENT_599	[p28l750t810r1054b860],
8	GC	NN	O	gc	appos	5	SENT_599	[p28l1075t810r1179b860],
9	.	.	O	.	_	0	SENT_599	[p28l1075t810r1179b860],

1	National	NNP	O	National	nn	2	SENT_600	[p28l1208t810r1456b860],
2	trends	NNS	O	trend	_	0	SENT_600	[p28l1479t810r1674b860],
3	in	IN	O	in	_	0	SENT_600	[p28l1701t810r1747b860],
4	cyclooxygen	NN	O	cyclooxygen	nn	8	SENT_600	[p28l1771t810r2152b873],
5	—	CD	NUMBER	—	num	8	SENT_600	[p28l1771t810r2152b873],
6	ase-2	NN	O	ase-2	nn	8	SENT_600	[p28l154t897r320b948],
7	inhibitor	NN	O	inhibitor	nn	8	SENT_600	[p28l352t898r599b948],
8	use	NN	O	use	prep_in	2	SENT_600	[p28l627t910r734b948],
9	since	IN	O	since	_	0	SENT_600	[p28l764t898r924b948],
10	market	NN	O	market	nn	11	SENT_600	[p28l955t898r1167b948],
11	release	NN	O	release	prep_since	2	SENT_600	[p28l1196t898r1438b948],
12	:	:	O	:	_	0	SENT_600	[p28l1196t898r1438b948],
13	nonselective	JJ	O	nonselective	amod	14	SENT_600	[p28l1472t898r1856b948],
14	diffusion	NN	O	diffusion	dep	2	SENT_600	[p28l1886t897r2148b948],
15	of	IN	O	of	_	0	SENT_600	[p28l153t985r213b1036],
16	a	DT	O	a	det	18	SENT_600	[p28l237t998r269b1036],
17	selectively	RB	O	selectively	advmod	18	SENT_600	[p28l297t986r618b1048],
18	cost	NN	O	cost	prep_of	14	SENT_600	[p28l642t985r1050b1036],
19	—	RB	O	—	advmod	20	SENT_600	[p28l642t985r1050b1036],
20	effective	JJ	O	effective	amod	21	SENT_600	[p28l642t985r1050b1036],
21	innovation	NN	O	innovation	dep	18	SENT_600	[p28l1081t986r1411b1036],
22	.	.	O	.	_	0	SENT_600	[p28l1081t986r1411b1036],

1	Arch	NNP	O	Arch	nn	3	SENT_601	[p28l1440t986r1571b1036],
2	Intern	NNP	O	Intern	nn	3	SENT_601	[p28l1604t986r1774b1036],
3	Med	NNP	O	Med	_	0	SENT_601	[p28l1806t986r1932b1036],
4	2005	CD	DATE	2005	num	3	SENT_601	[p28l1963t985r2146b1045],
5	;	:	O	;	_	0	SENT_601	[p28l1963t985r2146b1045],
6	165:171	CD	NUMBER	165:171	num	7	SENT_601	[p28l156t1072r609b1122],
7	—	NN	O	—	dep	3	SENT_601	[p28l156t1072r609b1122],
8	177	CD	NUMBER	177	dep	7	SENT_601	[p28l156t1072r609b1122],
9	.	.	O	.	_	0	SENT_601	[p28l156t1072r609b1122],

1	Received	VBN	O	receive	_	0	SENT_602	[p28l84t1301r354b1350],
2	November	NNP	DATE	November	tmod	1	SENT_602	[p28l387t1301r697b1350],
3	24	CD	DATE	24	num	2	SENT_602	[p28l724t1300r818b1359],
4	,	,	DATE	,	_	0	SENT_602	[p28l724t1300r818b1359],
5	2008	CD	DATE	2008	num	2	SENT_602	[p28l849t1300r1026b1350],
6	.	.	O	.	_	0	SENT_602	[p28l849t1300r1026b1350],

1	Accepted	JJ	O	accepted	_	0	SENT_603	[p28l1054t1301r1334b1361],
2	February	NNP	DATE	February	tmod	1	SENT_603	[p28l1368t1301r1631b1362],
3	11	CD	DATE	11	num	2	SENT_603	[p28l1660t1300r1752b1359],
4	,	,	DATE	,	_	0	SENT_603	[p28l1660t1300r1752b1359],
5	2009	CD	DATE	2009	num	2	SENT_603	[p28l1782t1300r1960b1350],
6	.	.	O	.	_	0	SENT_603	[p28l1782t1300r1960b1350],

1	Reprint	JJ	O	reprint	amod	2	SENT_604	[p28l10t1478r233b1539],
2	requests	NNS	O	request	_	0	SENT_604	[p28l258t1481r518b1539],

1	Address	NN	O	address	nn	2	SENT_605	[p28l79t1567r323b1616],
2	requests	NNS	O	request	_	0	SENT_605	[p28l353t1570r611b1627],
3	for	IN	O	for	mark	4	SENT_605	[p28l637t1566r720b1616],
4	reprints	VBZ	O	reprint	dep	2	SENT_605	[p28l749t1567r978b1627],
5	to	TO	O	to	prep	4	SENT_605	[p28l1004t1570r1077b1616],
6	:	:	O	:	_	0	SENT_605	[p28l1004t1570r1077b1616],
7	Andrew	NNP	PERSON	Andrew	nn	9	SENT_605	[p28l1106t1567r1336b1616],
8	T.	NNP	PERSON	T.	nn	9	SENT_605	[p28l1360t1567r1408b1615],
9	Chan	NNP	PERSON	Chan	dep	2	SENT_605	[p28l1439t1566r1607b1625],
10	,	,	O	,	_	0	SENT_605	[p28l1439t1566r1607b1625],
11	MD	NNP	O	MD	appos	9	SENT_605	[p28l1640t1567r1752b1625],
12	,	,	O	,	_	0	SENT_605	[p28l1640t1567r1752b1625],
13	MPH	NNP	O	MPH	appos	9	SENT_605	[p28l1785t1567r1940b1625],
14	,	,	O	,	_	0	SENT_605	[p28l1785t1567r1940b1625],
15	Gastrointestinal	JJ	O	gastrointestinal	amod	16	SENT_605	[p28l10t1655r489b1704],
16	Unit	NN	O	unit	appos	9	SENT_605	[p28l521t1655r652b1714],
17	,	,	O	,	_	0	SENT_605	[p28l521t1655r652b1714],
18	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	20	SENT_605	[p28l685t1655r1137b1704],
19	General	NNP	ORGANIZATION	General	nn	20	SENT_605	[p28l1165t1655r1397b1704],
20	Hospital	NNP	ORGANIZATION	Hospital	appos	9	SENT_605	[p28l1430t1655r1690b1715],
21	,	,	O	,	_	0	SENT_605	[p28l1430t1655r1690b1715],
22	55	CD	NUMBER	55	num	24	SENT_605	[p28l1721t1655r1800b1704],
23	Fruit	NNP	O	Fruit	nn	24	SENT_605	[p28l1830t1655r1962b1704],
24	Street	NNP	O	Street	appos	9	SENT_605	[p28l8t1742r207b1801],
25	,	,	O	,	_	0	SENT_605	[p28l8t1742r207b1801],
26	GRJ-728A	NN	O	grj-728a	appos	9	SENT_605	[p28l237t1742r552b1801],
27	,	,	O	,	_	0	SENT_605	[p28l237t1742r552b1801],
28	Boston	NNP	LOCATION	Boston	appos	9	SENT_605	[p28l585t1743r806b1801],
29	,	,	O	,	_	0	SENT_605	[p28l585t1743r806b1801],
30	MA	NNP	O	MA	appos	9	SENT_605	[p28l839t1743r934b1791],
31	02114	CD	DATE	02114	num	30	SENT_605	[p28l961t1742r1180b1791],
32	.	.	O	.	_	0	SENT_605	[p28l961t1742r1180b1791],

1	e-mail	VB	O	e-mail	dep	4	SENT_606	[p28l1211t1743r1412b1791],
2	:	:	O	:	_	0	SENT_606	[p28l1211t1743r1412b1791],
3	achan@partners.org;	NN	O	achan@partners.org;	nn	4	SENT_606	[p28l1442t1743r2065b1803],
4	fax	NN	O	fax	_	0	SENT_606	[p28l8t1830r114b1880],
5	:	:	O	:	_	0	SENT_606	[p28l8t1830r114b1880],
6	(617) 726 3673	CD	NUMBER	(617) 726 3673	dep	4	SENT_606	[p28l485t1830r663b1880],[p28l144t1830r308b1891],
7	.	.	O	.	_	0	SENT_606	[p28l485t1830r663b1880],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_607	[p28l6t2009r570b2069],

1	The	DT	O	the	det	2	SENT_608	[p28l79t2097r188b2146],
2	authors	NNS	O	author	nsubj	3	SENT_608	[p28l216t2097r445b2146],
3	thank	VBP	O	thank	_	0	SENT_608	[p28l471t2097r647b2146],
4	Patrice	NNP	PERSON	Patrice	nn	5	SENT_608	[p28l676t2097r885b2146],
5	Soule	NNP	PERSON	Soule	dobj	3	SENT_608	[p28l912t2096r1081b2146],
6	and	CC	O	and	_	0	SENT_608	[p28l1110t2097r1218b2146],
7	Hardeep	NNP	PERSON	Hardeep	nn	8	SENT_608	[p28l1251t2097r1505b2157],
8	Ranu	NNP	PERSON	Ranu	conj_and	5	SENT_608	[p28l1535t2097r1688b2146],
9	of	IN	O	of	_	0	SENT_608	[p28l1718t2096r1776b2146],
10	the	DT	O	the	det	19	SENT_608	[p28l1801t2097r1897b2146],
11	DanaFarber	NNP	O	DanaFarber	nn	19	SENT_608	[p28l1928t2097r2104b2146, p28l12t2185r206b2234],
12	Harvard	NNP	ORGANIZATION	Harvard	nn	19	SENT_608	[p28l235t2185r466b2234],
13	Cancer	NNP	ORGANIZATION	Cancer	nn	19	SENT_608	[p28l497t2185r707b2234],
14	Center	NNP	ORGANIZATION	Center	nn	19	SENT_608	[p28l734t2185r932b2234],
15	High	NNP	O	High	nn	19	SENT_608	[p28l962t2185r1091b2246],
16	Throughput	NNP	O	Throughput	nn	19	SENT_608	[p28l1119t2185r1467b2246],
17	Polymorphism	NN	O	polymorphism	nn	19	SENT_608	[p28l1497t2185r1931b2246],
18	Detection	NN	O	detection	nn	19	SENT_608	[p28l12t2272r298b2320],
19	Core	NN	O	core	prep_of	5	SENT_608	[p28l329t2271r465b2320],
20	for	IN	O	for	_	0	SENT_608	[p28l491t2271r574b2320],
21	technical	JJ	O	technical	amod	22	SENT_608	[p28l600t2272r872b2320],
22	assistance	NN	O	assistance	prep_for	3	SENT_608	[p28l903t2272r1238b2320],
23	.	.	O	.	_	0	SENT_608	[p28l903t2272r1238b2320],

1	Portions	NNS	O	portion	nsubjpass	7	SENT_609	[p28l1271t2272r1518b2320],
2	of	IN	O	of	_	0	SENT_609	[p28l1546t2271r1603b2320],
3	this	DT	O	this	det	4	SENT_609	[p28l1629t2272r1738b2320],
4	data	NNS	O	datum	prep_of	1	SENT_609	[p28l1766t2272r1898b2320],
5	were	VBD	O	be	auxpass	7	SENT_609	[p28l1927t2283r2072b2320],
6	previously	RB	DATE	previously	advmod	7	SENT_609	[p28l12t2360r314b2421],
7	presented	VBN	O	present	_	0	SENT_609	[p28l342t2360r641b2420],
8	in	IN	O	in	_	0	SENT_609	[p28l674t2360r721b2408],
9	abstract	JJ	O	abstract	amod	10	SENT_609	[p28l751t2360r999b2409],
10	form	NN	O	form	prep_in	7	SENT_609	[p28l1024t2359r1166b2409],
11	at	IN	O	at	_	0	SENT_609	[p28l1196t2362r1254b2409],
12	Digestive	JJ	O	digestive	amod	14	SENT_609	[p28l1284t2360r1558b2421],
13	Disease	NN	O	disease	nn	14	SENT_609	[p28l1589t2360r1825b2409],
14	Week	NN	DURATION	week	prep_at	7	SENT_609	[p28l1851t2360r2027b2409],
15	in	IN	O	in	_	0	SENT_609	[p28l2055t2360r2103b2408],
16	San	NNP	LOCATION	San	nn	17	SENT_609	[p28l8t2448r121b2497],
17	Diego	NNP	LOCATION	Diego	prep_in	14	SENT_609	[p28l154t2448r340b2509],
18	,	,	O	,	_	0	SENT_609	[p28l154t2448r340b2509],
19	CA	NNP	LOCATION	CA	conj_and	14	SENT_609	[p28l370t2448r466b2507],
20	,	,	O	,	_	0	SENT_609	[p28l370t2448r466b2507],
21	on	IN	O	on	conj_and	14	SENT_609	[p28l496t2460r566b2497],
22	May	NNP	DATE	May	pobj	21	SENT_609	[p28l599t2448r721b2509],
23	17-22	CD	DATE	17-22	num	22	SENT_609	[p28l750t2447r961b2507],
24	,	,	DATE	,	_	0	SENT_609	[p28l750t2447r961b2507],
25	2008	CD	DATE	2008	num	22	SENT_609	[p28l991t2448r1169b2507],
26	,	,	O	,	_	0	SENT_609	[p28l991t2448r1169b2507],
27	and	CC	O	and	_	0	SENT_609	[p28l1199t2448r1308b2497],
28	the	DT	O	the	det	30	SENT_609	[p28l1337t2448r1434b2497],
29	American	NNP	ORGANIZATION	American	nn	30	SENT_609	[p28l1459t2448r1750b2497],
30	Association	NNP	ORGANIZATION	Association	conj_and	14	SENT_609	[p28l1778t2448r2125b2497],
31	for	IN	ORGANIZATION	for	_	0	SENT_609	[p28l8t2535r91b2584],
32	Cancer	NNP	ORGANIZATION	Cancer	nn	33	SENT_609	[p28l118t2535r328b2584],
33	Research	NNP	ORGANIZATION	Research	prep_for	30	SENT_609	[p28l357t2536r635b2584],
34	Molecular	JJ	ORGANIZATION	molecular	amod	35	SENT_609	[p28l669t2536r965b2584],
35	Diagnostics	NNPS	ORGANIZATION	Diagnostics	dep	40	SENT_609	[p28l994t2536r1343b2596],
36	in	IN	O	in	_	0	SENT_609	[p28l1372t2536r1420b2584],
37	Cancer	NNP	O	Cancer	prep_in	35	SENT_609	[p28l1450t2535r1660b2584],
38	Therapeutic	JJ	O	therapeutic	amod	39	SENT_609	[p28l1684t2536r2045b2596],
39	Development	NNP	O	Development	dep	40	SENT_609	[p28l12t2624r415b2684],
40	meeting	NN	O	meeting	dep	30	SENT_609	[p28l444t2624r694b2685],
41	in	IN	O	in	_	0	SENT_609	[p28l722t2624r769b2672],
42	Philadelphia	NNP	LOCATION	Philadelphia	prep_in	40	SENT_609	[p28l802t2624r1192b2684],
43	,	,	O	,	_	0	SENT_609	[p28l802t2624r1192b2684],
44	PA	NN	ORGANIZATION	pa	appos	42	SENT_609	[p28l1225t2624r1320b2682],
45	,	,	O	,	_	0	SENT_609	[p28l1225t2624r1320b2682],
46	on	IN	O	on	_	0	SENT_609	[p28l1350t2636r1420b2673],
47	September	NNP	DATE	September	prep_on	30	SENT_609	[p28l1448t2623r1787b2684],
48	22-25	CD	DATE	22-25	num	47	SENT_609	[p28l1813t2623r2008b2682],
49	,	,	DATE	,	_	0	SENT_609	[p28l1813t2623r2008b2682],
50	2008	CD	DATE	2008	num	47	SENT_609	[p28l10t2712r188b2761],
51	.	.	O	.	_	0	SENT_609	[p28l10t2712r188b2761],

1	Representatives	NNS	O	representative	nsubj	13	SENT_610	[p28l221t2712r710b2772],
2	of	IN	O	of	_	0	SENT_610	[p28l737t2712r795b2761],
3	the	DT	O	the	det	4	SENT_610	[p28l820t2712r916b2761],
4	NCI	NNP	ORGANIZATION	NCI	prep_of	1	SENT_610	[p28l947t2712r1063b2771],
5	,	,	O	,	_	0	SENT_610	[p28l947t2712r1063b2771],
6	Pfizer	NNP	ORGANIZATION	Pfizer	nn	7	SENT_610	[p28l1096t2712r1262b2761],
7	Inc	NNP	ORGANIZATION	Inc	prep_of	1	SENT_610	[p28l1292t2712r1391b2771],
8	,	,	O	,	_	0	SENT_610	[p28l1292t2712r1391b2771],
9	and	CC	O	and	_	0	SENT_610	[p28l1422t2712r1531b2761],
10	affiliated	JJ	O	affiliated	amod	12	SENT_610	[p28l1561t2712r1827b2761],
11	academic	JJ	O	academic	amod	12	SENT_610	[p28l10t2800r306b2848],
12	institutions	NNS	O	institution	conj_and	4	SENT_610	[p28l335t2800r669b2848],
13	participated	VBD	O	participate	_	0	SENT_610	[p28l699t2800r1058b2860],
14	in	IN	O	in	_	0	SENT_610	[p28l1091t2800r1138b2848],
15	the	DT	O	the	det	16	SENT_610	[p28l1167t2800r1263b2848],
16	analysis	NN	O	analysis	prep_in	13	SENT_610	[p28l1291t2800r1535b2860],
17	and	CC	O	and	_	0	SENT_610	[p28l1562t2800r1672b2848],
18	interpretation	NN	O	interpretation	prep_in	13	SENT_610	[p28l1704t2800r2114b2860],
19	of	IN	O	of	_	0	SENT_610	[p28l10t2886r67b2935],
20	the	DT	O	the	det	21	SENT_610	[p28l93t2887r189b2936],
21	data	NNS	O	datum	prep_of	16	SENT_610	[p28l217t2887r367b2936],
22	.	.	O	.	_	0	SENT_610	[p28l217t2887r367b2936],

1	Conflicts	NNS	O	conflict	_	0	SENT_611	[p28l11t3063r271b3114],
2	of	IN	O	of	_	0	SENT_611	[p28l298t3063r362b3113],
3	interest	NN	O	interest	prep_of	1	SENT_611	[p28l381t3064r615b3113],

1	The	DT	O	the	det	2	SENT_612	[p28l79t3153r188b3202],
2	authors	NNS	O	author	nsubj	3	SENT_612	[p28l216t3153r445b3202],
3	disclose	VBP	O	disclose	_	0	SENT_612	[p28l472t3153r715b3202],
4	the	DT	O	the	det	5	SENT_612	[p28l742t3153r838b3202],
5	following	NN	O	following	dobj	3	SENT_612	[p28l864t3152r1153b3214],
6	:	:	O	:	_	0	SENT_612	[p28l864t3152r1153b3214],
7	Dr	NNP	O	Dr	nn	8	SENT_612	[p28l1186t3153r1251b3201],
8	Zauber	NNP	PERSON	Zauber	nsubj	14	SENT_612	[p28l1277t3153r1490b3202],
9	and	CC	O	and	_	0	SENT_612	[p28l1517t3153r1626b3202],
10	Dr	NNP	O	Dr	nn	11	SENT_612	[p28l1659t3153r1724b3201],
11	Bertagnolli	NNP	PERSON	Bertagnolli	nsubj	14	SENT_612	[p28l1753t3153r2076b3214],
12	are	VBP	O	be	cop	14	SENT_612	[p28l10t3253r106b3290],
13	the	DT	O	the	det	14	SENT_612	[p28l132t3241r228b3290],
14	recipients	NNS	O	recipient	parataxis	3	SENT_612	[p28l259t3241r552b3301],
15	of	IN	O	of	_	0	SENT_612	[p28l580t3241r637b3290],
16	research	NN	O	research	nn	17	SENT_612	[p28l666t3241r923b3290],
17	funding	NN	O	funding	prep_of	14	SENT_612	[p28l951t3241r1182b3302],
18	from	IN	O	from	_	0	SENT_612	[p28l1206t3241r1348b3290],
19	Pfizer	NNP	ORGANIZATION	Pfizer	nn	20	SENT_612	[p28l1381t3241r1548b3290],
20	Inc.	NNP	ORGANIZATION	Inc.	prep_from	17	SENT_612	[p28l1577t3241r1677b3290],
21	.	.	O	.	_	0	SENT_612	[p28l1577t3241r1677b3290],

1	Dr	NNP	O	Dr	nn	2	SENT_613	[p28l1709t3241r1775b3289],
2	Breazna	NNP	PERSON	Breazna	nsubj	11	SENT_613	[p28l1804t3241r2063b3300],
3	,	,	O	,	_	0	SENT_613	[p28l1804t3241r2063b3300],
4	Dr	NNP	O	Dr	nn	5	SENT_613	[p28l12t3329r78b3377],
5	Rosenstein	NNP	PERSON	Rosenstein	conj_and	2	SENT_613	[p28l107t3329r456b3387],
6	,	,	O	,	_	0	SENT_613	[p28l107t3329r456b3387],
7	and	CC	O	and	_	0	SENT_613	[p28l487t3329r596b3377],
8	Dr	NNP	O	Dr	nn	9	SENT_613	[p28l629t3329r694b3377],
9	Eagle	NNP	O	Eagle	conj_and	2	SENT_613	[p28l723t3329r885b3389],
10	are	VBP	O	be	cop	11	SENT_613	[p28l913t3340r1009b3377],
11	employees	NNS	O	employee	_	0	SENT_613	[p28l1037t3329r1366b3389],
12	of	IN	O	of	prep	11	SENT_613	[p28l1393t3328r1451b3377],
13	and	CC	O	and	_	0	SENT_613	[p28l1477t3329r1586b3377],
14	shareholders	NNS	O	shareholder	conj_and	11	SENT_613	[p28l1615t3329r2010b3377],
15	in	IN	O	in	_	0	SENT_613	[p28l2040t3329r2087b3377],
16	Pfizer	NNP	ORGANIZATION	Pfizer	nn	17	SENT_613	[p28l12t3415r180b3464],
17	Inc.	NNP	ORGANIZATION	Inc.	prep_in	14	SENT_613	[p28l209t3416r309b3464],
18	.	.	O	.	_	0	SENT_613	[p28l209t3416r309b3464],

1	Dr	NNP	O	Dr	nn	2	SENT_614	[p28l341t3416r406b3464],
2	Hawk	NNP	PERSON	Hawk	nsubj	4	SENT_614	[p28l436t3416r603b3464],
3	has	VBZ	O	have	aux	4	SENT_614	[p28l632t3416r735b3464],
4	served	VBN	O	serve	_	0	SENT_614	[p28l761t3416r958b3464],
5	as	IN	O	as	_	0	SENT_614	[p28l988t3428r1055b3464],
6	a	DT	O	a	det	7	SENT_614	[p28l1083t3428r1116b3464],
7	consultant	NN	O	consultant	prep_as	4	SENT_614	[p28l1145t3416r1463b3464],
8	for	IN	O	for	_	0	SENT_614	[p28l1488t3415r1571b3464],
9	Pozen	NNP	ORGANIZATION	Pozen	nn	12	SENT_614	[p28l1601t3416r1778b3464],
10	Pharmaceutical	NNP	ORGANIZATION	Pharmaceutical	nn	12	SENT_614	[p28l12t3504r487b3553],
11	Development	NNP	ORGANIZATION	Development	nn	12	SENT_614	[p28l520t3504r923b3564],
12	Company	NNP	ORGANIZATION	Company	prep_for	7	SENT_614	[p28l950t3504r1250b3565],
13	.	.	O	.	_	0	SENT_614	[p28l950t3504r1250b3565],

1	The	DT	O	the	det	3	SENT_615	[p28l1278t3504r1387b3553],
2	remaining	VBG	O	remain	amod	3	SENT_615	[p28l1417t3504r1724b3565],
3	authors	NNS	O	author	nsubj	4	SENT_615	[p28l1750t3504r1979b3553],
4	disclose	VB	O	disclose	_	0	SENT_615	[p28l10t3592r252b3640],
5	no	DT	O	no	det	6	SENT_615	[p28l283t3604r352b3640],
6	conflicts	NNS	O	conflict	dobj	4	SENT_615	[p28l381t3591r646b3640],
7	.	.	O	.	_	0	SENT_615	[p28l381t3591r646b3640],

1	The	DT	O	the	det	3	SENT_616	[p28l674t3592r783b3640],
2	statistical	JJ	O	statistical	amod	3	SENT_616	[p28l809t3592r1102b3641],
3	analysis	NN	O	analysis	nsubjpass	17	SENT_616	[p28l1132t3592r1375b3652],
4	of	IN	O	of	_	0	SENT_616	[p28l1403t3591r1460b3640],
5	the	DT	O	the	det	8	SENT_616	[p28l1486t3592r1582b3640],
6	entire	JJ	O	entire	amod	8	SENT_616	[p28l1610t3592r1783b3641],
7	data	NNS	O	datum	nn	8	SENT_616	[p28l1812t3592r1944b3641],
8	sets	NNS	O	set	prep_of	3	SENT_616	[p28l1972t3594r2096b3641],
9	pertaining	VBG	O	pertain	partmod	8	SENT_616	[p28l12t3680r318b3741],
10	to	TO	O	to	_	0	SENT_616	[p28l343t3683r401b3729],
11	efficacy	NN	O	efficacy	prep_to	9	SENT_616	[p28l429t3679r662b3741],
12	and	CC	O	and	_	0	SENT_616	[p28l688t3680r797b3729],
13	safety	NN	O	safety	conj_and	11	SENT_616	[p28l826t3679r1011b3741],
14	has	VBZ	O	have	aux	17	SENT_616	[p28l1039t3680r1143b3729],
15	been	VBN	O	be	auxpass	17	SENT_616	[p28l1173t3680r1316b3729],
16	independently	RB	O	independently	advmod	17	SENT_616	[p28l1349t3680r1777b3741],
17	confirmed	VBN	O	confirm	_	0	SENT_616	[p28l1804t3679r2107b3729],
18	by	IN	O	by	_	0	SENT_616	[p29l12t20r78b81],
19	Dr	NNP	O	Dr	nn	20	SENT_616	[p29l106t20r171b68],
20	Zauber	NNP	PERSON	Zauber	agent	17	SENT_616	[p29l197t20r424b79],
21	,	,	O	,	_	0	SENT_616	[p29l197t20r424b79],
22	who	WP	O	who	nsubjpass	25	SENT_616	[p29l453t20r576b69],
23	is	VBZ	O	be	auxpass	25	SENT_616	[p29l607t20r651b69],
24	not	RB	O	not	neg	25	SENT_616	[p29l680t23r774b69],
25	employed	VBN	O	employ	rcmod	20	SENT_616	[p29l801t20r1096b81],
26	by	IN	O	by	_	0	SENT_616	[p29l1128t20r1194b81],
27	any	DT	O	any	det	29	SENT_616	[p29l1220t32r1327b81],
28	corporate	JJ	O	corporate	amod	29	SENT_616	[p29l1353t23r1643b80],
29	entity	NN	O	entity	agent	25	SENT_616	[p29l1671t20r1853b81],
30	.	.	O	.	_	0	SENT_616	[p29l1671t20r1853b81],

1	The	DT	O	the	det	3	SENT_617	[p29l1881t20r1989b69],
2	corresponding	JJ	O	corresponding	amod	3	SENT_617	[p29l10t108r443b168],
3	author	NN	O	author	nsubj	13	SENT_617	[p29l469t108r666b157],
4	had	VBD	O	have	_	0	SENT_617	[p29l695t108r802b156],
5	full	JJ	O	full	amod	6	SENT_617	[p29l830t107r922b156],
6	access	NN	O	access	dobj	4	SENT_617	[p29l952t120r1156b156],
7	to	TO	O	to	_	0	SENT_617	[p29l1182t110r1240b157],
8	all	DT	O	all	prep_to	4	SENT_617	[p29l1268t108r1335b156],
9	of	IN	O	of	_	0	SENT_617	[p29l1365t107r1423b156],
10	the	DT	O	the	det	11	SENT_617	[p29l1448t108r1544b157],
11	data	NNS	O	datum	prep_of	8	SENT_617	[p29l1573t108r1706b157],
12	and	CC	O	and	_	0	SENT_617	[p29l1735t108r1844b156],
13	takes	VBZ	O	take	conj_and	4	SENT_617	[p29l1873t108r2041b157],
14	full	JJ	O	full	amod	15	SENT_617	[p29l8t195r99b245],
15	responsibility	NN	O	responsibility	dobj	13	SENT_617	[p29l132t196r531b257],
16	for	IN	O	for	_	0	SENT_617	[p29l556t195r639b245],
17	the	DT	O	the	det	18	SENT_617	[p29l664t196r760b245],
18	veracity	NN	O	veracity	prep_for	13	SENT_617	[p29l786t196r1022b257],
19	of	IN	O	of	_	0	SENT_617	[p29l1049t195r1106b245],
20	the	DT	O	the	det	21	SENT_617	[p29l1131t196r1228b245],
21	data	NNS	O	datum	prep_of	18	SENT_617	[p29l1256t196r1389b245],
22	and	CC	O	and	_	0	SENT_617	[p29l1419t196r1528b245],
23	analysis	NN	O	analysis	prep_of	18	SENT_617	[p29l1558t196r1817b257],
24	.	.	O	.	_	0	SENT_617	[p29l1558t196r1817b257],

1	Funding	NNP	O	Funding	_	0	SENT_618	[p29l10t373r252b434],

1	Supported	VBN	O	support	_	0	SENT_619	[p29l79t461r392b522],
2	by	IN	O	by	_	0	SENT_619	[p29l424t462r490b523],
3	the	DT	O	the	det	8	SENT_619	[p29l515t462r611b511],
4	Damon	NNP	ORGANIZATION	Damon	nn	8	SENT_619	[p29l641t462r856b511],
5	Runyon	NNP	ORGANIZATION	Runyon	nn	8	SENT_619	[p29l889t462r1111b523],
6	Cancer	NNP	ORGANIZATION	Cancer	nn	8	SENT_619	[p29l1142t461r1352b511],
7	Research	NNP	ORGANIZATION	Research	nn	8	SENT_619	[p29l1381t462r1659b511],
8	Foundation	NNP	ORGANIZATION	Foundation	prep_by	1	SENT_619	[p29l1692t462r2028b511],
9	Clinical	JJ	O	clinical	amod	11	SENT_619	[p29l10t550r225b599],
10	Investigator	NNP	O	Investigator	nn	11	SENT_619	[p29l258t550r613b611],
11	Award	NN	O	award	dep	8	SENT_619	[p29l637t550r826b599],
12	and	CC	O	and	_	0	SENT_619	[p29l857t550r966b599],
13	a	DT	O	a	det	16	SENT_619	[p29l996t562r1029b599],
14	career	NN	O	career	nn	16	SENT_619	[p29l1059t562r1250b599],
15	development	NN	O	development	nn	16	SENT_619	[p29l1277t550r1673b610],
16	award	NN	O	award	prep_by	1	SENT_619	[p29l1701t550r1883b599],
17	from	IN	O	from	_	0	SENT_619	[p29l1912t550r2053b599],
18	the	DT	O	the	det	23	SENT_619	[p29l9t638r105b687],
19	National	NNP	ORGANIZATION	National	nn	23	SENT_619	[p29l136t638r384b687],
20	Cancer	NNP	ORGANIZATION	Cancer	nn	23	SENT_619	[p29l415t637r625b686],
21	Institute	NNP	ORGANIZATION	Institute	nn	23	SENT_619	[p29l654t638r900b687],
22	(	NN	O	(	nn	23	SENT_619	[p29l922t637r1290b698],
23	CA107412	NN	O	ca107412	prep_from	16	SENT_619	[p29l922t637r1290b698],
24	;	:	O	;	_	0	SENT_619	[p29l922t637r1290b698],
25	to	TO	O	to	_	0	SENT_619	[p29l1319t640r1376b687],
26	A.T.C.	NNP	O	A.T.C.	prep_to	16	SENT_619	[p29l1403t637r1610b698],
27	)	CD	NUMBER	)	num	26	SENT_619	[p29l1403t637r1610b698],
28	;	:	O	;	_	0	SENT_619	[p29l1403t637r1610b698],
29	funding	NN	O	funding	prep_by	1	SENT_619	[p29l1638t637r1869b698],
30	from	IN	O	from	_	0	SENT_619	[p29l1893t637r2035b686],
31	the	DT	O	the	det	36	SENT_619	[p29l9t726r105b775],
32	National	NNP	ORGANIZATION	National	nn	36	SENT_619	[p29l136t726r384b775],
33	Cancer	NNP	ORGANIZATION	Cancer	nn	36	SENT_619	[p29l415t725r625b775],
34	Institute	NNP	ORGANIZATION	Institute	nn	36	SENT_619	[p29l654t726r900b775],
35	(	NN	O	(	nn	36	SENT_619	[p29l929t725r1405b786],
36	N01-CN95015	NN	O	n01-cn95015	prep_from	29	SENT_619	[p29l929t725r1405b786],
37	;	:	O	;	_	0	SENT_619	[p29l929t725r1405b786],
38	to	TO	O	to	_	0	SENT_619	[p29l1434t729r1492b775],
39	A.G.Z.	NNP	O	A.G.Z.	prep_to	29	SENT_619	[p29l1518t725r1693b775],
40	and	CC	O	and	_	0	SENT_619	[p29l1724t726r1833b775],
41	M.M.B.	NNP	O	M.M.B.	conj_and	39	SENT_619	[p29l1866t726r2107b786],
42	)	CD	NUMBER	)	num	41	SENT_619	[p29l1866t726r2107b786],
43	;	:	O	;	_	0	SENT_619	[p29l1866t726r2107b786],
44	sponsorship	NN	O	sponsorship	conj_and	8	SENT_619	[p29l8t814r374b874],
45	for	IN	O	for	_	0	SENT_619	[p29l400t814r483b863],
46	the	DT	O	the	det	48	SENT_619	[p29l509t814r605b863],
47	APC	NN	ORGANIZATION	apc	nn	48	SENT_619	[p29l631t814r757b863],
48	trial	NN	O	trial	prep_for	44	SENT_619	[p29l783t814r898b863],
49	from	IN	O	from	_	0	SENT_619	[p29l926t814r1067b863],
50	the	DT	O	the	det	53	SENT_619	[p29l1097t814r1193b863],
51	National	NNP	ORGANIZATION	National	nn	53	SENT_619	[p29l1224t814r1473b863],
52	Cancer	NNP	ORGANIZATION	Cancer	nn	53	SENT_619	[p29l1503t814r1714b863],
53	Institute	NNP	ORGANIZATION	Institute	prep_from	48	SENT_619	[p29l1742t814r1988b863],
54	and	CC	O	and	_	0	SENT_619	[p29l2017t814r2125b863],
55	Pfizer	NNP	ORGANIZATION	Pfizer	nn	57	SENT_619	[p29l12t901r194b960],
56	,	,	ORGANIZATION	,	_	0	SENT_619	[p29l12t901r194b960],
57	Inc	NNP	ORGANIZATION	Inc	prep_from	48	SENT_619	[p29l227t902r326b960],
58	,	,	O	,	_	0	SENT_619	[p29l227t902r326b960],
59	through	IN	O	through	_	0	SENT_619	[p29l355t902r587b962],
60	a	DT	O	a	det	63	SENT_619	[p29l618t914r650b950],
61	clinical	JJ	O	clinical	amod	63	SENT_619	[p29l680t902r887b950],
62	trials	NNS	O	trial	nn	63	SENT_619	[p29l916t902r1066b950],
63	agreement	NN	O	agreement	prep_through	44	SENT_619	[p29l1094t904r1441b962],
64	;	:	O	;	_	0	SENT_619	[p29l1094t904r1441b962],
65	and	CC	O	and	_	0	SENT_619	[p29l1471t902r1580b950],
66	additional	JJ	O	additional	amod	68	SENT_619	[p29l1611t902r1910b950],
67	NIH	NNP	ORGANIZATION	NIH	nn	68	SENT_619	[p29l1943t902r2045b950],
68	grants	NNS	O	grant	conj_and	8	SENT_619	[p29l9t993r200b1051],
69	CA127003	NN	O	ca127003	dep	68	SENT_619	[p29l227t989r573b1048],
70	,	,	O	,	_	0	SENT_619	[p29l227t989r573b1048],
71	CA131504	NN	O	ca131504	conj_and	69	SENT_619	[p29l603t989r949b1048],
72	,	,	O	,	_	0	SENT_619	[p29l603t989r949b1048],
73	and	CC	O	and	_	0	SENT_619	[p29l979t990r1088b1039],
74	CA137178	NN	O	ca137178	conj_and	69	SENT_619	[p29l1119t989r1464b1039],
75	.	.	O	.	_	0	SENT_619	[p29l1119t989r1464b1039],

1	June	NNP	DATE	June	_	0	SENT_620	[p29l7t1088r146b1137],
2	2009	CD	DATE	2009	dep	1	SENT_620	[p29l175t1088r336b1137],

1	Supplementary	NNP	O	Supplementary	nn	4	SENT_621	[p29l279t1298r983b1391],
2	Materials	NNPS	O	Materials	nn	4	SENT_621	[p29l1024t1299r1440b1372],
3	Study	NNP	O	Study	nn	4	SENT_621	[p29l277t1410r500b1506],
4	Population	NNP	O	Population	dep	19	SENT_621	[p29l532t1410r971b1506],
5	In	IN	O	in	_	0	SENT_621	[p29l277t1532r355b1589],
6	brief	NN	O	brief	prep_in	19	SENT_621	[p29l388t1526r577b1605],
7	,	,	O	,	_	0	SENT_621	[p29l388t1526r577b1605],
8	the	DT	O	the	det	16	SENT_621	[p29l615t1526r730b1590],
9	Adenoma	NNP	O	Adenoma	nn	10	SENT_621	[p29l762t1525r1125b1591],
10	Prevention	NNP	O	Prevention	dep	16	SENT_621	[p29l1158t1528r1559b1590],
11	with	IN	O	with	_	0	SENT_621	[p29l1592t1526r1757b1589],
12	Celecoxib	NNP	O	Celecoxib	prep_with	10	SENT_621	[p29l1794t1526r2147b1590],
13	(	CD	NUMBER	(	num	12	SENT_621	[p29l13t1632r224b1716],
14	APC	NN	ORGANIZATION	apc	nn	16	SENT_621	[p29l13t1632r224b1716],
15	)	CD	NUMBER	)	num	16	SENT_621	[p29l13t1632r224b1716],
16	trial	NN	O	trial	nsubjpass	19	SENT_621	[p29l276t1632r427b1696],
17	was	VBD	O	be	auxpass	19	SENT_621	[p29l472t1656r605b1696],
18	a	DT	O	a	dep	19	SENT_621	[p29l655t1656r694b1696],
19	randomized	VBN	O	randomize	_	0	SENT_621	[p29l740t1631r1205b1712],
20	,	,	O	,	_	0	SENT_621	[p29l740t1631r1205b1712],
21	placebo-controlled	JJ	O	placebo-controlled	amod	22	SENT_621	[p29l1254t1631r1952b1719],
22	trial	NN	O	trial	dobj	19	SENT_621	[p29l1999t1632r2150b1696],
23	designed	VBN	O	design	partmod	22	SENT_621	[p29l11t1737r338b1825],
24	to	TO	O	to	aux	25	SENT_621	[p29l364t1756r436b1802],
25	examine	VB	O	examine	xcomp	23	SENT_621	[p29l465t1740r770b1802],
26	the	DT	O	the	det	27	SENT_621	[p29l797t1738r912b1802],
27	effect	NN	O	effect	dobj	25	SENT_621	[p29l940t1738r1141b1802],
28	of	IN	O	of	_	0	SENT_621	[p29l1166t1738r1251b1802],
29	celecoxib	NN	O	celecoxib	prep_of	27	SENT_621	[p29l1266t1738r1598b1802],
30	on	IN	O	on	_	0	SENT_621	[p29l1627t1762r1721b1802],
31	occurrence	NN	O	occurrence	prep_on	25	SENT_621	[p29l1747t1761r2149b1802],
32	of	IN	O	of	_	0	SENT_621	[p29l11t1845r96b1909],
33	endoscopically	RB	O	endoscopically	advmod	34	SENT_621	[p29l140t1844r689b1932],
34	detected	VBN	O	detect	amod	35	SENT_621	[p29l742t1844r1053b1911],
35	adenomas	NNS	O	adenoma	prep_of	31	SENT_621	[p29l1107t1844r1481b1911],
36	among	IN	O	among	_	0	SENT_621	[p29l1539t1869r1796b1932],
37	patients	NNS	O	patient	prep_among	35	SENT_621	[p29l1851t1847r2148b1932],
38	who	WP	O	who	nsubj	56	SENT_621	[p29l9t1951r164b2015],
39	had	VBD	O	have	aux	40	SENT_621	[p29l196t1950r336b2017],
40	undergone	VBN	O	undergo	rcmod	37	SENT_621	[p29l365t1950r765b2038],
41	colonoscopic	JJ	O	colonoscopic	amod	42	SENT_621	[p29l796t1951r1282b2038],
42	removal	NN	O	removal	dobj	40	SENT_621	[p29l1313t1951r1610b2015],
43	of	IN	O	of	_	0	SENT_621	[p29l1640t1951r1725b2015],
44	all	DT	O	all	det	48	SENT_621	[p29l1743t1951r1830b2015],
45	colorec	JJ	O	colorec	amod	48	SENT_621	[p29l1860t1951r2148b2015],
46	—	NN	O	—	nn	48	SENT_621	[p29l1860t1951r2148b2015],
47	tal	JJ	O	tal	amod	48	SENT_621	[p29l11t2057r104b2121],
48	adenomas	NNS	O	adenoma	prep_of	42	SENT_621	[p29l136t2056r510b2123],
49	within	IN	O	within	_	0	SENT_621	[p29l542t2057r785b2121],
50	6	CD	DURATION	6	num	51	SENT_621	[p29l819t2061r856b2121],
51	months	NNS	NUMBER	month	prep_within	40	SENT_621	[p29l891t2057r1177b2121],
52	of	IN	O	of	_	0	SENT_621	[p29l1212t2057r1297b2121],
53	study	NN	O	study	nn	54	SENT_621	[p29l1317t2056r1522b2144],
54	entry	NN	O	entry	prep_of	51	SENT_621	[p29l1552t2075r1743b2144],
55	and	CC	O	and	_	0	SENT_621	[p29l1773t2056r1911b2123],
56	had	VBD	O	have	conj_and	40	SENT_621	[p29l1942t2056r2081b2123],
57	a	DT	O	a	det	59	SENT_621	[p29l2112t2081r2152b2121],
58	high	JJ	O	high	amod	59	SENT_621	[p29l10t2163r177b2250],
59	risk	NN	O	risk	dobj	56	SENT_621	[p29l207t2162r343b2227],
60	of	IN	O	of	_	0	SENT_621	[p29l372t2163r457b2227],
61	recurrent	JJ	O	recurrent	amod	62	SENT_621	[p29l474t2181r816b2227],
62	adenomas	NNS	O	adenoma	prep_of	59	SENT_621	[p29l844t2162r1218b2229],
63	on	IN	O	on	_	0	SENT_621	[p29l1249t2187r1343b2227],
64	the	DT	O	the	det	65	SENT_621	[p29l1372t2163r1487b2227],
65	basis	NN	O	basis	prep_on	56	SENT_621	[p29l1514t2163r1694b2227],
66	of	IN	O	of	_	0	SENT_621	[p29l1724t2163r1809b2227],
67	a	DT	O	a	det	68	SENT_621	[p29l1826t2187r1865b2227],
68	history	NN	O	history	prep_of	65	SENT_621	[p29l1891t2163r2152b2250],
69	of	IN	O	of	_	0	SENT_621	[p29l11t2269r96b2333],
70	either	CC	O	either	preconj	72	SENT_621	[p29l119t2269r332b2333],
71	multiple	JJ	O	multiple	amod	72	SENT_621	[p29l366t2269r681b2356],
72	adenomas	NNS	O	adenoma	prep_of	68	SENT_621	[p29l717t2268r1091b2335],
73	or	CC	O	or	_	0	SENT_621	[p29l1128t2292r1206b2333],
74	removal	NN	O	removal	conj_or	72	SENT_621	[p29l1240t2269r1536b2333],
75	of	IN	O	of	_	0	SENT_621	[p29l1571t2269r1656b2333],
76	a	DT	O	a	det	78	SENT_621	[p29l1678t2293r1718b2333],
77	single	JJ	O	single	amod	78	SENT_621	[p29l1750t2269r1963b2356],
78	adenoma	NN	O	adenoma	prep_of	68	SENT_621	[p29l1999t2268r2148b2335, p29l10t2397r226b2438],
79	more	RBR	O	more	advmod	80	SENT_621	[p29l266t2397r456b2438],
80	than	IN	O	than	quantmod	81	SENT_621	[p29l501t2374r671b2438],
81	5	CD	NUMBER	5	num	82	SENT_621	[p29l714t2378r752b2438],
82	mm	NN	O	mm	dobj	40	SENT_621	[p29l800t2398r948b2437],
83	in	IN	O	in	_	0	SENT_621	[p29l990t2376r1063b2437],
84	diameter	NN	O	diameter	prep_in	82	SENT_621	[p29l1106t2373r1450b2439],
85	.	.	O	.	_	0	SENT_621	[p29l1106t2373r1450b2439],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_622	[p29l1496t2376r1793b2438],
2	were	VBD	O	be	auxpass	3	SENT_622	[p29l1837t2397r2004b2438],
3	excluded	VBN	O	exclude	_	0	SENT_622	[p29l2048t2398r2147b2438, p29l11t2479r259b2546],
4	if	IN	O	if	mark	6	SENT_622	[p29l306t2480r368b2543],
5	they	PRP	O	they	nsubj	6	SENT_622	[p29l405t2480r564b2567],
6	had	VBD	O	have	advcl	3	SENT_622	[p29l609t2479r749b2546],
7	a	DT	O	a	det	8	SENT_622	[p29l797t2504r836b2544],
8	history	NN	O	history	dobj	6	SENT_622	[p29l882t2480r1143b2567],
9	of	IN	O	of	_	0	SENT_622	[p29l1190t2480r1275b2544],
10	familial	JJ	O	familial	amod	12	SENT_622	[p29l1311t2480r1595b2544],
11	adenomatous	JJ	O	adenomatous	amod	12	SENT_622	[p29l1643t2479r2148b2546],
12	polyposis	NN	O	polyposis	prep_of	8	SENT_622	[p29l10t2587r378b2674],
13	,	,	O	,	_	0	SENT_622	[p29l10t2587r378b2674],
14	hereditary	JJ	O	hereditary	amod	17	SENT_622	[p29l413t2586r792b2674],
15	nonpolyposis	JJ	O	nonpolyposis	amod	17	SENT_622	[p29l822t2587r1321b2674],
16	colon	NN	O	colon	nn	17	SENT_622	[p29l1356t2587r1562b2651],
17	cancer	NN	O	cancer	conj_or	12	SENT_622	[p29l1595t2610r1848b2667],
18	,	,	O	,	_	0	SENT_622	[p29l1595t2610r1848b2667],
19	inﬂammatory	JJ	O	inﬂammatory	amod	21	SENT_622	[p29l1883t2587r2148b2651, p29l11t2711r278b2780],
20	bowel	NN	O	bowel	nn	21	SENT_622	[p29l299t2693r517b2757],
21	disease	NN	O	disease	conj_or	12	SENT_622	[p29l543t2692r817b2772],
22	,	,	O	,	_	0	SENT_622	[p29l543t2692r817b2772],
23	or	CC	O	or	_	0	SENT_622	[p29l846t2716r923b2757],
24	large-bowel	JJ	O	large-bowel	amod	25	SENT_622	[p29l947t2693r1372b2780],
25	resection	NN	O	resection	conj_or	12	SENT_622	[p29l1398t2695r1730b2757],
26	other	JJ	O	other	amod	25	SENT_622	[p29l1756t2693r1954b2757],
27	than	IN	O	than	_	0	SENT_622	[p29l1979t2693r2150b2757],
28	appendectomy	NN	O	appendectomy	prep_than	6	SENT_622	[p29l11t2798r573b2886],
29	.	.	O	.	_	0	SENT_622	[p29l11t2798r573b2886],

1	Other	JJ	O	other	amod	3	SENT_623	[p29l620t2799r839b2863],
2	exclusion	NN	O	exclusion	nn	3	SENT_623	[p29l881t2799r1228b2863],
3	criteria	NNS	O	criterion	nsubj	4	SENT_623	[p29l1271t2801r1533b2863],
4	included	VBD	O	include	_	0	SENT_623	[p29l1572t2798r1897b2865],
5	a	DT	O	a	det	6	SENT_623	[p29l1938t2823r1978b2863],
6	history	NN	O	history	dobj	4	SENT_623	[p29l2017t2799r2148b2863, p29l11t2923r161b2992],
7	of	IN	O	of	_	0	SENT_623	[p29l189t2905r274b2969],
8	a	DT	O	a	det	12	SENT_623	[p29l292t2929r331b2969],
9	renal	JJ	O	renal	amod	12	SENT_623	[p29l359t2905r543b2969],
10	or	CC	O	or	_	0	SENT_623	[p29l573t2928r651b2969],
11	hepatic	JJ	O	hepatic	amod	12	SENT_623	[p29l679t2905r949b2992],
12	disorder	NN	O	disorder	prep_of	6	SENT_623	[p29l980t2904r1304b2985],
13	,	,	O	,	_	0	SENT_623	[p29l980t2904r1304b2985],
14	a	DT	O	a	det	18	SENT_623	[p29l1336t2929r1375b2969],
15	clinically	RB	O	clinically	advmod	16	SENT_623	[p29l1403t2905r1734b2992],
16	signiﬁcant	JJ	O	signiﬁcant	amod	18	SENT_623	[p29l1761t2905r2151b2992],
17	bleeding	JJ	O	bleeding	amod	18	SENT_623	[p29l9t3010r326b3098],
18	disorder	NN	O	disorder	appos	12	SENT_623	[p29l381t3010r705b3090],
19	,	,	O	,	_	0	SENT_623	[p29l381t3010r705b3090],
20	or	CC	O	or	_	0	SENT_623	[p29l761t3034r839b3075],
21	treatment	NN	O	treatment	conj_or	6	SENT_623	[p29l893t3029r1261b3075],
22	for	IN	O	for	_	0	SENT_623	[p29l1314t3011r1422b3075],
23	a	DT	O	a	det	25	SENT_623	[p29l1476t3035r1515b3075],
24	gastrointestinal	JJ	O	gastrointestinal	amod	25	SENT_623	[p29l1567t3011r2150b3098],
25	ulcer	NN	O	ulcer	prep_for	21	SENT_623	[p29l10t3117r193b3181],
26	before	IN	O	before	_	0	SENT_623	[p29l229t3117r460b3181],
27	study	NN	O	study	nn	28	SENT_623	[p29l502t3116r706b3204],
28	entry	NN	O	entry	prep_before	4	SENT_623	[p29l744t3135r948b3204],
29	.	.	O	.	_	0	SENT_623	[p29l744t3135r948b3204],

1	Beginning	VBG	DATE	begin	prep	14	SENT_624	[p29l992t3119r1373b3204],
2	in	IN	DATE	in	pcomp	1	SENT_624	[p29l1411t3119r1484b3180],
3	November	NNP	DATE	November	pobj	2	SENT_624	[p29l1522t3117r1911b3181],
4	1999	CD	DATE	1999	num	3	SENT_624	[p29l1956t3122r2148b3197],
5	,	,	DATE	,	_	0	SENT_624	[p29l1956t3122r2148b3197],
6	2457	CD	DATE	2457	num	8	SENT_624	[p29l10t3227r191b3288],
7	potential	JJ	O	potential	amod	8	SENT_624	[p29l231t3223r568b3310],
8	participants	NNS	O	participant	nsubjpass	14	SENT_624	[p29l607t3225r1053b3310],
9	at	IN	O	at	_	0	SENT_624	[p29l1095t3241r1163b3287],
10	91	CD	NUMBER	91	num	12	SENT_624	[p29l1204t3228r1285b3288],
11	clinical	JJ	O	clinical	amod	12	SENT_624	[p29l1331t3223r1594b3287],
12	sites	NNS	O	site	prep_at	8	SENT_624	[p29l1634t3225r1791b3287],
13	were	VBD	O	be	auxpass	14	SENT_624	[p29l1831t3246r1998b3287],
14	entered	VBN	O	enter	_	0	SENT_624	[p29l2039t3247r2148b3287, p29l11t3328r198b3395],
15	into	IN	O	into	_	0	SENT_624	[p29l232t3331r382b3393],
16	a	DT	O	a	det	18	SENT_624	[p29l421t3353r460b3393],
17	30-day	JJ	DURATION	30-day	amod	18	SENT_624	[p29l494t3328r742b3416],
18	placebo	NN	O	placebo	prep_into	14	SENT_624	[p29l775t3329r1057b3416],
19	run	VB	O	run	ccomp	14	SENT_624	[p29l1096t3331r1329b3393],
20	—	RB	O	—	advmod	19	SENT_624	[p29l1096t3331r1329b3393],
21	in	IN	O	in	_	0	SENT_624	[p29l1096t3331r1329b3393],
22	period	NN	O	period	prep_in	19	SENT_624	[p29l1365t3328r1605b3416],
23	during	IN	O	during	_	0	SENT_624	[p29l1641t3328r1892b3416],
24	which	WDT	O	which	rel	27	SENT_624	[p29l1925t3329r2149b3393],
25	they	PRP	O	they	nsubjpass	27	SENT_624	[p29l11t3435r169b3522],
26	were	VBD	O	be	auxpass	27	SENT_624	[p29l213t3458r380b3499],
27	required	VBN	O	require	rcmod	22	SENT_624	[p29l430t3434r742b3522],
28	to	TO	O	to	aux	29	SENT_624	[p29l789t3453r862b3499],
29	have	VB	O	have	xcomp	27	SENT_624	[p29l912t3435r1077b3499],
30	at	IN	O	at	quantmod	32	SENT_624	[p29l1127t3453r1195b3499],
31	least	JJS	O	least	mwe	30	SENT_624	[p29l1242t3435r1410b3499],
32	80	CD	PERCENT	80	dep	33	SENT_624	[p29l1458t3440r1602b3499],
33	%	NN	PERCENT	%	dep	34	SENT_624	[p29l1458t3440r1602b3499],
34	adherence	NN	O	adherence	dobj	29	SENT_624	[p29l1652t3434r2025b3501],
35	to	TO	O	to	_	0	SENT_624	[p29l2075t3453r2147b3499],
36	medication	NN	O	medication	nn	37	SENT_624	[p29l11t3540r430b3607],
37	use	NN	O	use	prep_to	29	SENT_624	[p29l469t3565r606b3621],
38	,	,	O	,	_	0	SENT_624	[p29l469t3565r606b3621],
39	as	IN	O	as	mark	40	SENT_624	[p29l648t3565r717b3605],
40	measured	VBN	O	measure	advcl	29	SENT_624	[p29l758t3540r1117b3607],
41	by	IN	O	by	_	0	SENT_624	[p29l1153t3541r1241b3628],
42	pill	NN	O	pill	nn	43	SENT_624	[p29l1277t3541r1397b3628],
43	counts	NNS	O	count	prep_by	40	SENT_624	[p29l1436t3559r1702b3605],
44	.	.	O	.	_	0	SENT_624	[p29l1436t3559r1702b3605],

1	Two	CD	DATE	two	num	2	SENT_625	[p29l1743t3546r1904b3605],
2	thousand	CD	DATE	thousand	nsubjpass	10	SENT_625	[p29l1946t3541r2148b3605, p29l11t3647r184b3714],
3	thirty	CD	DATE	thirty	num	6	SENT_625	[p29l216t3648r577b3735],
4	—	NN	O	—	nn	6	SENT_625	[p29l216t3648r577b3735],
5	ﬁve	NN	O	ﬁve	nn	6	SENT_625	[p29l216t3648r577b3735],
6	patients	NNS	O	patient	dep	2	SENT_625	[p29l610t3650r907b3735],
7	were	VBD	O	be	auxpass	10	SENT_625	[p29l940t3671r1107b3712],
8	subsequently	RB	O	subsequently	advmod	10	SENT_625	[p29l1141t3648r1630b3735],
9	randomly	RB	O	randomly	advmod	10	SENT_625	[p29l1660t3647r2022b3735],
10	assigned	VBN	O	assign	_	0	SENT_625	[p29l2052t3672r2148b3712, p30l11t16r250b104],

1	to	TO	O	to	_	0	SENT_626	[p30l288t35r360b81],
2	placebo	NN	O	placebo	pobj	1	SENT_626	[p30l399t17r701b104],
3	,	,	O	,	_	0	SENT_626	[p30l399t17r701b104],
4	200	CD	NUMBER	200	num	5	SENT_626	[p30l740t22r873b81],
5	mg	NN	O	mg	appos	2	SENT_626	[p30l913t41r1031b104],
6	of	IN	O	of	_	0	SENT_626	[p30l1068t17r1153b81],
7	celecoxib	NN	O	celecoxib	prep_of	5	SENT_626	[p30l1179t17r1511b81],
8	twice	RB	O	twice	advmod	7	SENT_626	[p30l1552t19r1739b81],
9	daily	RB	SET	daily	advmod	7	SENT_626	[p30l1778t16r1956b104],
10	(	RB	O	(	advmod	11	SENT_626	[p30l1994t17r2152b101],
11	low	JJ	O	low	amod	13	SENT_626	[p30l1994t17r2152b101],
12	dose	NN	O	dose	nn	13	SENT_626	[p30l11t122r223b207],
13	)	NN	O	)	dep	7	SENT_626	[p30l11t122r223b207],
14	,	,	O	,	_	0	SENT_626	[p30l11t122r223b207],
15	or	CC	O	or	_	0	SENT_626	[p30l271t146r349b187],
16	400	CD	NUMBER	400	num	17	SENT_626	[p30l393t128r526b187],
17	mg	NN	O	mg	dep	7	SENT_626	[p30l574t147r692b210],
18	of	IN	O	of	_	0	SENT_626	[p30l737t123r822b187],
19	celecoxib	NN	O	celecoxib	prep_of	17	SENT_626	[p30l856t123r1188b187],
20	twice	RB	O	twice	advmod	2	SENT_626	[p30l1237t125r1425b187],
21	daily	RB	SET	daily	advmod	2	SENT_626	[p30l1472t122r1650b210],
22	(	RB	O	(	advmod	23	SENT_626	[p30l1696t123r1888b210],
23	high	JJ	O	high	amod	25	SENT_626	[p30l1696t123r1888b210],
24	dose	NN	O	dose	nn	25	SENT_626	[p30l1936t122r2146b207],
25	)	NN	O	)	dep	2	SENT_626	[p30l1936t122r2146b207],
26	.	.	O	.	_	0	SENT_626	[p30l1936t122r2146b207],

1	Randomization	NN	O	randomization	nsubjpass	3	SENT_627	[p30l11t227r592b293],
2	was	VBD	O	be	auxpass	3	SENT_627	[p30l625t252r758b292],
3	stratiﬁed	VBN	O	stratiﬁed	_	0	SENT_627	[p30l795t227r1128b293],
4	on	IN	O	on	_	0	SENT_627	[p30l1162t251r1257b292],
5	the	DT	O	the	det	6	SENT_627	[p30l1292t228r1407b292],
6	basis	NN	O	basis	prep_on	3	SENT_627	[p30l1442t228r1621b292],
7	of	IN	O	of	_	0	SENT_627	[p30l1658t228r1743b292],
8	the	DT	O	the	det	9	SENT_627	[p30l1767t228r1882b292],
9	use	NN	O	use	dep	19	SENT_627	[p30l1918t252r2037b292],
10	or	CC	O	or	_	0	SENT_627	[p30l2073t251r2151b292],
11	nonuse	NN	O	nonuse	conj_or	9	SENT_627	[p30l10t358r280b398],
12	of	IN	O	of	_	0	SENT_627	[p30l320t334r405b398],
13	low-dose	JJ	O	low-dose	amod	15	SENT_627	[p30l430t333r757b400],
14	aspirin	NN	O	aspirin	nn	15	SENT_627	[p30l797t336r1052b421],
15	(	NN	O	(	prep_of	9	SENT_627	[p30l1093t334r1249b418],
16	325	CD	NUMBER	325	num	17	SENT_627	[p30l1093t334r1249b418],
17	mg	NN	O	mg	dep	19	SENT_627	[p30l1292t358r1410b421],
18	or	CC	O	or	_	0	SENT_627	[p30l1448t357r1525b398],
19	less	JJR	O	less	dep	30	SENT_627	[p30l1562t334r1689b398],
20	every	DT	SET	every	det	22	SENT_627	[p30l1730t357r1916b421],
21	other	JJ	SET	other	amod	22	SENT_627	[p30l1953t334r2151b398],
22	day	NN	SET	day	dep	19	SENT_627	[p30l11t439r140b527],
23	or	CC	O	or	_	0	SENT_627	[p30l174t463r251b504],
24	162.5	CD	NUMBER	162.5	num	25	SENT_627	[p30l294t444r483b504],
25	mg	NN	O	mg	conj_or	19	SENT_627	[p30l524t464r642b527],
26	or	CC	O	or	_	0	SENT_627	[p30l678t463r755b504],
27	less	JJR	O	less	conj_or	19	SENT_627	[p30l790t440r917b504],
28	every	DT	SET	every	det	29	SENT_627	[p30l956t463r1142b527],
29	day	NN	SET	day	dep	27	SENT_627	[p30l1177t439r1326b527],
30	)	CD	NUMBER	)	prep_of	6	SENT_627	[p30l1177t439r1326b527],
31	and	CC	O	and	_	0	SENT_627	[p30l1368t439r1506b506],
32	clinical	JJ	O	clinical	amod	33	SENT_627	[p30l1542t440r1806b504],
33	site	NN	O	site	prep_of	6	SENT_627	[p30l1842t442r1983b504],
34	.	.	O	.	_	0	SENT_627	[p30l1842t442r1983b504],

1	For	IN	O	for	_	0	SENT_628	[p30l2023t446r2151b504],
2	the	DT	O	the	det	3	SENT_628	[p30l11t547r126b611],
3	duration	NN	O	duration	prep_for	10	SENT_628	[p30l182t546r508b613],
4	of	IN	O	of	_	0	SENT_628	[p30l562t547r647b611],
5	the	DT	O	the	det	6	SENT_628	[p30l689t547r805b611],
6	study	NN	O	study	prep_of	3	SENT_628	[p30l860t546r1080b634],
7	,	,	O	,	_	0	SENT_628	[p30l860t546r1080b634],
8	patients	NNS	O	patient	nsubjpass	10	SENT_628	[p30l1136t549r1432b634],
9	were	VBD	O	be	auxpass	10	SENT_628	[p30l1486t570r1654b611],
10	required	VBN	O	require	_	0	SENT_628	[p30l1709t546r2021b634],
11	to	TO	O	to	aux	12	SENT_628	[p30l2075t565r2147b611],
12	abstain	VB	O	abstain	xcomp	10	SENT_628	[p30l11t653r279b717],
13	from	IN	O	from	_	0	SENT_628	[p30l314t653r497b717],
14	long	JJ	O	long	amod	17	SENT_628	[p30l531t653r902b740],
15	—	JJ	O	—	amod	17	SENT_628	[p30l531t653r902b740],
16	term	NN	O	term	nn	17	SENT_628	[p30l531t653r902b740],
17	use	NN	O	use	prep_from	12	SENT_628	[p30l937t677r1056b717],
18	of	IN	O	of	_	0	SENT_628	[p30l1092t653r1177b717],
19	nonsteroidal	JJ	O	nonsteroidal	amod	21	SENT_628	[p30l1200t652r1673b719],
20	antiinﬂammatory	JJ	O	antiinﬂammatory	amod	21	SENT_628	[p30l1708t653r2148b717, p30l11t777r278b846],
21	drugs	NNS	O	drug	prep_of	17	SENT_628	[p30l313t758r520b846],
22	(	VBP	O	(	rcmod	21	SENT_628	[p30l561t758r862b843],
23	deﬁned	VBN	O	deﬁned	dep	22	SENT_628	[p30l561t758r862b843],
24	as	IN	O	as	_	0	SENT_628	[p30l898t783r967b823],
25	more	JJR	DURATION	more	mwe	26	SENT_628	[p30l1007t782r1196b823],
26	than	IN	DURATION	than	quantmod	27	SENT_628	[p30l1235t759r1405b823],
27	21	CD	DURATION	21	num	28	SENT_628	[p30l1442t764r1525b822],
28	days	NNS	NUMBER	day	prep_as	23	SENT_628	[p30l1568t758r1727b846],
29	of	IN	O	of	_	0	SENT_628	[p30l1766t759r1851b823],
30	use	NN	O	use	prep_of	28	SENT_628	[p30l1876t783r1995b823],
31	per	IN	O	per	_	0	SENT_628	[p30l2033t782r2151b846],
32	year	NN	DURATION	year	prep_per	30	SENT_628	[p30l8t866r204b953],
33	)	RB	O	)	advmod	23	SENT_628	[p30l8t866r204b953],
34	,	,	O	,	_	0	SENT_628	[p30l8t866r204b953],
35	cycloogenase	NN	O	cycloogenase	conj_or	21	SENT_628	[p30l252t866r730b953],
36	2	CD	NUMBER	2	num	37	SENT_628	[p30l776t871r815b929],
37	inhibitors	NNS	O	inhibitor	dep	35	SENT_628	[p30l863t866r1249b946],
38	,	,	O	,	_	0	SENT_628	[p30l863t866r1249b946],
39	or	CC	O	or	_	0	SENT_628	[p30l1297t889r1374b930],
40	aspirin	NN	O	aspirin	conj_or	21	SENT_628	[p30l1418t868r1673b953],
41	unless	IN	O	unless	mark	44	SENT_628	[p30l1718t866r1947b930],
42	they	PRP	O	they	nsubj	44	SENT_628	[p30l1994t866r2152b953],
43	were	VBD	O	be	aux	44	SENT_628	[p30l9t1030r176b1071],
44	taking	VBG	O	take	dep	40	SENT_628	[p30l211t1006r449b1094],
45	low-dose	JJ	O	low-dose	amod	46	SENT_628	[p30l481t1006r807b1073],
46	aspirin	NN	O	aspirin	dobj	44	SENT_628	[p30l843t1009r1098b1094],
47	at	IN	O	at	_	0	SENT_628	[p30l1132t1025r1201b1071],
48	baseline	NN	O	baseline	prep_at	44	SENT_628	[p30l1232t1007r1547b1071],
49	.	.	O	.	_	0	SENT_628	[p30l1232t1007r1547b1071],

1	At	IN	O	at	_	0	SENT_629	[p30l96t1119r184b1177],
2	baseline	NN	O	baseline	prep_at	12	SENT_629	[p30l229t1113r527b1177],
3	and	CC	O	and	_	0	SENT_629	[p30l576t1112r714b1179],
4	1	CD	DATE	1	prep_at	12	SENT_629	[p30l768t1118r797b1176],
5	and	CC	O	and	_	0	SENT_629	[p30l851t1112r990b1179],
6	3	CD	DURATION	3	num	7	SENT_629	[p30l1037t1118r1074b1177],
7	years	NNS	NUMBER	year	prep_at	12	SENT_629	[p30l1123t1136r1307b1200],
8	after	IN	O	after	_	0	SENT_629	[p30l1357t1113r1527b1177],
9	randomization	NN	O	randomization	prep_after	2	SENT_629	[p30l1574t1112r2148b1193],
10	,	,	O	,	_	0	SENT_629	[p30l1574t1112r2148b1193],
11	patients	NNS	O	patient	nsubjpass	19	SENT_629	[p30l10t1222r307b1307],
12	underwent	VBD	O	undergo	_	0	SENT_629	[p30l336t1219r737b1286],
13	a	DT	O	a	det	16	SENT_629	[p30l763t1244r803b1284],
14	complete	JJ	O	complete	amod	16	SENT_629	[p30l827t1220r1166b1307],
15	physical	JJ	O	physical	amod	16	SENT_629	[p30l1193t1220r1493b1307],
16	examination	NN	O	examination	dobj	12	SENT_629	[p30l1521t1222r1985b1284],
17	and	CC	O	and	_	0	SENT_629	[p30l2013t1219r2151b1286],
18	were	VBD	O	be	auxpass	19	SENT_629	[p30l9t1349r176b1390],
19	queried	VBN	O	query	conj_and	12	SENT_629	[p30l217t1325r496b1413],
20	by	IN	O	by	_	0	SENT_629	[p30l532t1326r620b1413],
21	study	NN	O	study	nn	22	SENT_629	[p30l657t1325r862b1413],
22	staff	NN	O	staff	agent	19	SENT_629	[p30l899t1326r1073b1390],
23	about	IN	O	about	_	0	SENT_629	[p30l1101t1326r1317b1390],
24	a	DT	O	a	det	25	SENT_629	[p30l1356t1350r1396b1390],
25	range	NN	O	range	prep_about	19	SENT_629	[p30l1433t1349r1636b1413],
26	of	IN	O	of	_	0	SENT_629	[p30l1676t1326r1761b1390],
27	colorectal	JJ	O	colorectal	amod	30	SENT_629	[p30l1789t1326r2150b1390],
28	cancer	NN	O	cancer	nn	30	SENT_629	[p30l11t1455r247b1496],
29	risk	NN	O	risk	nn	30	SENT_629	[p30l310t1431r446b1496],
30	factors	NNS	O	factor	prep_of	25	SENT_629	[p30l508t1432r776b1496],
31	.	.	O	.	_	0	SENT_629	[p30l508t1432r776b1496],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_630	[p30l843t1434r1140b1496],
2	were	VBD	O	be	auxpass	3	SENT_630	[p30l1203t1455r1370b1496],
3	contacted	VBN	O	contact	_	0	SENT_630	[p30l1435t1431r1798b1498],
4	every	DT	O	every	det	6	SENT_630	[p30l1860t1455r2047b1518],
5	2	CD	NUMBER	2	num	6	SENT_630	[p30l2107t1437r2146b1495],
6	CELECOXIB	NN	O	celecoxib	dobj	3	SENT_630	[p30l134t1549r488b1608],
7	,	,	O	,	_	0	SENT_630	[p30l134t1549r488b1608],
8	CYP2C9	NN	O	cyp2c9	nn	10	SENT_630	[p30l518t1549r760b1598],
9	GENE	NN	O	gene	nn	10	SENT_630	[p30l789t1549r952b1598],
10	VARIANTS	NNS	O	variant	appos	6	SENT_630	[p30l978t1549r1301b1608],
11	,	,	O	,	_	0	SENT_630	[p30l978t1549r1301b1608],
12	AND	CC	O	and	_	0	SENT_630	[p30l1329t1549r1462b1597],
13	ADENOMA	NN	O	adenoma	conj_and	6	SENT_630	[p30l1489t1549r1808b1598],
14	2136.61	CD	NUMBER	2136.61	num	13	SENT_630	[p30l1882t1548r2141b1598],

1	months	NNS	DURATION	month	nsubj	3	SENT_631	[p30l11t1768r296b1832],
2	to	TO	O	to	aux	3	SENT_631	[p30l340t1787r411b1832],
3	report	VB	O	report	_	0	SENT_631	[p30l456t1787r683b1855],
4	use	NN	O	use	dobj	3	SENT_631	[p30l724t1792r843b1832],
5	of	IN	O	of	_	0	SENT_631	[p30l886t1768r970b1832],
6	concomitant	JJ	O	concomitant	amod	7	SENT_631	[p30l1000t1771r1473b1832],
7	medications	NNS	O	medication	prep_of	4	SENT_631	[p30l1514t1768r1982b1834],
8	.	.	O	.	_	0	SENT_631	[p30l1514t1768r1982b1834],

1	Patients	NNS	O	patient	nsubj	2	SENT_632	[p30l2027t1774r2138b1832, p30l11t1878r215b1939],
2	randomized	VBD	O	randomize	_	0	SENT_632	[p30l243t1875r689b1941],
3	to	TO	O	to	_	0	SENT_632	[p30l714t1894r786b1939],
4	the	DT	O	the	det	6	SENT_632	[p30l814t1875r929b1939],
5	APC	NN	ORGANIZATION	apc	nn	6	SENT_632	[p30l951t1881r1113b1939],
6	trial	NN	O	trial	prep_to	2	SENT_632	[p30l1142t1875r1291b1939],
7	who	WP	O	who	nsubj	9	SENT_632	[p30l1315t1875r1470b1939],
8	successfully	RB	O	successfully	advmod	9	SENT_632	[p30l1498t1875r1934b1962],
9	completed	VBD	O	complete	rcmod	6	SENT_632	[p30l1957t1899r2138b1939, p30l10t1982r238b2069],
10	the	DT	O	the	det	14	SENT_632	[p30l266t1982r380b2046],
11	primary	JJ	O	primary	amod	14	SENT_632	[p30l409t1985r704b2069],
12	3-year	JJ	DURATION	3-year	amod	14	SENT_632	[p30l730t1988r950b2069],
13	study	NN	O	study	nn	14	SENT_632	[p30l977t1982r1181b2069],
14	interval	NN	O	interval	nsubjpass	17	SENT_632	[p30l1206t1982r1486b2046],
15	were	VBD	O	be	auxpass	17	SENT_632	[p30l1512t2005r1678b2046],
16	also	RB	O	also	advmod	17	SENT_632	[p30l1707t1982r1849b2046],
17	offered	VBN	O	offer	ccomp	9	SENT_632	[p30l1880t1982r2141b2048],
18	the	DT	O	the	det	19	SENT_632	[p30l11t2090r126b2154],
19	option	NN	O	option	dobj	17	SENT_632	[p30l181t2093r427b2177],
20	of	IN	O	of	_	0	SENT_632	[p30l482t2090r566b2154],
21	participating	VBG	O	participate	prepc_of	19	SENT_632	[p30l607t2093r1088b2177],
22	in	IN	O	in	_	0	SENT_632	[p30l1140t2093r1212b2153],
23	an	DT	O	a	det	25	SENT_632	[p30l1266t2114r1353b2154],
24	extension	NN	O	extension	nn	25	SENT_632	[p30l1407t2093r1760b2154],
25	study	NN	O	study	prep_in	21	SENT_632	[p30l1814t2090r2018b2177],
26	in	IN	O	in	_	0	SENT_632	[p30l2068t2093r2139b2153],
27	which	WDT	O	which	det	28	SENT_632	[p30l9t2197r231b2261],
28	study	NN	O	study	rel	31	SENT_632	[p30l257t2197r461b2284],
29	medication	NN	O	medication	nsubjpass	31	SENT_632	[p30l484t2197r901b2262],
30	was	VBD	O	be	auxpass	31	SENT_632	[p30l924t2221r1056b2261],
31	continued	VBN	O	continue	rcmod	25	SENT_632	[p30l1084t2197r1462b2262],
32	in	IN	O	in	_	0	SENT_632	[p30l1485t2200r1557b2260],
33	a	DT	O	a	det	35	SENT_632	[p30l1583t2221r1622b2261],
34	blinded	JJ	O	blinded	amod	35	SENT_632	[p30l1642t2197r1926b2262],
35	manner	NN	O	manner	prep_in	31	SENT_632	[p30l1950t2221r2138b2261, p30l10t2327r129b2368],
36	for	IN	O	for	_	0	SENT_632	[p30l162t2304r269b2368],
37	an	DT	O	a	det	40	SENT_632	[p30l302t2328r390b2368],
38	additional	JJ	O	additional	amod	40	SENT_632	[p30l425t2304r806b2369],
39	2	CD	DURATION	2	num	40	SENT_632	[p30l839t2309r878b2367],
40	years	NNS	NUMBER	year	prep_for	35	SENT_632	[p30l913t2327r1113b2391],
41	.	.	O	.	_	0	SENT_632	[p30l913t2327r1113b2391],

1	Study	NNP	O	Study	nn	3	SENT_633	[p30l1152t2304r1368b2391],
2	drug	NN	O	drug	nn	3	SENT_633	[p30l1400t2304r1574b2390],
3	treatment	NN	O	treatment	nsubjpass	6	SENT_633	[p30l1608t2322r1974b2368],
4	was	VBD	O	be	auxpass	6	SENT_633	[p30l2006t2328r2138b2368],
5	initially	RB	O	initially	advmod	6	SENT_633	[p30l10t2412r295b2499],
6	planned	VBN	O	plan	_	0	SENT_633	[p30l316t2412r618b2499],
7	for	IN	O	for	_	0	SENT_633	[p30l642t2412r749b2476],
8	3	CD	DURATION	3	num	9	SENT_633	[p30l773t2417r810b2476],
9	years	NNS	NUMBER	year	prep_for	6	SENT_633	[p30l835t2435r1018b2499],
10	for	IN	O	for	mark	13	SENT_633	[p30l1044t2412r1151b2476],
11	all	DT	O	all	det	12	SENT_633	[p30l1175t2412r1261b2476],
12	participants	NNS	O	participant	nsubj	13	SENT_633	[p30l1285t2415r1728b2499],
13	(	VBP	O	(	advcl	6	SENT_633	[p30l1757t2412r2141b2498],
14	excluding	VBG	O	exclude	_	0	SENT_633	[p30l1757t2412r2141b2498],
15	the	DT	O	the	det	18	SENT_633	[p30l11t2519r126b2583],
16	extension	NN	O	extension	nn	18	SENT_633	[p30l156t2522r509b2583],
17	study	NN	O	study	nn	18	SENT_633	[p30l538t2519r785b2605],
18	)	NN	O	)	prep_excluding	13	SENT_633	[p30l538t2519r785b2605],
19	,	,	O	,	_	0	SENT_633	[p30l538t2519r785b2605],
20	with	IN	O	with	_	0	SENT_633	[p30l814t2519r979b2583],
21	the	DT	O	the	det	25	SENT_633	[p30l1010t2519r1124b2583],
22	last	JJ	O	last	amod	25	SENT_633	[p30l1153t2519r1282b2583],
23	expected	JJ	O	expected	amod	25	SENT_633	[p30l1311t2518r1630b2605],
24	study	NN	O	study	nn	25	SENT_633	[p30l1659t2519r1862b2605],
25	visit	NN	O	visit	prep_with	18	SENT_633	[p30l1885t2522r2040b2583],
26	in	IN	O	in	_	0	SENT_633	[p30l2068t2522r2140b2582],
27	April	NNP	DATE	April	prep_in	25	SENT_633	[p30l7t2626r194b2712],
28	2005	CD	DATE	2005	num	27	SENT_633	[p30l222t2630r420b2690],
29	.	.	O	.	_	0	SENT_633	[p30l222t2630r420b2690],

1	However	RB	O	however	advmod	17	SENT_634	[p30l453t2632r792b2705],
2	,	,	O	,	_	0	SENT_634	[p30l453t2632r792b2705],
3	at	IN	O	at	_	0	SENT_634	[p30l823t2644r891b2690],
4	the	DT	O	the	det	5	SENT_634	[p30l921t2626r1035b2690],
5	recommendation	NN	O	recommendation	nsubj	12	SENT_634	[p30l1066t2626r1703b2691],
6	of	IN	O	of	_	0	SENT_634	[p30l1733t2626r1817b2690],
7	the	DT	O	the	det	11	SENT_634	[p30l1835t2626r1949b2690],
8	APC	NN	ORGANIZATION	apc	nn	11	SENT_634	[p30l1976t2631r2137b2690],
9	trial	NN	O	trial	nn	11	SENT_634	[p30l11t2733r161b2797],
10	Data	NNP	ORGANIZATION	Data	nn	11	SENT_634	[p30l202t2738r382b2797],
11	Safety	NNP	ORGANIZATION	Safety	prep_of	5	SENT_634	[p30l421t2733r646b2819],
12	Monitoring	VBG	ORGANIZATION	monitor	prepc_at	17	SENT_634	[p30l681t2735r1116b2819],
13	Board	NNP	ORGANIZATION	Board	dobj	12	SENT_634	[p30l1156t2733r1394b2812],
14	,	,	O	,	_	0	SENT_634	[p30l1156t2733r1394b2812],
15	treatment	NN	O	treatment	nsubjpass	17	SENT_634	[p30l1437t2751r1803b2797],
16	was	VBD	O	be	auxpass	17	SENT_634	[p30l1841t2757r1974b2797],
17	terminated	VBN	O	terminate	_	0	SENT_634	[p30l2016t2751r2138b2797, p30l11t2839r319b2905],
18	prematurely	RB	O	prematurely	advmod	17	SENT_634	[p30l360t2840r812b2926],
19	on	IN	O	on	_	0	SENT_634	[p30l853t2864r947b2903],
20	December	NNP	DATE	December	prep_on	17	SENT_634	[p30l990t2840r1363b2903],
21	17	CD	DATE	17	num	20	SENT_634	[p30l1412t2845r1510b2919],
22	,	,	DATE	,	_	0	SENT_634	[p30l1412t2845r1510b2919],
23	2004	CD	DATE	2004	num	20	SENT_634	[p30l1554t2845r1752b2919],
24	,	,	O	,	_	0	SENT_634	[p30l1554t2845r1752b2919],
25	based	VBN	O	base	_	0	SENT_634	[p30l1795t2839r2004b2905],
26	on	IN	O	on	prepc_based_on	17	SENT_634	[p30l2046t2863r2140b2903],
27	the	DT	O	the	det	28	SENT_634	[p30l11t2947r126b3010],
28	results	NNS	O	result	pobj	17	SENT_634	[p30l163t2947r404b3010],
29	of	IN	O	of	_	0	SENT_634	[p30l442t2947r527b3010],
30	an	DT	O	a	det	33	SENT_634	[p30l551t2970r638b3010],
31	unscheduled	JJ	O	unscheduled	amod	33	SENT_634	[p30l674t2946r1147b3012],
32	safety	NN	O	safety	nn	33	SENT_634	[p30l1182t2947r1394b3033],
33	analysis	NN	O	analysis	prep_of	28	SENT_634	[p30l1428t2947r1713b3033],
34	performed	VBN	O	perform	partmod	33	SENT_634	[p30l1751t2946r2141b3033],
35	by	IN	O	by	_	0	SENT_634	[p30l9t3053r96b3140],
36	an	DT	O	a	det	40	SENT_634	[p30l136t3077r223b3117],
37	independent	JJ	O	independent	amod	40	SENT_634	[p30l265t3053r733b3140],
38	cardiovascular	JJ	O	cardiovascular	amod	40	SENT_634	[p30l775t3053r1307b3119],
39	safety	NN	O	safety	nn	40	SENT_634	[p30l1349t3053r1560b3140],
40	committee	NN	O	committee	agent	34	SENT_634	[p30l1600t3056r2012b3117],
41	.	.	O	.	_	0	SENT_634	[p30l1600t3056r2012b3117],

1	At	IN	O	at	_	0	SENT_635	[p30l2054t3059r2141b3117],
2	that	DT	O	that	det	3	SENT_635	[p30l11t3160r162b3224],
3	time	NN	O	time	prep_at	12	SENT_635	[p30l187t3163r370b3239],
4	,	,	O	,	_	0	SENT_635	[p30l187t3163r370b3239],
5	1762	CD	NUMBER	1762	num	6	SENT_635	[p30l404t3165r574b3225],
6	patients	NNS	O	patient	nsubj	12	SENT_635	[p30l602t3163r897b3247],
7	(	IN	O	(	_	0	SENT_635	[p30l927t3161r1188b3243],
8	86.6	CD	PERCENT	86.6	num	9	SENT_635	[p30l927t3161r1188b3243],
9	%	NN	PERCENT	%	prep_(	6	SENT_635	[p30l927t3161r1188b3243],
10	)	CD	NUMBER	)	dep	9	SENT_635	[p30l927t3161r1188b3243],
11	had	VBD	O	have	aux	12	SENT_635	[p30l1217t3160r1355b3226],
12	completed	VBN	O	complete	_	0	SENT_635	[p30l1380t3160r1768b3247],
13	3	CD	DURATION	3	num	14	SENT_635	[p30l1793t3166r1831b3224],
14	years	NNS	NUMBER	year	dobj	12	SENT_635	[p30l1857t3183r2039b3247],
15	of	IN	O	of	_	0	SENT_635	[p30l2067t3160r2152b3224],
16	treatment	NN	O	treatment	prep_of	14	SENT_635	[p30l11t3286r394b3346],
17	,	,	O	,	_	0	SENT_635	[p30l11t3286r394b3346],
18	and	CC	O	and	_	0	SENT_635	[p30l429t3267r567b3333],
19	273	CD	NUMBER	273	num	20	SENT_635	[p30l598t3273r728b3332],
20	patients	NNS	O	patient	nsubj	21	SENT_635	[p30l764t3270r1060b3354],
21	had	VBD	O	have	conj_and	12	SENT_635	[p30l1094t3267r1232b3333],
22	1	CD	DURATION	1	number	24	SENT_635	[p30l1271t3272r1299b3331],
23	to	TO	DURATION	to	dep	24	SENT_635	[p30l1338t3286r1410b3331],
24	3	CD	DURATION	3	num	25	SENT_635	[p30l1446t3273r1483b3331],
25	months	NNS	NUMBER	month	dobj	21	SENT_635	[p30l1519t3267r1804b3331],
26	of	IN	O	of	_	0	SENT_635	[p30l1839t3267r1923b3331],
27	treatment	NN	O	treatment	prep_of	25	SENT_635	[p30l1944t3286r2138b3331, p30l11t3394r203b3439],
28	remaining	VBG	O	remain	amod	27	SENT_635	[p30l250t3378r645b3462],
29	.	.	O	.	_	0	SENT_635	[p30l250t3378r645b3462],

1	In	IN	O	in	_	0	SENT_636	[p30l695t3381r772b3438],
2	addition	NN	O	addition	prep_in	7	SENT_636	[p30l820t3375r1153b3454],
3	,	,	O	,	_	0	SENT_636	[p30l820t3375r1153b3454],
4	639	CD	NUMBER	639	num	5	SENT_636	[p30l1204t3380r1332b3440],
5	patients	NNS	O	patient	nsubj	7	SENT_636	[p30l1383t3378r1678b3462],
6	had	VBD	O	have	aux	7	SENT_636	[p30l1727t3375r1866b3440],
7	begun	VBN	O	begin	_	0	SENT_636	[p30l1910t3375r2140b3462],
8	participation	NN	O	participation	dobj	7	SENT_636	[p30l10t3486r494b3570],
9	in	IN	O	in	_	0	SENT_636	[p30l531t3486r603b3546],
10	the	DT	O	the	det	12	SENT_636	[p30l642t3483r757b3547],
11	extension	NN	O	extension	nn	12	SENT_636	[p30l796t3486r1148b3547],
12	study	NN	O	study	prep_in	8	SENT_636	[p30l1188t3483r1391b3570],
13	with	IN	O	with	_	0	SENT_636	[p30l1425t3483r1589b3547],
14	a	DT	O	a	det	16	SENT_636	[p30l1629t3507r1668b3547],
15	median	JJ	O	median	amod	16	SENT_636	[p30l1704t3483r1979b3548],
16	duration	NN	O	duration	prep_with	7	SENT_636	[p30l2018t3483r2138b3548, p30l11t3593r235b3654],
17	of	IN	O	of	_	0	SENT_636	[p30l269t3590r354b3654],
18	treatment	NN	O	treatment	nn	19	SENT_636	[p30l377t3608r743b3654],
19	exposure	NN	O	exposure	prep_of	16	SENT_636	[p30l776t3613r1103b3676],
20	of	IN	O	of	_	0	SENT_636	[p30l1139t3590r1223b3654],
21	3.5	CD	DURATION	3.5	num	22	SENT_636	[p30l1246t3594r1349b3654],
22	years	NNS	NUMBER	year	prep_of	19	SENT_636	[p30l1384t3613r1584b3676],
23	.	.	O	.	_	0	SENT_636	[p30l1384t3613r1584b3676],

1	Genotyping	VBG	O	genotype	_	0	SENT_637	[p31l280t67r732b159],
2	In	IN	O	in	_	0	SENT_637	[p31l276t183r354b240],
3	brief	NN	O	brief	prep_in	6	SENT_637	[p31l382t177r570b256],
4	,	,	O	,	_	0	SENT_637	[p31l382t177r570b256],
5	we	PRP	O	we	nsubj	6	SENT_637	[p31l601t201r696b241],
6	extracted	VBD	O	extract	ccomp	1	SENT_637	[p31l728t177r1065b242],
7	genomic	JJ	O	genomic	amod	8	SENT_637	[p31l1095t180r1409b263],
8	DNA	NN	O	dna	dobj	6	SENT_637	[p31l1440t183r1632b241],
9	from	IN	O	from	_	0	SENT_637	[p31l1660t177r1842b241],
10	peripheral	JJ	O	peripheral	amod	13	SENT_637	[p31l1872t177r2138b264, p31l11t284r143b348],
11	white	JJ	O	white	amod	13	SENT_637	[p31l171t284r374b348],
12	blood	NN	O	blood	nn	13	SENT_637	[p31l403t284r618b349],
13	cells	NNS	O	cell	prep_from	6	SENT_637	[p31l648t284r801b348],
14	by	IN	O	by	_	0	SENT_637	[p31l831t284r918b370],
15	using	VBG	O	use	prepc_by	6	SENT_637	[p31l946t287r1148b370],
16	the	DT	O	the	det	21	SENT_637	[p31l1178t284r1292b348],
17	QiAmp	NN	O	qiamp	nn	21	SENT_637	[p31l1324t287r1591b370],
18	96	CD	NUMBER	96	num	21	SENT_637	[p31l1625t288r1709b348],
19	spin	NN	O	spin	nn	21	SENT_637	[p31l1742t287r1897b370],
20	blood	NN	O	blood	nn	21	SENT_637	[p31l1925t284r2141b349],
21	procedure	NN	O	procedure	nsubj	22	SENT_637	[p31l10t390r383b477],
22	(	CD	NUMBER	(	xcomp	15	SENT_637	[p31l451t391r758b477],
23	Qiagen	NNP	ORGANIZATION	Qiagen	nn	28	SENT_637	[p31l451t391r758b477],
24	,	,	O	,	_	0	SENT_637	[p31l451t391r758b477],
25	Chatsworth	NNP	LOCATION	Chatsworth	appos	28	SENT_637	[p31l826t391r1279b470],
26	,	,	O	,	_	0	SENT_637	[p31l826t391r1279b470],
27	CA	NNP	O	CA	appos	28	SENT_637	[p31l1347t391r1480b474],
28	)	NNP	O	)	dep	22	SENT_637	[p31l1347t391r1480b474],
29	and	CC	O	and	_	0	SENT_637	[p31l1549t390r1687b456],
30	performed	VBN	O	perform	conj_and	6	SENT_637	[p31l1751t390r2141b477],
31	genotyping	VBG	O	genotype	xcomp	30	SENT_637	[p31l11t501r429b585],
32	using	VBG	O	use	xcomp	31	SENT_637	[p31l468t501r671b585],
33	the	DT	O	the	det	35	SENT_637	[p31l711t498r826b562],
34	Taqman	NNP	O	Taqman	nn	35	SENT_637	[p31l864t504r1176b585],
35	Assay	NN	O	assay	dobj	32	SENT_637	[p31l1213t504r1420b585],
36	on	IN	O	on	_	0	SENT_637	[p31l1459t522r1553b562],
37	the	DT	O	the	det	39	SENT_637	[p31l1594t498r1709b562],
38	ABI	NNP	O	ABI	nn	39	SENT_637	[p31l1747t504r1885b562],
39	Prism	NN	O	prism	prep_on	32	SENT_637	[p31l1927t501r2140b562],

1	790OHT	NNP	O	790OHT	nn	4	SENT_638	[p31l13t640r318b699],
2	Sequence	NN	O	sequence	nn	4	SENT_638	[p31l347t640r690b721],
3	Detection	NN	O	detection	nn	4	SENT_638	[p31l722t637r1086b698],
4	System	NN	O	system	nsubj	5	SENT_638	[p31l1117t640r1378b721],
5	(	CD	NUMBER	(	_	0	SENT_638	[p31l1411t635r1533b717],
6	PE	NNP	ORGANIZATION	PE	nn	8	SENT_638	[p31l1411t635r1533b717],
7	Applied	NNP	ORGANIZATION	Applied	nn	8	SENT_638	[p31l1561t634r1853b721],
8	Biosystems	NNP	ORGANIZATION	Biosystems	dobj	5	SENT_638	[p31l1883t637r2138b721, p31l11t761r203b821],
9	,	,	O	,	_	0	SENT_638	[p31l1883t637r2138b721, p31l11t761r203b821],
10	Foster	NNP	LOCATION	Foster	nn	11	SENT_638	[p31l249t748r479b806],
11	City	NNP	LOCATION	City	appos	8	SENT_638	[p31l522t745r689b829],
12	,	,	O	,	_	0	SENT_638	[p31l522t745r689b829],
13	CA	NNP	LOCATION	CA	nn	14	SENT_638	[p31l735t742r869b825],
14	)	NNP	O	)	appos	8	SENT_638	[p31l735t742r869b825],
15	in	IN	O	in	_	0	SENT_638	[p31l916t745r988b805],
16	a	DT	O	a	det	17	SENT_638	[p31l1031t766r1070b806],
17	384	CD	NUMBER	384	prep_in	14	SENT_638	[p31l1112t742r1419b806],
18	—	RB	O	—	prep	5	SENT_638	[p31l1112t742r1419b806],
19	well	RB	O	well	advmod	18	SENT_638	[p31l1112t742r1419b806],
20	format	NN	O	format	pobj	18	SENT_638	[p31l1463t742r1733b806],
21	.	.	O	.	_	0	SENT_638	[p31l1463t742r1733b806],

1	We	PRP	O	we	nsubj	2	SENT_639	[p31l1777t748r1893b806],
2	genotyped	VBD	O	genotype	_	0	SENT_639	[p31l1937t766r2138b829, p31l11t849r215b936],
3	the	DT	O	the	det	6	SENT_639	[p31l258t849r372b913],
4	R144C	NN	O	r144c	nn	6	SENT_639	[p31l416t854r664b913],
5	(	NN	O	(	nn	6	SENT_639	[p31l712t849r791b932],
6	C	NN	O	c	dobj	2	SENT_639	[p31l712t849r791b932],
7	to	TO	O	to	_	0	SENT_639	[p31l837t868r908b913],
8	T	NN	O	t	nn	9	SENT_639	[p31l951t855r1007b912],
9	transition	NN	O	transition	prep_to	6	SENT_639	[p31l1049t852r1432b928],
10	;	:	O	;	_	0	SENT_639	[p31l1049t852r1432b928],
11	SNP	NN	O	snp	nn	15	SENT_639	[p31l1478t854r1639b913],
12	database	NN	O	database	nn	15	SENT_639	[p31l1683t849r2002b914],
13	ID	NN	O	id	nn	15	SENT_639	[p31l2044t855r2137b912],
14	rs1799853	NN	O	rs1799853	nn	15	SENT_639	[p31l11t956r421b1039],
15	)	NN	O	)	dep	6	SENT_639	[p31l11t956r421b1039],
16	and	CC	O	and	_	0	SENT_639	[p31l450t956r588b1021],
17	I359L	NN	O	i359l	nn	19	SENT_639	[p31l610t960r825b1021],
18	(	NN	O	(	nn	19	SENT_639	[p31l852t956r931b1039],
19	A	NN	O	a	dep	6	SENT_639	[p31l852t956r931b1039],
20	to	TO	O	to	_	0	SENT_639	[p31l955t974r1027b1020],
21	C	NN	O	c	prep_to	15	SENT_639	[p31l1055t961r1107b1020],
22	transversiong	JJ	O	transversiong	amod	29	SENT_639	[p31l1134t958r1606b1035],
23	SN	NN	O	sn	nn	29	SENT_639	[p31l1634t961r1746b1020],
24	P	NN	O	p	nn	29	SENT_639	[p31l1750t961r1795b1019],
25	database	NN	O	database	nn	29	SENT_639	[p31l1820t956r2139b1021],
26	ID	NN	O	id	nn	29	SENT_639	[p31l9t1068r102b1126],
27	rs1057910	NN	O	rs1057910	nn	29	SENT_639	[p31l165t1063r574b1146],
28	)	CD	NUMBER	)	num	29	SENT_639	[p31l165t1063r574b1146],
29	polymorphisms	NNS	O	polymorphism	tmod	2	SENT_639	[p31l637t1063r1219b1149],
30	of	IN	O	of	_	0	SENT_639	[p31l1280t1063r1365b1126],
31	the	DT	O	the	det	33	SENT_639	[p31l1413t1063r1527b1126],
32	CYPZC9	NN	O	cypzc9	nn	33	SENT_639	[p31l1589t1068r1891b1127],
33	gene	NN	O	gene	prep_of	29	SENT_639	[p31l1953t1086r2136b1149],
34	.	.	O	.	_	0	SENT_639	[p31l1953t1086r2136b1149],

1	Primer	NN	O	primer	nn	4	SENT_640	[p31l10t1173r261b1234],
2	and	CC	O	and	_	0	SENT_640	[p31l300t1170r438b1236],
3	probe	NN	O	probe	nn	4	SENT_640	[p31l477t1170r689b1257],
4	sequences	NNS	O	sequence	nsubjpass	8	SENT_640	[p31l730t1194r1094b1257],
5	have	VBP	O	have	aux	8	SENT_640	[p31l1136t1170r1301b1234],
6	been	VBN	O	be	auxpass	8	SENT_640	[p31l1340t1170r1512b1234],
7	previously	RB	DATE	previously	advmod	8	SENT_640	[p31l1552t1170r1932b1257],
8	published	VBN	O	publish	_	0	SENT_640	[p31l1970t1170r2138b1257, p31l10t1276r275b1343],
9	.1	NN	NUMBER	.1	dobj	8	SENT_640	[p31l1970t1170r2138b1257, p31l10t1276r275b1343],

1	Reference	NNP	O	Reference	_	0	SENT_641	[p31l280t1503r659b1563],

1	1	LS	NUMBER	1	_	0	SENT_642	[p31l13t1611r66b1661],
2	.	.	O	.	_	0	SENT_642	[p31l13t1611r66b1661],

1	Chan	NNP	PERSON	Chan	nn	2	SENT_643	[p31l110t1611r262b1661],
2	AT	NNP	O	AT	_	0	SENT_643	[p31l289t1611r379b1670],
3	,	,	O	,	_	0	SENT_643	[p31l289t1611r379b1670],
4	Tranah	NNP	O	Tranah	nn	5	SENT_643	[p31l407t1611r614b1661],
5	GJ	NNP	O	GJ	appos	2	SENT_643	[p31l644t1611r731b1670],
6	,	,	O	,	_	0	SENT_643	[p31l644t1611r731b1670],
7	Giovannucci	NNP	PERSON	Giovannucci	nn	8	SENT_643	[p31l762t1611r1126b1661],
8	EL	NNP	O	EL	appos	2	SENT_643	[p31l1159t1611r1244b1670],
9	,	,	O	,	_	0	SENT_643	[p31l1159t1611r1244b1670],
10	et	FW	O	et	nn	11	SENT_643	[p31l1274t1614r1333b1661],
11	al.	FW	O	al.	appos	2	SENT_643	[p31l1358t1611r1425b1661],
12	.	.	O	.	_	0	SENT_643	[p31l1358t1611r1425b1661],

1	A	DT	O	a	det	3	SENT_644	[p31l1454t1611r1493b1661],
2	prospective	JJ	O	prospective	amod	3	SENT_644	[p31l1520t1611r1869b1672],
3	study	NN	O	study	_	0	SENT_644	[p31l1896t1611r2060b1673],
4	of	IN	O	of	_	0	SENT_644	[p31l2084t1611r2144b1661],
5	genetic	JJ	O	genetic	amod	6	SENT_644	[p31l108t1701r329b1764],
6	polymorphisms	NNS	O	polymorphism	prep_of	3	SENT_644	[p31l360t1701r821b1764],
7	in	IN	O	in	_	0	SENT_644	[p31l852t1701r898b1751],
8	the	DT	O	the	det	12	SENT_644	[p31l925t1701r1022b1751],
9	cytochrome	NN	O	cytochrome	nn	12	SENT_644	[p31l1050t1701r1400b1764],
10	P450	NN	O	p450	nn	12	SENT_644	[p31l1431t1701r1592b1751],
11	2C9	NN	O	2c9	nn	12	SENT_644	[p31l1621t1701r1744b1751],
12	enzyme	NN	O	enzyme	prep_in	3	SENT_644	[p31l1772t1713r2000b1764],
13	and	CC	O	and	_	0	SENT_644	[p31l2029t1701r2137b1751],
14	the	DT	O	the	det	15	SENT_644	[p31l107t1791r204b1841],
15	risk	NN	O	risk	conj_and	12	SENT_644	[p31l237t1791r343b1841],
16	of	IN	O	of	_	0	SENT_644	[p31l372t1791r431b1841],
17	distal	JJ	O	distal	amod	19	SENT_644	[p31l457t1791r619b1841],
18	colorectal	JJ	O	colorectal	amod	19	SENT_644	[p31l652t1791r946b1841],
19	adenoma	NN	O	adenoma	prep_of	3	SENT_644	[p31l981t1791r1281b1841],
20	.	.	O	.	_	0	SENT_644	[p31l981t1791r1281b1841],

1	Clin	NNP	O	Clin	nn	3	SENT_645	[p31l1315t1791r1424b1841],
2	Gastroenterol	NNP	O	Gastroenterol	nn	3	SENT_645	[p31l1457t1791r1871b1841],
3	Hepatol	NNP	O	Hepatol	_	0	SENT_645	[p31l1907t1791r2136b1853],
4	2004	CD	DATE	2004	num	3	SENT_645	[p31l111t1881r678b1939],
5	;	:	O	;	_	0	SENT_645	[p31l111t1881r678b1939],
6	2:704	CD	NUMBER	2:704	num	7	SENT_645	[p31l111t1881r678b1939],
7	—	NN	O	—	dep	3	SENT_645	[p31l111t1881r678b1939],
8	712	CD	NUMBER	712	dep	7	SENT_645	[p31l111t1881r678b1939],
9	.	.	O	.	_	0	SENT_645	[p31l111t1881r678b1939],

